<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns:mv="http://macVmlSchemaUri" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=macintosh">
<style>
<!--
 /* Style Definitions */
body,p,ol,li
  {text-align: left;}
span.Section
  {font-size:24pt;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
</head>

<body lang=EN-US link=blue vlink=purple>

<div align=center>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span>Clinical</span></p>

<p style="text-align:center;"><span>Transitions </span></p>

<p style="text-align:center;"><span>2014</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section">Rheumatology,</span></p>

<p style="text-align:center;"><span
class="Section">Allergy, </span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Immunology</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>A 22-year-old man is brought
to the emergency room after being stung by several wasps. He is confused and
short of breath. His temperature is 100.4<sup>o</sup>F, pulse is 120/minute,
blood pressure is 85/55 mm Hg, and respirations are 30/minute. He has hives on
his back, wheezing over the posterior lung fields, and pitting edema of the
ankles. Intravenous access is obtained and 0.9% saline is administered. Which
of the following medicines should be administered next? </p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Furosemide</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Propranolol</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Nifedipine</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Lisinopril</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Atropine</p>

<p><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span>Epinephrine</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Anaphylaxis is an acute
multiorgan system reaction, potentially fatal, caused by the release of
chemical mediators from mast cells and basophils. The classic form involves
prior sensitization to an allergen with later re-exposure, producing symptoms
via an immunologic mechanism. The most common organ systems involved include
the cutaneous, respiratory, cardiovascular, and gastrointestinal systems. The
full-blown syndrome includes urticaria (hives) and/or angioedema with
hypotension and bronchospasm.<span >&nbsp; </span></p>

<p></p>

<p>Traditionally, the term
“anaphylaxis” is reserved for reactions mediated by immunoglobulin E (IgE), and
the term “anaphylactoid” is reserved for IgE-independent events (which are
clinically indistinguishable). Anaphylaxis is a type I hypersensitivity response.
IgE production requires the secretion of cytokines from T<sub>H</sub>2 cells.
These cytokines induce B cells to switch antibody production to the IgE
class.<span >&nbsp; </span>The IgE binds to Fc&#61541;
receptors on mast cells. When the antigen-binding region of IgE is cross-linked
by allergens, mast cell degranulation occurs, resulting in anaphylaxis.<span>&nbsp;&nbsp;&nbsp; </span></p>

<p></p>

<p>The physiologic responses to
the release of anaphylaxis mediators include smooth muscle spasm in the
respiratory and gastrointestinal (GI) tracts, vasodilation, increased vascular
permeability, and stimulation of sensory nerve endings. Increased mucous
secretion and increased bronchial smooth muscle tone, as well as airway edema,
contribute to the respiratory symptoms. Cardiovascular effects result from
decreased vascular tone and capillary leakage. Hypotension, cardiac
arrhythmias, syncope, and shock may result from intravascular volume loss,
vasodilation, and myocardial dysfunction. These physiologic events lead to some
or all of the classic symptoms of anaphylaxis: flushing; urticaria/angioedema;
pruritus; bronchospasm; laryngeal edema; abdominal cramping with nausea,
vomiting, and diarrhea; and feeling of impending doom. </p>

<p></p>

<p>Anaphylaxis is a medical
emergency that requires immediate recognition and intervention. Patients should
receive high-flow oxygen, cardiac monitoring, and intravenous access.
Epinephrine maintains blood pressure, antagonizes the effects of the released mediators,
and inhibits further release of mediators. Use of epinephrine for anaphylaxis
has no absolute contraindications. It is the drug of choice and it is usually
well tolerated and potentially lifesaving. Anaphylactic deaths correlate with
delayed administration of epinephrine. The initial dose can be repeated as
necessary, depending on the response. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer F is correct</b>. The presence of hypotension, tachycardia,
hives, and bronchospasm after a wasp sting suggests anaphylaxis. Epinephrine is
the drug of choice.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 35-year-old woman with a history of systemic lupus
erythematosus (SLE) is admitted to the hospital with left upper and lower
extremity weakness. Head CT reveals an ischemic stroke in the right middle
cerebral artery distribution.<span >&nbsp; </span>Labs
reveal thrombocytopenia and a prolonged aPTT.<span>&nbsp; </span>Her husband reports that she had several
miscarriages in the second trimester and a deep vein thrombosis several years
ago.<span >&nbsp; </span>What is the most likely cause
of her stroke?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Bacterial
     endocarditis</span></li>
 <li><span>Atherosclerotic
     disease</span></li>
 <li><span>Antiphospholipid
     syndrome</span></li>
 <li><span>Vasculitis
     of the central nervous system</span></li>
 <li><span>Cocaine
     use</span></li>
 <li><span>Sepsis</span></li>
</ol>

<span><br clear=all>
</span>

<p>Antiphospholipid syndrome
(APS) is a disorder of coagulation that causes thrombosis in arteries and
veins, as well as pregnancy-related complications such as miscarriage,
stillbirth, preterm delivery, and severe preeclampsia. The most common venous
event is deep vein thrombosis of the lower extremities; the most common
arterial event is stroke. Other common findings include thrombocytopenia,
livedo reticularis, and elevated aPTT. (The elevated aPTT indicates the
presence of lupus anticoagulant or anti-cardiolipin antibodies, which interfere
with phospholipids in the aPTT assay.) Antiphospholipid syndrome is characterized
by autoimmune production of antibodies against phospholipids, such as
cardiolipin and &#946;<sub>2</sub> glycoprotein I. The antibodies interfere
with the anti-thrombotic effects of phospholipids. Primary antiphospholipid
syndrome occurs in the absence of other related disease. Secondary
antiphospholipid syndrome occurs in conjunction with other autoimmune diseases,
particularly systemic lupus erythematosus (SLE). Antiphospholipid syndrome is
typically treated with heparin, warfarin, and antiplatelet agents.<span>&nbsp; </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. The most likely cause of stroke is antiphospholipid
syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Bacterial endocarditis can cause stroke through septic
embolization. This patient does not describe fever or chills. No mention is
made of a heart murmur or findings suggestive of peripheral embolization (e.g.,
Roth spots, Osler nodes, Janeway lesions, splinter hemorrhages.) Bacterial
endocarditis is more likely to cause thrombocytosis than thrombocytopenia and
would not explain the history of miscarriages.</span></p>

<p><span></span></p>

<p><b>Answer B is incorrect</b>.
Risk factors for stroke due to atherosclerosis include advanced age, smoking,
diabetes, hypertension, hyperlipidemia, and family history of atherosclerotic
disease. </p>

<p></p>

<p><b>Answer D is incorrect</b>.
Systemic lupus erythematosus is associated with CNS vasculitis, which can cause
stroke. In this patient, the history of deep vein thrombosis and multiple
miscarriages and the presence of thrombocytopenia and an elevated aPTT is more
consistent with antiphospholipid syndrome.</p>

<p></p>

<p><b>Answer E is incorrect</b>.
Cocaine can cause stroke, but it would not explain the other findings in this
patient. </p>

<p></p>

<p><b>Answer F is incorrect</b>.
Sepsis can result in stroke and multi-organ failure. This patient has no
symptoms or signs of systemic infection. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year-old man presents to the clinic with fever, cough,
and night sweats of one-month duration. He is fatigued and has lost eight
pounds unintentionally.<span >&nbsp; </span>His medical
history is significant for ankylosing spondylitis for which he takes
methotrexate and infliximab. Which of the following most likely explains his
symptoms?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Congestive heart failure</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Interstitial lung disease</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bronchogenic carcinoma</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Tuberculosis </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Methotrexate-induced lung injury</span></p>

<span><br
clear=all>
</span>

<p><span></span></p>

<p><b><span>Infliximab</span></b><span>is a chimeric<span
 antibody<span
 tumour necrosis factor alpha
(TNF-&#945;) used to treat<span It is approved for the
treatment of<span disease,<span
 spondylitis,<span
 arthritis, rheumatoid
arthritis, and<span colitis.
Infliximab works by binding to TNF-&#945;. TNF-&#945; is a chemical messenger (cytokine)
and a key part of the autoimmune reaction. In rheumatoid arthritis, infliximab
seems to work by preventing TNF-&#945; from binding to its<span
 the cell. Infliximab is an
artificial<span It was
originally developed in mice as a mouse antibody. Because humans have immune
reactions to mouse proteins, the mouse common domains were replaced with
similar human antibody domains. Because the antibodies were produced from one
cell grown into a clone of identical cells, it is called a<span
 antibody. Furthermore, as a
combination of mouse and human antibody amino acid sequences, it is called a
chimeric monoclonal antibody.</span></p>

<p><span></span></p>

<p><span>In the United States, Infliximab can cost $19,000 to
$22,000 a year per patient wholesale.</span></p>

<p><span></span></p>

<p><span>Other monoclonal antibodies targeting TNF-&#945; are<span
 and<span
 pegol<span
 binds and inhibits the action of
TNF-&#945;, but is not a monoclonal antibody. (It is instead a fusion of<span
 an<span
 constant region.) Infliximab
is administered by<span typically at six- to eight-week intervals, at a clinic or hospital.
It cannot be administered<span the digestive system<span
 destroy the drug.</span></p>

<p><span></span></p>

<p><span>Infliximab is a significant risk factor for reactivation of
latent tuberculosis, as well as for development of other serious infections
like aspergillosis, blastomycosis, candidiasis, coccidioidomycosis,
histoplasmosis, and pneumocystosis. Anti-TNF&#945; therapy also increases the
risk of lymphoma, heart failure, drug-induced lupus, and blood disorders
(leukopenia, neutropenia, thrombocytopenia).</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Active tuberculosis most likely explains the patient’s
fever, cough, night sweats, and weight loss.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.</span></b><span> Ankylosing spondylitis is associated with aortic
insufficiency, and anti-TNF&#945; therapy is associated with worsening heart
failure, but this patient does not have symptoms of heart failure, such as
shortness of breath and leg swelling. Fever and night sweats are not
characteristic of heart failure. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Ankylosing spondylitis increases the risk of interstitial
lung disease, which is usually mild and associated with apical fibrosis. This
patient does not have typical symptoms of interstitial lung disease, such as
exertional dyspnea. Weight loss and night sweats are not characteristic of
interstitial lung disease. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Anti-TNF therapy increases the risk of lymphoma, but not
bronchogenic carcinoma.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Methotrexate-induced lung injury is usually dose-related
and reversible with discontinuation of the medicine. Symptoms include fatigue,
dry cough, and shortness of breath. Fever, night sweats, and weight loss are
not typical of methotrexate-induced lung injury.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 68-year-old woman has a 6-month history severe pain and
swelling of the metacarpophalangeal joints, wrists, elbows, and knees. Previous
treatment with ibuprofen and methotrexate did not relieve symptoms. The serum
creatinine level is 2.6 mg/dL and the rheumatoid factor level is increased.
Which of the following is the most appropriate treatment? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acetaminophen</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Indomethacin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Colchicine</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Gold salts</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Etanercept</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>This patient has rheumatoid
arthritis, as indicated by the pattern of synovitis and the elevated rheumatoid
factor level. DMARDs (disease-modifying anti-rheumatic drugs) represent the
most important measure in the successful treatment of rheumatoid arthritis.
These agents can retard or prevent disease progression and reduce joint
destruction and loss of function. Consequently, early therapy with DMARDs is
the standard of care for treating rheumatoid arthritis. </p>

<p></p>

<p>DMARDs can be classified
into xenobiotic and biologic agents. The xenobiotic agents include gold salts,
D-penicillamine, chloroquine and hydroxychloroquine, sulfasalazine,
methotrexate, azathioprine, and cyclosporin A. Injectable gold salts and
D-penicillamine rarely induce sustained remission and have largely been
supplanted by more effective agents. Methotrexate and sulfasalazine are the
most active compounds and provide the best risk-benefit ratios. </p>

<p>Methotrexate (alone or in
combination with other agents) has become the standard of care for moderate to
severe RA. </p>

<p></p>

<p><span>“Biologic” agents have been developed to block tumor
necrosis factor (TNF)-alpha and interleukin-1, proinflammatory cytokines that
are important in the pathogenesis of rheumatoid arthritis. These agents improve
symptoms and significantly retard progression of joint erosions. TNF blockers
include etanercept, infliximab, and adalimumab. Most patients receiving TNF
blockers have a significant response to treatment.</span></p>

<p><span></span></p>

<p><span>Adverse effects of these agents include development of
infection, including reactivation of tuberculosis. Thoroughly searching for
latent tuberculosis using chest radiography and/or purified protein derivative
(PPD) testing is recommended before these agents are started. Rarely,
demyelinating disorders, bone marrow suppression, and formation of
auto-antibodies occur. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E
is correct. </span></b><span>Etanercept is a biologic agent and a
DMARD. It would be an appropriate choice in a patient with active rheumatoid
arthritis who has failed methotrexate therapy. </span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect. </span></b><span>Acetaminophen is not a DMARD and would
not slow disease progression.</span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect.</span></b><span> Indomethacin is a non-steroidal
anti-inflammatory drug (NSAID). NSAIDs are not DMARDS and would not be expected
to slow disease progression. Also, NSAIDs should not be used in patients with
renal insufficiency.</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect. </span></b><span>Colchicine is used to treat gout, not
rheumatoid arthritis. The likelihood of toxicity is increased in patients with
renal insufficiency. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Gold salts have been largely replaced
by more effective agents for treatment of rheumatoid arthritis. They should not
be used in patients with renal insufficiency, as they can cause renal disease. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 34-year-old man with peptic ulcer disease suddenly
develops pain, redness, and swelling of his right first metatarsophalanegal
joint. There is no history of injury. The serum uric acid level is 8 mg/dL.
Examination of the joint aspirate shows negatively birefringent crystals. Which
of the following drugs is most appropriate to treat the acute symptoms in this
patient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Colchicine</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Allopurinol</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Probenecid</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Sulfinpyrazone</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Morphine</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Gout is a common disorder of uric acid metabolism that can
lead to deposition of monosodium urate (MSU) crystals in soft tissue, recurrent
episodes of debilitating joint inflammation, and, if untreated, joint
destruction and renal damage. Gout is definitively diagnosed by demonstration
of urate crystals in aspirated synovial fluid. </span></p>

<p><span></span></p>

<p>Acute monoarticular
arthritis is the initial presentation in 90% of patients. Podagra, inflammation
of the first metatarsophalangeal joint, is the initial joint manifestation in
50% of cases (Figure 1). The attack begins abruptly and reaches maximum
intensity within 8-12 hours. The joint is red, hot, and exquisitely tender;
even a bed sheet on the swollen joint is uncomfortable. Untreated, the first
attack resolves spontaneously in less than 2 weeks. Acute flares of gout can be
precipitated by events that raise serum uric acid levels, such as consumption
of beer or liquor, overconsumption of high-purine foods, trauma, hemorrhage,
dehydration, or the use of medications that raise uric acid levels (e.g.,
thiazide diuretics). </p>

<p></p>

<p>Patients with gout are much
more likely to develop renal stones than are healthy individuals (by a factor
of 1000). Although patients with gout often have other risk factors for renal
disease (e.g., hypertension and diabetes), chronic urate nephropathy can itself
contribute to renal insufficiency. Although gout typically causes joint
inflammation, it can also cause inflammation of bursae and tendons. Tophi are
collections of urate crystals in the soft tissues. They can develop in patients
with untreated gout and may appear as lumps or nodules. While the classic
location of tophi is along the helix of the ear, they can be found in other
locations, such as the fingers, toes, and olecranon bursae.</p>

<p></p>

<p>Gout is managed in three
stages: (1) treating the acute attack, (2) providing prophylaxis to prevent
acute flares, and (3) lowering excess stores of urate to prevent gouty flares
and tissue deposition of urate crystals. Options for treating <i>acute</i> gout include nonsteroidal
anti-inflammatory drugs (NSAIDs), colchicine, and corticosteroids. NSAIDs are
the drugs of choice in most patients<i>. </i></p>

<p><i></i></p>

<p><i>Long-term</i> management of gout focuses on lowering uric acid levels.
(The goal of therapy is to lower serum uric acid levels to approximately 6
mg/dL or less.) Agents that lower uric acid levels should not be initiated
during an acute attack, as they may intensify and prolong the attack.
Typically, they should be started a few weeks after the attack has resolved and
with the protection of prophylactic colchicine to prevent another attack. </p>

<p></p>

<p>Medicines available for <i>chronic</i> management of gout include
allopurinol and febuxostat, which reduce uric acid production by inhibiting the
enzyme, xanthine oxidase; and probenecid and sulfinpyrzone, which enhance uric
acid excretion by the kidney. </p>

<p></p>

<p style="text-align:center;"><a href="file://localhost/javascript/refimgshow(1)"><span><img border=0 width=152 height=106
src="_%20Tutorials_files/image002.png"
alt="Description: Gout. Acute podagra due to gout in an elderly man." v:shapes="Picture_x0020_12"></span></a><span></span></p>

<p style="text-align:center;"><span>Gout: Podagra</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/a/ac/Fluorescent_uric_acid.JPG"><span><img border=0 width=238 height=179
src="_%20Tutorials_files/image004.png"
alt="Description: File:Fluorescent uric acid.JPG" v:shapes="Picture_x0020_11"></span></a><span></span></p>

<p style="text-align:center;"><span>Gout: Needle-like
crystals under polarized light</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is
correct</span></b><span>. Colchicine can be used in the
treatment of an acute gouty flare. It is an acceptable option in a patient with
peptic ulcer disease in whom NSAIDs should be avoided. </span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. Allopurinol can be used in the
long-term management of gout. It lowers serum uric acid levels by inhibiting
the enzyme, xanthine oxidase. It is not useful in the treatment of an acute
gouty flare. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Probenecid can be used in the
long-term management of gout. It enhances renal excretion of uric acid. It is
not useful in the treatment of an acute gouty flare. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Sulfinpyrazone can be used in the
long-term management of gout. It enhances renal excretion of uric acid. It is
not useful in the treatment of an acute gouty flare. </span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Morphine is an excellent analgesic
medicine, but it does not have anti-inflammatory properties, and its potential
for abuse makes it an unsatisfactory choice in the treatment of an acute gouty
flare. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 3-year-old girl is brought to clinic because she refuses
to walk and has stopped playing. Three weeks ago her parents noticed that her
right knee was swollen and that she was standing with her knee flexed. There is
no history of injury. Examination shows synovitis, decreased range of motion,
and a flexion contracture of the right knee. Rheumatoid factor is negative and
ANA is positive at 1:80. Which of the following statements is false?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>ANA+ juvenile idiopathic arthritis of
the oligoarthritis subtype is the most common form of childhood arthritis. </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Uveitis is likely to occur in up to
half of oligoarthritis juvenile idiopathic arthritis. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA-positivity strongly predicts
children at risk for asymptomatic uveitis. </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Nearly all juvenile oligoarthritis
patients will go on to have disabling disease. </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rheumatoid factor is usually negative
in juvenile idiopathic oligoarthritis. </span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>This patient has juvenile idiopathic arthritis (JIA) of the
oligoarthritis subtype. Juvenile idiopathic arthritis is the most common form
of arthritis in children. It affects girls more than boys (4:1), typically in
the 1-5 year age range. Three subtypes exist: oligoarticular, polyarticular,
and systemic. The oligoarticular type is the most common. All children in this
subtype are rheumatoid factor-negative. 50% will only have only one knee
involved. 30-50% develop asymptomatic uveitis. ANA-positivity correlates with
increased risk of eye disease. ANA-positive children should have eye exams
every three months to look for asymptomatic uveitis. The arthritis usually
resolves with time, resulting in little or no disease in adulthood. Treatment
includes NSAIDS, intraarticular glucocorticoids, and aggressive physical
therapy to prevent contractures. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is correct. </span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is True</span></b><span>: Juvenile idiopathic arthritis of the
oligoarthritis subtype is the most common form of childhood arthritis.<span>&nbsp; </span><b><span>&nbsp;</span></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is True</span></b><span>: Uveitis is likely to occur in up to
half of oligoarthritis juvenile idiopathic arthritis.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C
is True</span></b><span>: ANA-positivity predicts children at
risk for asymptomatic uveitis. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is False</span></b><span>: It is <i>not</i> true that nearly all children with JIA, oligoarthritis subtype,
will go on to have disabling adult disease. In fact, most children improve with
little or no residual disease as adults.</span></p>

<p><span></span></p>

<p><b><span>Answer E
is True</span></b><span>: Rheumatoid factor is usually negative
in juvenile idiopathic oligoarthritis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 45-year-old woman presents with a 3-month history of
fatigue and painful joints. Her hands, feet, ankles, wrists, and elbows are
very stiff in the morning and improve with activity.<span>&nbsp; </span>She is taking naproxen 500 mg twice
daily with minimal improvement.<span >&nbsp;
</span>Exam shows bilateral synovitis of the metacarpophalangeal joints,
proximal interphalangeal joints, wrists, ankles, elbows, and
metatarsophalangeal joints.<span >&nbsp; </span>You
suspect rheumatoid arthritis. Which of the following serological tests would
best correlate with aggressive, erosive disease accompanied by extra-articular
manifestations?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>RF 1:80; anti-cyclic citrullinated
peptide (anti-CCP) negative</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>RF negative; anti-CCP negative</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>RF negative; anti-CCP positive at 42</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>RF 1:1280; anti-CCP positive at 220</span></p>

<span><br
clear=all>
</span>

<p><span></span></p>

<p><span>Rheumatoid arthritis (RA) is a
chronic, systemic, inflammatory disorder of unknown cause. It is characterized
by symmetrical, polyarticular pain and swelling, morning stiffness, and
fatigue. RA has a variable course, often with periods of exacerbations and,
less frequently, true remissions. Outcomes are also variable, ranging from the
rarely seen remitting disease to severe disease that brings disability and
even, in some patients, premature death. Without treatment, the majority of
patients will experience progressive joint damage. In some patients this
results in significant disability within just a few years. The past decade has
seen an unprecedented change in the treatment paradigm for this disease.
Several targeted biologic therapies are available; the most notable are the
anti-tumor necrosis factor (TNF) therapies.</span></p>

<table border=0 cellspacing=8 cellpadding=0 width="100%">
 <tr>
  <td width="96%">
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><b><span>Clinical Features</span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P079010></a><span>RA is a symmetrical
    polyarthritis typically involving the small joints of the hands and feet,
    the wrists, and the ankles. Other joints frequently involved include the
    cervical spine, shoulders, elbows, hips, and knees. Any diarthrodial
    (synovial) joint may be involved, including the apophyseal,
    temporomandibular, and cricoarytenoid joints. Involved joints are swollen,
    warm, and tender, and they may have effusions. The synovium, normally a few
    cell layers thick, becomes palpable on examination&nbsp;<i>(synovitis).</i>&nbsp;Prolonged&nbsp;<i>morning
    stiffness,</i>&nbsp;usually lasting more than 1 hour and often many hours,
    is a classic feature in RA, and symptoms are generally improved with
    moderate activity.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P079011></a><span>Over time, RA
    progresses to joint destruction and deformity. Erosive lesions of bone and
    cartilage are radiographically and pathologically visible at the margins of
    bone and cartilage, the site of synovial attachment.&nbsp;<i>Tenosynovitis,</i>&nbsp;or
    inflammation of tendon sheaths, leads to tendon malalignment, stretching,
    and/or shortening. Among common deformities are ulnar deviation at the
    metacarpophalangeal joints and volar subluxation at these joints, volar
    subluxation at the wrists, and flexion and extension contractures in the
    proximal and distal interphalangeal (DIP) joints of the fingers that lead
    to characteristic<i>swan-neck deformity</i>&nbsp;(flexion contracture at
    the DIP joint and hyperextension at the proximal interphalangeal joint)
    or&nbsp;<i>boutonnière deformity</i>&nbsp;(flexion contracture at the
    proximal interphalangeal joint and hyperextension at the DIP joint).
    Erosions of the ulnar styloid can lead to sharp bony prominences and
    rupture of extensor tendons. Synovitis at the wrists can lead to median
    nerve compression and carpal tunnel syndrome. Cervical spine disease may
    lead to C1-C2 subluxation and spinal cord compression; caution should be
    taken in moving the neck when the patient is being anesthetized for a
    surgical procedure. The degree of subluxation can be monitored by looking
    at the distance between C1 and the odontoid in flexion-extension films.
    Rupture of synovial fluid from the knee into the calf (Baker cyst) may
    mimic deep-venous thrombosis or, occasionally, cellulitis.</span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><span></span></p>
  <p><a name=F079001></a><span></span></p>
  <p><a name=P079012></a><a name=T079002></a><span></span></p>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width=324>
   <tr>
    <td width="100%">
    <p style="text-align:center;"><b><span>Characteristics of Rheumatoid Arthritis</span></b></p>
    </td>
   </tr>
  </table>
  <p><a name=T079002.850></a><a name=T079002.800></a><a name=T079002.750></a><a
  name=T079002.700></a><a name=T079002.650></a><a name=T079002.600></a><a
  name=T079002.550></a><a name=T079002.500></a><a name=T079002.450></a><a
  name=T079002.400></a><a name=T079002.350></a><a name=T079002.300></a><a
  name=T079002.250></a><a name=T079002.200></a><a name=T079002.150></a><a
  name=T079002.100></a><a name=T079002.50></a><span></span></p>
  <div align=center>
  <table border=1 cellspacing=0 cellpadding=0 width=344>
   <tr>
    <td valign=top>
    <p><b><span>Articular</span></b><span></span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Morning
    stiffness, &quot;gelling&quot;</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Symmetrical
    joint swelling</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Predilection
    for wrists and proximal interphalangeal, metacarpophalangeal, and
    metatarsophalangeal joints</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Erosions
    of bone and cartilage</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Joint
    subluxation and ulnar deviation</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Inflammatory
    joint fluid</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Carpal
    tunnel syndrome</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Baker
    cyst</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><b><span>Nonarticular</span></b><span></span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Rheumatoid
    nodules: subcutaneous, pulmonary, scleral</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Lung
    disease</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Vasculitis,
    especially skin, and peripheral nerves</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Pleuropericarditis</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Scleritis
    and episcleritis</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Leg
    ulcers</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Felty
    syndrome</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="90%">
   <tr>
    <td width="100%"><a
    name=""></a></td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P079013></a><span></span></p>
    <p><span>The clinical course and severity of the arthritis are
    variable. Some patients have mild, slowly progressive disease with few
    deformities and little bony destructive change. At the opposite extreme are
    patients who have a rapidly progressive course that, if left untreated,
    leads to crippling and deforming arthritis. Most patients fall in between
    these extremes with various levels of disability; some have a waxing and
    waning course over a period of years with acute episodes of single- or
    multiple-joint exacerbations.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P079014></a><span>RA is a systemic
    disease with constitutional symptoms: fatigue, low-grade fever, weight
    loss, and myalgia. Anemia is also common. Specific organs other than the musculoskeletal
    system may be involved. Grossly palpable subcutaneous&nbsp;<i>rheumatoid
    nodules</i>&nbsp;can occur almost anywhere but are common along other
    extensor tendon surfaces, especially at the elbows, and less commonly in
    the lungs, pleura, pericardium, sclerae, and other sites, including the
    heart in rare cases. The occurrence of multiple pulmonary nodules in
    patients with RA and pneumoconiosis is known as&nbsp;<i>Caplan syndrome.</i>&nbsp;Pleuritis,
    pericarditis, and interstitial lung fibrosis occur in a few patients;
    pericarditis can be severe, and acute interstitial lung disease can be
    associated with pulmonary hemorrhage. Vasculitis, associated with
    circulating complexes of immunoglobulin G (IgG) and rheumatoid factor (RF),
    leads to cutaneous lesions, including ulcers and skin necrosis, and
    mononeuritis multiplex. Secondary<i>Sjögren syndrome</i>&nbsp;(sicca complex)
    is often present.&nbsp;<i>Felty syndrome </i>(splenomegaly, leukopenia, and
    recurrent pulmonary infections) is a rare complication and is often
    accompanied by leg ulcers and vasculitis. Extra-articular manifestations of
    RA are more commonly seen among patients who test positive for RF. Even in
    patients without vasculitis or pulmonary or pleuropericardial disease, the
    mortality rate in RA is increased by a variety of causes, including side effects
    of therapy and infection. Premature and accelerated atherosclerosis is an
    increasingly recognized problem among patients with RA and is thought, at
    least, to be partially a result of the effects of chronic inflammation.</span></p>
    </td>
   </tr>
  </table>
  </td>
 </tr>
</table>

<p><span>Rheumatoid arthritis (RA) is the most common inflammatory
arthritis. It affects women 2.5 times more than men. It can occur at any age
but has a peak incidence in the fourth and fifth decades of life. It is
associated with autoantibodies including rheumatoid factor (RF) and anti-cyclic
citrullinated peptide (CCP) antibodies. High titers of RF and anti-CCP predict
aggressive erosive disease with more extra-articular manifestations (rheumatoid
nodules, pulmonary involvement, eye disease, Felty’s syndrome, pericarditis,
myositis, and vasculitis).</span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span>RF is found in 75-85% of patients with rheumatoid arthritis.
RF is an antibody directed against the Fc portion of other antibodies. Low
levels of RF are found in hepatitis C with cryoglobulinemia, subacute
endocarditis, and primary biliary cirrhosis. Anti-cyclic citrullinated peptide
antibodies (anti-CCP) are found in nearly 70% of patients with rheumatoid
arthritis.<span >&nbsp; </span>They are detectable in
about 35% of patients who are RF-negative, and may precede the diagnosis of
rheumatoid arthritis by as many at 10 years.<span>&nbsp; </span>Citrullination occurs when arginine
residues on proteins (typically vimentin or fillagrin) are deiminated by the
enzyme peptidylarginine deiminase. The modified proteins become more antigenic,
leading to autoantibody formation. Anti-CCP antibodies are highly specific for
rheumatoid arthritis (95%) but low levels can be seen in 10% of patients with
psoriatic arthritis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct. </span></b><span>Patients with high titres of
rheumatoid factor and anti-CCP are most likely to have aggressive disease. </span><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Patients with low-titer RF and no anti-CCP are at low risk
for aggressive disease.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Patients with seronegative rheumatoid arthritis are likely
to have mild disease.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Patients with low-titer anti-CCP and negative RF are
likely to have mild disease. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 42-year-old woman has painful discoloration of her fingers
when exposed to cold and when holding a cold drink.<span>&nbsp; </span>Her fingers turn white, then blue, then
intensely red during these times.<span >&nbsp;
</span>Her hands and distal forearm feel “puffy,” and the skin in those areas
has thickened over the past 6 months. She coughs occasionally and gets short of
breath when she walks or climbs stairs. She denies fever, chest pain,
palpitations, and leg swelling. She also denies muscle aches, joint aches,
rash, heartburn, and oral ulcers. What is the most likely cause of her exertional
dyspnea?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congestive heart failure</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Valvular disorder</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulmonary hypertension</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenital heart disease</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Interstitial lung disease</span></p>

<span><br
clear=all>
</span>

<p><span></span></p>

<p><img width=150 height=105
src="_%20Tutorials_files/image006.png" align=left hspace=9 v:shapes="Picture_x0020_18"><img width=105 height=137
src="_%20Tutorials_files/image008.png" align=left hspace=9 v:shapes="Picture_x0020_17"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=364 height=262
src="_%20Tutorials_files/image010.png" alt="Description: 99CSC-10C07" v:shapes="Picture_x0020_10"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Scleroderma affects mainly women (&gt;75%) with a peak
incidence between 30 and 50 years of age. The etiology is unknown.<span>&nbsp; </span>It is characterized by progressive
fibrosis of the skin, but may involve internal organs. </span></p>

<p><span></span></p>

<p><span>Limited Systemic Sclerosis<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Formerly called “CREST” (an acronym for
calcinosis, Raynaud’s, esophageal dysmotility, sclerodactyly, telangiectasias)</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Skin involvement limited to hands,
face, and feet</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nail-fold capillary changes</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>10-15% risk of pulmonary hypertension,
the most serious complication of limited systemic sclerosis</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal disease is rare</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-centromere antibody (ACA) in
70-80%</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>10-year survival: 75%</span></p>

<p><span></span></p>

<p><span>Diffuse Systemic Sclerosis</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hand and face <i>plus</i> more proximal involvement (above the wrists)</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>More rapid progression</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Early incidence of heart, lung,
esophageal, and renal disease</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Heart (hypertension, enlarged heart,
heart failure) </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lung (interstitial lung disease)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Esophagus (dysphagia, gastroesophageal
reflux)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal (scleroderma renal crisis:
malignant hypertension causing renal failure; treated with ACE-inhibitor)</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>70% lifetime risk of interstitial lung
disease, the leading cause of death in diffuse systemic sclerosis</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>5% risk of pulmonary hypertension
(late)</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-Scl-70 antibodies in 30%</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>10-year survival: 50%</span></p>

<p><span></span></p>

<p><span>Interstitial lung disease: </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Leading cause of death in Diffuse
Systemic Sclerosis </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fibrosis begins at lung bases and
progresses upward</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Symptoms: cough, exertional dyspnea,
and eventually respiratory failure</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Therapy: cyclophosphamide or bone
marrow transplant</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct</span></b><span>.<span >&nbsp;
</span>This patient most likely has systemic sclerosis, or diffuse scleroderma,
based on skin thickening, edematous hands and forearms, and severe Raynaud’s.
Skin thickening above the wrist is suggestive of diffuse scleroderma.<span>&nbsp; </span>Scleroderma has three phases: edematous,
tightening, and atrophy (with claw-like hands).</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 30-year-old woman has had high, spiking fevers daily for a
week. She reports sore throat, muscle aches, and severe pain in the knees and
wrists. She has noticed swollen glands in her neck and a pale, pink rash, which
appears during the fever and resolves overnight.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Laboratory tests show: </span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>12
g/dl<span >&nbsp; </span></span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>17,900/mm<sup>3</sup>
(70% neutrophils)</span></p>

<p><span>Platelets<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>450,000/mm<sup>3</sup></span></p>

<p><span></span></p>

<p><span>AST <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>94
</span></p>

<p><span>ALT <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>88
</span></p>

<p><span></span></p>

<p><span>ESR <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;100
mm/h</span></p>

<p><span>ANA <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative
</span></p>

<p><span>RF<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative<span>&nbsp; </span></span></p>

<p><span>Ferritin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12,000
ng/ml</span></p>

<p><span></span></p>

<p><span>The rash is shown here: </span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=263 height=164
src="_%20Tutorials_files/image012.png"
alt="CREATOR: gd-jpeg v1.0 (using IJG JPEG v62), quality = 85&#10;" v:shapes="Picture_x0020_9"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Subacute bacterial endocarditis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Disseminated gonococcus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hepatitis B</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Still’s disease</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Parvovirus</span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>Adult-onset Still’s disease can occur at any age but peaks
between ages 15 and 35. Nearly all patients complain of fever and joint pain.
Most have sore throat, muscle aches, lymphadenopathy, and a salmon-pink rash
that comes and goes with the daily fevers. Other features include abdominal
pain and hepatosplenomegaly.<span >&nbsp;
</span>Laboratory tests show anemia, leukocytosis, elevated liver enzymes, and
negative ANA and RF. A very high ferritin level is classic for Still’s disease.
The disease tends to relapse and remit. Most patients respond to NSAIDs or
prednisone.</span></p>

<p><span></span></p>

<p><span>Subacute bacterial endocarditis (SBE) causes fever, myalgia,
arthralgia, and rash, but the rash is not evanescent as in Still’s disease.
Palpable purpura is the typical rash of SBE. Other cutaneous findings include
Osler nodes and Janeway lesions. Ferritin levels are elevated, but not as high
as in Still’s disease. </span></p>

<p><span></span></p>

<p><span>Disseminated gonococcus can cause fever, rash, and
arthritis.<span >&nbsp; </span>The arthritis typically
involves the wrists, hands, feet, and ankles. Knees are also commonly involved.
The rash often presents as hemorrhagic pustules on an erythematous base. The
bacterium can be cultured on Thayer-Martin media.</span></p>

<p><span></span></p>

<p><span>Acute
hepatitis B can be associated with fever, myalgia, arthralgia, elevated
AST/ALT, and rash. The rash usually takes the form of livedo reticularis or
palpable purpura. ALT and AST are very high in acute hepatitis. </span></p>

<p><span></span></p>

<p><span>Human
parvovirus 19 can cause fever, sore throat, myalgia, arthralgia, and rash. It
does not typically cause elevation of the AST or ALT.<span>&nbsp; </span>Infection can lead to transient aplastic
anemia. The rash is usually occurs in children and manifests as “slapped
cheeks” or as a maculopapular rash on the trunks and extremities. </span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Images</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=119 height=173
src="_%20Tutorials_files/image014.png" v:shapes="Picture_x0020_8"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Palpable purpura are
associated with </span></p>

<p style="text-align:center;"><span>vasculitis and
bacterial endocarditis. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=183 height=227
src="_%20Tutorials_files/image016.png" v:shapes="Picture_x0020_7"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Livedo reticularis, a
lace-like purplish discoloration, </span></p>

<p style="text-align:center;"><span>is associated with
vasculitis.</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=210 height=138
src="_%20Tutorials_files/image018.png" v:shapes="Picture_x0020_6"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Disseminated
gonococcus can appear as a </span></p>

<p style="text-align:center;"><span>hemorrhagic pustule
on an erythematous base.</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=190 height=245
src="_%20Tutorials_files/image020.png" v:shapes="Picture_x0020_5"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>“Slapped cheeks”
caused by human parvovirus 19 </span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer D
is correct.</span></b><span> The patient has Still’s disease. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 23-year-old woman has a 3-month history of photosensitive
rash, sores in her mouth, and progressive pain and stiffness in the joints of
the hands and feet, which are worse in the morning. Her laboratory tests show
leukopenia and thrombocytopenia. Her creatinine is elevated at 1.6 mg/dl, and
her urinalysis shows protein and microscopic hematuria.<span>&nbsp; </span>Autoantibody tests are ordered. Which of
the following serological tests are likely to be positive? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Rheumatoid factor 1:80 and anti-CCP</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA 1:640 in a nucleolar pattern,
anti-topoisomerase I</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA 1:1280 in a nuclear speckled
pattern and anti-Sm and anti-double stranded DNA</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>ANA 1:40, RF 1:40</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA 1:160 in nuclear homogenous,
anti-centromere</span></p>

<span><br
clear=all>
</span>

<p><span></span></p>

<p><span>This patient has presumed systemic lupus erythematosus based
on arthralgias, photosensitivity, oral ulcers, leukopenia, and
thrombocytopenia. There are 11 criteria for lupus. Any combination of 4 or more
makes it likely that the patient has lupus. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=230 valign=top>
  <p><span>Systemic Lupus Erythematosus</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Malar rash</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Discoid rash</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Photosensitivity</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Oral ulcers</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Arthritis (non-erosive)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Serositis (pleuritis, pericarditis)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Renal Disorder (proteinuria or
  cellular casts)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Neurological disorder (seizures or
  psychosis)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Hematologic disorder (hemolytic
  anemia, lymphopenia, thrombocytopenia)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Immunologic: anti-dsDNA, anti-Sm,
  and/or anti-phospholipid</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>ANA</span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span >&nbsp;</span></span></p>

<p><span>Although the patient has joint pain with morning stiffness
consistent with rheumatoid arthritis, the photosensitive rash and oral ulcers
are not typical of RA. Behcet’s disease causes recurrent oral ulcers, as well
as vaginal or penile ulcers, and can be associated with rash but does not
typically cause joint pain or significant cytopenias. Scleroderma is unlikely
because the patient does not have skin thickening, Raynaud’s phenomenon, or
heartburn. Polymyositis and dermatomyositis are unlikely because she does not
have muscle pain or weakness. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>ANA patterns: </span></p>

<p><span></span></p>

<p style="text-align:center"><span><img border=0 width=471 height=313
src="_%20Tutorials_files/image022.png" v:shapes="Picture_x0020_4"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Antibody associations</span></p>

<p><span></span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-ds (double-stranded) DNA</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Seen in 60% of patients with SLE</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Highly specific for SLE</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Low titer may be seen in other
inflammatory conditions</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Strongest clinical association with
nephritis and CNS disease</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-Sm (Smith)</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Seen in 10% to 30% of SLE patients</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Highly specific for SLE</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>clinical association with nephritis and
CNS disease</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-DNA<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>nephritis</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-nRNP<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>myositis,
Raynaud’s, milder disease</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-P<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>depression
and psychosis</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-histone<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>drug-induced
lupus</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-Ro<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>photosensitivity,
purpura, subacute cutaneous lupus<br>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>nephritis
(w/o anti-La), pneumonitis,<br>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>C2
deficiency<br>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>lymphopenia</span></p>

<p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp; </span><span>if mother is positive for anti-Ro, baby at risk for neonatal
heart block and neonatal lupus dermatitis<span>&nbsp; </span>
</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-La<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>absence
of nephritis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Anti-centromere and anti-nucleolar are typical patterns for
Scleroderma. SCL-70 is associated with systemic scleroderma and targets
DNA-topoiosmerase I.<span >&nbsp;
</span>Anti-centromere antibodies are typically associated with limited
scleroderma or CREST (calcinosis, Raynaud’s, esophageal dysmotility,
sclerodactyly, telangiectasias).</span></p>

<p><span></span></p>

<p><span>Rheumatoid factors are typically seen in rheumatoid arthritis
but may also be found in other diseases including chronic </span><a
href="http://en.wikipedia.org/wiki/Hepatitis" title=Hepatitis><span>hepatitis</span></a><span> C, </span><a
href="http://en.wikipedia.org/wiki/Primary_biliary_cirrhosis"
title="Primary biliary cirrhosis"><span>primary biliary cirrhosis</span></a><span>, any chronic viral infection, </span><a
href="http://en.wikipedia.org/wiki/Bacterial_endocarditis"
title="Bacterial endocarditis"><span>bacterial endocarditis</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Leukemia" title=Leukemia><span>leukemia</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Dermatomyositis" title=Dermatomyositis><span>dermatomyositis</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Infectious_mononucleosis"
title="Infectious mononucleosis"><span>infectious mononucleosis</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Systemic_sclerosis"
title="Systemic sclerosis"><span>systemic sclerosis</span></a><span> and </span><a
href="http://en.wikipedia.org/wiki/Systemic_lupus_erythematosus"
title="Systemic lupus erythematosus"><span>systemic lupus erythematosus</span></a><span> (SLE).<span >&nbsp;&nbsp;
</span>High titer RF predicts more aggressive, erosive rheumatoid arthritis.</span></p>

<p><span></span></p>

<p><span>Anti-CCP antibodies are directed again cyclic citrullinated
protein<b>. </b>During citrullination, arginine residues in proteins such as
vimentin can be enzymatically converted into citrulline residues, and if their
shapes are significantly altered, the proteins may be seen as </span><a
href="http://en.wikipedia.org/wiki/Antigens" title=Antigens><span>antigens</span></a><span> by the immune system and autoantibodies against them may
form. Anti-CCP antibodies are quite specific for rheumatoid arthritis although
low levels may be found in psoriatic arthritis. High titer anti-CCP predicts
more aggressive disease.</span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. ANA 1:1280 in a nuclear speckled pattern, anti-Sm, and
anti-double stranded DNA are most consistent with lupus.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Rheumatoid factor 1:80 and anti-CCP are most consistent
with rheumatoid arthritis.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span >&nbsp; </span>ANA 1:640 in a
nucleolar pattern and anti-topoisomerase I are most consistent with systemic
scleroderma.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. ANA 1:40 and RF 1:40 are consistent with a healthy control
(10-30% of the population has low-titer ANA). </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. ANA 1:160 in a nuclear homogenous pattern and
anti-centromere are most consistent with limited scleroderma or CREST. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 73-year-old woman has a 3-week history of fever, fatigue,
and right-sided headache. Today she has blurred vision in the left eye and
fatigue with chewing. Physical examination shows tenderness over a blood vessel
in the left temporal area. Histological examination of the vessel shows
multinucleated histiocytes infiltrating the wall of a medium-sized artery.<span>&nbsp; </span>Which of the following is the most
appropriate management?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Administration of ibuprofen</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Administration of prednisone</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Doppler ultrasound of the carotid
arteries</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>MRI of the head</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Surgical removal of the blood vessel</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Temporal arteritis (TA), also known as cranial or giant cell
arteritis, is the most common systemic vasculitis in adults. It primarily
affects medium-sized arteries of the head and the neck and can cause blindness.
The condition may present insidiously with fever, malaise, and/or weight loss.
In some patients, symptoms appear abruptly and may include headache, neck pain,
scalp tenderness, visual disturbance, fatigue with chewing (jaw claudication),
and fatigue with swallowing. Patients often have fever, headache, anemia, and
an elevated erythrocyte sedimentation rate (ESR). Polymyalgia rheumatica (PMR)
with extreme muscle tenderness of the shoulder and hip girdles may be present. </span></p>

<p><span></span></p>

<p><span>The diagnosis should be strongly suspected in Caucasians of
northern European descent, especially women above the age of 50, who report
temporal headache, scalp tenderness, jaw claudication, and/or visual changes.
Visual disturbances include diplopia, blurred vision, amaurosis fugax, and
blindness in one or both eyes. Visual hallucination also can occur. The scalp
may be focally or generally tender. Temporal arteries may be tender, inflamed,
dilated, thickened, or cordlike. </span></p>

<p><span></span></p>

<p><span>Diagnosis is made aided by a temporal artery biopsy,
preferably bilateral biopsies. Temporal artery biopsies may be negative even
when disease is present secondary to skip lesions (10%). Granulomatous
vasculitis is seen histologically. </span></p>

<p><span></span></p>

<p><span>High-dose glucocorticoids (such as prednisone 60 mg daily)
are the mainstay of therapy and may prevent permanent visual loss. Steroids
should be initiated if temporal arteritis is suspected on clinical
grounds.<span >&nbsp; </span>Clinicians should NOT
delay the start of steroids while waiting for a temporal artery biopsy. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is correct. </span></b><span>Prednisone, a glucocorticoid, is the
mainstay of therapy for temporal arteritis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year-old man with a history of hepatitis B presents to
the emergency department with fever, malaise, muscle aches, joint aches, and
rash on the legs. He describes increasing postprandial periumbilical pain,
which discourages him from eating. Examination reveals a lace-like purplish
discoloration on the legs. You suspect polyarteritis nodosa (PAN). Which of the
following is least likely to be associated with this condition?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Abdominal angiogram showing
microaneurysms of the mesenteric vessels.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Full thickness skin biopsy showing
patchy transmural arteritis, fibrinoid necrosis, and disruption of the elastic
laminae.</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Positive P-ANCA</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Serum creatinine of<span>&nbsp; </span>2.5 without red blood cell casts</span></p>

<span><br
clear=all>
</span>

<p><span>Polyarteritis nodosa (PAN) is a vasculitis of medium-sized
vessels. It typically affects the gut, kidneys, nerves, muscles, and skin. Both
men and women are affected. The condition can occur at any age. 10% of cases
are associated with hepatitis B. The clinical manifestations are varied and may
include weight loss, myalgias, neuropathy, renal insufficiency (due to renal
artery involvement, not glomerulonephritis), testicular pain, abdominal angina,
bowel ischemia, and rash (livedo reticularis, ulcerations, gangrene).</span></p>

<p><span></span></p>

<p><span>Diagnosis cannot be made using blood tests. (PAN is not
associated with autoantibodies.) Unlike microscopic polyangiitis and Wegener’s
granulomatosis, PAN is not associated with ANCA antibodies.<span>&nbsp; </span>Patients may present with an elevated
BUN and creatinine and mild proteinuria but do not typically have active
urinary sediment (e.g., RBC casts). The ESR and C-reactive protein levels are
elevated. Biopsy of affected peripheral sites such as skin and muscle are
preferred for diagnosis. Biopsy typically shows transmural arteritis with
granulocytes, fibrinoid necrosis, and disruption of the elastic laminae. Renal
or mesenteric angiograms may demonstrate typical microaneurysms and strictures
(beads on a string), which support the diagnosis. </span></p>

<p><span></span></p>

<p><img width=218 height=164
src="_%20Tutorials_files/image024.png" align=left hspace=9 v:shapes="Picture_x0020_16"><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><img width=215 height=167
src="_%20Tutorials_files/image026.png" align=left hspace=9 v:shapes="Picture_x0020_15"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Fibrinoid necrosis in
PAN</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Microaneurysms in PAN<br
clear=all>
</span></p>

<p style="text-align:center;"><span>The Vasculitides</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 width=504>
 <tr>
  <td width=129 valign=top>
  <p style="text-align:center;"><span>Primary
  Vasculitis</span></p>
  </td>
  <td width=234 valign=top>
  <p style="text-align:center;"><span>Predominant
  Symptoms</span></p>
  </td>
  <td width=58 valign=top>
  <p style="text-align:center;"><span>Age at
  onset</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>Male:
  female</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Takayasu’s </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Arm and leg claudication, bruits,
  decreased or absent pulses</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>15-25</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>1:9</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Giant Cell Arteritis</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Headache, jaw claudication, scalp
  tenderness, hip/shoulder stiffness, hand arthralgia</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>60-75 </span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>1:3</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Polyarteritis Nodosa</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Weight loss, fatigue, livedo
  reticularis, renal infarcts, hypertension, testicular pain, neuropathy,
  myopathy</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>40-60</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>2:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Churg-Strauss</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Asthma, eosinophilia, neuropathy,
  pulmonary infiltrates</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>40-60</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>2:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Wegener’s</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Upper and lower airways disease,
  renal disease, neuropathy</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>30-60</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>2:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Behcets</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Recurrent oral and genital
  ulceration, uveitis, thrombophlebitis</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>20-35</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>1:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Henoch-Schonlein Purpura</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Palpable purpura, arthritis,
  abdominal pain, bloody diarrhea</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>5-20</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>1:1</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span><span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C
is correct. </span></b><span>Polyarteritis nodosa is not associated
with autoantibodies. <b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 25-year-old man has been coughing up blood intermittently
for two hours. He reports low-grade fever, fatigue, chronic sinus drainage, and
frequent nosebleeds. On physical examination, he is mildly distressed.
Temperature is 100<sup>o</sup>F, pulse is 90/minute, blood pressure is 110/60
mm Hg, and respirations are 28/minute. A raised purplish-red rash is noted on
his lower legs. The oxygen saturation is 91% on room air. Chest x-ray shows
bilateral patchy infiltrates. </span></p>

<p><span></span></p>

<p><img width=183 height=159
src="_%20Tutorials_files/image028.png" align=left hspace=9 v:shapes="Picture_x0020_14"><img width=99 height=160
src="_%20Tutorials_files/image030.png" align=left hspace=9 v:shapes="Picture_x0020_13"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>You suspect vasculitis with possible diffuse alveolar
hemorrhage. Which antibody is most likely associated with this presentation?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Anti-CCP</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>P-ANCA</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Rheumatoid factor</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C-ANCA</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-glomerular basement membrane</span></p>

<span><br
clear=all>
</span>

<p><span>Wegener’s</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cardinal features: granulomatous
vasculitis of upper and lower respiratory tract, glomerulonephritis, and
variable degrees of disseminated vasculitis (which may produce<span>&nbsp; </span>palpable purpura)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Involves small arteries and veins
(hence lungs and kidneys are major targets)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Prevalence: 3 per 100,000</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Extremely rare in blacks</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Equal M:F ratio</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mean age of onset is 40</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sinus, nasal, or oral inflammation</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chest x-ray: nodules (with or without
cavitation) or fixed infiltrates</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Microhematuria or red blood cell casts
in urine</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Biopsy (sinus, lungs, kidney):
granulomatous necrotizing vasculitis</span></p>

<p><span></span></p>

<p><span>ANCA (anti-neutrophil cytoplasmic antibodies): C-ANCA and
P-ANCA</span></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><span>C-ANCA: “classical” antineutrophil cytoplasmic antibodies </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Diffusely granular cytoplasmic staining</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Proteinase-3 (PR-3) is the major target</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Found in &gt;90% of Wegener’s<span>&nbsp; </span>(rare in microscopic polyarteritis, SBE)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Titers fluctuate with disease activity </span></p>

<p><span></span></p>

<p><span>P-ANCA: “protoplasmic” antineutrophil cytoplasmic antibodies
</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Peri-nuclear staining</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Myeloperoxidase (MPO) is the major target </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>~70% microscopic polyarteritis; ~75% Churg-Strauss; 10-30%
Goodpasture’s; </span></p>

<p><span>~10% SLE; 50-80% ulcerative colitis, sclerosing cholangitis,
autoimmune hepatitis</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=180 height=190
src="_%20Tutorials_files/image032.png" v:shapes="Picture_x0020_3"><img border=0 width=169 height=190
src="_%20Tutorials_files/image034.png" v:shapes="Picture_x0020_2"></span><span></span></p>

<p><span></span></p>

<p><span>Differential of Palpable Purpura:</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypersensitivity vasculitis (e.g.,
drug-induced)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cryoglobulinemia (hepatitis C)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Paraneoplastic vasculitis</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Henoch-Schonlein purpura</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wegener’s granulomatosis </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Churg-Strauss vasculitis</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Microscopic polyarteritis </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polyarteritis nodosa (hepatitis B)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Subacute bacterial endocarditis</span></p>

<p><span></span></p>

<p><span>Diffuse Alveolar Hemorrhage:</span></p>

<p><span>Rapidly changing patchy pulmonary
infiltrates</span></p>

<p><span>Hemoptysis (usually)</span></p>

<p><span>Diagnosis: bronchoscopy shows
progressive returns of blood</span></p>

<p><span>Therapy: intravenous high-dose
glucocorticoids</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=398 height=247
src="_%20Tutorials_files/image036.png" v:shapes="Picture_x0020_1"></span><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. This patient presents with hemoptysis, nosebleeds, chronic
sinusitis, patchy lung infiltrates, and palpable purpura, consistent with
Wegener’s granulomatosis. Wegener’s is associated with C-ANCA.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Anti-CCP is found in rheumatoid arthritis and occasionally
in psoriatic arthritis. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. ANA is typical of lupus, scleroderma, and Sjogren’s
disease. These diseases can be associated with diffuse alveolar hemorrhage, but
are not associated with chronic sinus disease.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. P-ANCA is the most common antibody found in vasculitis and
is associated with microscopic polyarteritis, a common cause of diffuse
alveolar hemorrhage. However, microscopic polyarteritis is typically not
associated with chronic sinusitis. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Rheumatoid factor is associated with a variety of diseases
including rheumatoid arthritis, chronic hepatitis C, lymphoma, and subacute
bacterial endocarditis. Rheumatoid arthritis is rarely associated with
pulmonary vasculitis.</span></p>

<p><span></span></p>

<p><b><span>Answer F is incorrect</span></b><span>. Anti-glomerular basement membrane is associated with
Goodpasture’s disease, which can lead to diffuse alveolar hemorrhage and
glomerulonephritis. However, Goodpasture’s is not associated with chronic
sinusitis or palpable purpura.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section">Fluid,</span></p>

<p style="text-align:center;"><span
class="Section">Electrolytes, </span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Acid-Base</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=188 height=204
src="_%20Tutorials_files/image038.png" v:shapes="Picture_x0020_19"></span><span></span></p>

<p><span></span></p>

<p><span>In the diagram above, point X indicates the acid-base status
of a healthy person. Which of the following is the most likely cause of the
condition indicated by point Y?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ingestion of strong acid</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Prolonged vomiting</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diarrhea</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Adaptation to high altitude</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic obstructive pulmonary disease
(COPD)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Point X represents a normal acid-base status: The pH is 7.4,
the PCO<sub>2</sub> is 40 mm Hg, and the HCO<sub>3</sub><sup>-</sup> is 24
mEq/L. Point Y represents an abnormal acid-base status: the pH is almost 7.4,
the PCO<sub>2</sub> is 60 mm Hg, and the HCO<sub>3</sub><sup>-</sup> is 40
mEq/L. Note that the pH is almost identical in both cases: at or near 7.4. The
point here is that a normal pH can mean one of two things: either the patient
has a normal acid-base status or the patient has two acid-base processes that
are almost “canceling” each other out. This “canceling out” (i.e.,
“compensation”) is common in chronic acid-base disorders. In <i>acute</i> disorders, the body doesn’t have
time to compensate for the change in pH. In <i>chronic</i>
disorders, there is time to adapt. Adaptation can be (simplistically) regarded
as a partnership between lungs and kidneys.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>If the lungs retain too much CO<sub>2</sub> (respiratory
acidosis), the kidneys respond by retaining more HCO<sub>3</sub><sup>-</sup>
(metabolic alkalosis)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>If the lungs blow off too much CO<sub>2 </sub>(respiratory
alkalosis), the kidneys compensate by eliminating more HCO<sub>3</sub><sup>-</sup>
(metabolic acidosis)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>If the blood is too acidic (metabolic acidosis), the lungs
respond by blowing off more CO<sub>2</sub> (respiratory alkalosis)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>If the blood is too alkalotic (metabolic alkalosis), the
lungs respond by retaining more CO<sub>2</sub> (respiratory acidosis)</span></p>

<p><span></span></p>

<p><span>Here are some basic rules of compensation: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Compensation rarely produces a normal
pH, although the pH may approach normal. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Overcompensation does not occur (i.e.,
the compensatory process does not overwhelm the primary process)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sufficient time must elapse for
compensation to occur (about 24 hours).</span></p>

<p><span>At Point Y, we know that the acid-base status is abnormal
because the PCO<sub>2</sub> and HCO<sub>3</sub><sup>-</sup><sub> </sub>levels
are abnormal. The PCO<sub>2</sub> level is high (respiratory acidosis) and the
HCO<sub>3</sub><sup>-</sup><sub> </sub>level is high (metabolic alkalosis).
These two processes almost cancel each other out, resulting in a near normal
pH. </span></p>

<p><span>Which is the primary process? The pH at Point Y is slightly
lower than at Point X. This suggests that the primary process is respiratory
acidosis and the compensatory process is metabolic alkalosis. This combination
is commonly seen in severe chronic obstructive pulmonary disease (COPD),
characterized by chronic retention of CO<sub>2</sub> and compensatory retention
of HCO<sub>3</sub><sup>-</sup><sub> </sub>by the kidneys.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct.</span></b><span> COPD is a chronic disorder
characterized by respiratory acidosis and metabolic compensation. The PCO<sub>2</sub>
level is high, the HCO<sub>3</sub><sup>-</sup> level is high, and the pH is
near normal (due to compensation).</span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect.</span></b><span> Ingestion of strong acid would cause
an acute metabolic acidosis (low pH, low HCO<sub>3</sub><sup>-</sup>).</span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect.</span></b><span> Prolonged vomiting causes an acute
metabolic alkalosis (high pH, high HCO<sub>3</sub><sup>-</sup>).</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect.</span></b><span> Diarrhea causes an acute metabolic
acidosis (low pH, low HCO<sub>3</sub><sup>-</sup>).</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect.</span></b><span> Low oxygen tension at high altitudes
results in hyperventilation (to maintain normal blood oxygen levels).
Hyperventilation causes respiratory alkalosis, which, over time, leads to
metabolic compensation: the PCO<sub>2</sub> is low, the HCO<sub>3</sub><sup>-</sup>
is low, and the pH is near normal. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><!--[if supportFields]><span><span></span><span>&nbsp;</span>SEQ CHAPTER \h \r 1</span><![endif]--><!--[if supportFields]><span><span></span></span><![endif]--><span>A 55-year-old woman undergoes routine blood tests prior to
elective sinus surgery.<span >&nbsp; </span>The serum
calcium level is elevated at 11.3 mg/dl (normal: 8.4 to10.2 mg/dl). The serum
albumin concentration is normal. A second blood test shows a serum calcium
level of 11.2 mg/dl and a parathyroid hormone (PTH) level of 58 pg/ml (normal:
20 to 72 pg/ml).<span >&nbsp; </span>What is the most
likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Milk-alkali syndrome</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypercalcemia of malignancy</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Primary hyperparathyroidism</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Secondary hyperparathyroidism</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Calcium serves two principal
physiologic functions. First, insoluble calcium salts (primarily
hydroxyapatite) provide the structural characteristics that allow bones to
protect internal organs, to bear weight, and to function as the levers on which
muscles act during locomotion. Second, soluble calcium ions in the
extracellular fluid (ECF) and cytosol are critical for a myriad of biochemical
reactions, signaling cascades, and electrical systems that are necessary for
life. </p>

<p></p>

<p><span>Most of the calcium in the body (about 99%) is found in
bone. Only 1% is contained within the ECF and soft tissues. Therefore, the
skeleton is called on as a source of calcium when the ECF concentration falls.
Of the total circulating calcium, the ionized fraction is about 50%, with the
remainder bound to serum proteins, primarily albumin. Only the ionized fraction
of total serum calcium is physiologically important, and this component is
regulated on a minute-to-minute basis. </span></p>

<p></p>

<p>Hormones and organ systems regulate
the ECF ionized calcium concentration such that it is maintained in a very
narrow physiologic range. If the calcium level falls below the physiologic
range, PTH is rapidly secreted from the parathyroid glands and activates the
release of calcium and phosphate from the skeleton. In the kidney, PTH
increases the reabsorption of calcium from the urine while simultaneously
inhibiting phosphate reabsorption to dispose <a
name=4-u1.0-B978-1-4160-2805-5..50271-8--p189></a>of the phosphate released
from the skeleton. These actions return the calcium concentration back toward
normal and thus inhibit further PTH release. When hypocalcemia persists, PTH
also stimulates the renal production of 1,25(OH)<sub>2</sub> vitamin D, which
increases intestinal calcium absorption. </p>

<p></p>

<p>In the presence of <span
 PTH secretion is suppressed, and the
various organs alter their calcium handling in an opposite fashion so
circulating calcium levels fall.</p>

<p><span></span></p>

<p style="text-align:center;"><b><span>Causes of
Hypercalcemia in Adults</span></b></p>

<p style="text-align:center;"><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td valign=top>
  <p><b><span>Hyperparathyroidism</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Malignancy-associated hypercalcemia</span></b><span></span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Humoral
  hypercalcemia of malignancy</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Local osteolytic
  hypercalcemia<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Granulomatous disorders</span></b><span> (e.g., sarcoidosis)<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Endocrine disorders </span></b><span>(e.g., h</span><span>yperthyroidism,<br>
  adrenal insufficiency)<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Drugs </span></b><span>(e.g., thiazide diuretics, </span><span>Vitamin D intoxication)<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Miscellaneous </span></b><span>(e.g., m</span><span>ilk-alkali syndrome*, immobilization)<b></b></span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>*Milk-alkali syndrome is
caused by excessive consumption of milk (which is high in calcium) and certain
antacids, especially <span>calcium
carbonate</span></span> or <span>sodium
bicarbonate</span></span> (baking soda), over a long period of time. It is
associated with calcium deposits in the kidneys and in other tissues.
Consumption of excessive amounts of vitamin D, which is usually added to milk
bought at the supermarket, can worsen this condition. <b></b></p>

<p><b><span>Answer C is correct</span></b><span>. The
most likely diagnosis is primary hyperparathyroidism. In a person with a normal
feedback mechanism, high serum calcium levels should maximally suppress PTH
production by the parathyroid glands. In this vignette, however, the PTH level
is inappropriately “normal.” Thus, the normal feedback mechanism is broken. PTH
is being autonomously secreted by the parathyroid gland. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. In
PTH-independent hypercalcemic states, such as milk-alkali syndrome, regulation
of PTH secretion is normal. Elevated serum calcium levels suppress PTH
secretion, causing low PTH levels in the blood.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. In
PTH-independent hypercalcemic states, such as hypercalcemia of malignancy,
regulation of PTH secretion is normal. Elevated serum calcium levels suppress
PTH secretion, causing low PTH levels in the blood.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>.
Secondary hyperparathyroidism is not associated with hypercalcemia. In
secondary hyperparathyroidism (e.g., chronic renal failure), serum PTH levels
are high and serum calcium levels are low or inappropriately normal. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 68-year-old woman with type 2 diabetes mellitus and
hypertension presents to the clinic for a routine visit. </span></p>

<p><span></span></p>

<p><span>Blood test results: </span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>142
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>5.8
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp; </span></span></p>

<p><span>Cl<sup>-<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>114
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>16
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7-18 mg/dL)</span></p>

<p><span>Creatinine <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.0
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.6-1.2 mg/dL)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>What is the most likely cause of hyperkalemia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Increased dietary intake of potassium</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased mineralcorticoid activity at
the distal nephron</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal insufficiency</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Excessive release of potassium from
cells</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The principal mechanisms of hyperkalemia are excessive
intake of potassium, ineffective elimination of potassium, and excessive
release of potassium from cells. </span></p>

<p><span></span></p>

<p><i><span>Excessive
intake of potassium </span></i><span>rarely causes hyperkalemia in patients
with normal renal function.<span >&nbsp; </span>The
kidneys are proficient at excreting excess potassium. Very high doses of
potassium are required to overcome the normal renal capacity for elimination. </span></p>

<p><span></span></p>

<p><i><span>Ineffective
elimination of potassium</span></i><span> is usually due to
renal insufficiency, drugs, or low-aldosterone states. Renal insufficiency is
characterized by high BUN and creatinine levels. Many drugs, particularly
ACE-inhibitors, potassium-sparing diuretics, and NSAIDs, can cause
hyperkalemia. Low-aldosterone states should be suspected as a cause of hyperkalemia
when elevated potassium levels are accompanied by a normal-anion gap metabolic
acidosis. </span></p>

<p><span></span></p>

<p><i><span>Excessive
release of potassium from cells</span></i><span> is
caused by large-scale cellular breakdown or by conditions that shift potassium
from the intracellular to extracellular space. </span></p>

<p><span></span></p>

<p><span>These mechanisms are summarized below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=361 valign=top>
  <p style="text-align:center;"><span>Mechanisms of Hyperkalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=361 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=361 valign=top>
  <p><span>Excessive
  intake of potassium</span></p>
  </td>
 </tr>
 <tr>
  <td width=361 valign=top>
  <p><span>Ineffective
  elimination of potassium</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Renal insufficiency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Drugs</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>ACE-inhibitors
  and angiotensin-receptor blockers </span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Potassium-sparing
  diuretics </span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>NSAIDs
  </span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Calcineurin
  inhibitors (e.g., cyclosporin, tacrolimus)</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Trimethoprim
  </span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Pentamidine</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Mineralcorticoid deficiency or
  resistance</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Type
  IV renal tubular acidosis</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Addison’s
  disease</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Aldosterone
  deficiency</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Congenital
  adrenal hyperplasia (some types)</span></p>
  </td>
 </tr>
 <tr>
  <td width=361 valign=top>
  <p><span>Excessive
  release of potassium from cells</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Rhabdomyolysis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Burns</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Tumor lysis syndrome</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Massive blood transfusion</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Massive hemolysis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Conditions that shift potassium from
  the intracellular to extracellular space</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Acidosis</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Low
  insulin levels</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Beta-blocker
  therapy</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Digoxin
  overdose</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span>Answer B
is correct.<span >&nbsp; </span></span></b><span>The presence of hyperkalemia with a normal anion gap
acidosis suggests a low-aldosterone state. Several conditions are associated
with low aldosterone levels. One of the most common is type IV renal tubular
acidosis (RTA). This condition usually occurs in patients with diabetes
mellitus and hypertension. Typically, patients with type IV RTA have mild to
moderate renal insufficiency. The ability of the kidneys to produce renin is
impaired, resulting in suppression of the renin-angiotensin-aldosterone system.
</span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Increased dietary intake of potassium
rarely causes hyperkalemia in patients with normal renal function. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. This patient does not have renal
insufficiency, as the BUN and creatinine are normal. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. There is no reason to suspect major
cellular breakdown.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An 80-year-old man with dementia resides in a nursing home. He develops a
urinary tract infection, which causes an acute decline in his mental status.
Vital signs and laboratory tests before and after this decline are shown below.
</span></p>

<p><u><span>Before<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></u><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><u>After</u></span></p>

<p><span>Blood pressure<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>130/80
mm Hg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>105/60
mm Hg</span></p>

<p><span>Pulse<span >&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>70
/ minute<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>100
/ min</span></p>

<p><span>Hemoglobin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
g/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>17
g/dL</span></p>

<p><span>Sodium<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>150
mEq/L</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>90
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>95
mg/dL</span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>13
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>50
mg/dL</span></p>

<p><span>Creatinine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.2
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.3
mg/dL</span></p>

<p><span></span></p>

<p><span>Which of the following conditions best explains the changes shown above?</span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Dehydration</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gastrointestinal
hemorrhage</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diabetic
ketoacidosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
renal failure</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Syndrome
of inappropriate ADH (vasopressin)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypernatremia</span> is defined as an elevated serum sodium
concentration. It is generally not caused by an excess of sodium, but rather by
a relative deficit of free water. Consequently, hypernatremia is usually
synonymous with dehydration.</p>

<p></p>

<p>Water is lost from the body
in many ways, including perspiration, insensible losses from breathing, and
fecal and urinary losses. If the amount of water ingested falls below the
amount of water lost, the serum sodium level rises, leading to hypernatremia.
Ordinarily, a rise in the sodium level triggers thirst, which leads to
increased free water intake and subsequent correction of the abnormality.
Hypernatremia usually occurs in individuals who cannot adequately replace fluid
losses, such as infants, the mentally impaired, and the elderly.</p>

<p></p>

<p>Most patients with
hypernatremia are hypovolemic. In some less common conditions, however,
hypernatremic patients may be euvolemic or hypervolemic. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=188 valign=top>
  <p style="text-align:center;"><span>Causes of Hypernatremia</span></p>
  </td>
 </tr>
 <tr>
  <td width=188 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=188 valign=top>
  <p><span>Hypovolemia (dehydration)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Inadequate
  water intake</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Excessive water
  loss </span></p>
  <p><span>Euvolemia (diabetes insipidus)</span></p>
  <p><span>Hypervolemia </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Intake of
  hypertonic fluid (e.g. seawater)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Mineralcorticoid
  excess (Conn’s syndrome)</span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>In most patients,
hypernatremia is synonymous with dehydration. Symptoms and signs of dehydration
appear below. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=268 colspan=2 valign=top>
  <p style="text-align:center;"><span>Symptoms and Signs of Dehydration</span></p>
  </td>
 </tr>
 <tr>
  <td width=268 colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=134 valign=top>
  <p><span>Headache</span></p>
  <p><span>Fatigue</span></p>
  <p><span>Confusion</span></p>
  <p><span>Thirst</span></p>
  <p><span>Dry mouth</span></p>
  <p><span>Dry skin</span></p>
  <p><span>Decreased skin turgor</span></p>
  <p><span>Decreased urination</span></p>
  <p><span>Muscle cramps</span></p>
  </td>
  <td width=134 valign=top>
  <p><span>Dizziness</span></p>
  <p><span>Hypotension (resting or orthostatic)</span></p>
  <p><span>Increased heart rate</span></p>
  <p><span>Increased respiratory rate</span></p>
  <p><span>Hyperthermia</span></p>
  <p><span>Hemoconcentration</span></p>
  <p><span>Hyperalbuminemia</span></p>
  <p><span>Increased BUN/creatinine ratio</span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer A is correct</b>. The patient in the clincial vignette has a
normal serum sodium level on day 1 and a high serum sodium level on day 5. The
presence of hypernatremia on day 5 should alert the clinician to the
development of dehydration. (Dehydration is the most common cause of
hypernatremia.) Other findings consistent with dehydration include a drop in
blood pressure, a rise in pulse, a rise in hemoglobin level
(hemoconcentration), and an elevation in the BUN / creatinine ratio (due to
hypovolemia). </p>

<p></p>

<p><b>Answer B is incorrect</b>. Gastrointestinal hemorrhage may result in
hypotension, tachycardia, and an elevated BUN / creatinine ratio (from
hypovolemia), but hypernatremia does not usually occur, and the hemoglobin
concentration does not rise.<span >&nbsp; </span></p>

<p></p>

<p><b>Answer C is incorrect</b>. Diabetic ketoacidosis (DKA) is characterized
by hyperglycemia, ketosis, and metabolic acidosis. Hypotension, tachycardia,
and hypovolemia commonly occur. In this clinical vignette, DKA is unlikely
because of the normal serum glucose concentration.<span>&nbsp;&nbsp; </span></p>

<p></p>

<p><b>Answer D is incorrect</b>. Acute renal failure is defined as an abrupt
or rapid decline in renal filtration, usually marked by a rise in the serum
creatinine concentration. In this vignette, there is a slight rise in the
creatinine concentration and a large rise in the BUN. The increase in the BUN /
creatinine ratio is caused by hypovolemia. The presence of hypernatremia
suggests a state of dehydration. </p>

<p></p>

<p><b>Answer E is incorrect</b>.<span> The
syndrome of inappropriate ADH causes hyponatremia, not hypernatremia. </span></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A previously
healthy 47-year-old nurse visits the emergency department because of recurrent
episodes of nervousness, palpitations, and dizziness. The episodes resolve
after eating. She has never been hospitalized or undergone surgery. She does
not smoke or drink.<span >&nbsp; </span>Physical
examination shows no abnormalities. While in the emergency room, she has an
episode, during which her blood glucose level is found to be 43 mg/dL.
Laboratory studies during the episode show:</span></p>

<p><span></span></p>

<p><span>Blood
glucose <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>43
mg/dL</span></p>

<p><span>C
peptide <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.0
nmol/mL (N=0.5&#8211;2.5)</span></p>

<p><span>Insulin
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
&#956;U/mL (N=5&#8211;20)</span></p>

<p><span>Urine
sulfonylurea<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span>Insulin-like
growth factor II<span>&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span></span></p>

<p><span>Which
is the most likely cause of hypoglycemia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Factitious insulin use</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Factitious sulfonylurea use</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dumping syndrome</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Insulinoma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Non-beta-cell tumor</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypoglycemia is defined as an abnormally low plasma glucose
concentration. Clinically significant hypoglycemia is defined by Whipple’s
triad.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=316 valign=top>
  <p style="text-align:center;"><span>Whipple’s
  triad</span></p>
  </td>
 </tr>
 <tr>
  <td width=316 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=316 valign=top>
  <p><span>Signs and symptoms of hypoglycemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=316 valign=top>
  <p><span>Low plasma glucose concentration
  (&lt;45 mg /dL)</span></p>
  </td>
 </tr>
 <tr>
  <td width=316 valign=top>
  <p><span>Resolution of symptoms with
  normalization of glucose levels</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Hormonal regulation of plasma glucose levels relies on
insulin and four counter-regulatory hormones (glucagon, epinephrine, growth
hormone, and cortisol). Insulin is the predominant hormone and glucagon is the
predominant counter-regulatory hormone. Glucagon and epinephrine are part of
the rapid response to hypoglycemia, whereas growth hormone and cortisol are
part of the delayed response (2 to 3 hours later).<span>&nbsp; </span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Gluconeogenesis</span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Glycogenolysis</span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Peripheral Glucose Utilization</span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Lipolysis</span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Proteolysis</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Insulin</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Glucagon</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Epinephrine</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Growth hormone</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Cortisol</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>Symptoms of hypoglycemia appear below.<span>&nbsp; </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=319 colspan=2 valign=top>
  <p style="text-align:center;"><span>Symptoms
  of Hypoglycemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=319 colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=161 valign=top>
  <p><span>Blurred vision</span></p>
  <p><span>Confusion</span></p>
  <p><span>Convulsions</span></p>
  <p><span>Decreased alertness</span></p>
  <p><span>Dizziness</span></p>
  <p><span>Fainting</span></p>
  <p><span>Fatigue</span></p>
  <p><span>Hallucinations</span></p>
  <p><span>Headache</span></p>
  <p><span>Hunger</span></p>
  <p><span></span></p>
  </td>
  <td width=159 valign=top>
  <p><span>Insomnia</span></p>
  <p><span>Irritability</span></p>
  <p><span>Memory loss</span></p>
  <p><span>Nervousness</span></p>
  <p><span>Pallor</span></p>
  <p><span>Palpitations</span></p>
  <p><span>Sweating</span></p>
  <p><span>Tachycardia</span></p>
  <p><span>Trembling</span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypoglycemia is classified as “fasting” or “postprandial.” </span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=401 valign=top>
  <p style="text-align:center;"><span>Causes
  of Hypoglycemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=401 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=401 valign=top>
  <p><span>Fasting hypoglycemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Drugs (e.g., insulin, sulfonylureas, meglitinides,
  alcohol, beta-blockers)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Critical illness </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hormone deficiencies (growth hormone, cortisol,
  epinephrine, glucagon)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Endogenous hyperinsulinemia (insulinoma)<span>&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Exogenous hyperinsulinemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Non beta-cell tumors, which produce insulin-like growth
  factor II</span></p>
  <p><span>Postprandial hypoglycemia (e.g.,
  dumping syndrome)*</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The cause of hypoglycemia is often apparent from the medical
history; however, sometimes laboratory tests are needed to make a diagnosis.
Key laboratory tests include serum glucose, insulin, C-peptide, sulfonylurea,
and insulin-like growth factor levels. </span></p>

<p><span>C-peptide is a marker for <i>endogenous</i> insulin production. (It is not found in <i>exogenously</i> administered insulin.)
Sulfonylureas stimulate insulin secretion by the pancreas. Insulin-like growth
factor II (IGF-II), a molecule that has insulin-like effects, is produced by
certain non-beta-cell tumors. </span></p>

<p><span></span></p>

<p><span>The following table shows the utility of laboratory tests in
distinguishing various causes of hypoglycemia.<span>&nbsp; </span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=443 colspan=6 valign=top>
  <p style="text-align:center;"><span>Selected
  Conditions Causing Fasting Hypoglycemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=443 colspan=6 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Condition</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Plasma
  glucose (mg/dL)</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Insulin
  (&#956;U/mL)</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>C-Peptide
  (nmol/L)</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Plasma
  Sulfonylurea (nmol/L)</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Insulin-like
  Growth Factor II</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Normal</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>5-20</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>0.5-2.5</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Insulinoma</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 45</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt; 6</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt;
  0.2</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Exogenous insulin</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 45</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt; 6</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt;
  0.2</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Sulfonylurea use</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 45</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt; 6</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt;
  0.2</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>+</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Tumor secreting IGF II</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 45</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 6</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt;
  0.2</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>+</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>*Dumping syndrome occurs in people who have undergone
gastric surgery (e.g., gastrectomy, gastrojejunostomy, pyloroplasty, gastric
bypass, or vagotomy), and can be purely a mechanical complication of the
surgery. Rapid emptying into the upper small bowel of a meal rich in simple
carbohydrates results in abrupt hyperglycemia, early marked hyperinsulinemia,
and subsequent hypoglycemia.<span >&nbsp; </span>Other
GI surgery patients may have a more complicated mechanism underlying
post-prandial hypoglycemia that involves beta cell hyperplasia and GLP-1
secretion.</span></p>

<p><b><span>Answer D
is correct</span></b><span>. Hypoglycemia normally suppresses
insulin production. The C-peptide level should be &lt; 0.2 nmol/L and the
insulin level should be &lt;6 &#956;U/mL in hypoglycemic states not induced by
insulin. In this vignette, the insulin level (15 &#956;U/mL) is inappropriately
elevated. Either the patient is producing too much insulin or taking exogenous
insulin. If she were taking exogenous insulin, the C-peptide would be
suppressed (&lt; 0.2 nmol/L). Because the C-peptide is inappropriately high
(1.0 nmol/mL) we know that the insulin is endogenously derived. The best
explanation for this is insulinoma (an insulin-producing tumor).<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>.
Factitious insulin use would lead to suppression of the C-peptide (&lt; 0.2
nmol/L).</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.
Factitious sulfonylurea use would produce detectable levels of sulfonylurea in
the blood and urine. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Dumping
syndrome causes post-prandial hypoglycemia. It occurs in patients who have
undergone gastric surgery. This patient has no history of gastric surgery.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Most
non-beta-cell tumors cause hypoglycemia by elaborating insulin-like growth
factor II. In such situations, C-peptide and insulin levels would be
suppressed. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
30-year-old woman has been “weak and tired” for a month. Physical examination
shows no abnormalities. Laboratory studies show:</span></p>

<p><span></span></p>

<p><span>Serum</span></p>

<p><span>Sodium <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>Potassium <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.2
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Chloride <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>84 mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>Bicarbonate<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>34 mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Urine</span></p>

<p><span>Sodium<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>70
mEq/24 h</span></p>

<p><span>Potassium<span> </span>150 mEq/24 h</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which
of the following is most likely?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diarrhea</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aldosterone deficiency</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Surreptitious use of diuretics</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Laxative abuse</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal tubular acidosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Potassium is the most abundant intracellular cation.
Potassium deficiency causes many problems, the most dangerous of which is
cardiac dysrhythmia. Hypokalemia, defined as an abnormally low serum potassium
concentration, may be the result of poor oral intake, potassium redistribution,
renal potassium loss, or extrarenal potassium loss. Redistribution refers to
the movement of potassium from the extracellular to the intracellular
space.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The following conditions are associated with hypokalemia.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Causes
  of Hypokalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Inadequate intake</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Extra-renal loss<span>&nbsp; </span>(urine K<sup>+</sup> &lt; 20 mEq/L)</span></p>
  <p><span>(e.g., diarrhea)</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Renal loss<span>&nbsp; </span>(urine K<sup>+ </sup>&gt; 20 mEq/L)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Drugs (e.g., diuretics, amphotericin B, cisplatin)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Diabetic ketoacidosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hypomagnesemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>High aldosterone states</span></p>
  <p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Renal artery stenosis</span></p>
  <p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Cushing syndrome</span></p>
  <p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Primary
  hyperaldosteronism</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Shift from extracellular to
  intracellular space</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Alkalosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Drugs (e.g., insulin, epinephrine, &#946;-agonists)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hereditary defects (e.g., hypokalemic periodic paralysis)</span></p>
  </td>
 </tr>
</table>

</div>

<p style="text-align:center;"><span></span></p>

<p><span>The cause of hypokalemia is usually apparent from the
medical history. When it is not apparent, the following parameters may be
useful diagnostically.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=143 valign=top>
  <p style="text-align:center;"><span>Important
  Parameters in</span></p>
  <p style="text-align:center;"><span>Evaluating
  Hypokalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=143 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=143 valign=top>
  <p><span>Acid-base status</span></p>
  </td>
 </tr>
 <tr>
  <td width=143 valign=top>
  <p><span>Urinary potassium level</span></p>
  </td>
 </tr>
 <tr>
  <td width=143 valign=top>
  <p><span>Presence of hypertension</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The following table lists common causes of hypokalemia,
along with their acid-base and electrolyte patterns. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=359 colspan=4 valign=top>
  <p style="text-align:center;"><span>Common
  Causes of Hypokalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=359 colspan=4 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Condition</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Acid-base status</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>Urinary
  potassium</span></p>
  <p style="text-align:center;"><span>(mEq/L)</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span>Presence
  of hypertension</span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span></span></p>
  </td>
  <td width=82 valign=top>
  <p><span></span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Decreased intake</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&lt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Vomiting</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>variable</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Diarrhea</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic acidosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&lt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Diuretic use</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Laxative abuse</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Variable</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&lt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Hypomagnesemia</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Variable</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Diabetic Ketoacidosis</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic acidosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Renovascular hypertension</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span>Yes</span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Primary hyperaldosteronism</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span>Yes</span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Cushing’s syndrome</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span>Yes</span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Renal tubular acidosis</span></p>
  <p><span>(types I and II)</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic acidosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is correct</span></b><span>. The patient in the vignette has an
elevated bicarbonate level, indicating metabolic alkalosis. She also has a high
urinary potassium concentration, indicating renal potassium wasting. Diuretic
use is a common cause of metabolic alkalosis and renal potassium wasting.</span></p>

<p><span><span >&nbsp; </span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Diarrhea causes metabolic acidosis.
Urinary potassium levels would be low.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. Aldosterone excess, not deficiency,
leads to metabolic alkalosis and renal potassium wasting.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Laxative abuse results in low urinary
potassium levels.</span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Renal tubular acidosis (types I and
II) causes metabolic acidosis, not alkalosis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
65-year-old man presents to the emergency department with vomiting and
confusion. Review of the medical record reveals several previous visits for
“gastritis.” The patient carries a diagnosis of dementia and neuropathy. The ER
doctor tells you that the patient lives “under a bridge” and is a “frequent
flyer.”<span >&nbsp; </span>Physical examination shows
altered sensorium, jaundice, extensive bruising, telangiectasias on the upper
chest, gynecomastia, ascites, splenomegaly, palmar erythema, and testicular
atrophy. </span></p>

<p><span></span></p>

<p><span>Blood test
results: </span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>12 gm/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
13.5-17.5 g/dL)</span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>9,000/mm<sup>3</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
4,500-11,000/mm<sup>3</sup>)</span></p>

<p><span>Platelets<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>80,000/mm<sup>3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>(Normal:
150,000-400,000/mm<sup>3</sup>)</span></p>

<p><span></span></p>

<p><span>Na<sup>+<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>132
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+</sup>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.8
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>92
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>24
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>16
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7-18 mg/dL)</span></p>

<p><span>Creatinine
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.1
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.6-1.2 mg/dL)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Mg<sup>++</sup>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.2
mEq/L<span >&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal: 1.5-2.0 mEq/L)</span></p>

<p><span></span></p>

<p><span>Albumin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.8
gm/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.5 g/dL)</span></p>

<p><span>Bilirubin
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3.0
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.1-1.0 mg/dL)</span></p>

<p><span>AST<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>160
U/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
8-20 U/L)</span></p>

<p><span>ALT<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp; </span>70 U/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
8-20 U/L)</span></p>

<p><span></span></p>

<p><span>PT<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>18
seconds<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
11-15 seconds)</span></p>

<p><span>aPTT<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>35
seconds<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
25-40 seconds)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is
the most likely cause of hypomagnesemia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Renal insufficiency</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Autosomal recessive defect</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic alcohol ingestion</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hypokalemia </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Long-term alcohol abuse has many complications, including
cirrhosis, pancreatitis, gastritis, dementia, polyneuropathy, cardiomyopathy,
nutritional deficiencies, and sexual dysfunction. The patient in this vignette
has signs of cirrhosis: telangiectasias, ascites, palmar erythema,
gynecomastia, and testicular atrophy. Blood test results are compatible with a
diagnosis of cirrhosis: The patient has thrombocytopenia, hyponatremia,
hyperbilirubinemia, elevated transaminases, hypoalbuminemia, and elevated prothrombin
time. Chronic alcohol abuse is the most common cause of cirrhosis. Although no
history of alcohol use is elicited in this confused patient, alcohol abuse
should be suspected.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Hypomagnesemia is present. The most common causes of
hypomagnesemia are alcoholism, malnutrition, malabsorption, chronic diarrhea,
and medication (e.g., diuretics). Hypomagnesemia occurs in 30% of patients with
alcoholism and 85% of patients with delirium tremens. Malnutrition and chronic
diarrhea contribute to the hypomagnesemia. Also, alcohol stimulates renal
excretion of magnesium. </span></p>

<p><span></span></p>

<p><span>Patients with hypomagnesemia are often hypokalemic. The key
to restoring potassium levels in such patients is to replenish magnesium. As
long as magnesium levels remain low, the kidneys will “leak” potassium. Merely
giving potassium is not enough. Both magnesium and potassium must be
supplemented. Hypomagnesemia should be suspected when hypokalemia does not
correct with potassium supplementation. (Note: Hypomagnesemia causes
hypokalemia; hypokalemia does <i>not</i>
cause hypomagnesemia.)</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is correct</span></b><span>. Chronic alcohol ingestion would
explain the myriad abnormal findings in this patient. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
36-year-old woman presents with mild confusion of three days duration. Her
medical history is unremarkable and she takes no medication.<span>&nbsp; </span>On physical examination, her supine
blood pressure and pulse are 110/70 mm Hg and 84/minute; the sitting blood
pressure and pulse are 104/62 mm Hg and 90/minute. (The patient cannot stand
because of confusion and weakness.) The heart is regular, the lungs are clear,
and the abdomen is scaphoid. There is no peripheral edema and no focal
neurological findings.<span >&nbsp; </span></span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span>Blood test results: </span></p>

<p><span></span></p>

<p><span>Na<sup>+ <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>130
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+<span >&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>5.5
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Cl<sup>-</sup> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>88
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>20
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>26
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7-18 mg/dL)</span></p>

<p><span>Cr <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.0
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.6-1.2 mg/dL)<span >&nbsp; </span></span></p>

<p><span>Glucose <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>88
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
40-70 mg/dL)</span></p>

<p><span>Uric acid <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>8.5
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.0-8.2 mg/dL)</span></p>

<p><span></span></p>

<p><span>Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Surreptitious use of furosemide</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cirrhosis of the liver</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Addison’s disease</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>SIADH (syndrome of inappropriate ADH)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nephrotic syndrome</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hyponatremia is a common disorder with numerous potential
causes. Patients with hyponatremia should be classified as 1) edematous, 2)
euvolemic, or 3) volume-contracted.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><i><span>Edematous</span></i><span> patients have bilateral, gravity-dependent edema. Common
causes of edema include congestive heart failure, hepatic cirrhosis, and
chronic renal failure (especially nephrotic syndrome). In these conditions, the
extracellular space is expanded, but the “effective circulating fluid volume”
is reduced. The body has excess total body sodium, but due to decreased
effective circulating volume, ADH is secreted, which causes water retention and
hyponatremia. </span></p>

<p><span></span></p>

<p><i><span>Euvolemic</span></i><span> patients are neither orthostatic nor edematous.
Hyponatremia in euvolemic patients may be caused by SIADH (syndrome of
inappropriate ADH), drugs (many medications cause hyponatremia), polydipsia, or
hypothyroidism. (Note: Technically, these patients are hypervolemic <i>physiologically</i>, but they are euvolemic <i>clinically</i>. Hyponatremic patients are
classified using clinical criteria; consequently, patients who are not
orthostatic or edematous are considered euvolemic, even if the extracellular
volume is mildly increased.)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><i><span>Hypovolemic</span></i><span> patients
have a positive “tilt” sign; i.e., they have orthostatic hypotension.
(Orthostatic hypotension is characterized by a drop in systolic blood pressure
of at least 20 mm Hg and a drop in diastolic blood pressure of at least 10 mm
Hg when moving from a supine to a standing position. Typically the pulse rises
by at least 10 beats per minute.) In hypovolemic patients, total body sodium is
low, resulting in a real decrease in extracellular and circulating fluid. The
hyponatremia is caused by “appropriate” release of ADH as a compensatory
response to volume contraction. </span></p>

<p><span></span></p>

<p><span>Distinguishing
euvolemia from hypovolemia can be difficult. In this vignette, for example, the
blood pressure falls as the patient moves from supine to sitting (the patient
cannot stand), but not by 20 mm Hg. Also, the pulse rises by less than
10/minute. Thus, the patient could be mildly volume-contracted. </span></p>

<p><span></span></p>

<p><span>Mild
volume-contraction can be identified by measuring the fractional excretion of
sodium, the serum uric acid level, and the BUN-creatinine ratio. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=248 valign=top>
  <p style="text-align:center;"><span>Manifestations
  of Volume Contraction</span></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p><span>Low fractional excretion of sodium
  (FE<sub>Na </sub><u>&lt;</u>1%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p><span>High serum uric acid level</span></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p><span>High BUN-creatinine ratio (&gt;10)</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The <b>fractional
excretion of sodium</b> (FE<sub>Na</sub>) is the percentage of the sodium
filtered by the kidney that is excreted in the urine. The kidneys are very
sensitive to volume contraction and respond by conserving sodium, leaving very
little sodium in the urine. In a patient who is volume-contracted, the FE<sub>Na
</sub>is usually <u>&lt;</u> 1%. Volume contraction also raises the serum uric
acid level. (Uric acid excretion is volume-dependent; consequently, serum uric
acid levels are inversely proportional to extracellular volume.) Finally,
volume contraction raises the BUN-creatinine ratio. </span></p>

<p><b><span>Answer C
is correct</span></b><span>. The patient in the vignette has signs
of volume contraction: drop in blood pressure and rise in pulse when moving
from supine to sitting, high BUN-creatinine ratio, and high serum uric acid
level. Volume contraction occurs in Addison’s disease, which is characterized
by mineralcorticoid (aldosterone) deficiency. Sodium is lost in the urine,
resulting in volume depletion and appropriate release of ADH, which causes
hyponatremia. Potassium excretion in the distal tubule is impaired, resulting
in hyperkalemia.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>.
Furosemide (Lasix) causes hypokalemia, not hyperkalemia.<span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. This
patient has no stigmata of chronic liver disease and is not edematous. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. SIADH
is associated with low serum uric acid levels (due to volume expansion) and
normal serum potassium levels.<span >&nbsp;&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>.
Nephrotic syndrome causes generalized edema (anasarca). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 30-year-old man experiences vomiting and diarrhea for five
days while traveling in Mexico. He is dizzy when he stands. His serum sodium
concentration is 129 mEq/L. Which of the following is most likely? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Increased intravascular volume </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increased serum atrial natriuretic
peptide</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased serum aldosterone level</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Decreased serum ADH (vasopressin) level</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urine osmolality greater than serum
osmolality</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Fluid loss can result in hypovolemia, or decreased blood
volume. Common causes include vomiting, diarrhea, sweating, hemorrhage, severe
burns, and diuretic use. Symptoms include fatigue, muscle cramps, postural
dizziness, and, in severe cases, syncope and coma. Findings include dry mucous
membranes, decreased skin turgor, postural hypotension, postural tachycardia,
and decreased jugular venous pressure. Hypovolemia results in four major
physiological responses: </span></p>

<p><span></span></p>

<p><b><span>Baroreflex
response.</span></b><span> In hypovolemic states, baroreceptors
have reduced responses due to reduced blood pressure. The reduced activation
results in enhanced sympathetic outflow which increases heart rate, increases
cardiac contractility, and produces arterial vasoconstriction. The results are
increased cardiac output and increased total peripheral resistance.</span></p>

<p><span></span></p>

<p><b><span>Renal
response.</span></b><span> Hypovolemia activates the
renin-angiotensin-aldosterone axis. Specialized cells in the kidney release
renin, which initiates the conversion of angiotensinogen to angiotensin I. Angiotensin
I is converted to angiotensin II by angiotensin-converting enzyme. Angiotensin
II causes arterial vasoconstriction and stimulates the release of aldosterone
from the adrenal cortex as well as release of ADH (vasopressin) from the
posterior pituitary. Aldosterone causes the kidneys to reabsorb sodium, which
leads to water reabsorption. ADH (vasopressin) causes the kidneys to absorb
water. The effect is to increase urine osmolality. </span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Cardiac
response.</span></b><span> In hypovolemic states, atrial
baroreceptors are <i>not</i> activated and,
therefore, atrial natriuretic peptide is <i>not</i>
released. Atrial natriuretic peptide is a potent vasodilator and facilitates
salt and water excretion, responses that are opposite to what would be desired
in hypovolemia. </span></p>

<p><span></span></p>

<p><b><span>Central
nervous system response</span></b><span>: Thirst is elicited
by activation of the renin-angiotensin system and by reduction in atrial
natriuretic peptide levels.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct</span></b><span>. Hypovolemia activates the renin-angiotensin
system, which leads to increased levels of aldosterone and ADH (vasopressin).
Water is absorbed from the kidney and the urine concentration (osmolality) is
increased. </span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Loss of fluid leads to contraction,
not expansion, of intravascular volume. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is incorrect</span></b><span>. In hypovolemic states, atrial
baroreceptors are not stimulated to release atrial natriuretic peptide. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Hypovolemia activates the
renin-angiotensin system, which raises aldosterone levels. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Hypovolemia activates the
renin-angiotensin system, which raises ADH (vasopressin) levels. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 35-year old man with a 5-day history of severe diarrhea
feels dizzy when he stands. His blood pressure while supine is 115/75 mm Hg and
his pulse is 88/minute. While standing, his blood pressure is 80/60 mm Hg and
his pulse is 120/minute. In addition to controlling his diarrhea, which of the
following is the most appropriate initial therapy for intravenous
administration?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>5% Dextrose in water</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fresh frozen plasma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Desmopressin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>0.9%<span>&nbsp; </span>Saline</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The patient in this vignette has orthostatic hypotension, a
sign of hypovolemia. In severe hypovolemia, the primary goal is to replenish
intravascular volume. This can be done by administering intravenous fluids. </span></p>

<p><span></span></p>

<p><span>Two types of fluids are commonly used for intravenous
therapy: crystalloid and colloid. Crystalloids are aqueous solutions of mineral
salts. An example of a crystalloid solution would be saline solution, which
contains sodium chloride. Colloids contain larger insoluble molecules. An
example of a colloid solution would be whole blood. </span></p>

<p><span></span></p>

<p>Crystalloids are categorized
by their tonicity (i.e., osmolality). A fluid that is <i>isotonic</i> has the same number of particles (i.e., the same
osmolality) as plasma. Isotonic fluids remain confined to the extracellular
space. They do not promote fluid shift into or out of cells. </p>

<p></p>

<p>0.9% Saline, also known as
“normal” or “physiologic” saline, is the most commonly used isotonic fluid. It
is the mainstay of resuscitation therapy. Most patients who are hypovolemic
because of vomiting, diarrhea, excessive perspiration, or decreased oral intake
can be safely treated with intravenous normal saline. Patients who are
hypovolemic because of severe blood loss may require blood transfusion.<span>&nbsp; </span></p>

<p></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D
is correct.<span >&nbsp; </span></span></b><span>0.9% Saline is “normal,” or isotonic, saline. It is the most
commonly used intravenous fluid for treatment of hypovolemia. Its distribution
is limited to the extracellular fluid (ECF) space.<span>&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is incorrect.<span >&nbsp; </span></span></b><span>Administering 5% Dextrose is the equivalent of administering
pure water. The dextrose (glucose) is rapidly consumed, and the water is
distributed throughout the total body water compartment, of which 2/3 is
intracellular and 1/3 is extracellular. Because most of the fluid goes into the
intracellular space, it is not a good therapy for hypovolemia. (The goal of
treating hypovolemia is to restore extracellular volume.)<span>&nbsp; </span>5% Dextrose is known as a “maintenance”
fluid; 0.9% Saline is known as a “replacement” fluid.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is incorrect. </span></b><span>F<span>resh frozen plasma</span> (FFP) refers to the liquid portion of human
blood that has been frozen and preserved, and will be used for blood
transfusion. FFP is used to treat deficiencies of coagulation proteins for
which specific factor concentrates are unavailable or undesirable. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is incorrect. </span></b><span>Desmopressin is a synthetic replacement
for the hormone, vasopressin. It is used to treat diabetes insipidus. </span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 45-year-old man is brought to the emergency room because
of blurred vision, headache, abdominal pain, and vomiting. His blood pressure
is 125/80, pulse is 55, and respirations are 26/min. Lab studies show:</span></p>

<p><span></span></p>

<p><span>Arterial blood gas analysis (on room air):</span></p>

<p><span></span></p>

<p><span>pH<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>7.30<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7.35-7.45)</span></p>

<p><span>pO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>104
mmHg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
75-105 mm Hg)</span></p>

<p><span>pCO<sub>2</sub><span>&nbsp;&nbsp; </span>24
mmHg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
33-45 mm Hg)</span></p>

<p><span></span></p>

<p><span>Serum chemistries:</span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4.5
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>85
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Which of the following would best explain these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acetaminophen intoxication</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Narcotic intoxication</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Methanol intoxication</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Excessive diuretic use </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumonia</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The normal pH of arterial blood is 7.40 <u>+</u> 0.03. This
patient has a low pH (7.30), indicating acidosis. Acidosis may be classified as
respiratory or metabolic. Respiratory acidosis is characterized by a primary
increase in pCO<sub>2</sub> with a compensatory increase in HCO<sub>3</sub><sup>-
</sup>. Metabolic acidosis is characterized by a primary decrease in HCO<sub>3</sub><sup>-</sup>
and a compensatory decrease in pCO<sub>2</sub>. This patient has a low serum
HCO<sub>3</sub><sup>-</sup> of 15 mEq/L (normal is 22-28 mEq/L) and a low
arterial pCO<sub>2</sub> of 24 mmHg (normal is 35-45), indicating metabolic
acidosis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>There are two types of metabolic acidosis: “normal anion
gap” and “increased anion gap.” The anion gap is calculated as follows: Na<sup>
</sup>&#8211; (Cl<sup> </sup>+<sup> </sup>HCO<sub>3</sub>). A normal anion gap
is 12 <u>+</u> 2 mmol/L. In this patient, the anion gap is 40. Thus, the
patient has an increased anion gap metabolic acidosis. The principal causes of
increased anion gap metabolic acidosis are:</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=392 valign=top>
  <p style="text-align:center;"><span>Increased
  Anion Gap Metabolic Acidosis </span></p>
  </td>
 </tr>
 <tr>
  <td width=392 valign=top>
  <p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Ketoacidosis
  (caused by diabetes, alcohol, or starvation)</span></p>
  <p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Lactic acidosis
  (due to tissue hypoxia)</span></p>
  <p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Chronic renal
  failure (accumulation of sulfates, phosphates, and uric acid)</span></p>
  <p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Intoxication
  (salicylates, ethanol, methanol, formaldehyde, ethylene glycol, paraldehyde,
  isoniazid, metformin)</span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span >&nbsp;</span></span></p>

<p><span>General symptoms of acidosis include headache, fatigue,
sleepiness, abdominal pain, nausea, and vomiting. Treatment depends on the
underlying cause.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is correct</span></b><span>. Methanol intoxication causes an
increased anion gap acidosis.* </span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Acetaminophen intoxication causes
liver damage by depleting hepatic glutathione, which leads to accumulation of a
hepatotoxic metabolite. Treatment with acetylcysteine, a substrate for
glutathione, can prevent liver damage. </span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. Narcotic intoxication causes
respiratory depression, which results in respiratory acidosis. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Excessive diuretic use is associated
with metabolic alkalosis. </span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Pneumonia may be associated with
respiratory alkalosis. </span></p>

<p><span></span></p>

<p><span>*Note: Methanol and ethylene glycol intoxication produce
similar symptoms. Methanol is found in gas-line antifreeze, carburetor fluid,
duplicator fluid, and windshield washer fluid. Ethylene glycol is found in
anti-freeze and windshield de-icer. Both methanol and ethylene glycol are
metabolized by alcohol dehydrogenase. Methanol is metabolized to formic acid;
ethylene glycol is metabolized to glycolate. Both methanol and ethylene glycol
intoxication are treated with intravenous ethanol (which inhibits alcohol
dehydrogenase), intravenous sodium bicarbonate (to reverse life-threatening
acidosis), and hemodialysis (to remove the alcohols and their metabolites). A
major difference between methanol and ethylene glycol intoxication is that
methanol causes visual disturbance (blurred vision, decreased visual acuity,
whiteness of the visual field), whereas ethylene glycol causes renal failure
(due to calcium oxalate crystal deposition) and cardiopulmonary failure. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 24-year-old woman is worried about recent weight gain. She
has gained 3 lbs in the last 3 months. Her height is 5’6”. Her weight is 125
lbs. Her lab tests show:</span></p>

<p><span></span></p>

<p><span>Arterial blood gas analysis (on room air):</span></p>

<p><span></span></p>

<p><span>pH<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>7.34<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7.35-7.45)</span></p>

<p><span>pO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>102
mmHg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
75-105 mm Hg)</span></p>

<p><span>pCO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>31
mmHg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
33-45 mm Hg)</span></p>

<p><span></span></p>

<p><span>Serum chemistries:</span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.8
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>113
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7-18 mg/dL)</span></p>

<p><span>Cr<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.1
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.6-1.2 mg/dL)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>UA: pH 6.5; no blood, protein, or casts</span></p>

<p><span></span></p>

<p><span>Urine Na<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>65
mEq/L</span></p>

<p><span>Urine K<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>8
mEq/L</span></p>

<p><span>Urine Cl<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>94
mEq/L</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diuretic abuse</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Laxative abuse</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Surreptitious vomiting</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Renal tubular acidosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Alcoholic ketoacidosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>This patient has a low pH of 7.34, indicating acidosis. The
HCO<sub>3</sub><sup>- </sup>is low (15 mEq/L), indicating a metabolic acidosis.
The anion gap is normal at 12. Therefore, this patient has a normal anion gap
metabolic acidosis. </span></p>

<p><span></span></p>

<p><span>The two most common causes of normal anion gap acidosis are:</span></p>

<p><span><span>1)<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diarrhea</span></p>

<p><span><span>2)<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal tubular acidosis. </span></p>

<p><span></span></p>

<p><span>To distinguish these two, the urine anion gap is calculated.</span></p>

<p><span></span></p>

<p><span>Urine anion gap = Urine (Na + K &#8211; Cl).</span></p>

<p><span></span></p>

<p><span>In normal subjects, the urine anion gap is approximately
zero<strong>. </strong></span></p>

<p><strong><span></span></strong></p>

<p><span>In metabolic acidosis, the kidneys get rid of acid by
excreting NH<sub>4</sub><sup>+</sup> in the urine (if the kidneys are working
properly.) When NH<sub>4</sub><sup>+</sup> is excreted in the urine, Cl<sup>-</sup>
is excreted along with it. The rise in urinary Cl<sup>-</sup> causes the urine
anion gap to become negative, usually ranging from -20 to more than -50 meq/L. </span></p>

<p><span></span></p>

<p><span>An example of this situation would be diarrhea, which causes
metabolic acidosis. To get rid of the acid, the kidneys excrete NH<sub>4</sub><sup>+</sup>.
In the process of excreting NH<sub>4</sub><sup>+</sup>, Cl<sup>- </sup>is also
excreted. This increases the amount of Cl<sup>-</sup> in the urine, causing the
urine anion gap to become negative.<span >&nbsp;
</span></span></p>

<p><span>By contrast, if the kidneys cannot excrete NH<sub>4</sub><sup>+</sup>
adequately (e.g., renal tubular acidosis) the urine Cl<sup>-</sup> level does
not rise. The result is a positive urine anion gap. </span></p>

<p><span>In summary,</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A positive urine anion gap suggests
renal tubular acidosis. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A negative urine anion gap suggests
diarrhea. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is
correct</span></b><span>. This patient has a normal
anion gap metabolic acidosis. The two most common causes of this are diarrhea
and renal tubular acidosis, which can be distinguished by calculating the urine
anion gap. Here, the urine anion gap is 65+8 - 94 = -21 mEq/L. A negative urine
anion gap is consistent with diarrhea, which could be due to laxative abuse.
(Laxative abuse occurs in some patients who obsess over weight gain.)</span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Diuretic abuse causes a metabolic
alkalosis.</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Vomiting causes a metabolic
alkalosis.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Renal tubular acidosis causes a
normal anion gap metabolic acidosis with a positive urine anion gap. In this
patient, the urine anion gap is negative.</span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Ketoacidosis causes an increased
anion gap metabolic acidosis.</span></p>

<p><span></span></p>

<p><i><span>Note</span></i><span>: All of the choices above &#8211; diuretic abuse, laxative
abuse, surreptitious vomiting, renal tubular acidosis, and alcoholic
ketoacidosis &#8211; can cause hypokalemia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 34-year-old man presents with a 3-day history of vomiting.<span>&nbsp; </span>He feels lightheaded when he stands or
walks. Which of the following arterial blood gas values would be expected?</span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>pH<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>pCO<sub>2</sub><span>&nbsp; </span>(mmHg)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>HCO<sub>3</sub><sup>-</sup>
(mEq/dL)</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>7.30<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>28<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.30<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>55<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>27</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.40<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>40<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>24</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>7.50<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>30<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>22</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.50<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>47<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>35</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>Prolonged vomiting causes volume depletion, which reduces
GFR, thereby stimulating the renin-angiotensin-aldosterone axis. This leads to
bicarbonate reabsorption in the kidney, which causes metabolic alkalosis.
Metabolic alkalosis is characterized by an elevated pH and an elevated serum
bicarbonate (HCO<sub>3</sub><sup>-</sup>)<b>
</b>level. Respiratory compensation (through hypoventilation) increases the
arterial pCO<sub>2</sub>, which blunts the rise in the arterial pH.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct</span></b><span>.<span >&nbsp;
</span>Prolonged vomiting is associated with metabolic alkalosis. <b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is incorrect</span></b><span>. These values (low pH, low HCO<sub>3</sub><sup>-</sup>)
indicate metabolic acidosis with a compensatory decrease in pCO<sub>2</sub>.</span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. These values (low pH, high pCO<sub>2</sub>)
indicate respiratory acidosis with a compensatory increase in HCO<sub>3</sub><sup>-</sup>.</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. These values are within the normal
range.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. These values (high pH, low pCO<sub>2</sub>)
indicate respiratory alkalosis with a compensatory decrease in HCO<sub>3</sub><sup>-</sup>.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 20-year-old man has been weak and dizzy for the past two
days. He just returned from Mexico where he developed abdominal cramping and
diarrhea that have not yet subsided. The diarrhea is watery, voluminous, and
non-bloody. He has mild nausea but no vomiting. On examination, his supine
blood pressure is 115/65 mm Hg and his pulse is 110/minute. While standing, his
blood pressure is 80/50 mm Hg and his pulse is 160/minute. He is afebrile and
his abdomen is non-tender. The stool is heme-negative. What is the most
important initial treatment?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ciprofloxacin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Erythromycin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Metronidazole</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Rehydration</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Potassium chloride</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Gastrointestinal fluid loss from vomiting or diarrhea can
lead to severe volume depletion. In such individuals, rehydration is a top
priority. The presence of orthostatic hypotension in a patient with voluminous
diarrhea suggests significant volume depletion. (Orthostatic hypotension is
defined as a drop in systolic blood pressure of at least 20 mm Hg or a drop in
diastolic blood pressure of at least 10 mm Hg after rising from the supine to
the standing position.) The presence of resting tachycardia, as well as
tachycardia that increases with standing, also suggests volume depletion.
Worsening hypovolemia can lead to shock and cardiovascular collapse. These
complications can be prevented with prompt rehydration. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is correct</span></b><span>. Rehydration is the most important
initial treatment in a patient who is severely volume depleted.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 59-year-old man with diabetes, hypertension, and chronic
renal insufficiency is seen for a routine clinic visit.<span>&nbsp; </span>He is feeling well.<span>&nbsp; </span>His only medicines are metformin and
amlodipine.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Lab test results show: </span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>138
mEq/L</span></p>

<p><span>K<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5.5
mEq/L</span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>110
mEq/L</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>19
mEq/L</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>188
mg/dL</span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>25
mg/dL</span></p>

<p><span>Cr<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.0
mg/dL</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of the following best explains these values?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diabetic ketoacidosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hyporeninemic hypoaldosteronism</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lactic acidosis </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Metabolic acidosis secondary to
end-stage renal disease</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Metabolic acidosis secondary to
persistent diarrhea</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>The low bicarbonate concentration indicates metabolic
acidosis. The anion gap is normal: 138 - (110+19) = 9. Common causes of a
normal-anion gap metabolic acidosis include diarrhea and renal tubular acidosis
(RTA). Patients with diarrhea usually have low or normal serum potassium
levels. Patients with RTA have variable serum potassium levels, depending on
the type of RTA. The most common type of RTA is type IV RTA, which usually
occurs in people with diabetes. Diabetes affects the kidneys in such a way that
renin production is impaired. This leads to “blunting” of the
renin-angiotensin-aldosterone axis (renin, angiotensin, and aldosterone levels
are reduced). Reduction in aldosterone results in hyperkalemia and a
normal-anion gap metabolic acidosis. The combination of hyperkalemia and a
normal anion gap acidosis suggests type IV RTA, or hyporeninemic
hypoaldosteronism.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is correct</span></b><span>. The combination of hyperkalemia and a
normal anion gap acidosis suggests type IV RTA, or hyporeninemic
hypoaldosteronism.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Diabetic ketoacidosis (DKA) causes a
high-anion gap metabolic acidosis. Hyperglycemia is usually severe. Patients
feel ill and must be admitted to the hospital. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Lactic acidosis causes a high-anion
gap metabolic acidosis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. End-stage renal disease causes a
high-anion gap metabolic acidosis (usually with a higher serum creatinine level
than is seen in this patient). </span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Diarrhea can cause a normal-anion gap
metabolic acidosis, usually associated with hypokalemia, not hyperkalemia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 54-year-old man presents with a 3-month history of
exertional shortness of breath. He sleeps on three pillows to breathe
comfortably, and often wakes up at night coughing, wheezing, and gasping for
air. Physical examination shows jugular venous distension, an S3 at the cardiac
apex, late inspiratory crackles in the lung bases, and pitting edema of the
legs. The level of which of the following substances found in the pulmonary
capillaries would be increased in this patient? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Renin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Angiotensin-converting enzyme</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Angiotensin II</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Aldosterone</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Vasopressin</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The patient has symptoms and signs of congestive heart
failure. Left-sided heart failure causes orthopnea (sleeping on three pillows
to breathe comfortably), paroxysmal nocturnal dyspnea (waking up at night
coughing, wheezing, and gasping for air), and pulmonary edema (crackles in the
lung bases).<span >&nbsp; </span>Right-sided heart
failure causes jugular venous distension and pitting edema of the legs.<span>&nbsp; </span>Decreased cardiac output results in
decreased “effective circulating volume,” which activates the
renin-angiotensin-aldosterone system and the sympathetic nervous system. </span></p>

<p><span></span></p>

<p><span>These are the steps in the renin-angiotensin-aldosterone
system:</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased perfusion of the
juxtaglomerular apparatus in the kidney's macula densa stimulates the
juxtaglomerular cells to release the enzyme renin.</span></p>

<p><span></span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renin cleaves an inactive peptide, <span>angiotensinogen</span>, converting it into <span>angiotensin I</span>.</span></p>

<p><span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Angiotensin I is converted to <span>angiotensin II</span> by
angiotensin-converting enzyme (ACE), which is found mainly in lung capillaries.</span></p>

<p><span></span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Angiotensin II is the major bioactive
product of the renin-angiotensin system. It is a potent vasoconstrictor of
arterioles throughout the body. In the kidney, it constricts afferent and
efferent arterioles within the glomerulus, and stimulates sodium reabsorption
in the tubules. In the adrenal cortex, it stimulates release of aldosterone
from the zona glomerulosa. </span></p>

<p><span></span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aldosterone</span><span> stimulates reabsorption of sodium and water and secretion
of potassium in the distal convoluted tubules of the kidneys. This increases
blood volume and blood pressure.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B
is correct. </span></b><span>Angiotensin-converting enzyme is
produced mainly by the pulmonary vascular endothelium. </span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect. </span></b><span>Renin is produced by juxtaglomerular
cells in the kidney. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect.</span></b><span> Angiotensin I is converted to
angiotensin II through removal of two C-terminal residues by the enzyme <span>angiotensin-converting enzyme.</span> </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect.</span></b><span> Aldosterone is produced by the zona
glomerulosa cells of the adrenal gland.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect.</span></b><span> Vasopressin is produced by the
hypothalamus and stored in the posterior pituitary. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An 82-year-old woman with a history of diabetes mellitus and
osteoarthritis is brought to the emergency department because of confusion. Her
blood pressure is 108/52 mm Hg, pulse is 92/minute, and respirations are
24/minute. </span></p>

<p><span></span></p>

<p><span>Lab studies show:</span></p>

<p><span></span></p>

<p><span>Arterial blood gas analysis (on room air):</span></p>

<p><span></span></p>

<p><span>pH<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>7.25</span></p>

<p><span>pO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>97
mmHg</span></p>

<p><span>pCO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>22
mmHg</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
mEq/L</span></p>

<p><span></span></p>

<p><span>Serum chemistries:</span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>136
mEq/L</span></p>

<p><span>K<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3.9
mEq/L</span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>102
mEq/L</span></p>

<p><span>CO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
mEq/L</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>200
mg/dL</span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>18
mg/dL</span></p>

<p><span>Cr<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.4
mg/dL</span></p>

<p><span></span></p>

<p><span>Ketones<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of the following would best explain these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diabetic ketoacidosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Prolonged vomiting</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal tubular acidosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Diarrhea</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Salicylate intoxication</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>The patient has a low pH, indicating acidosis. The serum HCO<sub>3</sub>
is also low, indicating metabolic acidosis. The anion gap is elevated at 22.
Thus, the patient has a high-anion gap metabolic acidosis. Salicylate
intoxication is associated with a high-anion gap metabolic acidosis. (The
history of osteoarthritis in this patient is a clue that she may be taking
aspirin.)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct</span></b><span>. Salicylate intoxication is associated
with a high-anion gap metabolic acidosis.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Diabetic ketoacidosis causes a
high-anion gap metabolic acidosis, but the presence of serum ketones is
required to make the diagnosis. </span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. Prolonged vomiting causes metabolic
alkalosis. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Renal tubular acidosis causes a
normal-anion gap metabolic acidosis.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Diarrhea causes a normal-anion gap
metabolic acidosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 65-year-old man with a history of congestive heart failure
due to coronary artery disease presents with a 4-day history of fever, myalgia,
productive cough, and worsening shortness of breath. On exam he is noted to be
agitated and confused. Temperature is 39.2</span><span><span>°</span></span><span>C,
pulse is 130/minute, blood pressure is 80/40 mmHg, and respirations are
32/minute. He is flushed and diaphoretic with warm skin. His neck veins are
flat. Cardiac exam reveals a rapid rate and a short systolic ejection murmur.
Chest exam reveals increased fremitus, dullness to percussion, and crackles in
the right mid-lung field. The left chest is unremarkable. Laboratory tests show
a white blood cell count of 16,000/mm<sup>3</sup>. The electrocardiogram is
unchanged from a previous reading, except for the presence of sinus
tachycardia. Transthoracic echocardiogram reveals normal chamber size, good biventricular
contractility, and a left ventricular ejection fraction of 60%. What is the
most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Cardiogenic
shock</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hemorrhagic
shock</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Septic
shock</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Shock
due to massive pulmonary embolism</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cardiac
tamponade</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Shock is
the final common pathway for several potentially lethal clinical events,
including severe hemorrhage, extensive trauma or burns, large myocardial
infarction, massive pulmonary embolism, and microbial sepsis. <span>Shock is characterized by systemic hypotension
due either to reduced cardiac output or to reduced effective circulating blood
volume</span>. The consequences are <span>impaired
tissue perfusion and cellular hypoxia</span>. At the outset the cellular injury
is reversible; however, prolonged shock eventually leads to irreversible tissue
injury that often proves fatal.</span></p>

<p><span>The causes
of shock fall into three general categories:<a
name=4-u1.0-B978-1-4377-0792-2..50009-2--celi> </a></span></p>

<p><span><span></span></span></p>

<table border=0 cellpadding=0>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Cardiogenic
  shock</span></i><span>
  results from low cardiac output due to myocardial pump failure. This can be
  due to intrinsic myocardial damage (infarction), ventricular arrhythmias,
  extrinsic compression (e.g., cardiac tamponade<a
  name=4-u1.0-B978-1-4377-0792-2..50009-2--intr></a>), or outflow obstruction
  (e.g., pulmonary embolism).</span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Hypovolemic
  shock</span></i><span>
  results from low cardiac output due to the loss of blood or plasma volume,
  such as can occur with massive hemorrhage or fluid loss from severe burns.</span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Septic
  shock</span></i><span>
  results from vasodilation and peripheral pooling of blood as part of a
  systemic immune reaction to bacterial or fungal infection. Its complex
  pathogenesis is discussed in further detail below.</span></p>
  </td>
 </tr>
</table>

<span></span>

<p><a name=4-u1.0-B978-1-4377-0792-2..50009-2--ceta></a><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Type of Shock</span></b></p>
   <p style="text-align:center;"><b><span></span></b></p>
   </td>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Clinical Example</span></b></p>
   <p style="text-align:center;"><b><span></span></b></p>
   </td>
   <td width=148 valign=bottom>
   <p style="text-align:center;"><b><span>Principal Mechanisms</span></b></p>
   <p style="text-align:center;"><b><span></span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width=444 colspan=3 valign=top>
  <p><b><span></span></b></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>&nbsp;<b>CARDIOGENIC</b></span></p>
  <p><span></span></p>
  </td>
  <td width=206 valign=top>
  <p><span>Myocardial
  infarction</span></span></p>
  <p><span>Ventricular
  rupture</span></span></p>
  <p><span>Arrhythmia</span></span></p>
  <p><span>Cardiac
  tamponade</span></span></p>
  <p><span>Pulmonary
  embolism</span></span><span></span></p>
  </td>
  <td width=148 valign=top>
  <p><span>Failure
  of myocardial pump resulting from intrinsic myocardial damage, extrinsic
  pressure, or obstruction to outflow</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>HYPOVOLEMIC</span></b></p>
  <p><span></span></p>
  </td>
  <td width=206 valign=top>
  <p><span>Fluid
  loss (e.g., hemorrhage, vomiting, diarrhea, burns, or trauma)</span></p>
  </td>
  <td width=148 valign=top>
  <p><span>Inadequate
  blood or plasma volume</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>&nbsp;<b>SEPTIC</b></span></p>
  </td>
  <td width=206 valign=top>
  <p><span>Overwhelming
  microbial infections (bacterial and fungal)</span></p>
  <p><span>Superantigens
  (e.g., toxic shock syndrome)</span></p>
  </td>
  <td width=148 valign=top>
  <p><span>Peripheral
  vasodilation and pooling of blood; endothelial activation/injury;
  leukocyte-induced damage, disseminated intravascular coagulation; activation
  of cytokine cascades</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
principal signs of shock are low blood pressure, decreased urine output, and
confusion, but these are not always present. Common findings in shock are
listed below.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=243 valign=top>
  <p style="text-align:center;"><span>Signs and Symptoms</span></p>
  <p><b><span></span></b></p>
  </td>
  <td width=236 valign=top>
  <p style="text-align:center;"><span>Physiology</span></p>
  </td>
 </tr>
 <tr>
  <td width=243 valign=top>
  <p><b><span></span></b></p>
  </td>
  <td width=236 valign=top>
  <p><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=243 valign=top>
  <p><span>Cardiogenic
  shock</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Distended jugular veins<span>&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Weak or absent pulse </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Arrhythmia (sometimes) </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Pulsus paradoxus (in the case of tamponade) </span></p>
  <p><b><span></span></b></p>
  </td>
  <td width=236 valign=top>
  <p><span>Cardiogenic
  shock</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Central
  venous pressure: &#8593; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cardiac
  output: &#8595; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic
  vascular resistance: &#8593; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous
  oxygen saturation: &#8595; </span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=243 valign=top>
  <p><span>Hypovolemic
  shock</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Tachycardia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Rapid, weak, thready pulse </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Cool, clammy skin </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Rapid and shallow respirations </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Hypothermia </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Thirst and dry mouth </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Cold and mottled skin</span></p>
  </td>
  <td width=236 valign=top>
  <p><span>Hypovolemic
  shock </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Central
  venous pressure: &#8595;<span >&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cardiac
  output: &#8595;<span >&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic
  vascular resistance: &#8593;</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous
  oxygen saturation: &#8595; </span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=243 valign=top>
  <p><span>Septic
  shock</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Fever</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Warm and sweaty skin</span></p>
  </td>
  <td width=236 valign=top>
  <p><span>Septic
  shock</span></p>
  <p><span></span></p>
  <p><span>Early</span></p>
  <p><span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Central
  venous pressure: variable </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cardiac
  output: &#8593; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic
  vascular resistance: &#8595; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous O<sub>2</sub>
  saturation: &#8593;</span></p>
  <p><span>Late</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Central
  venous pressure: variable </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cardiac
  output: &#8595; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic
  vascular resistance: &#8593;</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous O<sub>2</sub>
  saturation: variable </span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct. </span></b><span>The
presence of fever, productive cough, consolidative findings on lung exam, and
elevated white blood cell count suggest that the patient has pneumonia and
hypotension is due to septic shock. Septic shock develops as a consequence of
vasodilation, particularly of the capacitance vessels, by nitric oxide and
other mediators produced as part of the generalized systemic inflammatory
response syndrome. The vasodilation causes a relative intravascular volume
deficit and large volumes of fluid must be administered to restore the
intravascular volume. Cardiac output is maintained during the initial stages of
the disease, although vasopressors such as norepinephrine are sometimes needed
to restore the systemic blood pressure and prevent subsequent organ failure. </span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Cardiogenic shock is unlikely because the patient has no acute EKG changes,
left ventricular contractility is well preserved, and lung exam does not show
evidence of pulmonary edema. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
This patient has no history of hematemesis, melena, or trauma. </span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Hypotension due to massive pulmonary embolism is caused by obstruction of the
pulmonary vasculature and inadequate filling of the left ventricle.
Characteristic findings on echocardiogram include an enlarged right ventricle
with decreased contractility. </span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect</span></b><span>.
Cardiac tamponade is associated with jugular venous distension, hypotension,
tachycardia, and pulsus paradoxus. This patient does not have jugular venous
distension, and pericardial fluid was not seen on the echocardiogram. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 66-year-old
man with a 30 pack-year smoking history presents with a cough and weight loss
of three months duration. The cough is productive of bloody sputum. The patient
has lost 15 pounds.<span >&nbsp; </span>Temperature is
37.4<sup>o</sup>C, blood pressure is 140/70 mm Hg without orthostatic change,
pulse is 80/minute, and respiratory rate is 24/minute.<span>&nbsp; </span>Lung examination reveals dullness to
percussion in the right lower posterior lung field. The legs are not edematous.</span></p>

<p><span></span></p>

<p><span>Blood test
results: </span></p>

<p><span></span></p>

<p><span>Na<sup>+<span>&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>120
mEq/L </span></p>

<p><span>K<sup>+<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>
</sup>4.0 mEq/L </span></p>

<p><span>Cl<sup>-<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>
</sup>88 mEq/L </span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp; </span>24 mEq/L </span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>10
mg/dL</span></p>

<p><span>Creatinine
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1
mg/dL</span></p>

<p><span></span></p>

<p><span>What is
the most likely cause of hyponatremia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Congestive
heart failure</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diuretic
use</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>SIADH</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Starvation</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The patient in this vignette is hyponatremic and
clinically euvolemic. (He is considered “euvolemic” because he is neither
orthostatic nor edematous.) Causes of euvolemic hyponatremia include: </span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>SIADH
(syndrome of inappropriate ADH)</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Drugs
(many medications cause hyponatremia)</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polydipsia</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypothyroidism</span></p>

<p><span></span></p>

<p><span>SIADH is characterized by “inappropriate”
release of ADH, i.e., release independent of serum osmolality. Common causes of
SIADH include small-cell carcinoma of the lung, pneumonia, brain tumor, head
trauma, stroke, meningitis, and encephalitis. (SIADH is usually due to
pulmonary or intracranial pathology.) The presence of significant hyponatremia
in a clinically euvolemic patient should raise concern for SIADH.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. SIADH is an important
cause of hyponatremia. Typically, patients with SIADH are clinically
euvolemic.<span >&nbsp; </span>A major cause of SIADH
is small-cell carcinoma of the lung. The findings of weight loss, hemoptysis,
pleural effusion, and tachypnea in this patient are worrisome for lung cancer.
The final diagnosis was small cell carcinoma of the lung, which caused SIADH
and all the presenting symptoms and signs. </span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section">Molecular
</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Cellular</span></p>

<p style="text-align:center;"><span
class="Section">Systems</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following is <i>not</i> true of
apoptosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>It
can occur under normal physiological conditions</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is characterized by chromatin aggregation, nuclear condensation, and
cytoplasmic shrinking</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is characterized by partition of the nucleus and cytoplasm into membrane-bound
vesicles, which are phagocytized</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>It
elicits a major inflammatory response</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is an energy-dependent process</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i><span>A<span>poptosis</span></span></i><span> is a pathway of cell
death that is induced by a tightly regulated “suicide” program in which cells
destined to die activate enzymes that degrade the cells’ own nuclear DNA and
nuclear and cytoplasmic proteins. Apoptotic cells break up into fragments, called
apoptotic bodies, which contain portions of the cytoplasm and nucleus. The
plasma membrane of the apoptotic bodies remains intact, but its structure is
altered in such a way that it becomes a “tasty” target for phagocytes. The dead
cell and its fragments are rapidly devoured, before the contents have leaked
out, and therefore cell death by this pathway does not elicit an inflammatory
reaction in the host. </span></p>

<p><span></span></p>

<p><span>Apoptosis
is a unique mechanism of cell death, distinct from necrosis. Necrosis is
characterized by loss of membrane integrity, enzymatic digestion of cells,
leakage of cellular contents, and frequently a host reaction. </span></p>

<p><span></span></p>

<p><span>CAUSES OF
APOPTOSIS </span></p>

<p><span>Apoptosis
occurs normally both during development and throughout adulthood, and serves to
eliminate unwanted, aged, or potentially harmful cells. It is also a pathologic
event when diseased cells become damaged beyond repair and are eliminated.</span></p>

<p><span></span></p>

<p><span>Apoptosis
in Physiologic Situations </span></p>

<p><span></span></p>

<p><i><span>Death
by apoptosis is a normal phenomenon that serves to eliminate cells that are no
longer needed, and to maintain a steady number of various cell populations in
tissues</span></i><span>.
It is important in the following physiologic situations: </span></p>

<p><span></span></p>

<table border=0 cellpadding=0>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>The
  programmed destruction of cells during embryogenesis</span></i><span>, including
  implantation, organogenesis, developmental involution, and metamorphosis. </span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Involution
  of hormone-dependent tissues upon hormone withdrawal</span></i><span>, such as endometrial
  cell breakdown during the menstrual cycle, ovarian follicular atresia in menopause,
  the regression of the lactating breast after weaning, and prostatic atrophy
  after castration.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Cell
  loss in proliferating cell populations</span></i><span>, such as immature lymphocytes in the bone
  marrow and thymus that fail to express useful antigen receptors<a
  name=4-u1.0-B978-1-4377-0792-2..50006-7--intr>, B lymphocytes in germinal
  centers, and epithelial cells in intestinal crypts.</a></span></p>
  <span></span>
  <p><span><span></span></span></p>
  </td>
  <span></span>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><span><i><span>Elimination of
  potentially harmful self-reactive lymphocytes</span></i></span><span><span>, either before or
  after they have completed their maturation, so as to prevent reactions against
  one’s own tissues.</span></span></p>
  <span></span>
  <p><span><span></span></span></p>
  </td>
  <span></span>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><span>Death of
  host cells that have served their useful purpose, such as neutrophils in an <i>acute
  inflammatory response</i>, and lymphocytes at the end of an <i>immune
  response</i>. In these situations cells undergo apoptosis because they are
  deprived of necessary survival signals, such as growth factors.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>Apoptosis
in Pathologic Conditions </span></p>

<p><i><span>Apoptosis
eliminates cells that are injured beyond repair without eliciting a host
reaction, thus limiting collateral tissue damage</span></i><span>. Death by apoptosis is
responsible for loss of cells in a variety of pathologic states:<a
name=4-u1.0-B978-1-4377-0792-2..50006-7--celi> </a></span></p>

<p><span><span></span></span></p>

<table border=0 cellpadding=0>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>DNA
  damage</span></i><span>.
  Radiation, cytotoxic anticancer drugs, and hypoxia can damage DNA, either
  directly or via production of free radicals. If repair mechanisms cannot cope
  with the injury, the cell triggers intrinsic mechanisms that induce
  apoptosis. In these situations elimination of the cell may be a better
  alternative than risking mutations in the damaged DNA, which may result in
  malignant transformation. These injurious stimuli can cause apoptosis if the
  insult is mild, but larger doses of the same stimuli may result in necrotic
  cell death.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Accumulation
  of misfolded proteins</span></i><span>. Improperly folded proteins may arise because of
  mutations in the genes encoding these proteins or because of extrinsic
  factors, such as damage caused by free radicals. Excessive accumulation of
  these proteins in the endoplasmic reticulum results in apoptotic cell death.
  Apoptosis caused by the accumulation of misfolded proteins may be responsible
  for certain degenerative diseases of the central nervous system and other
  organ systems.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Cell
  death in certain infections</span></i><span>, particularly viral infections, in which loss
  of infected cells is largely due to apoptosis that may be induced by the
  virus (as in adenovirus and HIV infections) or by the host immune response
  (as in viral hepatitis). An important host response to viruses consists of
  cytotoxic T lymphocytes <a name=4-u1.0-B978-1-4377-0792-2..50006-7--p26></a>specific
  for viral proteins, which induce apoptosis of infected cells in an attempt to
  eliminate reservoirs of infection. During this process there can be
  significant tissue damage. The same T-cell-mediated mechanism is responsible
  for cell death in <i>tumors</i> and cellular rejection of <i>transplants</i>.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Pathologic
  atrophy in parenchymal organs after duct obstruction</span></i><span>, such as occurs in
  the pancreas, parotid gland, and kidney.</span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

<span></span>

<p><a name=4-u1.0-B978-1-4377-0792-2..50006-7--cese></a><span></span></p>

<p><span>CELLULAR
CHANGES IN APOPTOSIS </span></p>

<p><b><span></span></b></p>

<p><b><span>Overview. </span></b><span>The
morphological features of apoptosis consist of chromatin condensation, cell
shrinkage, and membrane blebbing, which can be clearly observed by light</span></span><span> microscopy. The
biochemical features include DNA fragmentation, protein cleavage at specific locations,
increased mitochondrial membrane permeability, and the appearance of
phosphatidylserine on the cell membrane surface.</span></p>

<p><span></span></p>

<p><b><span>Cell
shrinkage</span></b><span>.
The cell is smaller in size; the cytoplasm is dense; and the organelles, though
relatively normal, are more tightly packed. (Recall that in other forms of cell
injury, an early feature is cell swelling, not shrinkage.)</span></p>

<p><span></span></p>

<p><b><span>Chromatin
condensation</span></b><span>.
This is the most characteristic feature of apoptosis. The chromatin aggregates
peripherally, under the nuclear membrane, into dense masses of various shapes
and sizes. The nucleus itself may break up, producing two or more fragments.</span></p>

<p><span></span></p>

<p><b><span>Formation
of cytoplasmic blebs and apoptotic bodies</span></b><span>. The apoptotic cell first shows
extensive surface blebbing, then undergoes fragmentation into membrane-bound
apoptotic bodies composed of cytoplasm and tightly packed organelles, with or
without nuclear fragments.</span></p>

<p><span></span></p>

<p><b><span>Phagocytosis
of apoptotic cells or cell bodies, usually by macrophages</span></b><span>. The apoptotic bodies
are rapidly ingested by phagocytes and degraded by the phagocyte's lysosomal
enzymes.</span></p>

<p><span>Plasma
membranes are thought to remain intact during apoptosis, until the last stages,
when they become permeable to normally retained solutes. This classical
description is accurate with respect to apoptosis <a
name=4-u1.0-B978-1-4377-0792-2..50006-7--p27></a>during physiologic conditions
such as embryogenesis and deletion of immune cells. However, forms of cell
death with features of necrosis as well as of apoptosis are not uncommon after
many injurious stimuli. Under such conditions the severity rather than the
nature of the stimulus determines the pathway of cell death, necrosis being the
major pathway when there is advanced ATP depletion and membrane damage.</span></p>

<p><span></span></p>

<p><span>On
histologic examination, in tissues stained with hematoxylin and eosin, the
apoptotic cell appears as a round or oval mass of intensely eosinophilic
cytoplasm with fragments of dense nuclear chromatin. Because the cell shrinkage
and formation of apoptotic bodies are rapid and the pieces are quickly
phagocytosed, considerable apoptosis may occur in tissues before it becomes
apparent in histologic sections. In addition, apoptosis&#8212;in contrast to
necrosis&#8212;does not elicit inflammation, making it more difficult to detect
histologically.</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=348 height=249
src="_%20Tutorials_files/image040.png" alt="Description: Apoptosis" v:shapes="Picture_x0020_347188"></span><span></span></p>

<p style="text-align:center;"><span><img border=0 width=399 height=264
src="_%20Tutorials_files/image042.png" alt="Description: Necrosis" v:shapes="Picture_x0020_347187"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Apoptosis does <i>not</i> elicit a major inflammatory
response.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 38-year-old woman has a cast removed from her leg after 8 weeks of
immobilization. Which of the following best characterizes her gastrocnemius
muscle at this time?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Decrease
in number of fibers</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Conversion
to fast fibers</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Increase
in cytoplasmic content</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Increase
in mitochondrial content</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Increase
in number of satellite cells</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Atrophy is a reduction in the size of a tissue or organ. It is
associated with a reduction in the size and number of cells comprising that
tissue or organ</span><span>.
Atrophy may be physiologic or pathologic. P<span>hysiologic atrophy</span> is normal; examples include dissolution of
the thyroglossal duct during fetal development and decrease in uterine size
after childbirth. <span>Pathologic atrophy,
by contrast, </span>is abnormal and is usually caused by one of the following: </span></p>

<p><span></span></p>

<p><i><span>Disuse</span></i><span>. When a fractured bone
is immobilized in a plaster cast or when a patient is restricted to bed rest,
atrophy of skeletal muscle ensues. At first, there is a decrease in cell size,
which is reversible. With prolonged disuse, there is a decrease in the number
of muscle fibers due to apoptosis. Muscle atrophy may be accompanied by
increased bone resorption, resulting in osteoporosis.</span></p>

<p><span></span></p>

<p><i><span>Denervation</span></i><span>. Nerve damage can cause
muscle atrophy.</span></p>

<p><span></span></p>

<p><i><span>Ischemia</span></i><span>.</span><span> Decrease in blood
supply to a tissue can cause atrophy. Senile atrophy, for example, is a
progressive atrophy of the brain due to atherosclerosis. </span></p>

<p><span></span></p>

<p><i><span>Malnutrition</span></i><span>. Protein-calorie
malnutrition (marasmus) can cause muscle atrophy. Muscle protein is broken down
to produce energy after adipose stores are depleted. “Cachexia” is a term used
for profound muscle wasting. It can occur in marasmus, cancer, and chronic
inflammatory diseases. </span></p>

<p><span></span></p>

<p><i><span>Loss of
endocrine stimulation</span></i><span>.
Many tissues are dependent on endocrine stimulation for normal function. Loss
of estrogen stimulation after menopause results in atrophy of the breast,
endometrium, and vaginal epithelium.</span></p>

<p><span></span></p>

<p><i><span>Pressure</span></i><span>. Prolonged tissue
compression causes atrophy. An example would be a decubitus ulcer in a
bedridden patient.<span >&nbsp; </span><a
name=4-u1.0-B978-1-4377-0792-2..50006-7--p10></a></span></p>

<p><span></span></p>

<p><span>Atrophy is associated with decreased protein synthesis and increased
protein degradation. At first, the </span><span></span></p>

<p><span>cell size
and the number of organelles is reduced. In muscle cells, there is loss of
mitochondria and myofilaments. This “downsizing” reduces the metabolic needs of
the cell, allowing it to survive in an adverse environment. If the
precipitating cause of atrophy continues, the cell may become irreversibly
damaged and die, often by apoptosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct. </span></b><span>Muscle atrophy, characterized
by a decrease in the number of muscle fibers, would be expected after eight
weeks of immobilization.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
69-year-old man with a history of prostatic hypertrophy has the recent onset of
increased difficulty urinating. Symptoms began shortly after he started taking
a nasal decongestant orally for cold symptoms. Which of the following types of
receptors is most likely to be involved in these adverse events?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>&#945;1-adrenergic</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#946;1-adrenergic</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#946;2-adrenergic</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>nicotinic
at the neuromuscular junction</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>muscarinic
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>There are
two types of adrenergic receptors: alpha and beta. The beta receptors are
further divided into beta 1 and beta 2. Norepinephrine excites alpha receptors
mainly. Epinephrine excites alpha and beta receptors equally. Certain alpha
functions are excitatory while others are inhibitory. Likewise, certain beta
functions are excitatory while others are inhibitory. The major adrenergic
receptor functions are listed below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=174 valign=top>
  <p><span>Alpha-adrenergic
  receptor</span></p>
  </td>
  <td width=198 valign=top>
  <p><span>Beta-adrenergic
  receptor</span></p>
  </td>
 </tr>
 <tr>
  <td width=174 valign=top>
  <p><span></span></p>
  </td>
  <td width=198 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=174 valign=top>
  <p><span>Vasoconstriction
  (&#945;<sub>1</sub>)</span></p>
  <p><span>Pupillary
  dilatation (&#945;<sub>1</sub>)</span></p>
  <p><span>Intestinal
  relaxation (&#945;<sub>1</sub>)</span></p>
  <p><span>Pilomotor
  contraction (&#945;<sub>1</sub>)</span></p>
  <p><span>Bladder
  sphincter contraction(&#945;<sub>1</sub>)</span></p>
  </td>
  <td width=198 valign=top>
  <p><span>Cardiac
  acceleration (&#946;<sub>1</sub>)</span></p>
  <p><span>Increased
  myocardial contractility (&#946;<sub>1</sub>)</span></p>
  <p><span>Vasodilatation
  (&#946;<sub>2</sub>)</span></p>
  <p><span>Intestinal
  relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Uterus
  relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Bronchodilatation
  (&#946;<sub>2</sub>)</span></p>
  <p><span>Bladder
  wall relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Glycogenolysis
  (&#946;<sub>2</sub>)</span></p>
  <p><span>Lipolysis
  (&#946;<sub>1</sub>)</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>There are
two types of cholinergic receptors: nicotinic and muscarinic. These receptors
are activated by acetylcholine. Nicotinic receptors are found in the synapses
between the pre- and postganglionic neurons of both the sympathetic and
parasympathetic systems and also in the membranes of skeletal muscle fibers at
the neuromuscular junction. Muscarinic receptors are found in all effector
cells stimulated by the postganglionic cholinergic neurons of the
parasympathetic nervous system. The major muscarinic receptor functions are
listed below.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=230 valign=top>
  <p style="text-align:center;"><span>Muscarinic receptor</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Pupillary
  constriction</span></p>
  <p><span>Ciliary
  muscle contraction</span></p>
  <p><span>Gland
  stimulation (nasal, lacrimal, salivary, gastric, pancreatic, sweat)</span></p>
  <p><span>Cardiac
  deceleration</span></p>
  <p><span>Decreased
  myocardial contractility</span></p>
  <p><span>Bronchoconstriction</span></p>
  <p><span>Increased
  peristalsis</span></p>
  <p><span>Bladder
  wall contraction</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. Oral decongestants
stimulate alpha-adrenergic receptors, resulting in bladder sphincter
contraction. In patients already predisposed to bladder outlet obstruction
because of prostatic hypertrophy, the administration of a nasal decongestant
can cause difficulty with urination and urinary retention. Any male patient who
is having trouble with urination should be asked about his use of nasal
decongestants. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 15-year-old boy is severely burned. Nitrogen loss occurs during the
first few days after the burn. During this period, which of the following
substances plays a major role in nitrogen loss? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Insulin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Cortisol </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Growth hormone</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Parathyroid hormone</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Erythropoietin</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Catabolism</span> is the process by which large molecules (polymers) are
broken into smaller molecules (monomers) to produce energy. Specifically,
polysaccharides, lipids, proteins, and nucleic acids are broken down into
monosaccharides, fatty acids, amino acids, and nucleotides. The monomers may
then be used to construct new polymers or they may be broken down further to
produce energy. During the breakdown process, waste products are released.
These include lactic acid, acetic acid, carbon dioxide, ammonia, and urea. Some
of the energy released by catabolism is lost as heat; the rest is used to
synthesize adenosine triphosphate (ATP). This molecule provides the chemical
energy needed for anabolism. Hormones are important regulators of catabolism;
traditionally, they have been classified as anabolic or catabolic. The
“classic” catabolic hormones are cortisol, glucagon, and epinephrine. These are
released during periods of high stress, such as in burns, sepsis, trauma, or
surgery.<span >&nbsp; </span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/1/11/Catabolism_schematic.svg"><span><img border=0 width=235 height=217
src="_%20Tutorials_files/image044.png"
alt="Description: File:Catabolism schematic.svg" v:shapes="Picture_x0020_347186"></span></a></p>

<p style="text-align:center;">Catabolism</p>

<p><span>Anabolism, by contrast,</span> is the process by which molecules are
constructed from smaller units. This utilizes energy, usually in the form
adenosine triphosphate, which is derived from catabolism. Anabolic processes
tend to “build up” organs and tissues. They allow growth and differentiation of
cells and an increase in body size. Examples of anabolic processes include
growth and mineralization of bone and increase in muscle mass &#8211; processes
that involve synthesis of complex molecules. The “classic” anabolic hormones
are insulin, testosterone, estrogen, and growth hormone. </p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer B is correct</b>. Major burns result in a severe catabolic
state. The rate of catabolism is proportional to the surface area burned. The
release of catabolic hormones &#8211; cortisol, glucagon, epinephrine &#8211;
triggers breakdown of carbohydrates, fats, and proteins. Cortisol triggers
protein breakdown, which causes muscle wasting and nitrogen loss. </p>

<p></p>

<p><b>Answer A is incorrect</b>. Insulin is an anabolic hormone. It promotes
glucose uptake by muscle and adipose tissue, stimulates glycogen and fatty acid
synthesis, and inhibits lipolysis and proteolysis.</p>

<p></p>

<p><b>Answer C is incorrect</b>. Growth hormone stimulates protein synthesis
and increases muscle mass and mineralization of bone.</p>

<p></p>

<p><b>Answer D is incorrect</b>. Parathyroid hormone promotes release of
calcium from bone, absorption of calcium in the kidney, and absorption of
calcium in the intestine.</p>

<p></p>

<p><b>Answer E is incorrect</b>. Erythropoietin stimulates red blood cell
production.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Each of
the following photomicrographs represents changes in the respiratory epithelium
caused by smoking. Which image illustrates squamous metaplasia? </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=462 height=291
src="_%20Tutorials_files/image046.png" alt="Description: respiratory pathology"
v:shapes="Picture_x0020_347185"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Cellular adaptation</b>
refers to changes made by a cell in response to adverse environmental changes.
The adaptation may be physiologic or pathologic. The five major types of
adaptation are atrophy, hypertrophy, hyperplasia, dysplasia, and metaplasia.</p>

<p></p>

<p><b>Atrophy</b> is a decrease
in cell size. If enough cells in an organ atrophy, the entire organ will
decrease in size. Thymus atrophy in childhood is an example of physiologic
atrophy. Skeletal muscle atrophy is a pathologic adaptation to skeletal muscle
disuse. Tissue and organs especially susceptible to atrophy include skeletal
muscle, cardiac muscle, secondary sex organs, and the brain.</p>

<p></p>

<p><b>Hypertrophy</b> is an
increase in cell size. If enough cells of an organ hypertrophy, the organ
itself will enlarge. The heart and kidneys are especially susceptible to
hypertrophy. Hypertrophy may be caused by mechanial signals (e.g., stretch) or
trophic signals (e.g., growth factors). Physiologic hypertrophy occurs in
skeletal muscle with sustained weight-bearing exercise. Pathologic hypertrophy
occurs in cardiac muscle as a result of hypertension.</p>

<p></p>

<p><b>Hyperplasia</b> is an
increase in the number of cells due to increased cell mitosis. Physiologic
hyperplasia may be compensatory or hormonal. Compensatory hyperplasia permits
tissue and organ regeneration. It is common in epithelial cells of the
epidermis and intestine, hepatocytes, bone marrow cells, and fibroblasts.
Hormonal hyperplasia occurs mainly in organs that depend on estrogen (e.g.,
endometrial cells during pregnancy). Pathologic hyperplasia is an abnormal
increase in cell division (e.g., endometriosis).</p>

<p></p>

<p><b>Metaplasia</b> occurs
when a differentiated cell type is replaced by another cell type, which may be
less differentiated. It is a reversible process. Metaplasia occurs in the
respiratory tract as a response to smoking. Bronchial cells convert from
mucus-secreting, ciliated, columnar epithelium to non-mucous-secreting,
non-ciliated, squamous epithelium. The cells may become dysplasic or cancerous
if the stimulus (e.g., cigarette smoking) is not removed.</p>

<p><b></b></p>

<p><b>Dysplasia</b> refers to
abnormal changes in cellular shape, size, and organization. Sometimes called
&quot;atypical hyperplasia,” dysplasia is not a true adaptation but, rather,
the earliest pre-cancerous lesion recognizable in a biopsy. Tissues prone to
dysplasia include cervical and respiratory epithelia. Dysplasia can be mild (low-grade),
moderate, or severe (high-grade). Mild dysplasia is at low risk of transforming
into cancer. Severe dysplasia is at high risk. In most organs, carcinoma <i>in situ</i> (CIS) is synonmyous with severe
(high-grade) dysplasia. CIS immediately precedes the development of frank
carcinoma and resembles invasive carcinoma except for the lack of basement
membrane disruption.<span >&nbsp; </span></p>

<p></p>

<p><span encountered principally in epithelia, and it is characterized by a
constellation of changes that <span>include
a loss in the uniformity of the individual cells as well as a loss in their
architectural orientation</span>. Dysplastic cells exhibit considerable
pleomorphism and often contain large hyperchromatic nuclei with a high
nuclear-to-cytoplasmic ratio. The architecture of the tissue may be disorderly.
For example, in squamous epithelium the usual progressive maturation of tall
cells in the basal layer to flattened squamous cells on the surface may be lost
and replaced by a scrambling of dark basal-appearing cells throughout the epithelium.
Mitotic figures are more abundant than usual. Frequently, they appear in
abnormal locations within the epithelium. For example, in dysplastic stratified
squamous epithelium, mitoses are not confined to the basal layers but instead
may appear at all levels, including surface cells. When dysplastic changes are
marked and involve the entire thickness of the epithelium but the lesion
remains confined by the basement membrane, it is considered a preinvasive
neoplasm and is referred to as <i>carcinoma in situ</i>. Once the tumor cells
breach the basement membrane, the tumor is said to be <i>invasive</i>. </p>

<p></p>

<p style="text-align:center;">Photomicrographs
of normal respiratory epithelium appear below.</p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span><img border=0 width=247 height=307
src="_%20Tutorials_files/image048.png" alt="Description: respiratory epithelium"
v:shapes="Picture_x0020_347184"></span></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=353 height=264
src="_%20Tutorials_files/image050.png"
alt="Description: respiratory epithelium 2" v:shapes="Picture_x0020_347183"></span></p>

<p></p>

<p>Respiratory epithelium
lining the upper airways is classified as <i>ciliated pseudostratified columnar
epithelium.</i> Although all cells in the epithelium touch the basement
membrane and, therefore, comprise a single layer, the nuclei are not aligned in
the same plane. Thus, the epithelium appears to have several layers. The term
“pseudostratified” describes this arrangement.</p>

<p></p>

<p>The majority of cells
composing the <i>ciliated pseudostratified columnar epithelium</i> are of three
types: a) ciliated cells, b) goblet cells, and c) basal cells. The ciliated
cells are columnar epithelial cells with specialized ciliary modifications.
Goblet cells, so named because they are shaped like a wine goblet, are columnar
epithelial cells that secrete mucus. The basal cells are small, nearly cuboidal
cells that differentiate into other cells types. They respond to epithelial
injury by migrating to the denuded site and differentiating to restore the
epithelial cell layer.</p>

<p>Some of the earliest changes
in smoking-damaged respiratory epithelium include goblet cell hyperplasia <b>(A)</b>,
basal cell hyperplasia <b>(B)</b>, and squamous metaplasia <b>(C)</b>. More
ominous changes include the appearance of squamous dysplasia <b>(D)</b>,
characterized by the presence of disordered squamous epithelium, with loss of
nuclear polarity, nuclear hyperchromasia, pleomorphism, and mitotic figures.
Squamous dysplasia may, in turn, progress through the stages of mild, moderate,
and severe dysplasia. Carcinoma-in-situ (CIS) <b>(E)</b> is the stage that
immediately precedes invasive squamous carcinoma <b>(F)</b>, and apart from the
lack of basement membrane disruption in CIS, the cytologic features are similar
to those in frank carcinoma. Unless treated, CIS will eventually progress to
invasive cancer.</p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer C is correct.<span >&nbsp; </span></b>This
image illustrates<b> </b>squamous cell
metaplasia, which can occur in the respiratory tract as a response to smoking.
In squamous cell metaplasia, bronchial cells are converted from
mucus-secreting, ciliated, columnar epithelium to non-mucus-secreting,
non-ciliated, squamous epithelium.</p>

<p></p>

<p>Here’s a key to the images: <b></b></p>

<p><b><span><span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Goblet cell hyperplasia</span></p>

<p><b><span><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Basal cell hyperplasia</span></p>

<p><b><span><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Squamous metaplasia</span></p>

<p><b><span><span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Squamous dysplasia</span></p>

<p><b><span><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Carcinoma in situ (CIS)</span></p>

<p><b><span><span>F.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Squamous carcinoma</span></p>

<p><span></span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Several
contiguous cells are labeled with a fluorescent dye that cannot cross cell
membranes. One cell is experimentally bleached with light that destroys the
dye, but the cell soon recovers dye fluorescence. This recovery is best
explained by the presence of which of the following structures between the
bleached cell and the fluorescent neighbor? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Cell
membrane</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Basal
lamina</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tight
junctions</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Desmosomes</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gap
junctions</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>In many
tissues (e.g., connective tissue), each cell is separated from the next by an
extracellular coating or matrix. In some tissues (e.g., </span><a
href="http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/A/AnimalTissues.html#epithelial"><span>epithelia</span></a><span>), however, the plasma
membranes of adjacent cells are pressed together by junctions. </span></p>

<p><span></span></p>

<p><span>There are
three major types of cellular junction: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tight junctions</span><span> </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anchoring junctions</span><span> (e.g., desmosomes)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gap junctions</span><span> </span></p>

<p><a name=tight><b><span></span></b></a></p>

<p><span><b><span>Tight</span></b></span><b><span> Junctions</span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=281 height=226
src="_%20Tutorials_files/image052.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1"
v:shapes="Picture_x0020_347182"></span><span></span></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><span>Tight junction</span></p>

<p><b><span></span></b></p>

<p><span>Epithelial
cells provide the interface between masses of cells and a cavity or space (a
lumen). The part of the cell exposed to the lumen is called its <span>apical</span> surface. The rest of the cell
(i.e., its sides and base) make up the <span>basolateral</span>
surface. </span></p>

<p><span></span></p>

<p><span>Tight
junctions seal adjacent epithelial cells in a narrow band just beneath their
apical surface. They have two major functions: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>They
prevent the passage of molecules and ions through the space between cells. (In
order to pass through the tissue, therefore, molecules must enter the cell
itself by diffusion or active transport.)<span >&nbsp;
</span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>They
block the movement of membrane proteins between the apical and basolateral
surfaces of the cell, allowing the unique function of each surface to be
preserved (e.g., receptor-mediated endocytosis can be restricted to the apical
surface, and exocytosis can be restricted to the basolateral surface.</span></p>

<p><a name=adherens><b><span></span></b></a></p>

<p><span><b><span>Anchoring</span></b></span><b><span> Junctions</span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=282 height=226
src="_%20Tutorials_files/image054.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1"
v:shapes="Picture_x0020_347181"></span><span></span></p>

<p style="text-align:center;"><span>Belt desmosome</span></p>

<p><span>Anchoring
junctions provide strong mechanical attachments between adjacent cells. They
hold epithelial cells together and bind <span>cardiac
muscle</span> cells tightly. The most common anchoring junction is the
desmosome. “Ordinary” desmosomes form spot welds between cells. “Belt”
desmosomes form a belt that encircles the cell. Anchoring junctions are built
from <span>cadherins, </span>transmembrane
proteins with extracellular segments that bind to each other and intracellular
segments that bind to stress fibers (e.g., actin, keratin). </span></p>

<p><span></span></p>

<p><span>Note: <span>Pemphigus</span> is an autoimmune disease
characterized by formation of antibodies against </span><a
href="http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/J/Junctions.html#adherens#adherens"><span>cadherins</span></a><span>. The loosening of the
adhesion between adjacent epithelial cells causes blistering. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Gap Ju<span>nctions</span></span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=180 height=308
src="_%20Tutorials_files/image056.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1"
v:shapes="Picture_x0020_347180"></span><b><span></span></b></p>

<p style="text-align:center;"><span>Gap junction</span></p>

<p><span>Gap
junctions are intercellular channels that permit the free passage of ions and
small molecules between cells. They are cylinders constructed from six copies
of transmembrane proteins (<span>connexins)</span>.<span>&nbsp; </span>Because ions can flow through them, gap
junctions allow changes in the membrane potential to pass from cell to cell. </span></p>

<p><span></span></p>

<p><b><span>Examples:</span></b><span> </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
action potential in cardiac muscle flows from cell to cell through gap
junctions, allowing rhythmic contraction to occur. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>At
some “electrical synapses” in the brain, gap junctions transmit action
potentials to the postsynaptic cell without release of neurotransmitters. This
allows for faster signal transmission. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>As
birth approaches, gap junctions between smooth muscle cells in the uterus allow
for powerful, coordinated contractions.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. Gap junctions are
intercellular channels that permit the free passage of small molecules between
cells.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A newborn baby undergoes chromosomal
analysis. Some cells have a 46, XY karyotype and others have a 45, X karyotype.
Which of the following mechanisms best explains this abnormality?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Nondisjunction
in mitosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Reciprocal
translocation</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Robertsonian
translocation</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Genetic imprinting</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Uniparental
disomy</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Chromosome
abnormalities fall into two categories: numerical and structural. </span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0 width=158>
 <tr>
  <td width=158>
  <p style="text-align:center;"><b><span>Numerical</span></b><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image058.png" alt="Description:  " v:shapes="Picture_x0020_347179"></span><a
  href="http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3393"><span>Trisomy</span></a><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image060.png" alt="Description:  " v:shapes="Picture_x0020_347178"></span><span>Monosomy</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image062.png" alt="Description:  " v:shapes="Picture_x0020_347177"></span><span>Mosaicism</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p style="text-align:center;"><b><span>Structural</span></b><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image064.png" alt="Description:  " v:shapes="Picture_x0020_347176"></span><span>Deletion</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image066.png" alt="Description:  " v:shapes="Picture_x0020_347175"></span><span>Inversion</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image068.png" alt="Description:  " v:shapes="Picture_x0020_347174"></span><span>Duplication</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image070.png" alt="Description:  " v:shapes="Picture_x0020_347173"></span><span>Insertion</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image072.png" alt="Description:  " v:shapes="Picture_x0020_347172"></span><span>Ring</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image074.png" alt="Description:  " v:shapes="Picture_x0020_347171"></span><a
  href="http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3246"><span>Marker</span></a><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image076.png" alt="Description:  " v:shapes="Picture_x0020_347170"></span><a
  href="http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3388"><span>Translocation</span></a><span>, reciprocal</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image078.png" alt="Description:  " v:shapes="Picture_x0020_347169"></span><a
  href="http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3388"><span>Translocation</span></a><span>, Robertsonian</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><a name=Background></a><b><span>Abnormalities of
Chromosome Number</span></b></p>

<p><b><span></span></b></p>

<p><i><span>Trisomy</span></i><span>
is a type of aneuploidy (abnormal chromosome number) in which there are three
copies of a particular chromosome (instead of the usual two). Trisomy is not
usually compatible with life. An exception is trisomy 21, the cause of Down
syndrome. </span></p>

<p><span></span></p>

<p><i><span>Monosomy</span></i><span>
is a type of aneuploidy in which there is one copy of a chromosome (instead of
the usual two). This is almost always fatal. The only complete monosomy
compatible with life is Turner syndrome, in which there is one X chromosome
(instead of the usual pair). </span></p>

<p><span></span></p>

<p><span>Aneuploidy
is usually caused by <i>meiotic <span>nondisjunction</span></i><span>, which</span> is an error in the production
of germ cells (eggs and sperm). To produce germ cells with 23 chromosomes,
cells in the ovary and testes (each with 46 chromosomes) undergo two separate
cell divisions: meiosis I and meiosis II. With nondisjunction, the chromosomes
do not segregate properly during one of these divisions, and one of the
daughter cells ends up with too many chromosomes while the other ends up with
too few. </span></p>

<p><span></span></p>

<p><span>The
origin of the extra chromosome depends on the timing of nondisjunction. If
nondisjunction occurs in meiosis I, the germ cell will have two different
copies of a certain chromosome, one from the individual’s mother and one from
the father (i.e., the future embryo’s grandmother and grandfather). If
nondisjunction occurs in meiosis II, the germ cell will have two identical
copies of a chromosome, either from the individual’s mother or father (i.e.,
the future embryo’s grandmother or grandfather). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=345 height=289
src="_%20Tutorials_files/image080.jpg" alt="Description: meiotic nondisjunction"
v:shapes="Picture_x0020_347168"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Meiotic Nondisjunction</span></p>

<p><span></span></p>

<p><span></span></p>

<p><a name="Abnormalities_of_Chromosome_Structure"></a><b><span>Abnormalities of Chromosome Structure</span></b></p>

<p><b><span></span></b></p>

<p><span>Abnormalities
of chromosomal structure can be either <i>unbalanced</i>
or <i>balanced</i>. Unbalanced
rearrangements have missing or extra genetic material, which usually leads to
major abnormalities. Balanced rearrangements, by contrast, involve no extra or
missing genetic material and may occur in healthy individuals.</span></p>

<p><span></span></p>

<p><span>Unbalanced
rearrangements include <i>deletions</i>, <i>duplications</i>, <i>marker</i> or <i>ring</i>
chromosomes, and <i>isochromosomes</i>. A
deletion results in loss of a chromosomal segment. A duplication results in
repetition of a chromosome segment. Generally, duplications are less harmful
than deletions. A marker chromosome is a very small, unidentified chromosome
that can be seen on a karyotype. Individuals with a marker chromosome usually
have this chromosome in addition to the normal 46 chromosomes. A ring
chromosome occurs when a chromosome is broken in two places and the ends unite
(with or without loss of genetic information). An <span>isochromosome</span> is a chromosome that has lost one of its arms and
replaced it with an exact copy of the other arm. (A person with 46 chromosomes
containing an isochromosome has a single copy of one arm, and three copies of
the other arm.) </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=250 height=182
src="_%20Tutorials_files/image082.png" alt="Description: three" v:shapes="Picture_x0020_347167"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp; </span>Deletion<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Duplication<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Inversion</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=316 height=243
src="_%20Tutorials_files/image084.png" alt="Description: marker" v:shapes="Picture_x0020_347166"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Marker chromosome (mar)</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=388 height=250
src="_%20Tutorials_files/image086.png" alt="Description: ring" v:shapes="Picture_x0020_347165"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Ring Chromosome</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=204 height=234
src="_%20Tutorials_files/image088.png" alt="Description: isochromosome" v:shapes="Picture_x0020_347164"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Isochromosome</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Balanced
rearrangements include <i>inversions</i> (<i>pericentric</i> or <i>paracentric</i>) and <i>translocations</i>
(<i>Robertsonian or reciprocal</i>). An
inversion occurs when there are two breaks in a chromosome and the area in
between is inverted (turned around) and reinserted. The inversion is called
pericentric if the centromere is included and paracentric if the centromere is
not included. Many inversions in the general population are considered normal
variants. </span></p>

<p><span></span></p>

<p><span>Translocations</span><span> are of two major types. A Robertsonian
translocation occurs when two acrocentric chromosomes fuse near the centromere
region with loss of the short arms. (An acrocentric chromosome is a chromosome
with the centromere near one end.) The resulting balanced karyotype has only 45
chromosomes, including the translocation chromosome, which, in effect, is made
up of the long arms of two chromosomes.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=249 height=139
src="_%20Tutorials_files/image090.png" alt="Description: robertsonian.gif"
v:shapes="Picture_x0020_347163"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Robertsonian translocation</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span>A
reciprocal translocation involves the breakage of nonhomologous chromosomes
with an even exchange of broken-off segments. Usually two chromosomes are
involved and the total number of chromosomes is unchanged. Reciprocal
translocations are relatively common and are usually harmless. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=210 height=164
src="_%20Tutorials_files/image092.png" alt="Description: reciprocal.png"
v:shapes="Picture_x0020_347162"></span><span></span></p>

<p style="text-align:center;"><a name=Mosaicism></a><span>Reciprocal Translocation</span></p>

<p><span></span></p>

<p><b><span>Mosaicism</span></b></p>

<p><b><span></span></b></p>

<p><span>Most
chromosomal anomalies appear in every cell of the body. However, sometimes
different cells have different chromosomal constitutions. For example, a person
may have 46 chromosomes in half of their cells and 45 in the other half. This
is known as mosaicism. </span></p>

<p><span></span></p>

<p><span>Mosaicism
is usually caused by <i>mitotic
nondisjunction</i>. The effects of mosaicism depend on the timing of
nondisjunction, the chromosomal anomaly, the fraction of the body's cells
carrying the anomaly, and the tissues affected. Generally a person with
mosaicism is less severely affected than someone carrying the genetic anomaly
in every cell.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Genetic imprinting and
Uniparental disomy</span></b></p>

<p><b><span></span></b></p>

<p><i><span>Genomic imprinting</span></i><span> is a phenomenon in
which expression of alleles is influenced by chemical changes to the DNA, such
as covalent modification or methylation, rather than changes to the sequence
itself. Genomic imprinting is a reversible type of gene inactivation because
the sequence is not changed.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><i><span>Uniparental disomy</span></i><span> is a phenomenon in
which both paired chromosomes originate from a single parent. (Normally, the
chromosomes originate from different parents.) The presence of two identical
chromosomes from the same parent is called <i>isodisomy</i>.
The presence of different chromosomes from the same parent is called <i>heterodisomy</i>. Prader-Willi syndrome
(“rag doll” syndrome) and Angelman syndrome (“happy puppet” syndrome) are the
principal examples of uniparental disomy. </span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=305 height=209
src="_%20Tutorials_files/image094.png" alt="Description: isodisomy" v:shapes="Picture_x0020_347161"></span><span></span></p>

<p><span></span></p>

<div>

<p><b><span>Testing</span></b></p>

<p><span></span></p>

<p><span>A fetus can be tested
for chromosomal abnormalities using amniocentesis and chorionic villus
sampling. With both techniques, pictures of the chromosomes are taken,
producing a karyotype.</span></p>

<p><span>The chromosomes are
evaluated for size and structure.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. M<span>osaicism</span>
denotes the presence of two populations of cells with different genotypes in a
single individual. It is caused by mitotic nondisjunction.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. A reciprocal translocation involves breakage
of nonhomologous chromosomes with an even exchange of broken-off segments.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. A Robertsonian translocation occurs when two
acrocentric chromosomes fuse near the centromere region with loss of the short
arms.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>.<i> </i>Genomic
imprinting is a phenomenon in which the expression of alleles is influenced by
chemical changes to the DNA (e.g., methylation) rather than changes in the
sequence itself.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Uniparental disomy occurs when both paired
chromosomes originate from a single parent. </span></p>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
1-week-old newborn has microcephaly, intrauterine growth retardation, widely
spaced eyes, and a cat-like cry. Which of the following karyotypes is most
likely? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>47,XX,+21</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>45,X</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>47,XXY</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>46,XX,del(5)(p15)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>69,XXY</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Down syndrome</b></p>

<p><b></b></p>

<p>Down syndrome is
characterized by the presence of an extra copy of genetic material from
chromosome 21, either in whole (trisomy 21) or in part (such as due to
translocations). The syndrome is usually associated with impaired cognitive
ability and physical growth. Features include small chin, round face, big
tongue, almond-shapes eyes, upslanting palpebral fissures, short limbs, a
single transverse palmar crease, poor muscle tone, and a larger than normal
space between the big and second toes. Affected individuals are at higher risk
of congenital heart defects, gastroesophageal reflux disease, recurrent ear
infections, obstructive sleep apnea, and thyroid dysfunction. Three cytogenetic
variants cause Down syndrome: trisomy 21, chromosomal translocation, and
mosaicism. </p>

<p><span></span></p>

<p><i><span>Trisomy 21</span></i><span> accounts for nearly 95% of all patients
with Down syndrome and is due to meiotic nondisjunction. With nondisjunction, a
gamete (<span>i.e.</span>, a sperm or egg
cell) is produced with an extra copy of chromosome 21; the gamete thus has 24
chromosomes. When combined with a normal gamete from the other parent, the
embryo now has 47 chromosomes, with three copies of chromosome 21. The
likelihood of nondisjunction in the mother increases with maternal age.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><i>Robertsonian translocation</i> in one of the parents is responsible for
2-3% of Down cases. The long arm of chromosome 21 becomes attached to another
chromosome, often chromosome 14. A person with such a translocation is phenotypically
normal. During reproduction, normal disjunctions have a significant chance of
creating a gamete with an extra chromosome 21, producing a child with Down
syndrome. “Translocation Down syndrome” is often referred to as “<span>familial Down syndrome</span>.” </p>

<p></p>

<p><i><span>Mosaicism</span></i><span> explains 1-2% of Down cases. In mosaic Down,
some cells in the body are normal and others have trisomy 21. This is due to
mitotic nondisjunction during an early cell division in a normal embryo.
Individuals with mosaic Down have a normal cell line and usually milder
physical stigmata.</span></p>

<p><span></span></p>

<p><b>Turner syndrome</b></p>

<p><b></b></p>

<p><span>Turner syndrome </span>encompasses several conditions, of which monosomy
X (absence of an entire sex chromosome, the Barr body) is most common. Monosomy
X is caused by meiotic nondisjunction in either parent. In some individuals
with Turner syndrome, the X chromosome is missing in some cells but not others,
a condition referred to as mosaicism. Mosaicism is caused by mitotic
nondisjunction. </p>

<p></p>

<p>Affected individuals are
phenotypic females with features that include short stature, broad chest, low
hairline, low-set ears, and webbed neck. Gonadal dysfunction (non-working
ovaries) results in amenorrhea and sterility. Other potential findings include
cognitive deficits, congenital heart disease, diabetes, hypothyroidism, and
difficulty with vision and hearing. </p>

<p></p>

<p></p>

<p></p>

<p><b>Klinefelter syndrome</b></p>

<p><b></b></p>

<p>Klinefelter syndrome is the
most common chromosomal disorder to be associated with male hypogonadism and
infertility. The “classic” karyotype is 47, XXY, although some individuals have
additional X and Y chromosomes. The syndrome is characterized by hypogonadism
(small testes, aspermia), gynecomastia in late puberty, psychosocial problems,
and elevated urinary gonadotropin levels.</p>

<p></p>

<p>The XXY karyotype can be
caused by nondisjunction in the first meiotic division in the mother,
nondisjunction in the second meiotic division in the mother, or nondisjunction
in the first meiotic division of the father. The XXY karyotype cannot be caused
by nondisjunction in the second meiotic division of the father. The likelihood
of nondisjunction in the mother increases with maternal age.</p>

<p></p>

<p><b>Patau syndrome</b></p>

<p><b></b></p>

<p>Patau syndrome (trisomy 13)
is the least common and most severe of the viable autosomal trisomies. Median
survival is fewer than 3 days. </p>

<p></p>

<p><b>Edwards syndrome</b></p>

<p><b></b></p>

<p><span>Edwards syndrome</span> (trisomy 18) is the second most common autosomal
trisomy (after Down syndrome). The survival rate is very low due to heart and
kidney abnormalities.</p>

<p></p>

<p><b>Cri du chat syndrome</b></p>

<p><b></b></p>

<p><span>Cri du chat syndrome</span>, also known as <span>Lejeune syndrome</span>, is a rare genetic disorder caused by partial
deletion of the short arm of chromosome 5. Its name refers to the cat-like
“meow” of affected children (cry of the cat, in French). Features include
microcephaly, mental retardation, intrauterine growth retardation, and widely
spaced eyes. </p>

<p><b></b></p>

<p><b>Prader-Willi syndrome</b></p>

<p><b></b></p>

<p>Prader-Willi syndrome is a
disorder caused by loss of expression of genes on <i>paternally</i> derived chromosome 15. It is an example of genomic
“imprinting,” in which certain genes are expressed in a parent-of-origin-specific
manner. Features include diminished fetal activity, obesity, mental
retardation, hypotonia, short stature, and small hands and feet.</p>

<p></p>

<p><b>Angelman syndrome</b></p>

<p><b></b></p>

<p>Angelman syndrome is a
disorder caused by loss of expression of genes on <i>maternally</i> derived chromosome 15. It is an example of genomic
“imprinting,” in which certain genes are expressed in a
parent-of-origin-specific manner. Features include intellectual and
developmental delay, seizures, jerky movements (especially hand-flapping),
frequent laughter or smiling, and usually a happy demeanor.</p>

<p><b>Triploidy</b></p>

<p><b></b></p>

<p>Triploidy is a chromosomal
abnormality where three complete sets of the haploid genome instead of the
normal two sets are present within the conceptus. A triploid conceptus will
possess 69 chromosomes. Generally, triploidy is incompatible with life, and is
associated with miscarriage and hydatidiform moles.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>47,XX,+21 (trisomy 21) corresponds to
Down syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.</span></b><span><span>&nbsp; </span>45,X, (monosomy X) corresponds to Turner
syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>47,XXY corresponds to Klinefelter
syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer D is correct.</span></b><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>46,XX,del(5)(p15)
corresponds to cri du chat syndrome. The designation indicates deletion of band
15 on the short arm (p) of chromosome 5. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>69,XXY is an example of triploidy.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
21-year-old man is admitted to the emergency room with fever, headache,
somnolence, irritability, muscle aches, and vomiting of 24 hours duration. He
has been hospitalized three times prior to this for meningococcal meningitis.
One of his brothers was hospitalized six months ago with meningococcal
meningitis. On physical examination, the patient is disoriented and lethargic.
His temperature is 102.6<sup>o </sup>F; blood pressure is 90/60 mm Hg. Nuchal
rigidity is noted. Petechiae are present on the upper and lower extremities.
Cerebrospinal fluid (CSF) tests show the following:</span></p>

<p><span></span></p>

<p><span>Color<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>turbid
</span></p>

<p><span>Cell count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5300/mm<sup>3</sup>
(normal: 0-5/mm<sup>3</sup>)</span></p>

<p><span>97% neutrophils</span></p>

<p><span>3% monocytes</span></p>

<p><span>rare red blood cells</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>70
mg/dL (normal: 40-70 mg/dL) </span></p>

<p><span>Protein<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>45
mg/dL (normal: &lt;40 mg/dL) </span></p>

<p><span></span></p>

<p><span>CSF Gram
stain shows gram-negative diplococci. The patient is treated with ceftriaxone,
which leads to clinical improvement. Blood cultures grow <i>Neisseria
meningitidis</i>. After immunization against pneumococcus, meningococcus, and <i>Haemophilus
influenzae</i>, the patient has no more episodes of meningitis.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Which of
the following conditions has most likely predisposed the patient to recurrent
infection?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Bruton’s
agammaglobulinemia</span></p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Complement
C2 deficiency</span></p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Terminal
complement deficiency</span></p>

<p><span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Asplenia</span></p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Chronic
granulomatous disease</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>The complement system helps,
or “complements,” the ability of antibodies and phagocytic cells to clear
pathogens. It is part of the innate immune system, which is not adaptable and
does not change over the course of an individual's life. However, it can be
recruited and brought into action by the adaptive immune system.</p>

<p></p>

<p>The complement system
consists of a number of small proteins found in the blood, generally
synthesized by the liver, and normally circulating as inactive precursors
(pro-proteins). When stimulated by one of several triggers, proteases in the
system cleave specific proteins to release cytokines and initiate an amplifying
cascade of further cleavages. The end-result is massive amplification of the
response and activation of the cell-killing membrane attack complex (MAC). </p>

<p></p>

<p>Over 25 proteins and protein
fragments make up the complement system, including serum proteins, serosal
proteins, and cell membrane receptors. Most of these proteins are synthesized
by hepatocytes, but significant numbers are produced by tissue macrophages,
blood monocytes, and epithelial cells. Complement accounts for about 5% of the
globulin fraction of blood serum. The basic functions of complement are listed
below.</p>

<p></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Opsonization
- enhancing phagocytosis of antigens </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chemotaxis
- attracting macrophages and neutrophils </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lysis
- rupturing membranes of foreign cells </span></p>

<p><span></span></p>

<p>Three biochemical pathways
activate the complement system: the classical pathway, the alternative pathway,
and the mannose-binding lectin (MBL) pathway (Figure 1).</p>

<p><span>All three
pathways generate variants of the protease, C3-convertase. The classical
pathway typically requires antigen/antibody complexes for activation (specific
immune response), whereas the alternative and mannose-binding lectin (MBL)
pathways are activated by C3 hydrolysis or by antigens without the presence of
antibodies (non-specific immune response). </span></p>

<p><span></span></p>

<p><span>In all
three pathways, a C3-convertase cleaves and activates C3, creating C3a and C3b.
This causes a cascade of further cleavage and activation. C3b binds to the
surface of pathogens, leading to greater internalization by phagocytic cells
(opsonization). <span C5a, and, to a lesser extent, C4a are
called “anaphylatoxins” because they stimulate histamine release from mast
cells, which increases vascular permeability and causes vasodilation. C5a is a
powerful chemotactic agent for neutrophils, monocytes, eosinophils, and
basophils. </span>C5b initiates the membrane attack pathway, which results in
the membrane attack complex (MAC), consisting of C5b, C6, C7, C8, and polymeric
C9. The MAC is the cytolytic end-product of the complement cascade; it forms a
transmembrane channel, which causes osmotic lysis of the target cell (Figure
2).</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Figure 1</span></p>

<p style="text-align:center;"><span><img border=0 width=272 height=235
src="_%20Tutorials_files/image096.png"
alt="Description: http://www.surgicalnotes.co.uk/files/images/complement.gif"
v:shapes="Picture_x0020_347160"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Figure 2</span></p>

<p style="text-align:center;"><span><img border=0 width=471 height=469
src="_%20Tutorials_files/image098.png" alt="Description: 008006" v:shapes="Picture_x0020_347159"></span><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct</span></b><span>.<span> </span>Complement deficiencies in the late phase can
compromise formation of the membrane attack complex (MAC) and inhibit lysis of
target cells. The problem may not be apparent until the late teenage years.
Patients with terminal complement deficiency often have recurrent infections
with <i>Neisseria meningitidis</i>, which can be fatal. It is not unusual for
patients to have recurrent infections with the same serotype, usually Y or
W135. In this vignette, the patient had a deficiency of C8.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Patients with Bruton’s agammaglobulinemia usually suffer from recurrent
pyogenic bacterial infections in the first year of life due to lack of
opsonizing antibodies. The defect is in the gene coding for Bruton’s tyrosine
kinase, an enzyme essential to B cell, but not T cell, development.<span>&nbsp; </span>T cell numbers and function are normal,
so patients typically do not have problems with viral or other intracellular
infections.<span >&nbsp; </span>Most cases are
X-linked, affecting predominantly males, although females with two defective
genes will have the disease. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
Complement deficiencies in the early phase (e.g., C2) can result in poor
opsonization and increased susceptibility to infection. This is usually
observed early in life (not in a 21-year-old, as in this case). Any deficiency
of early components of the classical, alternative, or MBL (mannose-binding
lectin) pathways &#8211; or in C3b itself &#8211; can compromise opsonization.</span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Asplenic patients are at a high risk for infection with encapsulated
bacteria.<span >&nbsp; </span>The spleen plays an
important role in the removal of opsonized bacteria, senescent cells, and other
particles, such as immune complexes. Asplenic infants under six months of age
are susceptible to Gram-negative pathogens such as <i>Escherichia coli</i> and <i>Klebsiella</i>,
whereas older infants and adults are susceptible to <i>Streptococcus
pneumoniae, Haemophilus influenza type b, </i>and <i>Neisseria meningitidis</i>.</span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect</span></b><span>.
Patients with Chronic Granulomatous Disease (CGD) are not unduly susceptible to
infection with <i>Neisseria meningitidis</i>. CGD results from a defect in the
phagocyte oxidase enzyme complex, which results in deficient production of
reactive oxygen species in phagocytes. These ions are important in the
bactericidal activity of phagocytes. Patients with CGD disease are susceptible
to bacterial and fungal infections, particularly with catalase-positive
organisms. These include <i>Staphylococcus aureus, Aspergillus fumigatus, </i>and<i>
Candida albicans</i>.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 52-year-old man with
hepatic cancer is treated with a new chemotherapeutic agent that, as a side
effect, blocks kinesin. One week later, he develops skeletal muscle weakness.
Which of the following most likely explains his weakness?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Decrease
in the number of pre-synaptic neurotransmitter vesicles</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Decrease
in the number of post-synaptic neurotransmitter receptors</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Decrease
in pre-synaptic neuron calcium permeability</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Impaired
motorneuron action potential conduction</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>Impaired
skeletal muscle action potential conduction</p>

<p></p>

<p><span>&nbsp; </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>The <span>cytoskeleton</span> is a cellular &quot;scaffolding&quot; or
&quot;skeleton&quot; within the cytoplasm. It is composed of protein and plays
an important role in both intracellular transport (e.g., the movement of
vesicles and organelles) and cellular division. Eukaryotic cells contain three
main kinds of cytoskeletal filaments: microfilaments, intermediate filaments,
and microtubules. (Microfilaments and intermediate filaments are the “cables”;
microtubules are the “support beams.”)<span >&nbsp;
</span></p>

<p></p>

<p><span (actin filaments)<b> </b>a</span>re the thinnest filaments of
the cytoskeleton. They are composed of linear polymers of actin subunits, which
generate force by elongation at one end and shrinkage at the other, causing net
movement of the intervening strand. Actin filaments serve as tracks for the
movement of myosin molecules, which attach to the microfilaments and
&quot;walk&quot; along them.</p>

<p></p>

<p><i><span>Intermediate filaments</span></i><span> are more heterogeneous
and stable than actin filaments. Like actin, they maintain cell shape by
bearing tension. They anchor organelles, provide structural support for the
nuclear lamina and sarcomere, and participate in some cell-cell and cell-matrix
junctions.</span></p>

<p><span></span></p>

<p><span>The
following proteins are found in various intermediate filaments:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>vimentins,
which provide structural support to many cells </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>keratin,
found in skin, hair, and nails </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>neurofilaments,
found in neural cells </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>lamin,
which gives structural support to the nuclear envelope</span></p>

<p><i><span></span></i></p>

<p><i><span>Microtubules</span></i><span> are hollow cylinders that play a key
role in the mitotic spindle and in intracellular transport. They are comprised
of polymers of alpha and beta tubulin and are typically organized by the
centrosome. Microtubules employ proteins called kinesins and dyneins to
transport vesicles and organelles (e.g., mitochondria) within the cell. </span></p>

<p><span></span></p>

<p><span>Kinesins
transport cargo in an anterograde direction (usually from the cell center to
the periphery). Dyneins transport cargo in a retrograde direction (usually from
the periphery to the center). Kinesins and dyneins “walk”unidirectionally along
microtubule tracks, using one molecule of ATP at each step. Thse movements
allow mitosis, meiosis, and intracellular transport (e.g., axonal transport) to
occur. </span></p>

<p><span></span></p>

<p><span>To
transmit nerve impulses, neurons release neurotransmitters from the terminal of
the axon. The neuron must constantly supply new materials&#8197;to the terminal
to replenish substances lost by exocytosis. Molecules must be synthesized in
the cell body and transported down the axon (in some cases, several meters in
length) to the synapse. This process of axonal transport occurs on
microtubules. <span>Anterograde transport
using </span>kinesins proceeds from the cell body to the synapse and is
responsible for axonal growth and renewal of synaptic vesicles. R<span>etrograde transport, by contrast, is used to
move</span> “old” materials from the synapse to cell body where they can be degraded
by lysosomes. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. Kinesins interact with
microtubules to move “cargo” (e.g., vesicles, organelles) in an anterograde
direction (usually from the cell body to the periphery). In neurons, they
transport vesicles (e.g., neurotransmitter vesicles) from the cell body, where
they are manufactured, to the synapse, where they are released. Interference
with this process by a chemotherapeutic agent would decrease the number of
pre-synaptic neurotransmitter vesicles.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
11-month-old girl is developmentally delayed and has had three seizures in the
past month. Her skin is fair and her hair is lighter in color than that of
other family members. Her diapers have a musty odor. She was born at home and
did not undergo neonatal screening. Which of the following substances will most
likely be found in high concentrations in the urine?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Phenylacetic
acid</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Isoleucine</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Homocysteine</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Homogentisic
acid</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Phenylketonuria
(PKU) is an autosomal recessive disorder and one of the most common disorders
of amino acid metabolism. The most important disorders of amino acid metabolism
are listed below.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=194 valign=top>
  <p><span>Disorders
  of Amino Acid Metabolism</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Phenylketonuria</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Maple Syrup Urine Disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Homocystinuria</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Tyrosinemia</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Hereditary
disorders of amino acid processing can result from defects either in the
breakdown of amino acids or in the body's ability to get amino acids into
cells. Because these disorders cause symptoms early in life, newborns are
routinely screened for several common ones. In the U.S., newborns are commonly
screened for phenylketonuria, maple syrup urine disease, homocystinuria, and
tyrosinemia.</span></p>

<p><span></span></p>

<p><b><span>PHENYLKETONURIA (PKU)<a
name=sec23-ch282-ch282c-1447></a><span></span></span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1447a></a><a name=sec23-ch282-ch282c-1448></a><span>Phenylketonuria (PKU) is
a disorder that causes a buildup of the essential amino acid phenylalanine.
(Essential amino acids cannot be synthesized in the body and must be consumed
in food.) Excess phenylalanine is normally converted to tyrosine, another amino
acid, and eliminated from the body. Without the enzyme that converts it to
tyrosine (phenylalanine hydroxylase), phenylalanine builds up in the blood and
is toxic to the brain, causing intellectual disability. PKU is usually caused
by deficiency of phenylalanine hydroxylase; however, rare cases have been
associated with impaired metabolism of biopterin, an essential cofactor in the
phenylalanine hydroxylase reaction. </span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span><img border=0 width=186 height=194
src="_%20Tutorials_files/image100.png" v:shapes="Picture_x0020_347158"></span></b><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1448a></a><a name=Symptoms></a><b><span>Symptoms</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1450></a><span>Newborns with PKU rarely have symptoms right
away, although sometimes they are sleepy or eat poorly. If not treated, affected
infants progressively develop intellectual disability over the first few years
of life. Other symptoms include seizures, nausea and vomiting, eczema-like
rash, lighter skin and hair than their family members, aggressive or
self-injurious behavior, hyperactivity, and psychiatric symptoms. Untreated
children often give off a musty body and urine odor as a result of a by-product
of phenylalanine (phenylacetic acid) in the urine and sweat.</span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1450a></a><a name=Diagnosis></a><b><span>Diagnosis</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1450b></a><span>PKU is usually diagnosed with a blood test.<a
name=sec23-ch282-ch282c-1450c></a> Amniocentesis or chorionic villus sampling
with DNA analysis can be done to determine whether a fetus has the disorder.<a
name=sec23-ch282-ch282c-1450d></a> </span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1450e></a><a name=Prognosis></a><b><span>Prognosis</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1450f></a><span>A phenylalanine-restricted diet, if started
early and maintained well, allows for normal development. However, if very
strict control of the diet is not maintained, affected children may begin to
have difficulties in school.<a name=sec23-ch282-ch282c-1450g></a> A
phenylalanine-restricted diet should continue for life, otherwise intelligence
may decrease and neurologic and psychiatric problems may ensue.</span></p>

<p><span></span></p>

<p><a name="Prevention%0Aand_Treatment"></a><a
name=sec23-ch282-ch282c-1450h></a><b><span>Prevention and Treatment</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1451></a><span>To prevent intellectual disability, people must
restrict phenylalanine intake (but not eliminate it altogether because people
need some phenylalanine to live) beginning in the first few weeks of life.
Because all natural sources of protein contain too much phenylalanine for
children with PKU, affected children cannot have meat, milk, or other common
foods that contain protein. Instead, they must eat a variety of
phenylalanine-free processed foods, which are specially manufactured.
Low-protein natural foods, such as fruits, vegetables, and restricted amounts
of certain grain cereals can be eaten. Special nutritional products, including
infant formula without phenylalanine, are also available. </span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1454></a><b><span>Maple Syrup Urine
Disease</span></b></p>

<p><b><span></span></b></p>

<p><a
name=sec23-ch282-ch282c-1454a></a><a name=sec23-ch282-ch282c-1455></a>Maple
syrup urine disease (MSUD), also called branched-chain ketoaciduria, is an
autosomal recessive metabolic disorder affecting branched-chain amino acids.
The condition gets its name from the distinctive sweet odor of affected
infants’ urine. </p>

<p></p>

<p>MSUD is caused by a
deficiency of the branched-chain alpha-keto dehydrogenase complex (BCKDH),
leading to a buildup of the branched-chain amino acids (leucine, isoleucine,
and valine) and their toxic by-products in the blood and urine.</p>

<p></p>

<p>The disease is characterized
by the presence of sweet-smelling urine, with an odor similar to that of maple
syrup. Infants with this disease seem healthy at birth but if left untreated
suffer severe brain damage and eventually die. From early infancy, symptoms
include poor feeding, vomiting, dehydration, lethargy, hypotonia, seizures,
hypoglycemia, ketoacidosis, and neurological decline.</p>

<p></p>

<p><a name=sec23-ch282-ch282c-1457></a><span>In the U.S., newborns are routinely screened for
maple syrup urine disease with a blood test.<a name=sec23-ch282-ch282c-1458></a>
Children with the disease must consume a special artificial diet that is low in
three amino acids (leucine, isoleucine, and valine). </span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1459></a><b><span>Homocystinuria</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1459a></a><a name=sec23-ch282-ch282c-1460></a><span>Homocystinuria, also
called cystathionine beta synthase deficiency, is an autosomal recessive
disorder. Children with the condition are unable to metabolize the amino acid
homocysteine, which, along with certain toxic by-products, builds up to cause a
variety of symptoms. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=385 height=204
src="_%20Tutorials_files/image102.png" v:shapes="Picture_x0020_347157"></span><span></span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1461></a><span></span></p>

<p><span>Infants
with this disorder are normal at birth. Early symptoms begin after three years
of age and include dislocation of the lens of the eye. Most children have
skeletal abnormalities, including osteoporosis. Children are usually tall and
thin with a curved spine, chest deformities, elongated limbs, and long,
spiderlike fingers. Homocystinuria has several features in common with Marfan syndrome,
but unlike Marfan syndrome in which the joints tend to be “loose,” the joints
in homocystinuria tend to be “tight.” Without early diagnosis and treatment,
psychiatric disorders and intellectual disability occur. Homocystinuria causes
a hypercoagulable state, resulting in strokes and other thromboembolic events. <a
name=sec23-ch282-ch282c-1462></a>In the U.S., newborns are routinely screened
for homocystinuria with a blood test. </span></p>

<p><a name=sec23-ch282-ch282c-1463></a><span></span></p>

<p><a name=sec23-ch282-ch282c-1464></a><b><span>Tyrosinemia</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1464a></a><span>There are three types of tyrosinemia. Each is <a
name=sec23-ch282-ch282c-1465></a>characterized by deficiency of a specific
enzyme involved in the metabolism of tyrosine. Accumulation of toxic
by-products may result in liver failure, renal failure, and mental retardation.
</span></p>

<p><b><span>Answer A is correct</span></b><span>. Seizures, fair skin,
light-colored hair, a musty body odor, and developmental delays suggest a
diagnosis of phenylketonuria (PKU). PKU is caused by deficiency of
phenylalanine hydroxylase, the enzyme that converts phenylalanine to tyrosine.
Phenylacetic acid appears in high concentrations in the urine.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Isoleucine is a branched-chain amino acid. Patients with
maple syrup urine disease have an accumulation of branched-chain amino acids
(leucine, isoleucine, and valine) due to a deficiency in </span>branched-chain
alpha-keto dehydrogenase complex<span>. Symptoms include po</span>or
feeding, vomiting, dehydration, lethargy, hypotonia, seizures, hypoglycemia,
ketoacidosis, and neurological decline. <span>The urine
smells sweet, not musty as in phenylketonuria.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Homocysteine
accumulates in patients with cystathionine beta synthase deficiency
(homocystinuria). This results in a Marfan-like syndrome. Symptoms include
dislocation of the lens of the eye; tall, thin body habitus; curved spine;
chest deformity; elongated limbs; and long, spiderlike fingers. Patients with
homocystinuria are predisposed to thromboembolic events. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Homogentisic acid
appears in the urine of patients with alkaptonuria (<span>black urine disease),</span> which is a rare, autosomal recessive
disorder of phenylalanine and tyrosine metabolism. A defect in the enzyme
homogentisate</span><a
href="http://en.wikipedia.org/wiki/Homogentisate_1,2-dioxygenase"
title="Homogentisate 1,2-dioxygenase"></a><span> 1, 2-dioxygenase results in accumulation of
homogentisic acid. This leads to ochronosis (blue or brownish-blue
discoloration of cartilage and connective tissue, especially in the ears,
sclerae, and joints). Patients with alkaptonuria have black urine, skin
pigmentation, and arthritis. Heart valve deformities and kidney stones are
common.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An inherited metabolic disorder is characterized by increased
concentrations of hepatic glycogen and no detectable increase in glucose levels
after oral administration of fructose. Deficiency of which of the following
enzymes is most likely?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Glucokinase</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Fructokinase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Glucose-6-phosphatase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Phosphoglucomutase </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Glycogen synthase</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Glycogen storage disease type I</span><span> (<span>GSD I</span>),
or <span>von Gierke's disease</span>, is the
most common glycogen storage disease. It is an autosomal recessive disease
caused by deficiency of glucose-6-phosphatase. This deficiency inhibits two
pathways needed to produce glucose in the liver: glycogenolysis and
gluconeogenesis. The result is hypoglycemia, which occurs during periods of
fasting. Glycogen accumulates in the liver and kidneys, causing enlargement of
these organs. </span></p>

<p><span></span></p>

<p>Hepatic glycogen serves as a
form of rapidly accessible glucose, allowing blood glucose levels to be maintained
between meals. For about three hours after a carbohydrate-containing meal,
insulin directs liver cells to take glucose from the blood, convert it to
glucose-6-phosphate, and add this molecule to glycogen strands (glycogen
synthesis).<span >&nbsp; </span></p>

<p></p>

<p>When digestion of a meal is
complete, insulin levels fall and glucose molecules are removed from glycogen
in the form of glucose-6-phosphate. This process is called glycogenolysis. The
glucose-6-phosphate remains in the liver cell until phosphate is cleaved by
glucose-6-phosphatase. This dephosphorylation produces free glucose, which can
be transported out of the liver and into the blood, where it can travel to the
brain and other organs. Glycogenolysis can supply glucose needs for 12&#8211;18
hours.</p>

<p></p>

<p>When fasting continues for
more than a few hours, falling insulin levels permit catabolism of
triglycerides in adipose tissue and protein in muscle tissue. The products of
these processes are free fatty acids and amino acids, respectively. Free fatty
acids are converted to acetyl-CoA, some of which is diverted to produce
ketones. Amino acids are used to synthesize new glucose-6-phosphate in liver
cells by the process of gluconeogenesis. The last step of gluconeogenesis, like
the last step of glycogenolysis, is the dephosphorylation of
glucose-6-phosphate to free glucose by glucose-6-phosphatase.</p>

<p></p>

<p>Thus, glucose-6-phosphatase
mediates the final steps in both pathways of glucose production: glycogenolysis
and gluconeogenesis.<span >&nbsp; </span></p>

<p><span></span></p>

<p><span>The
principal metabolic effects of glucose-6-phosphatase deficiency (glycogen
storage disease type I, or von Gierke’s disease) are:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypoglycemia
(fasting)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lactic
acidosis </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hyperuricemia</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypertriglyceridemia<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Hypoglycemia</span></b><span> is “fasting” or
“post-absorptive” because it occurs after digestion of the meal (usually about
four hours later). The inability to maintain adequate blood glucose levels
during a fast occurs because of impaired glycogenolysis and gluconeogenesis.
Fasting hypoglycemia is the most significant complication of GSD I. Chronic
hypoglycemia results in chronically low insulin levels and high levels of
glucagon and cortisol.</span></p>

<p><span></span></p>

<p><b><span>Lactic
acidosis</span></b><span>
occurs because of impaired gluconeogenesis. In the liver and muscle, lactic
acid is oxidized to form pyruvic acid, which is then converted to
glucose-6-phosphate through gluconeogenesis. Accumulation of
glucose-6-phosphate inhibits conversion of lactate to pyruvate.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Hyperuricemia</span></b><span> is due to several
factors. First of all, patients with GSD I are in a catabolic state, and purine
catabolism produces uric acid. Also, uric acid is produced when excess
glucose-6-phosphate is metabolized via the pentose phosphate pathway. Finally,
uiric acid competes with lactic acid and other organic acids for renal
excretion in the urine. </span></p>

<p><span></span></p>

<p><span>Clinical
manifestations of GSD I are discussed below.</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Post-absorptive
hypoglycemia can be mild, cause developmental delays, or lead to seizures and
coma. </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tissue
accumulation of glycogen causes liver and kidney enlargement. </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lactic
acidosis causes vomiting and hyperventilation.</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hyperuricemia
can cause gout and renal disease.</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Impaired
growth occurs because of chronically low insulin levels, high levels of
counterregulatory hormones, acidosis, decreased caloric intake, and
malabsorption. </span></p>

<p></p>

<p>The diagnosis of GSD I is
made by genetic testing and/or liver biopsy with an assay for
glucose-6-phosphatase activity. The mainstay of treatment is frequent ingestion
of food that is high in glucose or starch. (Starch is readily digested to
glucose).</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=339 height=288
src="_%20Tutorials_files/image104.png" v:shapes="Picture_x0020_347156"></span><span></span></p>

<p style="text-align:center;"><span>Fructose metabolism</span></p>

<p><span></span></p>

<p><span>Fructose
did not result in increased blood glucose, so the block must be in an enzyme
that is common to all pathways leading to free glucose secretion in the liver.</span></p>

<p style="text-align:center;"><span><img border=0 width=332 height=303
src="_%20Tutorials_files/image106.png" alt="Description: TXT-200812288725161"
v:shapes="Picture_x0020_347155"></span><span></span></p>

<p><i><span>Glucokinase</span></i><span>: phosphorylates glucose to produce
glucose-6-phosphate<i></i></span></p>

<p><i><span>Fructokinase</span></i><span>: <span> </span>phosphorylates
fructose to produce fructose-1-phosphate</span></p>

<p><i><span>Glucose-6-phosphatase</span></i><span>: hydrolyzes
glucose-6-phosphate to produce glucose</span></p>

<p><i><span>Phosphoglucomutase</span></i><span>: interconverts glucose
1-phosphate and glucose 6-phosphate</span></p>

<p><i><span>Glycogen synthase</span></i><span>: converts short
polymers of glucose into long polymers</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct. </span></b><span>Glucose-6-phosphatase catalyzes the final step in gluconeogeneis and
glycogenolysis. Deficiency of the enzyme results in fasting hypoglycemia and
high concentrations of hepatic glycogen. Hypoglycemia occurs because of
impaired gluconeogenesis. Fructose administration does not solve the problem
because gluconeogenesis is needed to convert fructose to glucose. Glycogen
accumulates in the liver because it cannot be broke down into glucose (due to
impaired glycogenolysis). </span></p>

<p><b><span><span >&nbsp;</span></span></b></p>

<p><b><span>Answer A is incorrect.</span></b><span> Glucokinase is an
enzyme that phosphorylates glucose to produce glucose-6-phosphate. This is the
first step in glycolysis and glycogen synthesis. Deficiency of this enzyme
causes hyperglycemia. In fact, mutations of the glucokinase gene are
responsible for certain types of diabetes. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect.</span></b><span> Fructokinase is an
enzyme that phosphorylates fructose to produce fructose-1-phosphate. Enzyme
deficiency results in high fructose levels in the serum and urine (after
fructose ingestion). This is a benign condition.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>Phosphoglucomutase
interconverts glucose 1-phosphate and glucose 6-phosphate. This is important in
glycogen synthesis and glycogenolysis.<span >&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect.</span></b><span> Glycogen synthase
converts short glucose polymers into long polymers. Enzyme deficiency results
in glycogen deficiency. Glyogen is needed to produce glucose in the fasting
state. If glycogen stores are inadequate, fasting results in hypoglycemia.
After a meal, glucose is used to make glycogen. If glycogen synthesis is
impaired, glucose levels rise, causing postprandial hyperglycemia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
3-year-old girl with a history of fractures of the right humerus and left tibia
presents with pain in her left forearm after a fall. Physical examination shows
blue sclerae. Which of the following is true?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Her
condition is transmitted as an autosomal dominant trait</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Her
condition results from a defect in type 1 collagen</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Her
condition is associated with early deafness</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Her
condition is associated with osteoporosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>All
of the above</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Common
inherited disorders of connective tissue appear below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=221 valign=top>
  <p><span>Inherited
  Disorders of Connective Tissue</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Marfan</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Ehlers-Danlos</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Osteogenesis Imperfecta</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span>Marfan syndrome</span></b><span> is an autosomal
dominant disorder with an incidence of about 1 in 10,000 births. Nearly 30% of
cases are due to spontaneous (sporadic) mutations. The condition is caused by
abnormal biosynthesis of fibrillin-1, a protein that is the major component of
elastic tissue and nonelastic tissues such as aortic adventitia and the
suspensory ligament of the eye. In Marfan syndrome, elastic fibers in the
extracellular matrix are not correctly formed.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><a
name=4-u1.0-B978-1-4160-2450-7..50702-7--cese></a>Individuals with Marfan are
typically tall, with long limbs and long thin fingers. The most serious
complications are defects of the heart valves and aorta. There are no unique
signs or symptoms, but the constellation of long limbs, dislocated lenses, and
aortic root dilation is sufficient to make the diagnosis. More than thirty
clinical features are associated with the syndrome, most involving the
skeleton, skin, and joints. Considerable variability exists within families
carrying the same mutation.</p>

<p></p>

<p>Skeletal abnormalities
include scoliosis, pectus excavatum or pectus carinatum, and abnormal joint
flexibility. Ocular abnormalities include dislocation of the lens (80%),
near-sightedness, astigmatism, detachment of the retina, and glaucoma. Affected
individuals are predisposed to spontaneous pneumothorax. The most serious
complications involve the cardiovascular system and include prolapse of the
mitral and aortic valves resulting in regurgitation, aortic aneurysm, and
angina. Heart problems may be unapparent until weakening of the connective
tissue (cystic medial degeneration) in the ascending aorta causes aortic
dissection. </p>

<p></p>

<p><span><span>Ehlers</span></b></span><b><span>-<span syndrome</span></b><span> is a group of
genetically heterogeneous connective tissue disorders in which the essential
defect is a deficiency of fibrillar collagen. The syndrome is characterized by <a
name=4-u1.0-B978-1-4160-2450-7..50486-2--intr></a>soft, velvety skin that is
hyperelastic; lax, hypermobile joints that are easily subluxed; easy bruising
due to fragile skin and blood vessels; delayed wound healing; and unusual
scarring. More than ten variants have been described. The most serious variants
are associated with rupture of visceral organs. </span></p>

<p><span></span></p>

<p><b><span>Osteogenesis imperfecta (OI)</span></b><span>, or brittle bone
disease, is an autosomal dominant disorder characterized by structural and/or
quantitative defects in type I collagen, the primary component of the extracellular
matrix of bone and skin. It is a generalized disorder of connective tissue and
the most common genetic cause of osteoporosis. The clinical spectrum is broad,
ranging from a lethal form in infancy to a mild form in adults. The prevalence
in infants is about <a name=4-u1.0-B978-1-4160-2450-7..50701-5--p288></a>1 in
20,000. The disorder is characterized by a triad of symptoms: fragile bones,
blue sclerae, and early deafness. Bone fractures occur with only mild trauma.
Other findings include dental abnormalities, easy bruising, joint laxity, and
short stature.</span></p>

<p>[Collagen is the main
component of connective tissue and is the most abundant protein in mammals,
making up about 25% to 35% of the whole-body protein content. It is found in
fibrous tissues, such as tendon, ligament and skin, and is also abundant in cornea,
cartilage, bone, blood vessels, the gut, and intervertebral disc. Fibroblasts
create collagen. Collagen molecules are comprised of three polypeptide strands.
Each strand forms a helix, and the three helices are twisted together into a
triple helix or “super helix,” stabilized by numerous hydrogen bonds. Collagen
is broken down by a special group of collagenases called matrix
metalloproteinases.]</p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct</b>. Osteogenesis imperfecta is an autosomal
dominant disorder characterized by defects in type I collagen. It is the most
common genetic cause of osteoporosis. The disorder is characterized by a triad
of symptoms: fragile bones, blue sclerae, and early deafness.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 3-month-old boy is
unresponsive when he arrives in the emergency room. His mother says that he
stopped eating the previous day and has been vomiting. Examination shows
hepatomegaly. Serum studies show hypoglycemia. Ketones are absent in the serum
and urine. The boy regains consciousness after glucose infusion. Which of the
following is most likely? </p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Fructose-1,6-bisphosphatase deficiency</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Glucose-6-phosphatase deficiency </p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Medium-chain acyl CoA dehydrogenase deficiency</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Methylmalonyl-CoA mutase deficiency</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Ornithine carbamoyltransferase deficiency</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>In this vignette, the infant
presents with hypoglycemia. Answering the question requires an understanding of
carbohydrate and lipid metabolism. </p>

<p></p>

<p>The brain depends on glucose
for fuel. The importance of glucose to the brain is apparent from the number of
nervous, hormonal, and metabolic responses to falling glucose levels. The three
most important responses are <i>glycogenolysis</i>, <i>gluconeogenesis</i>, and
<i>fatty acid oxidation.</i></p>

<p></p>

<p><span>When the body is denied glucose for more
than 4 hours, hepatic glycogen is used for fuel. Through glycogenolysis,
glycogen is broken down to glucose monomers. The liver contains about 12 hours
worth of glycogen. When hepatic glycogen is depleted, three events occur. 1)
Muscle glycogen is broken down, which may continue for days. 2) Gluconeogenesis
occurs, in which glucose is generated from non-carbohydrate substrates. 3)
Lipolysis occurs, in which fats (triglycerides) are broken down into glycerol
and fatty acids. </span></p>

<p><span></span></p>

<p><span>Each triglyceride molecule is composed of
one glycerol and three fatty acid molecules. Fatty acids are transported from
the cytosol to the mitochondria by carnitine (a quaternary ammonium compound).
In the mitochondria, fatty acids are broken down through beta-oxidation to
produce acetyl CoA, which enters the Krebs cycle to produce energy. If fatty
acid breakdown is excessive, the Krebs cycle is overwhelmed and “extra” acetyl
CoA is used to produce ketones, which the brain uses for energy. (The brain
cannot use fatty acids directly because they do not cross the blood-brain
barrier.) </span></p>

<p><span></span></p>

<p><span>The three metabolic responses to
hypoglycemia are regulated by hormones. As glucose levels drop, insulin
secretion is suppressed and counter-regulatory hormone secretion is enhanced.
Counter-regulatory hormones (glucagon, epinephrine, norepinephrine, cortisol,
and growth hormone) oppose insulin action. </span></p>

<p><span></span></p>

<p><span>Hypoglycemia may be ketotic or
non-ketotic. Ketones are formed by fatty acid oxidation. The principal ketones
are acetoacetate and beta-hydroxybutyrate. Prolonged fasting causes ketosis
because a fall in blood glucose triggers lipolysis, fatty acid oxidation, and
ketone production. In patients with disorders that impede fatty acid oxidation,
ketone production will be impaired. These patients will develop a non-ketotic
hypoglycemia.</span></p>

<p><span></span></p>

<p><span>The infant in this vignette has <i>non-ketotic</i>
hypoglycemia, suggesting a disorder of fatty acid oxidation. Of the five
inherited metabolic disorders listed, only one represents a disorder of fatty
acid metabolism: medium-chain acyl-CoA dehydrogenase deficiency. </span></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p style="text-align:center;"><span><img border=0 width=430 height=365
src="_%20Tutorials_files/image108.png" v:shapes="Picture_x0020_347154"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Glycolysis
and Gluconeogenesis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span><img border=0 width=424 height=427
src="_%20Tutorials_files/image110.png" v:shapes="Picture_x0020_347153"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=415 height=275
src="_%20Tutorials_files/image112.png" alt="Description: FA-Ox" v:shapes="Picture_x0020_347152"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Ketogenesis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=313 height=417
src="_%20Tutorials_files/image114.png" alt="Description: Ketogenesis" v:shapes="Picture_x0020_347151"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b>Answer C is correct</b>.
Medium-chain acyl CoA dehydrogenase (MCAD) is an enzyme involved in fatty acid
oxidation (&#946;-oxidation). If the enzyme is deficient, fatty acids cannot be
catabolized in response to falling glucose levels. The result is lipid
accumulation and liver enlargement. Ketones are not produced. The patient
develops <i>non-ketotic</i> hypoglycemia.<span >&nbsp;
</span></p>

<p></p>

<p><b>Answer A is incorrect</b>.
Fructose-1,6-bisphosphatase is necessary for gluconeogenesis. It converts
fructose-1,6-bisphosphate to fructose-6-phosphate. Deficiency of this enzyme
inhibits gluconeogenesis, and impaired gluconeogenesis results in hypoglycemia.
Ketone production is not inhibited because fatty acid metabolism still takes
place.<span >&nbsp;&nbsp; </span></p>

<p></p>

<p><b>Answer B is incorrect</b>.
Glucose-6-phosphatase is an enzyme that catalyzes the final step in
gluconeogenesis and glycogenolysis. Enzyme deficiency leads to fasting
hypoglycemia. This condition is called glycogen storage disease type 1, or von
Gierke’s disease. It is the most common glycogen storage disorder. Glycogen
accumulates in the liver causing hepatomegaly. Lactic acidosis occurs because
of impaired gluconeogenesis. Ketosis occurs because breakdown of fatty acids
remains intact.<span >&nbsp;&nbsp; </span></p>

<p></p>

<p><b><span>Answer D is incorrect</span></b><span>. Methylmalonyl-CoA
mutase converts methylmalonyl CoA to succinyl CoA, a metabolite in the Krebs
cycle. Deficiency of this enzyme leads to methylmalonic acidemia, a type of
organic acidemia.<span >&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b>Answer E is incorrect</b>.
Ornithine carbamoyltransferase is a urea cycle enzyme. It converts ornithine to
citrulline. Enzyme deficiency results in hyperammonemia and neurological
problems. Ornithine carbamoyltransferase deficiency is the most common urea
cycle disorder. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 2-week-old baby girl
delivered at term is brought to the physician by her mother because of an
increasingly severe diaper rash since birth. No congenital anomalies were noted
after delivery. Physical examination shows a red and swollen umbilical remnant
that has not separated. There are ulcerations of the skin but no purulent
exudate in the area of the diaper. A culture of one of the ulcers grows <i>Staphylococcus
aureus</i>. Despite antibiotic therapy, 1 month later she develops a perirectal
fissure, culture of which grows <i>Escherichia
coli</i> but a smear of which shows scarce segmented neutrophils. Laboratory
studies show:<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><u>Patient’s
value</u><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><u>Normal
value</u></span></p>

<p><span>Hemoglobin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12.6
g/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>11-17
g/dL</span></p>

<p><span>Hematocrit<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>38%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>30-40%</span></p>

<p><span>Mean corpuscular volume<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>98 &#956;m<sup>3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>86-110
&#956;m<sup>3</sup></span></p>

<p><span>Leukocyte count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>89,000/mm<sup>3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>6-17.5/
mm<sup>3</sup></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Neutrophils<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>89%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>31%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Bands<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>6%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>6-14%</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Lymphocytes<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>61%</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Monocytes<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5%</span></p>

<p><span>Platelet count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>250,000/mm<sup>3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>250-475,000/mm<sup>3</sup></span></p>

<p><span>Serum</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>IgA<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>92
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0-5
mg/dL</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>IgG<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>766
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>831-1231
mg/dL</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>IgM<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>101
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>6-16
mg/dL</span></p>

<p><span></span></p>

<p><span>Peripheral blood smear: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>normochromic,
normocytic erythrocytes</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>leukocytes
with normal morphology</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>This patient most likely
has which of the following conditions?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
myelogenous leukemia </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acquired
immunodeficiency syndrome</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chédiak-Higashi
syndrome</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Common
variable immunodeficiency</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Leukocyte
adhesion deficiency</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Because leukocytes play
a central role in host defense, defects in leukocyte function, both inherited
and acquired, lead to increased vulnerability to infection. Impairments of
virtually every phase of leukocyte function have been identified &#8211; from
adherence to vascular endothelium to microbicidal activity. These include the
following:<a name=4-u1.0-B978-1-4377-0792-2..50007-9--celi></a> </span></p>

<p><span></span></p>

<table border=0 cellpadding=0 width="95%">
 <tr>
  <td width="3%" valign=top>
  <p><span>• </span></p>
  </td>
  <td>
  <p><b><span>Inherited
  defects in leukocyte adhesion</span></b><span>. Peripheral blood leukocytes undergo a
  sequence of activation that leads to migration of cells into the site of
  inflammation. First, the cells roll along endothelial surfaces, a process
  that requires expression of selectins on the endothelial cells and their
  ligands on leukocytes. Next, cells adhere to the endothelial surface and
  enter the tissues by diapedesis; this process requires the family of
  integrins. Genetic defects of integrins and selectin-ligands cause <i>leukocyte
  adhesion deficiencies </i>(LAD) types 1 and 2. LAD is characterized by marked
  leukocytosis and localized bacterial infections that are difficult to detect
  until they have progressed extensively (due to lack of leukocyte recruitment
  at the site of infection). Affected individuals suffer from bacterial
  infections beginning in the neonatal period. Infections such as omphalitis
  (infection of the umbilical cord stump), pneumonia, gingivitis, abscesses,
  and peritonitis are common and often life-threatening. </span></p>
  </td>
 </tr>
 <tr>
  <td width="3%" valign=top>
  <p><span>• </span></p>
  </td>
  <td>
  <p><b><span>Inherited
  defects in phagolysosome function</span></b><span>. One such disorder is <i>Chédiak-Higashi
  syndrome</i>, an autosomal recessive condition characterized by defective
  fusion of phagosomes and lysosomes in phagocytes (causing susceptibility to
  infection), as well as abnormalities in 1) melanocytes (leading to albinism),
  2) nerve cells (associated with nerve defects), and 3) platelets (causing
  bleeding disorders). The main leukocyte abnormalities are neutropenia
  (decreased numbers of neutrophils), defective degranulation, and delayed
  microbial killing. Leukocytes contain giant granules, which can be readily
  seen in peripheral blood smears and are thought to result from aberrant
  phagolysosome fusion. </span></p>
  </td>
 </tr>
 <tr>
  <td width="3%" valign=top>
  <p><span>• </span></p>
  </td>
  <td>
  <p><b><span>Inherited
  defects in microbicidal activity</span></b><span>. The importance of oxygen-dependent
  bactericidal mechanisms is shown by the existence of a group of congenital
  disorders called <i>chronic granulomatous disease</i>, which are
  characterized by defects in bacterial killing and render patients susceptible
  to recurrent bacterial infection. Chronic granulomatous disease results from
  inherited defects in the genes encoding components of phagocyte oxidase,
  which generates <span>superoxide</span>. The name of
  the disease comes from the macrophage-rich chronic inflammatory reaction that
  tries to control the infection when the initial neutrophil defense is
  inadequate. This often leads to collections of activated macrophages that
  wall off microbes, forming aggregates called granuloma<i>s</i>.</span></p>
  </td>
 </tr>
 <tr>
  <td width="3%" valign=top>
  <p><span>• </span></p>
  </td>
  <td>
  <p><b><span>Acquired
  deficiencies</span></b><span>.
  Clinically, the most frequent cause of leukocyte defects is <i>bone marrow
  suppression</i>, leading to <a name=4-u1.0-B978-1-4377-0792-2..50007-9--p56></a>decreased
  production of leukocytes. This is seen following therapies for cancer
  (radiation and chemotherapy) and when the marrow space is compromised by
  tumors, which may arise in the marrow (e.g., leukemias) or be metastatic from
  other sites.</span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

<p style="text-align:center;"><a
name=4-u1.0-B978-1-4377-0792-2..50007-9--ceta></a><span><br>
Defects in Leukocyte Function</span></p>

<p style="text-align:center;"><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p><span>Disease</span></p>
   </td>
   <td valign=bottom>
   <p><span>Defect</span></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td colspan=2 valign=top>
  <p><span>GENETIC</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leukocyte
  adhesion deficiency 1</span></p>
  </td>
  <td valign=top>
  <p><span>Defective
  leukocyte adhesion because of mutations affecting &#946; chain of CD11/CD18 <i>integrins</i></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leukocyte
  adhesion deficiency 2</span></p>
  </td>
  <td valign=top>
  <p><span>Defective
  leukocyte adhesion because of mutations affecting enzyme required for
  synthesis of ligand for <i>selectins</i></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Chronic
  granulomatous disease </span></p>
  <p><span></span></p>
  </td>
  <td valign=top>
  <p><span>Decreased
  oxidative burst</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Myeloperoxidase
  deficiency (MPO)</span></p>
  </td>
  <td valign=top>
  <p><span>Decreased
  microbial killing because of defective MPO&#8212;H<sub>2</sub>O<sub>2</sub>
  system</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Chédiak-Higashi
  syndrome</span></p>
  </td>
  <td valign=top>
  <p><span>Decreased
  leukocyte functions because of mutations affecting protein involved in
  lysosomal membrane traffic</span></p>
  </td>
 </tr>
 <tr>
  <td colspan=2 valign=top>
  <p><span>ACQUIRED</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Bone
  marrow suppression: tumors, radiation, and chemotherapy</span></p>
  </td>
  <td valign=top>
  <p><span>Production
  of leukocytes</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Diabetes,
  malignancy, sepsis, chronic dialysis</span></p>
  </td>
  <td valign=top>
  <p><span>Adhesion
  and chemotaxis</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leukemia,
  anemia, sepsis, diabetes, malnutrition</span></p>
  </td>
  <td valign=top>
  <p><span>Phagocytosis
  and microbicidal activity</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
E is correct. </span></b><span>The
presence of recurrent, hard-to-eradicate bacterial infections in a newborn is
worrisome for some hereditary defect of immunity or leukocyte function. Several
clues in the vignette reveal the diagnosis. The skin ulcers are infected, but
there is no purulence. Also, the perirectal fissure is infected, but neutrophils
are scarce. Clearly, something is inhibiting the normal neutrophil response to
bacterial infection. One might suspect that the patient is neutropenic and
cannot generate an inflammatory response, but the opposite is true. The patient
has a profound leukocytosis. (The leukocyte count is 89,000/mm<sup>3</sup>.)
Thus, the patient is mounting a dramatic response to infection, but the
leukocytes cannot make their way to the site of infection. This can be
explained by leukocyte adhesion deficiency (LAD), a genetic disorder associated
with a defect in integrins or in the ligand for selectins, which are necessary
for leukocyte adhesion, an important step in the leukocytic response to
infection. (Also, of note, the patient has omphalitis, which occurs in LAD.) </span></p>

<p><span></span></p>

<p><b>Answer A is incorrect. </b>Acute
myeloid leukemia (AML), also known as acute myelogenous leukemia, is a cancer
of the myeloid line of blood cells, characterized by the rapid growth of
abnormal white blood cells that accumulate in the bone marrow and interfere
with the production of normal blood cells. (The word “myeloid” is used to
describe any leukocyte that is not a lymphocyte). AML is the most common acute
leukemia affecting adults, and its incidence increases with age. Symptoms are
caused by replacement of normal bone marrow with leukemic cells, which causes a
drop in red blood cells, platelets, and normal white blood cells. This can
result in fatigue, shortness of breath, easy bruising and bleeding, and
increased risk of infection. Several risk factors and chromosomal abnormalities
have been identified, but the specific cause is not clear. As an acute
leukemia, AML progresses rapidly and is typically fatal within weeks or months
if left untreated.</p>

<p></p>

<p><b>Answer B is incorrect. </b>Acquired
immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus
(HIV), a retrovirus that primarily infects cells of the immune system, such as
CD4<sup>+</sup> T cells, macrophages, and dendritic cells. The virus
progressively weakens the immune system, leaving individuals susceptible to
opportunistic infections and tumors. </p>

<p></p>

<p><b><span>Answer
C is incorrect. </span></b><span>Chédiak-Higashi
syndrome is a rare autosomal recessive disorder caused by a mutation in the
lysosomal trafficking regulator gene, LYST. The mutation disrupts microtubule
polymerization, resulting in impaired phagolysosome formation. (A phagolysosome
is a membrane-enclosed organelle that forms when a phagosome fuses with a
lysosome. Under normal conditions, after fusion, the pathogen contained within
the phagosome is digested by enzymes in the lysosome.) Chédiak-Higashi syndrome
is characterized by recurrent pyogenic infections, partial albinism, and
peripheral neuropathy. </span></p>

<p><span></span></p>

<p><b>Answer D is incorrect. </b>Common
variable immunodeficiency (CVID) is a group of approximately 150 disorders
characterized by low serum immunoglobulin levels. Affected individuals are
predisposed to recurrent infection of the ears, sinuses, and respiratory
system, as well as digestive problems, blood disorders, and cancer. Symptoms
typically occur in children ages 2 to 8 or in adults above age 30. </p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 2-year-old boy with mental retardation
presents with weakness and a protuberant abdomen. Physical examination shows
hepatosplenomegaly. His blood hemoglobin level is 9 mg/dl and his platelet
count is 20,000/mm<sup>3</sup>. Bone marrow examination shows lipid-laden
macrophages. Additional studies show accumulation of glucocerebroside in the
reticuloendothelial cells (macrophage system). Which of the following enzymes
is most likely deficient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ceramidase
</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#945;-Galactosidase
</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#946;-Glucosidase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hexosaminidase
</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#945;-L-Iduronidase</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sphingomyelinase
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><a
href="http://en.wikipedia.org/wiki/Lysosome" title=Lysosome></a>Lysosomes are
organelles that serve as the cell’s “recycling center.” They process unwanted
materials into substances that the cell can use. Specific enzyme deficiencies
can result in lysosomal storage diseases (LSDs), a group of about forty
disorders in which intracellular accumulation of lipid, glycoprotein, or <a
href="http://en.wikipedia.org/wiki/Mucopolysaccharides"
title=Mucopolysaccharides>mucopolysaccharide</a> results in organ failure.<span>&nbsp; </span>The most common lysosomal storage
disease is Gaucher disease. Other lysosomal storage diseases include Tay-Sachs,
Niemann-Pick, Fabry, Farber, and Hurler disease.</p>

<p></p>

<p><b>Gaucher disease</b> is the most common of the lysosomal storage
diseases. It is an aut<span>osomal recessive </span>disorder
characterized by the accumulation of lipid in certain cells (e.g., macrophages)
and organs. The disease is caused by a hereditary deficiency of the enzyme
glucocerebrosidase (also known as acid &#946;-glucosidase). When the enzyme is
deficient, glucocerebroside accumulates, particularly in the liver, spleen,
kidneys, lungs, brain, and bone marrow. Symptoms include distended abdomen;
enlarged liver, spleen, and lymph nodes; anemia and thrombocytopenia; skeletal
disorders; severe neurologic complications, including mental retardation; and
yellow fatty deposits on the sclerae. Affected individuals are predisposed to
infection. Some forms of Gaucher's disease may be treated with enzyme
replacement therapy. </p>

<p></p>

<p>Ceramidase deficiency causes
<b>Farber disease</b>, an autosomal
recessive disorder that results in arthritis, hepatosplenomegaly, dysphagia,
and mental retardation. Swollen joints and joint contractures occur. </p>

<p></p>

<p>&#945;-Galactosidase
deficiency causes <b>Fabry disease</b>, an
X-linked disorder that results in renal failure, cardiomyopathy,
angiokeratomas, anhidrosis, Raynaud’s phenomenon, neuropathy, and keratopathy.</p>

<p></p>

<p>Hexosaminidase deficiency
causes <b>Tay-Sach disease</b>, an
autosomal recessive disorder that results in blindness, deafness, neurological
impairment, and paralysis. A “cherry-red” macula is seen in all patients.
Hepatosplenomegaly does not occur.</p>

<p></p>

<p>&#945;-L-Iduronidase
deficiency causes <b>Hurler syndrome</b>,
an autosomal recessive disorder that results in mental retardation, an abnormal
face, dwarfism, and hepatosplenomegaly.<span >&nbsp;
</span></p>

<p></p>

<p>Sphingomyelinase deficiency
causes <b>Niemann-Pick disease</b>, an
autosomal recessive disorder that results in ataxia, dysarthria, dysphagia,
dystonia, hepatosplenomegaly, and thrombocytopenia. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b><span>Answer C is correct</span></b><span>. The patient has Gaucher disease, caused by
&#946;-Glucosidase deficiency.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
3-year-old boy has a tendency toward self-mutilation. He bites his fingers and
lips. He has choreoathetosis, delayed motor development, and arthritis. Serum
uric acid levels are very high. Which of the following is most likely?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Phosphoribosylpyrophosphate
(PRPP) synthetase deficiency</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Adenine
phosphoribosyltransferase (APRT) deficiency</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypoxanthine-guanine
phosphoribosyltransferase (HPRT) deficiency </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Xanthine
oxidase inhibition</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Uric acid
is a product of purine metabolism. Purines are essential for life. In addition
to being part of DNA and RNA, they are components of ATP, GTP, cAMP, NADH, and
coenzyme A. The most common purines appear below. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=349 height=209
src="_%20Tutorials_files/image116.png" alt="Description: Purines.gif" v:shapes="Picture_x0020_347150"></span><span></span></p>

<p><span></span></p>

<p><span>Adenine
and guanine are purines that are used to make DNA. Their breakdown results in
uric acid. The following conditions are associated with elevated serum uric
acid levels (hyperuricemia). </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=479 colspan=2 valign=top>
  <p style="text-align:center;"><span>Causes of Hyperuricemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Increased Urate Production (10%)</span></p>
  </td>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Decreased Urate Excretion (90%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=239 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Ethanol</span></p>
  <p><span>Disorders
  of purine metabolism</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>PRPP synthetase
  overactivity</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>HPRT deficiency </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Glucose-6-phosphatase
  deficiency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>G6PD deficiency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Fructose-1-phosphate
  aldolase deficiency<span >&nbsp; </span></span></p>
  <p><span>Conditions
  with increased cell turnover</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cytotoxic drugs (tumor
  lysis syndrome)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Myeloproliferative
  diseases</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Sickle cell disease,
  thalassemia</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Dehydration</span></p>
  <p><span>Renal
  insufficiency </span></p>
  <p><span>Acidosis</span></p>
  <p><span>Hypothyroidism</span></p>
  <p><span>Drugs
  (e.g., diuretics, low-dose salicylates)</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>To
understand how specific enzyme disorders can increase uric acid levels, one
must understand purine metabolism. A schematic of purine metabolism appears
below. </span></p>

<p style="text-align:center;"><span><img border=0 width=390 height=245
src="_%20Tutorials_files/image118.png" alt="Description: Purine metabolism.jpg"
v:shapes="Picture_x0020_347149"></span><span></span></p>

<p><span></span></p>

<p><span>PRPP:
Phosphoribosylpyrophosphate</span></p>

<p><span>HPRT:
Hypoxanthine-guanine phosphoribosyltransferase</span></p>

<p><span>APRT:
Adenine phosphoribosyltransferase</span></p>

<p><span></span></p>

<p><span>Purine
metabolism has three major components: </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>De novo</span></i><span> synthesis of purines via PRPP</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Purine
interconversion (GMP &#8596; IMP &#8596; AMP)</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>“Salvage”
pathways that recapture intermediate breakdown products, preventing further
breakdown to uric acid</span></p>

<p><span></span></p>

<p><span>Many
enzymes are involved in purine metabolism. These enzymes include PRPP
synthetase, PRPP amidotransferase, APRT, and xanthine oxidase. Deficiency (or
inhibition) of any of these enzymes will decrease uric acid production. <i>Deficiency
of hypoxanthine-guanine phosphoribosyltransferase (HPRT), however, has the
opposite effect</i>. This enzyme participates in the <i>salvage pathway</i> of
purine metabolism. It converts hypoxanthine to IMP and guanine to GMP.<span>&nbsp; </span>Deficiency of this enzyme <i>increases</i>
uric acid production because intermediate breakdown products have no other
“path” to follow.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>HPRT
deficiency results in Lesch-Nyhan syndrome, which is a rare X-linked disorder
characterized by self-mutilating behavior, neurological impairment, and
arthritis. Uric acid levels are extremely high. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct</span></b><span>.
HPRT is part of the “salvage” pathway. It recaptures intermediate breakdown
products, preventing further degradation to uric acid. Deficiency of this
enzyme blocks the salvage pathway, forcing intermediate products to be further
degraded to uric acid.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Phosphoribosylpyrophosphate (PRPP) synthetase converts ribose-5-phosphate to
PRPP. This is the first step of <i>de novo</i> purine synthesis. Deficiency of
this enzyme inhibits purine metabolism and reduces uric acid formation. PRPP
synthetase <i>overactivity</i>, not deficiency, is associated with high uric
acid levels. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
Adenine phosphoribosyltransferase (APRT) converts adenine to AMP. Deficiency of
this enzyme reduces uric acid production. </span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect</span></b><span>.
Allopurinol is a drug used in the treatment of gout. It works by inhibiting
xanthine oxidase. Xanthine oxidase converts 1) hypoxanthine to xanthine and 2)
xanthine to uric acid. By blocking xanthine oxidase, allopurinol lowers uric
acid levels, thus preventing gouty attacks, which are caused by the deposition
of uric acid crystals in joints. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>The control curve in the
graph below illustrates the relationship between initial velocity of reaction
and substrate concentration for an enzyme obeying Michaelis-Menten kinetics.
Which of the following curves best represents the results that would be obtained
by halving the amount of enzyme? </p>

<p style="text-align:center;"><span><img border=0 width=215 height=170
src="_%20Tutorials_files/image120.png" v:shapes="Picture_x0020_347148"></span></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Curve 1</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Curve 2</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Curve 3</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Control curve</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Enzymes speed up the rate of
a chemical reaction without being consumed in the process. They achieve this by
temporarily binding to a <span>substrate,
thereby l</span>owering the activation energy needed to convert it to a
product. </p>

<p><span></span></p>

<p><span>The rate
at which an enzyme works is influenced by several factors: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Substrate
concentration. Adding more substrate keeps the enzyme active site occupied more
often, thus allowing the reaction to occur more frequently. This makes the
apparent rate of reaction higher. At higher substrate concentrations, however,
the enzyme will eventually be saturated and the observed rate is maximized.
This is evidenced by the plateau in the curve at high substrate
concentrations.<span >&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Temperature.
Higher temperatures accelerate the reaction.<span>&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Inhibitors.
Adding inhibitors keeps the active site from working on the productive
reaction, thus the apparent rate of reaction is lower.<span>&nbsp;&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acidity.
The pH affects protein conformation and charge state, which influence enzymatic
activity.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The study
of the rate at which an enzyme works is called <span>enzyme kinetics</span>. The following figure shows the relationship
between substrate concentration and velocity of reaction.</span></p>

<p style="text-align:center;"><span><img border=0 width=202 height=250
src="_%20Tutorials_files/image122.png" alt="Description: Michaelis_Menten"
v:shapes="Picture_x0020_347147"></span><span></span></p>

<p><span></span></p>

<p><span>From the
figure, we see that <a name="Michaelis_Menten"></a>at low levels of substrate,
the velocity of reaction rises almost linearly with increased substrate
concentration. As substrate levels rise further, the gains in velocity level
off. The asymptote represents the maximum velocity of the reaction. The
substrate concentration that produces a velocity that is one-half of the
maximum velocity is called the Michaelis-Menten constant (<span>K<sub>m</sub></span>). This constant is
inversely related to the affinity between substrate and enzyme. The lower the <span>K<sub>m</sub></span>, the greater is the
affinity. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>There are
two types of enzyme inhibitors. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Competitive
inhibitors “compete” with a substrate for a specific site on an enzyme. By
binding to that site, the inhibitor prevents the substrate from binding </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Noncompetitive
inhibitors bind to the enzyme at a different site, taking it “out of
commission.”<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
difference between competitive and noncompetitive inhibition is illustrated
below.<span >&nbsp; </span></span></p>

<p style="text-align:center;"><span><img border=0 width=191 height=164
src="_%20Tutorials_files/image124.png" alt="Description: Michaelis_Menten2"
v:shapes="Picture_x0020_347146"></span><span></span></p>

<p><a name="Competitive_Inhibition"><span></span></a></p>

<p><span><span>Competitive Inhibition</span></span><span></span></p>

<p><span></span></p>

<p><span>When a
competitive inhibitor is present, higher substrate concentrations are needed to
displace the inhibitor and achieve the same velocity. <span>V<sub>max</sub></span> can still be reached if enough substrate is
available. The <span>K<sub>m</sub></span> is
larger because the enzyme’s affinity for substrate is diminished by the
inhibitor.</span></p>

<p><span></span></p>

<p><a name="Noncompetitive_Inhibition"><span>Noncompetitive Inhibition</span></a><span></span></p>

<p><span></span></p>

<p><span>When a
noncompetitive inhibitor is present, it binds to the enzyme, taking it “out of
commission.” The velocity of reaction is reduced for all substrate
concentrations. The <span>K<sub>m</sub></span>
is unchanged, however, because enzymes still “in commission” have the same
affinity for substrate. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>Halving the amount of
enzyme is the functional equivalent of using a noncompetitive inhibitor to
inactivate half of the enzymes present. The curve produced by halving the
amount of enzyme would, therefore, resemble the curve for non-competitive
inhibition. In both cases, t<span>he velocity
of reaction would be reduced for all concentrations of substrate, and V<sub>max</sub>
would be reduced as well.<span >&nbsp;&nbsp;&nbsp;
</span><sub></sub></span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A normal
peptide has 100 amino acids. Following mutation, it has only 20. Amino acids
1-10 are the same as the normal peptide; 11-20 differ from the normal peptide.
Which of the following mutations occurred?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Nucleotide
substitution in codon 11 (the codon that codes for amino acid 11)</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleotide
deletion in codon 11</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleotide
substitution in codon 20</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Nucleotide
deletion in codon 20</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleotide
insertion in codon 20</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The effect
of a genetic mutation depends on its location and its ability to alter protein
function. <span>The major types of mutation
appear below. </span></span></p>

<p><span></span></p>

<p><b><span>Substitution.
</span></b><span>A</span><span> single nucleotide is exchanged for another. There are three
basic types:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Silent
mutation, which codes for the same amino acid </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Missense
mutation, which codes for a different amino acid<span>&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nonsense
mutation, which codes for a stop codon </span></p>

<p><b><span></span></b></p>

<p><b><span>Insertion.</span></b><span> One or more nucleotides
is inserted into DNA. The mutation is often reversible. The reading frame may
be altered.</span></p>

<p><span></span></p>

<p><b><span>Deletion.
</span></b><span>O</span><span>ne or more nucleotides is deleted from DNA. The mutation is
usually irreversible. The reading frame may be altered. </span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td>
  <p><b><span>Frameshift.<span>&nbsp; </span></span></b><span>If the number
  of nucleotides inserted or deleted is not divisible by three, a frameshift
  mutation occurs. This is because each codon contains three nucleotides. The
  addition or deletion of only one or two nucleotides alters the reading frame,
  </span><span>resulting
  in a completely different protein.</span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><b><span>Answer B is correct.<span>&nbsp; </span></span></b><span>In the clinical vignette, amino acids
  1-10 are unchanged and amino acids 11-20 are different. Thus, the first amino
  acid to be altered is amino acid 11, indicating that the mutation must be in
  codon 11 (which codes for amino acid 11). Could this mutation be a
  substitution? Consider the following: If a silent mutation had occurred, the
  amino acid sequence would not have changed. If a missense mutation had
  occurred, amino acid 11 would have changed, but amino acids 12-20 would have
  been the same. If a nonsense mutation had occurred, the sequence would have
  ended at amino acid 10, not amino acid 20. Therefore, a substitution mutation
  cannot explain the new sequence. The only way to explain a change in sequence
  that encompasses the entire remaining length of the protein is with a
  frameshift mutation. This mutation could be an insertion or a deletion.
  Either way, the number of nucleotodes inserted or deleted would not be
  divisible by three. (If the number were divisible by three, the reading frame
  would not have “shifted.”) The answer is, therefore, B (i.e., a deletion in
  codon 11) because this is the only option that produces a frameshift mutation
  at codon 11. Also, we can assume that the frameshift mutation resulted in a
  nonsense codon at position 21, since the protein was terminated at amino acid
  20. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>In patients with AIDS, the failure to form granulomas in tissues infected
by <i>Mycobacterium tuberculosis</i> is most
likely due to which of the following?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Inability of T lymphocytes to provide helper
functions for B lymphocytes</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Inability of T lymphocytes to recruit and
immobilize monocytes</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Clonal deletion of T lymphocytes reactive to
mycobacterial antigens</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Decreased production of tumor necrosis
factor-&#945; by macrophages</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Poor phagocytic activity of macrophages</span></p>

<p><span><span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A granuloma</span> is an<b> </b><span>organized
collection of macrophages</span> that have gathered around a microorganism or
foreign substance to “wall it off” from the body (see Figure 1). Macrophages
(also known as histiocytes) define the granuloma.<span> They originate as monocytes, which are recruited by T-cells into tissues
where they differentiate into macrophages. Cytokines produced by T-cells
“activate” macrophages, rendering them more “aggressive.” </span></p>

<p><span></span></p>

<p>Granulomatous macrophages
are sometimes called “epithelioid” because they resemble epithelial cells.
These macrophages form a tight “ball” around the microorganism or foreign
substance. They are so tightly clustered that the borders of individual cells
are difficult to appreciate. The “ball” of macrophages is surrounded by a
collar of lymphocytes, which produce cytokines that keep the macrophages
activated. Some macrophages fuse to form multinucleated giant cells (Langhans
giant cells). (See Figure 2.) </p>

<p></p>

<p>Granulomas form in response
to antigens that are resistant to &quot;first-responder&quot; inflammatory
cells, such as neutrophils and eosinophils. Thus, granulomas represent a type
of chronic inflammation. Some granulomas contain areas of necrosis. The
identification of necrosis usually indicates that the granuloma has an
infectious cause. The term “caseation” (turning into cheese) is used to describe
necrosis that looks “cheese-like” to the unaided eye. Caseating necrosis is
typical of tuberculosis. </p>

<p></p>

<p>T<span>uberculosis is the prototypic granulomatous disease and should always
be considered in the differential diagnosis in patients with granulomatous inflammation.
</span>Granulomas occur in the following conditions.</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=top>
   <p><b><span>Disease</span></b></p>
   </td>
   <td valign=top>
   <p><b><span>Cause</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td valign=top>
  <p><span>Tuberculosis</span></p>
  </td>
  <td valign=top>
  <p><i><span>Mycobacterium
  tuberculosis</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leprosy</span></p>
  </td>
  <td valign=top>
  <p><i><span>Mycobacterium
  leprae</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Syphilis</span></p>
  </td>
  <td valign=top>
  <p><i><span>Treponema
  pallidum</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Fungal
  disease</span></p>
  </td>
  <td valign=top>
  <p><i><span>Histoplasma,
  Coccidioides, Cryptococcus</span></i></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Cat-scratch
  disease</span></p>
  </td>
  <td valign=top>
  <p><i><span>Bartonella</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Sarcoidosis</span></p>
  </td>
  <td valign=top>
  <p><span>Unknown</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Crohn’s
  disease </span></p>
  </td>
  <td valign=top>
  <p><span>Unknown</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Wegener’s
  granulomatosis</span></p>
  </td>
  <td valign=top>
  <p><span>Unknown</span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b></b></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/f/f2/Necrogran10x.jpg"><span><img border=0 width=281 height=212
src="_%20Tutorials_files/image126.png" alt="Description: File:Necrogran10x.jpg"
v:shapes="Picture_x0020_347145"></span></a></p>

<p style="text-align:center;"><span>Figure 1. Granuloma in a patient with tuberculosis </span></p>

<p style="text-align:center;"><b></b></p>

<p style="text-align:center;"><span><img border=0 width=269 height=181
src="_%20Tutorials_files/image128.png"
alt="Description: giant_cell_S98-40211-03" v:shapes="Picture_x0020_347144"></span></p>

<p style="text-align:center;"><span>Figure 2. Langhans giant cells</span></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer B is correct. </b>A granuloma is an organized collection of
macrophages. T cells recruit monocytes into tissues where they differentiate to
form macrophages. T cells also elaborate cytokines that activate macrophages.
In patients with AIDS, T cells are depleted and granuloma formation is
impaired. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A specific congenital form of deafness results from mutation of a
sequence of connexin 26 that encodes the channel within the connexin of the gap
junction. The mutation is most likely to affect which of the following domains
of the protein? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Amino terminus</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Carboxyl terminus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Cytoplasmic loop</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Extracellular loop</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Transmembrane region</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Gap junction beta-2</span> (GJB2) also known as <b>connexin-26</b><b> (Cx26)</b> is a protein that in humans is
encoded by the <i>GJB2</i> gene. Defects in this gene lead to the most common
form of congenital deafness in developed countries, called DFNB1, also known as
Connexin 26 deafness or GJB2-related deafness. <span>The
prevalence and availability of interventions makes identifying those individuals
with hearing loss a public health issue. Universal newborn screening for
hearing loss has been widely adopted since it is known that early
identification and management of deafness is important for the development of
language and social skills. Research has shown that children with hearing loss
identified before six months of age and who have begun appropriate
interventions immediately after diagnosis demonstrate superior language skills
over those identified after six months of age.</span></p>

<p><span></span></p>

<p one in 1000 infants has profound hearing loss, with
at least half of these cases thought to be of genetic origin. Despite this
number, genetic causes of hearing loss are frequently undiagnosed. Also,
children who are the only deaf individuals in their families may have a genetic
or inherited cause for their deafness. There are many genes that contribute to
hearing loss. These genes may be inherited in a variety of fashions: autosomal
dominant, autosomal recessive, X-linked, or mitochondrial. <span>Infection in the mother during pregnancy or illness of the
infant requiring care in a neonatal intensive care unit may result in isolated
or sporadic cases of newborn hearing loss within families. </span></p>

<p><span></span></p>

<p><span>The most
common cause of congenital deafness in children is caused by a mutation
(autosomal recessive) of a gene called GBJ2. The gap junction gene called GJB2
encodes the protein connexin 26(Cx26). Many people simply refer to the gene as
the “<span>connexin 26 gene</span>.” In
two-thirds of persons with Cx26-related deafness, a single mutation is found
called 35delG. This mutation causes a defect in the transmembrane region of the
connexin protein. Connexins are expressed in many different tissues. Connexin
26 functions in the inner ear and is involved in junctions that allow the transport
of materials between cells.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span>**</span></p>

<p><b>Presbycusis</b>, or
age-related hearing loss, is the cumulative effect of aging on hearing. It is
defined as a progressive bilateral symmetrical age-related sensorineural
hearing loss. The hearing loss is most marked at higher frequencies. Hearing
loss that accumulates with age but is caused by factors other than normal aging
is not presbycusis. Deterioration in hearing has been found to start from about
the age of 18 years. Age affects high frequencies more than low frequencies and
men more frequently than women. One early consequence is that even young adults
may lose the ability to hear very high frequency tones. Despite this,
age-related hearing loss may only become noticeable later in life. The effects
of age can be exacerbated by exposure to environmental noise, whether at work
or in leisure time (shooting, music, etc.). With presbycusis, detection of
high-pitched sounds becomes more difficult, and speech perception is affected. </p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct.</b> Mutation of the connexin 26 gene causes a
defect in the transmembrane region of the connexin protein. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 31-year-old woman with type 1 diabetes mellitus stops taking her
insulin. Two days later she develops nausea, vomiting, abdominal pain, and
frequent urination. Blood tests reveal a metabolic acidosis with increased
anion gap. While performing the physical examination, her physician notices
that her breath has “fruity” odor. Which of the following substances most
likely explains that odor?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Oxaloacetate</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Malate</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Fumarate</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Succinate</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Acetone</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span>Ketones<b> </b></span>are by-products of fatty acid oxidation, produced
mainly in the mitochondria of liver cells. They are a fuel source for the brain
and are synthesized when glucose levels are low and when carbohydrate stores
(e.g., glycogen) have been exhausted.<span >&nbsp;
</span></p>

<p></p>

<p>Fatty acids are
enzymatically broken down during &#946;-oxidation to form acetyl-CoA. Under
normal conditions, acetyl-CoA is further oxidized and its energy transferred as
electrons to NADH, FADH<sub>2</sub>, and GTP in the citric acid cycle (TCA
cycle). However, if the amount of acetyl-CoA generated in &#946;-oxidation
(fatty acid oxidation) overwhelms the processing capacity of the TCA cycle,
acetyl-CoA is then used instead in the biosynthesis of ketones.</p>

<p></p>

<p><span>After they
are produced in the liver, ketones are transported to other tissues, such as
the brain and heart. Ketones can cross the blood-brian barrier and enter the
central nervous system. In the brain, they can be reconverted to acetyl-CoA to
produce energy, via the citric acid cycle. The heart has little need for
ketones, as it can burn fatty acids. The brain cannot burn fatty acids and must
rely on ketones when glucose is not available. </span></p>

<p><span></span></p>

<p>The three principal ketones
are acetoacetic acid, beta-hydroxybutyric acid, and acetone. Acetone is
produced by spontaneous decarboxylation of acetoacetate. It is not used as an
energy source, but is instead exhaled or excreted as waste. It is responsible
for the characteristic “fruity” odor of the breath of persons in ketoacidosis. </p>

<p></p>

<p>Ketogenesis may or may not
occur, depending on levels of available carbohydrates in the cell or body. </p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>When
the body has ample carbohydrates available as energy source, glucose is
completely oxidized to CO<sub>2</sub>; acetyl-CoA is formed as an intermediate
in this process, first entering the citric acid cycle followed by complete
conversion of its chemical energy to ATP in oxidative phosporylation. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>When
the body has excess carbohydrates available, some glucose is fully metabolized,
and some of it is stored by using acetyl-CoA to create fatty acids.<span>&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>When
the body has no free carbohydrates available, fat must be broken down into
acetyl-CoA in order to get energy. Acetyl-CoA is not being recycled through the
citric acid cycle because the citric acid cycle intermediates (mainly
oxaloacetate) have been depleted to feed the gluconeogenesis pathway, and the
resulting accumulation of acetyl-CoA activates ketogenesis. </span></p>

<p><span></span></p>

<p><span>Ketone
bodies are created at moderate levels in everyone’s bodies, such as during
sleep and other times when no carbohydrates are available. However, when
ketogenesis happens at higher-than-normal levels, the body is said to be in a
state of ketosis. Both acetoacetate and beta-hydroxybutyrate are acidic, and, if
levels of these ketones are too high, the pH of the blood drops, resulting in
ketoacidosis. Ketoacidosis occurs in individuals with untreated type I diabetes
mellitus (diabetic ketoacidosis) and in alcoholics after prolonged
binge-drinking without sufficient intake of carbohydrates (alcoholic
ketoacidosis). Ketoacidosis produces an increased-anion-gap metabolic acidosis.
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Ketogenesis</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=303 height=328
src="_%20Tutorials_files/image130.png" alt="Description: ketogenesis_pathway"
v:shapes="Picture_x0020_347143"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer E is correct. </span></b><span>In this patient with
type 1 diabetes mellitus, failure to take insulin has led to a state of
diabetic ketoacidosis (DKA). (In the absence of insulin, glucose cannot enter
the cell. The cell is “starved” of glucose, and ketogenesis occurs.) DKA is
commonly associated with nausea, vomiting, abdominal pain, and frequent
urination (due to hyperglycemia). Ketones are produced in abundance, resulting
in a metabolic acidosis with an increased anion gap. The main ketones are
acetoacetate, &#946;-hydroxybutyrate, and acetone. Acetone is responsible for
the “fruity” breath of people with DKA. <b></b></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
14-year-old boy falls and scrapes his knee. Which of the following complement
components will enhance vascular permeability and attract inflammatory cells to
the area of injury?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>C1q</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C4b</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C5a</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>C7</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C9</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
principal mediators of inflammation (and their actions) are listed below. </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p><b><span>Mediator</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Principal
   Sources</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Actions</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td colspan=3 valign=top>
  <p><b><span>CELL-DERIVED</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Histamine</span></p>
  </td>
  <td valign=top>
  <p><span>Mast
  cells, basophils, platelets</span></p>
  </td>
  <td valign=top>
  <p><span>Vasodilation,
  increased vascular permeability, endothelial activation</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Serotonin</span></p>
  </td>
  <td valign=top>
  <p><span>Platelets</span></p>
  </td>
  <td valign=top>
  <p><span>Vasodilation,
  increased vascular permeability</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Prostaglandins</span></p>
  </td>
  <td valign=top>
  <p><span>Mast
  cells, leukocytes</span></p>
  </td>
  <td valign=top>
  <p><span>Vasodilation,
  pain, fever</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leukotrienes</span></p>
  </td>
  <td valign=top>
  <p><span>Mast
  cells, leukocytes</span></p>
  </td>
  <td valign=top>
  <p><span>Increased
  vascular permeability, chemotaxis, leukocyte adhesion and activation</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Platelet-activating
  factor</span></p>
  </td>
  <td valign=top>
  <p><span>Leukocytes,
  mast cells</span></p>
  </td>
  <td valign=top>
  <p><span>Vasodilation,
  increased vascular permeability, leukocyte adhesion, chemotaxis,
  degranulation, oxidative burst</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Reactive
  oxygen species</span></p>
  </td>
  <td valign=top>
  <p><span>Leukocytes</span></p>
  </td>
  <td valign=top>
  <p><span>Killing
  of microbes, tissue damage</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Nitric
  oxide</span></p>
  </td>
  <td valign=top>
  <p><span>Endothelium,
  macrophages</span></p>
  </td>
  <td valign=top>
  <p><span>Vascular
  smooth muscle relaxation, killing of microbes</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Cytokines
  (TNF, IL-1)</span></p>
  </td>
  <td valign=top>
  <p><span>Macrophages,
  endothelial cells, mast cells</span></p>
  </td>
  <td valign=top>
  <p><span>Local
  endothelial activation (expression of adhesion molecules),
  fever/pain/anorexia/hypotension, decreased vascular resistance (shock)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Chemokines</span></p>
  </td>
  <td valign=top>
  <p><span>Leukocytes,
  activated macrophages</span></p>
  </td>
  <td valign=top>
  <p><span>Chemotaxis,
  leukocyte activation</span></p>
  </td>
 </tr>
 <tr>
  <td colspan=3 valign=top>
  <p><b><span>PLASMA
  PROTEIN&#8211;DERIVED</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Complement</span></b><span> products (C5a, C3a, C4a)</span></p>
  </td>
  <td valign=top>
  <p><span>Plasma (produced
  in liver)</span></p>
  </td>
  <td rowspan=3 valign=top>
  <table border=0 cellpadding=0>
   <tr>
    <td width=1>
    <p><span>&nbsp;&nbsp;</span></p>
    </td>
    <td width="4%" valign=top>
    <p><span></span></p>
    </td>
    <td>
    <p><span>Leukocyte
    chemotaxis and activation, vasodilation (mast cell stimulation)</span></p>
    </td>
   </tr>
   <tr>
    <td width=1>
    <p><span>&nbsp;&nbsp;</span></p>
    </td>
    <td width="4%" valign=top>
    <p><span></span></p>
    </td>
    <td>
    <p><span>Increased
    vascular permeability, smooth muscle contraction, vasodilation, pain</span></p>
    </td>
   </tr>
   <tr>
    <td width=1>
    <p><span>&nbsp;&nbsp;</span></p>
    </td>
    <td width="4%" valign=top>
    <p><span></span></p>
    </td>
    <td>
    <p><span>Endothelial
    activation, leukocyte recruitment</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Kinins</span></p>
  </td>
  <td valign=top>
  <p><span>Plasma (produced
  in liver)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Proteases
  activated during coagulation</span></p>
  </td>
  <td valign=top>
  <p><span>Plasma
  (produced in liver)</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td>
  <p><a
  name=4-u1.0-B978-1-4377-0792-2..50007-9--spar></a><span>IL-1 = interleukin-1; MAC = membrane
  attack complex; TNF = tumor necrosis factor</span></p>
  </td>
 </tr>
</table>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct.</span></b><span><span>&nbsp; </span>Complement components C5a, C3a, and C4a
are mediators of inflammation. Their actions include vasodilation, increased
vascular permeability, and leukocyte chemotaxis.<span>&nbsp; </span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Each of
the following conditions is associated with necrosis of a specific
morphological type. Match each condition with the corresponding type of
necrosis. </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Abscess
due to <i>Staphylococcus aureus</i></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Active
tuberculosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acute
pancreatitis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Polyarteritis
nodosa</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal
infarction</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Coagulation
necrosis</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Liquefactive
necrosis</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Caseous
necrosis</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fat
necrosis</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fibrinoid
necrosis </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Tissue
necrosis can be classified into several distinct morphological categories. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=131 valign=top>
  <p style="text-align:center;"><span>Morphological Patterns of Tissue Necrosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Coagulative necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Liquefactive necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Gangrenous necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Caseous necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Fat necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Fibrinoid necrosis</span><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span>Coagulative
necrosis</span></b><span>
is the type of necrosis seen in <span>infarcts
(ischemic necrosis) of any organ</span> except the brain. The basic tissue
architecture is preserved for at least a few days. Cell outlines can still be
seen by light microscopy. Proteolysis of dead cells does not occur and the
tissue retains a firm texture. Eosinophilic, anucleate cells may be present for
days or weeks. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=452 height=173
src="_%20Tutorials_files/image132.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347142"></span><span></span></p>

<p><span></span></p>

<p><span>Coagulative
necrosis. <b>A.</b> Wedge-shaped kidney infarct (yellow). <b>B.</b> Microscopic
view of the edge of the infarct, with normal kidney (N) and necrotic cells in
the infarct (I) showing preserved cellular outlines with loss of nuclei and an
inflammatory infiltrate (which is difficult to discern at this magnification).</span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Liquefactive
necrosis</span></b><span>
occurs in bacterial<b> </b>and sometimes
fungal infection. Micro-organisms attract leukocytes, and the enzymes of the
leukocytes digest (“liquefy”) tissue. Dead cells are completely digested, and
the tissue is transformed into a viscous material. Following acute
inflammation, the material may be creamy yellow (pus). Note: Although ischemia
causes coagulative necrosis in most tissues, it causes liquefactive necrosis in
the brain.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=284 height=226
src="_%20Tutorials_files/image134.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347141"></span><span></span></p>

<p style="text-align:center;"><span>Liquefactive necrosis. An infarct in the brain, showing
dissolution of the tissue.</span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Gangrenous
necrosis</span></b><span>
is not a distinctive pattern, but the term is commonly used in clinical
practice. It usually applies to a limb that has lost its blood supply. If an
ischemic limb becomes secondarily infected with bacteria, “dry gangrene” may
turn into “<span>wet gangrene,” which is a
mixture of </span>coagulative necrosis (from ischemia) and liquefactive
necrosis (from bacterial infection). </span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Caseous
necrosis</span></b><span>
is characteristic of tuberculous infection. The term “caseous” (cheese-like) is
derived from the friable, yellow-white appearance of the necrotic area seen
with the unaided eye. On microscopic examination, the necrotic focus appears as
a collection of lysed cells with an amorphous granular <a
name=4-u1.0-B978-1-4160-2973-1..50004-1--p11></a>appearance. The tissue
architecture is obliterated and cellular outlines cannot be seen. Foci of
necrosis may be enclosed within a distinctive inflammatory border, producing a
“granuloma.”</span></p>

<p style="text-align:center;"><span><img border=0 width=284 height=226
src="_%20Tutorials_files/image136.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347140"></span><span></span></p>

<p><span>Caseous
necrosis. Tuberculosis of the lung, with a large area of caseous necrosis
containing yellow-white, cheesy debris.&nbsp; </span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Fat
necrosis</span></b><span>
occurs with acute pancreatitis. Pancreatic enzymes leak out of acinar cells and
ducts, liquefying the membranes of fat cells in the peritoneum. Lipase breaks
down the triglyceride esters. Fatty acids are released, which combine with
calcium to produce a chalky white substance (fat saponification). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=284 height=189
src="_%20Tutorials_files/image138.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347139"></span><span></span></p>

<p><span></span></p>

<p><span>Fat
necrosis. The areas of white chalky deposits represent foci of fat necrosis
with calcium soap formation (saponification) at sites of lipid breakdown in the
mesentery.</span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Fibrinoid
necrosis</span></b><span>
occurs in certain types of vasculitis (e.g., polyarteritis nodosa). Immune
complexes are deposited in the walls of arteries. When stained with H&amp;E,
these immune complexes, together with fibrin that has leaked out of the
vessels, have a bright, pink appearance, called “fibrinoid.”<span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=284 height=189
src="_%20Tutorials_files/image140.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347137"></span><span></span></p>

<p><span>Fibrinoid
necrosis in an artery. The wall of the artery shows a circumferential bright
pink area of necrosis.&nbsp;</span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answers </span></b></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>2</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>3</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>4</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>5</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>1</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4160-2973-1..50004-1--cete></a><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
4-month-old white female was admitted to the hospital with a two-week history
of fever, nasal congestion, and cough. She was well until two months ago when
she developed an oral ulcer, intermittent fever, recurrent otitis, decreased
appetite, and weight loss. On physical examination, tonsils are absent and
lymph nodes are not palpable. Bilateral wheezing is heard over the anterior and
posterior lung fields. Chest radiograph shows patchy infiltrates and no thymic
shadow. A nasal-wash viral culture is positive for parainfluenza 3 virus, and a
blood PCR is positive for adenovirus. She is treated with trimethoprim /
sulfamethoxazole for suspected infection with <i>Pneumocystis jiroveci</i>;
however, she dies on the fifth hospital day due to overwhelming adenoviral infection.
Her parents had premature twin girls who died shortly after birth. Currently,
they have a healthy two-year-old son.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><u><span>Immunologic
Data<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Patient’s
Value <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Normal
Value</span></u></p>

<p><span></span></p>

<p><span>Serum
immunoglobulins</span></p>

<p><span>IgG,
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>65
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>192&#8211;515</span></p>

<p><span>IgA,
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12&#8211;31</span></p>

<p><span>IgM,
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>39&#8211;92</span></p>

<p><span>IgE,
IU/mL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0&#8211;150</span></p>

<p><span>Anti-A,
titer, counts per minute<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;1:32</span></p>

<p><span>Anti-B,
titer, counts per minute<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;1:16</span></p>

<p><span>Diphtheria
toxoid antibody, IU/mL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0.19
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;0.10</span></p>

<p><span>Tetanus
toxoid antibody, IU/mL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0.05
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;0.16</span></p>

<p><span>Lymphocyte
subpopulations, cells per mm<sup>3</sup></span></p>

<p><span>CD3+
T cells <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1111&#8211;5183</span></p>

<p><span>CD20+
B cells <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>144&#8211;671</span></p>

<p><span>CD16+
NK cells <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>142
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>152&#8211;709</span></p>

<p><span>CD56+
NK cells <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>134
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>223&#8211;1040</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Severe
congenital neutropenia</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bruton’s
agammaglobulinemia</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Severe
combined immunodeficiency </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>DiGeorge
syndrome</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wiskott-Aldrich
syndrome</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ataxia-telangiectasia</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Common
variable immunodeficiency</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Hyper-IgM
Syndrome</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Job’s
syndrome (Hyperimmunoglobulin E syndrome)</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Selective
IgA deficiency</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=443 valign=top>
  <p style="text-align:center;"><span>Immunodeficiency Syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Severe
  combined immunodeficiency (SCID)</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Stem cell disorder
  causing near complete failure of the immune system (B and T cells), usually
  due to a defect in common gamma chain protein or adenosine deaminase</span></p>
  <p><span></span></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent infection
  with viral, bacterial, and fungal pathogens; chronic diarrhea, ear
  infections, profuse oral candidiasis, recurrent pneumonia; death by age 1 if
  untreated</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Ataxia-telangiectasia
  </span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Defect in DNA repair
  caused by a mutation in the ATM gene</span></p>
  <p><span></span></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent
  infections, imbalance, slurred speech, poor coordination, telangiectasias,
  IgA deficiency</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Job’s
  syndrome (Hyperimmunoglubulin E syndrome)</span></p>
  <p><b><span><span>&nbsp;</span></span></b><span><span >&nbsp;</span></span></p>
  <p><i><span>Description</span></i><span>: Failure of T helper
  cells to produce interferon-&#947; (a macrophage-activating factor)</span></p>
  <p><span></span></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent “cold”
  staphylococcal infections, eczema-like skin rash, severe lung infections with
  pneumatoceles, and very high IgE levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Bruton’s
  agammaglobulinemia</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: X-linked disorder; mutation
  of tyrosine kinase gene impairs B-cell maturation</span></p>
  <p><span></span></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent infection
  with extracellular, pyogenic bacteria (<i>Staphylococcus aureus,
  Streptococcus pneumoniae, Streptococcus pyogenes, Hemophilus influenzae</i>);
  no circulating B cells; low serum levels of all antibody classes; normal T
  lymphocyte levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Common
  variable immunodeficiency<span >&nbsp; </span></span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Group of disorders
  resulting in inadequate antibody production</span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent
  infections; low serum levels of IgG, IgA, and IgM; normal B and T lymphocyte
  levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Hyper-IgM
  syndrome</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Defect in CD40
  ligand on T helper cells inhibits “class switch” between immunoglobulin
  subtypes</span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent upper and
  lower respiratory tract infections, high IgM levels, undetectable IgG and IgA
  levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Selective
  IgA deficiency </span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Defect of B-cell
  maturation that impairs IgA production</span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Usually healthy; may
  have recurrent ear, sinus, and lung infections; low serum IgA levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Wiskott-Aldrich
  Syndrome</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: X-linked disorder;
  mutation of WASp gene impairs IgM response to bacteria</span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent pyogenic
  infections, eczema, thrombocytopenia (classic triad); low serum levels of
  IgM; high serum levels of IgA and IgE; normal IgG levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>DiGeorge
  Syndrome</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Deletion of small
  piece of chromosome 22 causing maldevelopment of thymus and parathyroid
  glands, results in T cell deficiency and hypocalcemia </span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent infections
  with viral and fungal pathogens; T cell deficiency; CATCH mnemonic (Cardiac
  abnormality, Abnormal faces, Thymic aplasia, Cleft palate, Hypocalcemia)</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Selected
gene mutations resulting in devastating immunodeficiency diseases are shown
below</span></p>

<p><b><span></span></b></p>

<p><span><img border=0 width=450 height=338
src="_%20Tutorials_files/image142.png"
alt="Description: S9781416046882-012-f002" v:shapes="Picture_x0020_347136"></span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct.</span></b><span><span>&nbsp; </span>Most children with Severe Combined
Immunodeficiency Disease (SCID) appear normal at birth but begin to have
repeated infections at two to four months of age, which corresponds with waning
levels of maternal IgG acquired <i>in utero</i>.<span>&nbsp; </span>Most cases of SCID are due to mutations
in the gene encoding the common gamma chain (&#947;<sub>c</sub>), a protein
that is shared by the receptors for interleukins IL-2, IL-4, IL-7, IL-9, IL-15
and IL-21. These interleukins and their receptors are involved in the
development and differentiation of T and B cells. Because the common gamma
chain is shared by many interleukin receptors, mutations that result in a
non-functional common gamma chain cause widespread defects in interleukin
signaling. The result is a near complete failure of the immune system to
develop and function, with low or absent T cells and NK cells and
non-functional B cells. The second most common form of SCID is caused by a
defective enzyme, adenosine deaminase (ADA), necessary for the breakdown of
purines. Numerous other mutations are associated with SCID (including mutations
of Janus kinase 3, <i>RAG-1</i>,<i> RAG-2</i>,<i> </i>and <i>Artemis</i>).
Serious viral infections, lack of peripheral B and T lymphocytes, radiographic
absence of a thymic shadow, absence of tonsils, and absence of palpable lymph
nodes are all consistent with a diagnosis of SCID.</span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect.</span></b><span><span>&nbsp; </span>Patients with severe congenital
neutropenia present with very low circulating neutrophil counts and severe
infections, which usually occur when the absolute neutrophil count is &lt;500
cells/mm<sup>3</sup>.<span >&nbsp; </span>Infections
occur in the oral and mucosal surfaces (gingivitis, periodontitis), skin,
perirectal and genital areas, lungs, GI tract, and bloodstream. The condition
has its onset in infancy. Affected children can be treated with exogenous
G-CSF.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect.</span></b><span><span>&nbsp; </span>Patients with Bruton’s agammaglobulinemia
usually suffer from recurrent pyogenic bacterial infections due to a lack of
opsonizing antibodies.<span >&nbsp; </span>The defect
is in Bruton’s tyrosine kinase, an enzyme essential to B-cell, but not T-cell,
development.<span >&nbsp; </span>T-cell number and
function are normal, so patients typically do not have problems with viral or
other intracellular infections.<span >&nbsp;
</span>Most cases are X-linked, but females with two defective genes will also
have the disease.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect.</span></b><span><span>&nbsp; </span>Children with DiGeorge syndrome suffer
from recurrent viral and fungal infections within the first year of life.<span>&nbsp; </span>They also exhibit <i>c</i>ardiac
defects, <i>a</i>bnormal facial features, <i>t</i>hymic hypoplasia, <i>c</i>left
palate, <i>h</i>ypocalcemia, and chromosome 22 deletion (CATCH-22).<span>&nbsp; </span>DiGeorge syndrome occurs when there is
defective embryogenesis that affects the thymus and other organs that derive
from the third and fourth pharyngeal pouches.<span>&nbsp; </span>Because these patients have little to no
thymic tissue, T cells are low to absent.<span >&nbsp;
</span>The number of B cells is not affected, although patients will exhibit
reduced immunoglobulin levels due to a paucity of T helper cells.</span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect.</span></b><span>
Children with Wiskott-Aldrich syndrome (WAS) present with thrombocytopenia
associated with petechiae, purpura, mucosal bleeding, and intermittent bloody diarrhea.<span>&nbsp;&nbsp; </span>They have eczema, as well as
recurrent bacterial and viral infections, especially in the ear.<span>&nbsp; </span>The disease is due to a mutation of the
WAS protein, which is important for reorganization of the actin
cytoskeleton.<span >&nbsp; </span>Cell adhesion and
migration is affected, which impairs the function of hematopoietic-derived
cells.<span >&nbsp; </span>The disease is X-linked, so
males with the gene will be affected, while females will be asymptomatic
carriers. Patients typically have decreased IgM and increased IgA and IgE
levels.<span >&nbsp; </span>T cell subsets are usually
decreased.</span></p>

<p><span></span></p>

<p><b><span>Answer
F is incorrect. </span></b><span>Ataxia-telangiectasia
is a rare, inherited, neurodegenerative disease that causes severe disability.
Patients present with poor coordination (because of cerebellar dysfunction) and
small, dilated blood vessels in the skin and mucous membranes
(telangiectasias).<span >&nbsp; </span>The immune
system is affected in the majority of patients. Symptoms usually begin in early
childhood (toddler stage) with imbalance, slurred speech, and increased
infections. The condition is caused by a defect in the ATM gene, which is
responsible for recognizing and correcting errors in duplicating DNA.</span></p>

<p><span></span></p>

<p><b>Answer G is incorrect. </b>Common
variable immunodeficiency (CVID) is a group of 20-30 immunological disorders
manifested by hypogammaglobulinemia. Patients are predisposed to infection with
common bacterial and viral pathogens. CVID is the most commonly encountered
primary immunodeficiency.</p>

<p></p>

<p><b>Answer H is incorrect. </b>Hyper-IgM
syndrome is a heterogeneous group of disorders in which a defect in the CD40
ligand on T helper cells inhibits “class switch” between immunoglobulin
subtypes. Patients have high IgM levels and undetectable IgG and IgA levels.
This predisposes them to recurrent upper and lower respiratory tract
infections.</p>

<p></p>

<p><b>Answer I is incorrect. </b>Job’s
syndrome (Hyperimmunoglobulin E syndrome) is a group of disorders characterized
by abnormal neutrophil chemotaxis. T-cell production of interferon gamma is
impaired. Patients present with recurrent &quot;cold&quot; staphylococcal
infections, unusual eczema-like skin rashes, severe lung infections resulting
in pneumatoceles (balloon-like lesions in the lung), and very high
concentrations of the serum IgE.</p>

<p></p>

<p><b><span>Answer
J is incorrect. </span></b><span>Selective
IgA deficiency is a disorder of B-cell maturation resulting in decreased or
absent serum IgA levels. Serum IgG and IgM levels are normal. Patients may be
asymptomatic or may have recurrent ear, sinus, or lung infections.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
4-year-old boy presents with recurrent pyogenic infections. He had normal
antibody responses to childhood immunizations and recovered normally from
chicken pox and measles. Deficiency or dysfunction of which of the following
cells is most likely to explain his condition?<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>B
lymphocyte</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>T
lymphocyte</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Neutrophil</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Macrophage</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Eosinophil</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Pus</span> is a viscous exudate, typically whitish-yellow that forms at
the site of an infection. An accumulation of pus in an enclosed tissue space is
known as an abscess, whereas a visible collection of pus within or beneath the
epidermis is known as a pustule. Pus is comprised of dead leukocytes (mostly
neutrophils) in a protein-rich fluid. The fluid is usually whitish-yellow, but
other colors can occur. (Blue-green pus may result from infection with <i>Pseudomonas
aeruginosa</i><span> and brown pus is
typical of a</span>moebic abscesses in the liver.)</p>

<p></p>

<p>During infection,
macrophages and other cells of the innate immune system release chemokines that
trigger neutrophils to seek the site of infection (chemotaxis). The neutrophils
engulf and destroy bacteria.<span >&nbsp; </span>Some
bacteria fight back by releasing toxins called leukocidins.<a
href="http://en.wikipedia.org/wiki/Pus#cite_note-Biology-1#cite_note-Biology-1"></a>
As neutrophils die, they are engulfed and destroyed by macrophages, forming
viscous pus.</p>

<p></p>

<p>Bacteria causing pus
formation are called <span>suppurative</span>,
<span>pyogenic</span>, or <span>purulent</span>. “Pyogenic” means
pus-forming. Examples of pyogenic bacteria include <i>Staphylococcus aureus </i><span>and</span> <i>Streptococcus pneumoniae.</i><span> </span></p>

<p><span></span></p>

<p>Defense against pyogenic
bacteria depends on intact neutrophil function and adequate humoral immunity.
Humoral immunity depends on antibodies, which are produced by B-lymphocytes.
B-lymphocytes are assisted by T helper cells. Therefore, neutrophils,
B-lymphocytes, and T-lymphocytes are all involved in defense against pyogenic
infections. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>.<span>&nbsp; </span>The patient in this vignette had a
normal antibody response to childhood immunizations, suggesting adequate
B-lymphocyte function. He also recovered normally from two viral infections,
chicken pox and measles, suggesting adequate T-lymphocyte function. Neutrophil
deficiency or dysfunction is, therefore, the likely source of the problem.<span>&nbsp; </span>Possible causes include congenital
neutropenias and chronic granulomatous disease.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>[Note: The
importance of neutrophils in protecting against pyogenic infection is apparent
from studies done on patients with Job’s syndrome (hyperimmunoglobulin-E
syndrome). These patients have impaired neutrophil chemotaxis, which
predisposes them to recurrent staphylococcal infections.]</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>The
illustration below shows the dose-response curve for drug X. Which curve
represents the dose-response curve for drug X plus a non-competitive receptor
antagonist? </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=204 height=164
src="_%20Tutorials_files/image144.png" v:shapes="Picture_x0020_31"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>A</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>D</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>A
non-competitive receptor antagonist binds <i>irreversibly</i>
to the receptor. This reduces the efficacy, or maximum response, of the drug.
Because the binding is irreversible, the drug cannot overcome the antagonism
even if it is administered in high doses. Consequently, the height of the curve
is shortened (Curve C), meaning that the <i>efficacy</i>
of the drug is reduced. </span></p>

<p><span></span></p>

<p><span>By
contrast, a competitive antagonist binds <i>reversibly</i>
to the receptor. Antagonism <i>can</i> be
overcome by increasing the dose of the drug. Thus, the efficacy of the drug is <i>not</i> reduced. The drug can still produce
a maximum response if administered at high enough doses. The <i>potency </i>of the drug, however, is
reduced, because more drug is needed to produce the same effect. (Potency is
inversely related to the amount of drug needed to produce a given effect.) This
reduction in potency produced by a competitive antagonist is represented by
Curve D. </span></p>

<p><span></span></p>

<p><span>Non-competitive
antagonists reduce efficacy. Competitive antagonists reduce potency. </span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Dose-response curve</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=249 height=304
src="_%20Tutorials_files/image146.png"
alt="Description: competitive%20and%20noncompetitive%20antagonist" v:shapes="Picture_x0020_30"></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. Curve C represents the
dose-response curve for drug X plus a non-competitive receptor antagonist.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
30-year-old woman presents with fatigue, weakness, body aches, and
light-headedness upon standing. She is found to have primary adrenal
insufficiency (Addison disease). Treatment is initiated with prednisone, a
glucocorticoid. Through which of the following receptor types do
glucocorticoids produce their effects?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ligand-gated
ion channel </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>G-protein
coupled receptor </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Enzyme-linked
receptor </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Nuclear
receptor </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Immunoglobulin-like
receptor</span></p>

<p><span></span></p>

<span><br clear=all>
</span>

<p><span>Receptors are proteins that “translate” extracellular signals into
intracellular effects. T</span>hey may be located in the cell membrane or
within the cytoplasm or nucleus. Molecules (e.g., drugs, hormones,
neurotransmitters) that bind to receptors are called ligands. Ligands may
activate or inactivate a receptor. Activated receptors regulate cellular
biochemical processes (e.g., ion conductance, enzymatic activity, DNA
transcription). </p>

<p>Receptors are <span>classified into four major types: </span><span>&nbsp;</span></p>

<p></p>

<p><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Ligand-gated ion channels. These transmembrane
receptors contain a central pore, or ion channel, which opens in response to
the binding of a ligand. The channel is usually selective to one or more ions
(e.g., Na<sup>+</sup>, K<sup>+</sup>, Ca<sup>2+</sup>, or Cl<sup>-</sup>). Ion
channels are especially important at certain neuronal synapses, where they
convert chemical signals from neurotransmitters to electrical signals in the
postsynaptic neuron. The prototype of a ligand-gated ion channel is the
nicotinic acetylcholine receptor. When acetylcholine binds to the receptor, the
receptor’s configuration changes, allowing the pore to open. Na<sup>+</sup>
ions flow down an electrochemical gradient into the cell. When many channels
open at once, the intracellular Na<sup>+</sup> concentration rises to a level
at which the positive charge within the cell is enough to depolarize the
membrane, initiating an action potential.</p>

<p></p>

<p><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>G-protein-coupled receptors.<span>&nbsp; </span>These transmembrane receptors do <i>not</i> contain a central pore, or ion
channel. Instead, they are <i>indirectly</i>
linked with ion channels through G- proteins, which serve as signal
transducers. G-proteins may activate other enzymes, such as adenyl cyclase or
phospholipase. Because several steps exist between receptor activation and ion
channel opening, these ion channels take longer to open than ligand-gated ion
channels &#8211; and they stay open longer than ligand-gated channels.
G-protein-coupled receptors include receptors for norepinephrine, epinephrine,
dopamine, serotonin, histamine, muscarinic acetylcholine, and GABA<sub>B</sub>.
</p>

<p></p>

<p><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span>Enzyme-linked
receptors. These</span> transmembrane receptors have enzymatic activity on the
intracellular side, triggered by ligand binding on the extracellular side. Most
enzyme-linked receptors are tyrosine kinases, which phosphorylate tyrosine
residues. Tyrosine kinases include the receptors for insulin, peptide hormones,
and growth factors (e.g., epidermal growth factor, fibroblast growth factor,
vascular endothelial growth factor). </p>

<p><span></span></p>

<p><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span>Nuclear
receptors. These receptors are located in the cytosol or in the nucleus (rather
than in the cell membrane). They </span>have the ability to directly bind DNA
and regulate the expression of adjacent genes. These receptors are considered
transcriptional activators. Steroid hormones and thyroid hormones bind to
nuclear receptors. There are two major types of nuclear receptors. Class I
receptors are located in the cytosol. When activated by ligand, they
translocate to the nucleus, bind to a specific DNA sequence, and enhance DNA
transcription. Class II receptors are located in the nucleus (regardless of
ligand-binding status). When bound by ligand, they promote DNA transcription. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width=375>
 <tr>
  <td width=375 colspan=4>
  <p style="text-align:center;"><b><span>Types of Receptors</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p style="text-align:center;"><b><span>Type</span></b></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><b><span>Structure</span></b></p>
  </td>
  <td width=71 valign=top>
  <p style="text-align:center;"><b><span>Cellular Location</span></b></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><b><span>Examples</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p><span>Ligand-gated
  ion channels</span></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><span><img border=0 width=87 height=44
  src="_%20Tutorials_files/image148.png"
  alt="Description: MMPE_20RX_TAB304_01a_eps" v:shapes="Picture_x0020_29"></span><span></span></p>
  </td>
  <td width=71 valign=top>
  <p><span>Cell
  surface transmembrane</span></p>
  </td>
  <td width=89 valign=top>
  <p><span>Acetylcholine
  (nicotinic)</span></p>
  <p><span>GABA<sub>A</sub>
  </span></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p><span>G-protein&#8211;coupled
  receptors</span></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><span><img border=0 width=114 height=44
  src="_%20Tutorials_files/image150.png"
  alt="Description: MMPE_20RX_TAB304_01b_eps" v:shapes="Picture_x0020_28"></span><span></span></p>
  </td>
  <td width=71 valign=top>
  <p><span>Cell
  surface transmembrane</span></p>
  </td>
  <td width=89 valign=top>
  <p><span>Acetylcholine
  (muscarinic)</span></p>
  <p><span>GABA<sub>B</sub></span></p>
  <p><span>Norepinephrine</span></p>
  <p><span>Epinephrine</span></p>
  <p><span>Dopamine</span></p>
  <p><span>Serotonin</span></p>
  <p><span>Histamine</span></p>
  <p><span>Eicosanoids</span></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p><span>Enzyme-linked
  receptors</span></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><span><img border=0 width=84 height=59
  src="_%20Tutorials_files/image152.png"
  alt="Description: MMPE_20RX_TAB304_01c_eps" v:shapes="Picture_x0020_27"></span><span></span></p>
  </td>
  <td width=71 valign=top>
  <p><span>Cell
  surface transmembrane</span></p>
  </td>
  <td width=89 valign=top>
  <p><span>Insulin </span></p>
  <p><span>Peptide
  hormones</span></p>
  <p><span>Growth
  factors</span></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p><span>Nuclear
  receptors</span></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><span><img border=0 width=101 height=61
  src="_%20Tutorials_files/image154.png"
  alt="Description: MMPE_20RX_TAB304_01d_eps" v:shapes="Picture_x0020_26"></span><span></span></p>
  </td>
  <td width=71 valign=top>
  <p><span>Cytoplasm</span></p>
  </td>
  <td width=89 valign=top>
  <p><span>Steroid hormones</span></p>
  <p><span>Thyroid
  hormone</span></p>
  <p><span>Vitamin
  D</span></p>
  <p><span>Vitamin
  A</span></p>
  </td>
 </tr>
 <tr>
  <td width=375 colspan=4 valign=top>
  <p style="text-align:center;"><span>GABA = &#947;-aminobutyric acid; GTP =
  guanosine triphosphate; GDP = guanosine diphosphate.</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct.</span></b><span> The glucocorticoid
receptor is a nuclear receptor. It functions, therefore, as a transcriptional
activator. Nuclear receptors are multi-domain proteins consisting of a ligand
binding domain (LBD), transactivation domain (AD), and DNA-binding domain (DBD).
The effect of ligand binding has differing effects depending on the specific
hormone receptor.</span></p>

<p><span></span></p>

<p><span>The
glucocorticoid receptor is a soluble protein found in the cytosol and nucleus.
In the absence of ligand, it is tethered to other proteins in large aggregates
in the cytosol. Upon binding to glucocorticoid, the conformation of the
receptor is altered, which allows its release from the protein aggregate. The
freed receptor then travels into the nucleus and binds to specific elements in
the promoters of certain genes. This binding causes the transactivation domain
to recruit and facilitate assembly of the RNA polymerase II initiation complex,
which transcribes DNA. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=434 height=249
src="_%20Tutorials_files/image156.png"
alt="Description: iMac HD:Users:Karla:Downloads:ch10f67.jpg" v:shapes="Picture_x0020_25"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Southern
blot analysis is performed on a patient with sickle cell trait. The single
base-pair mutation destroys the MstII restriction enzyme site marked by the
asterisk. The arrows show restriction enzyme-binding sites. DNA from this
patient is treated with MstII and run on an electrophoresis gel. The fragments
are then hybridized with a labeled probe that binds to the normal gene at the
position shown on the map. Which lane in this Southern blot analysis represents
the patient?</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><img border=0 width=239 height=104
src="_%20Tutorials_files/image158.png" v:shapes="Picture_x0020_24"></span><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>A</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>D</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>F</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>. Patients with sickle
cell trait are heterozygous for the sickle cell gene. The &#946;<sub>A</sub>
globin gene results in a 1.15-Kb fragment after treatment with MstII. The
&#946;<sub>S</sub> globin gene results in a 1.35-Kb fragment due to loss of the
Mst restriction site. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Lane A represents a
patient with sickle cell anemia (homozygous for the &#946;<sub>S</sub> globin
gene).</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Lane C represents a
normal patient (homozygous for the &#946;<sub>A</sub> globin gene).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answers D, E, and F are incorrect</span></b><span>. These lanes represent
no patient. The probe does not bind the 0.2-Kb fragment that results from MstII
cleavage. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 7-month-old boy is brought
to the clinic because his eyes have been crossed for 3 days. Physical
examination shows strabismus and a white pupillary reflex in the left eye.
Ophthalmologic examination shows a solitary retinal tumor in the left eye.
Molecular analysis of the tumor shows two faulty copies of a gene for a protein
that serves as an important inhibitor of cell-cycle progression. Where in the
cell cycle does this regulatory protein exert its effect? </p>

<p style="text-align:center;"><span><img border=0 width=241 height=156
src="_%20Tutorials_files/image160.png" v:shapes="Picture_x0020_23"></span></p>

<p style="text-align:center;"></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>A</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>B</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>C</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>D</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=390 height=287
src="_%20Tutorials_files/image162.png" alt="Description: CellCycle" v:shapes="Picture_x0020_22"></span></p>

<p>The cell cycle consists of
four phases: G<sub>1</sub> phase, S phase (synthesis), G<sub>2</sub> phase, and
M phase (mitosis). The M phase (mitosis) is composed of two processes: mitosis,
in which the cell's chromosomes are divided between the two daughter cells, and
cytokinesis, in which the nucleus, cytoplasm, organelles, and cell membrane are
separated in two. In the G<sub>1</sub> (Gap 1) phase, cell growth occurs. This
phase is marked by protein synthesis, cytoplasmic enlargement, and organelle
production. In the S phase (synthesis), DNA replication occurs. In the G<sub>2</sub>
(Gap 2) phase, the cell resumes its growth and prepares for mitosis. The G<sub>0</sub>
phase is a state of quiescence in which cells have temporarily or reversibly
stopped dividing. </p>

<p></p>

<p><span>Retinoblastoma</span> is the most common primary malignant intraocular tumor
of childhood. Hereditary and nonhereditary forms exist. The hereditary form is
usually bilateral and multifocal, whereas the nonhereditary form is usually
unilateral and unifocal. <a name=4-u1.0-B978-1-4160-2450-7..50631-9--p260></a>In
most patients, the initial sign is a white pupillary reflex (leukocoria),
caused by the reflection of light off the white tumor (see image below). The
second most common sign is strabismus. The cure rate for retinoblastoma is
approximately 95%.</p>

<p></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=152 height=116
src="_%20Tutorials_files/image164.png" alt="Description: cancer4" v:shapes="Picture_x0020_21"></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;">Leukocoria
in child with retinoblastoma</p>

<p style="text-align:center;"></p>

<p>The hereditary form of
retinoblastoma is associated with inactivation of the <span gene (RB1), a tumor suppressor gene </span>located
on chromosome 13.<span >&nbsp; </span>Tumor suppressor
genes are sometimes called “anti-oncogenes.” They protect cells from
progressing to cancer. Mutations of these genes facilitate progression to
cancer.<span> Unlike oncogenes</span>, tumor
suppressor genes generally follow the “two-hit hypothesis”; i.e., two
mutational events are required for tumor development<a
name=4-u1.0-B978-1-4160-2450-7..50504-1--intr></a>. </p>

<p></p>

<p>In the inherited form of <span
 both RB1 alleles are usually mutated.
One mutation is inherited through the germinal cells; the other occurs later in
somatic retinal cells. (Usually both alleles must be mutated because a single
normal allele can produce enough protein to prevent progression to cancer.)
Mutations of tumor suppressor genes are usually recessive; mutations of
oncogenes, by contrast, are usually dominant.</p>

<p></p>

<p>Tumor-suppressor genes work
by inhibiting the cell cycle or by promoting apoptosis. The first
tumor-suppressor gene discovered was the retinoblastoma gene, which codes for
retinoblastoma protein (pRb). This protein blocks the cell cycle so that the
cell cannot leave the G<sub>1 </sub>phase and enter the S phase. Thus, the cell
remains stalled in the G<sub>1</sub> phase. This is a protective mechanism. It
prevents damaged DNA from replicating. If the retinoblastoma gene is mutated,
replication of damaged DNA goes unregulated, and cancer can occur.</p>

<p></p>

<p></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=347 height=397
src="_%20Tutorials_files/image166.png"
alt="Description: Figure 24-9. The seven types of proteins that participate in controlling cell growth."
v:shapes="Picture_x0020_20"></span></p>

<h3><span><span seven types of proteins that
participate in controlling cell growth</span></span></h3>

<h3><span></span></h3>

<p><span>Cancer
can result from expression of mutant forms of these proteins: growth factors
(I), growth factor receptors (II), signal-transduction proteins (III),
transcription factors (IV), pro- or anti-apoptotic proteins (V), cell cycle
control proteins (VI), and DNA repair proteins (VII). Mutations changing the
structure or expression of proteins in classes I&#8197;&#8211;&#8197;IV
generally give rise to dominantly active <i>oncogenes</i>.
The class VI proteins mainly act as <i>tumor
suppressors</i>; mutations in the genes encoding these proteins act recessively
to release cells from control and surveillance, greatly increasing the
probability that the mutant cells will become tumor cells. Class VII mutations
greatly increase the probability of mutations in the other classes.
Virus-encoded proteins that activate growth-factor receptors (Ia) also can
induce cancer.</span></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer D is correct. </b>The retinoblastoma gene codes for
retinoblastoma protein (pRb), which blocks the cell cycle so that the cell
cannot leave the G<sub>1 </sub>phase and enter the S phase. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Smoking
increases the risk of each of the following <i>except</i>:
</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Pancreatic
cancer</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aortic
aneurysm</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Susceptibility
to pneumonia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Ulcerative
colitis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Spontaneous
abortion</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Leukoplakia</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Osteoporosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span>Health Hazards of Tobacco Use</span></b></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="50%" valign=top>
  <p><b><span>CANCER</span></b></p>
  <p><span>Lung</span></p>
  <p><span>Larynx</span></p>
  <p><span>Oral
  cavity</span></p>
  <p><span>Esophagus</span></p>
  <p><span>Pancreas</span></p>
  <p><span>Bladder</span></p>
  <p><span>Kidney</span></p>
  <p><span>Stomach</span></p>
  <p><span>Leukemia</span></p>
  <p><span>Cervix</span></p>
  <p><b><span></span></b></p>
  <p><b><span>CARDIOVASCULAR
  DISEASE</span></b></p>
  <p><span>Sudden
  death</span></p>
  <p><span>Acute
  myocardial infarction</span></p>
  <p><span>Unstable
  angina</span></p>
  <p><span>Stroke</span></p>
  <p><span>Peripheral
  arterial occlusive disease </span></p>
  <p><span>Aortic
  aneurysm</span></p>
  <p><b><span></span></b></p>
  <p><b><span>PULMONARY
  DISEASE</span></b></p>
  <p><span>Lung
  cancer</span></p>
  <p><span>Chronic
  bronchitis</span></p>
  <p><span>Emphysema</span></p>
  <p><span>Asthma</span></p>
  <p><span>Susceptibility
  to pneumonia</span></p>
  <p><span>Susceptibility
  to pulmonary tuberculosis</span></p>
  <p><span>Increased
  morbidity from viral respiratory infection</span></p>
  <p><b><span></span></b></p>
  <p><b><span></span></b></p>
  <p><span></span></p>
  </td>
  <td width="50%" valign=top>
  <p><b><span>GASTROINTESTINAL
  DISEASE</span></b><span>
  </span></p>
  <p><span>Peptic
  ulcer</span></p>
  <p><span>Gastroesophageal
  reflux</span></p>
  <p><span>Crohn's
  disease</span></p>
  <p><b><span></span></b></p>
  <p><b><span>REPRODUCTIVE
  DISTURBANCES</span></b><span></span></p>
  <p><span>Reduced
  fertility</span></p>
  <p><span>Premature
  birth</span></p>
  <p><span>Lower
  birth weight</span></p>
  <p><span>Spontaneous
  abortion</span></p>
  <p><span>Abruptio
  placentae</span></p>
  <p><span>Premature
  rupture of membranes</span></p>
  <p><span>Increased
  perinatal mortality</span></p>
  <p><b><span></span></b></p>
  <p><b><span>ORAL
  DISEASE</span></b><span></span></p>
  <p><span>Oral
  cancer</span></p>
  <p><span>Leukoplakia</span></p>
  <p><span>Gingivitis</span></p>
  <p><span>Gingival
  recession</span></p>
  <p><span>Tooth
  staining</span></p>
  <p><b><span></span></b></p>
  <p><b><span>OTHER</span></b><span></span></p>
  <p><span>Non&#8211;insulin-dependent
  diabetes mellitus</span></p>
  <p><span>Earlier
  menopause</span></p>
  <p><span>Osteoporosis</span></p>
  <p><span>Cataract</span></p>
  <p><span>Tobacco
  amblyopia</span></p>
  <p><span>Age-related
  macular degeneration</span></p>
  <p><span>Premature
  skin wrinkling</span></p>
  <p><span>Graves'
  disease, including ophthalmopathy</span></p>
  <p><span>Aggravation
  of hypothyroidism</span></p>
  <p><span>Altered
  drug metabolism or effects<b></b></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Smokers have an
increased risk of developing Crohn’s disease and a decreased risk of developing
ulcerative colitis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>In each of
four tubes is placed a DNA fragment with DNA polymerase, a radiolabeled primer,
and the adenine, thymine, cytosine, and guanine deoxynucleotides. Each tube
contains one of the four bases as dideoxynucleotides. The tubes are run on
electrophoresis gel and viewed by autoradiography. What is this technique
called?<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Northern
blot</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Southern
blot</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Western
blot</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Sequencing</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polymerase
chain reaction (PCR)</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Enzyme-linked
immunosorbent assay (ELISA)</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Allele-specific
oligonucleotide probe</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Sequencing uses
dideoxynucleotides to terminate growing DNA strands. DNA fragments are
separated by gel electrophoresis and the sequence is determined by the position
of the bands on the gel. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. In the Northern blot
technique, RNA is separated by electrophoresis, denatured, and transferred to
filter paper. Radiolabeled DNA is used as a probe. The hybridized DNA/RNA
strand is visualized by autoradiography.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. In the Southern blot
technique, DNA is separated by electrophoresis, denatured, and transferred to
filter paper. Radiolabeled DNA is used as a probe. The hybridized DNA/DNA
strand is visualized by autoradiography.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. In the Western blot
technique, protein is separated by electrophoresis and labeled antibodies are
used as a probe. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Polymerase chain
reaction (PCR) is used to produce many copies of a DNA segment. The DNA segment
is mixed with primer, polymerase, and deoxynucleotides. The solution is heated
to denature the DNA and cooled to allow synthesis. Through repeated cycles of
heating a cooling, DNA can be amplified more than a million times. </span></p>

<p><span></span></p>

<p><b><span>Answer F is incorrect</span></b><span>. In the enzyme-linked
immunosorbent assay (ELISA), labeled antibodies are used to determine if the
serum contains antibodies against a specific antigen on the ELISA plate. </span></p>

<p><span></span></p>

<p><b><span>Answer G is incorrect</span></b><span>. Allele-specific
oligonucleotide probes are short, radiolabeled DNA sequences complementary to
an allele of interest. The probes can be used to detect disease-causing
mutations. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 42-year-old woman receives an allogeneic bone marrow transplant from a
matched, unrelated donor. She is treated with cyclosporine. One month later she
develops fever, enteritis, hepatitis, and dermatitis. Which of the following
best explains these findings?</span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span>A. Hyperacute transplant rejection</span></p>

<p><span>B. Acute transplant rejection</span></p>

<p><span>C. Chronic transplant rejection</span></p>

<p><span>D. Graft-versus-host disease</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Transplant rejection</span><span> occurs when the host’s immune system attacks a transplanted
organ or tissue. </span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=320 colspan=2 valign=top>
  <p style="text-align:center;"><span>Types of Transplant</span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span></span></p>
  </td>
  <td width=252 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span>Autograft</span></p>
  </td>
  <td width=252 valign=top>
  <p><span>Tissue
  transplanted from one part of the body to another in the same individual</span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span>Isograft</span></p>
  </td>
  <td width=252 valign=top>
  <p><span>Donor
  and recipient are genetically identical individuals</span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span>Allograft</span></p>
  </td>
  <td width=252 valign=top>
  <p><span>Donor
  and recipient are genetically non-identical members of the same species</span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span>Xenograft</span></p>
  </td>
  <td width=252 valign=top>
  <p><span>Donor
  and recipient belong to different species</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Transplant
rejection is a normal occurrence because the immune system is designed to
distinguish “self” from “foreign” antigens as a means of protecting the
individual from foreign invasion. The main types of transplant rejection are
hyperacute, acute, and chronic. </span></p>

<p><span></span></p>

<p><i>Hyperacute rejection</i> usually occurs within 24 hours of
transplantation. The response is so quick that the graft never becomes
vascularized. Hyperacute rejection is characterized by thrombotic occlusions
and hemorrhages of the graft vasculature that begin minutes to hours after the
graft is placed. These occur because of preexisting host antibodies that bind
to antigens present in the graft endothelium. The complement system is
activated and there is an influx of neutrophils. Endothelial cells and
platelets shed lipid particles, which promote coagulation. The resulting
inflammation prevents vascularization of the graft. The graft suffers
irreversible damage from ischemia. </p>

<p></p>

<p>There are several
explanations for the preexisting antibodies that initiate hyperacute rejection.
Recipients of blood transfusions sometimes develop antibodies to major
histocompatibility class (MHC) antigens from the transfused blood. If some of
these antigens match those in a graft, then hyperacute rejection may occur.
Multiple pregnancies may also expose woman to the paternal antigens of the
fetus, resulting in the creation of antibodies. Finally, prior recipients of
transplants may have already formed antibodies to other MHC antigens &#8211;
antibodies that may be present at the time of a second transplant. Usually
hyperacute rejection can be avoided by screening for anti-graft antibodies
(crossmatching).<span >&nbsp;&nbsp; </span></p>

<p></p>

<p><i><span>Acute rejection</span></i><span> usually begins a week
after transplantation and most likely occurs to some degree in all transplants
(except between identical twins). It is caused by mismatched HLA antigens that
are present on all cells. HLA antigens are polymorphic; therefore, the chance
of a perfect match is extremely rare. The reason that acute rejection occurs a
week after transplantation is because the T cells involved in rejection must
differentiate and the antibodies must be produced before rejection is
initiated. Some T cells cause graft cells to lyse; others produce cytokines
that recruit other inflammatory cells, eventually causing necrosis of allograft
tissue. Endothelial cells in vascularized grafts such as kidneys are some of
the earliest victims of acute rejection. Damage to the endothelial lining is an
early predictor of irreversible acute graft failure. The risk of acute
rejection is highest in the first three months after transplantation and is
lowered by immunosuppressive agents. The diagnosis of acute rejection is based
on clinical data, laboratory testing, and tissue biopsy. </span></p>

<p><span></span></p>

<p><i><span>Chronic rejection</span></i><span> occurs months to years
following transplantation. It is characterized by graft arterial occlusions,
which result from the proliferation of smooth muscle cells and the production
of collagen by fibroblasts. This process, termed accelerated or graft
arteriosclerosis, results in fibrosis, which can cause ischemia and cell death.
The fibrous lesions occur without evidence of an overt cause (such as vascular
injury or infection), although it is hypothesized that chronic rejection is the
result of multiple acute rejections. This hypothesis is based on the knowledge
that the resulting fibrosis is similar to the fibrosis that accompanies the
natural healing of a wound. Now that there are treatments for acute rejection,
chronic rejection is the major cause of graft loss. Most recipients must take
immunosuppressive drugs for the rest of their lives, and even that may not be
enough to combat chronic rejection. This poses a dilemma in the trend of
immunotherapy, since immunosuppression is highly focused to prevent acute
rejection and does not substantially address chronic rejection mechanisms. </span></p>

<p><span></span></p>

<p><i>Graft-versus-host disease</i> (GVHD) is a common complication of
allogeneic bone marrow<a
href="http://en.wikipedia.org/wiki/Hematopoietic_stem_cell_transplantation"
title="Hematopoietic stem cell transplantation"></a> transplantation in which
functional T cells in the transplanted marrow recognize the recipient as
&quot;foreign&quot; and mount an immunologic attack. <i>Acute</i> graft-versus-host-disease occurs within the first 100 days
and is characterized by selective damage to the gastrointestinal tract, liver,
and skin. Gastrointestinal involvement may result in severe intestinal
inflammation, sloughing of the mucosal membrane, severe diarrhea, abdominal pain,
nausea, and vomiting. Liver involvement results in hepatitis and serum
bilirubin elevation. Skin disease may manifest as a diffuse, often lacy,
maculopapular rash. <i>Chronic</i>
graft-versus-host disease occurs more than 100 days after transplantation. As
in acute disease, the gastrointestinal tract, liver, and skin are affected.
Additionally, connective tissue and exocrine glands may be damaged. </p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=330 height=278
src="_%20Tutorials_files/image168.png" alt="Description: GvHdisease" v:shapes="Picture_x0020_347138"></span></p>

<p style="text-align:center;">Rash
in graft-versus-host disease</p>

<p></p>

<p>The most commonly used drugs
in transplant patients include steroids, which block cytokine secretion;
cyclosporine and tacrolimus, which inhibit calcineurin; and azathioprine and
mycophenolate mofetil, which block T-cell proliferation. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer D is correct</b>. Acute graft-versus-host disease (GVHD) occurs
when T cells in the transplanted marrow attack host cells. It typically
presents as enteritis, hepatitis, and dermatitis within 100 days of allogeneic
bone marrow transplant.<span >&nbsp; </span></p>

<p></p>

<p><b>Answer A is incorrect</b>. Hyperacute transplant rejection is an
immediate antibody and complement-mediated response to transplanted tissue
caused by pre-existing antibodies to tissue antigens.<span>&nbsp;&nbsp; </span></p>

<p></p>

<p><b>Answer B is incorrect</b>. Acute transplant rejection occurs when host
T cells attack transplanted tissue cells because of HLA mismatch. </p>

<p></p>

<p><b>Answer C is incorrect</b>. Chronic transplant rejection occurs months
to years after transplantation and results in fibrosis of the graft.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span lang=EN-GB>Bilateral ovarian masses are identified on pelvic
examination of a 40-year-old woman. Ultrasound examination reveals
multiloculated cystic masses involving both ovaries. The patient is treated
with total abdominal hysterectomy with removal of both adnexa. Pathologic
examination demonstrates papillary carcinoma producing serous fluid. Which of
the following tumor markers would be most useful in monitoring for recurrence?</span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><span
lang=EN-GB><span>A.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Alpha-fetoprotein</span></p>

<p><span
lang=EN-GB><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Beta-2-microglobulin</span></p>

<p><span
lang=EN-GB><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>BCR-ABL</span></p>

<p><span
lang=EN-GB><span>D.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>CA 19-9</span></p>

<p><span
lang=EN-GB><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>CA-125</span></p>

<p><span
lang=EN-GB><span>F.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>CEA</span></p>

<p><span
lang=EN-GB><span>G.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Her2/neu</span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p>Tumor markers are substances
that are produced by cancer cells or by other cells of the body in response to
cancer. Most tumor markers are made by normal cells as well as by cancer cells;
however, they are produced at much higher levels in cancerous conditions. These
substances can be found in the blood, urine, stool, tumor tissue, or other
tissues or bodily fluids of some patients with cancer. Most tumor markers are
proteins. However, more recently, patterns of gene expression and changes to
DNA have also begun to be used as tumor markers. Markers of the latter type are
assessed in tumor tissue specifically.</p>

<p></p>

<p>Thus far, more than 20
different tumor markers have been characterized and are in clinical use. Some
are associated with only one type of cancer, whereas others are associated with
two or more cancer types. There is no “universal” tumor marker that can detect
any type of cancer.</p>

<p>There are some limitations
to the use of tumor markers. Sometimes, noncancerous conditions can cause the
levels of certain tumor markers to increase. In addition, not everyone with a
particular type of cancer will have a higher level of a tumor marker associated
with that cancer. Moreover, tumor markers have not been identified for every
type of cancer.</p>

<p></p>

<p></p>

<p>Some of the most commonly
used tumor markers appear below. </p>

<p></p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><b><span>Tumor Marker</span></b><span></span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><b><span>Cancer Type</span></b><span></span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><b><span>Tissue Analyzed</span></b><span></span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><b><span>How Used</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Alpha-fetoprotein (AFP)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Liver cancer;<br>
  germ cell tumors</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To help diagnose liver cancer and follow
  response to treatment; to assess stage, prognosis, and response to treatment
  of germ cell tumors</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Beta-2-microglobulin (B2M)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Multiple myeloma; chronic lymphocytic
  leukemia; some lymphomas</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood, urine, or cerebrospinal fluid</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To determine prognosis and to follow response
  to treatment</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Beta-human chorionic gonadotropin (Beta-hCG)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Choriocarcinoma;<br>
  testicular cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Urine or blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To assess stage, prognosis, and response to
  treatment of testicular cancer</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>BCR-ABL</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Chronic myeloid leukemia</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood and/or bone marrow</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To confirm diagnosis and monitor disease
  status</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>CA19-9</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Pancreatic cancer;<br>
  gallbladder cancer;<br>
  bile duct cancer;<br>
  gastric cancer</span></p>
  <p style="text-align:center;"><span>&nbsp;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To assess whether treatment is working</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>CA-125</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Ovarian cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To help in diagnosis, assessment of response
  to treatment, and evaluation of recurrence</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Calcitonin</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Medullary thyroid cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To aid in diagnosis, to check whether
  treatment is working, and to assess recurrence</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Carcinoembryonic antigen (CEA)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Colorectal cancer; breast cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To check whether colorectal cancer has spread;
  to look for breast cancer recurrence and assess response to treatment</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Estrogen receptor (ER)/progesterone receptor
  (PR)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Breast cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Tumor tissue</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To determine whether treatment with hormonal
  therapy (such as tamoxifen) is appropriate</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>HER2/neu</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Breast cancer; gastric cancer; esophageal
  cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Tumor tissue</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To determine whether treatment with
  trastuzumab is appropriate</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Immunoglobulins</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Multiple myeloma; Waldenstrom
  macroglobulinemia</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood and urine</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To help diagnose disease, assess response to
  treatment, and look for recurrence</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Prostate-specific antigen (PSA)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Prostate cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To help in diagnosis, assess response to
  treatment, and &nbsp;look for recurrence</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Thyroglobulin</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Thyroid cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Tumor tissue</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To evaluate response to treatment and to look
  for recurrence</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Answer E is correct. </b><span lang=EN-GB>Serous papillary cystadenocarcinomas of the ovaries are derived from the
surface epithelium of the ovaries and express CA-125. </span><b></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 15-year-old boy has a lifelong history of
developmental delays and unusual movements such as hand-flapping. He has a
meager vocabulary. Two maternal uncles have mental retardation. Physical
examination shows coarse facial features and large testes. DNA testing shows an
expansion of a trinucleotide repeat. The patient has four sisters. If the
parents appear healthy, on average how many of the sisters are likely to be
carriers of the gene mutation?</span></span></p>

<p><span></span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>A.<span>&nbsp;&nbsp; </span></span></span></span><span>0</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span>1</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span>2</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>D.<span>&nbsp;&nbsp; </span></span></span></span><span>3</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span>4</span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span><span >&nbsp;</span></span></span></p>

<p><span>Fragile</span></span><span> <span
 syndrome</span><span> is the most common heritable form of mental
retardation. The syndrome is named after a “fragile site” on the <span
 chromosome that prevents chromatin from condensing
properly during mitosis. The syndrome is inherited as an <span
 disorder. Testing for F<span syndrome is a common indication for DNA
analysis and genetic counseling. </span></p>

<p><span></span></p>

<p><span>The
disorder is caused by massive expansion of the trinucleotide gene sequence,
CGG, in a gene called <i>FMR1</i> (<span <span
 mental retardation 1). In normal individuals, this
sequence is repeated less than 60 times. In patients with F<span
 <span syndrome, up to
several thousand repeats occur. These additional repeats interfere with DNA
replication and chromatin condensation.</span></p>

<p><span><span>&nbsp;</span></span></p>

<p>Prominent features of the
syndrome include mental retardation, long face, large ears, flat feet, and
large testes (macroorchidism). Behavioral features include stereotypic
movements (e.g., hand-flapping) and atypical social development, particularly
shyness and limited eye contact. Some individuals meet the diagnostic criteria
for autism. </p>

<p></p>

<p>Because the syndrome is
X-linked, males are predominantly affected, and their mothers are obligatory
carriers of the abnormal gene. </p>

<p></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer C is correct</b>. The patient in the clinical vignette has
Fragile X syndrome, an X-linked disorder. As expected, only males in the family
are affected (which in this case includes the patient and two maternal uncles).
The patient’s mother must be a carrier of the mutation because males get their
X chromosome from the mother (and their Y chromosome from the father). The
mother is healthy, so only one of her X chromosomes is affected. The father is
also healthy, so his X chromosome is fine. The mother and father have four daughters.
Each has inherited an X chromosome from the mother and an X chromosome from the
father. The X chromosome from the father is normal; the X chromosome from the
mother has a 50% chance of being abnormal. (The mother has one normal and one
abnormal X chromosome). Therefore, each daughter has a 50% chance of inheriting
the “bad” X chromosome (and becoming a carrier). Because there are four
daughters, two of them will, on average, carry the mutated gene. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>A 30-year-old woman has severe abdominal pain, nausea,
vomiting, and diarrhea, and is admitted to the hospital for 2 weeks for a
suspected intestinal infection. Evaluation, including upper and lower
endoscopies, does not establish a definite cause for her symptoms. She gradually
improves and is discharged after 2 weeks. Symptoms recur 2 years later, leading
to multiple emergency department visits. She is admitted to a psychiatric unit
with mental status changes and hallucinations, and then transferred to the
emergency department with abdominal pain, a grand mal seizure, and
hyponatremia. On admission to a medical unit her pulse is 120 bpm and BP is
174/114 mmHg. She is disoriented but has no focal neurologic signs. MRI shows
subcortical abnormalities, and the spinal fluid is normal. After
cholecystectomy for a distended gallbladder, she is discharged and stays with a
family member in another city because her symptoms are worse and muscle
weakness has developed. She is admitted to the hospital and progresses to
quadriparesis, respiratory failure, and aspiration pneumonia. Urinary
porphobilinogen (PBG) is reported as 44 mg/24 hours (reference range 0-4).
Following treatment with intravenous glucose and stopping harmful drugs
(including phenytoin), she improves gradually and is discharged for physical
therapy and rehabilitation. She recovers almost completely over a period of
several months, although residual painful hyperesthesia of the lower
extremities, mild proximal muscle weakness, and impaired short-term memory are
noted. Deficiency of which of the following enzymes is most likely in this
patient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Ferrochelatase</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Porphobilinogen deaminase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Protoporphyrinogen oxidase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Uroporphyrinogen decarboxylase</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Uroporphyrinogen III cosynthase</span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><b><span>Porphyrias</span></b></p>
  </td>
 </tr>
</table>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064019></a><i><span>Porphyria</span></i><span>&nbsp;is the name given to a group of genetic
  or acquired diseases associated with deficient synthesis of heme. Heme is an
  essential cofactor for the structure and function of hemoglobin and proteins
  such as cytochrome P-450. Bone marrow produces more than 80% of body heme.
  Liver produces about 15% of total heme, but its synthesis can be increased
  10-fold. For example, heme synthesis will be induced by ingestion of a drug
  that relies on a heme-containing enzyme for detoxification. This induction of
  hepatic heme synthesis underlies the important observation that certain drugs
  trigger porphyria attacks. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=T064003></a><span></span></p>

<p><span></span></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0>
 <tr>
  <td>
  <p style="text-align:center;"><b><span>List of Drugs Precipitating Attacks of Acute Intermittent
  Porphyria</span></b></p>
  </td>
 </tr>
</table>

</div>

<p><a name=T064003.50></a><a name=T064003.100></a><a name=T064003.150></a><a
name=T064003.200></a><a name=T064003.250></a><a name=T064003.300></a><a
name=T064003.350></a><a name=T064003.400></a><a name=T064003.450></a><a
name=T064003.500></a><a name=T064003.550></a><a name=T064003.600></a><a
name=T064003.650></a><a name=T064003.700></a><a name=T064003.750></a><a
name=T064003.800></a><a name=T064003.850></a><a name=T064003.900></a><a
name=T064003.950></a><a name=T064003.1000></a><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td valign=top>
  <p><span>Barbiturates</span></p>
  <p><span>Carbamazepine</span></p>
  <p><span>Chlorpropamide</span></p>
  <p><span>Chlordiazepoxide</span></p>
  <p><span>Danazol</span></p>
  <p><span>Dapsone</span></p>
  <p><span>Ergot preparations</span></p>
  </td>
  <td valign=top>
  <p><span>Estrogens</span></p>
  <p><span>Ethanol</span></p>
  <p><span>Glutethimide</span></p>
  <p><span>Griseofulvin</span></p>
  <p><span>Meprobamate</span></p>
  <p><span>Oral contraceptives</span></p>
  <p><span>Phenytoin</span></p>
  </td>
  <td valign=top>
  <p><span>Progestins</span></p>
  <p><span>Pyrazinamide</span></p>
  <p><span>Sulfonamide
  antibiotics</span></p>
  <p><span>Theophylline</span></p>
  <p><span>Tolbutamide</span></p>
  <p><span>Valproic acid</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width="90%">
 <tr>
  <td width="100%"></td>
 </tr>
</table>

</div>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064020></a><span></span></p>
  <p><span>Porphyrias result from
  partial deficiency of one of seven enzymes involved in biosynthesis of heme.
  Attacks of porphyria are associated with the accumulation of the biochemical
  intermediates in the heme synthesis pathway that precede the deficient
  enzyme. Some of these intermediates are toxic and can lead to the observable
  sign of dark, reddish urine. The two major classes of porphyria, bone marrow
  and hepatic, derive from the organ accounting for the overproduction of heme
  synthesis intermediates.</span></p>
  <p><span></span></p>
  <p><span>Most hepatic
  porphyrias (e.g., acute intermittent porphyria and porphyria cutanea tarda)
  have acute onset of pain as a result of the accumulation of early
  intermediates of heme synthesis such as &#948;-aminolevulinic acid (ALA) and
  porphobilinogen (PBG). Named&nbsp;<i>acute</i>&nbsp;for their hallmark abrupt
  presentation (and sometimes resolution), these porphyrias also have chronic
  features, including pain, neuropathy, and depression. Excess porphyrins,
  produced in bone marrow porphyrias (e.g., erythropoietic porphyria) deposit
  in skin and absorb light, which confers photosensitivity and results in
  cutaneous manifestations such as blistering of sun-exposed skin. </span></p>
  <p><span>The three most common
  porphyrias are discussed below.</span></p>
  </td>
 </tr>
</table>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC064013></a><span>ACUTE INTERMITTENT
  PORPHYRIA</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064021></a><i><span>Acute
  intermittent porphyria</span></i><span>&nbsp;(AIP)
  is an autosomal dominant disorder due to diminished activity of
  porphobilinogen (PBG) deaminase. PBG deaminase is the third enzyme in the
  pathway of heme biosynthesis. There is accumulation of the two intermediates
  of the pathway before this enzyme (ALA and PBG). A high urinary PBG level
  during an attack is a critical diagnostic feature, although the level is
  often normal between attacks. Finding deficient PBG deaminase enzyme activity
  in red blood cells confirms the diagnosis.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=F064001></a><span></span></p>

<p><a name=P064023></a><span></span></p>

<p><a name=T064004></a><span></span></p>

<p><a name=T064004.50></a><a name=T064004.100></a><a name=T064004.150></a><a
name=T064004.200></a><a name=T064004.250></a><a name=T064004.300></a><a
name=T064004.350></a><a name=T064004.400></a><a name=T064004.450></a><span></span></p>

<p><span></span></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width="90%">
 <tr>
  <td width="100%"></td>
 </tr>
</table>

</div>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064022></a><span>Acute attacks
  punctuate prolonged well periods in patients with AIP. The acute presentation
  of AIP can be dramatic and life-threatening. Abdominal pain, largely thought
  to be the result of neurotoxicity, is present in more than 90% of patients
  with acute attacks. Abdominal pain may be severe enough to prompt surgical
  evaluation for an acute abdomen and can be associated with nausea, vomiting,
  and bowel dysmotility. Neuropathy is evidenced by decreased sensation or
  muscle weakness that may involve cranial and respiratory nerves. Sympathetic
  tone is high with hypertension and tachycardia. Central nervous system
  manifestations include anxiety, paranoia, depression, and seizures, which may
  result in part from hyponatremia due to inappropriate secretion of
  antidiuretic hormone.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064024></a><span>Most patients suffer
  their initial attack after puberty. Triggers of attacks include drugs,
  particularly barbiturates, carbamazepine, and sulfonamides. Caloric
  restriction, fasting, surgery, and infections can precipitate attacks.
  Treatment of patients starts with prevention. Adequate caloric intake,
  particularly carbohydrates, and avoidance of triggers such as alcohol and
  offending drugs are important. Intravenous formulations of heme, such as
  hematin, are effective in reducing the duration and severity of attacks.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=HC064014></a><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%"><a
  name=P064026></a></td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC064015></a><span>PORPHYRIA CUTANEA
  TARDA</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064027></a><i><span>Porphyria
  cutanea tarda</span></i><span>&nbsp;(PCT) is the
  most common porphyria and shows the cardinal feature of bullous involvement
  of sun-exposed skin. This results from accumulation of uroporphyrinogen,
  which absorbs light and confers photosensitivity. PCT is due to decreased
  activity of the hepatic enzyme uroporphyrinogen decarboxylase. More than 75%
  of patients have sporadic&nbsp;disease. Most other cases occur in people
  heterozygous for a mutation in&nbsp;<i>UROD</i>, the gene that codes the
  enzyme.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064028></a><span>PCT typically begins
  in early adulthood with subacute appearance of fragile skin and includes
  vesicles and bullae, grayish skin discoloration, and hypertrichosis of the
  face. Liver disease is typical. Increased porphyrins in plasma, urine, and
  feces are required to attribute clinical manifestations to PCT. Avoiding and
  minimizing liver toxins such as alcohol and excess iron is a mainstay of
  therapy. Treatment includes avoiding triggers or removing any excess iron by
  phlebotomy and chloroquine (which forms a complex with porphyrin that
  improves excretion).</span></p>
  </td>
 </tr>
</table>

<p></span></p>

<p name=P064029></a><span></span></p>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%"><a
  name=P064030></a></td>
 </tr>
</table>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC064016></a><span>ERYTHROPOIETIC
  PORPHYRIA</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064031></a><i><span>Erythropoietic
  porphyria</span></i><span>&nbsp;(EPP) results
  from deficiency of the last enzyme in heme biosynthesis, ferrochelatase.
  Large amounts of protoporphyrin accumulate and produce serious cutaneous
  damage through a photodynamic reaction as observed in patients with PCT. A
  brief exposure to sunlight can produce burning, redness, and edema suggestive
  of angioedema developing within hours and resolving over several days.
  Manifestations of EPP typically occur in childhood. A massive increase in
  erythrocyte protoporphyrin levels is the diagnostic hallmark of EPP, so much
  so that fluorescent red blood cells can sometimes be visualized on a blood
  smear. Avoidance of sun or use of potent sunscreens is the mainstay of
  prevention. </span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span><img border=0 width=470 height=279
  src="_%20Tutorials_files/image170.png" v:shapes="Picture_x0020_347254"></span><span></span></p>
  </td>
 </tr>
</table>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%"><a
  name=P064032></a></td>
 </tr>
</table>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p><b><span>Answer A is
correct. </span></b><span>The presence of intermittent acute attacks of
severe abdominal pain associated with neuropsychiatric findings, hyponatremia,
and a hyperadrenergic response, with elevated levels of urinary
porphobilinogen, suggests a diagnosis of acute intermittent porphyria. The
deficient enzyme is porphobilinogen deaminase.</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section">Microbiology</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Infectious
Diseases</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
32-year-old man with AIDS and a CD4 count of 50/mm<sup>3</sup> develops an
infection that affects the eyes, lungs, gastrointestinal tract, and central
nervous system.<span >&nbsp; </span>A tissue biopsy is
shown below. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=212 height=147
src="_%20Tutorials_files/image172.png"
alt="Description: Histopathology_of_cytomegalovirus_infection_of_kidney_-_PHIL_09G0036_lores"
v:shapes="Picture_x0020_347241"></span><span></span></p>

<p><span></span></p>

<p><span>Which of
the following organisms is the most likely cause of infection? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Candida
albicans</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cryptococcus
neoformans</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Herpes
simplex</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mycobacterium
avium</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumocystis<span>&nbsp; </span>jiroveci</span></p>

<p><span></span></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><span>Cells
infected with cytomegalovirus (CMV) typically have a large, round intranuclear
inclusion with a perinuclear halo. This resembles an “owl’s eye.”<span>&nbsp; </span>CMV infection may cause retinitis,
pneumonitis, inflammation of the GI tract, and inflammation of the nervous
system. In patients with HIV, infection usually occurs when the CD4 count is
less than 100/mm<sup>3</sup>.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><i><span>Candida albicans</span></i><span> has a range of clinical
presentations, from superficial mucocutaneous disease in immunocompetent
individuals to invasive illness in immunocompromised hosts. Histologically, the
fungus may appear as ovoid yeast cells, hyphae, or pseudohyphae. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=247 height=150
src="_%20Tutorials_files/image174.png" alt="Description: candida" v:shapes="Picture_x0020_347240"></span><span></span></p>

<p style="text-align:center;"><i><span>Candida albicans</span></i></p>

<p style="text-align:center;"><span>(potassium hydroxide preparation)</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><i><span>Cryptococcus neoformans</span></i><span> causes meningitis in
people with AIDS. The fungus is visualized by methenamine silver or periodic
acid-Schiff stain, and appears as a round or oval yeast with a polysaccharide
capsule. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=242 height=170
src="_%20Tutorials_files/image176.png" alt="Description: 01G0018_lores" v:shapes="Picture_x0020_347239"></span><span></span></p>

<p style="text-align:center;"><i><span>Cryptococcus neoformans</span></i></p>

<p style="text-align:center;"><span>(methenamine silver stain)<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></p>

<p><span></span></p>

<p><span>Herpes
simplex virus causes recurrent orolabial, genital, and perianal lesions in
HIV-infected individuals. Tzanck smear shows multinucleated epithelial giant
cells. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=218 height=165
src="_%20Tutorials_files/image178.png" alt="Description: f4-u1" v:shapes="Picture_x0020_347238"></span><span></span></p>

<p style="text-align:center;"><span>Multinucleated giant cell caused by herpes simplex</span></p>

<p style="text-align:center;"><span>(Tzanck smear)</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><i><span>Mycobacterium avium</span></i><span> causes disseminated
disease in immunocompromised hosts. The bacterium travels by blood from the
lungs to the liver, spleen, and bone marrow. Bacteria can be seen in
macrophages, granulomas, and giant cells with acid-fast staining.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=244 height=161
src="_%20Tutorials_files/image180.png" alt="Description: AIDS071" v:shapes="Picture_x0020_347237"></span><span></span></p>

<p style="text-align:center;"><i><span>Mycobacterium avium</span></i><span></span></p>

<p style="text-align:center;"><span>Macrophages containing numerous acid-fast bacilli</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><i><span>Pneumocystis jiroveci</span></i><span> causes pneumonia in
people with AIDS.</span></p>

<p><span><span>&nbsp; </span></span></p>

<p style="text-align:center;"><span><img border=0 width=280 height=195
src="_%20Tutorials_files/image182.png" alt="Description: pneuomcyst" v:shapes="Picture_x0020_347236"></span><span></span></p>

<p style="text-align:center;"><i><span>Pneumocystis jiroveci</span></i></p>

<p style="text-align:center;"><span>(fungal cysts stained with methenamine silver)</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer C is correct.</span></b><span> The infection is most
likely caused by cytomegalovirus. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Match each
of the following organisms with the most appropriate clinical scenario.</span></p>

<p><span></span></p>

<p><i><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Streptococcus agalactiae</span></i></p>

<p><i><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Streptococcus bovis</span></i></p>

<p><i><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Hemophilus influenzae</span></i></p>

<p><i><span><span>D.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Legionella pneumophila</span></i></p>

<p><i><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Pseudomonas aeruginosa</span></i></p>

<p><i><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Salmonella enteritidis</span></i></p>

<p><i><span><span>G.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Yersinia enterocolita</span></i></p>

<p><i><span><span>H.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Bartonella henselae</span></i></p>

<p><i><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Chlamydia trachomatis</span></i></p>

<p><i><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Rickettsia rickettsii</span></i><i><span></span></i></p>

<p><i><span><span>K.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Helicobacter pylori</span></i><i><span></span></i></p>

<p><i><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium difficile</span></i><i><span></span></i></p>

<p><i><span><span>M.<span>&nbsp;&nbsp;
</span></span></span></i><span>Respiratory syncytial virus</span><i><span></span></i></p>

<p><i><span><span>N.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Proteus mirabilis</span></i><i><span></span></i></p>

<p><i><span><span>O.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Mycoplasma pneumoniae</span></i><i><span></span></i></p>

<p><i><span><span>P.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Rhizopus oryzae</span></i><i><span></span></i></p>

<p><i><span><span>Q.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Pasteurella multocida</span></i><i><span></span></i></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>63-year-old
man with colon cancer and bacteremia</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>9-year-old
girl with a pruritic, erythematous rash that develops days after soaking in a
hot tub </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>50-year-old
man who developed fever and cough ten days after attending a convention. Two
colleagues developed similar symptoms after the convention. Temperature is 101<sup>o</sup>F,
pulse is 76/minute, blood pressure is 130/70 mm Hg, and respirations are
18/minute. Chest X-ray shows a patchy infiltrate in the right lower lobe.
Sputum Gram stain shows neutrophils and small gram-negative rods that stain
poorly. Sputum cultures grow opal-like colonies on yeast extract. </span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>13-year-old
girl with sickle cell disease has pain in the right arm. X-ray shows bony
lesions consistent with osteomyelitis</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>24-year-old
man has pain with urination for three days. He is sexually active with three
partners and does not use condoms. His temperature is 37°C (98.6°F). Physical
examination is normal except for a clear, watery urethral discharge. Urinalysis
shows 10&#8211;20 white blood cells per high-powered field, but no bacteria.</span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>1-year-old
baby evaluated for sepsis has gram-positive cocci in pairs and chains in the
blood. The bacteria agglutinate with group B antiserum. </span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>8-year-old
boy has fever, difficulty with swallowing, drooling, hoarseness, and stridor.
He holds his head forward and insists on sitting in bed.</span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>6-year-old
boy has fever, abdominal pain, tenderness in the right lower quadrant, and
leukocytosis. At surgery, he is found to have a normal appendix, terminal
ileitis, and mesenteric lymphadenitis.<span >&nbsp;
</span></span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>16-year-old
boy has fever, malaise, and a red nodule on his forearm one week after playing
with a kitten. He develops axillary lymphadenopathy. </span></p>

<p><span><span>10.<span>&nbsp;
</span></span></span><span>43-year-old
man develops fever, malaise, headache, and a petechial rash on his palms and
soles four days after hiking in the woods</span></p>

<p><span><span>11.<span>&nbsp;
</span></span></span><span>80-year-old
woman develops watery diarrhea and mild abdominal cramping soon after
completing a ten-day course of clindamycin.</span></p>

<p><span><span>12.<span>&nbsp;
</span></span></span><span>32-year-old
man with one-week history of epigastric burning that is worse on an empty
stomach and improved after eating. The urea breath test is positive.<span>&nbsp; </span></span></p>

<p><span><span>13.<span>&nbsp;
</span></span></span><span>An
8-month-old girl has a 1-day history of rapid breathing. Her temperature is
38.4<sup>o</sup>C (101.1<sup>o</sup>F), pulse is 160/minute, respirations are
60/minute, and blood pressure is 100/70 mm Hg. Bilateral expiratory wheezing
and crackles are heard on auscultation. Chest x-ray shows areas of atelectasis
and hyperinflation.</span></p>

<p><span><span>14.<span>&nbsp;
</span></span></span><span>A
65-year-old woman has a two-day history of fever, flank pain, and burning with
urination. She has had three urinary tract infections in the past year. Her
temperature is 39.1<sup>o</sup>C (102.3<sup>o</sup>F). Physical examination
reveals right flank tenderness. Her white blood cell count is 16,000/mm<sup>3</sup>.
The urine has an aromatic smell. Urine pH is 9, with numerous white blood cells
and &gt;100,000 bacterial colonies/mL. Urine culture grows a urease-positive
organism. </span></p>

<p><span><span>15.<span>&nbsp;
</span></span></span><span>A
40-year-old woman with poorly controlled type 1 diabetes mellitus has a
one-week history of facial pain and swelling. Examination shows ecchymoses over
the left orbital and periorbital regions with proptosis. There is a necrotic
lesion with a black eschar in the left naris. Microscopic examination of the
lesion shows broad, irregularly shaped, nonseptate hyphae with braches at right
angles.</span></p>

<p><span><span>16.<span>&nbsp;
</span></span></span><span>A
32-year-old woman has a three-day history of fever and dry cough. Laboratory
tests show cold agglutinating antibodies in the serum. Routine blood and sputum
cultures are negative. A chest x-ray is abnormal.</span></p>

<p><span><span>17.<span>&nbsp;
</span></span></span><span lang=EN-GB>A
38-year-old letter carrier is severely bitten by a pit bull guarding a
junkyard. Several days later, the wound is inflamed and purulent. The exudate
is cultured on blood agar and yields gram-negative rods.</span></span><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answers</span></b></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>6.<span>&nbsp; </span><span>Group
B Streptococcus (GBS)</span>, or “<i><span>Streptococcus
agalactiae</span></i><span>,”</span> is the leading cause of sepsis, pneumonia, and meningitis in
newborns in the United States and Europe.<span >&nbsp;
</span>The bacterium, which colonize the mother’s vagina, is transmitted to the
baby during delivery. In pregnant women, GBS causes urinary tract infection,
chorioamnionitis, postpartum endometritis, and peripartum bacteremia. Its
virulence is largely due to a capsular polysaccharide that resists phagocytic
ingestion. In the U.S., testing for GBS is recommended at the 36-week antenatal
appointment of every pregnancy. The vagina and rectum are swabbed and cultures
are grown in enriched media. Prophylactic antibiotics are given to all women
who test positive. This strategy has led to a marked reduction in newborn
infection.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>1.
<span >&nbsp;</span><i>Streptococcus
bovis</i> bacteremia is associated with colon cancer (for unknown reasons).</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.<span>&nbsp; </span><i>Hemophilus
influenzae</i>, type B, is the most common cause of epiglottitis.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>3.<span>&nbsp; </span><i>Legionella
pneumophila</i> causes Legionnaire’s disease.</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>2.<span>&nbsp; </span><i>Pseudomonas
aeruginosa</i> causes “hot tub folliculitis.”</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>4.<span>&nbsp; </span>Children with sickle cell disease are
predisposed to osteomyelitis caused by salmonella.</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>8.<span>&nbsp; </span><i>Yersinia
enterocolita</i> can cause an appendicitis-like syndrome characterized by
terminal ileitis and mesenteric lymphadenitis.<span>&nbsp; </span></span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>9.<span>&nbsp; </span><i>Bartonella
henselae</i> causes “cat scratch disease.”</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>5.<span>&nbsp; </span><i>Chlamydia
trachomatis</i> is the most common cause of non-gonococcal urethritis.</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>10.
<i>Rickettsia rickettsii</i><span> causes
Rocky Mountain spotted fever.</span></span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>12.
<i>Helicobacter pylori</i> is a gram-negative, curved bacterium that can
inhabit various areas of the stomach, particularly the antrum. It causes a
chronic low-level inflammation of the stomach lining and is strongly linked to
the development of duodenal and gastric ulcers and stomach cancer. Over 80% of
individuals infected with the bacterium are asymptomatic. The bacterium
produces urease, which converts urea to ammonia and carbon dioxide. Four tests
are available for detecting <i>H. pylori</i><span>: blood antibody test, urea breath test, stool antigen test, and
stomach biopsy. During the urea breath test, p</span>atients swallow urea
labelled with an uncommon isotope, either radioactive carbon-14 or
non-radioactive carbon-13. In the subsequent 10&#8211;30 minutes, the detection
of isotope-labelled carbon dioxide in exhaled breath indicates that the urea
was split; this indicates that urease is present in the stomach, and hence that
<i>H. pylori</i> bacteria are present. The <span>Rapid urease test</span>, also known as the CLO test (Campylobacter-like
organism test), is a rapid test for diagnosis of <i>Helicobacter pylori</i>.
The test is performed at the time of gastroscopy. A biopsy of mucosa is taken
from the antrum of the stomach, and is placed into a medium containing urea and
an indicator such as phenol red. The urease produced by <i>H. pylori</i>
hydrolyzes urea to ammonia, which raises the pH of the medium, and changes the
color of the specimen from yellow (negative) to red (positive).</span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>11.
<i>Clostridium difficile</i><span> is the
most common infectious cause of antibiotic-associated colitis. </span></span></p>

<p><span><span>M.<span>&nbsp; </span></span></span><span>13.<span>&nbsp; </span>Respiratory syncytial virus (</span><span>RSV) is the most common
cause of bronchiolitis (and pneumonia) in children under 1 year of age.
Symptoms include coughing, wheezing, and shortness of breath. Fever,
tachycardia, and tachypnea <span>are
typical. </span></span></p>

<p><span><span>N.<span>&nbsp;&nbsp;
</span></span></span><span>14. <i>Proteus mirabilis</i> is a gram-negative rod
with urease activity. </span><span>Urease
hydrolyzes urea to ammonia (NH<sub>3</sub>), which gives the urine an aromatic
smell. Ammonia makes the urine more alkaline (pH of 9, in this example). If
left untreated, the increased alkalinity can lead to the formation of crystals
of struvite, calcium carbonate, and/or apatite. The bacteria can be found
throughout the stones, and these bacteria lurking in the stones can reinitiate
infection after antibiotic treatment.</span></p>

<p><span><span>O.<span>&nbsp;&nbsp;
</span></span></span><span>16.
<i>Mycoplasma pneumoniae</i><span> is
associated with pneumonia and cold agglutinins in the serum. </span></span></p>

<p><span><span>P.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>15.
<i>Rhizopus oryzae</i><span> is the
principal cause of mucormycosis, an aggressive fungal disease characterized by </span>invasion
of the vasculature, resulting in thrombosis and death of surrounding tissue.
Affected skin progresses from erythematous to black, due to necrosis.
Mucormycosis predominates in individuals with poorly controlled diabetes
mellitus. </span></p>

<p><span><span>Q.<span>&nbsp;&nbsp;
</span></span></span><span>17.
<i>Pasteurella multocida</i></span><span> </span></span><span lang=EN-GB>Pasteurella multocida is
a gram-negative rod that is normal flora of the oral cavity of dogs and cats.
It often causes a local abscess following introduction under the skin by an
animal bite. Most cases occur in children who are injured while playing with a
pet. </span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A newborn
girl has fever, irritability, a deformed nasal bridge, and a rash on the palms
and soles. Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired toxoplasmosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired syphilis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired rubella</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired cytomegalovirus</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired herpes simplex</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span><br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p>The TORCH complex is a group
of congenital infections with similar presentations. TORCH is an acronym for
toxoplasmosis, other (syphilis), rubella, cytomegalovirus, and herpes simplex.
These conditions may be associated with abnormalities of the brain, heart,
skin, eyes, and ears. Findings include fever, poor feeding, irritability, low
birth weight, microcephaly, mental retardation, visual impairment, hearing
impairment, hepatosplenomegaly, jaundice, and a “blueberry muffin” rash.
(“Blueberry muffin” rash, originally described in infants with congenital
rubella syndrome, can occur with any of the TORCH organisms.) Typically, the
infected mother is asymptomatic or mildly symptomatic.<span>&nbsp; </span></p>

<p></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=145 height=124
src="_%20Tutorials_files/image184.png" v:shapes="Picture_x0020_347235"></span></p>

<p style="text-align:center;">“Blueberry
muffin” rash</p>

<p style="text-align:center;"><b></b></p>

<p><span>In
newborns, <b>congenital syphilis</b> is
associated with fever, irritability, deformity of the nasal bridge (saddle
nose), and a rash affecting the palms and soles. In older infants and young
children, findings include bone pain, clouding of the cornea, blindness,
deafness, peg-shaped teeth (Hutchinson teeth), joint swelling, and saber shins.
Newborns may have a rash around the mouth, genitalia, and anus that eventually
scars.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=119 height=171
src="_%20Tutorials_files/image186.png" v:shapes="Picture_x0020_347234"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>“Saddle nose” deformity</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=170 height=127
src="_%20Tutorials_files/image188.png" v:shapes="Picture_x0020_347233"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Hutchinson teeth</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=179 height=274
src="_%20Tutorials_files/image190.png"
alt="Taken from:004-01, v4htp/tp page 168Extracted on 31/10/2003" v:shapes="Picture_x0020_347232"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>“Saber shin” deformity</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=141 height=207
src="_%20Tutorials_files/image192.png" alt="Description: Secondary Syphilis"
v:shapes="Picture_x0020_347231"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Syphilitic rash affecting the palms and soles</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Congenital toxoplasmosis</span></b><span> is associated with
hepatosplenomegaly, jaundice, retinal disease, hearing loss, and rash
(petechial or ecchymotic). </span></p>

<p><span></span></p>

<p>The classic triad of <b>congenital rubella syndrome</b> is
sensorineural deafness, ocular abnormalities (especially cataracts and
microphthalmia), and congenital heart disease (especially patent ductus
arteriosus). </p>

<p><span>&nbsp;</span></p>

<p><b><span>Cytomegalovirus</span></b><span> (CMV) infection is
associated with hepatosplenomegaly, jaundice, retinal disease, seizures,
microcephaly, and rash (petechial).</span></p>

<p><span></span></p>

<p><b><span>Congenital herpes
simplex</span></b><span>
is associated with encephalitis, meningitis, and blisters.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct. </span></b><span>The most likely
diagnosis is congenitally acquired syphilis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Which
of the following organisms is the most frequently identified parasite causing
chronic diarrhea in AIDS?</p>

<p></p>

<p><i><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></i><i>Cryptosporidium
parvum</i></p>

<p><i><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></i><i>Isospora
belli</i></p>

<p><i><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></i><i>Giardia
lamblia</i></p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span><i>Entamoeba
histolytica</i></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>More
than one hundred million individuals around the world are currently infected
with the human immunodeficiency virus (HIV). A very substantial number of these
patients have developed or will ultimately develop diarrhea. Diarrhea occurs in
about 50% of the HIV-infected individuals in the United States. Specific
enteric pathogens can be isolated (if patients undergo very exhaustive and
intensive evaluation) in most individuals with severe diarrhea. </p>

<p></p>

<p>Clinical
presentations vary among patients with AIDS-related diarrhea. Small-bowel
diarrhea tends to produce postprandial stools that are very large in volume.
These patients also often have severe postprandial peri-umbilical abdominal
pain. Diarrhea can be lessened by the avoidance of food and nutrients. Weight
loss commonly occurs in these patients. By contrast, large-intestinal diarrhea,
also called “colitic diarrhea,” is associated with frequent, small-volume
stools. These patients do not commonly become dehydrated. Colonic diarrhea may
also be associated with the presence of visible blood and mucus. Patients with
large-bowel diarrhea often have lower quadrant abdominal pain and/or the
sensation of rectal urgency (tenesmus).</p>

<p></p>

<p><span>A
large number of organisms have been identified in the stools or
gastrointestinal tract mucosa of patients with refractory AIDS-related
diarrhea.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=339 height=212
src="_%20Tutorials_files/image194.png" alt="Description: cello_table_01"
v:shapes="Picture_x0020_347230"></span><span></span></p>

<p><span></span></p>

<p><span>The
major identified causes of AIDS-related diarrhea are <i>Cryptosporidium</i> and
<i>Microsporidium</i> protozoa. Enteric pathogenic bacteria such as <i>Salmonella</i>,
<i>Campylobacter</i>, <i>Shigella</i>, and <i>Clostridium difficile</i>, along
with other pathogens such as mycobacterium (principally <i>Mycobacterium avium</i>
complex or MAC), and occasionally <i>Mycobacterium tuberculosis</i>, can also
cause diarrhea. Viruses and fungi also can play a significant role in
AIDS-related diarrhea. Classifying the etiology of HIV-infected patients with
diarrhea can be a problem because many different organisms may be found in the
stools of patients with AIDS who have refractory diarrhea. It is not known if
these organisms are true pathogens, but they are clearly associated with the
stools of patients with refractory diarrhea.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Cryptosporidium parvum</span></i><span> is the most frequently identified
parasite causing chronic diarrhea in AIDS, even in developed countries. This
organism is extracellular, lining the brush border of the enterocytes in the
small bowel and less frequently the large bowel. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus
(CMV) is a parenteral infection, which can involve the gastrointestinal tract
anywhere from the mouth to the anus. CMV typically is associated with very
large ulcers that disproportionately involve the right colon. However, very
characteristic of early CMV in the gut are submucosal hemorrhages, not
dissimilar to those seen with ischemic colitis. CMV is very well named, and it
tends to produce both large intranuclear and intracytoplasmic inclusions. The
infected cell is gigantic in size. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mycobacterium
avium complex includes atypical mycobacteria that involve the
reticuloendothelial system. Characteristically, MAC-infected patients have
extensive adenopathy, very large livers, and large spleens. They also have
substantial systemic illness, with fevers, anorexia, and massive infiltration
of the gut lamina propria mononuclear cells. The organism is visible with
acid-fast stains.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Microsporidia are unique
intracellular organisms. These organisms are found in the supranuclear apical
surfaces of the enterocytes. Various life cycles of the organism, all of which
are intracellular, can be seen with the use of special stains. Microsporidia
are a major cause of diarrhea in patients with AIDS.<span></span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is correct. </span></b><i><span>Cryptosporidium parvum</span></i><span> is the most frequently
identified parasite causing chronic diarrhea in AIDS.</span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>.<span>&nbsp; </span><i>Isospora
belli</i> is found thus far only in the human small intestine.<span>&nbsp; </span>It is transmitted by fecal-oral route
and may cause diarrhea in immunocompetent hosts.<span>&nbsp; </span>It can cause prolonged and severe
diarrhea in AIDS patients.</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>.<span>&nbsp; </span><i>Giardia
lamblia </i>is a flagellated protozoan and is a common cause of diarrhea
world-wide.<span >&nbsp; </span>It is transmitted by
ingestion of the cyst from contaminated water.<span>&nbsp; </span>The trophozoite form lives in the upper
small intestine and causes irritation leading to gastrointestinal
symptoms.<span >&nbsp; </span>Patients with giardiasis
have a characteristic light-colored fatty stool with abdominal pain, cramps
with flatulence.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>.<span>&nbsp; </span><i>Entamoeba
histolytica</i> commonly causes diarrhea and dysentery in developing countries
where sanitation is poor.<span >&nbsp; </span>Humans
are the only host and it is acquired by ingesting the cyst stage.<span>&nbsp; </span>Blood and mucus are found in the stools
and if the disease progress, the bowel may become perforated.<span>&nbsp; </span>The organism may also spread to the
liver and cause abscesses.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A patient
who was treated with clindamycin for aspiration pneumonia develops diarrhea.
The stool contains a toxin that kills cultured epithelial cells. Stool culture
grows an anaerobic gram-positive rod. The same organism is cultured from the
bedpan. Which of the following is most likely to sterilize the bedpan? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Boiling
for 45 minutes</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Exposure
to benzalkonium chloride for 1 hour</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Exposure
to ethyl alcohol for 1 hour</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Exposure
to high-pressure saturated steam (121<sup>o</sup>C) for 15 minutes</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Heating
in an oven at 150<sup>o</sup>C for 30 minutes</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Disinfection</span></b><span>: the process of
eliminating most pathogenic microorganisms, but <i>not</i> bacterial spores</span></p>

<p><span></span></p>

<p><b><span>Sterilization</span></b><span>: the process of killing all living
microorganisms, <i>including</i> bacterial
spores</span></p>

<p><span></span></p>

<p style="text-align:center;"><span>***</span></p>

<p style="text-align:center;"><span></span></p>

<p><span>This
patient has <i>Clostridium difficile</i>
colitis, a common cause of diarrhea usually occurring in patients who have been
treated with broad-spectrum antibiotics. <i>C.
difficile</i> is an anaerobic, gram-positive, toxin-producing rod, which can
exist as an endospore. </span></p>

<p><span></span></p>

<p><span>An
endospore is a “stripped-down,” dormant form of a bacterium. It is not a true
spore (i.e. not an offspring). Most bacteria cannot convert themselves into
endospores, but bacteria of the genera <i>Bacillus</i> and <i>Clostridium</i>
can.<span >&nbsp; </span>When these bacteria are exposed
to an inhospitable environment (e.g., desiccation), they can convert themselves
from a vegetative form to an endospore form. The endospore enables the bacteria
to survive for years, even millennia, in an untoward environment. When the
environment becomes favorable, the endospore converts back to the bacterium’s
vegetative state. </span></p>

<p><span></span></p>

<p>An endospore consists of a
bacterium's DNA and part of its cytoplasm, surrounded by a very tough outer
coating. Endospores can survive without nutrients. They are resistant to
ultraviolet radiation, desiccation, high temperature, extreme freezing, and
chemical disinfectants. Common anti-bacterial agents that destroy vegetative
cell walls do not destroy endospores. Household cleaning products are
ineffective, as are most alcohols, quaternary ammonium compounds (e.g.
benzalkonium chloride), and detergents. Endospores are able to survive boiling
at 100°C for hours. While resistant to extreme heat and radiation, endospores <i>can</i> be destroyed by autoclaving. An <span>autoclave</span> sterilizes material by
subjecting it to high pressure saturated steam at 121&nbsp;°C or more,
typically for 15&#8211;20 minutes. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. <i>Clostridium difficile</i> can exist as an endospore, which is resistant
to standard techniques of disinfection. Sterilization is necessary to eliminate
endospores. The most common method of sterilization is autoclaving, by which
materials are subjected to high-pressure saturated steam at 121&nbsp;°C or
more, typically for 15&#8211;20 minutes. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
14-year-old boy presents with a 2-day history of left ear pain. He swims every
morning. The left ear canal is red and swollen. He experiences pain when the auricle
is pulled and when the tragus is pushed. What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
bacterial otitis media</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serous
otitis media</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bullous
myringitis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>External
otitis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mastoiditis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Otitis externa</span></b><span>, or swimmer’s ear, is inflammation of
the external auditory canal, usually caused by bacterial infection (although
sometimes caused by fungal infection). Patients have ear pain and erythema and
swelling of the ear canal, occasionally with discharge. The pain worsens when
the auricle is pulled and when the tragus is pushed. Excessive moisture and
trauma are the most common precipitants.</span></p>

<p><b><span></span></b></p>

<p><b><span>Otitis media</span></b><span> (inflammation of the middle ear) often
occurs with viral upper respiratory tract infection. The ear gets congested,
with mild discomfort and popping. If bacterial contamination occurs, pus and
pressure may develop, causing fever and severe, continuous ear pain. Otoscopic
examination will then show a bulging, erythematous ear drum with indistinct
landmarks and displacement of the light reflex. In severe cases, the ear drum
may perforate. Rare complications include mastoiditis and meningitis.</span></p>

<p><b><span></span></b></p>

<p><b><span>Serous otitis media</span></b><span> is a collection of
fluid in the middle ear caused by negative pressure resulting from Eustachian
tube dysfunction. The fluid may accumulate after a viral upper repiratory tract
infection or before or after acute bacterial otitis media.</span></p>

<p><b><span></span></b></p>

<p><b><span>Bullous myringitis</span></b><span> is an inflammatory
condition of the ear drum, characterized by severe ear pain and painful,
fluid-filled vesicles on the ear drum. It is usually associated with acute
bacterial otitis media.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Mastoiditis</span></b><b><span> </span></b><span>is
an infection of the mastoid process (the portion of the temporal bone located
behind the ear). It is usually caused by untreated acute bacterial otitis
media. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct. </span></b><span>The most likely
diagnosis is external otitis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 57-year-old woman with a
history of frequent urinary tract infections has fever, nausea, flank pain, and
muscle aches. Her temperature is 39.7<sup>o</sup>C (103.5<sup>o</sup>F) and her
blood pressure is 80/50 mm Hg. Blood cultures are positive for a Gram-negative
rod. Which of the following is the most likely cause of hypotension?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Endotoxin</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Superantigen</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Erythrogenic toxin</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Hemolysin</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>An endotoxin is a structural
part of a bacterium. The prototypical example of an endotoxin is
lipopolysaccharide (LPS), which is found in the cell wall of most Gram-negative
bacteria.<span >&nbsp; </span>LPS consists of a core
polysaccharide chain, O-specific polysaccharide side chains (O-antigen), and a
lipid component, Lipid A,<span> </span>which is
responsible for the toxic effects. Injection of a small amount of endotoxin in
human volunteers causes fever, hypotension, and activation of inflammation and
coagulation. Endotoxins are largely responsible for the dramatic clinical
manifestations of infections with pathogenic Gram-negative bacteria.</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=231 height=233
src="_%20Tutorials_files/image196.png"
alt="Description: http://www.glycosan.com/images/endotoxin_structure.jpg"
v:shapes="Picture_x0020_347229"></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;">Endotoxin</p>

<p style="text-align:center;"></p>

<p>A comparison of endotoxin
and exotoxins appears below. </p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Endotoxin</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Exotoxin</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Disease
  (examples)</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Gram-negative
  sepsis</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Tetanus,
  Botulism, Diphtheria</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Source</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Lipopolysaccharide
  found in the cell wall of most gram-negative bacteria; released when lysed</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Polypeptide
  secreted by certain species of gram-positive and gram-negative bacteria</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Gene
  location</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Bacterial
  chromosome</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Plasmid
  or bacteriophage</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Clinical
  effects</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Fever,
  shock</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Depends
  on toxin</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Antigenicity</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Poorly
  antigenic</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Induces
  high-titer antibodies, called antitoxins</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Vaccines</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>None</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Toxoids
  used as vaccines</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Heat
  stability</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Stable
  at 100<sup>o</sup>C for 1 hour</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Destroyed
  rapidly at 60<sup>o</sup>C</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. Endotoxin is the main
cause of fever and hypotension in patients with Gram-negative sepsis.
Inflammation and activation of the coagulation cascade occur. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span> Superantigens </span>are produced by many different micro-organisms.
They stimulate T-cell activation, resulting in massive cytokine release.
Compared to a normal T-cell response in which .001-.0001% of T-cells are
activated, superantigens activate up to 20% of T-cells. Toxic Shock Syndrome
Toxin 1 (TSST-1) is a superantigen produced by <i>Staphylococcus aureus</i>. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>.<b> </b><span>Erythrogenic toxin, produced by </span><i>Streptococcus
pyogenes</i>, is the cause of scarlet fever. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. <span>Hemolysins</span> are exotoxins that cause
lysis of red blood cells <i>in vitro</i>. Visualization of hemolysis on agar
plates facilitates the categorization of some bacteria, such as <i>Streptococcus</i>
and <i>Staphylococcus</i>.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Each of
the following clinical vignettes describes a condition that is caused by an
exotoxin-producing bacterium. Match the vignette with the causative organism.</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
72-year woman develops fever, abdominal pain, and non-bloody diarrhea after
being treated for aspiration pneumonia with clindamycin. Sigmoidoscopy shows
patches of yellow exudate in the distal colon. </span></p>

<p><span></span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
4-year old boy in Uzbekistan develops low-grade fever, sore throat, and a
thick, tough, gray-to-black coating in the back of the throat. </span></p>

<p><span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
26-year old man in India has vomiting and profuse, watery diarrhea, which
results in hypotension and death within hours.</span></p>

<p><span></span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
3-year old boy has bloody diarrhea. Blood tests show a low hemoglobin
concentration, a low platelet count, and an elevated serum creatinine level.
The reticulocyte count is elevated and the haptoglobin level is low.
Examination of a peripheral blood smear shows a few schistocytes. </span></p>

<p><span></span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
10-year old girl has sneezing, runny nose, and a mild cough. Two weeks later,
she develops uncontrollable fits of coughing followed by an inspiratory gasp.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
64-year old man with peripheral arterial disease sustains a deep injury to his
leg. The area becomes swollen and painful, its color changes from red to bronze
to blackish green, and a foul-smelling discharge develops. Large blisters
appear, and gas bubbles are felt beneath the skin. </span></p>

<p><span></span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
24-year old woman develops high fever, delirium, and a sunburn-like rash, which
is intensely red and affects the entire body, including eyes, lips, mouth,
palms, and soles. She is hypotensive. Her delirium progresses to coma, and she
develops multi-organ failure. The rash desquamates ten days later. </span></p>

<p><span></span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
13-year old girl develops high fever, sore throat, and a rash that begins on
her neck and spreads to her chest and back. The rash is red, fine, and
rough-textured. It is worse in the skin folds. (Converging erythematous lines
appear in the axilla and groin.) Examination reveals tonsillar exudate,
cervical lymphadenopathy, and a bright, red “strawberry” tongue. The rash peels
five days later. Anti-streptolysin O titers are elevated.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>After
eating home-canned asparagus, a 42-year old man develops blurred vision and
difficulty with swallowing and speaking, followed by weakness of the arms and
legs. </span></p>

<p><span></span></p>

<p><span><span>10.<span>&nbsp;
</span></span></span><span>Seven
days after injuring his leg, a 32-year old man develops tightening of his jaw,
stiffness of his neck, and trouble swallowing. This is followed by tightening
of the pectoral and calf muscles. His temperature, pulse, and blood pressure
are elevated. </span></p>

<p><span></span></p>

<p><span><span>11.<span>&nbsp;
</span></span></span><span>A
1-month old neonate develops a diffuse, erythematous rash with blistering.
Large patches of skin can be seen peeling away. Gentle stroking causes the skin
to separate. </span></p>

<p><span></span></p>

<p><span><span>12.<span>&nbsp;
</span></span></span><span>Two
hours after eating a sandwich of sliced meat, a 43-year old woman becomes
violently ill with nausea, vomiting, abdominal pain, and diarrhea. Her symptoms
resolve the following day.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>13.<span>&nbsp;
</span></span></span><span>A
43-year old man who makes drums out of animal hide develops a boil-like lesion
on his forearm, which evolves into a large, painless, necrotic ulcer. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Staphylococcus aureus</span></i><span> <i></i></span></p>

<p><i><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Streptococcus pyogenes</span></i></p>

<p><i><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Corynebacterium diphtheriae</span></i></p>

<p><i><span><span>D.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Vibrio cholerae</span></i></p>

<p><i><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Escherichia coli<span>&nbsp; </span></span></i><span>0157:H7<i></i></span></p>

<p><i><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Bordetella pertussis</span></i></p>

<p><i><span><span>G.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium perfringens</span></i></p>

<p><i><span><span>H.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium tetani</span></i></p>

<p><i><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium botulinum</span></i></p>

<p><i><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium difficile</span></i></p>

<p><i><span><span>K.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Bacillus anthracis</span></i></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i>Clostridium difficile</i> colitis should be suspected when diarrhea
occurs in a patient who has recently taken antibiotics. The diarrhea is usually
non-bloody and may be accompanied by fever and abdominal pain. <i>Clostridium difficile</i> colitis is
classically associated with clindamycin use, but any broad-spectrum antibiotic
can cause the condition. “Pseudomembranes,” patches of yellowish exudate
comprised of inflammatory debris, can be seen using sigmoidoscopy or
colonoscopy (hence, the term “pseudomembranous colitis”).<span>&nbsp; </span>Clostridia are Gram-positive, anaerobic,
spore-forming bacilli.<span >&nbsp; </span>Eradication
of normal gut flora with antibiotic use causes overpopulation of these
bacteria, which naturally reside in the colon. The bacteria release toxins that
can cause bloating, diarrhea, and abdominal pain. There are several known
toxins. The best-characterized are enterotoxin (<span>toxin A</span>) and cytotoxin (<span>toxin
B</span>), both of which cause diarrhea and inflammation. Enzyme-linked
immunoabsorbant assays (ELISA) are available for detecting toxins A and B in
the stool. Experts recommend sending as many as three stool samples for ELISA
testing if initial tests are negative. Patients with <i>C. difficile</i><span> colitis should be treated with oral </span>metronidazole
or vancomycin. If treatment is effective, the toxin clears from the stool.<span>&nbsp; </span></p>

<p></p>

<p>D<span>iphtheria</span> is an upper respiratory tract illness caused by <i>Corynebacterium
diphtheriae</i>, a Gram-positive bacterium. The condition is characterized by
sore throat, low fever, and an adherent membrane (a “<span>pseudomembrane”</span>) on the tonsils, pharynx, or nasal cavity.
Patients may present with a “bull” neck. Diphtheria has largely been eradicated
in industrialized nations through widespread vaccination. The vaccine is
composed of the diphtheria toxoid. </p>

<p></p>

<p><span>Cholera</span> is an infection of the small intestine caused by the
bacterium <i>Vibrio cholerae</i>. The main symptoms are profuse watery diarrhea
and vomiting. The diarrhea is frequently described as &quot;rice water.&quot;
An untreated person may produce 10-20 liters of stool a day. Disease
transmission is primarily through consumption of contaminated water or food.
The severity of the diarrhea and vomiting can lead to rapid dehydration and
electrolyte imbalance. Primary treatment is rehydration. Cholera affects 3-5
million people worldwide and causes more than 100,000 deaths each year.</p>

<p></p>

<p><i><span>Escherichia coli</span></i><span>
O157:H7</span> is an enterohemorrhagic strain of the bacterium <i>Escherichia
coli</i><span>.</span> Infection often leads
to hemorrhagic diarrhea and, occasionally, to renal failure, especially in
young children and the elderly. Transmission is via the fecal-oral route. <i>E.
coli</i> is a Gram-negative bacillus, of which there are hundreds of serotypes.
Most are harmless. Serotype O157:H7, however, can produce Shiga-like toxins,
which cause severe illness. In some individuals (particularly children under
five years of age and the elderly), infection can lead to hemolytic uremic
syndrome (HUS), a condition characterized by hemolytic anemia,
thrombocytopenia, and acute renal failure. In HUS, bacterial toxins stimulate
platelet activation and the formation of microthrombi in arterioles and
capillaries. Platelets are consumed and red blood cells are damaged as they
squeeze through the narrowed blood vessels. This process is called
&quot;microangiopathic hemolysis.&quot; Schistocytes, or fragments of sheared
red blood cells, appear in the blood and are a key finding in the diagnosis of
HUS. </p>

<p></p>

<p><span>Pertussis</span>, also known as <span>whooping
cough, </span>is a highly contagious disease caused by the bacterium <i>Bordetella
pertussis</i>. The condition lasts about six weeks and is named after the
&quot;whoop&quot; sound made from the inspiration of air after a cough. (The
high-pitched “whoop” occurs mainly in infants and children.) The classic
symptoms are paroxysmal cough, inspiratory whoop, and post-tussive vomiting
(after-cough vomiting). The cough is violent and has been associated with
subconjunctival hemorrhage, rib fracture, and syncope. Patients present with
mild respiratory symptoms, such as sneezing, runny nose, and cough (catarrhal
stage). After one to two weeks, the cough develops into uncontrollable fits,
each followed by a high-pitched &quot;whoop&quot; (in younger children) or a
gasp (in older children). This is the paroxysmal stage. The “whoop” or gasp
occurs as the patient struggles to inhale. Between coughing fits, the patient
often appears well. The pertussis vaccine, an acellular vaccine, saves many
lives each year. </p>

<p></p>

<p><span>Gas gangrene</span> (also known as &quot;Clostridial myonecrosis&quot; or
&quot;myonecrosis&quot;) is a deadly form of gangrene usually caused by <i>Clostridium
perfringens.</i> The condition usually occurs at the site of trauma or a recent
surgical wound. The onset of illness is sudden and dramatic. Predisposing
conditions include peripheral arterial disease and diabetes. Clostridia produce
many different toxins that can cause potentially deadly syndromes. The site of
infection becomes inflamed, swollen, and very tender. Palpation of the region
elicits crackling because of subcutaneous gas. Vesicles appear which merge into
large blisters. A serosanguinous discharge is common. The edge of the infected
area may expand over minutes. High fever, tachycardia, sweating, and exquisite
pain are typical.<span >&nbsp; </span>If the condition
is not treated, shock ensues and death soon follows. </p>

<p><span></span></p>

<p>Toxic shock syndrome usually
results from infection with <i>Staphylococcus aureus</i><span>. Patients present with</span> high fever, low blood pressure, and
confusion, which may progress rapidly to stupor, coma, and multi-organ failure.
The characteristic rash, often seen early in the course of illness, resembles
sunburn, and can involve any region of the body, including the lips, mouth,
eyes, palms and soles. D<span>esquamation
occurs </span>after 10&#8211;14 days. Toxic shock syndrome is caused by a
superantigen toxin, which is produced by <i>Staphylococcus aureus</i><span>. The superantigen is called toxic shock
syndrome toxin 1 (TSST-1). </span></p>

<p></p>

<p><span>Scarlet fever</span> is caused by an exotoxin (“erythrogenic toxin”)
produced by <i>Streptococcus pyogenes</i>. The disease is characterized by high
fever, sore throat, tonsillar exudate, cervical lymphadenopathy, bright red
tongue (“strawberry tongue”), and characteristic rash. The rash is fine, red,
and rough-textured. It usually appears on the neck and face, often leaving a
clear unaffected area around the mouth. It then spreads to the chest, back, and
extremities. Classic red streaks that run together (Pastia lines) appear in body
creases, especially the axillae, elbows, and groin. The rash blanches with
pressure and fades by the sixth day. The affected skin desquamates. Blood tests
show marked leukocytosis and an elevated antistreptolysin O titer. Streptococci
may be cultured from the throat. Two types of complications are possible:
“septic” and “immune.” Septic complications result from bacteremia, and include
sinusitis, pneumonia, and meningitis. Immune complications include acute
glomerulonephritis, rheumatic fever and erythema nodosum. </p>

<p></p>

<p><span>Botulism</span> is a paralytic illness caused by botulinum toxin, which
is produced by the bacterium <i>Clostridium botulinum</i><span>. The toxin prevents the release of
acetylcholine at motor nerve endings in the parasympathetic system. It</span>
enters the body in one of three ways: by colonization of the digestive tract by
the bacterium, by ingestion of toxin from foods, or by bacterial wound
contamination.<span >&nbsp; </span>All forms lead to
paralysis, which typically starts with the muscles of the face and spreads to
the limbs. Initial manifestations include blurred vision, ptosis, loss of
facial expression, swallowing problems, and difficulty speaking. Severe
botulism can lead to respiratory failure. The autonomic nervous system may be
impaired, causing dry mouth, postural hypotension, and constipation.</p>

<p></p>

<p><span>Tetanus</span> is characterized by prolonged contraction of skeletal
muscle. The condition is caused by a neurotoxin produced by the Gram-positive,
anaerobic bacterium <i>Clostridium tetani</i>. The toxin acts by binding
inhibitory neurons, blocking the release of neurotransmitters. Infection
generally occurs through wound contamination. <span>Generalized tetanus</span> occurs in 80% of cases and follows a
descending pattern. The first sign is trismus (“lockjaw”) and facial spasm,
followed by stiffness of the neck, difficulty swallowing, and rigidity of
pectoral and calf muscles. Other findings include elevated temperature,
elevated blood pressure, rapid heart rate, and sweating. The tetanus vaccine,
composed of tetanus toxoid, is very effective at preventing disease.</p>

<p></p>

<p><span>Staphylococcal scalded skin syndrome </span>is induced by epidermolytic
exotoxins A and B, which are released by <i>Staphylococcus aureus</i> and cause
detachment within the epidermal layer. The exotoxins are proteases that cleave
desmoglein-1, which holds the granulosum and spinosum layers of the epidermis
together. The disease most commonly affects neonates and usually begins with
fever, irritability, and a faint rash. Within 1-2 days, the rash progresses to
a blistering eruption. Tissue paper-like wrinkling of the epidermis occurs and
large bullae appear. As sheets of epidermis are shed, a moist erythematous base
is revealed. Although the clinical picture is dramatic, the process usually
ends with desquamation, and healing is complete in 5-7 days.</p>

<p></p>

<p>Staphylococcal food
poisoning is caused by enterotoxins produced by <em>Staphylococcus aureus</em><em><span>. The bacteria multiply in
food, where they produce heat-resistant enterotoxins (toxins that cannot be
destroyed by cooking). When ingested, the </span></em>toxins are fast-acting,
sometimes causing illness in as little as thirty minutes. On average, symptoms
occur one to six hours after eating, and include nausea, vomiting, abdominal
pain, and diarrhea. The illness is usually brief, and most patients recover in
one to three days. <span>Foods associated with staph food
poisoning include meats; poultry and egg products; salads such as egg, tuna,
chicken, potato, and macaroni; bakery products such as cream-filled pastries,
cream pies, and chocolate éclairs; sandwich fillings; and milk and dairy
products. </span></p>

<p></p>

<p><span>Anthrax</span> is a disease caused by the bacterium <i>Bacillus anthracis</i>.
The bacterium enters the body through the lungs, intestines, or skin. Symptoms
depend on site of entry. Lung infection causes flu-like symptoms, followed by
respiratory collapse. Intestinal infection causes abdominal pain, hematemesis,
and diarrhea. Cutaneous infection results in a boil-like lesion that forms a
large, painless, necrotic ulcer. Anthrax can be contracted in laboratory
accidents or by handling infected animals or their wool or hides.</p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Answers </span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>J</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>D</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>F</span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>G</span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A</span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>I</span></p>

<p><span><span>10.<span>&nbsp; </span></span></span><span>H</span></p>

<p><span><span>11.<span>&nbsp; </span></span></span><span>A</span></p>

<p><span><span>12.<span>&nbsp; </span></span></span><span>A</span></p>

<p><span><span>13.<span>&nbsp; </span></span></span><span>K</span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following molecules is considered an endogenous pyrogen?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Interleukin-1</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Histamine</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serotonin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Nitric
oxide</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Platelet-activating
factor</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Infection
can be defined as invasion of a pathogen that triggers an immune response.
Manifestations of infection are protean and are due as much to our immune
response as to the attributes of the particular pathogen. The inflammatory
response that accompanies infection is usually marked by fever. </span></p>

<p><span></span></p>

<p><span>Fever is
an elevation in body temperature above the normal range in response to a
central nervous system change in the set point. Normal oral temperature ranges
from 36.0 to 37.7° C, with a circadian variation of 1° C or more between the
morning nadir and the evening peak. Mean oral temperature in healthy adults is
36.8 ± 0.4° C, with women exhibiting slightly higher values than men. Rectal
temperatures are 0.4° C higher than oral and 0.8° C higher than aural (tympanic
membrane) temperatures. Clinicians generally define significant fever as a
temperature higher than 38.3° C (101.0° F). </span></p>

<p><span></span></p>

<p><span>The vast
majority of acute febrile illnesses lasting less than two weeks have an
infectious cause. These infections occur predominantly where body surfaces
interact with the environment, such as the upper and lower respiratory tracts,
gastrointestinal and genitourinary systems, and skin. The majority of acute
respiratory and gastrointestinal infections are viral in nature. As the duration
of the febrile illness lengthens beyond three weeks, other inflammatory
illnesses become more prominent in the differential diagnosis. Most chronic
febrile illnesses are not caused by infection.</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4377-1604-7..00288-8--s001></a><a
name=4-u1.0-B978-1-4377-1604-7..00288-8--st00></a><span>Infection ensues when a pathogen overcomes both
nonspecific innate and specific adaptive humoral and cellular immune responses.
The normal indigenous microflora, host physical barriers (e.g., skin, mucous
membranes, cilia), and soluble factors (e.g., cytokines, complement) provide
important barricades to pathogen invasion. Disruption of these barriers, which
provide a first line of defense, permits the invasion of pathogens. </span></p>

<p><span></span></p>

<p><span>The acute
phase response triggered by such disruption provides direct antimicrobial
activity and prompts the development of adaptive immunity mediated by
lymphocytes and macrophages. This inflammatory response plays an important role
in containing infection. Unfortunately, an exaggerated response may worsen the
clinical condition. </span></p>

<p><span></span></p>

<p><span>Body
temperature is regulated both physiologically and behaviorally. Basal metabolic
processes, governed especially by thyroid hormones but also by catecholamines
and growth hormone, are responsible for the normal resting body temperature.
Thermogenesis may be increased up to 80% by hyperthyroidism and decreased as
much as 50% by hypothyroidism. Moderate activity increases thermogenesis and
results in a transiently increased temperature until heat-dissipating processes
are engaged.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
hypothalamus contains temperature-sensitive neurons that have receptors for
pro-inflammatory and anti-inflammatory cytokines, which are continuously
balanced to maintain a homeothermic set point. When body temperature becomes
elevated, cutaneous vasodilation and sweating occur, and people may reduce
activity and seek a cooler environment. In contrast, low body temperature is
increased by shivering, piloerection, cutaneous vasoconstriction, adding
clothes, and seeking a warmer environment. </span></p>

<p><span>In febrile
illness, symptoms are often due to the fever itself. Malaise is the rule, and many
febrile patients experience myalgia secondary to muscle contractions used to
raise temperature. The chill associated with rigors may be related to surface
vasoconstriction that accompanies the increase in core temperature. The body’s
thermoregulatory mechanisms rarely allow fevers to exceed 41° C (106° F).
Temperatures exceeding 41° C are often due to a drug-induced imbalance in these
mechanisms and may cause direct cellular damage. </span></p>

<p><span></span></p>

<p><span>Fever is a
complex physiologic process involving metabolic and immunologic responses.
Bacteria release cell wall products such as peptidoglycans and endotoxin, as
well as enterotoxins, which bind to Toll-like receptors (TLRs) on phagocytes
(neutrophils, macrophages) and endothelial cells. As a result, pyrogenic
cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor
(TNF)-&#945; are released into the circulation and bind to cytokine receptors
in the hypothalamus. This stimulates the brain to produce prostaglandin E<sub>2</sub>
(PGE<sub>2</sub>) and cyclic adenosine monophosphate (cAMP), which trigger
neurons in the thermoregulatory center to raise the hypothalamic thermostatic
set point. In addition, neuronal signals to the cortex prompt behavioral
changes to conserve heat (e.g., shivering, adding clothing). The hypothalamus
also triggers sympathetic peripheral efferent nerves that constrict peripheral
blood vessels and conserve central heat.</span></p>

<p><a name=4-u1.0-B978-1-4377-1604-7..00288-8--f001></a><span></span></p>

<p><span>Leukocytosis
often occurs in response to infection. Neutrophilia is the norm in most acute
infections, whatever the cause. Neutropenia may be seen in rickettsial, severe
viral and overwhelming bacterial infections. Eosinophilia is typical of
invasive helminthic and some protozoal infections. Lymphocytosis may accompany
many viral and rickettsial infections and is common during convalescence from
acute bacterial infection. Monocytosis may be seen in tuberculosis. Virtually
all infections have an impact on the erythroid system, but given the long
half-life of erythrocytes, usually only chronic infections or other
inflammatory diseases result in anemia. Few acute infections produce anemia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>A pyrogen is a substance
that causes fever. Exogenous pyrogens are usually microbes or their products.
The best studied exogenous pyrogens are the lipopolysaccharides of
gram-negative bacteria (commonly called endotoxins) and <i>Staphylococcus aureus</i> toxin, which causes toxic shock syndrome.
Exogenous pyrogens usually cause fever by inducing release of endogenous
pyrogens. The principal endogenous pyrogens are interlekin-1, interleukin-6,
and tumor necrosis factor-&#945;. They stimulate production of Prostaglandin E2,
which plays a critical role in adjusting the hypothalamic set point. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.<span>&nbsp; </span></span></b><span>Histamine is a vasoactive amine released by mast
cells upon activation and promotes inflammation by altering permeability of the
endothelium.<span >&nbsp; </span>It is responsible for
many of the symptoms associated with allergies.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.<span>&nbsp; </span></span></b><span>Serotonin (5-hydroxytryptamine) is a monoamine
neurotransmitter found in the gastrointestinal tract and the CNS.<span>&nbsp; </span>It affects intestinal movements, mood,
appetite, sleep, muscle contraction, hemostasis, and blood clotting.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect.<span>&nbsp; </span></span></b><span>Nitric oxide (NO) is produced from arginine by
three forms of nitric oxide synthase, depending on the cell type.<span>&nbsp; </span>Inside of a phagocyte, NO is
microbicidal but NO also mediates vasodilation.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.<span>&nbsp; </span></span></b><span>Platelet-activating factor (PAF) is a
phospholipid mediator released by platelets, endothelial cells, neutrophils,
monocytes, and macrophages.<span >&nbsp; </span>PAF is
proinflammatory in that it attracts leukocytes, amplifies production of lipid
mediators and activates neutrophils, eosinophils, and platelets.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A healthy
42-year old man travels to California. Six weeks later, he develops fever,
cough, pleuritic chest pain, sore muscles, and left knee swelling. Red tender
nodules appear on his shins. A chest x-ray shows a left pleural effusion. Which
of the following conditions is most likely? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Coccidioidomycosis
</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Histoplasmosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Blastomycosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Aspergillosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cryptococcosis</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mucormycosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Fungal
pathogens can be classified as endemic or opportunistic. Endemic pathogens,
which occur in specific geographic areas, can cause disease in immunocompetent
individuals. Opportunistic pathogens, which are ubiquitous, cause disease in
immunocompromised hosts. In the proper setting, all can cause pneumonia and
other respiratory diseases. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=338 colspan=3 valign=top>
  <p style="text-align:center;"><span>Fungal Pathogens</span></p>
  </td>
 </tr>
 <tr>
  <td width=338 colspan=3 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=77 rowspan=3 valign=top>
  <p><span>Endemic</span></p>
  </td>
  <td width=109 valign=top>
  <p><span>Coccidioidomycosis<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Southwestern
  U.S. </span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Histoplasmosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Mississippi
  and Ohio Rivers</span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Blastomycosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Mississippi
  and Ohio Rivers</span></p>
  </td>
 </tr>
 <tr>
  <td width=338 colspan=3 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=77 rowspan=4 valign=top>
  <p><span>Opportunistic</span></p>
  </td>
  <td width=109 valign=top>
  <p><span>Candidiasis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Ubiquitous</span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Aspergillosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Ubiquitous</span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Mucormycosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Ubiquitous</span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Cryptococcosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Ubiquitous</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span>Risk
factors for endemic pathogens include travel to endemic regions and exposure to
bird, bat, or rodent droppings. Risk factors for opportunistic pathogens
include immunocompromised states, such as HIV infection, immunosuppressive
therapy, and oncologic therapy. Symptoms of fungal lung infection include
fever, cough, chest pain, and shortness of breath. </span></p>

<p><span></span></p>

<p><span>Endemic
mycoses are prone to causing rheumatologic symptoms, such as pericarditis,
pleuritis, arthritis, and rash (e.g., erythema multiforme and erythema
nodosum.)(See images below.) Lymphadenopathy is common and may result in large
airway obstruction (pressure effect). In a minority of patients, fungemia leads
to disseminated disease.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Erythema nodosum: red, tender nodules, usually on the shins </span></p>

<p style="text-align:center;"><span>.</span></p>

<p style="text-align:center;"><span><img border=0 width=377 height=248
src="_%20Tutorials_files/image198.png" alt="Description: erythem nodosum"
v:shapes="Picture_x0020_347228"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Erythema multiforme: “target lesions”</span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/6/68/EMminor09.JPG"><span><img border=0 width=362 height=272
src="_%20Tutorials_files/image200.png" alt="Description: File:EMminor09.JPG"
v:shapes="Picture_x0020_347227"></span></a><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. This patient has both
respiratory and rheumatologic symptoms. Endemic mycoses can produce
rheumatologic symptoms, such as pleuritis, arthritis, and erythema nodosum (red
tender nodules on the shins). This patient most likely has coccidioidomycosis
(also known as California disease, desert rheumatism, San Joaquin Valley fever,
and Valley fever) given his recent travel to California. <i>Coccidioides immitis</i> appears in tissue as a spherule with
endospores.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Histoplasmosis is an
endemic mycosis of the Mississippi and Ohio River Valleys. <i>Histoplasma capsulatum</i> appears in tissue (often macrophages) as
intracellular yeasts.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Blastomycosis is an
endemic mycosis of the Mississippi and Ohio River Valleys. <i>Blastomyces dermatitidis</i> appears in tissue as broad-based budding
yeasts.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Aspergillosis affects
mainly immunocompromised individuals. <i>Aspergillus
sp. </i>appears in tissue as branching, septate hyphae.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Cryptococcus is best
known for causing meningitis in patients with AIDS. <i>Cryptococcus neoformans</i> appears in tissue as encapsulated yeast.</span></p>

<p><span></span></p>

<p><b><span>Answer F is incorrect</span></b><span>. Mucormycosis occurs in
immunocompromised hosts, especially those with diabetes. The most common sites
of infection are sinus, brain, and lung. <i>Mucor
spp.</i> appears in tissue as coenocytic hyphae branching with wide angles.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 40-year
old man with AIDS is started on highly active antiretroviral therapy (HAART).
He subsequently notices increased abdominal fat, thinning of the arms and legs,
prominence of the superficial veins, and a “hallowing out” of the face. These
changes are probably caused by a medicine in which of the following classes? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Protease
inhibitor</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleoside
analog reverse transcriptase inhibitor (NARTI)</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleotide
analog reverse transcriptase inhibitor (NtARTI)</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Non-nucleoside
reverse transcriptase inhibitor (NNRTI)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fusion
inhibitor</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Antiretroviral drugs</span> are medications for the treatment of
infection by retroviruses, primarily HIV. When several such drugs, typically
three or four, are taken in combination, the approach is known as <span>Highly Active Antiretroviral Therapy</span>,
or <span>HAART</span>. The National
Institutes of Health and other organizations recommend offering antiretroviral
treatment to all patients with AIDS. Because of the complexity of selecting and
following a regimen, the severity of the side-effects, and the importance of
compliance to prevent viral resistance, such organizations emphasize the
importance of involving patients in therapy choices, and recommend analyzing
the risks and the potential benefits to patients with low viral loads.<b></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. Protease inhibitors
can cause a redistribution of fat. This may result in truncal obesity, thinning
of the arms and legs, prominence of the superficial veins, and a “hallowed out”
face. The following drugs are protease inhibitors: saquinavir, ritonavir, indinavir,
nelfinavir, and amprenavir.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect. </span></b><span>Some nucleoside analog
reverse transcriptase inhibitors (NARTIs) can cause anemia, bone marrow
suppression, pancreatitis, peripheral neuropathy, and gastrointestinal
disturbance. The following drugs are NARTIs: zidovudine,&nbsp;didanosine,
zalcitabine, stravudine, lamivudine, abacavir, emtricitabine, entecavir, and
apricitabine.&nbsp;</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><span>Nucleotide analog
reverse transcriptase inhibitors (NtARTIs) can cause gastrointestinal
disturbance. Tenofovir is an NtARTI.<span >&nbsp;&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>Some non-nucleoside
reverse transcriptase inhibitors (NNRTIs) can cause hepatitis and rash. The
following drugs are NNRTIs: efavirenz, nevirapine, delavirdine, etravirine,
rilpivirine&nbsp;<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect</span></b><span>. The fusion inhibitor,
infuvirtide, can cause a reaction at the injection site. This drug is not
recommended for HAART.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 60-year-old
woman has never been vaccinated for hepatitis B. Her serological tests show the
following:</span></p>

<p><span></span></p>

<p>HBsAg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p>HBeAg <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p>HBcAb IgM<span>&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p>HBcAb IgG<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>positive</span></p>

<p>HBsAb<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>positive</span></p>

<p><span></span></p>

<p><span>Which is
correct?</span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B but was not infected.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B and is in the acute disease phase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B and is in the “window” phase<span>&nbsp; </span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B and is chronically infected</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B and has recovered</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hepatitis
B Serology</span></p>

<p><span></span></p>

<p><span>What do
the different Hepatitis B serologic markers mean?</span></p>

<p><span></span></p>

<p><span>Hepatitis B surface antigen (HBsAg): </span><span>A protein on the surface of HBV; it can be
detected in high levels in serum during acute or chronic HBV infection. The
presence of HBsAg indicates that the person is infectious. The body normally
produces antibodies to HBsAg as part of the normal immune response to
infection. HBsAg is the antigen used to make Hepatitis B vaccine. </span></p>

<p><span></span></p>

<p><span>Hepatitis B surface antibody (anti-HBs): </span><span>The presence of anti-HBs indicates
recovery and immunity from HBV infection. Anti-HBs develop in people who have
been successfully vaccinated against Hepatitis B. </span></p>

<p><span></span></p>

<p><span>Total Hepatitis B core antibody (anti-HBc): </span><span>Appears at the onset of
symptoms in acute Hepatitis B and persists for life. The presence of anti-HBc
indicates previous or ongoing infection with HBV in an undefined time frame.</span></p>

<p><span></span></p>

<p><span>IgM antibody to Hepatitis B core antigen (IgM anti-HBc):</span><span> Indicates recent
infection with HBV (≤6 months). Its presence indicates acute infection. </span></p>

<p><span></span></p>

<p><span>Hepatitis B e antigen (HBeAg):</span><span> A secreted product of the nucleocapsid gene of
HBV that is found in serum during acute and chronic Hepatitis B. Its presence
indicates that the virus is replicating and the infected person has high levels
of HBV. </span></p>

<p><span></span></p>

<p><span>Hepatitis B e antibody (HBeAb or anti-HBe):</span><span> Produced by the immune system
temporarily during acute HBV infection or consistently during or after a burst
in viral replication. </span></p>

<p><span></span></p>

<p><span>Spontaneous
conversion from e antigen to e antibody (a change known as seroconversion) is a
predictor of long-term clearance of HBV in patients undergoing antiviral
therapy and indicates lower levels of HBV. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>How to interpret Hepatitis B serologic test results</span></p>

<p><span></span></p>

<p><span>The
following table provides interpretations for Hepatitis B serologic markers. </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 width="95%">
 <thead>
  <tr>
   <td colspan=3 valign=top>
   <p style="text-align:center;"><b><span>Interpretation of Hepatitis B
   Serologic Test Results</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width=102>
  <p style="text-align:center;"><b><span>Tests</span></b></p>
  </td>
  <td width=106>
  <p style="text-align:center;"><b><span>Results</span></b></p>
  </td>
  <td width=249>
  <p style="text-align:center;"><b><span>Interpretation</span></b></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>negative<br>
  negative<br>
  negative</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Susceptible</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>negative<br>
  positive<br>
  positive</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Immune due to natural infection</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>negative<br>
  negative<br>
  positive</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Immune due to Hepatitis B vaccination</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  IgM anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>positive<br>
  positive<br>
  positive<br>
  negative</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Acutely infected </span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  IgM anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>positive<br>
  positive<br>
  negative<br>
  negative</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Chronically infected</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>negative<br>
  positive<br>
  negative</span></p>
  </td>
  <td>
  <p><span>Interpretation
  unclear; four possibilities: </span></p>
  <p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>&nbsp;Resolved infection (most common) </span></p>
  <p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>False-positive anti-HBc, thus susceptible </span></p>
  <p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>&quot;Low level&quot; chronic infection </span></p>
  <p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Resolving acute infection </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=306 height=205
src="_%20Tutorials_files/image202.png"
alt="Description: http://pathmicro.med.sc.edu/virol/hepb-cd1.gif" v:shapes="Picture_x0020_347226"></span><span></span></p>

<p style="text-align:center;"><span><img border=0 width=306 height=205
src="_%20Tutorials_files/image204.png"
alt="Description: http://pathmicro.med.sc.edu/virol/hepb-cd2.gif" v:shapes="Picture_x0020_347225"></span></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span>Answer E is correct</span></b><span>. The presence of HBcAb IgG and HBsAb
indicates that she has been exposed to hepatitis B and has produced antibodies
conferring immunity. </span></p>

<p></span></p>

<p><span>Answer A is incorrect</span></b><span>. The presence of HBcAb IgG and HBsAb
indicates previous infection with hepatitis B.</span></p>

<p></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. In the acute phase of
disease, hepatitis B surface antigen (HBsAg) is positive and hepatitis B
surface antibody (HBsAb) is negative.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect</span></b><span>. In the serological
“window,” hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody
(HBsAb) are negative, while IgM hepatitis B core antibody (IgM HBcAb) is
positive.<span >&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. In chronic infection,
hepatitis B surface antigen (HBsAg) is positive and hepatitis B surface
antibody (HBsAb) is negative. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
41-year-old woman develops high spiking fevers and chills a week after
returning from central Africa. Which of the following tests on the patient’s
blood will most likely establish the diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Gram
stain</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Giemsa
stain</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Silver
stain</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Acid-fast
stain</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>KOH
stain</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>India
ink stain</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The <b>Gram</b> stain is the most
commonly used stain in microbiology. Bacteria are categorized as gram-positive
or gram-negative based on their ability to take up the stain. Those with large
amounts of peptidoglycan in their cell walls retain methyl (or crystal) violet and
are called gram-positive. Those with walls composed mainly of lipids and
lipopolysaccharides do not retain methyl (or crystal) violet and are called
gram-negative. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=424 height=186
src="_%20Tutorials_files/image206.png"
alt="Description: Gram Positive and Gram Negative Bacteria" v:shapes="Picture_x0020_347224"></span><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp; </span>Gram-positive
Staphylococcus<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Gram-negative E. Coli</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The <b>Giemsa</b> stain is the principal
stain used in the diagnosis of malaria. It is an effective stain for detecting
protozoa, such as trichomonas, cryptosporidium, giardia, toxoplasma, and
leishmania. It is also effective for <i>Helicobacter pylori </i>and for bacteria
that lack peptidoglycan cell walls (e.g., rickettsia, chlamydia). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=235 height=160
src="_%20Tutorials_files/image208.png" alt="Description: 070525090316-large"
v:shapes="Picture_x0020_347223"></span><span></span></p>

<p style="text-align:center;"><span>Malaria:
Giemsa stain</span></p>

<p><span></span></p>

<p><b><span>Silver</span></b><span> stains are primarily
used when Gram and Giemsa stains are ineffective. Because silver stains are
laborious to implement, they are usually reserved for cases in which the
suspected pathogen is a spirochete, legionella, bartonella, or <i>H. pylori.</i></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=310 height=216
src="_%20Tutorials_files/image210.png" alt="Description: T" v:shapes="Picture_x0020_347222"></span><span></span></p>

<p style="text-align:center;"><span>Syphilis:
Silver stain<span></span></span></p>

<p><i><span></span></i></p>

<p><b><span>Acid-fast</span></b><span> stains are primarily
used for mycobacteria, such as <i>Mycobacterium tuberculosis</i>. These
bacteria have thick, waxy cell walls, which contain large amounts of a lipid
called mycolic acid. Mycolic acid resists staining and decolorization by
acid-alcohol (hence, the term “acid-fast”).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=304 height=196
src="_%20Tutorials_files/image212.png"
alt="Description: M tuberculosis acid fast" v:shapes="Picture_x0020_347221"></span><span></span></p>

<p style="text-align:center;"><span>Tuberculosis:
Acid-fast stain</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The <b>KOH</b> (potassium hydroxide)
stain is commonly used to diagnose fungal infections of the skin and nails. The
stain dissolves debris, allowing the fungal hyphae to be visualized.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=271 height=198
src="_%20Tutorials_files/image214.png" alt="Description: Fungus" v:shapes="Picture_x0020_347220"></span><span></span></p>

<p style="text-align:center;"><span>Dermatophyte:
KOH</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>India Ink</span></b><span> can be used to
visualize the capsule of <i>Cryptococcus neoformans</i>. By staining the
background, the capsule becomes visible.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=273 height=184
src="_%20Tutorials_files/image216.png"
alt="Description: 180px-Cryptococcus_neoformans_using_a_light_India_ink_staining_preparation_PHIL_3771_lores"
v:shapes="Picture_x0020_347219"></span><span></span></p>

<p style="text-align:center;"><span>Cryptococcus:
India ink</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer
B is correct.</span></b><span><span>&nbsp; </span>Spiking fevers and chills in a patient
who has visited central Africa is suggestive of malaria. The diagnosis can be made
by detecting the parasite (Plasmodium) on a Giemsa-stained blood smear.<span>&nbsp; </span><b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year
old man had unprotected anal intercourse with a male prostitute seven days ago.
He is asymptomatic but worried that he may have acquired HIV. He underwent HIV
testing 3 and 6 months ago. Both tests were negative. Which of the following
provides the earliest evidence of HIV infection?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>CD4
cell count</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Western
blot assay</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>RNA
polymerase chain reaction (PCR)</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Enzyme-linked
immunosorbent assay (ELISA)</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=376 height=263
src="_%20Tutorials_files/image218.png" alt="Description: HIV_Virion-en-2"
v:shapes="Picture_x0020_347218"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p>HIV is a retrovirus. A <span>retrovirus</span> is an RNA virus that is
duplicated in a host cell using the reverse transcriptase enzyme to produce DNA
from its RNA genome. The DNA is then incorporated into the host cell’s genome
by an integrase enzyme. This allows the virus to replicate as part of the host
cell’s DNA. HIV is composed of two copies of single-stranded RNA, which is
bound to reverse transcriptase, integrase, and proteins that protect the RNA
from nucleases. The RNA is enclosed by a capsid, or protein shell. The capsid
is surrounded by a matrix, which ensures the integrity of the virion. The
matrix, in turn, is surrounded by an envelope, which is comprised of plasma
membrane from the host cell and viral glycoproteins.</p>

<p></p>

<p><span>HIV
is most commonly diagnosed by testing blood or saliva for antibodies to the
virus. Antibody tests include Western blot assay and ELISA (enzyme-linked
immunosorbent assay). These tests are not accurate immediately after infection
because up to 12 weeks are needed to form antibodies to the virus. In rare
cases, six months may elapse before antibodies are detected. By contrast,
nucleic acid-based tests (NAT) allow HIV to be detected as early as four days
following infection. A commonly used NAT employs the polymerase chain reaction
to amplify viral RNA. </span></p>

<p><span><span>&nbsp;</span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. The polymerase chain
reaction can be used to amplify viral RNA, allowing HIV to be detected as early
as four days following infection.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. The CD4 count is
neither sensitive nor specific for early diagnosis of acute HIV infection. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. The Western blot assay
is used to detect antibodies to HIV. These antibodies usually appear 3-4 weeks
after infection.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. The enzyme-linked
immunosorbent assay (ELISA) is used to detect antibodies to HIV. These
antibodies usually appear 3-4 weeks after infection. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
22-year-old man receives the tetanus vaccine. Six hours later, he has pain and
massive swelling at the site of injection. The following day, the skin breaks
down, forming an ulcer at the site. Which of the following events plays a
critical role in this reaction?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Local
release of histamine</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Predominant
synthesis of IgM antibodies</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Local
fixation of complement by preformed circulating antibodies</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Antigen
capture by Langerhans cells in the epidermis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Accumulation
of mononuclear cells at the site of injection</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypersensitivity
refers to excessive and undesirable reactions produced by the normal immune
system. Hypersensitivity reactions require a pre-sensitized (immune) host
state. They are divided into four types based on mechanism and time taken for
the reaction. A particular clinical condition may involve more than one type of
reaction.</span></p>

<p><span>&nbsp;</span></p>

<p><b><span>Type I Hypersensitivity</span></b></p>

<p><b><span></span></b></p>

<p><span>Type I
hypersensitivity is known as immediate or anaphylactic hypersensitivity. The
reaction may involve skin (urticaria and eczema), eyes (conjunctivitis),
nasopharynx (rhinitis), bronchopulmonary tissues (asthma), or gastrointestinal
tract (gastroenteritis). Reactions range from minor to deadly, and typically
occur 15-30 minutes after antigen exposure. </span></p>

<p><span></span></p>

<p><span>Immediate
hypersensitivity is mediated by<b> </b>IgE. The primary cellular component is
the mast cell or basophil. The reaction is amplified by neutrophils,
eosinophils, and platelets. Biopsy of affected tissue demonstrates mainly<b> </b>mast
cells and eosinophils. IgE is produced in response to certain allergens. It has
a very high affinity for receptor on mast cells and basophils. Subsequent
exposure to the same allergen cross-links the cell-bound IgE and triggers mast
cell degranulation. </span></p>

<p><span></span></p>

<p><span>Mast cells
can be triggered by other stimuli, such as exercise, emotional stress,
chemicals, and anaphylotoxins (<i>e.g.</i>, C4a, C3a, C5a, <i>etc.</i>). These
non-IgE-mediated reactions are not hypersensitivity reactions, although they
produce similar symptoms.</span></p>

<p><span></span></p>

<p><span>Diagnostic
tests for immediate hypersensitivity include skin tests, measurement of total
IgE, and measurement of specific IgE to a suspected allergen. Total IgE and
specific IgE are measured by enzyme immunoassay (ELISA). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Type II Hypersensitivity</span></b></p>

<p><span></span></p>

<p><span>Type II
hypersensitivity is known as cytotoxic hypersensitivity. It is primarily
mediated by complement and antibodies of the IgM or IgG class. Triggering
antigens are usually endogenous, although some exogenous antigens can attach to
cells and cause type II hypersensitivity. Drug-induced hemolytic anemia,
Goodpasture’s syndrome, and pemphigus are examples of type II hypersensitivity.
The reaction occurs minutes to hours after antigenic exposure. </span></p>

<p><span></span></p>

<p><span>Diagnosis
involves detection of antibodies against affected tissue. These antibodies may
be circulating or may be found in biopsied tissue by immunofluorescent
staining. The staining pattern is smooth and linear. Treatment often involves
anti-inflammatory or immunosuppressive agents.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Type III Hypersensitivity</span></b><span></span></p>

<p><span></span></p>

<p><span>Type III
hypersensitivity is known as immune complex hypersensitivity. The reaction may
be general (<span>e.g.</span>, serum
sickness) or may involve an individual organ, such as the skin (systemic lupus
erythematosus, Arthus reaction), kidneys (lupus nephritis), lungs (aspergillosis),
blood vessels (polyarteritis), or joints (rheumatoid arthritis). Many
microorganisms elicit a type III hypersensitivity reaction.</span></p>

<p><span></span></p>

<p><span>The
reaction, which occurs 3-10 hours after exposure to an antigen, is mediated by
soluble immune complexes, usually of the IgG class, sometimes of the IgM class.
The antigen may be exogenous (chronic bacterial, viral, or parasitic infection)
or endogenous (systemic lupus erythematosus). The antigen is soluble and not
attached to the involved organ. Lesions are composed of soluble immune
complexes and complement. Damage is wrought by neutrophils and platelets. </span></p>

<p><span></span></p>

<p><span>Diagnosis
involves detection of immune complexes in the serum or biopsied tissue. The
immunofluorescent pattern is “granular” (as opposed to the “linear” pattern of
type II hypersensitivity). Serum complement levels are depleted. Treatment
includes anti-inflammatory and immunosuppressive agents.</span></p>

<p><span></span></p>

<p><b><span>Type IV Hypersensitivity</span></b></p>

<p><b><span></span></b></p>

<p><span>Type IV
hypersensitivity is known as cell-mediated or delayed-type hypersensitivity.
The classical example is the tuberculin (Montoux) reaction, which peaks 48
hours after injection of antigen and is characterized by erythema and
induration.&nbsp; </span></p>

<p><span>&nbsp;</span></p>

<p><span>Type IV
hypersensitivity occurs in many infectious diseases (e.g., tuberculosis,
leprosy, blastomycosis, histoplasmosis, toxoplasmosis, leishmaniasis).
Granulomas are a product of type IV hypersensitivity. Contact dermatitis due to
poison ivy, chemicals, and heavy metals is another example of delayed
hypersensitivity. &nbsp;</span></p>

<p><span></span></p>

<p><span>Damage is
wrought by T lymphocytes and monocytes or macrophages. Cytotoxic T cells cause
direct damage; helper T cells secrete cytokines, which activate cytotoxic T
cells and recruit monocytes and macrophages. Corticosteroids and other
immunosuppressive agents are used in treatment.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span>Hypersensitivity Reactions</span></b></p>

<p style="text-align:center;"><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p><b><span>Type of Reaction</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Prototypic
   Disorder</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Immune
   Mechanisms</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Pathologic
   Lesions</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td valign=top>
  <p><b><span>Immediate
  (type I) hypersensitivity</span></b><span></span></p>
  </td>
  <td valign=top>
  <p><span>Anaphylaxis<sup>1</sup>,
  </span></p>
  <p><span>Allergic
  rhinitis, </span></p>
  <p><span>Bronchial
  asthma (atopic forms)</span></p>
  </td>
  <td valign=top>
  <p><span>Production
  of IgE antibody; immediate release of vasoactive amines and other mediators
  from mast cells; later recruitment of inflammatory cells</span></p>
  </td>
  <td valign=top>
  <p><span>Vascular
  dilation, edema, smooth muscle contraction, mucus production, tissue injury,
  inflammation</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Antibody-mediated
  (type II) hypersensitivity</span></b><span></span></p>
  </td>
  <td valign=top>
  <p><span>Autoimmune
  hemolytic anemia,</span></p>
  <p><span>Goodpasture
  syndrome</span></p>
  </td>
  <td valign=top>
  <p><span>IgG, IgM
  binding to antigen on target cell or tissue; complement activation; lysis or
  phagocytosis of target cell; recruitment of leukocytes</span></p>
  </td>
  <td valign=top>
  <p><span>Phagocytosis
  and lysis of cells; inflammation</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Immune
  complex&#8211;mediated (type III) hypersensitivity</span></b><span></span></p>
  </td>
  <td valign=top>
  <p><span>Systemic
  lupus erythematosus,</span></p>
  <p><span>Glomerulonephritis
  (some types), </span></p>
  <p><span>Serum
  sickness<sup>2</sup>, Arthus reaction<sup>3</sup></span></p>
  </td>
  <td valign=top>
  <p><span>Deposition
  of antigen-antibody complexes;<span >&nbsp;
  </span>complement activation; recruitment of leukocytes; release of enzymes
  and other toxic molecules</span></p>
  </td>
  <td valign=top>
  <p><span>Inflammation,
  necrotizing vasculitis (fibrinoid necrosis)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Cell-mediated
  (type IV) hypersensitivity</span></b><span></span></p>
  </td>
  <td valign=top>
  <p><span>Contact
  dermatitis, Multiple sclerosis, </span></p>
  <p><span>Type I
  diabetes, Rheumatoid arthritis, Inflammatory bowel disease </span></p>
  <p><span>Tuberculosis</span></p>
  </td>
  <td valign=top>
  <p><span>Cytokine
  release by activated T cells; inflammation and macrophage activation; T-cell
  mediated cytotoxicity</span></p>
  </td>
  <td valign=top>
  <p><span>Perivascular
  cellular infiltrates; edema; granuloma formation; cell destruction</span></p>
  </td>
 </tr>
</table>

<p></p>

<p><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>Anaphylaxis</b>
is an acute, multi-system, severe, type I hypersensitivity reaction caused by
IgE-mediated degranulation of mast cells and basophils. Symptoms develop over
minutes to hours and can include hypotension; swelling of the lips, tongue and
throat; cardiac ischemia; stridor; wheezing; shortness of breath; abdominal
pain; vomiting; diarrhea; flushing; hives; and loss of consciousness. Common
triggers include insect bites or stings, foods, medication, and latex.
Anaphylaxis is a medical emergency that may require resuscitation measures,
such as airway management, supplemental oxygen, and intravenous fluids.<span>&nbsp; </span>Epinephrine (adrenaline) is the primary
treatment for anaphylaxis. It improves airway patency and blood pressure, and
may be life-saving.</p>

<p></p>

<p></p>

<p><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>Serum sickness</b> can develop as a result
of exposure to antibodies derived from animals. These sera are generally
administered in order to prevent or treat an infection or envenomation. When
antiserum is given, the immune system can mistake the proteins for harmful antigens.
Antibodies are produced, which combine with these proteins to form immune
complexes. Symptoms include fever, malaise, rash, arthralgia, and
lymphadenopathy. Hypotension, splenomegaly, glomerulonephritis, and proteinuria
may occur. </p>

<p></p>

<p><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>Arthus reactions</b> (type III
hypersensitivity reactions) can occur after vaccination for tetanus or
diphtheria. The reactions are characterized by local vasculitis, immune complex
deposition, and complement activation. Immune complexes form in the setting of
high concentrations of vaccine antigen and circulating antibody. Severe pain,
swelling, induration, edema, hemorrhage, and even necrosis occur 4&#8211;12
hours after vaccination.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. The patient in the
vignette has had an Arthus reaction to the tetanus vaccine. This is a type III
hypersensitivity reaction, characterized by deposition of immune complexes and
activation of complement.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Local release of
histamine occurs in type I hypersensitivity reactions. </span></p>

<p><span><span>&nbsp;</span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. IgM binding to antigen
occurs in some type II hypersensitivity reactions. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Antigen capture by
Langerhans cells occurs in type IV hypersensitivity reactions.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Mononuclear cell
accumulation occurs in type IV hypersensitivity reactions. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
11-year-old girl is brought to the emergency department because of a 4-day
history of fever and an 8-hour history of lethargy. Her parents say that she
has been sleeping most of the day and has been unresponsive when awake. Her
temperature is 102.6<sup>o</sup>F. Physical examination shows nuchal rigidity
and numerous petechial hemorrhages. A lumbar puncture yields cloudy
cerebrospinal fluid (CSF). Microscopic examination of the CSF shows numerous
segmented neutrophils and a Gram stain shows gram-negative diplococci. Which of
the following is correct? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>She
should be placed in a private room. Hospital personnel should wear a mask.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
should be placed in a private room. Hospital personnel should wear a gown. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
should be placed in a negative-pressure room. </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>She
may be placed in a semi-private room. Hospital personnel should wear a gown.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>There are two tiers of
precautions to prevent transmission of infectious agents: standard precautions
and transmission-based precautions. Standard precautions apply to all patients,
regardless of diagnosis. Transmission-based precautions apply to patients who
may be infected or colonized with infectious agents that require additional
measures to prevent transmission. Since the infecting agent is often unknown at
the time of admission, transmission-based precautions may be applied
empirically according to the clinical syndrome or likely etiologic agent, and
then modified when the pathogen is identified or ruled out. There are three
categories of transmission-based precautions: contact, droplet, and airborne.</p>

<p><span>&nbsp;</span></p>

<p><strong>Contact Precautions.</strong>
Contact precautions reduce transmission of infectious agents spread by direct
or indirect contact with the patient. (“Indirect” contact is contact with
potentially contaminated materials.) These precautions apply to patients with
excessive wound drainage and fecal incontinence. A single-patient room is
recommended. Healthcare personnel should wear a gown and gloves. Conditions for
which contact precautions apply include certain <span>gastrointestinal
infections (e.g., C. difficile colitis), skin and wound infections (e.g.
impetigo), and colonization with multidrug-resistant organisms (e.g., MRSA).</span></p>

<p></p>

<p><strong>Droplet Precautions.
</strong><strong><span>Droplet
precautions</span></strong> <span>reduce transmission of
infectious agents released by sneezing or coughing. Large droplet sprays can
spread as far as three feet. </span>A single-patient room is recommended.
Healthcare personnel should wear a mask. <span>Conditions
for which droplet precautions apply include influenza, meningococcal
meningitis, mumps, rubella, and pertussis.</span> </p>

<p></p>

<p><strong>Airborne Precautions</strong>
<strong><span>Airborne
precautions</span></strong><span> reduce transmission of
airborne particles (i.e., particles so small that they can be suspended in the
air for long periods of time). </span>Patients should be placed in an
airborne-infection isolation room (AIIR), which is a single-patient room with
special air handling capacity (e.g., negative pressure ventilation, frequent
air exchanges, adequate exhaust system). Healthcare personnel should wear a
respirator or mask. Conditions for which airborne precautions apply include
tuberculosis, measles, and chicken pox.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct.</span></b><span> The patient has
meningitis due to <i>Neisseria meningitidis</i>
as indicated by the Gram stain (gram-negative diplococci) and the presence of
petechial hemorrhages. This condition is associated with spread by respiratory
droplets (often by sneezing or coughing). Suspected cases should be placed
under “droplet precautions.” Droplets are not generally communicable beyond
three feet; therefore, a negative-pressure room is unnecessary.
(Negative-pressure rooms are used to prevent airborne pathogens, such as <i>M. tuberculosis</i>, from escaping the room
when the door is open.) Gowns are not needed because spread occurs through the
respiratory route, not by contact.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect. </span></b><span>Gowns are used for
contact precautions, not droplet precautions. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect. </span></b><span>A negative-pressure room
is used for airborne precautions, not droplet precautions. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>A private room is
recommended for droplet precautions. A gown is not needed. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 37-year-old woman presents to the
emergency department with a fever. Chest x-ray film shows multiple patchy
infiltrates in both lungs. Echocardiography and blood cultures suggest a
diagnosis of acute bacterial endocarditis limited to the tricuspid valve. Which
of the following is the most probable etiology?&nbsp; </span></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB><span>A.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Congenital
heart disease</span></span></p>

<p><span lang=EN-GB><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Illicit
drug use</span></span></p>

<p><span lang=EN-GB><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Rheumatic
fever</span></span></p>

<p><span lang=EN-GB><span>D.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Rheumatoid
arthritis</span></span></p>

<p><span lang=EN-GB><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Systemic
lupus erythematosus</span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span>Infective
endocarditis (IE) can be clinically classified as follows: </span></p>

<p><span></span></p>

<p><b><span>Native
valve endocarditis (NVE)</span></b></p>

<p><span>The
following are the main underlying causes of NVE:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rheumatic
valvular disease - Primarily involves the mitral valve followed by the aortic
valve</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenital
heart disease - Underlying etiologies include a patent ductus arteriosus,
ventricular septal defect, tetralogy of Fallot, or any native or surgical
high-flow lesion. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mitral
valve prolapse with an associated murmur</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Degenerative
heart disease - Including calcific aortic stenosis due to a bicuspid valve,
Marfan syndrome, or syphilitic disease</span></p>

<p><span></span></p>

<p><span>Approximately
70% of infections in NVE are caused by <i>Streptococcus</i> species, including <i>S
viridans, Streptococcus bovis</i>, and enterococci. <i>Staphylococcus</i>
species cause 25% of cases and generally demonstrate a more aggressive acute
course.</span></p>

<p><span></span></p>

<p><b><span>Prosthetic
valve endocarditis (PVE)</span></b></p>

<p><span>Early PVE,
which presents shortly after surgery, has a different bacteriology and
prognosis than late PVE, which presents in a subacute fashion similar to NVE.
Infection associated with aortic valve prostheses is particularly associated
with local abscess and fistula formation, and valvular dehiscence. This may
lead to shock, heart failure, heart block, pericardial tamponade, and
peripheral emboli to the central nervous system and elsewhere. Early PVE may be
caused by a variety of pathogens, including <i>S aureus</i> and <i>S
epidermidis</i>. Late disease is most commonly caused by streptococci.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>IVDA
infective endocarditis</span></b></p>

<p><span>Diagnosis
of endocarditis in intravenous drug users can be difficult and requires a high
index of suspicion. Two thirds of patients have no previous history of heart
disease or murmur on admission. A murmur may be absent in those with tricuspid
disease, owing to the relatively small pressure gradient across this valve.
Pulmonary manifestations may be prominent in patients with tricuspid infection:
one third have pleuritic chest pain, and three quarters demonstrate chest
radiographic abnormalities. <i>S aureus</i> is the most common etiologic
organism in patients IE die to intravenous drug use.</span></p>

<p><b><span></span></b></p>

<p><b><span>Healthcare-associated
infective endocarditis</span></b></p>

<p><span>Endocarditis
may be associated with new therapeutic modalities involving intravascular
devices such as central or peripheral intravenous catheters, rhythm control
devices such as </span><span><span>pacemakers</span></span><span> and defibrillators,
hemodialysis shunts and catheters, and chemotherapeutic and hyperalimentation
lines. Thr most coomon cause of health-care associated IE is <i>S aureus.</i><span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Fungal
endocarditis</span></b></p>

<p><span>Fungal
endocarditis is found in intravenous drug users and intensive care unit
patients who receive broad-spectrum antibiotics.</span><a
href="file://localhost/javascript/showrefcontent('refrenceslayer')%3B"></a><sup><span> </span></sup><span><span>&nbsp;</span></span></p>

<p><span><span><strong><span lang=EN-GB>Answer B is correct.</span></strong><span
 lang=EN-GB> The most
probable etiology of bacterial endocarditis involving the tricuspid valve is
illicit intravenous drug use, which can introduce skin organisms into the
venous system that then attack the tricuspid valve. Staphylococcus aureus
accounts for most cases of endocarditis in intravenous drug users.</span></span><span
lang=EN-GB></span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><strong><span lang=EN-GB>Answer A is incorrect.</span></strong><span
 lang=EN-GB> The
endocarditis associated with congenital heart disease typically involves either
damaged valves or atrial or ventricular septal defects. The tricuspid valve is
not particularly vulnerable.&nbsp; </span></span></p>

<p><span lang=EN-GB></span></p>

<p><strong><span lang=EN-GB>Answer C is incorrect.</span></strong><span
 lang=EN-GB> Rheumatic
fever most commonly damages the mitral and aortic valves, and tricuspid damage
is usually less severe and seen only when the mitral and aortic valves are
heavily involved. </span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><strong><span lang=EN-GB>Answer D is incorrect.</span></strong><span
 lang=EN-GB> Rheumatoid
arthritis is not associated with bacterial endocarditis.&nbsp; </span></span></p>

<p><span lang=EN-GB></span></p>

<p><strong><span lang=EN-GB>Answer E is incorrect.</span></strong><span
 lang=EN-GB> Systemic
lupus erythematosus can produce small, aseptic vegetations on valves, but is
not associated with bacterial endocarditis.</span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span>Pandemics
of influenza type A occurred in 1918 (Spanish flu), 1957 (Asian flu), 1968
(Hong Kong flu). Which of the following best explains these pandemics? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Degradation
of nucleoprotein and involution of the lipid envelope</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Absence
of hemagglutinin </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Absence
of neuraminidase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Antigenic
drift</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Antigenic
shift</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=297 height=175
src="_%20Tutorials_files/image220.png"
alt="Description: http://www.chm.bris.ac.uk/webprojects2006/Kelly/influenzafigure1.jpg"
v:shapes="Picture_x0020_347217"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>The
influenza virus has hemagglutinin (HA) and neuraminidase (NA) molecules on its
surface. These molecules allow the virus to penetrate the host cell.<span>&nbsp; </span>Hemagglutinin, named for its ability to
agglutinate red blood cells, binds to sialic acid receptors, allowing fusion of
the virus with the host cell. Neuraminidase degrades neuraminic acid, a
component of mucin, which protects the airways. </span></p>

<p><span></span></p>

<p><span>Humans
develop immunity to a particular strain of influenza by producing antibodies to
HA and NA. A change in either of these molecules impedes recognition of the
virus by the host’s immune system. Pandemic spread can occur when two different
strains of the influenza virus infect the same cell and exchange RNA. This is
called antigenic shift. An example of this is “avian flu,” in which a human
influenza virus and an avian influenza virus infect the same porcine host and
exchange RNA, producing a new virus. </span></p>

<p><span></span></p>

<p><span>Flu
strains are named after the HA and NA molecules on their surface (e.g., H3N2).
Here’s an example of antigenic shift: An H3N2 virus and an H5N1virus infect the
same cell, exchange RNA, and produce a new virus, H3N1. H3N1 would not be
recognized by the host’s pre-existing antibodies. </span></p>

<p><span></span></p>

<p><span>Antigenic
shift differs from antigenic drift, in which minor changes in HA and NA are
caused by genetic mutations. Such mutations make the virus less antigenic to
pre-existing antibodies. The molecular changes occurring with antigenic shift
are more dramatic than those that occur with antigenic drift. Increases in
viral toxicity are usually greater with antigenic shift, though they may be
quite great with antigenic drift. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. Antigenic shift best
explains pandemics.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A scientific investigator injects an experimental animal with a newly
discovered strain of bacteria to evaluate T-lymphocyte activation. It is found
that bacterial engulfment by macrophages results in the presentation of
bacterial-derived peptide ligands to CD4+ T lymphocytes. Which of the following
cell surface molecules on the macrophage is most directly involved in the
presentation of the processed peptides?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>CD28</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Class II MHC </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Fc receptor</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Interleukin-2 receptor</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Membrane immunoglobulin</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The major histocompatibility complex</span> (<span>MHC</span>) is a large gene family that encodes MHC molecules. MHC
molecules play an important role in the immune system and autoimmunity.</p>

<p></p>

<p>Proteins are continually
synthesized and destroyed in the cell. These include normal proteins (self) and
microbial pathogens (nonself). The MHC proteins act as “signposts” that serve
to alert the immune system if foreign material is present inside a cell. They
achieve this by displaying fragmented pieces, or <i>antigens</i><span>,</span> on the host cell’s surface. These
antigens may be <i>self</i> or <i>nonself</i>. (The protein fragment is
sometimes compared to a hot dog, and the MHC protein to the bun.) The
presentation of MHC/peptide on cell surfaces allows for pathogen surveillance
by immune cells, usually T cells or natural killer (NK) cells. If T cells or NK
cells recognize an MHC/peptide combination, the cells become activated and
launch an immune response against the presented antigen. </p>

<p></p>

<p>Because MHC genes must
defend against a great variety of microbes in the environment, the MHC
molecules (coded for by the MHC genes) must be able to present a wide range of
peptides. MHC genes achieve this through several mechanisms: (1) the MHC locus
is polygenic, (2) MHC genes are highly polymorphic and numerous alleles exist,
and (3) several MHC genes are codominantly expressed.</p>

<p></p>

<p>There are two general
classes of MHC molecules: Class I and Class II. Class I MHC molecules are found
on all nucleated cells and present peptides to cytotoxic T cells. Class II MHC
molecules are found on certain immune cells, chiefly macrophages, B cells and
dendritic cells, collectively known as professional antigen-presenting cells
(APCs). These APCs specialize in the uptake of pathogens and subsequent
processing into peptide fragments within phagosomes. The Class II MHC molecules
on APCs present these fragments to helper T cells, which stimulate an immune
reaction from other cells.</p>

<p></p>

<p><span>There are
two classical pathways by which proteins can be processed and displayed.</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Phagocytic cells such as
macrophages and immature dendritic cells engulf pathogens in a process known as
phagocytosis. Pathogen-containing endosomes then fuse with lysosomes and
mediate their destruction. Degraded particles are then loaded onto MHC Class II
molecules and trafficked to the cell surface. </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>All nucleated cells can
also present cytosolic peptides on their class I MHC. This pathway is
particularly important during infection by a bacterium or virus, or if the cell
is cancerous. In a normal cell, class I MHC continually present self-peptides
derived from basal protein turnover and defective ribosomal products. However,
during a viral infection or tumor development, peptides loaded onto class I MHC
will include those of processed pathogens degraded in the proteasome.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. Class II MHC molecules
are found on certain immune cells, chiefly macrophages, B cells, and dendritic
cells, collectively known as professional antigen-presenting cells (APCs).
These APCs specialize in the uptake of pathogens and subsequent processing into
peptide fragments within phagosomes. The Class II MHC molecules on APCs present
these fragments to helper T cells (CD4+ lymphocytes).</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.<span>&nbsp; </span></span></b><span>CD28 is a molecule on the surface of T cells
that recognizes B7-1 (CD80) and B7-2 (CD86) on professional antigen presenting
cells.<span >&nbsp; </span>This interaction is the
“second” signal required for T cell activation.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>Fc receptors are expressed on a wide
range of cells and serve to recognize the Fc portion of an immunoglobulin
molecule.<span >&nbsp; </span>Thus, Fc receptors for
IgG are designated Fc&#61543; and so on.<span >&nbsp;
</span>These receptors facilitate the effector function of the different
classes of antibodies.<span >&nbsp; </span>For example,
macrophages and neutrophils express Fc&#61543; receptors and bind to IgG-coated
pathogens to facilitate phagocytosis.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect.</span></b><span><span>&nbsp; </span>The IL-2 receptor on resting T cells is
composed of 2 subunits, alpha and beta.<span >&nbsp;
</span>Following activation of T cells, the &#945; subunit (CD25) is expressed
resulting in a high-affinity receptor for IL-2.<span>&nbsp; </span>IL-2 serves as an autocrine growth
factor to stimulate proliferation of T cells in response to activation signals.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>Membrane immunoglobulins are integral
proteins on B cell surfaces that bind foreign antigens and are critically
involved in the regulation of the immune response.<span>&nbsp; </span>Naïve B cells express membrane-bound IgM
and IgD.<span >&nbsp; </span>Plasmablasts express high
levels whereas plasma cells express low levels of membrane
immunoglobulins.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Malaria
can be caused by any of four major species of Plasmodium. Which species causes
cerebral malaria? Which species have a dormant phase in the liver? And which
species produces the longest interval between febrile episodes?</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=90 valign=top>
  <p><span>Cerebral
  malaria</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Dormant
  phase in liver</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Longest
  interval between febrile episodes</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=90 valign=top>
  <p><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>A.</span></p>
  </td>
  <td width=90 valign=top>
  <p><i><span>P.
  falciparum</span></i><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><i><span>P.
  vivax, P. ovale</span></i><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><i><span>P.
  malariae</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>B.</span></p>
  </td>
  <td width=90 valign=top>
  <p><i><span>P.
  malariae</span></i><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><i><span>P.
  falciparum, P. vivax</span></i><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><i><span>P.
  ovale</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>C.</span></p>
  </td>
  <td width=90 valign=top>
  <p><i><span>P.
  ovale</span></i><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><i><span>P. malariae,</span></i><span> <i>P. falciparum</i></span></p>
  </td>
  <td width=135 valign=top>
  <p><i><span>P.
  vivax</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>D.</span></p>
  </td>
  <td width=90 valign=top>
  <p><i><span>P.
  vivax</span></i><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><i><span>P.
  ovale, P. malariae</span></i><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><i><span>P.
  falciparum</span></i><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span>&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Malaria is
caused by parasites of the genus Plasmodium. Four major species can infect
humans: <i>P. falciparum</i><span>, <i>P.
vivax</i></span>, <i>P. ovale</i><span>,</span>
and <i>P. malariae</i><span>. <i>P.
falciparum</i> is the most deadly; <i>P. vivax</i></span>, <i>P.</i> <i>ovale</i> and <i>P. malariae</i> cause milder disease. </span></p>

<p><span></span></p>

<p><span>Symptoms
of malaria include fever, chills, vomiting, anemia (due to intravascular
hemolysis), arthralgias, and seizures. Malaria is characterized by recurrent
episodes of chills and rigors followed by fevers and sweating.<span>&nbsp; </span>These recurrences typically occur every
three days with <i>P. malariae</i><span>, </span>every
two days with <i>P. vivax</i> and <i>P. ovale</i>, and every 36-48 hours with <i>P.
falciparum </i><span>(although</span> a less
pronounced, almost continuous, fever can occur with <i>P. falciparum</i><span>)</span>. </span></p>

<p><span></span></p>

<p>Severe malaria is caused
almost exclusively by <i>P. falciparum</i>. Cerebral ischemia may result in
encephalopathy, stroke, seizure, coma, and death. Young children and pregnant
women are especially vulnerable. Other findings may include splenomegaly,
hepatomegaly, hypoglycemia, hemolytic anemia with hemoglobinuria, and renal
failure. (In “blackwater fever,” hemoglobin from lysed red blood cells darkens
the urine and causes renal failure.) Falciparum malaria can progress rapidly
and cause death within hours or days. The morbidity and mortality of falciparum
malaria are due to the high levels of parasitemia and the adherence of
parasites to erythrocytes. Sticky erythrocytes bind to the endothelium,
clogging the capillaries in the central nervous system and elsewhere. </p>

<p></p>

<p>Infection with <i>P. vivax</i>
and <i>P. ovale</i> (but not <i>P. falciparum</i><span>) can cause chronic malaria. (Parasites r</span>emain dormant in the
liver for months or years, then re-emerge in the blood, causing disease.)<span>&nbsp; </span></p>

<p></p>

<p><span>Malaria
develops in two phases: exoerythrocytic and erythrocytic. During a mosquito
bite, sporozoites enter the blood and migrate to the liver, where they infect
hepatocytes and multiply into merozoites (exoerythrocytic phase). The
merozoites then escape into the blood, where they infect red blood cells and
develop into ring forms (erythrocytic phase).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
diagnosis of malaria is usually made by detecting ring forms of the parasite in
blood smears.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=243 height=179
src="_%20Tutorials_files/image222.png" alt="Description: Malaria1" v:shapes="Picture_x0020_347216"></span><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>Severe malaria,
including cerebral malaria, is caused almost exclusively by <i>P. falciparum</i>.
Cerebral ischemia may result in encephalopathy, stroke, seizure, coma, and
death. <i>P. vivax</i> and <i>P. ovale</i><span> are the only species that have a dormant phase in the liver. Patients
infected with these organisms may be asymptomatic for months or years, and then
become ill when the parasites leave the liver and enter the blood. <i>P. vivax</i></span>
and <i>P. ovale</i><span> are the only
species of <i>Plasmodium</i> associated with relapse, which can occur even in
people who were adequately treated for malaria initially. On average, infection
with <i>P. malariae</i></span> is associated with the longest interval between <span>febrile episodes &#8211; three days. </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An 18-year-old man is brought to the
emergency department because of fever, a poorly localized headache, and a stiff
neck for 12 hours. The symptoms were preceded by nasal congestion, muscle
aches, and chills 3 days ago. His temperature is 38.7°C (101.6°F). Physical
examination shows nuchal rigidity and photophobia. There is no papilledema.
Neurologic examination shows no focal findings. Which of the following is the
most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
meningitis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cluster
headache</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Idiopathic
intracranial hypertension</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Migraine</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Subarachnoid
hemorrhage</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Temporal
arteritis</span></p>

<p><span><span>G.<span>&nbsp;&nbsp; </span></span></span><span>Tension-type headache<span></span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Meningitis</span> is inflammation of the protective membranes covering
the brain and spinal cord, known collectively as the meninges. The inflammation
is usually caused by microbial infection and less commonly by certain drugs.
Meningitis can be life-threatening because of the inflammation’s proximity to
the brain and spinal cord; therefore the condition is classified as a medical
emergency.</p>

<p><span>&nbsp;</span></p>

<p>The most common symptoms of
meningitis are headache and neck stiffness associated with fever, confusion or
altered consciousness, vomiting, and an inability to tolerate light
(photophobia) or loud noises (phonophobia). Sometimes, especially in small
children, only nonspecific symptoms may be present, such as irritability and
drowsiness. If a rash is present, it may indicate a particular cause of
meningitis; for instance, meningitis caused by meningococcal bacteria may be
accompanied by a characteristic rash.</p>

<p><span>&nbsp;</span></p>

<p>A lumbar puncture may be
used to diagnose or exclude meningitis. This involves inserting a needle into
the spinal canal to extract a sample of cerebrospinal fluid (CSF), the fluid
that envelops the brain and spinal cord. The CSF is then examined in a medical
laboratory. The usual treatment for meningitis is the prompt application of
antibiotics (for bacterial meningitis).</p>

<p></p>

<p>Meningitis can lead to
serious long-term consequences such as deafness, epilepsy, hydrocephalus and
cognitive deficits, especially if not treated quickly. Some forms of meningitis
(such as those associated with meningococci, <i>Haemophilus influenzae</i> type
B, pneumococci or mumps virus infections) may be prevented by immunization. </p>

<p><span></span></p>

<p><span>In adults,
a severe headache is the most common symptom of meningitis &#8211; occurring in
almost 90% of cases of bacterial meningitis, followed by nuchal rigidity
(inability to flex the neck forward passively due to increased neck muscle tone
and stiffness). The classic triad of diagnostic signs consists of nuchal
rigidity, sudden high fever, and altered mental status; however, all three
features are present in less than half of all cases of bacterial meningitis.</span></p>

<p><span></span></p>

<p><span>Nuchal
rigidity occurs in 70% of adult cases of bacterial meningitis. Other signs of
meningism include the presence of positive Kernig sign or Brudzinski sign.
Kernig sign is assessed with the patient lying supine, with the hip and knee flexed
to 90 degrees. In a patient with a positive Kernig sign, pain limits passive
extension of the knee. A positive Brudzinski's sign occurs when flexion of the
neck causes involuntary flexion of the knee and hip. Although Kernig and
Brudzinski signs are both commonly used to screen for meningitis, the
sensitivity of these tests is limited. They do, however, have very good
specificity for meningitis: the signs rarely occur in other diseases.</span></p>

<p><span></span></p>

<p><span>Meningitis
caused by the bacterium <i>Neisseria meningitidis</i> (known as “meningococcal
meningitis”) can be differentiated from meningitis with other causes by a
rapidly spreading petechial rash which may precede other symptoms. The rash
consists of numerous small, irregular purple or red spots (“petechiae”) on the
trunk, lower extremities, mucous membranes, conjuctiva, and (occasionally) the
palms of the hands or soles of the feet. The rash is typically non-blanching:
the redness does not disappear when pressed with a finger or a glass tumbler.
Although this rash is not necessarily present in meningococcal meningitis, it
is relatively specific for the disease.</span></p>

<p></p>

<p>The types of bacteria that
cause bacterial meningitis vary by age group. In premature babies and newborns
up to three months old, common causes are <i>group B streptococci</i> (which
normally inhabit the vagina and are mainly a cause during the first week of
life) and those that normally inhabit the digestive tract such as <i>Escherichia
coli</i> (carrying K1 antigen). <i>Listeria monocytogenes</i> may affect the
newborn and occurs in epidemics. Older children are more commonly affected by <i>Neisseria
meningitidis</i> (meningococcus), <i>Streptococcus pneumoniae</i> (serotypes 6,
9, 14, 18 and 23) and those under five by <i>Haemophilus influenzae</i> type B
(mainly in countries that do not offer vaccination). In adults, <i>N.
meningitidis</i> and <i>S. pneumoniae</i> together cause 80% of all cases of
bacterial meningitis, with increased risk of <i>L. monocytogenes</i> in those
over 50 years old. Since the pneumococcal vaccine was introduced, however,
rates of pneumococcal meningitis have declined in children and adults. </p>

<p></p>

<p>Recent trauma to the skull
gives bacteria in the nasal cavity the potential to enter the meningeal space.
Similarly, individuals with a cerebral shunt or related device are at increased
risk of infection through those devices. In these cases, infections with
staphylococci are more likely, as well as infections by pseudomonas and other
Gram-negative bacilli. The same pathogens are also more common in those with an
impaired immune system. In some people, an infection in the head and neck area,
such as otitis media or mastoiditis, can lead to meningitis. Tuberculous
meningitis, meningitis due to infection with <i>Mycobacterium tuberculosis</i>,
is more common in those from countries where tuberculosis is common, but is
also encountered in those with immune problems, such as AIDS. </p>

<p></p>

<p>A literature review of 363
reported cases of <i>recurrent</i>
meningitis showed that 59% of cases are due to anatomical abnormalities, 36%
due to immune deficiencies (such as complement deficiency, which predisposes
especially to recurrent meningococcal meningitis), and 5% due to ongoing
infections in areas adjacent to the meninges.</p>

<p></p>

<p>The term <i>aseptic
meningitis</i> refers loosely to all cases of meningitis in which no bacterial
infection can be demonstrated. This is usually due to viruses, but it may be
due to bacterial infection that has already been partially treated, with
disappearance of the bacteria from the meninges, or by infection in a space
adjacent to the meninges (e.g. sinusitis). Endocarditis (infection of the heart
valves with spread of small clusters of bacteria through the bloodstream) may
cause aseptic meningitis. Aseptic meningitis may also result from infection
with spirochetes, a type of bacteria that includes <i>Treponema pallidum</i>
(the cause of syphilis) and <i>Borrelia burgdorferi</i> (known for causing Lyme
disease). Meningitis may be encountered in cerebral malaria (malaria infecting
the brain). Fungal meningitis, e.g. due to <i>Cryptococcus neoformans</i>, is
typically seen in people with immune deficiency such as AIDS.</p>

<p></p>

<p>Meningitis may occur as the
result of several non-infectious causes: spread of cancer to the meninges (<i>malignant
meningitis</i>) and certain drugs (mainly non-steroidal anti-inflammatory drugs
and antibiotics). It may also be caused by several inflammatory conditions such
as sarcoidosis (which is then called neurosarcoidosis), connective tissue
disorders such as systemic lupus erythematosus, and certain forms of vasculitis
such as Behçet's disease. </p>

<p>The most important test in
identifying or ruling out meningitis is analysis of the cerebrospinal fluid
through lumbar puncture (LP, spinal tap). However, lumbar puncture is
contraindicated if there is a mass in the brain or the intracranial pressure
(ICP) is elevated, as it may lead to brain herniation. If someone is at risk
for either a mass or raised ICP (recent head injury, a known immune system
problem, localizing neurological signs, or evidence on examination of a raised
ICP), a CT or MRI scan is recommended prior to the lumbar puncture. If a CT or
MRI is required before LP, or if LP proves difficult, professional guidelines
suggest that antibiotics should be administered first to prevent delay in
treatment, especially if this may be longer than 30&nbsp;minutes.</p>

<p></p>

<div align=center>

<table border=1 cellpadding=0>
 <tr>
  <td width=390 colspan=4>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><b><span>CSF Findings in
  Meningitis</span></b></p>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=390 colspan=4>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><b><span>Type of </span></b></p>
  <p style="text-align:center;"><b><span>meningitis</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><b><span>Glucose</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><b><span>Protein</span></b></p>
  </td>
  <td width=170>
  <p style="text-align:center;"><b><span>Cells</span></b></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td width=170>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><b><span>Acute
  bacterial</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><span>low</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>high</span></p>
  </td>
  <td width=170>
  <p><span>Neutrophils
  predominate; </span></p>
  <p><span>WBCs
  &gt; 500/mm&sup3;</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><b><span>Acute
  viral</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><span>normal</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>normal or high</span></p>
  </td>
  <td width=170>
  <p><span>Lymphocytes
  predominate;</span></p>
  <p><span>WBCs
  &lt; 100/mm&sup3;</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><b><span>Tuberculous</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><span>low</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>high</span></p>
  </td>
  <td width=170>
  <p><span>Lymphocytes
  predominate;</span></p>
  <p><span>WBC
  count variable</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><b><span>Fungal</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><span>low</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>high</span></p>
  </td>
  <td width=170>
  <p><span>Lymphocytes
  predominate;</span></p>
  <p><span>WBC
  count variable</span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer A is correct. </b>Fever, headache, stiff neck, and photophobia
suggest a diagnosis of acute meningitis.</p>

<p></p>

<p><b>Answer B is incorrect. </b>Cluster headaches are excruciating
unilateral headaches of extreme intensity. The duration of the common attack
ranges from as short as 15 minutes to three hours or more. The onset of an
attack is rapid, and most often without the preliminary signs that are
characteristic of a migraine. Cluster headaches occur periodically: spontaneous
remissions interrupt active periods of pain. The pain may be very sharp and may
cause pain around the eye area and may also be a pain within the back of the
eye.</p>

<p></p>

<p><b>Answer C is incorrect. </b><span>Idiopathic
intracranial hypertension</span>, also called <span>pseudotumor cerebri</span>, is a neurological disorder characterized by
increased intracranial pressure in the absence of a tumor or other diseases.
The main symptoms are headache, nausea and vomiting, as well as pulsatile
tinnitus, double vision, and other visual symptoms. If untreated, it may lead
to swelling of the optic disc in the eye (papilledema), which can progress to
vision loss. Fever and nuchal rigidity are not typical.<span>&nbsp; </span></p>

<p></p>

<p><b>Answer D is incorrect. </b>The typical migraine headache is unilateral
and pulsating and lasts from two to 72 hours. Symptoms include nausea,
vomiting, photophobia (increased sensitivity to light) and phonophobia (increased
sensitivity to sound). Approximately one-third of people who suffer from
migraine headaches perceive an aura &#8211; transient visual, sensory,
language, or motor disturbances signaling the migraine will soon occur. Fever
and nuchal rigidity are not typical of migraine. </p>

<p></p>

<p><b>Answer E is incorrect. </b>A <span>subarachnoid
hemorrhage</span><a
href="http://en.wikipedia.org/wiki/Wikipedia:IPA_for_English#Key"
title="Wikipedia:IPA for English"></a> is bleeding into the subarachnoid
space&#8212;the area between the arachnoid membrane and the pia mater
surrounding the brain. This may occur spontaneously, usually from a ruptured
cerebral aneurysm, or may result from head injury. Symptoms of SAH include a
severe headache with a rapid onset (“thunderclap headache”), vomiting,
confusion or a lowered level of consciousness, and sometimes seizures. The
diagnosis is generally confirmed with a CT scan of the head, or occasionally by
lumbar puncture.</p>

<p></p>

<p><b>Answer F is incorrect.</b> <span>Giant-cell
arteritis</span> is an inflammatory disease of blood vessels most commonly
involving large and medium arteries of the head. It is a form of vasculitis.
The name giant cell arteritis reflects the type of inflammatory cell involved
as seen on a biopsy. The terms “giant-cell arteritis” and “temporal arteritis”
are sometimes used interchangeably, because of the frequent involvement of the
temporal artery. However, it can involve other large vessels (such as the
aorta). The disease typically affects older people. Symptoms include fever,
malaise, headache, scalp tenderness, jaw claudication, tongue claudication, and
visual changes. Diagnosis is made by temporal artery biopsy. Corticosteroids
are the mainstay of treatment.<span >&nbsp; </span></p>

<p></p>

<p><b>Answer G is incorrect. </b>A <span>tension
headache</span> is the most common type of primary headache. The pain can
radiate from the neck, back, eyes, or other muscle groups in the body. It is
often described as a constant pressure, as if the head were being squeezed in a
vise, and it is frequently bilateral and typically mild to moderate in severity.
Fever and nuchal rigidity are not characteristic of trension-type headache. </p>

<p><span>An
18-year-old man presents to his physician with fever, headache, and malaise.
Physical examination shows exudative pharyngitis, cervical lymphadenopathy, and
hepatosplenomegaly.<span >&nbsp; </span>The white blood
cell (WBC) count is 13,000/mm<sup>3</sup> with 60% lymphocytes. Atypical
lymphocytes are seen on peripheral blood smear. The heterophile antibody test
is positive. Which organism is the most likely cause of this condition?<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Epstein-Barr
virus</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Toxoplasma
gondii</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>HIV<span>&nbsp; </span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Streptococcus,
group A</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=231 height=176
src="_%20Tutorials_files/image224.png"
alt="Description: http://nmagz.files.wordpress.com/2009/09/190px-tonsillitis.jpg"
v:shapes="Picture_x0020_347215"></span><span></span></p>

<p style="text-align:center;"><span>Exudate on the tonsils</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=232 height=175
src="_%20Tutorials_files/image226.png"
alt="Description: http://farm1.static.flickr.com/56/145052719_6d46149085.jpg"
v:shapes="Picture_x0020_347214"></span><span></span></p>

<p style="text-align:center;"><span>Blood smear with atypical lymphocytes</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Lymphocytosis
can be reactive or malignant. Reactive lymphocytosis is usually caused by viral
infection. The lymphocytes may be normal or “atypical.” Normal lymphocytes have
a large, dark-staining nucleus with scant cytoplasm. The nucleus is about the
size of a red blood. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=224 height=154
src="_%20Tutorials_files/image228.png"
alt="Description: http://upload.wikimedia.org/wikipedia/commons/1/17/Lymphocyte2.jpg"
v:shapes="Picture_x0020_347213"></span><span></span></p>

<p style="text-align:center;"><span>Normal lymphocyte</span></p>

<p style="text-align:center;"><span></span></p>

<p><span>“Atypical”
lymphocytes are larger and have abundant basophilic cytoplasm and a large
irregularly-shaped nucleus. They resemble monocytes, hence the term
“mononucleosis.”</span></p>

<p><span><span>&nbsp;</span></span></p>

<p style="text-align:center;"><span><img border=0 width=215 height=164
src="_%20Tutorials_files/image230.png" alt="Description: atypical lymphocyte"
v:shapes="Picture_x0020_347212"></span><span></span></p>

<p style="text-align:center;"><span>Atypical lymphocyte</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>Several
infectious agents cause a “mononucleosis-like” pattern on peripheral blood
smear. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Mononucleosis-like Syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Epstein-Barr Virus</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Cytomegalovirus</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Toxoplasmosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>HIV</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span>Answer A is correct</span></b><span>. The prototype of a
mononucleosis syndrome is infectious mononucleosis, caused by the Epstein-Barr
virus. (The Epstein-Barr virus infects B lymphocytes.) Infectious mononucleosis
is characterized by fever, malaise, and sore throat. Physical examination may
show exudative pharyngitis, cervical lymphadenopathy, and hepatosplenomegaly.
The white blood cell (WBC) count is usually elevated with a preponderance of
atypical lymphocytes. A positive heterophile antibody test is specific for the
disease. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Cytomegalovirus (CMV)
infection is usually asymptomatic in immunocompetent hosts. Cervical
lymphadenopathy and exudative pharyngitis are rare. In immunocompromised hosts,
CMV can cause retinitis, hepatitis, and colitis. Congenital CMV is associated
with low birth weight, microcephaly, seizures, hepatosplenomegaly, and a
petechial rash similar to the &quot;blueberry muffin&quot; rash of congenital
rubella syndrome. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. The protozoan, <i>Toxoplasma gondii</i>, is transmitted by
ingesting undercooked meat or food contaminated by cat feces. Toxoplasmosis is
usually asymptomatic in immunocompetent hosts. In immunocompromised
individuals, it can present as a brain lesion with focal neurological deficits.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Two to four weeks after
exposure the HIV, patients often develop a flu-like illness characterized by fever,
malaise, sore throat, lymphadenopathy, and rash. The symptoms usually subside
within fourteen days. The diagnosis of acute HIV infection is based on a
positive HIV-1 RNA test and a negative HIV antibody test (by enzyme-linked
immunosorbent antibody assay (ELISA) and Western blot analysis). (The ELISA and
Western blot tests are negative because the host has not yet developed
antibodies to the virus.)</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Group A beta-hemolytic
streptococcus causes pharyngitis (“strep throat”). As in infectious
mononucleosis, patients usually have fever, cervical lymphadenopathy, and
exudative pharyngitis. Unlike the Epstein-Barr virus, however, Group A
Streptococcus does not cause hepatosplenomegaly. Also, the heterophile antibody
test would be negative in Group A streptococcal infection. Throat culture is
the gold standard for diagnosing “strep throat.” </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>After
infection with the measles virus, an 8-year old boy produces antibodies to all
eight viral proteins. The next year he is again exposed to the measles virus.
Antibodies to which of the following viral proteins are most likely to be
protective?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Nucleocapsid</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polymerase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Matrix</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hemagglutinin</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nonstructural
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=326 height=245
src="_%20Tutorials_files/image232.png" alt="Description: 5769426" v:shapes="Picture_x0020_347211"></span><span></span></p>

<p><span></span></p>

<p>Paramyxoviruses include the <span>measles,</span> mumps, <span>parainfluenza,</span> and <span>respiratory syncytial (RSV) viruses.</span>
These viruses are transmitted in respiratory droplets and initiate infection in
the respiratory tract. The measles virus causes a generalized infection
characterized by a maculopapular rash <span>(rubeola)</span>.
Parainfluenza virus causes upper and lower respiratory tract infection,
primarily in children, including pharyngitis, croup, bronchitis, bronchiolitis,
and pneumonia. The mumps virus causes a systemic infection whose most prominent
manifestation is parotitis. RSV causes mild upper respiratory tract infections
in children and adults, but can cause life-threatening pneumonia in infants.</p>

<p></p>

<p><span>The
paramyxoviruses have similar morphologies. They consist of a negative-sense, <span>single-stranded ribonucleic acid (RNA)</span>
molecule in a helical nucleocapsid surrounded by an <span>envelope</span>. The envelope contains a viral attachment protein. For
the measles virus, the attachment protein is hemagglutinin (H). For the mumps
and parainfluenza viruses, the attachment protein is
hemagglutinin-neuraminidase (HN). For the respiratory syncytial virus, the
attachment protein is glycoprotein (G). In addition to having an attachment
protein, the envelope of each of these viruses contains a fusion protein (F). </span></p>

<p><span></span></p>

<p>Replication of the
paramyxoviruses begins with the binding of H, HN, or G proteins to sialic acid
residues on the host cell surface. This allows the virus to fuse with the
plasma membrane and penetrate the cell. The RNA then replicates in the
cytoplasm, and the virion exits the cell by budding from the plasma membrane.
The measles and mumps virus have only <span>one
serotype. The use of l</span>ive attenuated vaccines has made these conditions
rare in developed countries.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Each of the
paramyxoviruses has a viral attachment protein in its envelope. For the measles
virus, the attachment protein is hemagglutinin. Antibodies to hemagglutinin
would protect the host from infection. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Eight
weeks after a renal transplant, a patient develops fever and leukopenia,
followed by prostration and severe pulmonary and hepatic dysfunction. Which of
the following is the most likely viral cause? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Parvovirus
B19</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Influenza
virus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Coxsackie
virus</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Adenovirus
type 12</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Lifelong
immunosuppression is generally necessary for all recipients of solid organ
transplants. As a result, infection is the primary cause of mortality after
transplantation. Two-thirds of transplant patients have at least one
significant infection. Signs of <span are
often blunted by an impaired inflammatory response. Feverishness or mild,
non-specific symptoms may herald a severe <span management usually translates into increased patient survival and
graft function.</span></p>

<p><span></span></p>

<p>The timing of post-transplant
<span can be separated into three periods.</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&lt;1 month</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>1-6 months</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&gt;6 months </p>

<p><i><span></span></i></p>

<p><i><span>First Month after Transplant </span></i></p>

<p><i><span></span></i></p>

<p><span>These
infections are likely to be related to the transplant procedure, catheters, or
intubation, although “standard” infections may also occur. Nosocomial pathogens
are especially prominent. </span></p>

<p><a name=4-u1.0-B978-0-323-05472-0..00182-1--s003></a><i><span></span></i></p>

<p><i><span>Months 1 through 6<span>&nbsp; </span></span></i></p>

<p><i><span></span></i></p>

<p><span>These
infections are divided into two general types: immunomodulating viral
infections and opportunistic infections. Immunomodulating viruses include
cytomegalovirus (CMV), hepatitis B and C, BK polyomavirus, human herpesvirus 6,
and Epstein-Barr virus (EBV). Opportunistic infections include <i>Pneumocystis</i>,
<i>Listeria</i>, and fungal species.</span></p>

<p><span></span></p>

<p><span>CMV is the
most important and prevalent viral pathogen after transplantation. It can
infect many systems and cause severe pneumonitis, hepatitis, GI inflammation,
and leukopenia. CMV infection may be primary or secondary due to reactivation
of latent virus in lymphocytes. Although survival has improved with earlier
diagnosis (bronchoscopy) and early treatment (gangcyclovir and CMV-specific
immunoglobulin), CMV infection is often fatal. </span></p>

<p><span></span></p>

<p><span>EBV can
also infect transplant recipients. It causes a mononucleosis-like syndrome,
associated with lymphadenopathy, weakness, and low-grade fever. EBV is also
associated with B-cell lymphoproliferative disease<a
name=4-u1.0-B978-0-323-05472-0..00182-1--s004></a><a
name=4-u1.0-B978-0-323-05472-0..00182-1--st00></a>.</span></p>

<p><span></span></p>

<p><i><span></span></i></p>

<p><i><span>After 6 Months</span></i></p>

<p><i><span></span></i></p>

<p><span>Six months
after transplant, patients receiving immunosuppressive therapy are divided into
three groups relative to infection susceptibility: healthy transplant, chronic
rejection, and chronic (and typically progressive) viral infection. The latter
group includes infection with CMV, EBV, varicella, herpes simplex, or viral
hepatitis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>CMV is the most
important and prevalent viral pathogen after transplantation. It can infect
many systems and cause severe pneumonitis, hepatitis, GI inflammation, and
leukopenia.</span></p>

<p><span></span></p>

<p><span>CMV is a
member of the Human Herpesvirus family and is a double-stranded enveloped virus
with icosahedral symmetry.<span >&nbsp; </span>The
virus attaches to C3 receptors on B cells and after entering the cell, it
replicates its genome and matures in the nucleus.<span>&nbsp; </span>After the primary infection, the virus
may remain latent in WBCs for an indefinite period of time.<span>&nbsp; </span>Transplant patients can acquire CMV from
donor tissues or lymphocytes or from an endogenous reactivation.<span>&nbsp; </span>CMV prophylaxis is essential in
transplant patients.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 27-year-old man with AIDS is brought to
the hospital 30 minutes after having a seizure. He currently takes no
medications. A CT scan of the head shows multiple ring-enhancing lesions. Which
of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Amoebiasis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cysticercosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Echinococcosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Schistosomiasis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Toxoplasmosis</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Trichinosis</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=332 height=313
src="_%20Tutorials_files/image234.png" alt="Description: F2" v:shapes="Picture_x0020_347210"></span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>A <span>ring-enhancing lesion</span> is an abnormal
finding on CT scan obtained using radiocontrast. On the image there is an area
of decreased radiodensity surrounded by a bright rim from concentration of the
enhancing contrast dye. </span></p>

<p><span></span></p>

<p><b><span>Multiple ring-enhancing lesions</span></b><span> of the brain can be
caused by a variety of infectious, neoplastic, inflammatory, or vascular
diseases. Although newer imaging techniques are useful in making a diagnosis,
early brain biopsy is often needed because several of these diseases are
potentially life-threatening.The differential diagnosis of multiple
ring-enhancing lesions depends on the age and the immune status of the patient.
In the immunocompetent host, malignancies (both primary and metastatic) and
pyogenic abscesses remain the most likely diagnoses in patients with
large-sized lesions. Primary and metastatic tumors, on imaging, often manifest
as rounded, well-circumscribed, ring-enhancing lesions of variable sizes
surrounded by a variable amount of edema. Metastatic tumors are the most common
intracranial neoplasm in adults. Lung cancer, breast cancer and melanoma
account for the majority of patients with metastasis in the brain. Pyogenic
brain abscesses are often caused by hematogenous spread of bacteria from a
primary source. The likely sources of primary infection include cyanotic heart
disease, endocarditis, suppurative lung diseases, skin infection, and abdominal
and pelvic infections.</span></p>

<p><span></span></p>

<p><span>Abscesses caused by
atypical microorganisms and demyelinating disease should also be considered in
the differential diagnosis of multiple enhancing lesions of the brain. In
tropical countries, cysticercus granuloma frequently needs to be differentiated
from intracranial tuberculoma. Cysticercosis is an infection by a parasite, <i>Taenia
solium</i> (a pork tapeworm) that creates cysts in different areas in the body.
The organism is acquired by eating undercooked meat that contain the larvae or
by ingesting eggs from contaminated food and water.<span><span>&nbsp; </span></span>The term “neurocysticercosis” is
used when cysts appear in the brain parenchyma. Neurocysticercosis is the most
common parasitic disease of the CNS and is a major cause of seizures worldwide.
Tuberculomas are frequently encountered brain lesions in tropical countries.
Intracranial tuberculoma can occur with or without tuberculous meningitis.</span></p>

<p><span></span></p>

<p><span>In
HIV-infected patients, the leading causes of multiple enhancing lesions are
toxoplasmosis and primary CNS lymphoma. Toxoplasmosis is a common cause of
multiple intracranial mass lesions in patients with acquired immunodeficiency
syndrome (AIDS). <i>Toxoplasma gondii </i>is
the etiologic agent and is acquire by ingestion of oocysts from cat feces or
tissue cysts from undercooked meat.<span >&nbsp;
</span>It is also one of the TORCH infections, which are transmitted
transplacentally.<span><span >&nbsp;
</span></span>It occurs in 3-10% of patients with AIDS in the United States and
in up to 50% of the patients in Europe and Africa. For an immunosuppressed
patient who presents with focal neurologic signs and multiple ring-enhancing
lesions of the brain on imaging, cerebral toxoplasmosis would be the most
likely diagnosis, and current guidelines suggest that all such patients be
treated with antitoxoplasma treatment. Combination of pyrimethamine/sulfadiazine
and folinic acid is considered the standard regime for the treatment of
cerebral toxoplasmosis. After approximately two weeks of treatment, a decrease
in the number and size of lesions with reduction in edema should be observed. A
lack of response to such therapy should alert the clinician about the
possibility of other conditions such as CNS lymphoma or progressive multifocal
leukoencephalopathy. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. Toxoplasmosis would be
the most likely cause of multiple ring-enhancing lesions in the brain of a
patient with AIDS. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 26-year-old man with multiple sexual
partners has a painful ulcer on his penis. Physical examination shows a 1-cm
ulcer with no induration on the frenulum. Tender lymphadenopathy is noted in
the right inguinal region. A culture of the ulcer grows colonies on
supplemented chocolate agar. A Gram stain of the colonies shows gram-negative
coccobacilli. Which of the following organisms is the most likely cause of
disease?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><i><span>Treponema pallidum</span></i><span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Herpes
simplex virus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Neisseria gonorrhoeae</span></i><span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><i><span>Trichomonas vaginalis</span></i><span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Haemophilus ducreyi</span></i><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A useful
clinical approach to evaluating sexually transmitted diseases (STDs) is based
on the pattern of presenting symptoms. Four basic patterns exist: genital
discharge syndromes, genital ulcer syndromes, pelvic inflammatory disease, and
dermatologic syndromes. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>STD Patterns</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Genital
  discharge syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Genital
  ulcer syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Pelvic
  inflammatory disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Dermatologic
  syndromes</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b><span>Genital
discharge syndromes.</span></b><span>&nbsp;Discharge
syndromes can be further divided into those causing urethritis/cervicitis and
those causing vaginitis. </span></p>

<p><span></span></p>

<p><span>The
principal causes of urethritis and cervicitis are <i>Neisseria gonorrhoeae</i>
and <i>Chlamydia trachomatis</i>. Concurrent infection with these organisms
often occurs. Their clinical manifestations are similar and patients are often
treated presumptively for both organisms. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=479 colspan=3 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>STDs Causing Genital Discharge</span></p>
  <p style="text-align:center;"><i><span></span></i></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><i><span></span></i></p>
  <p style="text-align:center;"><i><span>Neisseria gonorrhoeae</span></i></p>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><i><span></span></i></p>
  <p style="text-align:center;"><i><span>Chlamydia trachomatis</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Gram
  Stain</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>Gram-negative diplococci</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>---</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Incubation
  period</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>2-30 days</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>1-3 weeks</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Manifestations</span></p>
  </td>
  <td width=319 colspan=2 valign=top>
  <p><span></span></p>
  <p><span>Urethritis,
  cervicitis, epididymitis, prostatitis, orchitis, conjunctivitis, pharyngitis,
  proctitis, pelvic inflammatory </span></p>
  <p><span>disease,
  and perihepatitis (Fitz-Hugh&#8211;Curtis syndrome)</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Symptoms</span></p>
  </td>
  <td width=319 colspan=2 valign=top>
  <p><span></span></p>
  <p><span>Men:
  Dysuria, penile discharge, scrotal pain</span></p>
  <p><span></span></p>
  <p><span>Female:
  May be asymptomatic; symptoms may include dysuria, vaginal discharge, pelvic
  pain, abnormal vaginal bleeding</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Special
  features</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Disseminated
  gonococcal infection<sup>1</sup>: </span></p>
  <p><span>1)
  arthritis-dermatitis syndrome </span></p>
  <p><span>2)
  septic arthritis</span></p>
  <p><span>3)
  endocarditis, myocarditis meningitis</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Diagnosis</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>1) Gram
  stain</span></p>
  <p><span>2)
  Culture</span></p>
  <p><span>3)
  Nucleic acid amplification tests</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>1) Cell
  culture</span></p>
  <p><span>2)
  Nucleic acid amplification tests </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=4-u1.0-B978-0-323-05472-0..00096-7--f005></a><sup><span>1</span></sup><span>Disseminated gonococcal
infection (DGI) results from gonococcal bacteremia. The principal manifestation
is the arthritis-dermatitis syndrome, characterized by fever, chills,
monoarticular or oligoarticular arthritis, non-itchy rash, and tenosynovitis.
The rash consists of tender, hemorrhagic pustules on an erythematous base,
usually on the distal extremities. The second most common manifestation is
septic arthritis, which presents as an acute monoarticular or oligoarticular
arthritis. The knees are most commonly involved. The affected joint is warm,
erythematous, swollen, and tender. DGI can also cause endocarditis,
myocarditis, and meningitis.</span></p>

<p><span>The principal conditions
associated with vaginitis are listed below.<span>&nbsp; </span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td colspan=5>
   <p style="text-align:center;"><span></span></p>
   <p style="text-align:center;"><span>Vaginitis</span></p>
   <p style="text-align:center;"><span></span></p>
   </td>
  </tr>
  <tr>
   <td>
   <p style="text-align:center;"><span>Condition</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Vaginal</span></p>
   <p style="text-align:center;"><span>pH</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Discharge </span></p>
   <p style="text-align:center;"><span>Appearance</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Wet mount</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Treatment</span></p>
   </td>
  </tr>
  <tr>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td>
  <p><span>Bacterial*
  vaginosis</span></p>
  </td>
  <td>
  <p><span>&gt;4.5</span></p>
  </td>
  <td>
  <p><span>Gray,
  white, milky/creamy; amine odor present</span></p>
  </td>
  <td>
  <p><span>Clue
  cells** </span></p>
  </td>
  <td>
  <p><span>Metronidazole</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><i><span>Trichomonas</span></i><span> infection</span></p>
  </td>
  <td>
  <p><span>&gt;4.5</span></p>
  </td>
  <td>
  <p><span>Gray,
  yellow, greenish, or white; often frothy; homogeneous</span></p>
  </td>
  <td>
  <p><span>Trichomonads
  </span></p>
  </td>
  <td>
  <p><span>Metronidazole</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><i><span>Candida</span></i><span>***<i> </i>infection</span></p>
  </td>
  <td>
  <p><span>&lt;4.5</span></p>
  </td>
  <td>
  <p><span>White,
  often curdy</span></p>
  </td>
  <td>
  <p><span>Mycelia </span></p>
  </td>
  <td>
  <p><span>Fluconazole,
  intravaginal imidazoles</span></p>
  </td>
 </tr>
</table>

<p><span>*The role
of sexual activity in transmitting bacterial vaginosis is unknown. </span></p>

<p><span></span></p>

<p><span>**Clue
cells are vaginal </span><a href="http://en.wikipedia.org/wiki/Epithelial"
title=Epithelial><span>epithelial</span></a><span> cells that are covered
with </span><a href="http://en.wikipedia.org/wiki/Bacteria" title=Bacteria><span>bacteria</span></a><span>, causing a stippled
appearance.</span></p>

<p><span></span></p>

<p><span>***
Candida vaginitis is not an STD.<span >&nbsp; </span></span></p>

<p><b><span>Genital
ulcer syndromes.</span></b><span>&nbsp;The
vast majority of genital ulcers are caused by herpes simplex virus and
syphilis. Other important causes include chancroid and lymphogranuloma
venereum.<span >&nbsp; </span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td width=472 colspan=6>
   <p style="text-align:center;"><span></span></p>
   <p style="text-align:center;"><span>STDs Causing Genital Ulcers</span></p>
   <p style="text-align:center;"><span></span></p>
   </td>
  </tr>
  <tr>
   <td width=97>
   <p style="text-align:center;"><span>Disease</span></p>
   </td>
   <td width=88>
   <p style="text-align:center;"><span>Ulcer</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Incubation period</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Pain with ulcer</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Inguinal adenopathy</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Diagnostic test</span></p>
   </td>
  </tr>
  <tr>
   <td width=97>
   <p><span></span></p>
   </td>
   <td width=88>
   <p><span></span></p>
   </td>
   <td>
   <p><span></span></p>
   </td>
   <td>
   <p><span></span></p>
   </td>
   <td>
   <p><span></span></p>
   </td>
   <td>
   <p><span></span></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width=97>
  <p style="text-align:center;"><span>Syphilis </span></p>
  <p style="text-align:center;"><span>(primary)</span></p>
  <p style="text-align:center;"><span>(<i>Treponema pallidum</i>)</span></p>
  </td>
  <td width=88>
  <p><span>Chancre:
  papule that ulcerates;<span >&nbsp; </span>painless
  and indurated (firm); clean base with sharp borders; single lesion (usually);
  heals spontaneously; leaves thin, atrophic scar </span></p>
  </td>
  <td>
  <p><span>10&#8211;90
  days (average 21 days)</span></p>
  </td>
  <td>
  <p><span>No</span></p>
  </td>
  <td>
  <p><span>Firm,
  discrete, movable, nontender, nonsuppurative, may last for months</span></p>
  </td>
  <td>
  <p><span>Darkfield
  examination; </span></p>
  <p><span>VDRL
  positive (77%);</span></p>
  <p><span>FTA-ABS
  positive</span></p>
  <p><span>(86%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=97>
  <p style="text-align:center;"><span>Herpes genitalis</span></p>
  <p style="text-align:center;"><span>(HSV-2, HSV-1)</span></p>
  </td>
  <td width=88>
  <p><span>Multiple
  small grouped vesicles on a red base, which form shallow ulcers; may
  coalesce; resolve spontaneously, but recurrence is common; associated fever</span></p>
  </td>
  <td>
  <p><span>2&#8211;7
  days</span></p>
  </td>
  <td>
  <p><span>Yes</span></p>
  </td>
  <td>
  <p><span>Bilateral,
  soft, tender</span></p>
  </td>
  <td>
  <p><span>Tzank
  smear positive;</span></p>
  <p><span>Tissue
  culture isolation;</span></p>
  <p><span>HSV-2
  antigen</span></p>
  </td>
 </tr>
 <tr>
  <td width=97>
  <p style="text-align:center;"><span>Chancroid</span></p>
  <p style="text-align:center;"><span>(<i>Haemophilus ducreyi</i>)</span></p>
  </td>
  <td width=88>
  <p><span>Soft,
  non-indurated, very painful ulcer</span></p>
  </td>
  <td>
  <p><span>3&#8211;6
  days</span></p>
  </td>
  <td>
  <p><span>Yes</span></p>
  </td>
  <td>
  <p><span>Unilateral
  (usually), very tender, suppurative</span></p>
  </td>
  <td>
  <p><span>Gram stain
  (Gram-negative coccobacillus);</span></p>
  <p><span>Culture</span></p>
  </td>
 </tr>
 <tr>
  <td width=97>
  <p style="text-align:center;"><span>Lymphogranuloma venereum*</span></p>
  <p style="text-align:center;"><span>(<i>Chlamydia trachomatis</i>)</span></p>
  </td>
  <td width=88>
  <p><span>Transient
  ulcer, often not noticed; usually single</span></p>
  </td>
  <td>
  <p><span>5&#8211;21
  days</span></p>
  </td>
  <td>
  <p><span>No</span></p>
  </td>
  <td>
  <p><span>Firm,
  tender, matted, caseating, suppurative; sinus tracts; fistulas; multiple
  abscesses</span></p>
  </td>
  <td>
  <p><span>Lymphogranuloma
  venereum complement fixation </span></p>
  <p><span></span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

<p><span>*Lymphogranuloma
venereum may be associated with fever, arthritis, pericarditis, proctitis,
meningoencephalitis, keratoconjunctivitis, preauricular adenopathy, edema of
eyelids, erythema nodosum</span></p>

<p><span></span></p>

<p><b>Pelvic inflammatory
disease. </b>Pelvic inflammatory disease (PID) is characterized by inflammation
of the upper female genital tract. <i>C. trachomatis </i>and <i>N</i>. <i>gonorrhoeae</i>
are the most common causes. Low abdominal pain is the dominant symptom. Fever,
malaise, and anorexia are common. Vaginal discharge is often present.
Examination usually shows low abdominal tenderness, cervical motion tenderness,
and bilateral adnexal tenderness, sometimes with a palpable mass. Most women
have signs of cervicitis. Right upper quadrant abdominal tenderness is
sometimes present due to Fitz-Hugh-Curtis syndrome, in which intra-abdominal
extension of infection results in perihepatitis, which can mimic acute
cholecystitis or viral hepatitis. Complications of PID include ectopic
pregnancy and infertility. </p>

<p><span></span></p>

<p><b><span>Dermatologic
syndromes.</span></b><span>&nbsp;The
most common STDs with primarily dermatologic presentations are listed below. </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=479 colspan=3 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>STDs with Skin Manifestations</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p style="text-align:center;"><span>Organism</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span>Condition</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span>Description</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Human
  papillomavirus</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Genital
  warts (condyloma acuminata)<span >&nbsp; </span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Discrete,
  papillary, cauliflower-like lesions on a moist surface</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><i><span>Treponema
  pallidum</span></i></p>
  </td>
  <td width=160 valign=top>
  <p><span>Secondary
  syphilis</span></p>
  <p><span><span>1)<span>&nbsp;&nbsp;&nbsp;
  </span></span></span><span>rash</span></p>
  <p><span><span>2)<span>&nbsp;&nbsp;&nbsp;
  </span></span></span><span>condyloma lata</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Symmetrical,
  reddish-pink, non-itchy lesions on trunk and extremities, often involving
  palms and soles. In moist areas (vulva, scrotum), rash produces flat, broad,
  whitish, wart-like lesions called <i>condyloma lata</i> </span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><i><span>Neisseria
  gonorrhea</span></i></p>
  </td>
  <td width=160 valign=top>
  <p><span>Disseminated
  gonococcal infection</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Hemorrhagic
  pustules on an erythematous base, usually on distal extremities </span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><i><span>Phthirus
  pubis</span></i><span>
  (crab louse)</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>“Crabs”
  or “Pubic lice” (pediculosis pubis)</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Itching;
  lice and nits on pubic hairs</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><i><span>Sarcoptes
  scabiei</span></i><span>
  (mite)</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Scabies</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Itching;
  trails of burrowing mites with pimple-like “bites” </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=280 height=210
src="_%20Tutorials_files/image236.png" v:shapes="Picture_x0020_347209"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><i><span>Neisseria gonorrhoeae</span></i><span>:</span></p>

<p style="text-align:center;"><span>Gram-negative diplococci</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=290 height=188
src="_%20Tutorials_files/image238.png" v:shapes="Picture_x0020_347208"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Disseminated Gonococcal Infection (DGI): </span></p>

<p style="text-align:center;"><span>hemorrhagic pustule on an erythematous base</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=194 height=224
src="_%20Tutorials_files/image240.png" v:shapes="Picture_x0020_347207"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><i><span>Trichomonas vaginalis</span></i><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=337 height=226
src="_%20Tutorials_files/image242.png" v:shapes="Picture_x0020_347206"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Herpetic ulcers</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=206 height=140
src="_%20Tutorials_files/image244.png" v:shapes="Picture_x0020_347205"></span><span></span></p>

<p style="text-align:center;"><span>Primary syphilis:</span></p>

<p style="text-align:center;"><span>Chancre</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=250 height=341
src="_%20Tutorials_files/image246.png" v:shapes="Picture_x0020_347204"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Secondary syphilis:</span></p>

<p style="text-align:center;"><span>Erythematous rash on palms and soles</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=262 height=171
src="_%20Tutorials_files/image248.png" v:shapes="Picture_x0020_347203"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Secondary syphilis:</span></p>

<p style="text-align:center;"><span>Condyloma lata</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=242 height=183
src="_%20Tutorials_files/image250.png" v:shapes="Picture_x0020_347202"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Condyloma acuminatum</span></p>

<p style="text-align:center;"><span>(genital warts)</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=251 height=187
src="_%20Tutorials_files/image252.png" v:shapes="Picture_x0020_347201"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Crab louse</span></p>

<p style="text-align:center;"><span>(causes “crabs,” or pediculosis pubis)</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=261 height=241
src="_%20Tutorials_files/image254.png" v:shapes="Picture_x0020_347200"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Scabies mite</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=252 height=150
src="_%20Tutorials_files/image256.png" alt="Description: clue2" v:shapes="Picture_x0020_347199"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Clue cells:</span></p>

<p style="text-align:center;"><span>Bacterial vaginosis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=403 height=241
src="_%20Tutorials_files/image258.png" v:shapes="Picture_x0020_347198"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Candida</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=434 height=289
src="_%20Tutorials_files/image260.png" alt="Description: tzank" v:shapes="Picture_x0020_347197"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Tzank smear:</span></p>

<p style="text-align:center;"><span>Multinucleated giant cells associated with herpes infection</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>.<span>&nbsp; </span><i>Haemophilus ducreyi</i><span> is the cause of chancroid, which is
characterized by painful, non-indurated ulceration and tender lymphadenopathy.
The organism is a gram-negative coccobacillus.<span>&nbsp; </span></span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. <i>Treponema pallidum</i><span> is the cause of syphilis. Primary syphilis
usually presents as a chancre, which is a painless, indurated ulcer, usually
associated with non-tender lymphadenopathy. The organism is a spirochete.<span>&nbsp;&nbsp;&nbsp; </span></span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Herpes genitalis
usually presents with shallow, painful ulceration and tender lymphadenopathy.
It is usually caused by herpes simplex virus 2, but may be caused by herpes
simplex virus 1. The Tzank smear shows multi-nucleated giant cells. Herpes
simplex is a DNA virus.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>.
<i>Neisseria gonorrhoeae</i><span> usually
presents with genital discharge, not genital ulceration. Gram stain shows
gram-negative diplococci. </span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>.
<i>Trichomonas vaginalis</i><span> is a
protozoan that causes vaginitis, not genital ulceration. </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Which of
the following is <i>not</i> true of <i>Staphylococcus aureus</i>? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>It
is a gram-positive, cluster-forming coccus.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is a catalase-positive, coagulase-positive bacterium. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is most commonly identified by latex agglutination (It clumps latex beads
coated with fibrinogen and IgG.) </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>It
colonizes the skin and nares.</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is the most common cause of suppuration (pus-formation).</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is the most common cause of boils and abscesses.</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>It
is the most common cause of osteomyelitis and septic arthritis.</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>It
is a major cause of surgical wound infections.</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is a major cause of spontaneous bacterial peritonitis.</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is a major cause of intravascular catheter-related infections.</span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>It
produces enterotoxins, which cause vomiting and diarrhea.<span>&nbsp; </span></span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
produces toxic shock syndrome toxin (TSST-1), the main cause of toxic shock
syndrome.</span></p>

<p><span><span>M.<span>&nbsp;
</span></span></span><span>It
produces exfoliatin toxin, which causes scalded skin syndrome.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=353 height=265
src="_%20Tutorials_files/image262.png" alt="Description: 191428_xlarge" v:shapes="Picture_x0020_347196"></span><span></span></p>

<p><span></span></p>

<p><span>Staphylococci
are gram-positive, catalase-positive cocci that occur in microscopic clusters
resembling grapes. These bacteria are identified by latex agglutination. (The
bacteria clump latex beads coated with fibrinogen and IgG). Bacteriologic
cultures of the nose and skin of normal humans invariably yields staphylococci.
Difference between <i>Staphylococcus aureus</i> and <i>Staphylococcus
epidermidis </i><span>are summarized below. </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=176 valign=top>
  <p style="text-align:center;"><i><span>Staphylococcus aureus</span></i></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><i><span>Staphylococcus epidermidis</span></i></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><i><span></span></i></p>
  </td>
  <td width=189 valign=top>
  <p><i><span></span></i></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Large
  yellow colonies<span></span></span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Small
  white colonies<span></span></span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Hemolytic
  on blood agar <span></span></span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Non-hemolytic
  on blood agar<span></span></span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Coagulase-positive </span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Coagulase-negative</span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Often pathogenic</span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Usually non-pathogenic (but may cause disease in
  the hospital setting)</span></p>
  </td>
 </tr>
</table>

</div>

<p><i><span></span></i></p>

<p><i><span>Staphylococcus
aureus</span></i><span>
causes a variety of suppurative (pus-forming) infections and toxic states. It
causes superficial skin lesions such as <span>boils</span>,
<span>sties,</span> and <span>furuncules</span>; more serious infections,
such as <span>pneumonia</span>; and
deep-seated infections, such as endocarditis, <span>osteomyelitis, and septic arthritis</span>. <i>S. aureus</i> is a major
cause of <span>hospital acquired (nosocomial)
pneumonia, </span>surgical wound infections, and infections associated with
intravascular catheters and indwelling medical devices. The organism causes <span>food poisoning</span> by releasing
enterotoxins into food, <span>toxic shock
syndrome</span> by releasing superantigens (principally toxic shock syndrome
toxin-1, or TSST-1) into blood, and scalded skin syndrome by releasing
exfoliatin toxin. </span></p>

<p><span></span></p>

<p><i><span>S.
aureus</span></i><span>
expresses many potential <span>virulence
factors</span>: (1) <span>surface proteins</span>
that promote colonization of host tissues; (2) invasins that promote bacterial
spread in tissues (<span>leukocidin</span>, <span>kinases</span>, <span>hyaluronidase</span>); (3) surface factors that inhibit phagocytic
engulfment (<span>capsule</span>, <span>Protein A</span>); (4) biochemical properties
that enhance their survival in phagocytes (<span>carotenoids</span>, <span>catalase</span>
production); (5) immunological disguises (<span>Protein A</span>, <span>coagulase</span>);
(6) membrane-damaging toxins that lyse eukaryotic cell membranes (<span>hemolysins</span>, <span>leukotoxin</span>, <span>leukocidin)</span>;
(7) exotoxins that damage host tissues; and (8) inherent and acquired <span>resistance to antimicrobial agents</span>.</span></p>

<p><span></span></p>

<p><span>Hospital
strains of <i>S. aureus</i> are usually resistant to a variety of different
antibiotics. A few strains are resistant to all clinically useful antibiotics
except vancomycin, and vancomycin-resistant strains are increasingly reported.
The term “<span>MRSA”</span> refers to m<span>ethicillin-resistant <i>Staphylococcus aureus</i></span>.
Methicillin resistance is widespread and most methicillin-resistant strains are
also multi-drug-resistant.</span></p>

<p><span></span></p>

<p><span>The principal mechanism by which <i>Staphylococcus
aureus</i> resists beta-lactam antibiotics (e.g. penicillin) is production of
beta-lactamase. </span><span>Genes
encoding for beta-lactamase are widespread in the bacterial kingdom and are
found on the chromosome and on plasmids.<a
name=4-u1.0-B978-0-323-04475-2..50037-6--p487></a> The <span of gram-positive bacteria (e.g. <i>Staphylococcus aureus</i>) are released into
the extracellular environment. The <span of gram-negative bacteria remain within the
periplasm.<b> </b><span>(The<b> </b>periplasm</span>
is the space between the peptidoglycan cell wall and the external outer
membrane of gram-negative bacteria.) Hundreds of different <span
 enzymes
have been described. All have the same function but with differing amino acid
sequences that influence their affinity for different <span><span></span></p>

<p><span>Staphylococcal
disease has been a perennial problem in the hospital environment since the
beginning of the antibiotic era. <i>S aureus</i> has responded to the
introduction of antibiotics by the usual bacterial means of developing drug
resistance: (1) mutation in chromosomal genes and (2) acquisition of resistance
genes as extrachromosomal plasmids. <span>MRSA
represents an increasingly large proportion of </span>staphylococcal infections
occurring in and out of the hospital.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer I is correct</span></b><span>. <i>Staphylococcus aureus</i> is not a major cause of spontaneous bacterial
peritonitis.<span >&nbsp; </span>Spontaneous bacterial
peritonitis is usually caused by gram-negative bacteria, especially <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>. Other causes
include streptococci (often pneumococcus) and enterococci. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following clinical scenarios is <i>least</i>
likely to be associated with <i>Streptococcus
pyogenes</i> infection? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>8-year
old boy with sore throat is found to have high fever, tonsillar exudate, and
cervical lymphadenopathy.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8-year
old boy has fever, shortness of breath, and migratory arthitis two weeks after
developing a sore throat. Examination shows a new heart murmur, non-tender
subcutaneous nodules, and a serpiginous rash. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8-year
old boy has hematuria, renal insufficiency, edema, and mild elevation of blood
pressure ten days after developing a sore throat</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>8-year
old boy develops fever and sore throat. Examination shows a bright red, tongue
with a “strawberry” appearance, and a fine, red “sandpaper-like” rash on the
chest.<span >&nbsp; </span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8-year
old boy develops fever and a red, swollen, warm, hardened and painful rash on
the arm. The rash has the consistency of an orange peel and has a raised,
sharply demarcated border.</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>1-day
old newborn evaluated for sepsis has blood cultures that grow gram-positive
cocci in pairs and chains. The bacteria agglutinate with group B antiserum.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>The classification of Streptococcus is shown
below:</span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/9/9d/Strep_Classification.svg"><span><img border=0 width=392 height=234
src="_%20Tutorials_files/image264.png"
alt="Description: File:Strep Classification.svg" v:shapes="Picture_x0020_347195"></span></a><span></span></p>

<p><i><span></span></i></p>

<p><span></span></p>

<p><i><span>Streptococcus pyogenes</span></i> (Group A, beta-hemolytic streptococcus)
can cause pharyngitis (Strep throat), rheumatic fever, post-streptococcal
glomerulonephritis, erysipelas, and scarlet fever. <i><span>Streptococcus agalactiae</span></i> (Group B, beta-hemolytic
streptococcus) can cause neonatal sepsis and meningitis (if the bacterium
colonizes the mother’s vagina and is transmitted to the newborn during
delivery). <i><span>Streptococcus pneumoniae</span></i><span> can cause a
number of different conditions, including </span>pneumonia, acute sinusitis,
otitis media, meningitis, cellulitis, and spontaneous bacterial peritonitis. <i><span>Streptococcus viridans</span></i><span> can cause dental
caries and endocarditis. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer F is correct. </span></b><span>Neonatal sepsis
associated with streptococcal bacteremia would be due to Group B “strep” (<i><span>Streptococcus agalactiae</span></i><span>), not Group A
“strep” (<i>Streptococcus pyogenes</i>). </span><span>&nbsp;&nbsp;&nbsp;</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect. </span></b><span>Group A streptococcus
causes streptococcal pharyngitis (Strep throat), which is characterized by the
following triad: high fever, tonsillar exudate, and cervical
lymphadenopathy.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b>Answer B is incorrect. </b>Acute rheumatic fever (ARF) is a
complication of pharyngeal respiratory infection with Group A streptococcus.
Infection triggers the formation of antibodies, which cross-react with
auto-antigens on interstitial connective tissue particularly of the endocardium
and synovium. Findings may include pancarditis (inflammation of the
endocardium, myocardium, and pericardium); migratory polyarthritis;
subcutaneous nodules; rash; and Sydenham’s chorea (involuntary, purposeless
movement). The most common clinical finding is a migratory arthritis involving
multiple joints. The test for anti-streptolysin O (ASO) antibodies is often
used to make the diagnosis. </p>

<p></p>

<p><b><span>Answer C is incorrect. </span></b><span>Post-streptococcal
glomerulonephritis (PSGN) is an uncommon complication of either respiratory or
skin infection with Group A streptococcus. It is classified as a type III
hypersensitivity reaction. Symptoms develop within 10 days of developing “strep
throat” or within 3 weeks of acquiring a skin infection. PSGN is characterized
by hematuria, renal insufficiency, edema, and a rise in blood pressure. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>Group A streptococcus is
the cause of scarlet fever, which is characterized by fever; sore throat; a
bright red, “strawberry” tongue; and a fine, red “sandpaper-like” rash.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Group A streptococcus
is the cause of erysipelas, which is characterized by a red, painful rash with
a sharply-demarcated raised border.<b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 33-year-old woman living in Maryland has a one-week history of
low-grade fever, fatigue, and a red rash over the skin behind her left knee.
She is an avid hiker. Her temperature is 38<sup>o</sup>C (100.4<sup>o</sup>F).
Physical examination shows an 8-cm, warm, nontender, erythematous lesion with
partial central clearing over the skin of the left popliteal area. Which of the
following is the most likely causal organism? </span></p>

<p><span></span></p>

<p><i><span><span>A.<span>&nbsp;&nbsp;&nbsp; </span></span></span></i><i><span>Borrelia burgdorferi</span></i></p>

<p><i><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></i><i><span>Ehrlichia chaffeensis</span></i></p>

<p><i><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></i><i><span>Francisella tularensis</span></i></p>

<p><i><span><span>D.<span>&nbsp;&nbsp; </span></span></span></i><i><span>Rickettsia rickettsii<span>&nbsp;&nbsp; </span></span></i></p>

<p><i><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span></i><i><span>Babesia microti</span></i></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Rocky
Mountain spotted fever</span></b><span> is the most lethal and most frequently reported rickettsial
illness in the United States. The disease is caused by <i>Rickettsia rickettsii</i>,
an intracellular species of bacterium that is spread to humans by <i>Dermacentor</i>
ticks. The disease can be difficult to diagnose in the early stages, and can be
fatal without prompt treatment.</span></p>

<p><span></span></p>

<p><span>The name
“Rocky Mountain spotted fever” is a misnomer, as the disease is broadly
distributed throughout the continental United States, and occurs as far north
as Canada and as far south as Central America and parts of South America.
People infected with <i>R. rickettsii</i> usually notice symptoms after an
incubation period of one to two weeks. The early clinical presentation is
nonspecific. Initial symptoms include fever, severe headache, nausea, vomiting,
and muscle pain. Later signs and symptoms include maculopapular rash, petechial
rash, abdominal pain, and joint pain.</span></p>

<p><span></span></p>

<p>The classic triad of
findings is fever, rash, and history of tick bite; however, this combination is
often not identified when the patient presents initially. The rash has a
centripetal pattern of spread, meaning it begins at the extremities and courses
toward the trunk.</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=217 height=139
src="_%20Tutorials_files/image266.png" alt="Description: RMSF" v:shapes="Picture_x0020_347194"></span></p>

<p></p>

<p>The rash first appears after
the onset of fever and is often subtle. Most often it begins as small, flat,
pink, non-itchy spots (macules) on the wrists, forearms, and ankles. These turn
pale when pressure is applied and eventually become raised. The characteristic
red, spotted, petechial rash is usually not seen until the sixth day or later,
but this type of rash occurs in less than 60% of patients. The rash involves
the palms or soles in as many as 50% to 80%; however, this distribution may not
occur until later in the course of the disease. 10-15% may never develop a
rash.</p>

<p></p>

<p>Abnormal laboratory findings
include thrombocytopenia and elevated liver enzyme levels. The disease can be
very severe, and patients often require hospitalization. <i>R. rickettsii</i>
can infect endothelial cells throughout the body, causing dysfunction of the
respiratory, gastrointestinal, renal, and neurologic systems. Diagnostic tests
include IFA on blood samples, immunostaining of biopsy of the rash, or PCR on
blood and skin biopsies.<span >&nbsp;
</span>Appropriate antibiotic treatment should be initiated <span>immediately.</span> Doxycycline is the
treatment of choice. (Failure to respond to a tetracycline antibiotic argues
against a diagnosis of Rocky Mountain spotted fever.)</p>

<p></p>

<p><b></b></p>

<p><b>Lyme disease</b> is the
most common tick-borne disease in the Northern Hemisphere.<span>&nbsp; </span>It is named after the town of Lyme,
Connecticut, where a number of cases were identified in 1975. Lyme disease is
caused by spirochetes belonging to the genus <i>Borrelia</i>. Most cases are
caused by <i>Borrelia burgdorferi.</i> <i>Borrelia</i> is transmitted to humans
by the bite of infected ticks belonging to the genus <i>Ixodes</i> (“hard
ticks”). </p>

<p></p>

<p>Lyme disease can produce a
range of symptoms. The incubation period is usually one to two weeks, but can
be shorter (days) or longer (months to years). The disease usually occurs
during tick season (May to September). Asymptomatic infection occurs in less
than 7% of infected individuals. Early symptoms include fever, malaise,
headache, and muscle soreness. A classic sign is a circular, outwardly
expanding rash, called erythema chronicum migrans. It appears at the site of
the tick bite within a month of the bite. The rash is red, may be warm, and is
generally painless. Classically, the innermost part is dark red and indurated
(firm), the outer edge remains red, and the portion in between clears. This
gives the lesion the appearance of a bullseye (see figure). Erythema chronicum
migrans is thought to occur in 80% of infected patients. </p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=161 height=190
src="_%20Tutorials_files/image268.png" alt="Description: lyme-disease-rash"
v:shapes="Picture_x0020_347193"></span></p>

<p></p>

<p>Days to weeks after
infection, the bacteria may spread through the bloodstream. Symptoms of early
dissemination include migrating pain in the muscles, joints, and tendons, and
heart palpitations due to arrhythmia. Various neurological problems may occur,
including facial palsy, meningitis, and encephalitis (resulting in memory loss,
sleep disturbance, or mood change). After several months, untreated patients
may go on to develop chronic symptoms that affect the brain, nerves, eyes,
joints, and heart. </p>

<p>The diagnosis of Lyme
disease is based on symptoms, objective physical findings (such as erythema
migrans, facial palsy, or arthritis), history of possible exposure to infected
ticks, and serological blood tests. The classic “bullseye” rash is considered
sufficient to establish a diagnosis, even when serologic blood tests are
negative. Doxycycline is the drug of choice in adults. </p>

<p><b><span></span></b></p>

<p><b><span>Ehrlichiosis </span></b><span>(sometimes called Rocky Mountain
“spotless” fever) is a tick-borne disease caused by bacteria belonging to the
genus <em>Ehrlichia</em><em><span> or </span>Anaplasma</em><em><span>. Most cases are caused by </span></em><i>Ehrlichia chaffeensis</i><span>, a </span>tiny, obligate intracellular
bacterium that resembles <em>Rickettsia</em><em><span>. The organism</span></em> infects white blood
cells, multiplies within the cytoplasm, and forms large, mulberry-shaped
aggregates, called morulae. The incubation period is 1-2 weeks. Symptoms are
usually acute and range from mild to severe. Most patients have fever, chills,
malaise, headache, and myalgias. Cough, vomiting, arthralgias, neurologic
symptoms (e.g. altered sensorium and neck stiffness) also occur, but rash is
uncommon. Laboratory abnormalities include leukopenia, thrombocytopenia, and
elevated hepatic transaminase levels. The estimated death rate is 1% to 10%;
hospitalization rates are as high as 60%. Most deaths are due to cardiac,
respiratory, or renal failure.</span></p>

<p><span></span></p>

<p><b><span>Tularemia
</span></b><span>is a
serious disease caused by the bacterium <i>Francisella tularensis</i><span>,</span> a gram-negative coccobacillus. The
disease affects a variety of wild animals, including rabbits, deer, squirrels,
muskrat, and beaver. Humans can acquire the bacteria from direct contact with
these animals, from the bite of a tick or fly that has fed on an infected
animal, or from contaminated food or water. Tularemia usually occurs in the
summer months and is most common in people who have had contact with infected
animals (e.g. hunters, furriers, butchers, laboratory workers, game wardens,
and veterinarians). In the U.S., most cases occur in the southeastern and Rocky
Mountain states. The primary vectors are ticks and deer flies.<span>&nbsp; </span>This organism is also listed on the
CDC’s list of category A biological weapons.</span></p>

<p><span></span></p>

<p>The incubation period is
1-14 days. Symptoms include fever, chills, malaise, anorexia, rash, and
enlarged lymph nodes. There are five characteristic clinical syndromes:
ulceroglandular/glandular (the most common type, representing 75% of all
forms), oropharyngeal, pneumonic, oculoglandular, and typhoidal. In
ulceroglandular fever, a tender red bump appears in the area of the tick bite.
Within a few weeks, the bump ulcerates. Nearby lymph nodes swell enormously,
become very tender, and may drain purulent fluid (see figure). Smears of
aspirates from enlarged lymph nodes usually contain the organisms.<span>&nbsp; </span>Streptomycin and gentamicin are the
drugs of choice for treating tularemia.</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=190 height=186
src="_%20Tutorials_files/image270.png" alt="Description: tularemia_2" v:shapes="Picture_x0020_347192"></span></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Babesiosis</b> is a
tick-borne disease caused by the malaria-like parasite, <i>Babesia</i><span>. </span>In North America, the disease is
primarily found in eastern Long Island, Fire Island, Nantucket Island, and
Martha's Vineyard off of the coast of Massachusetts. It is sometimes called
“the malaria of the Northeast.”<span> </span>Most
cases of <i>Babesia</i> infection are asymptomatic. Some individuals have mild
fever and diarrhea. In severe cases, symptoms resemble malaria, with fevers up
to 40.5°C (105°F), shaking chills, and severe hemolytic anemia. Organ failure
may follow. Fulminant cases occur mostly in the very young, the very old, and
in people who are asplenic or otherwise immunocompromised. Diagnosis is made by
identifying parasites (which resemble a “Maltese cross”) on a Giemsa-stained
thin blood smear (see figure). Treatment is usually a two-drug regimen (quinine
and clindamycin or atovaquone and azithromycin).</p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=213 height=181
src="_%20Tutorials_files/image272.png" alt="Description: cow40_answer2" v:shapes="Picture_x0020_347191"></span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>The skin lesion in the
popliteal area, which resembles a bullseye, is called erythema chronicum
migrans. This is a common characteristic of Lyme disease, which is caused by
the spirochete, <i><span>Borrelia burgdorferi</span></i><span>.</span><span>&nbsp;&nbsp; </span><b><span >&nbsp;</span></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect. </span></b><i><span>Ehrlichia chaffeensis</span></i><span> causes ehrlichiosis.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><i><span>Francisella tularensis</span></i><span> causes tularemia.</span><span></span></p>

<p><i><span></span></i></p>

<p><b><span>Answer D is incorrect. </span></b><i><span>Rickettsia rickettsii </span></i><span>causes </span><span>Rocky
Mountain spotted fever.<i><span><span >&nbsp; </span></span></i></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect. </span></b><i><span>Babesia microti</span></i><span> causes babesiosis.</span></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A&nbsp;38-year-old
man presents to the emergency department with a two-day history of cough
productive of blood-tinged sputum. He reports fevers, night sweats, and a
15-pound weight loss. He smokes two packs of cigarettes a day and occasionally
uses intravenous drugs.&nbsp;He lives in a homeless shelter and is
HIV-positive. </span></p>

<p><span></span></p>

<p><span>Blood
tests show:</span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>12 g/dl</span></p>

<p><span>WBC<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>11,500/mm3</span></p>

<p><span>Platelet<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>380,000/mm3
</span></p>

<p><span></span></p>

<p><span>Chest
X-ray shows a cavitary lesion in the right upper lobe. </span></p>

<p><span>&nbsp;</span></p>

<p><span>What is
the most likely diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Squamous
cell carcinoma of the lung</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tuberculosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lung
abscess from chronic aspiration</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Aspergilloma</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=244 valign=top>
  <p style="text-align:center;"><span>Risk Factors for Tuberculosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Immunosuppression</span></b><span> </span></p>
  <p><i><span>Diseases</span></i><span>: HIV/AIDS, diabetes,
  end-stage renal disease, cancer, silicosis, gastrectomy </span></p>
  <p><i><span>Drugs</span></i><span>: glucocorticoids,
  chemotherapeutic agents, immunosuppressive drugs</span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Close
  contact with infected person</span></b><span> </span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Migration
  from country with high rate of TB</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Advanced
  age</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Substance
  abuse</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Malnutrition</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Lack
  of medical care</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Living
  or working in residential care facility</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Living
  in refugee camp or shelter</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Health
  care work</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>International
  travel</span></b><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span>Pulmonary
tuberculosis can produce fever, night sweats, weight loss, cough, hemoptysis,
and adenopathy. The patient in this vignette has several symptoms of active
tuberculosis and several risk factors as well: homelessness, HIV infection, and
substance abuse. Cavitation in the upper lobe is highly suspicious for
tuberculosis. The patient should be placed in negative-pressure&nbsp;isolation
room. Three&nbsp;sputum samples should be obtained, stained, and cultured for
acid-fast bacilli (AFB). If the patient has active tuberculosis, treatment
should be started with a four-drug regimen: isoniazid, pyrazinamide, rifampin,
and ethambutol. “Direct observed therapy” (DOT) may be continued in the
outpatient setting. (Note: HIV-positive patients often do not generate a robust
response to the tuberculin skin test. Induration &lt;5 mm is often seen.)</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
B is correct.<span >&nbsp; </span></span></b><span>The patient has symptoms and risk factors of active pulmonary
tuberculosis.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Bronchogenic carcinoma is uncommon in people under the age of 40, although it
can occur. Squamous cell carcinoma is particularly prone to cavitation. </span></p>

<p><span>&nbsp;</span></p>

<p><b><span>Answer
C is incorrect</span></b><span>.<span>&nbsp; </span>Alcoholism and drug abuse can produce
altered levels of consciousness predisposing to aspiration pneumonia. The right
lower lobe is usually involved and cavitation may occur. </span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.&nbsp;&nbsp;Aspergillus
infection is more common in patients undergoing chemotherapy. An aspergilloma
is a fungal mass that colonizes a pre-existing cavity formed by a necrotizing
infection. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
43-year-old man presents with a chronic cough, night sweats, and weight loss. A
chest x-ray shows infiltrates in the right upper lobe. A lung biopsy shows
multiple necrotizing granulomas. Acid-fast staining of the granulomatous tissue
shows numerous acid-fast bacilli. Tissue culture grows <i>Mycobacterium
tuberculosis</i>. Which of the following inflammatory mediators is principally
responsible for controlling tuberculous infection?</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=154 height=205
src="_%20Tutorials_files/image274.png"
alt="Description: http://pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/cheese1.jpg"
v:shapes="Picture_x0020_347190"></span><span></span></p>

<p style="text-align:center;"><span>Caseous necrosis of tuberculosis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=149 height=148
src="_%20Tutorials_files/image276.png"
alt="Description: http://pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/afb.jpg"
v:shapes="Picture_x0020_347189"></span></p>

<p style="text-align:center;"><span>Acid-fast stain: <i>Mycobacterium tuberculosis</i></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Bradykinin</span></p>

<p><span>B.<span>&nbsp; </span>Interferon-&#947;</span></p>

<p><span>C.<span>&nbsp; </span>Leukotriene B4</span></p>

<p><span>D.<span>&nbsp; </span>Prostaglandin E2</span></p>

<p><span>E.<span>&nbsp; </span>Trimolecular complex (C567)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><a
name=4-u1.0-B978-1-4377-0792-2..50013-4--p368></a>Macrophages are the primary
cells infected by <i>M. <span Early
in infection, the bacilli replicate essentially unchecked, while later in
infection, the cell response stimulates macrophages to contain the
proliferation of bacteria.<a name=4-u1.0-B978-1-4377-0792-2..50013-4--celi></a>
</p>

<p></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span </i></span><span
 enters macrophages
by endocytosis</span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span inside the
macrophage, <i>M. </i></span><span replicates within the phagosome by blocking fusion of the phagosome
and lysosome. </span>Infected macrophages are eventually destroyed and bacteria
are released, causing bacteremia, seeding of multiple sites, and infection of
other macrophages. <span"mso-spacerun:yes">&nbsp;</span>Despite the bacteremia, most people at
this stage are asymptomatic or have a mild flu-like illness.</span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span cells
(i.e., dendritic cells) encounter mycobacterial antigens in draining lymph
nodes. These APCs produce IL-12, which allows differentiation of T<sub>H</sub>1
cells. (This process occurs about 3 weeks after infection and represents the
body’s mounting of an immune response). </span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span T<sub>H</sub>1
cells produce IFN-&#947;. <i>INF-</i>&#947; <i>is the critical mediator that
enables macrophages to contain the M. </i></span><span infection</i>. IFN-&#947; stimulates formation of the
phagolysosome in infected macrophages, exposing the bacteria to an inhospitable
acidic environment. IFN-&#947; also stimulates expression of inducible nitric
oxide synthase, which produces nitric oxide, capable of destroying several
mycobacterial constituents, from cell wall to DNA.</span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span cells also
orchestrate the formation of granulomas and caseous necrosis. They produce
IFN-&#947;, which causes macrophages to differentiate into the “epithelioid
histiocytes” that characterize the granulomatous response. Some of these
epithelioid histiocytes fuse to form giant cells. In many people this response
halts the infection before significant tissue destruction occurs. In others,
the infection progresses due to advanced age or immunosuppression, and the
ongoing immune response results in tissue destruction with caseation and
cavitation. </span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span macrophages
secrete tumor necrosis factor (TNF), which recruits monocytes. The importance
of TNF is underscored by the fact that patients with rheumatoid arthritis who
are treated with a TNF antagonist have an increased risk of </span><span
 reactivation.</span></p>

<p></p>

<p>In summary, immunity to <i>M.
<span is primarily mediated by T<sub>H</sub>1
cells, which stimulate macrophages to kill the bacteria via <span immune response, while largely effective, comes at the cost of
hypersensitivity and tissue destruction. Reactivation of the infection or
re-exposure to the bacilli in a previously sensitized host results in rapid
mobilization of a defensive reaction, but also increased tissue necrosis. Just
as hypersensitivity and resistance are correlated, so, too, the loss of
hypersensitivity (indicated by tuberculin negativity in a previously
tuberculin-positive individual) may be an ominous sign that resistance to the
organism has faded.</p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b>Answer B is correct</b>. <span
 T<sub>H</sub>1 cells produce IFN-&#947;, a critical mediator
that enables macrophages to contain the M. </span><span infection. IFN-&#947; stimulates formation of the phagolysosome in
infected macrophages, exposing the bacteria to an inhospitable acidic
environment. IFN-&#947; also stimulates expression of inducible nitric oxide
synthase, which produces nitric oxide, capable of destroying several
mycobacterial constituents, from cell wall to DNA.</span></p>

<p><span><b><span>Answer
A is incorrect</span></b><span>.
Bradykinin is a small vasoactive peptide produced in response to injured blood
vessels.<span >&nbsp; </span>Factor XII initiates the
kinin cascade by activating kallikrein. This cascade produces bradykinin, which
increases vascular permeability and permits the efflux of plasma proteins into
injured tissue. This contributes to the pain associated with inflammation.</span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect</span></b><span>.
Leukotriene B4 is a lipid mediator of inflammation. It acts as a
chemoattractant for leukocytes and increases vascular permeability.<span>&nbsp; </span>Leukotrienes and prostaglandins are
derived from arachidonic acid, which is generated from membrane
phospholipids.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Prostaglandin E2 is a lipid mediator of inflammation. It is a vasodilator and
an inducer of fever. Prostaglandins and leukotrienes are derived from
arachidonic acid, which is generated from membrane phospholipids.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect</span></b><span>.
The trimolecular complex (C567) is part of the terminal complement pathway,
which generates the membrane attack complex (MAC).<span>&nbsp; </span>The MAC appears on the surface of
intruding bacteria and produces transmembrane channels, which disrupt the
phospholipid bilayer, leading to osmotic lysis and cell death. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 4-year-old boy is brought to the
physician because of a 2-day history of fever and an itchy rash. The rash began
on his face and then spread to his trunk, arms, and legs. Several children at
his day-care center have had similar symptoms. His temperature is 38.9°C
(102°F), pulse is 100/min, respirations are 20/min, and blood pressure is
110/60 mm Hg. Physical examination shows multiple red papules and vesicles over
the face, trunk, and upper and lower extremities. Some vesicles contain clear
fluid, whereas others are crusted. Which of the following is the most likely
causal virus?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Measles</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rubella</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Herpes
simplex virus 1</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Erythrovirus
B19</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Varicella-zoster
virus</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Measles</b>, also known
as <span>rubeola</span> or <span>morbilli</span>, is an infection of the
respiratory system caused by a paramyxovirus of the genus <i>Morbillivirus</i>.
Morbilliviruses, like other paramyxoviruses, are enveloped, single-stranded RNA
viruses. </p>

<p>Classic symptoms of measles
include four-day fevers and the three Cs &#8211; cough, coryza (runny nose) and
conjunctivitis (red eyes). The fever may reach 40°C (104°F). Koplik's spots
inside the mouth are pathognomonic (diagnostic) for measles, but are not often
seen because they are transient, disappearing within a day. The characteristic
rash is a generalized erythematous maculopapular rash that begins several days
after fever commences. The rash, often itchy, starts on the head and spreads to
most of the body. It appears two to four days after initial symptoms, lasts for
up to eight days, and changes color from red to brown before disappearing.</p>

<p><span>&nbsp; </span></p>

<p>Measles is spread through
droplets from a person’s nose or mouth, and is highly contagious &#8211; 90% of
those sharing a living space with an infected person will catch it.
Complications are relatively common and include diarrhea, pneumonia, and acute
encephalitis.</p>

<p></p>

<p><b>Rubella</b>, commonly
known as <span>German measles</span>, is a
disease caused by the rubella virus, a member of the togaviridae family. The
name “rubella” is derived from the Latin word meaning <i>little red</i>. The
disease is transmitted via airborne droplets from the upper respiratory tract
and is usually mild, lasting 1-3 days. Children recover more quickly than
adults. Infection of the mother during pregnancy can be serious; if the mother
is infected within the first 20 weeks of pregnancy, the child may be born with
congenital rubella syndrome (CRS).<span >&nbsp; </span></p>

<p></p>

<p>The primary finding is rash
on the face that spreads to the trunk and limbs, and usually fades after three
days (hence, the term “three-day measles”). Other symptoms include fever,
lymphadenopathy, joint pains, headache, and conjunctivitis. The fever rarely
rises above 38 <sup>o</sup>C (100.4 <sup>o</sup>F), and the rash (usually
itchy) is pink or light red. It disappears with no staining or peeling of the
skin. </p>

<p></p>

<p><b>Herpes simplex virus-1 (HSV-1) </b>is a double-stranded DNA virus and
belongs to the Alpha Herpesvirus family.<span >&nbsp;
</span>Herpesviruses can establish latent infection and persist indefinitely in
the host.<span >&nbsp; </span>HSV-1is acquired via
close contact to the virus from mucosal or genital and oral secretions.<span>&nbsp; </span>Primary HSV infection results in
orolabial herpes or gingovostomatitis and recurrent infections manifest as cold
sores and fever blisters.<span >&nbsp; </span>HSV-1
infection in neonates or immunocompromised hosts can be very severe.<span>&nbsp; </span>Symptoms associated with orolabial
herpes include fever, chills, mayalgias, cervical lymphadenopathy, and
irritability.</p>

<p></p>

<p><b>Erythrovirus B19</b> causes “slapped cheek syndrome” or Fifth’s
disease.<span >&nbsp; </span>This single-stranded DNA
virus belongs to the parvoviridae family and can be spread by aerosal, fomites
or transplacental transmission.<span >&nbsp;
</span>Most cases are subclinical and occur in late winter to early spring.<span>&nbsp; </span>After a 7-10 day incubation, most
patients present with low-grade fever, headache, and mild respiratory
symptoms.<span >&nbsp; </span>A slapped-cheek rash
appears 7 days later.<span >&nbsp; </span>The rash
spreads and red blotches extend down to the trunk, arms, and legs.<span>&nbsp; </span>The rash, which has a lacy net-like
appearance, usually spares the palms and soles.<span>&nbsp; </span>Serious complications include still
births if the mother is infected during the second trimester and transient
aplastic crises in sickle-cell patients.<span >&nbsp;
</span>The virus lyses immature erythroid precursors. </p>

<p><b>Varicella zoster virus</b>
(<b>VZV</b>) is one of eight herpes viruses known to infect humans. It commonly
causes chickenpox in children and zoster (shingles) in adults. Primary
infection results in chickenpox (varicella), a highly contagious disease spread
by coughing and sneezing and by direct contact with fluid from infected
vesicles on the skin.<span >&nbsp; </span></p>

<p>Initial symptoms may include
fever, malaise, headache, sore throat, myalgia, and itching. The chicken pox
rash begins on the face and trunk and spreads to the extremities. Lesions start
as 2-4 mm erythematous papules that develop an irregular outline (rose petal).
A thin-walled, clear vesicle (dew drop) develops on top of the erythematous
area. This “dew drop on a rose petal” is characteristic of chicken pox. After
8-12 hours, the fluid gets cloudy and the vesicle breaks, leaving a crust. The
fluid is highly contagious, but once the lesions crust over, the patient is no
longer infectious. The crust usually falls off after 7 days. Each lesion goes
through this cycle in about 7 days, and new lesions crop up daily. Rare
complications include pneumonia and encephalitis. </p>

<p></p>

<p>When clinical symptoms have
resolved, VZV remains dormant in the nervous system, particularly in the
trigeminal and dorsal root ganglia. In about 10&#8211;20% of cases, the virus
reactivates later in life causing shingles. Shingles usually presents with pain
and vesicular rash in a dermatomal distribution. Complications include
postherpetic neuralgia (severe pain in the distribution of the affected nerve).<span>&nbsp; </span>The rash described in the vignette is
typical of chickenpox, which is caused by the varicella-zoster virus.</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct. </b>The rash described in the vignette is typical
of chickenpox, which is caused by the varicella-zoster virus.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>HIV-1 is sensitive to
solvents such as chloroform and 20% diethyl ether, whereas hepatitis A virus is
resistant to such solvents. This resistance is best explained by the absence of
which of the following in hepatitis A virus?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Single-stranded
RNA</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Reverse
transcriptase</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Spherical
structure</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Icosahedral
symmetry</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>Viral
envelope</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Many viruses have an <span>envelope</span> surrounding the protein
capsid. The envelope is usually derived from portions of the host cell membrane
(which is comprised of phospholipids and proteins), but also includes virally
derived glycoproteins. Functionally, the envelope is used by viruses to enter
the host cell. Glycoproteins on the surface of the envelope bind to receptor
sites on the host’s membrane. The viral envelope then fuses with the host’s
membrane, allowing the capsid and viral genome to enter the host.</p>

<p></p>

<p>The viral envelope, which is
composed of a lipid bilayer, is relatively sensitive to desiccation, heat, and
detergents. Consequently, enveloped viruses are easier to sterilize than
non-enveloped viruses. They have limited survival outside the host and
typically must transfer directly from host to host.</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=131 valign=top>
  <p>Naked DNA viruses</p>
  </td>
  <td width=216 valign=top>
  <p>Enveloped DNA viruses</p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p></p>
  </td>
  <td width=216 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p>Adenovirus</p>
  <p>Human papillomavirus</p>
  <p>Jacob-Creutzfeld</p>
  <p>Parvovirus (e.g., B19)</p>
  <p></p>
  <p></p>
  </td>
  <td width=216 valign=top>
  <p>Hepatitis B virus</p>
  <p>Herpesvirus</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Epstein-Barr virus</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Cytomegalovirus</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Herpes simplex virus 1 </p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Herpes simplex virus 2</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Varicella zoster virus</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Roseola virus (HHV-6)</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Kaposi’s sarcoma virus (HHV-8)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></p>
  <p>Smallpox</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=131 valign=top>
  <p>Naked RNA viruses</p>
  </td>
  <td width=216 valign=top>
  <p>Enveloped RNA viruses</p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p></p>
  </td>
  <td width=216 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p>Hepatitis A virus</p>
  <p>Poliovirus</p>
  <p>Rhinovirus</p>
  <p>Coxsackievirus</p>
  <p>Norwalk virus</p>
  <p>Rotavirus</p>
  <p></p>
  </td>
  <td width=216 valign=top>
  <p>Hepatitis C</p>
  <p>HIV</p>
  <p>Influenza</p>
  <p>Parainfluenza</p>
  <p>Measles</p>
  <p>Mumps</p>
  <p>Rubella</p>
  <p>Respiratory syncitial
  virus</p>
  <p>Rabies</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E
is correct</span></b><span>.<span>&nbsp; </span>Enveloped viruses possess an outer
coating, or envelope, which is composed of a lipid layer (fat-like substance
that is water insoluble). The envelope is relatively sensitive to detergents
and is needed to aid in attachment of the virus to the host cell. Loss of the
envelope results in loss of infectivity. Enveloped viruses are easily
inactivated by routine surface cleaning and disinfection. HIV-1 has an
envelope; hepatitis A virus does not. This explains why HIV is more sensitive
to detergents than hepatitis A.<span >&nbsp; </span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section">Heart</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Lung</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Chest Pain</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Costochondritis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Esophageal
rupture</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gastroesophageal
reflux</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Myocardial
infarction</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pericarditis</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pleuritis</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Pneumonia</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Pneumothorax</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulmonary
embolism</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Stable
angina</span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>Thoracic
aortic dissection</span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Varicella-zoster</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>28-year-old
man develops sudden-onset chest pain and shortness of breath while standing.
The pain is sharp. Physical examination reveals diminished breath sounds and
hyperresonance to percussion over the right lung.</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>29-year-old
woman experiences sudden, severe chest pain while undergoing
esophagogastroduodenoscopy.<span >&nbsp; </span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>32-year-old
woman presents with mild, left-sided chest pain. The pain began three days ago
and is constant. Physical examination reveals tenderness over the ribs near the
upper left sternum.</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>37-year-old
woman presents with low-grade fever, sore throat, dry cough, and diffuse muscle
and joint aches. She develops a sharp localized pain in the right chest pain
that worsens with inspiration. </span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>38-year-old
woman “catches a cold” and, soon afterward, develops chest pain. The pain is
sharp and constant. It is worse when she is supine and relieved with sitting
and leaning forward.</span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>48-year-old
woman has a three-day history of fever, chills, and productive cough. Today she
has a sharp pain in the right lower chest. The pain is worse with inspiration.
Physical examination reveals bronchial breath sounds and egophony over the
right lower lung field. </span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>51-year-old
woman suddenly develops chest pain and shortness of breath three days after
undergoing hip surgery. The pain is sharp and worsened by deep breathing.</span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>57-year-old
man with hypertension is brought to the emergency department with a sudden,
excruciating pain in the chest. The pain is described “ripping” and “tearing.”
Blood pressures are unequal in both arms. </span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>58-year-old
man with hypertension visits the clinic because of mid-sternal chest pressure
that occurs when he walks two or three blocks. The pressure goes away with
rest.<span >&nbsp; </span></span></p>

<p><span><span>10.<span>&nbsp;
</span></span></span><span>62-year-old
man with a 30-pack-year smoking history is brought to the emergency department
with severe, crushing pain in the chest that radiates to the left arm and jaw.
The pain is a deep, heavy pressure that won’t go away. It has been present for
more than an hour and is accompanied by shortness of breath, sweating, and
nausea. </span></p>

<p><span><span>11.<span>&nbsp;
</span></span></span><span>70-year-old
man presents with sharp pain and a vesicular rash over the right chest. The
pain and rash have a band-like distribution.</span></p>

<p><span><span>12.<span>&nbsp;
</span></span></span><span>72-year-old
man visits his physician because of chest “burning” that is worse after meals,
especially when he is supine.</span></p>

<p><span>The
evaluation of chest pain begins with a complete medical interview. The history
may reveal nuances in the quality, location, duration, provoking events, and
relieving measures, which serve to accurately focus the subsequent evaluation.
However, with few exceptions, such as evident injury to the chest wall, a
specific diagnosis cannot be made with complete confidence from the clinical
history alone. Physical examination may reveal evidence of pleural, lung
parenchymal, or airway disease; localized chest wall involvement; or signs of
mitral valve prolapse, aortic valve stenosis, or other cardiac abnormalities.</span></p>

<p><span></span></p>

<p><span>For adults
who present to the emergency department with new-onset chest pain, the
immediate concern is to properly identify and characterize potentially
life-threatening conditions, such as myocardial infarction, acute pulmonary
embolism, or tension pneumothorax that requires urgent management. Some
diagnostic features are listed in the table below. <a
name=4-u1.0-B978-1-4160-4710-0..00030-4--t001></a></span></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span>Differential Diagnosis
of Chest Pain</span></b></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td>
   <p style="text-align:center;"><b><span>Diagnosis</span></b></p>
   </td>
   <td>
   <p style="text-align:center;"><b><span>Pain</span></b></p>
   </td>
   <td>
   <p style="text-align:center;"><b><span>ECG</span></b></p>
   </td>
   <td>
   <p style="text-align:center;"><b><span>CXR</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td>
  <p><span>Angina pectoris</span></p>
  </td>
  <td>
  <p><span>Substernal, constricting;</span></p>
  <p><span>transient,
  effort-related; relieved by nitroglycerin </span></p>
  </td>
  <td>
  <p><span>Local ST depression;
  occasional elevation</span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Myocardial infarction</span></p>
  </td>
  <td>
  <p><span>Acute, severe,
  persistent, substernal, crushing pain;</span></p>
  <p><span>radiation to the jaw or
  arm; S4 gallop; sometimes last systolic murmur; possible hypotension; &#8593;
  troponin</span></p>
  </td>
  <td>
  <p><span>Local ST elevation or
  depression</span></p>
  </td>
  <td>
  <p><span>Possible vascular
  congestion or cardiomegaly</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Pulmonary embolism</span></p>
  </td>
  <td>
  <p><span>Sudden onset, pleuritic
  pain; dyspnea; tachycardia; sometimes mild fever, sometimes hemoptysis; shock
  if severe; risk factors for venous thrombosis</span></p>
  </td>
  <td>
  <p><span>Nonspecific; occasional
  RV strain</span></p>
  </td>
  <td>
  <p><span>Normal or opacities ±
  small pleural effusion</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Pulmonary artery
  hypertension</span></p>
  </td>
  <td>
  <p><span>Gradual onset; dyspnea,
  fatigue, and edema</span></p>
  </td>
  <td>
  <p><span>Tall right precordial R
  waves, right axis deviation, RV strain</span></p>
  </td>
  <td>
  <p><span>Prominent pulmonary
  arteries</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Bacterial pneumonia</span></p>
  </td>
  <td>
  <p><span>Pleuritic pain; onset in
  minutes to hours; fever; chills; cough; purulent sputum; often dyspnea and
  tachycardia; signs of consolidation </span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
  <td>
  <p><span>Consolidation</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Pneumothorax</span></p>
  </td>
  <td>
  <p><span>Sudden, sharp, unilateral
  pain; dyspnea; maybe diminished breath sounds; maybe subcutaneous air;
  asthenic habitus; tendency toward recurrence<span>&nbsp; </span></span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
  <td>
  <p><span>Collapsed lung</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Tension pneumothorax</span></p>
  </td>
  <td>
  <p><span>Significant shortness of
  breath, hypotension, neck vein distension; unilateral diminished breath
  sounds and hyperresonance to percussion; sometimes subcutaneous air</span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
  <td>
  <p><span>Collapsed lung; tracheal
  deviation</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Pericarditis</span></p>
  </td>
  <td>
  <p><span>Constant or intermittent,
  sharp, pleuritic pain; often aggravated by breathing, swallowing food, or
  supine position; relieved by sitting and leaning forward; pericardial
  friction rub</span></p>
  </td>
  <td>
  <p><span>Generalized ST elevation</span></p>
  </td>
  <td>
  <p><span>Possible enlarged
  silhouette</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Aortic dissection</span></p>
  </td>
  <td>
  <p><span>Sudden, severe,
  substernal, tearing pain; radiation to the back; may have syncope, stroke, or
  leg ischemia; pulse or BP may be unequal in limbs; age &gt;55; history of
  hypertension; prostration; aortic insufficiency </span></p>
  </td>
  <td>
  <p><span>Nonspecific; LVH or
  inferior MI</span></p>
  </td>
  <td>
  <p><span>Widened mediastinum</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Esophageal reflux</span></p>
  </td>
  <td>
  <p><span>Recurrent, burning,
  substernal pain; radiating from epigastrium to throat; exacerbated by bending
  down or lying down; relieved by antacids; may mimic angina</span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Musculoskeletal</span></p>
  </td>
  <td>
  <p><span>Persistent; worsened by
  cough or deep breathing; diffuse or focal tenderness; increased</span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Herpes zoster</span></p>
  </td>
  <td>
  <p><span>Sharp, band-like pain in
  mid-thorax (unilaterally); linear, vesicular rash; pain may precede rash by several
  days; dysesthesia</span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
  <td>
  <p><span>Normal</span></p>
  </td>
 </tr>
</table>

<p><span>CXR, chest
x-ray; ECG, electrocardiogram; LVH, left ventricular hypertrophy; MI,
myocardial infarction; NTG, nitroglycerin; RV, right ventricular</span></p>

<p><span></span></p>

<p><span>A standard
12-lead electrocardiogram (ECG), appropriate chest imaging, measurement of
oxygen saturation and arterial blood gases, and blood chemistry profiles (e.g.,
troponin, D-dimer) often provide important data. In the appropriate clinical
setting, some patients may require echocardiography or pulmonary function testing.
Many other noninvasive or invasive tests are available for the evaluation of
pain believed to be of respiratory, cardiac, or gastrointestinal origin. If
diagnosis remains uncertain, admission to chest pain observation units that
offer a safe and effective means of care for patients with possible unstable
angina who are considered to be at intermediate risk for cardiovascular events
may be considered.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>3.
Mild persistent chest pain with tenderness over a costochondral junction
suggests a diagnosis of costochondritis. </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>2.
Esophageal rupture may be precipitated by endoscopy.</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>12.
Gastroesophageal reflux commonly produced “heartburn.” It is worse after meals
and in the supine position. </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>10.
Myocardial infarction typically produces severe chest pain with radiation,
shortness of breath, nausea, and diaphoresis. </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>5.
Acute pericarditis may be viral in origin. The pain is often sharp and worsened
in the supine position. A scratchy friction rub may be heard on physical
examination.</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>4.
Pleuritis, which is often viral in origin, produces a sharp pain that worsens
with inspiration.</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>6.
Pneumonia typically produces fever, chills, productive cough, bronchial breath
sounds, egophony, and whispered pectoriloquy.</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>1.
Spontaneous pneumothorax is associated with sudden onset chest pain, diminished
breath sounds, and hyperresonance to percussion. </span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.
Sudden onset chest pain and shortness of breath soon after surgery is worrisome
for pulmonary embolism.</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>9.
Stable angina is characterized by chest pressure that worsens with activity and
improves with rest.</span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>8.
Thoracic aortic dissection is associated with sudden, severe “tearing” chest
pain and unequal blood pressure readings in the upper extremities.</span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>11.
Varicella-zoster is associated with pain and a vesicular rash in a dermatomal
distribution. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Shortness of Breath</span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acidosis (metabolic)</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anemia</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Psychogenic</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Asthma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bronchogenic carcinoma</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Emphysema</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Heart failure</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Laryngeal dysfunction</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pericardial effusion</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pleural effusion</span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>Pneumonia</span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumothorax</span></p>

<p><span><span>M.<span>&nbsp;
</span></span></span><span>Pulmonary arterial hypertension</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>26-year-old woman with longstanding amphetamine
use presents with shortness of breath. Physical examination reveals jugular
venous distension and an accentuated S2 over the left 2<sup>nd</sup>
intercostal space.</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>28-year-old man suddenly develops chest pain and
shortness of breath while standing. Physical examination reveals diminished
breath sounds and hyperresonance to percussion over the right lung.</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>33-year-old woman visits the emergency room with
palpitations, shortness of breath, dizziness, and numbness and tingling in the
fingers.<span >&nbsp; </span>She appears anxious and
frightened.<span >&nbsp; </span>Heart and lung
examination are normal.</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>34-year-old woman with type 1 diabetes mellitus
ran out of insulin three days ago.<span >&nbsp;
</span>Today she has fatigue, nausea, abdominal pain, urinary frequency, and
shortness of breath.</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>38-year-old woman presents with cough and
shortness of breath.<span >&nbsp; </span>Examination
reveals high-pitched wheezing during inspiration.<span>&nbsp; </span>Exhalation is normal.</span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>42-year-old woman has cough and shortness of
breath whenever she jogs in cold weather.</span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>50-year old man has high fever, chills, and a
productive cough.<span >&nbsp; </span>Physical
examination reveals bronchial breath sounds, dullness to percussion, and
egophony in the right lower lung field.</span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>54-year-old woman with breast cancer presents
with fatigue and shortness of breath.<span >&nbsp;
</span>Physical examination reveals jugular venous distension, distant heart
sounds, and pulsus paradoxus.</span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>57-year-old man with a 30-pack-year smoking
history presents with fatigue, weight loss, shortness of breath, and coughing
up blood.<span >&nbsp; </span>The serum sodium
concentration is 120 mEq/L.</span></p>

<p><span><span>10.<span>&nbsp;
</span></span></span><span>58-year-old man presents with shortness of breath
on exertion and bilateral ankle swelling. Physical examination reveals jugular
venous distension, an S3, and bibasilar late-inspiratory crackles.</span></p>

<p><span><span>11.<span>&nbsp;
</span></span></span><span>63-year-old man with a 30-pack-year smoking
history has progressive shortness of breath over five years. Lung examination
reveals diffusely diminished breath sounds, increased expiratory phase, and
hyperresonance to percussion over all lung fields.</span></p>

<p><span><span>12.<span>&nbsp;
</span></span></span><span>69-year-old woman with breast cancer presents
with shortness of breath. Physical examination reveals decreased breath sounds
and dullness to percussion over the left lower lung field.</span></p>

<p><span><span>13.<span>&nbsp;
</span></span></span><span>87-year-old man has fatigue and shortness of
breath with exertion.<span >&nbsp; </span>Heart and
lung examination are normal.<span >&nbsp; </span>Fecal
occult blood testing is positive.</span></p>

<p><i><span>Dyspnea</span></i><span>&nbsp;</span></span><span>(shortness of
breath) is a common complaint of patients with pulmonary disease. Timing and
acuity of onset, exacerbating and alleviating factors, and degree of functional
impairment are key elements of the history. Associated symptoms such as cough,
hemoptysis, chest pain, wheezing, orthopnea, and paroxysmal nocturnal dyspnea,
as well as environmental triggers, should be elicited and are helpful in
developing a differential diagnosis. If dyspnea is recent, of sudden onset, and
accompanied by chest pain, then diseases such as pneumothorax, pulmonary
embolism, and pulmonary edema should come to mind. If the dyspnea is
long-standing and is slowly progressive, then chronic conditions such as
chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pulmonary
arterial hypertension, and neuromuscular disorders are in the differential
diagnosis. The progression of chronic dyspnea may be insidious. Asking specific
questions to quantify changes in functional status over time is important.
Dyspnea may occur during exertion or at rest and may be episodic or continuous.
Episodic dyspnea associated with exertion suggests parenchymal lung disease or
cardiac dysfunction. Dyspnea that is seasonal or triggered by environmental
exposure suggests diseases such as asthma and hypersensitivity pneumonitis.
Positional dyspnea can occur in patients with severe obstructive lung disease,
diaphragmatic paralysis, or neuromuscular weakness.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>4. Diabetic ketoacidosis results from insulin
deficiency. Symptoms include abdominal pain, fatigue, urinary frequency, and
shortness of breath. Increased ventilation is part of respiratory compensation
for metabolic acidosis.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>13. Anemia may result from occult blood loss in
the stool. Mild shortness of breath may occur. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>3. Psychogenic shortness of breath may associated
with anxiety, palpitations, dizziness, and numbness and tingling in the fingers.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>6. Asthma is often associated with cough and
wheezing. Common precipitants include cold air, exercise, pollen, and mold.</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>9. Lung cancer usually occurs in smokers and may
be associated with fatigue, anorexia, weight loss, and hemoptysis. Hyponatremia
due to SIADH occurs with small cell lung cancer. </span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>11. Emphysema is associated with gradually
progressive shortness of breath, prolonged expiratory phase, wheezing, and
hyperresonance to percussion. </span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>10. Heart failure may be associated with jugular
vein distension, an S3, bibasilar late-inspiratory crackles, and pitting edema
of the legs and ankles.</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>5. Laryngeal dysfunction causes stridor &#8211;
high-pitched inspiratory wheezing.</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>8. Pericardial effusion with impending tamponade
is associated with jugular vein distension, distant heart sounds, and pulsus
paradoxus.</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>12. Pleural effusion is associated with decreased
breath sounds and dullness to percussion. </span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>7. Pneumonia is associated with fever, chills,
cough, bronchial breath sounds, egophony, and whispered pectoriloquy.</span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>2. Pneumothorax is associated with diminished
breath sounds and hyperresonance to percussion. </span></p>

<p><span><span>M.<span>&nbsp; </span></span></span><span>1. Severe pulmonary hypertension can cause jugular vein distension and
an accentuated S2 over the left 2<sup>nd</sup> intercostal space.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
43-year-old woman with asthma visits the clinic.<span>&nbsp; </span>She reports shortness of breath and
wheezing about three times per week. She wakes up at night coughing and
wheezing about three times per month.<span >&nbsp;
</span>She uses a short-acting beta-agonist inhaler to relieve her symptoms.
She has been hospitalized only once for asthma.<span>&nbsp; </span>Her most recent pulmonary function test
showed an FEV<sub>1</sub> of 80% of predicted. Her only medication is albuterol
inhaler.<span >&nbsp; </span>How would you classify her
asthma and what change would you make to her treatment regimen? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>The
patient’s asthma is “intermittent.” No change is medicine is needed.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
patient’s asthma is “mild persistent.” A steroid inhaler should be added to her
regimen. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
patient’s asthma is “moderate persistent.” A long-acting bronchodilator inhaler
should be added to her regimen.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>The
patient’s asthma is “severe persistent.” Oral steroids should be added to her
regimen.</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Asthma</span> is a chronic inflammatory disease of the airways
characterized by variable and recurring symptoms, reversible airflow
obstruction, and bronchospasm. Symptoms include wheezing, coughing, chest
tightness, and shortness of breath. Asthma is clinically classified according
to the frequency of symptoms, forced expiratory volume in 1 second (FEV1), and
peak expiratory flow rate. </p>

<p></p>

<p>It is thought to be caused
by a combination of genetic and environmental factors. Treatment of acute
symptoms is usually with an inhaled short-acting beta-2 agonist. Symptoms can
be prevented by avoiding triggers, such as allergens and irritants, and by
using “controller” medicines, such as inhaled corticosteroids and oral
leukotriene antagonists.</p>

<p></p>

<p><span>The
clinical classification of asthma in adults appears below. </span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=469 colspan=4 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>Classification of Asthma by Severity in Adults</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=107 valign=top>
  <p style="text-align:center;"><span>Severity</span></p>
  </td>
  <td width=114 valign=top>
  <p style="text-align:center;"><span>Symptom frequency (daytime)</span></p>
  </td>
  <td width=135 valign=top>
  <p style="text-align:center;"><span>Symptom frequency</span></p>
  <p style="text-align:center;"><span>(nighttime)</span></p>
  </td>
  <td width=112 valign=top>
  <p style="text-align:center;"><span>FEV<sub>1</sub> </span></p>
  <p style="text-align:center;"><span>(% of predicted)</span></p>
  </td>
 </tr>
 <tr>
  <td width=107 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=114 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=135 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=112 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Intermittent</span></p>
  </td>
  <td width=114 valign=top>
  <p style="text-align:center;"><span>≤2
  per week</span></p>
  </td>
  <td width=135 valign=top>
  <p style="text-align:center;"><span>≤2
  per month</span></p>
  </td>
  <td width=112 valign=top>
  <p style="text-align:center;"><span>≥80%</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Mild persistent</span></p>
  </td>
  <td width=114 valign=top>
  <p style="text-align:center;"><span>&gt;2
  per week,<br>
  but not daily</span></p>
  </td>
  <td width=135 valign=top>
  <p style="text-align:center;"><span>3-4
  per month</span></p>
  </td>
  <td width=112 valign=top>
  <p style="text-align:center;"><span>≥80%</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Moderate persistent</span></p>
  </td>
  <td width=114 valign=top>
  <p style="text-align:center;"><span>Daily</span></p>
  </td>
  <td width=135 valign=top>
  <p style="text-align:center;"><span>&gt;1
  per week but not nightly</span></p>
  </td>
  <td width=112 valign=top>
  <p style="text-align:center;"><span>60&#8211;80%</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Severe persistent</span></p>
  </td>
  <td width=114 valign=top>
  <p style="text-align:center;"><span>Throughout
  the day</span></p>
  </td>
  <td width=135 valign=top>
  <p style="text-align:center;"><span>Frequent
  (often 7x/week)</span></p>
  </td>
  <td width=112 valign=top>
  <p style="text-align:center;"><span>&lt;60%</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>FEV1:<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Forced
expiratory volume in 1 second</span></p>

<p><span></span></p>

<p><span>Management of patients with asthma has four components.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Monitoring of symptoms and lung
function</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Patient education</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Controlling environmental factors
and co-morbid conditions</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pharmacologic therapy</span></p>

<p><span></span></p>

<p><span>The goals
of asthma management are:</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Freedom from frequent or troublesome
symptoms of asthma (cough, chest tightness, wheezing, or shortness of breath),
including symptoms that disturb sleep</span><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Minimal need (≤2 times per week) of
inhaled short-acting beta-agonists</span><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Optimization of lung function</span><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Maintenance of normal daily
activities</span><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Satisfaction with asthma care on the
part of patients and families</span><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Prevention of recurrent
exacerbations</span><span></span></p>

<p><span>Pharmacologic
treatment is the mainstay of management in most patients. A stepwise approach
is recommended, as outlined below. </span></p>

<p><span></span></p>

<p><span>Intermittent
(Step 1).</span></span><span>&nbsp;Patients
with mild intermittent asthma are best treated with a short-acting inhaled
beta-agonist.</span></p>

<p><span></span></p>

<p><b><span>Mild persistent (Step 2).</span></b><span>&nbsp;Patients with mild persistent asthma should be treated
with a controller medication. The preferred choice is a low-dose inhaled
glucocorticoid. Regular use of inhaled glucocorticoids reduces the frequency of
symptoms, reduces the need for beta-agonists, improves quality of life, and
decreases asthma exacerbations. Short-acting beta-agonists can still be used
for symptomatic relief.</span></p>

<p><span></span></p>

<p><b><span>Moderate persistent (Step 3). </span></b><span>For moderate persistent asthma, a long-acting inhaled
beta-agonist may be added to the low-dose glucocorticoid inhaler.
Alternatively, the dose of inhaled glucocorticoid may be raised.&nbsp;</span></p>

<p><span></span></p>

<p><b><span>Severe persistent (Steps 4, 5, 6). </span></b><span>For severe persistent asthma, the preferred treatment is
medium or high-dose inhaled glucocorticoids in combination with a long-acting
inhaled beta-agonist. Anti-IgE therapy may be beneficial in some patients. Oral
glucocorticoids are sometimes needed.</span></p>

<p><span></span></p>

<p><span>Note: In some patients, leukotriene modifiers, theophylline,
or cromolyn may be used at various stages. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct. </span></b><span>The patient’s asthma is
classified as “mild persistent” based on frequency of symptoms (daytime and
nighttime), as well as the FEV1. All patients with mild persistent asthma
&#8211; or more severe forms &#8211; should be treated with a controller
medication. Airway inflammation is characteristic of asthma. Regular use of a
controller medicine reduces inflammation. All patients with asthma, except
those in the very mildest class, should be treated with a controller
medication. The preferred choice is an inhaled glucocorticoid. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Beta-blockers
have which of the following cardiovascular effects? </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Choice</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Heart Rate</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Blood Pressure</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Contractility</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>End-diastolic volume</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Ejection time</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>A</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>no effect</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>no effect</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>no effect</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>B</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>C</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>D</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>E</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>A</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>D</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Beta-blockers decrease
heart rate, blood pressure, and cardiac contractility. Decreasing heart rate
allows more time for ventricular filling (increased end-diastolic volume) and
for systolic ejection (increased ejection time). Beta-blockers also reduce
renin secretion, thereby dampening the renin-angiotensin-aldosterone cascade.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 5-year-old boy has fever, purulent
nasal discharge, and a cough productive of green, foul-smelling mucus. He has
had many similar episodes over the past three years. His height and weight are
below the 10th percentile. The cardiac apex is located in the right chest.
Coarse rhonchi are heard bilaterally. A chest radiograph shows findings
consistent with bronchiectasis.</span></p>

<p><span>Which of the following is the most likely
diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
bronchopulmonary aspergillosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Alpha-1-antitrypsin
deficiency</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cystic
fibrosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Primary
ciliary dyskinesia (Kartagener’s syndrome)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Bronchiectasis
is a type of obstructive lung disease characterized by localized, irreversible
dilation of bronchi and bronchioles. Damage to the bronchial tree occurs
because of repeated cycles of airway infection and inflammation. Patients with
bronchiectasis typically present with chronic cough and copious mucopurulent
sputum. Other symptoms may include dyspnea, hemoptysis, fatigue, and weight
loss. Recurrent infections ultimately cause loss of lung function. Pulmonary
function tests show airflow obstruction. The diagnosis is confirmed by
high-resolution chest CT.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Several
congenital and acquired diseases can cause bronchiectasis. This tutorial will
focus on congenital diseases associated with bronchiectasis.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=311 valign=top>
  <p style="text-align:center;"><span>Causes of Bronchiectasis</span></p>
  </td>
 </tr>
 <tr>
  <td width=311 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=311 valign=top>
  <p><span>Congenital</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cystic fibrosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Primary ciliary
  dyskinesia (Kartagener’s syndrome)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Alpha-1-antitrypsin
  deficiency</span></p>
  <p><span>Acquired</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Postinfectious</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Aspiration /
  Gastroesophageal reflux disease (GERD)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Immune deficiency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Rheumatoid arthritis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Inflammatory bowel
  disease </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Acute bronchopulmonary
  aspergillosis (ABPA)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Idiopathic</span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span>&nbsp;</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Congenital Causes of Bronchiectasis</span></b><span></span></p>

<p><span></span></p>

<p><i>Cystic fibrosis</i> is an autosomal recessive disease caused by a
mutation in the gene encoding the cystic fibrosis transmembrane conductance
regulator (CFTR). This gene is required to regulate the components of mucus,
sweat, and digestive juices. The disease affects several different organs, but
most morbidity and mortality is related to pulmonary infections. Pancreatic
insufficiency is also a common cause of morbidity. The hallmark symptoms are
salty-tasting skin; poor growth despite normal food intake; accumulation of thick,
sticky mucus; recurrent sinus infections; frequent chest infections with
coughing and shortness of breath; and diarrhea. Males may be infertile because
of congenital absence of the vas deferens. Symptoms often appear in infancy and
childhood. Bowel obstruction due to meconium ileus occurs in newborn babies. As
the child grows, he or she must struggle to expectorate thick mucus. (Ciliated
epithelial cells have a mutated protein that results in abnormally viscous
mucus production.) Poor growth in children is the result of chronic lung
infection, poor absorption of nutrients through the gastrointestinal tract, and
increased metabolic demand due to chronic illness. </p>

<p></p>

<p><i>Primary ciliary dyskinesia</i> (<i><span>PCD</span></i>), also known as <span>immotile ciliary syndrome</span> or <span>Kartagener’s Syndrome,</span> is a rare,
autosomal recessive disorder characterized by impaired ciliary action along the
lining of the respiratory tract and fallopian tubes. Cilia are complex
organelles that beat synchronously in the respiratory tract, moving mucus
toward the throat. In PCD, ciliary dysfunction results in impaired mucus
clearance, which predisposes the patient to sinusitis, bronchitis, otitis
media, bronchiectasis, and pneumonia. Infertility is common because of
defective ciliary action in the fallopian tubes and diminished sperm motility.
50% of individuals with PCD develop situs inversus, where the laterality of the
internal organs is the mirror-image of normal. Situs inversus can occur with or
without dextrocardia, a condition in which the heart is located on the right
side of the body. </p>

<p></p>

<p><i><span>Alpha 1-antitrypsin deficiency</span></i><span> is an autosomal
recessive disorder characterized by decreased alpha 1-antitrypsin activity in
the lungs and deposition of abnormal alpha 1-antitrypsin protein in the liver.
Untreated, the condition results in emphysema and cirrhosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Primary ciliary
dyskinesia is associated with recurrent sinusitis, pneumonia, bronchiectasis,
and dextrocardia. (The location of the apical impulse in the right chest
indicates dextrocardia.)</span></p>

<p><span></span></p>

<p><b>Answer A is incorrect</b>. Patients with acute bronchopulmonary
aspergillosis have asthma, eosinophilia, elevated serum IgE levels, positive
immunonologic tests for <i>Aspergillus</i>,
and central bronchiectasis.</p>

<p></p>

<p><b><span>Answer B is incorrect</span></b><span>. Patients with
alpha-1-antitrypsin deficiency develop emphysema and cirrhosis.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Cystic fibrosis and
primary ciliary dyskinesia can have similar presentations. Both are associated
with recurrent lung infections, poor growth, and bronchiectasis; however,
dextrocardia is not a feature of cystic fibrosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
cardiac ventricular action potential is depicted below.<span>&nbsp; </span>Phase 2 of the action potential involves
influx of which of the following ions?<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://en.wikipedia.org/wiki/File:Action_potential"><span><img border=0 width=163 height=97
src="_%20Tutorials_files/image278.png"
alt="Description: Plot of membrane potential versus time. The initial resting phase (region 4) is negative and constant flowed by sharp rise (0) to a peak (1).  The plateau phase (2) is slightly below the peak. The plateau phase is followed by a fairly rapid return (3) back to the resting potential (4)."
v:shapes="Picture_x0020_347253"></span></a><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Sodium</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Potassium</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Calcium</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Magnesium</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<b><span><br clear=all>
</span></b>

<p><b><span></span></b></p>

<p style="text-align:center;"><b><span>Cardiac Action Potentials</span></b></p>

<p><span></span></p>

<p><b><span>“Fast
Response” Action Potentials</span></b></p>

<p><span></span></p>

<p><span>Fast
action potentials are found in atrial and ventricular myocytes and fast
conducting Purkinje fibers.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=290 height=218
src="_%20Tutorials_files/image280.png" v:shapes="Picture_x0020_347252"></span><span></span></p>

<p style="text-align:center;"><span>Figure </span><!--[if supportFields]><span><span></span><span>&nbsp;</span>SEQ Figure \* ARABIC <span></span></span><![endif]--><span><span>1</span></span><!--[if supportFields]><span><span></span></span><![endif]--><span>: </span><span>Major currents during the phases of the
fast response action potential.</span></p>

<p><span></span></p>

<p><b><span>Phase 0</span></b><span>: rapid activation of
the voltage-gated sodium channel when membrane potential reaches a threshold of
-65 mV.<span >&nbsp; </span>The inward Na<sup>+</sup>
causes rapid depolarization.<span >&nbsp; </span>After
approximately 1-2 msec the channel inactivates.<span>&nbsp; </span>The Na<sup>+</sup> channel remains in
the inactive state until the membrane repolarizes (which occurs at
approximately -55 mV) during Phase 3.<span >&nbsp;
</span>The conduction rate of action potentials in cardiac tissue is dependent
on the rate of rise in the depolarization of the action potential (dV/dt).<span>&nbsp;&nbsp; </span>The faster the rate of rise, the
faster the conduction of the action potentials thought the tissue.</span></p>

<p><span></span></p>

<p><b><span>Phase 1</span></b><span>: activation of
transient potassium channels (I<sub>to</sub>).<span>&nbsp; </span>These channels allow K<sup>+</sup> to
pass out of the cell and produce a brief, limited repolarization.<span>&nbsp; </span>This repolarization produces a “notch”
in the fast action potential in certain regions of the heart.<span>&nbsp; </span>The size of the “notch” is due to the
number of transient potassium channels expressed in that region.</span></p>

<p><span></span></p>

<p><b><span>Phase 2</span></b><span>: activation of L-type
calcium channels and delayed rectifier potassium channels.<span>&nbsp; </span>The L-type Ca<sup>++</sup> channels are
slow to activate and inactivate and produce a “long-lasting” Ca<sup>++</sup>
current.<span >&nbsp; </span>The L-type Ca<sup>++</sup>
channels activate at approximately -20 mV.<span >&nbsp;
</span>The inward calcium currents drive the membrane potential toward the Ca<sup>++</sup>
equilibrium potential (+120 mV to + 130mV).<span>&nbsp; </span>At the same time voltage-gated potassium
channels are activated.<span >&nbsp; </span>The K<sup>+</sup>
current is due to activation of several types of delayed rectifier K<sup>+</sup>
channels.<span >&nbsp; </span>The outward K<sup>+</sup>
current counterbalances the inward Ca<sup>++</sup> current producing a
sustained plateau.</span></p>

<p><span>Differences
in the shapes of Phase 2 of the fast action potentials among different regions
of the heart are due to the differences in the distributions of K<sup>+</sup>
channels expressed in the myocardial cells.</span></p>

<p><b><span></span></b></p>

<p><b><span>Phase
3: </span></b><span>the
repolarization of the action potential is initiated by the slow inactivation of
the voltage-gated Ca<sup>++</sup> channels while K<sup>+</sup> conduction is
maintained.<span >&nbsp; </span>Once the Ca<sup>++</sup>
channels are inactive, the K<sup>+</sup> conductance causes repolarization of
the membrane potential.<span >&nbsp; </span>The
repolarization phase is produced by activation of two types of K<sup>+</sup>
channels, the rapidly activating (I<sub>Kr</sub>, <i>HERG</i>) and the slowly
activating (I<sub>Ks</sub>) channels.<span >&nbsp;
</span>The I<sub>Kr</sub> activates at approximately -45 mV and causes a rapid
repolarization of the membrane potential.<span >&nbsp;
</span>Further repolarization is caused by the activation of the I<sub>Ks</sub>
channels.<span >&nbsp; </span>During this
repolarization, the Na channels make the transition from the inactive state to
the closed state.</span></p>

<p><span></span></p>

<p><span>Inhibition
of the I<sub>Ks</sub> can cause the prolongation of the fast action potential
and the long Q-T syndrome.<span >&nbsp;
</span>Inhibition can be caused by genetic mutations or by drugs.</span></p>

<p><span></span></p>

<p><b><span>Phase
4: </span></b><span>Na<sup>+</sup>
and Ca<sup>++</sup> are removed from the cytoplasm by various active transport
processes.<span >&nbsp; </span>K<sup>+</sup>
conductance though leak channels and the inward rectifier maintain the membrane
potential at resting levels (-90 to -80 mV). </span></p>

<p><span></span></p>

<p><b><span>“Slow
Response” Action Potentials</span></b></p>

<p><span></span></p>

<p><span>These
pacemaker action potentials are present in the SA node and the AV node and are
responsible for the automaticity of these tissues.<span>&nbsp; </span>Automaticity refers to the ability of
these cells to depolarize on their own and thus initiate a heart beat.</span></p>

<p><span></span></p>

<p><span>Slow
response action potentials have distinctive phases 0, 3 and 4.<span>&nbsp; </span>There is no phase 1 and the plateau
phase 2 is brief.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=258 height=214
src="_%20Tutorials_files/image282.png" v:shapes="Picture_x0020_347251"></span><span></span></p>

<p style="text-align:center;"><span>Figure </span><!--[if supportFields]><span><span></span><span>&nbsp;</span>SEQ Figure \* ARABIC <span></span></span><![endif]--><span><span>2</span></span><!--[if supportFields]><span><span></span></span><![endif]--><span>: </span><span>Major currents during the slow response
action potential.</span></p>

<p><span></span></p>

<p><b><span>Phase
4:</span></b><span> slow
depolarization due to inward Na<sup>+</sup> conductance through F-type
(“funny”, I<sub>f</sub>) channels.<span >&nbsp;
</span>The I<sub>f</sub> channels are activated by hyperpolarization of the
membrane potential below </span></p>

<p><span>-50
mV.<span >&nbsp; </span>When the membrane potential
depolarizes to -55 mV, T-type channels Ca<sup>++</sup> channels are activated
causing further depolarization due to the inward Ca<sup>++</sup> current.</span></p>

<p><span></span></p>

<p><b><span>Phase
0:</span></b><span> depolarization
due to inward Ca<sup>++</sup> conductance through L-Type channels.</span></p>

<p><span></span></p>

<p><b><span>Phase
3:</span></b><span>
repolarization due inactivation of L-type Ca<sup>++</sup> channels and outward
K<sup>+</sup> conductance through delayed rectifier K<sup>+</sup>
channels.<span >&nbsp; </span>The repolarization of the
membrane potential activates the I<sub>f</sub> channels and phase 4 slow
depolarization.</span></p>

<p><span></span></p>

<p><b><span>Autonomic
Nervous System Regulation of Cardiac action potentials</span></b></p>

<p><span></span></p>

<p><span>Automaticity
can be affected by altering the slow response action potential (pacemaker
potential).<span >&nbsp; </span>The slow wave action
potentials can be altered by changing the slope of the phase 4 depolarization,
changing the maximum negativity in phase 4 (aka end diastolic potential) or
changing the threshold for the phase 0 depolarization.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=218 height=218
src="_%20Tutorials_files/image284.jpg" v:shapes="Picture_x0020_347250"></span><span></span></p>

<p style="text-align:center;"><span>Figure </span><!--[if supportFields]><span><span></span><span>&nbsp;</span>SEQ Figure \* ARABIC <span></span></span><![endif]--><span><span>3</span></span><!--[if supportFields]><span><span></span></span><![endif]--><span>: </span><span>Effects of sympathetic and parasympathetic
stimulation on slow response action potentials.</span></p>

<p><span></span></p>

<p><span>Parasympathetic
nervous system </span></p>

<p><span></span></p>

<p><span>Parasympathetic
stimulation of the SA node 1) <b>decreases</b> the slope of the phase 4
depolarization though reduction of the I<sub>f</sub> current and the Ca<sup>++</sup>
current and 2) <b>hyperpolarizes</b> the maximum negativity membrane potential
by activating K<sup>+</sup> channels (K<sub>ACh</sub>).<span>&nbsp; </span>Both of these effects cause a decrease
frequency of the slow response action potential and decrease heart rate.</span></p>

<p><span></span></p>

<p><span>Parasympathetic
stimulation has similar effects on the slow response action potential in the AV
node, and the result is to decrease conduction velocity through the AV node.</span></p>

<p><span></span></p>

<p><span>Sympathetic
nervous system</span></p>

<p><span></span></p>

<p><span>Sympathetic
stimulation of the SA node causes an <b>increase</b> in the slope of the phase
4 depolarization through activation of I<sub>f</sub> and Ca<sup>++</sup>
currents.<span >&nbsp; </span>Increasing the slope of
the phase 4 depolarization causes an increase in heart rate.</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct. </span></b><span>Phase
2 of the action potential is associated with an influx of calcium ions.<span>&nbsp; </span>At the same time, potassium ions leave
the cell, prolonging phase 2.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
31-year-old woman has a two-day history of constant pain in the mid-chest. The
pain is worse when she lies down and improves when she sits and leans forward.
Temperature is 36.8<sup>o</sup>C, pulse is 80/minute, blood pressure is 125/80
mm Hg, and respiratory rate is 18/minute. The heart rhythm is regular. A
friction rub is heard in the left parasternal area. The lungs are clear to
auscultation. A 12-lead ECG shows widespread ST-segment elevation and
concomitant PR-segment depression. What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
myocardial infarction</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acute
pericarditis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumonia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pulmonary
embolism</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumothorax</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gastroesophageal
reflux</span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0>
 <tr>
  <td width=468>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=4-u1.0-B978-1-4160-4710-0..00030-4--sp00></a><span>ACUTE PERICARDITIS</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P011002></a><span>Acute pericarditis, inflammation of the visceral and parietal
    pericardium, can result from a number of different causes. Although a
    definitive cause is often not determined (and the condition is then
    called&nbsp;<i>idiopathic pericarditis</i>), viral infection is probably
    the most common cause.&nbsp;<i>Viral pericarditis</i>&nbsp;is usually
    self-limiting, although occasionally the symptoms may recur once or more
    before complete resolution. Although less common, pericarditis caused by
    bacterial infection or tuberculosis can be life-threatening. Pericardial
    inflammation can also result from direct pericardial injury (trauma, injury
    early after myocardial infarction or pericardiotomy) due to autoimmune
    mechanisms (late after myocardial infarction-Dressler syndrome, in
    connective tissue disease) or to uremia. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P011003></a><span>The classic clinical presentation of pericarditis is chest
    pain, typically abrupt in onset, sharp, worse in supine position, and
    relieved by sitting upright and leaning forward. On heart auscultation, the
    presence of a&nbsp;<i>pericardial rub</i>&nbsp;indicates contact between
    two inflamed layers of the pericardium. Pericardial rub usually has a
    characteristic high-pitched, leathery quality, with three components that
    correspond to movement of the heart during the cardiac cycle (ventricular
    systole, early ventricular diastole, and atrial contraction; not all three
    components are always audible). Serial auscultation is advised because the
    rub may be intermittent and vary in intensity. The absence of an audible
    rub does not exclude the diagnosis of pericarditis. Chest pain from
    myocardial ischemia or pulmonary embolism may mimic pericarditis, and these
    conditions should be considered in the differential diagnosis.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P011004></a><span>Electrocardiogram (ECG) changes are common. During the acute
    phase, depression of the PR segments and diffuse ST-segment elevations are
    typical and result from inflammation of the myocardium adjacent to visceral
    pericardium. Flattening and inversion of T waves may also be present. Most
    of the ECG abnormalities resolve over several days to weeks, but T-wave
    abnormalities may persist longer. ST-segment elevations in pericarditis may
    be mistaken for the current of injury seen in ST-elevation myocardial
    infarction. In pericarditis, however, multiple leads are affected,
    reciprocal ST-segment depressions are not seen, and ECG changes evolve much
    slower than in acute myocardial infarction.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=P011005></a><span></span></p>
  <p><a name=T011001></a><span></span></p>
  <p><span></span></p>
  <p><a name=T011001.50></a><a name=T011001.100></a><a name=T011001.150></a><a
  name=T011001.200></a><a name=T011001.250></a><a name=T011001.300></a><a
  name=T011001.350></a><a name=T011001.400></a><a name=T011001.450></a><a
  name=T011001.500></a><a name=T011001.550></a><a name=T011001.600></a><a
  name=T011001.650></a><a name=T011001.700></a><a name=T011001.750></a><a
  name=T011001.800></a><a name=T011001.850></a><a name=T011001.900></a><a
  name=T011001.950></a><a name=T011001.1000></a><a name=T011001.1050></a><a
  name=T011001.1100></a><a name=T011001.1150></a><a name=T011001.1200></a><a
  name=T011001.1250></a><span></span></p>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="90%">
   <tr>
    <td width="100%"></td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P011006></a><span>The treatment of acute pericarditis is directed at managing
    the underlying cause and providing pain relief. For most patients,
    nonsteroidal anti-inflammatory drugs are effective in relieving the chest
    discomfort and facilitating the resolution of inflammation; colchicine can
    be an effective alternative. Glucocorticoids are used if the former therapy
    is not sufficiently effective. Although most cases of idiopathic and viral
    pericarditis are self-limited, complications include recurrences, large
    pericardial effusion, cardiac tamponade, and pericardial constriction.</span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  </td>
 </tr>
</table>

<p><b><span>Answer B is correct. </span></b><span><span>&nbsp;</span>The chest pain associated with acute
pericarditis is worse at rest and better with sitting and leaning forward.
Physical examination may reveal a pericardial friction rub. (Also, the ECG may
show widespread ST-segment elevation and concomitant PR-segment depression. By
contrast, the ST-segment elevation associated with myocardial infarction is
localized, not diffuse, and not associated with concomitant PR-segment
depression.) </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A two-week
old female baby is brought to the emergency room. Examination reveals mild
cyanosis of the face and trunk and moderate cyanosis of the extremities. Which
of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ventricular
septal defect</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Atrial
septal defect</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tetralogy
of Fallot</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Patent
ductus arteriosus</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=302 height=242
src="_%20Tutorials_files/image286.png" alt="Description: 18088" v:shapes="Picture_x0020_347249"></span><span></span></p>

<p><span></span></p>

<p><b><span>Tetralogy of Fallot</span></b><span> is the most common
cause of cyanosis in the first few weeks of life. The condition is associated
with ventricular septal defect, overriding aorta, right ventricular
hypertrophy, and pulmonary stenosis. Cyanosis, caused by a right-to-left shunt,
may be worsened by agitation. Clubbing of the fingers and toes may occur.
(Mnemonic: The 5 T’s of early cyanotic heart disease are Tetralogy of Fallot,
transposition of the great vessels, truncus arteriosus, total anomalous
pulmonary venous return, and tricuspid atresia.) </span></p>

<p><span></span></p>

<p><b><span>Ventricular septal defects (VSDs)</span></b><span> are the most common <i>non</i>-cyanotic congenital heart defects.
Infants present with dyspnea, tachypnea, and feeding difficulties. A
holosystolic murmur may be heard. </span></p>

<p><span></span></p>

<p><b>Atrial septal defects (ASDs)</b> may be inapparent until adulthood,
when the Eisenmenger syndrome may occur. (In the Eisenmenger syndrome,
left-to-right shunting leads to pulmonary hypertension, which in turn, causes
increased pressure in the right heart and reversal of the shunt in a right-to-left
direction.)</p>

<p></p>

<p><b>Patent ductus arteriosus (PDA) </b>is associated with a continuous
(systolic and diastolic) murmur. Cyanosis does not occur unless the
Eisenmenger’s syndrome develops. In the fetus, the ductus arteriosus shunts
blood from the left pulmonary artery to the aorta, allowing blood to bypass the
high-resistance lungs. Failure of the duct to close is common in premature
babies and in cases of congenitally acquired rubella. Indomethacin can used to
close the PDA. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer C is correct</b>.<span >&nbsp;
</span>Tetralogy of Fallot is the most common cause of cyanosis in the first
few weeks of life.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
19-year-old man has severe hypertension despite taking several
anti-hypertensive medicines. He reports frequent headaches and has leg weakness
that is worse with activity. His blood pressure is 190/110 mm Hg in both arms
and 130/80 mm Hg in both legs. Femoral pulses are weak and delayed when
compared to carotid pulses. A systolic murmur is noted in the left
infra-clavicular area (anteriorly) and under the left scapula (posteriorly). An
ejection click is audible in the right second intercostal space. Renal
function, electrolytes, and urinalysis are normal. Chest x-ray shows
cardiomegaly and mild pulmonary congestion. Electrocardiogram shows left
ventricular hypertrophy. Imaging studies show coarctation of the aorta. Which
of the following congenital cardiac anomalies is most likely present in this
patient? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Atrial
septal defect</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ventricular
septal defect</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Transposition
of the great arteries</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Bicuspid
aortic valve</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Patent
ductus arteriosus</span></p>

<p><span></span></p>

<span><br clear=all>
</span>

<p><span>Coarctation of the aorta
is a relatively common disorder, accounting for 5-8% of all congenital heart
defects. It is characterized by narrowing of the aorta where the ductus
arteriosus (ligamentum arteriosum after regression) inserts &#8211; i.e.,
distal to the origin of the left subclavian artery. </span></p>

<p><span></span></p>

<p><span>Coarctation is
associated with numerous congenital cardiac anomalies, including bicuspid
aortic valve, patent ductus arteriosus, ventricular septal defect, and mitral
valve disease. It may be associated with various types of cyanotic heart
disease (e.g., transposition of the great arteries), and it is the most common
cardiovascular defect in Turner syndrome. Tests can distinguish among the
possible causes of coarctation. A bicuspid aortic valve will present with an ejection
click in the aortic area. A patent ductus arteriosus produces a continuous,
machine-like murmur in left infra-clavicular and left scapular area. <span>A ventricular septal defect produces a holosystolic
murmur. Mitral valve disease produces a pansystolic murmur due to
regurgitation. </span>Transposition of the great arteries usually presents
early in life with cyanosis.</span></p>

<p><span></span></p>

<p><span>The disorder imposes
significant afterload on the left ventricle, increasing wall stress and causing
compensatory left ventricular hypertrophy. In some cases, afterload increases
gradually, allowing arterial collateral vessels to form, bypassing the
obstruction. In such cases, patients may be asymptomatic until they become
hypertensive and complications ensue. (The mechanism of hypertension is incompletely
understood.)</span></p>

<p><span></span></p>

<p><span>Often the diagnosis of
coarctation is made when hypertension is incidentally noted during a routine
physical examination. The patient may present with headache, chest pain,
fatigue, or even life-threatening intracranial hemorrhage. True claudication is
rare, although leg pain and weakness may occur. </span></p>

<p><span></span></p>

<p><span>In adults, coarctation
is best diagnosed by simultaneous palpation of the femoral and brachial pulses
and by measuring blood pressure in both arms and legs. A pressure difference of
more than 20 mm Hg, with higher values in the arms, is suggestive of
coarctation. Weak and delayed femoral pulses also suggest coarctation. A
systolic murmur is often heard in the left infraclavicular and left scapular
areas. An S4 indicates a hypertrophied, noncompliant left ventricle. Surgical
or endovascular repair is the treatment of choice.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=292 height=234
src="_%20Tutorials_files/image288.png" alt="Description: ::18128.jpg" v:shapes="Picture_x0020_347248"></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct.</span></b><span> The patient in this vignette has signs of
aortic coarctation (i.e., significant blood pressure gradient between the upper
and lower extremities; weak and delayed femoral pulses) and signs of a bicuspid
aortic valve (ejection click in the aortic area).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A</span></b><span> <b>is incorrect</b>. Aortic coarctation is not usually associated with
atrial septal defect. Fixed splitting of S2 would suggest atrial septal defect.</span></p>

<p><span></span></p>

<p><b><span>Answer B</span></b><span> <b>is incorrect</b>. Aortic coarctation may be associated with ventricular
septal defect, but this condition produces a holosystolic murmur. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Aortic coarctation may
be associated with transposition of the great arteries, but this condition
usually presents early in life with cyanosis. </span></p>

<p><span></span></p>

<p><b><span>Answer E</span></b><span> <b>is incorrect. </b>Aortic coarctation may be associated with patent
ductus arteriosus, but this condition produces a continuous, machine-like
murmur in left infra-clavicular and left scapular area. <span><span >&nbsp;</span></span><b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
60-year-old man presents with an eight-month history of exertional shortness of
breath, wheezing, and daily sputum production.<span>&nbsp; </span>He is a 50-pack year smoker.<span>&nbsp; </span>On physical examination, he has markedly
reduced breath sounds over the posterior lung fields and mild end-expiratory
wheezing. Spirometry shows a forced expiratory volume in 1 second (FEV<sub>1</sub>)
of 1.5 L (60% of predicted).<span >&nbsp; </span>His
forced vital capacity (FVC) is 2.3 L. The FEV<sub>1</sub>/FVC ratio is 0.65.
Which of the following interventions is most likely to improve his long-term
survival?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Inhaled
corticosteroids</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Oral
corticosteroids</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Smoking
cessation</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Inhaled
ipratropium</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span><img border=0 width=470 height=331
src="_%20Tutorials_files/image290.png"
alt="Description: http://www.studentconsult.com/content/9781416061090/legends/Chapter_17-WebFig.4.jpg"
v:shapes="Picture_x0020_347480"></span><span></span></p>

<p><span></span></p>

<p><span>Smoking
cessation is the single most effective method for preventing chronic
obstructive pulmonary disease (COPD) and for slowing its progression.
Pharmacologic therapy, including inhaled corticosteroids and anticholinergic
agents, can alleviate symptoms, increase exercise capacity, reduce the number
and severity of exacerbations, and improve health status; however, only smoking
cessation improves survival. No pharmacologic therapy can prevent a decline in
lung function. Every tobacco user should be offered counseling and nicotine
replacement (patch, gum, inhaler, and nasal spray). A quit date should be
established, abstinence should be emphasized, and involvement of family and
friends should be sought. Several drugs are available for treating tobacco
dependency. These drugs can be quite effective and should be considered in
selected patients.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>This man’s history as a
smoker and his spirometry results indicating that he has an obstructive disease
suggest that he has chronic obstructive pulmonary disease (COPD). Smoking
cessation is the only therapy that has been shown to improve survival in COPD. </span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A
68-year-old woman presents to clinic with a one-month history of dry, hacking
cough.<span >&nbsp; </span>She denies fever, nasal
congestion, sore throat, chest pain, shortness of breath, or weight loss.<span>&nbsp; </span>She does not smoke and has not traveled
recently. She is unaware of any sick contacts.<span>&nbsp; </span>She has diabetes, hypertension, and
hyperlipidemia. Medications include aspirin 81 mg daily, metformin 500 mg twice
daily, lisinopril 20 mg daily, and pravastatin 20 mg each evening. Her hemoglobin
A1C is 6.0.<span >&nbsp; </span>On physical
examination, she is afebrile, pulse is 83/minute, blood pressure is 142/83 mm
Hg, and respirations are 14/minute.<span >&nbsp;
</span>Her heart is regular and without murmur, her lungs are clear, her
abdomen is soft, and her extremities are non-edematous.<span>&nbsp; </span>A chest X-ray shows no infiltrate. Which
of the following is most appropriate?</span></p>

<p></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Prescribe
a seven-day course of antibiotic</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Recommend
daily use of a cough suppressant/expectorant (dextromethorphan/guaifenesin) </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Send
sputum for culture, cytology, and AFB/fungal smears </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Obtain
a CT scan of the chest </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Stop
lisinopril</span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p>Cough</span></i><span style='font-family:"Times New Roman";color:black;background:
white'>&nbsp;</span></span><span>is a frustrating symptom for both the patient and
the physician. The three most common causes of chronic cough are postnasal
drip, asthma, and gastroesophageal reflux disease. Cough may be mild and
infrequent, or it may be severe enough to induce emesis or syncope. Cough may
be dry or may produce sputum or blood (</span><i><span>hemoptysis</span></i><span>). The symptom may begin months after initiation of a drug (e.g.,
angiotensin-converting enzyme [ACE] inhibitors) leading to a dry, hacking
cough.<span style='font-family:"Times New Roman";color:black'>Bordetella
pertussis</span></i><span>&nbsp;</span></span><span>infection (whooping cough) and viral lower respiratory infections can
produce a cough that may last for 3 months or longer. Patients with asthma
often have a cough. On occasion, cough is their only symptom, a condition
sometimes referred to as<span style='font-family:"Times New Roman";color:black'>cough-variant
asthma.</span></i><span>&nbsp;</span></span><span>Nocturnal cough should raise the suggestion of asthma, heart failure, or
gastroesophageal reflux disease.</span><span></span></p>

<p></span></p>

<p>Angiotensin
converting enzyme (ACE) inhibitors are a common cause of subacute (3-8 weeks)
and chronic (&gt; 8 weeks) cough.<span >&nbsp;
</span>The cough is thought to be bradykinin-mediated.<span>&nbsp; </span>It usually begins within a week of
starting the medication, but can occur much later. It is more common in women,
and usually resolves 3-4 weeks after stopping the medicine. If the cough does
not resolve, other explanations should be sought. Switching to a different
ACE-inhibitor is not helpful because reintroduction of <i>any</i> ACE-inhibitor will likely cause the cough to recur. </span></p>

<p></span></p>

<p></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Answer E is correct</span></b><span>.<span>&nbsp; </span>Lisinopril is an ACE-inhibitor, and
ACE-inhibitors are a common cause of non-productive cough. The cough resolves
with discontinuation of the medicine. </span></p>

<p></span></p>

<p><span>Answer A is incorrect</span></b><span>. There is no evidence
that the patient has a bacterial infection.</span></p>

<p></span></p>

<p><span>Answer B is incorrect</span></b><span>. Although this might
improve symptoms, it is not the most appropriate solution to the scenario.</span></p>

<p></span></p>

<p><span>Answer C is incorrect</span></b><span>. There is no evidence
that the patient has an infection.</span></p>

<p></span></p>

<p><span>Answer D is incorrect</span></b><span>. A CT scan is not
indicated in this patient because there is no evidence of an abnormality.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 6-month-old infant has poor growth despite a large food intake. He has
had two episodes of pneumonia and frequent bulky stools. Chest x-ray shows
increased markings and hyperinflation. Trypsin is absent in a fresh stool
sample and the fat content is increased. Which of the following is the most
likely cause of the infant’s disorder?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Autoimmune disorder</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Disaccharidase deficiency</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Villous atrophy of the jejunum</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Defective ion transport at the epithelial surface </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Inability to synthesize apolipoprotein B</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Cystic fibrosis</span><span>
(CF) is a multi-system, autosomal recessive disorder that causes progressive
disability and often early death. It is one of the most common life-shortening
inherited diseases in the United States. </span></p>

<p><span></span></p>

<p><span>CF is
caused by mutation of the gene for the cystic fibrosis transmembrane
conductance regulator (CFTR), a chloride channel protein on the apical surface
of epithelial cells in exocrine gland tissues. This channel is required to
regulate the components of sweat, digestive juices, and mucus. Malfunction
causes abnormal chloride ion transport, which leads to abnormally viscid
secretions. Because chloride ions cannot be excreted, sodium is absorbed to
excess, and water follows passively. This desiccates the mucosal surface and
alters the viscosity of the mucous blanket. </span></p>

<p><span></span></p>

<p><span>The name <i>cystic
fibrosis</i> refers to characteristic scarring (fibrosis) and cyst formation in
the pancreas. Features of the disease include poor growth, recurrent sinus and
lung infections, progressive obstructive pulmonary disease, pancreatic insufficiency,
diarrhea, intestinal malabsorption, and infertility. Other findings may include
nasal polyposis, cholelithiasis, cirrhosis, and rectal prolapse. </span></p>

<p><span></span></p>

<p><span>More than
1500 different mutations in the CFTR gene have been identified. CF is most
common among Caucasians; one in 25 people of European descent carries an allele
for the disease. There is no sex predilection. Affected individuals can be
diagnosed prenatally by genetic testing or in early childhood by a sweat test.
The median age at diagnosis is 6-8 months. Antibiotics are required to treat
recurrent lung infections. Ultimately, lung transplantation may be necessary.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. A diagnosis of cystic
fibrosis is suggested by the presence of poor growth, recurrent pneumonia,
bulky stools (which suggest malabsorption), hyperinflation (which suggests
obstructive pulmonary disease), absent trypsin in the stool (which suggests
pancreatic insufficiency), and increased fat in the stool (which indicates
malabsorption). Cystic fibrosis is an autosomal recessive disorder that affects
the chloride ion channel on the epithelial surface of exocrine glands. This
leads to abnormally viscid secretions, which impair lung, pancreatic, and
intestinal function. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Cystic fibrosis is not
an autoimmune disorder.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Lactase deficiency, a
type of dissacharidase deficiency, causes lactose intolerance, which is manifested
by abdominal bloating, cramping, gas, and diarrhea after ingestion of dairy
products. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Villous atrophy occurs
in celiac disease. Manifestations include abdominal pain, diarrhea, and
malabsorption.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. <span>Abetalipoproteinemia is</span> characterized
by fat malabsorption. Features include poor growth, abdominal pain, diarrhea,
fatty stools, muscle weakness, slurred speech, and difficulty with balance and
coordination.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 41-year-old man visits his
doctor because of fatigue and shortness of breath. Physical examination shows
jugular venous distension, an apical impulse that is inferiorly and laterally
displaced, and late inspiratory crackles in the lung bases. An echocardiogram
shows a dilated left ventricle with an ejection fraction of 30% (normal &gt;
55%) and diffuse hypokinesis.<span >&nbsp;
</span>Coronary arteriography shows no atherosclerotic lesions. His height is
173 cm (5 ft 8 in) and his weight is 68 kg (150 lbs). The BMI is 23 kg/m2. His
blood pressure is 95/65 mm Hg. He eats red meat almost every day, drinks four
beers every evening, and does not exercise.<span>&nbsp; </span>Which of the following is the most
important recommendation for preventing further heart damage?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Lose weight</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Avoid heavy exertion</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Begin an exercise program</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Consume more vegetables and fruits</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Avoid alcoholic beverages</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Cardiac enlargement may be
due to hypertrophy or dilation of the heart muscle. Hypertension is the most
common cause of left ventricular hypertrophy. Myocardial infarction is the most
common cause of left ventricular dilation. Although hypertension and ischemic
heart disease are the principal causes of cardiac enlargement, other causes
exist. Identifying those causes is an important step in managing the patient. </p>

<p></p>

<p>There are three major types
of cardiomyopathy: dilated, hypertrophic, and restrictive. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=140 valign=top>
  <p>Types of Cardiomyopathy</p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;">Dilated</p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;">Hypertrophic</p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;">Restrictive</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>Dilated cardiomyopathy is
characterized by chamber enlargement and impaired systolic function. Patients
may be asymptomatic for many years despite impaired left ventricular function.
Most develop congestive heart failure, which may be gradual or abrupt in onset.
Some present with arrhythmias or even sudden cardiac death. The main causes of
dilated cardiomyopathy appear below. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=259 valign=top>
  <p style="text-align:center;">Causes of Dilated Cardiomyopathy</p>
  </td>
 </tr>
 <tr>
  <td width=259 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=259 valign=top>
  <p>Genetic</p>
  <p>Toxin-induced (e.g.,
  alcohol, doxorubicin)</p>
  <p>Radiation</p>
  <p>Infectious (e.g., viral,
  trypanosomiasis)</p>
  <p>Metabolic (e.g., beriberi)</p>
  <p>Sarcoidosis</p>
  <p>Hemochromatosis</p>
  <p>Peripartum or postpartum</p>
  </td>
 </tr>
</table>

</div>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct</b>. The patient in this clinical vignette has a
dilated heart, but no history of myocardial infarction and no evidence of
coronary artery disease or hypertension. Left ventricular hypokinesis is
diffuse rather than segmental. (Segmental hypokinesis often indicates previous
myocardial infarction.) Therefore, the patient has a non-ischemic dilated
cardiomyopathy, which has many potential causes. Long-term alcohol abuse is an
important cause to identify because abstinence from alcohol can prevent further
cardiac deterioration. The patient’s history of heavy beer consumption suggests
alcoholic cardiomyopathy as the correct diagnosis. Alcohol avoidance should be
recommended to prevent a worsening of his condition. <b></b></p>

<p><b></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
56-year-old man presents with mild confusion and abdominal swelling. He has a
history of alcoholism and has been diagnosed with hepatic cirrhosis.<span>&nbsp; </span>His blood pressure is 90/60 mm Hg and
his pulse is 98/minute. He is mildly jaundiced. The jugular veins are not
distended. Shifting dullness is noted in the abdomen. Severe pitting edema is
present in both legs. </span></p>

<p><span></span></p>

<p><span>Blood test
results: </span></p>

<p><span></span></p>

<p><span>Na<sup>+<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>122
mEq/L </span></p>

<p><span>K<sup>+</sup>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3.3 mEq/L </span></p>

<p><span>Cl<sup>-</sup>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>90 mEq/L </span></p>

<p><span>HCO<sub>3</sub><sup>-</sup>
26 mEq/L<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>What is
the most likely cause of hyponatremia? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Decreased
effective circulating volume</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased
aldosterone</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congestive
heart failure</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Metabolic
alkalosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Effective circulating volume</span> (<span>ECV</span>) is the volume of arterial blood effectively perfusing tissue.
It is a dynamic quantity and not a distinct, measurable compartment. The
concept of ECV is useful for understanding cardiovascular and renal physiology.
Although ECV normally varies with extracellular fluid (ECF), the two become
uncoupled in disorders like congestive heart failure and cirrhosis. In these
conditions, the kidney responds as if the body were truly hypovolemic. </p>

<p></p>

<p>There are several volume and
pressure sensing systems that influence ECF and ECV. If they contract then
volume preserving systems become active, and if they expand then volume
depletion systems become active. Volume sensors, also known as low pressure
baroreceptors, are located in the atria, right ventricle, and large pulmonary
vessels. They become active when the blood volume increases; in essence they
sense fullness of the vascular system. When active, these volume sensors send
neural activity to the brainstem via the glossopharyngeal and vagus nerves,
resulting in decreases in sympathetic nerve activity and antidiuretic hormone
(ADH) secretion; these effects will enhance the excretion of sodium and water.
Atrial and ventricular cells also secrete atrial natriuretic peptide and brain
natriuretic peptide, respectively, when volume is high, resulting in sodium and
water excretion and reduction of ADH secretion.</p>

<p></p>

<p>High pressure baroreceptors
are located in the carotid sinus, aortic arch, and the juxtaglomerular (JG)
apparatus of the kidneys. The baroreceptor reflex increases sympathetic
activity to the vasculature if blood pressure decreases and vice versa to
increase or decrease vascular tone, respectively, to control blood pressure. In
addition, changes in sympathetic activity alter excretion of sodium and water.
Increasing sympathetic activity directly increases renin secretion from
juxtaglomerular cells; the resultant increase in angiotensin II produces
vasoconstriction, and the secretion of aldosterone elicited by angiotensin II
enhances salt and water reabsorption by the kidneys. JG cells directly detect
the lower perfusion pressure that occurs when blood pressure decreases and
respond by secreting renin. Glomerular filtration rate also decreases with
lower perfusion pressure and the resultant sympathetic-mediated constriction of
afferent and efferent arterioles which reduces delivery of NaCl to the macula
densa, and this process (tubuloglomerular feedback) also enhances renin
secretion.</p>

<p></p>

<p>Hepatic cirrhosis is
associated with decreased albumin in plasma, which results in edema due to a
reduction in plasma oncotic pressure. Edema reduces ECV which the pressure and
volume sensors interpret as a contraction (reduction) of ECV. Thus, volume
conserving mechanisms become active. The net effect is relatively more
conservation of water than salt, resulting in hyponatremia.</p>

<p></p>

<p>Congestive heart failure
causes a reduction in cardiac output and thus ECV. The resultant decrease in
blood pressure activates volume conserving systems which overfill the vascular
system, causing jugular venous distension, pulmonary crackles, edema, and
abnormal cardiac findings. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>.<span>&nbsp; </span>Cirrhosis is associated with low serum
albumin levels, low intravascular oncotic pressure, and decreased effective
circulating volume. This results in ADH release, reabsorption of water, and
hyponatremia. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Cirrhosis is
associated with decreased effective circulating volume, which activates the
renin-angiotensin-aldosterone system. Aldosterone levels are increased not
decreased.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Congestive heart
failure is associated with pulmonary crackles, distended neck veins, abnormal
cardiac findings, and dependent edema.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Metabolic alkalosis is
associated with an elevated serum bicarbonate (HCO<sub>3</sub><sup>-</sup>)
level.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
66-year-old woman comes to the clinic for a first-time visit. Her pulse is
82/minute and her blood pressure is 166/92 mm Hg. Cardiac examination reveals a
loud S2 at the right second intercostal space and a low-pitched, late-diastolic
heart sound at the apex, which is heard with the patient lying in the left
lateral decubitus position. Which of the following best explains the extra
heart sound? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Papillary
muscle tension after the rapid filling phase</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increased
stiffness of the left ventricular wall</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Restricted
motion of the aortic valve cusps</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Increase
flow through the aortic valve</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Forceful
opening of the mitral valve</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An <b>S4</b> is a low-pitched, late-diastolic
heart sound. The sound is produced by blood being forced into the stiff left
ventricle. It is a pathological sign, usually indicating hypertrophy of the
left ventricular wall. The most common cause of left ventricular hypertrophy is
hypertension, which causes accentuation of the second heart sound in the right
second intercostal space (the aortic area).<span>&nbsp; </span>Other causes of an S4 include left
ventricular hypertrophy due to aortic stenosis and restrictive
cardiomyopathy.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p>An <b>S3</b>, or <span>ventricular gallop</span>,
is a low-pitched, early-diastolic heart sound. Like the S4, it is best heard in
the left lateral decubitus position. In adults, the S3 is often a sign of left
ventricular dilation and congestive heart failure. It is thought to be caused
by the oscillation of blood back and forth between the walls of the left
ventricle, initiated by inrushing blood from the atria. It may also result from
tensing of the chordae tendineae during rapid filling and expansion of the
ventricle. An S3 indicates increased volume of blood within the ventricle. </p>

<p></p>

<p><span>In aortic
stenosis, the first heart sound may be followed by a sharp ejection sound at
the apex. This <b>ejection “click”</b> is
caused by blood flowing against the partially fused leaflets of the aortic valve.
(It is more common with a mobile bicuspid valve than with an immobile calcified
valve.) </span></p>

<p><span></span></p>

<p><span>Increased
flow through the aortic valve causes a systolic <b>“flow” murmur</b>.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
opening <b>“snap”</b> of mitral stenosis is
a high-pitched, early-diastolic sound caused by forceful opening of the mitral
valve. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct.</span></b><span> The low-pitched,
late-diastolic heart sound is an S4. The sound is produced by blood being
forced into the stiff left ventricle.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 53-year-old woman dies 3 days after an
automobile collision. She sustained multiple injuries including a femoral
fracture. Widespread petechiae are found in the cerebral white matter at
autopsy. Which of the following is the most likely cause of these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
respiratory distress syndrome</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Contrecoup
injury</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fat
embolization</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Septicemia</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Subdural
hematoma</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Fat embolism syndrome (FES)
is the occurrence of hypoxia, confusion, and petechiae a few days after a long
bone fracture. The syndrome involves embolization of fat from the marrow of the
bone or from soft tissue surrounding the bone. This syndrome is distinct from
“regular” pulmonary embolism (a thromboembolic event) and from post-traumatic
pulmonary insufficiency, shock lung, and adult respiratory distress syndrome
(ARDS). </p>

<p></p>

<p>FES usually occurs after
lower limb fractures, especially femoral fractures. The disease
characteristically begins 1 to 2 days after fracture (following what has been
called the “<span>latent”</span> or “<span>lucid”</span> period). Sixty percent of all
cases are seen in the first 24 hours after trauma, and 90 percent of all cases
appear within 72 hours. The major signs are respiratory insufficiency, cerebral
involvement, and petechial rash. Minor signs include fever, tachycardia,
retinal changes, jaundice, and renal changes. Petechiae are transient and are
distributed on the cheek, neck, axillae, palate, and conjunctivae. The
condition can be fatal. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer C is correct.</b> The development of petechiae after femoral
fracture suggests a diagnosis of fat embolism syndrome.<span>&nbsp; </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
32-year-old man has a three-month history of fatigue and shortness of breath.
He had rheumatic fever as a child. Physical examination reveals an early
diastolic sound followed by a soft, rumbling, diastolic murmur at the 4<sup>th</sup>
intercostal space, four centimeters left of the sternal border. The murmur is
heard best in the left lateral decubitus position. Which of the following valve
defects is most likely in this patient? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Aortic
stenosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aortic
regurgitation</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulmonic
stenosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pulmonic
regurgitation</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mitral
stenosis</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mitral
regurgitation</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Tricuspid
stenosis</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Tricuspid
regurgitation</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 align=left
 width="99%">
 <thead>
  <tr>
   <td width="100%" colspan=2 valign=bottom>
   <p style="text-align:center;"><b><span>&nbsp;</span></b></p>
   <p style="text-align:center;"><b><span>&nbsp;Pathologic Heart Murmurs</span></b><span></span></p>
   <p><b><span></span></b></p>
   </td>
  </tr>
  <tr>
   <td width="100%" colspan=2 valign=bottom>
   <p style="text-align:center;"><b><span></span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><b><span>Systolic</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><i><span>Holosystolic&nbsp;</span></i></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Mitral
  regurgitation</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Blowing,
  holosystolic murmur at apex radiating to left axilla </span></p>
  <p><span>S<sub>1
  </sub>decreased </span></p>
  <p><span>S<sub>3</sub>
  with severe regurgitation (volume overload)</span></p>
  <p><span>Left
  ventricular dilation is common </span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Tricuspid
  regurgitation</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Blowing,
  holosystolic murmur at lower left sternal border; increased with inspiration</span></p>
  <p><span>Right
  ventricular dilation is common </span></p>
  <p><span>S<sub>3<span>&nbsp; </span></sub>sometimes audible along lower
  left sternal border </span></p>
  <p><span>Jugular
  venous pressure often elevated</span></p>
  <p><span>Large
  <i>v</i> waves in jugular veins</span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Ventricular
  septal defect</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Harsh,
  loud, holosystolic murmur at left lower sternal border with radiation to
  right sternal border, sometimes with a thrill</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><i><span>Midsystolic</span></i></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Aortic
  stenosis</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Midsystolic
  murmur at right 2<sup>nd</sup> interspace with radiation to neck and down
  left sternal border toward apex; often loud, harsh, and with a thrill</span></p>
  <p><span>Heard
  best with patient sitting and leaning forward</span></p>
  <p><span>Ejection
  click means valve is mobile</span></p>
  <p><span>As
  stenosis worsens, S<sub>2</sub> decreases and murmur peaks later</span></p>
  <p><span>Paradoxical
  splitting of S<sub>2 </sub>(sometimes)</span></p>
  <p><span>S<sub>4</sub>
  (with decreased compliance of left ventricle)</span></p>
  <p><span>Sustained
  apical impulse (with left ventricular hypertrophy) </span></p>
  <p><span>Carotid
  pulse may rise slowly and be weak (<i>pulsus
  parvus et tardus</i>)</span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Hypertrophic
  Cardiomyopathy</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Midsystolic
  murmur at lower left sternal border with radiation to apex and sometimes base</span></p>
  <p><span>Increased
  with Valsalva; decreased with squatting</span></p>
  <p><span>S<sub>3</sub>
  and/or S<sub>4 </sub>may be present</span></p>
  <p><span>Apical
  impulse may be sustained</span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Pulmonic
  stenosis </span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Midsystolic
  murmur at left 2<sup>nd</sup> interspace with radiation to neck and left
  shoulder; often harsh, sometimes with a thrill; increased with inspiration</span></p>
  <p><span>Early
  pulmonic ejection sound (sometimes)</span></p>
  <p><span>Widely
  split S<sub>2</sub> (in severe stenosis)</span></p>
  <p><span>Right
  ventricular impulse may be increased</span></p>
  <p><span>Right-sided
  S<sub>4 </sub>may be present</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><i><span>Late systolic</span></i></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Mitral
  valve prolapse</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Late-systolic
  murmur preceded by high-pitched click (usually at apex)</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><b><span>Diastolic</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><i><span>Early diastolic</span></i></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Aortic
  regurgitation</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>High-pitched,
  blowing, early diastolic, decrescendo murmur at 2<sup>nd</sup> to 4<sup>th</sup>
  left interspace with radiation to apex </span></p>
  <p><span>Heart
  best with patient sitting and leaning forward, in exhalation</span></p>
  <p><span>Ejection
  sound may be present</span></p>
  <p><span>S<sub>3</sub>
  and/or S<sub>4</sub> (if severe regurgitation)</span></p>
  <p><span>Apical
  pulse becomes progressively stronger, wider, longer, and displaced
  (inferiorly and laterally)</span></p>
  <p><span>Increased
  pulse pressure, bounding pulses</span></p>
  <p><span>Midsystolic
  flow murmur or Austin Flint murmur (if severe) </span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Pulmonic<span>&nbsp; </span>regurgitation</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Early
  diastolic decrescendo murmur at left 2<sup>nd</sup> interspace</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><i><span>Mid&#8211;late diastolic</span></i></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Mitral
  stenosis </span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Low-pitched,
  mid-to-late, rumbling diastolic murmur at apex</span></p>
  <p><span>Heard
  best with patient in left lateral decubitus position, after exhalation</span></p>
  <p><span>Opening
  snap precedes murmur</span></p>
  <p><span>Accentuated
  S<sub>1</sub></span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Tricuspid
  stenosis</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Low-pitched,
  mid-to-late, rumbling diastolic murmur at lower left sternal border;
  increases with inspiration</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><b><span>Continuous (Systolic and Diastolic)</span></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Venous
  hum</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Continuous
  low-pitched, humming murmur above medial third of clavicles with radiation to
  1<sup>st</sup> an 2<sup>nd</sup><span >&nbsp;
  </span>interspaces</span></p>
  <p><span>Disappears
  with compression of vein</span></p>
  </td>
 </tr>
 <tr>
  <td width="20%" valign=top>
  <p><span>Patent
  ductus arteriosus</span></p>
  </td>
  <td width="79%" valign=top>
  <p><span>Continuous
  murmur at left 2<sup>nd</sup> interspace with radiation to left clavicle;
  loud, harsh, and machinery-like</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4160-2805-5..50053-7--spar></a><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. Mitral stenosis
produces as l</span><span>ow-pitched, mid-to-late, rumbling
diastolic murmur at apex. (The 4<sup>th</sup> intercostal space, four
centimeters from the left sternal border, approximates the apical area.) The
murmur is often preceded by an early diastolic sound (opening snap). </span><span>Rheumatic heart disease
is responsible for 99% of mitral valve stenosis in adults in the United States.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Aortic stenosis
produces a harsh, m</span><span>idsystolic murmur at right 2<sup>nd</sup>
intercostal space with radiation to the neck and down the left sternal border
toward the apex.</span><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Aortic regurgitation
produces a h</span><span>igh-pitched, blowing, early
diastolic, decrescendo murmur at the 2<sup>nd</sup> to 4<sup>th</sup> left
intercostal space with radiation to the apex.</span><span></span></p>

<p><span></span></p>

<p><b><span>Answer</span></b><b><span> C is incorrect</span></b><span>.
Pulmonic stenosis produces a midsystolic murmur at the left 2<sup>nd</sup>
intercostal space with radiation to the neck and left shoulder. The murmur
increases with inspiration. </span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>. Pulmonic regurgitation produces an
early diastolic decrescendo murmur at the left 2<sup>nd</sup> intercostal
space.</span></p>

<p><span></span></p>

<p><b><span>Answer
F is incorrect</span></b><span>. Mitral regurgitation produces a
blowing, holosystolic murmur at the apex with radiation to the left axilla.</span></p>

<p><span></span></p>

<p><b><span>Answer
G is incorrect</span></b><span>. Tricuspid stenosis produces a
low-pitched, mid-to-late, rumbling diastolic murmur at lower left sternal
border that increases with inspiration. </span></p>

<p><span></span></p>

<p><b><span>Answer
H is incorrect</span></b><span>. Tricuspid regurgitation produces a
blowing, holosystolic murmur at the lower left sternal border that increases
with inspiration. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
57-year-old man with a history of coronary artery disease, mild chronic
obstructive pulmonary disease (COPD), and cirrhosis is brought to the emergency
room after being found on the floor, lethargic and confused. His medications
include tiotropium inhaler, lorazepam, and nitroglycerin tablets. On physical
examination, he is somnolent and mildly cyanotic. The results of arterial blood
gas measurements are as follows: pH 7.24, PCO<sub>2</sub> 70 mmHg, PO<sub>2</sub>
40 mmHg, and HCO<sub>3</sub><sup>-</sup> 29 mEq/L. What explains the patient’s
hypoxemia? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Shunt</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Diffusion limitation</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Hypoventilation</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Ventilation-to-perfusion
mismatch </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypoxemia</span><span>
is defined as a low partial pressure of oxygen in the blood, specifically a PO<sub>2</sub>
&lt; 60&nbsp;mmHg. </span></p>

<p><span></span></p>

<p><span>The major
mechanisms of hypoxemia are hypoventilation, ventilation-perfusion mismatch,
right-to-left shunt, diffusion limitation, and reduced inspired oxygen tension.
</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=190 valign=top>
  <p style="text-align:center;"><span>Mechanisms of Hypoxemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=190 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=190 valign=top>
  <p><span>Hypoventilation</span></p>
  </td>
 </tr>
 <tr>
  <td width=190 valign=top>
  <p><span>Ventilation-perfusion
  mismatch</span></p>
  </td>
 </tr>
 <tr>
  <td width=190 valign=top>
  <p><span>Right-to-left
  shunt</span></p>
  </td>
 </tr>
 <tr>
  <td width=190 valign=top>
  <p><span>Diffusion
  limitation</span></p>
  </td>
 </tr>
 <tr>
  <td width=190 valign=top>
  <p><span>Reduced
  inspired oxygen tension</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b>Hypoventilation</b>.<span>&nbsp; </span>Arterial and alveolar carbon dioxide
tensions increase during hypoventilation, causing alveolar oxygen tension to
decrease. As a result, diffusion of oxygen from the alveolus to the pulmonary
capillary declines. The net effect is hypoxemia. </p>

<p></p>

<p>The principal causes of hypoventilation appear below. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;">Causes of Hypoventilation</p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p>CNS depression (e.g., drug overdose)</p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p>CNS event (e.g., stroke)</p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p>Obesity-hypoventilation</p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p>Neurologic impairment (e.g., amyotrophic lateral
  sclerosis)</p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p>Muscular impairment (e.g., myasthenia gravis)</p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p>Chest wall deformity (e.g., kyphoscoliosis)</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<p>Of the five major mechanisms of hypoxemia, only
hypoventilation results in hypercapnia (increased PaCO<sub>2</sub>). </p>

<p></p>

<p>Hypoxemia in hypercapnic patients may be due either to <i>pure</i> hypoventilation or to
hypoventilation <i>plus</i> another
mechanism. To distinguish these, the A-a gradient is used. The A-a gradient is
the alveolar-arterial oxygen difference. In patients with <i>pure</i> hypoventilation, the A-a gradient is normal. In patients with hypoventilation
<i>plus</i> another mechanism of hypoxemia,
the A-a gradient is increased.<span >&nbsp; </span></p>

<p></p>

<p>The A-a gradient can be calculated as follows:</p>

<p><b><span>A-a gradient = PA<sub>O2</sub>
&#8722; Pa<sub>O2</sub></span></b><span></span></p>

<p><span>Where:</span></p>

<p><span>PA<sub>O2</sub></span><span> = alveolar PO<sub>2</sub> (calculated from the Alveolar Gas
Equation)</span></p>

<p><span>Pa<sub>O2</sub></span><span> = arterial PO<sub>2</sub> (measured by arterial blood gas
analysis)</span></p>

<p><u><span>Alveolar Gas Equation</span></u><span>: </span></p>

<p><span>PA<sub>O2</sub>
<b><sub><span >&nbsp;</span></sub></b>= </span><span>[Fi<sub>O2 </sub>(P<sub>atm </sub>&#8211; P<sub>H2O</sub>)
&#8211; (Pa<sub>CO2 </sub>/ 0.8) ]</span></p>

<p><span>Fi<sub>O2</sub> = fraction of
inspired oxygen (0.21 for room air)</span></p>

<p><span>P<sub>atm</sub> = atmospheric
pressure (730 mm Hg in Oklahoma)</span></p>

<p><span>P<sub>H2O</sub> = vapor pressure of
water at body temperature (47 mmHg)</span></p>

<p><span>Therefore, </span></p>

<p><span>PA<sub>O2 </sub>=
(.21)(730 &#8211; 47) &#8211; </span><span>(Pa<sub>CO2 </sub>/
0.8)</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>PA<sub>O2 </sub>= 143 &#8211; (</span>Pa<sub>CO2
</sub>/ 0.8)</span></p>

<p><span>Take home
messages: </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>An
elevated PCO<sub>2</sub> indicates that hypoventilation is the cause of
hypoxemia.</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
normal A-a gradient indicates that hypoventilation is the <i>sole</i> cause of hypoxemia.</span></p>

<p><span></span></p>

<p><b><span>Ventilation-perfusion mismatch.</span></b><span> Ventilation-perfusion
(V/Q) mismatch refers to an imbalance of blood flow and ventilation. Common
causes include obstructive lung diseases, pulmonary vascular disease, and
interstitial lung disease. V/Q mismatch is characterized by an increased A-a
gradient. The hypoxemia can be corrected by administering supplemental oxygen. </span></p>

<p><span></span></p>

<p><b>Right-to-left shunt.</b>
A right-to-left shunt exists when blood passes from the right to the left side
of the heart without being oxygenated. There are two types of right-to-left
shunts: anatomic and physiologic. Anatomic shunts exist when the alveoli are
bypassed. Examples include intracardiac shunts and pulmonary arteriovenous
malformations (AVMs). Physiologic shunts exist when non-ventilated alveoli are
perfused. Examples include atelectasis and disorders of alveolar filling (e.g.,
pneumonia, acute respiratory distress syndrome).</p>

<p></p>

<p><span>Right-to-left shunts cause extreme V/Q mismatch, with a V/Q
ratio of zero in some lung regions. The net effect is hypoxemia, which <i>cannot</i> be corrected with supplemental
oxygen.</span></p>

<p><span></span></p>

<p><b><span>Diffusion limitation</span></b><span>. Diffusion limitation
exists when the movement of oxygen from the alveolus to the pulmonary capillary
is impaired. It is usually a consequence of alveolar or interstitial
inflammation or fibrosis (e.g., interstitial lung disease). Diffusion
limitation usually coexists with V/Q mismatch.<span>&nbsp; </span></span><span></span></p>

<p><span></span></p>

<p><b><span>Reduced inspired oxygen tension. </span></b><span>Reduced inspired oxygen
tension </span><span>is most commonly associated with
high altitude.</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct</span></b><span>. The high PCO<sub>2</sub> indicates that
hypoventilation is the cause of hypoxemia.<span >&nbsp;
</span>The normal A-a gradient (see below) indicates that hypoventilation is
the <i>sole</i> cause of hypoxemia. Overdose
of lorazepam could explain the presentation.<span>&nbsp; </span></span></p>

<p><span>From the alveolar gas equation, </span></p>

<p><span>PA<sub>O2</sub>
= 143 &#8211; (70 / 0.8)</span><span> </span></p>

<p><span>In the clinical vignette, the Pa<sub>CO2 </sub>is 70 mm
Hg.<span >&nbsp; </span></span></p>

<p><span>Therefore,<span> </span></span></p>

<p><span>PA<sub>O2</sub>
= 143 &#8211; (70 / 0.8)</span><span> </span></p>

<p><span>PA<sub>O2</sub>
= 55 mm Hg</span></p>

<p><span>A-a Gradient = <span>PA<sub>O2</sub></span> &#8211; PaO2</span></p>

<p><span>In the clinical vignette, the PaO<sub>2 </sub>is 40 mm Hg</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>A-a
Gradient = 55 &#8211; 40 = 15 mm Hg (Normal: 5 &#8211; 20 mm Hg)</span></p>

<p><span>The
patient’s A-a gradient is normal. This indicates that hypoventilation is the
sole cause of hypoxemia.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A cardiac
catheterization is done on a healthy person. A blood sample from the catheter
shows an oxygen saturation of 75%. The pressure readings oscillate from 12 mm
Hg to 25 mm Hg. Where is the catheter located?</span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Right
atrium</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Left
atrium</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulmonary
artery</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Left
ventricle</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aorta</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
typical pressures and oxygen saturations in a normal heart appear below.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=276 height=253
src="_%20Tutorials_files/image292.png" v:shapes="Picture_x0020_347247"></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=95 valign=top>
  <p><span>Location</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Blood pressure</span></p>
  </td>
  <td width=63 valign=top>
  <p><span>Oxygen saturation</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><span></span></p>
  </td>
  <td width=63 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span>Right atrium</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Mean: 0-8 mm Hg</span></p>
  </td>
  <td width=63 valign=top>
  <p><span>75%</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span>Right ventricle</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>15-30 / 0-8 mm Hg.</span></p>
  </td>
  <td width=63 valign=top>
  <p><span>75%</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span>Pulmonary artery</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>15-30 / 3-12 mm Hg</span></p>
  </td>
  <td width=63 valign=top>
  <p><span>75%</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span>Left atrium</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Mean: 1-10 mm Hg</span></p>
  </td>
  <td width=63 valign=top>
  <p><span>95%</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span>Left ventricle</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>100-140 / 3-12 mm Hg</span></p>
  </td>
  <td width=63 valign=top>
  <p><span>95%</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span>Aorta</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>100-140 / 60-90 mm Hg</span></p>
  </td>
  <td width=63 valign=top>
  <p><span>95%</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. An oxygen saturation
of 75% indicates that blood has been taken from the right side of the
circulation. Pressures ranging from 12 to 25 mm Hg are consistent with
pressures in the pulmonary artery. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Right atrial pressures
range from 0-8 mm Hg, and oxygen saturation is 75%.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Left atrial pressures
range from 1-10 mm Hg, and oxygen saturation is 95%.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Left ventricular
pressures range from 100-140 mm Hg systolic, and 3-12 mm Hg diastolic. Oxygen
saturation is 95%.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Normal oxygen
saturation in the aorta is 95% and pressures range from 100-140 mm Hg systolic
and 60-90 mm Hg diastolic.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
55-year-old man is brought to the emergency room by his family because he has
been confused for three days. He has smoked a package of cigarettes daily for
thirty-five years. A chest radiograph shows a 6-cm mass in the left lung.
Laboratory tests show:</span></p>

<p><span></span></p>

<p><span>Na<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>115
mEq/L</span></p>

<p><span>K<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4.0
mEq/L</span></p>

<p><span>Cl<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>76
mEq/L</span></p>

<p><span>HCO3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>30
mEq/L</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>210
mg/dL</span></p>

<p><span>Creatinine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.3
mg/dL</span></p>

<p><span></span></p>

<p><span>Which of
the following is the mostly likely diagnosis?</span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Medullary
carcinoma of the thyroid </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Small
cell carcinoma of the lung</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Adenocarcinoma
of the lung </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hepatocellular
carcinoma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal
cell carcinoma</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mesothelioma</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A diagnosis of lung cancer
must be considered when a lung mass is found in a longtime smoker. Most primary
lung cancers are <span>carcinomas</span>.
Prolonged exposure to tobacco is the most common etiology. In nonsmokers, lung
cancer is often attributed to genetic factors, radon gas, asbestos, and air
pollution (including secondhand smoke). </p>

<p></p>

<p><span>The two
main types of lung cancer are <span>small
cell </span>and <span>non-small cell</span>.
The distinction is important because treatment varies: non-small cell lung
cancer (NSCLC) is sometimes treated with surgery; small cell lung cancer (SCLC)
responds better to chemotherapy and radiation.</span></p>

<p><span></span></p>

<p><span>Non-small
cell lung cancers are grouped together because their prognosis and management
are similar. The main types of non-small cell lung cancer are squamous cell
carcinoma, adenocarcinoma, and large cell carcinoma. Squamous cell carcinoma
usually starts near a central bronchus. Cavitation and necrosis are common.
Adenocarcinoma usually originates in the lung periphery. Although most cases
occur in smokers, this is the principal histological type seen in non-smokers. </span></p>

<p><span></span></p>

<p><span>Small cell
cancer is less common than non-small cell cancer. Formerly known as &quot;oat
cell&quot; carcinoma, small cell cancer usually arises in the large airways,
and grows rapidly. Despite being more sensitive to chemotherapy and radiation
than other histologic types, small cell cancer is often metastatic at
presentation and carries a worse prognosis. It is strongly associated with
smoking. The cancer cells contain dense neurosecretory vesicles, which contain
neuroendocrine hormones. These hormones are responsible for paraneoplastic
syndromes. </span></p>

<table border=1 cellpadding=0 align=left>
 <tr>
  <td>
  <p style="text-align:center;"><span>Paraneoplastic Syndrome</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Type of Cancer</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Mechanism</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span></span></p>
  </td>
  <td>
  <p><span></span></p>
  </td>
  <td>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>SIADH</span></p>
  </td>
  <td>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Small-cell
  lung cancer </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>CNS
  malignancies</span></p>
  </td>
  <td>
  <p><span>Antidiuretic hormone (ADH)</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>Cushing syndrome</span></p>
  </td>
  <td>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Small-cell
  lung cancer </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Neural
  tumors </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Thymoma</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Pancreatic
  carcinoma </span></p>
  </td>
  <td>
  <p><span>Ectopic ACTH and ACTH-like substance</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><a href="http://en.wikipedia.org/wiki/Hypercalcemia"
  title=Hypercalcemia><span>Hypercalcemia</span></a><span></span></p>
  </td>
  <td>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Lung
  cancer (typically squamous cell) </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Breast
  carcinoma </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Renal
  carcinoma </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Ovarian
  carcinoma</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Multiple
  myeloma (may occur independent of osteolytic lesions)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Adult
  T cell leukemia/lymphoma </span></p>
  </td>
  <td>
  <p><a
  href="http://en.wikipedia.org/wiki/Parathyroid_hormone-related_protein"
  title="Parathyroid hormone-related protein"><span>PTHrP</span></a><span> (Parathyroid hormone-related protein),
  TGF-&#945;, TNF, IL-1 </span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>Hypoglycemia</span></p>
  </td>
  <td>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Hepatocellular
  carcinoma</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Sarcomas</span></p>
  </td>
  <td>
  <p><span>Insulin or insulin-like substance or
  &quot;big&quot; IGF-II</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>Polycythemia</span></p>
  </td>
  <td>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Cerebellar
  hemangioblastoma</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Hepatocellular
  carcinoma </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Renal
  cell carcinoma </span></p>
  </td>
  <td>
  <p><span>Erythropoietin</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>Carcinoid syndrome</span></p>
  </td>
  <td>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Bronchial
  adenoma (carcinoid type) </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Gastric
  carcinoma</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Pancreatic
  carcinoma</span></p>
  </td>
  <td>
  <p><span>Serotonin, </span><a
  href="http://en.wikipedia.org/wiki/Bradykinin" title=Bradykinin><span>bradykinin</span></a><span>
  </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>Paraneoplastic syndromes are</span> consequences of cancer that are not
actually due to the local presence of tumor. They are mediated by substances
produced by the tumor or by the immune system, and may be apparent even before
the tumor is visible. There are four major types of paraneoplastic syndromes:
endocrine, neurologic, mucocutaneous, and hematologic. The main endocrine
syndromes appear below. </p>

<p></p>

<p>Routine laboratory studies
often provide clues to the presence of paraneoplastic syndromes. SIADH is
associated with hyponatremia, Cushing syndrome is associated with
hyperglycemia, and polycythemia is associated with an elevated hematocrit.
These findings can be detected with blood tests. Hypercalcemia and hypoglycemia
are also detected with routine blood tests.</p>

<p></p>

<p>Mesothelioma is a rare form
of cancer that develops from the protective lining that covers many of the
body’s internal organs, the mesothelium. It is usually caused by exposure to
asbestos. It most commonly occurs in the pleura, but may occur in the
peritoneum or the pericardium. Unlike lung cancer, there is no association
between mesothelioma and smoking. Symptoms include shortness of breath due to
pleural effusion, chest wall pain, and general symptoms such as weight loss.
X-ray may reveal pleural thickening, commonly seen after asbestos exposure. The
classic histopathology of the mesothelioma is a biphasic tumor with both an
epithelioid and sarcomatoid, or “spindle cell,” component.</p>

<p></p>

<p><b></b></p>

<b><span><br
clear=all>
</span></b>

<p><b>Answer B is correct</b>. The patient in this vignette has hyponatremia
and hyperglycemia. Given the presence of a lung mass, one should suspect lung
cancer producing ADH (vasopressin) and ACTH (hyperglycemia), resulting in hyponatremia
and hyperglycemia, respectively. Small cell lung carcinoma would be the most
likely histologic type.<span >&nbsp;&nbsp; </span></p>

<p></p>

<p><b>Answer A is incorrect</b>. Medullary carcinoma of the thyroid, which
originates from parafollicular cells of the thyroid, elicits calcitonin.<span>&nbsp;&nbsp; </span></p>

<p></p>

<p><b>Answer C is incorrect</b>. Adenocarcinoma of the lung is not commonly
associated with SIADH or ACTH production.<span >&nbsp;
</span></p>

<p></p>

<p><b>Answer D is incorrect</b>. Hepatocellular carcinoma may cause
hypoglycemia and polycythemia. </p>

<p></p>

<p><b>Answer E is incorrect</b>. Renal cell carcinoma may cause hypercalcemia
and polycythemia.</p>

<p></p>

<p><b>Answer F is incorrect</b>. The presentation of the patient suggests an
association between smoking and the type of lung cancer. Mesothelioma is not
associated with smoking.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 79-year-old
woman with advanced dementia resides in a nursing home. She is admitted to the
hospital with a three-week history of fever and cough. The cough is productive
of foul-smelling, yellow-green sputum. Temperature is 38.5<sup>o</sup> C (101.3<sup>
o</sup> F), pulse is 85/minute, blood pressure is 120/80 mm Hg, and
respirations are 22/minute. Crackles are heard over the right lower lung field.
The white blood cell count is 15,000/mm<sup>3</sup>. A CT scan shows an
irregular, thick-walled, cavitary lesion in the right lower lobe. </span></p>

<p><span></span></p>

<p><span>What is the
most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Bacterial endocarditis with septic embolism </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Tuberculosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Anaerobic lung abscess</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Bronchogenic carcinoma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Metastatic cancer<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>The differential diagnosis for lung
cavitation appears below.<b></b></span></p>

<p><b><span></span></b></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=352 valign=top>
  <p style="text-align:center;"><span>Lung Cavitation: Differential Diagnosis<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td width=352 valign=top>
  <p><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=352 valign=top>
  <p><span>Cavitating pneumonia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><i><span>Staphylococcus aureus</span></i></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Gram-negative bacilli (Klebsiella, Pseudomonas, Legionella)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Anaerobes</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Mycobacteria</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Fungi</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pneumocystis</span></p>
  </td>
 </tr>
 <tr>
  <td width=352 valign=top>
  <p><span>Septic emboli (bacterial or fungal)</span></p>
  </td>
 </tr>
 <tr>
  <td width=352 valign=top>
  <p><span>Pulmonary vasculitis (especially Wegener’s granulomatosis)</span></p>
  </td>
 </tr>
 <tr>
  <td width=352 valign=top>
  <p><span>Pulmonary embolism and infarction</span></p>
  </td>
 </tr>
 <tr>
  <td width=352 valign=top>
  <p><span>Infected bullae and cysts</span></p>
  </td>
 </tr>
 <tr>
  <td width=352 valign=top>
  <p><span>Cancer (primary or secondary)</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Infection is the most common cause of
lung cavitation. One or more cavities may be present. If the lesion is single,
abscess from necrotizing Gram-negative or staphylococcal pneumonia should be a
primary consideration, especially if the patient is acutely ill with severe
pneumonia. If multiple cavities are present, the infection is likely due to
hematogenous dissemination (septic emboli), and a source for this dissemination
should be sought (e.g., right-sided endocarditis). </span></p>

<p><span></span></p>

<p><span>Lung abscesses secondary to aspiration
are frequently right-sided and most often involve the lower lobe.* Most
patients with anaerobic lung abscess have risk factors for aspiration, such as
poor dental hygiene, seizure disorder, or alcoholic blackouts. The
manifestation is often indolent, with complaints of cough, fever, and malaise
lasting weeks to months.</span></p>

<p><span></span></p>

<p><span>Tubercular cavities are usually located
in the upper zone, either the posterior segment of the upper lobe or apical
segment of the lower lobe. Because of the high concentration of tuberculous
bacilli in the cavity, patients usually have a sputum smear that is strongly
positive for acid-fast bacilli.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>A variety of fungi can cause cavitary
lesions. <i>Aspergillus, Mucor</i>, and <i>Candida </i>rarely cause disease in
normal hosts. The endemic fungi (histoplasma, blastomyces, and coccidiodes),
however, can produce cavitary lesions in immunocompetent hosts. These organisms
should be considered if travel to an endemic area has occurred.</span></p>

<p><span></span></p>

<p><span>Pulmonary lesions due to infected
bullae/cysts are thin-walled cavities with smooth outline. Thick-walled
cavities may result from pulmonary vasculitis, of which Wegener’s
granulomatosis is the prototype. Wegener’s granulomatosis often results in
bilateral cavitary lesions. Pulmonary embolism with infarction is a rare cause
of lung cavitation. Neoplasia, either primary (bronchogenic carcinoma,
lymphoma) or metastatic (from squamous cell) can produce cavities. These are
usually thick-walled. A fluid level is seen more commonly with primary tumors
than with metastasis.</span></p>

<p><span></span></p>

<p>*<span> </span></span><span
 lang=EN-GB>Because the
right main bronchus is wider and more vertical than the left, aspiration is
more likely to occur in the right main bronchus. The superior segmental
bronchus of the lower lobar bronchus is the only segmental bronchus that exits
from the posterior wall of the lobar bronchi. Therefore, if a patient is supine
at the time of aspiration, the object is most likely to enter the <i>superior segmental bronchus of the right
lower lobe</i>.</span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is correct</span></b><span>.
<span>Anaerobic lung abscess usually occurs
in individuals who are predisposed to aspiration of gastric contents (e.g.,
dementia). The clinical presentation may be indolent, with symptoms lasting
weeks or months. The abscess is usually right-sided and located in the lower
lung zone. All of these characteristic apply to the patient in this vignette. </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
52-year-old man has a six-day history of fever, productive cough, and shortness
of breath. Lung examination reveals dullness of percussion, increased tactile
fremitus, bronchial breath sounds, and crackles in the left lung base. Which of
the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Chronic
bronchitis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congestive
heart failure<span >&nbsp; </span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lobar
pneumonia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pleural
effusion</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumothorax</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Emphysema</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Asthma</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 width=463>
 <tr>
  <td width=463 colspan=6 valign=top>
  <p style="text-align:center;"><span>Physical Signs in Selected Chest Disorders</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span></span></p>
  </td>
  <td width=80 valign=top>
  <p><span></span></p>
  </td>
  <td width=81 valign=top>
  <p><span></span></p>
  </td>
  <td width=65 valign=top>
  <p><span></span></p>
  </td>
  <td width=83 valign=top>
  <p><span></span></p>
  </td>
  <td width=73 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Condition</span></p>
  </td>
  <td width=80 valign=top>
  <p><span>Trachea</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Percussion
  Note</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Breath
  Sounds</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Tactile
  fremitus and transmitted voice sounds</span></p>
  </td>
  <td width=73 valign=top>
  <p><span>Adventitious
  sounds</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span></span></p>
  </td>
  <td width=80 valign=top>
  <p><span></span></p>
  </td>
  <td width=81 valign=top>
  <p><span></span></p>
  </td>
  <td width=65 valign=top>
  <p><span></span></p>
  </td>
  <td width=83 valign=top>
  <p><span></span></p>
  </td>
  <td width=73 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span></span></p>
  <p><span>Normal</span></p>
  <p><span></span></p>
  </td>
  <td width=80 valign=top>
  <p><span></span></p>
  <p><span>Midline</span></p>
  </td>
  <td width=81 valign=top>
  <p><span></span></p>
  <p><span>Resonant</span></p>
  </td>
  <td width=65 valign=top>
  <p><span></span></p>
  <p><span>Normal*</span></p>
  </td>
  <td width=83 valign=top>
  <p><span></span></p>
  <p><span>Normal</span></p>
  </td>
  <td width=73 valign=top>
  <p><span></span></p>
  <p><span>None</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Chronic
  bronchitis</span></p>
  </td>
  <td width=80 valign=top>
  <p><span>Midline</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Resonant</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=73 valign=top>
  <p><span>None; or
  scattered coarse crackles in early inspiration and perhaps expiration; or
  wheezes or rhonchi</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Pulmonary
  edema (e.g., from left-sided heart failure)</span></p>
  </td>
  <td width=80 valign=top>
  <p><span>Midline</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Resonant</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=73 valign=top>
  <p><span>Late
  inspiratory crackles in dependent<span >&nbsp;
  </span>areas of lungs; possibly wheezes</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Consolidation
  (e.g., lobar pneumonia)</span></p>
  </td>
  <td width=80 valign=top>
  <p><span>Midline</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Dull
  over consolidation</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Bronchial
  over involved area</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Increased
  over involved area with</span></p>
  <p><span>bronchophony,
  egophony,</span></p>
  <p><span>whispered
  pectoriloquy</span></p>
  </td>
  <td width=73 valign=top>
  <p><span>Late
  inspiratory crackles over the involved area</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Atelectasis</span></p>
  <p><span>(lobar
  obstruction)</span></p>
  </td>
  <td width=80 valign=top>
  <p><span>May be
  shifted toward involved</span></p>
  <p><span>Side</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Dull
  over airless area</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Usually
  absent when bronchial plug persists</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Usually
  absent when bronchial plug persists</span></p>
  </td>
  <td width=73 valign=top>
  <p><span>None</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Pleural effusion
  </span></p>
  </td>
  <td width=80 valign=top>
  <p><span>Shifted
  toward opposite side in large effusion</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Dull
  over effusion</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Decreased<span>&nbsp; </span>(although bronchial sounds may be
  heard at the top of a large effusion)</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Decreased<span>&nbsp; </span>(but may be increased at the top
  of<span >&nbsp; </span>effusion)</span></p>
  </td>
  <td width=73 valign=top>
  <p><span>None,
  except possibly a pleural rub</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Pneumothorax</span></p>
  </td>
  <td width=80 valign=top>
  <p><span>Shifted
  toward opposite side if large pneumothorax</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Hyperresonant
  over pleural air</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Decreased
  over pleural air</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Decreased
  over pleural air </span></p>
  </td>
  <td width=73 valign=top>
  <p><span>None,
  except a possible pleural rub</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Emphysema</span></p>
  </td>
  <td width=80 valign=top>
  <p><span>Midline</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Diffusely
  hyperresonant</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Decreased</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Decreased</span></p>
  </td>
  <td width=73 valign=top>
  <p><span>None, or
  the crackles, wheezes, and rhonchi of associated chronic bronchitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=81 valign=top>
  <p><span>Asthma</span></p>
  </td>
  <td width=80 valign=top>
  <p><span>Midline</span></p>
  </td>
  <td width=81 valign=top>
  <p><span>Normal-to-diffusely
  hyperresonant</span></p>
  </td>
  <td width=65 valign=top>
  <p><span>Often
  obscured by wheezes</span></p>
  </td>
  <td width=83 valign=top>
  <p><span>Decreased</span></p>
  </td>
  <td width=73 valign=top>
  <p><span>Wheezes,
  possibly crackles</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>*A normal
lung is characterized by vesicular breath sounds except over the trachea where
breath sounds are bronchial and over the large bronchi where they are
bronchovesicular. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>.<span>&nbsp; </span>Pneumonia often causes fever, productive
cough, and shortness of breath. Physical findings include dullness of
percussion, increased tactile fremitus, bronchial breath sounds, egophony,
whispered pectoriloquy, and crackles over the involved area. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Chronic bronchitis
usually produces normal findings on lung examination. However, scattered coarse
crackles may be heard in early inspiration, and wheezes or rhonchi may be
present. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Congestive heart
failure is associated with late inspiratory crackles in dependent areas of
lungs. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Pleural effusion is
associated with dullness to percussion, decreased breath sounds, and decreased
tactile fremitus over the effusion. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Pneumothorax is
associated with hyperresonance to percussion, decreased breath sounds, and
decreased tactile fremitus over the pleural air.</span></p>

<p><span></span></p>

<p><b><span>Answer F is incorrect</span></b><span>. Emphysema is
associated with diffuse hyperresonance to percussion, decreased breath sounds,
and decreased tactile fremitus. Wheezes, crackles, and rhonchi may be present
with associated chronic bronchitis. </span></p>

<p><span></span></p>

<p><b><span>Answer G is incorrect</span></b><span>. Asthma is associated
with resonance or hyperresonance to percussion, decreased tactile fremitus, and
wheezing, which may obscure breath sounds. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
68-year-old man presents to the emergency room with crushing chest pain that
radiates to the neck and jaw. He is diagnosed with a myocardial infarction. His
left ventricular ejection fraction is 45%. Three days later he becomes
hypotensive and short of breath. Examination reveals a new holosystolic murmur,
loudest at the apex, radiating to the left axilla. The ejection fraction is now
25%. What caused the deterioration? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ruptured
papillary muscle </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ruptured
interventricular septum </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ruptured
left ventricular free wall</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Ventricular
aneurysm</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dressler’s
syndrome</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span style='font-family:"Times New Roman"'>Complications of Acute
Myocardial Infarction</span></b></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p><b><span>Complication</span></b></p>
   </td>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Manifestations</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td valign=top>
  <p><span>Ischemic</span></p>
  </td>
  <td valign=top>
  <p><span>infarct
  extension, recurrent infarction</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Mechanical</span></p>
  </td>
  <td valign=top>
  <p><span>papillary
  muscle rupture with mitral regurgitation</span></p>
  <p><span>ventricular
  septal rupture </span></p>
  <p><span>cardiac
  free wall rupture </span></p>
  <p><span>ventricular
  aneurysm </span></p>
  <p><span>heart
  failure</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Arrhythmic</span></p>
  </td>
  <td valign=top>
  <p><span>atrial
  or ventricular arrhythmias </span></p>
  <p><span>sinus or
  atrioventricular node dysfunction</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Embolic</span></p>
  </td>
  <td valign=top>
  <p><span>embolization</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Inflammatory</span></p>
  </td>
  <td valign=top>
  <p><span>pericarditis</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. The murmur described
in this vignette is typical of acute mitral regurgitation, which in the setting
of a recent myocardial infarction is most likely caused by rupture of one of
the left ventricular papillary muscles. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Rupture of the
interventricular septum produces a holosystolic murmur that is loudest at the
left sternal border. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Rupture of the left
ventricular free wall causes cardiac tamponade, which is associated with pulsus
paradoxus, jugular venous distension, and decreased heart sounds. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Ventricular aneurysm
may be associated with arrhythmias and thrombus formation resulting in emboli. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Dressler’s syndrome is
a type of pericarditis that occurs several weeks after myocardial infarction.
Symptoms include fever, sharp chest pain, and pericardial friction rub. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
4-hour-old female newborn delivered at 30 weeks’ gestation has respiratory
distress. Her temperature is 36.5<sup>o</sup>C (97.7<sup>o</sup>F), pulse is
160/minute, respirations are 85/minute, and blood pressure is 68/40 mm Hg.
Arterial blood gas analysis on room air shows:</span></p>

<p><span></span></p>

<p><span>pH<span> </span>7.18</span></p>

<p><span>pCO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>78
mm Hg</span></p>

<p><span>pO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>55
mm Hg</span></p>

<p><span></span></p>

<p><span>Endotracheal
intubation and mechanical ventilation are required. The primary cause of this
patient’s condition is a dysfunction of which of the following cell types?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Alveolar
macrophages</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumocytes</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulmonary
chondrocytes</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pulmonary
vascular endothelial cells</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Smooth
muscle cells</span></p>

<p><span></span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>There are
many causes of respiratory distress in the newborn, including sepsis,
pneumonia, excessive sedation of the mother, fetal head injury during delivery,
aspiration of blood or amniotic fluid, and perinatal depression or intrauterine
hypoxia brought about by a number of reasons including coiling of the umbilical
cord about the neck (nuchal cord). However, the most common cause is
respiratory distress syndrome (RDS), also known as <span>hyaline membrane disease</span> because of the formation of “membranes”
in the peripheral air spaces of infants who succumb to this condition. </span></p>

<p><span></span></p>

<p><span>RDS is basically a disease of premature infants<i>.</i></span><span> Other contributing
influences are <span>maternal diabetes,
cesarean section</span> before the onset of labor, and <span>twin gestation.</span>The fundamental defect in RDS is the inability of
the immature lung to synthesize sufficient surfactant. Surfactant is a complex
of surface-active phospholipids, principally dipalmitoylphosphatidylcholine
(lecithin), and at least two groups of surfactant-associated proteins.
Surfactant is synthesized by type II pneumocytes. With the healthy newborn’s
first breath, it rapidly coats the surface of alveoli, reducing surface tension
and decreasing the pressure required to keep alveoli open. In a lung deficient
in surfactant, alveoli tend to collapse, and a relatively greater inspiratory
effort is required with each breath to open the alveoli. Thus, surface tension
is increased and lung compliance is decreased. The infant rapidly tires from
breathing, and generalized atelectasis sets in. The resulting hypoxia sets into
motion a sequence of events that lead to epithelial and endothelial damage and
eventually to the formation of hyaline membranes. </span></p>

<p><span></span></p>

<p>RDS begins shortly after
birth and is manifested by tachypnea, tachycardia, chest wall retractions
(recession), expiratory grunting, nasal flaring, and cyanosis during breathing
efforts. As the disease progresses, the baby may develop ventilatory failure
(rising carbon dioxide levels in the blood), and prolonged cessations of
breathing (apnea). Findings include hypotension and acidosis. Radiographic
findings include low lung volumes, diffuse reticulogranular pattern
(homogeneous ground-glass appearance) due to diffuse alveolar atelectasis and
air bronchograms due to alveolar collapse. The disorder may be associated with
other conditions that accompany prematurity, such as <span>patent ductus arteriosus, intraventricular hemorrhage,</span> and <span>necrotizing enterocolitis.</span> The
clinical course for the acute disease lasts about 2 to 3 days. During the first
day, the patient worsens and requires more support. During the second day, the
baby may be remarkably stable on adequate support. Resolution is noted during
the third day, heralded by a prompt diuresis.</p>

<p></p>

<p><a name=4-u1.0-B978-1-4160-2973-1..50010-7--f22></a><a
name=4-u1.0-B978-1-4160-2973-1..50010-7--cese></a><span>A major thrust in the control of RDS focuses on
prevention, either by delaying labor until the fetal lung reaches maturity or
by inducing maturation of the lung in the fetus at risk. Critical to these
objectives is the ability to assess fetal lung maturity accurately. Because
pulmonary secretions are discharged into the amniotic fluid, analysis of
amniotic fluid phospholipids provides a good estimate of the level of
surfactant in the alveolar lining. Prophylactic administration of exogenous surfactant
at birth to extremely premature infants (gestational age &lt;28 weeks) has been
shown to be very beneficial, such that it is now uncommon for infants to die of
acute RDS.<span >&nbsp; </span>The introduction of
antenatal steroids has also decreased the incidence of RDS by as much as 50% in
premature infants.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. Neonatal Respiratory
Distress Syndrome (RDS) (“hyaline membrane disease”) should be suspected in a
premature newborn with respiratory distress, tachypnea, tachycardia,
hypotension, and acidosis. The fundamental abnormality is insufficient
pulmonary surfactant produced by type II pneumocytes. This results in failure
of the lungs to expand after birth. RDS is characterized by hyaline membranes,
which consist of underdeveloped epithelial cells and plasma proteins lining the
airways. The condition can be ameliorated by prophylactic administration of
steroids, surfactant therapy, and by improved ventilation techniques.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
72-year-old man presents to the emergency department with a one-week history of
progressive shortness of breath. Two days prior to his arrival he develops a
cough and a sharp pain in his left chest. The pain increases with inspiration.
He does not expectorate blood or sputum. He has lost 10 lb in two months. He
was healthy before the symptoms began and he takes no medication. He has a 25
pack-year history of smoking and was exposed to asbestos in the military. On
physical examination, temperature is 98.4 F<sup>o</sup>, blood pressure is
156/92 mm Hg, pulse is 110/minute, and respirations are 25/minute. The O<sub>2</sub>
saturation is 98% on room air. His heart is regular. Lung exam reveals dullness
to percussion over the left posterior lung field from the lung base to just
below the scapula. Tactile fremitus and breath sounds are decreased in this
region. Mild clubbing of the fingers is noted. There is no jugular venous
distention, lower extremity edema, or jaundice. </span></p>

<p><span></span></p>

<p><span>Laboratory
tests show the following:</span></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><span>Hgb<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>10
g/dL</span></p>

<p><span>WBC<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>9,800/mm<sup>3</sup></span></p>

<p><span>Platelet<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>390,000/mm<sup>3</sup></span></p>

<p><span></span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>14
mg/dL</span></p>

<p><span>Creatinine
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.2
mg/dL</span></p>

<p><span></span></p>

<p><span>AST <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>14
IU/L</span></p>

<p><span>ALT <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>20
IU/L</span></p>

<p><span>Alk Phos <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>60
IU/L</span></p>

<p><span></span></p>

<p><span>INR <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.2</span></p>

<p><span></span></p>

<p><span>B-type
natriuretic peptide (BNP):<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>90
pg/ml (Normal: &lt;100 pg/ml)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Chest
X-ray shows a large left-sided pleural effusion. </span></p>

<p><span></span></p>

<p><span>Chest CT
shows a large left-sided fluid collection without loculation or septation.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is
the most likely explanation for the effusion?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Hepatic
hydrothorax</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congestive
heart failure</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Malignant
pleural effusion</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Para-pneumonic
effusion </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Pleural effusion</span> is excess fluid that accumulates in the pleura,
the fluid-filled space that surrounds the lungs. Excessive amounts of such
fluid can impair breathing by limiting the expansion of the lungs during
respiration.</p>

<p><span></span></p>

<p><span>Four types of fluids can accumulate in the pleural space:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serous fluid (hydrothorax)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Blood (hemothorax)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chyle (chylothorax)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pus (empyema)</span></p>

<p></p>

<p>Pleural effusion is usually
diagnosed on the basis of medical history and physical exam, and confirmed by
chest x-ray. Once accumulated fluid is more than 500 ml, there are usually
detectable clinical signs in the patient, such as decreased movement of the
chest on the affected side, dullness to percussion over the fluid, diminished
breath sounds on the affected side, decreased vocal fremitus, and pleural friction
rub. Above the effusion, where the lung is compressed, there may be bronchial
breath sounds and egophony. In large effusion there may be tracheal deviation
away from the effusion. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=185 valign=top>
  <p style="text-align:center;"><span>Common causes of
  pleural effusion</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Congestive heart failure</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Pneumonia</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Cancer</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Pulmonary embolism</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Lung inflammation</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Cirrhosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Post open-heart surgery</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><span>Once a
pleural effusion is diagnosed, the cause must be determined. Pleural fluid is
drawn out of the pleural space in a process called thoracentesis. A needle is
inserted through the back of the chest wall in the sixth, seventh, or eighth
intercostal space. The fluid is then sent to the laboratory for testing. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct. </span></b><span>A
malignant effusion is likely given the risk factors for bronchogenic carcinoma
(smoking and asbestos exposure) and the presence of weight loss and anemia.
Dullness to percussion and diminished breath sounds are common findings in
pleural effusion. Symptoms may include cough, shortness of breath, and
pleuritic chest pain. The next step in the diagnostic work-up would be
thoracentesis to obtain fluid for analysis. Cytological analysis of the fluid
would be the best method for detecting a malignant source of effusion. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. In patients with liver
failure and ascites, diaphragmatic defects can lead to unilateral pleural
effusions. In this case, hepatic hydrothorax is unlikely given the absence of
liver disease.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Heart failure is
unlikely given a normal heart exam and the absence of jugular venous distension
and edema. Pleural effusions caused by heart failure are usually right-sided or
bilateral. Pulmonary edema is usually seen on chest x-ray. An elevated B-type
natriuretic peptide (BNP) would be expected. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. A parapneumonic
effusion is possible, but unlikely given the absence of fever, purulent sputum,
and leukocytosis. The chest CT shows no septation or loculation to suggest
infection of the pleural space. Nevertheless, infection must be ruled out by
fluid analysis. Thoracentesis is indicated.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
62-year-old man with diabetes, hypertension, and hyperlipidemia presents with a
3-day history of fever, chills, productive cough, and shortness of breath. Six
months ago, he was admitted to the MICU with pneumonia and septic shock for
which he was intubated and mechanically ventilated. Two weeks ago, he had the
“flu” from which he recovered.<span >&nbsp; </span>He
has no recent contact with sick people and he has not traveled out of state. He
smokes a pack of cigarettes daily and drinks alcohol occasionally. His
medications are metformin, hydrochlorothiazide, lisinopril, simvastatin, baby
aspirin, and a multi-vitamin. </span></p>

<p><span></span></p>

<p><span>His
temperature is 101.4<sup>o</sup> F, pulse is 90/minute, blood pressure is
135/85 mmHg, and respirations are 22/minute. Lung exam shows increased
fremitus, crackles, bronchial breath sounds and whispered pectoriloquy in the
left upper lung field. Laboratory studies show a white blood cell count of
14,000/mm<sup>3 </sup>(80% neutrophils). Sputum gram stain shows &lt;10
epithelial cells and &gt;25 white blood cells per high-powered field.
Gram-positive cocci in pairs and chains are seen. A chest x-ray shows
infiltrates in the left upper lobe with air bronchograms.</span></p>

<p><span></span></p>

<p><span>Which of
the following is the correct diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Community-acquired
pneumonia </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aspiration
pneumonia</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hospital-acquired
pneumonia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Health
care-associated pneumonia</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ventilator-associated
pneumonia</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>The
clinical classification of pneumonia is important because it affects the choice
of antibiotics. Each clinical category is associated with a spectrum of pathogens,
which determines the appropriate choice of empiric therapy.</span></p>

<p><b><span></span></b></p>

<p><span>Community-acquired pneumonia (CAP) refers to pneumonia in
people who have not recently been in a hospital or another health care facility
(nursing home, rehabilitation facility).<span >&nbsp;
</span></span>CAP is generally divided into two categories: typical and
atypical. Whenever a bacterial cause is identified, 50% of CAP cases are due to
pneumococcus. The rest are due to <i>Staphylococcus
aureus</i> and gram-negative bacteria like <i>Haemophilus
influenzae</i> and <i>Moraxella catarrhalis</i>,
which are common in smokers. Atypical pneumonias (~ 20% of CAP) are caused by <i>Mycoplasma pneumoniae</i>, <i>Chlamydophila pneumoniae</i>, <i>Legionella pneumoniae</i> and viruses
(typically influenza A and B). Post-influenza pneumonia, which this patient
appears to have, is often due to <i>Streptococcus</i>
<i>pneumoniae</i> or <i>Staphylococcus aureus</i>. Generally atypical pneumonia has an
insidious onset with a predominance of constitutional symptoms. It usually
occurs in younger patients, causes non-productive cough, and presents with
multilobar involvement. Various serologic tests are available to detect typical
and atypical pathogens.</p>

<p></p>

<p>Hospital
Acquired Pneumonia (HAP) is defined as pneumonia that occurs more than 48 hours
after hospital admission. </p>

<p></p>

<p>Health Care
Associated Pneumonia (HCAP) is defined as pneumonia that occurs in residents of
long-term care facilities, patients on hemodialysis, patients receiving
outpatient infusions of chemotherapy or antibiotics, and patients receiving
outpatient wound care. HCAP also includes patients who develop pneumonia within
90 days of hospital discharge.</p>

<p></p>

<p>Ventilator-associated
pneumonia (VAP) is defined as pneumonia that develops 48-72 hours after being
placed on mechanical ventilation. It is sometimes caused by <i>Pseudomonas</i>.</p>

<p></p>

<p><span>Hospital-acquired
pneumonia (HAP), health care-associated pneumonia (HCAP), and
ventilator-associated pneumonia (VAP) come under the common heading of
nosocomial pneumonia. These are the pneumonias that are directly or indirectly
associated with health care and hospitals. Most nosocomial pneumonias are due
to bacterial pathogens, especially enteric gram-negative bacteria and
methicillin-resistant <i>Staphylococcus
aureus</i> (MRSA). Elderly patients are at high risk of developing nosocomial
pneumonia.</span></p>

<p><b><span></span></b></p>

<p><span>Aspiration
pneumonia usually occurs after material in the oropharynx is aspirated into the
lungs in such settings as endotracheal intubation, seizure, drug/alcohol
intoxication, and stroke (if associated with dysphagia). Poor dental hygiene
predisposes to aspiration pneumonia and lung abscess. Lung infiltrates usually
appear in right lower lobe. The chest X-ray may show air-fluid levels
consistent with lung abscess. Patients usually have bad breath and sputum
Gram-stain typically shows mixed flora. The most common pathogens are
anaerobes.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>The patient in the
vignette has community-acquired pneumonia (CAP), probably due to <i>Streptococcus</i> <i>pneumoniae</i>, which is the most common cause of CAP. The patient
vignette developed pneumonia six months after being hospitalized for septic
shock. This is too far out to be considered health care-associated pneumonia.
If pneumonia had occurred <i>within 90 days</i>
of his discharge from the hospital, the diagnosis would be health
care-associated pneumonia, not community-acquired pneumonia.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
21-year-old man with no previous medical problems presents to the emergency
department with sudden onset of shortness of breath, dry cough, and stabbing
pain in the left chest.<span >&nbsp; </span>Symptoms
began when he was sitting on the sideline during an intramural basketball game;
he plays the position of center. On physical examination, he is in mild
respiratory distress. Temperature is 98.6<sup>o</sup>F, pulse is 115/minute,
blood pressure is 135/75 mm Hg, and respirations are 28/minute. The oxygen
saturation is 93% on room air.<span >&nbsp; </span>Lung
exam reveals hyperresonance to percussion, decreased tactile fremitus, and
decreased breath sounds over the left hemithorax. What is the most likely
diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Pneumonia</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pleural
effusion</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumothorax</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pulmonary
embolism</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Myocardial
infarction<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Pneumothorax
is defined as air in the normally airless pleural space.<span>&nbsp; </span>There are two types of pneumothorax:
spontaneous and traumatic.<span >&nbsp;
</span>Traumatic pneumothoraces are often iatrogenic (e.g., placement of a
central intravenous line).<span >&nbsp;
</span>Spontaneous pneumothoraces occur without trauma.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Spontaneous
pneumothorax can be further divided into two types.<span>&nbsp; </span>Primary pneumothorax occurs without
underlying lung disease.<span >&nbsp; </span>It is
caused by spontaneous rupture of subpleural blebs at the apex of the lungs. Air
escapes into the pleural space, causing lung collapse.<span>&nbsp; </span>This condition is most common in tall,
lean, young men, who typically have good pulmonary reserve, and who, therefore,
may not experience severe respiratory distress. The recurrence rate of primary
pneumothorax is 50% in two years.<span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Secondary
pneumothorax occurs as a complication of underlying lung disease, especially
COPD. Other predisposing conditions include asthma, interstitial lung disease,
neoplasms, cystic fibrosis, and tuberculosis. Secondary pneumothorax may be
life-threatening if the patient lacks adequate pulmonary reserve.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Symptoms
of a pneumothorax include ipsilateral chest pain (usually sudden in onset),
dyspnea, and cough. Findings include hyperresonance, decreased (or absent)
tactile fremitus, and decreased breath sounds over the affected area.<span>&nbsp; </span>In a tension pneumothorax, the trachea
may deviate toward the contralateral side. Chest x-ray may show a visceral
pleural line.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer
C is correct</span></b><span>.<span>&nbsp; </span>Sudden onset shortness of breath and
stabbing chest pain in a patient with hyperresonance to percussion, decreased
tactile fremitus, and decreased breath sounds over the left hemithorax suggests
a diagnosis of spontaneous left-sided pneumothorax. </span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Pneumonia in a young person usually presents with fever and productive
cough.<span >&nbsp; </span>Findings include increased
fremitus, dullness to percussion, bronchial breath sounds, and crackles over
the affected area. Egophony and whispered pectoriloquy may be heard. Chest
x-ray often shows an infiltrate or area of consolidation.</span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
Pleural effusion is unlikely in a previously healthy person. Most effusions are
caused by congestive heart failure, pneumonia, malignancy, pulmonary embolism,
or cirrhosis with ascites.<span >&nbsp; </span>Patients
may have exertional dyspnea. Findings include dullness to percussion, decreased
tactile fremitus, and decreased breath sounds over the affected area.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Pulmonary embolism is unlikely in a previously healthy person.<span>&nbsp; </span>Risk factors include age &gt;60,
malignancy, prior history of deep vein thrombosis or pulmonary embolism,
hereditary hypercoagulable state, prolonged immobilization, cardiac disease, obesity,
nephrotic syndrome, major surgery, trauma, pregnancy, and estrogen use.<span>&nbsp; </span>Pulmonary embolism can present with many
of the symptoms of pneumothorax, but the physical findings are different. </span></p>

<p><span><span>&nbsp;&nbsp; </span></span></p>

<p><b><span>Answer
E is incorrect</span></b><span>.
Myocardial infarction is unlikely in a young person with no risk factors for
coronary artery disease. Symptoms of myocardial infarction include left-sided
chest tightness, radiation of pain to the left arm or jaw, shortness of breath,
diaphoresis, nausea, and vomiting.<span >&nbsp;&nbsp;
</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 60-year-old man with poorly controlled
hypertension is admitted to the emergency department with a three-week history
of progressive shortness of breath. He has been sleeping in a recliner for the
past three nights. One hour prior to admission, his breathing worsened and he
summoned the ambulance to take him to the hospital. He is sitting upright and
his respirations are labored. He says he is “suffocating.” Blood pressure is
220/124 mmHg, pulse is 136/minute, and respirations are 36/minute. His heart rate
is rapid with a regular rhythm. The heart is barely audible over the
respiratory noise. Expiratory wheezes are present diffusely, and crackles are
heard up to the mid-lung fields. The extremities are slightly cool and
cyanotic. Pitting ankle edema is present. </span></p>

<p><span></span></p>

<p><span>What of the following best explains the
patient’s distress? </span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Chronic
obstructive pulmonary disease (COPD) exacerbation</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Cardiogenic
pulmonary edema</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Asthma
exacerbation</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Bilateral
diaphragm paralysis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Shortness of breath may be caused by lung
disease, heart disease, anxiety, or deconditioning. Often the medical history
and physical examination are revealing. Orthopnea (shortness of breath with
recumbency) may be due to heart or lung disease. Common causes include
pulmonary edema from left ventricular heart failure, asthma, and chronic
bronchitis. Orthopnea can cause a patient to sleep in a recliner. </span></p>

<p><span></span></p>

<p><span>Wheezing may be of cardiac or pulmonary
origin. Remember: “Not all that wheezes is asthma.” Wheezing is neither
sensitive nor specific for asthma. Patients with mild or severe asthma may not
wheeze at all, while patients with cardiogenic pulmonary edema may wheeze
considerably. The term “cardiac asthma” is used to describe wheezing associated
with cardiogenic pulmonary edema.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Sometimes the patient’s characterization
of his breathing may be informative (i.e., certain words may suggest certain
etiologies):</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=142 valign=top>
  <p style="text-align:center;"><span>Condition</span></p>
  </td>
  <td width=146 valign=top>
  <p style="text-align:center;"><span>Descriptor</span></p>
  </td>
 </tr>
 <tr>
  <td width=142 valign=top>
  <p><span>Asthma</span></p>
  </td>
  <td width=146 valign=top>
  <p><span>Chest
  tightness or constriction</span></p>
  </td>
 </tr>
 <tr>
  <td width=142 valign=top>
  <p><span>COPD,
  severe asthma, respiratory muscle weakness, pulmonary fibrosis</span></p>
  </td>
  <td width=146 valign=top>
  <p><span>Increased
  work or effort of breathing</span></p>
  </td>
 </tr>
 <tr>
  <td width=142 valign=top>
  <p><span>Pulmonary
  edema</span></p>
  </td>
  <td width=146 valign=top>
  <p><span>Suffocating,
  smothering</span></p>
  </td>
 </tr>
 <tr>
  <td width=142 valign=top>
  <p><span>Deconditioning</span></p>
  </td>
  <td width=146 valign=top>
  <p><span>Heavy
  breathing, breathing more than usual</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The presence of crackles in the lungs is
compatible with pulmonary edema. With mild pulmonary edema, late inspiratory
crackles are commonly heard in the lung bases.<span>&nbsp; </span>With severe pulmonary edema, the
crackles often rise to the mid-lung fields. Pulmonary edema is usually caused
by left heart failure. Other findings suggestive of heart failure are cool,
cyanotic extremities and ankle edema. </span></p>

<p><span></span></p>

<p><span>Many conditions can precipitate heart
failure. The two most important are myocardial ischemia and hypertension. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B
is correct. </span></b><span><span>&nbsp;&nbsp;</span>Shortness of breath and wheezing in
a patient with very high blood pressure, pulmonary crackles, leg edema, and
cyanotic extremities suggests a diagnosis of cardiogenic pulmonary edema. The
patient is severely hypertensive, which provides an explanation for his heart
failure.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Match each
of the following clinical vignettes with the correct diagnosis.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>A
60-year-old man with a 60 pack/year smoking history has shortness of breath on
exertion. An arterial blood gas shows a PO<sub>2</sub> of 56 mm Hg and a PCO<sub>2</sub>
of 44 mm Hg.</p>

<p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="19%">
  <p style="text-align:center;">Patient</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">FEV1</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">FEV1/FVC</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">TLC</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">DLCO/VA</p>
  </td>
 </tr>
 <tr>
  <td width="19%">
  <p style="text-align:center;">1</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">0.7 L (23%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">25%</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">9.7 L (150%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">0.9 (19%)</p>
  </td>
 </tr>
</table>

<p></p>

<p><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>A
30-year-old woman with tuberous sclerosis has shortness of breath and a cough.
A chest radiograph shows reticulonodular infiltrates.</p>

<p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="19%">
  <p style="text-align:center;">Patient</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">FEV1</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">FEV1/FVC</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">TLC</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">DLCO/VA</p>
  </td>
 </tr>
 <tr>
  <td width="19%">
  <p style="text-align:center;">2</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">1.1 L (42%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">56%</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">3.0 L (64%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">1.5 (29%)</p>
  </td>
 </tr>
</table>

<p></p>

<p><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>A
36-year-old man is wheelchair bound. His arterial blood gas shows a PO<sub>2</sub>
of 60 mm Hg and a PCO<sub>2</sub> of 52 mm Hg.</p>

<p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="19%">
  <p style="text-align:center;">Patient</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">FEV1</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">FEV1/FVC</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">TLC</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">DLCO/VA</p>
  </td>
 </tr>
 <tr>
  <td width="19%">
  <p style="text-align:center;">3</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">1.0 L (33%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">85%</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">2.7 L (50%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">8.2 (144%)</p>
  </td>
 </tr>
</table>

<p></p>

<p><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>A
22-year-old woman has shortness of breath when the pollen count is high. On
physical exam, she is wheezing.</p>

<p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="19%">
  <p style="text-align:center;">Patient</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">FEV1</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">FEV1/FVC</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">TLC</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">DLCO/VA</p>
  </td>
 </tr>
 <tr>
  <td width="19%">
  <p style="text-align:center;">4</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">1.8 L (60%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">61%</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">4.9 L (100%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">6.8 (122%)</p>
  </td>
 </tr>
</table>

<p></p>

<p><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>A
43-year-old woman has progressive shortness of breath with exertion. A chest
radiograph shows reticulonodular infiltrates, especially in the lung bases.</p>

<p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="19%">
  <p style="text-align:center;">Patient</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">FEV1</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">FEV1/FVC</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">TLC</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">DLCO/VA</p>
  </td>
 </tr>
 <tr>
  <td width="19%">
  <p style="text-align:center;">5</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">1.4 L (49%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">78%</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">2.7 L (52%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">2.6 (51%)</p>
  </td>
 </tr>
</table>

<p></p>

<p><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>A
55-year-old woman has shortness of breath with exertion. The chest radiograph
is normal. While breathing room air, her PO<sub>2</sub> is 48 mm Hg. While
breathing 100% oxygen, her PO<sub>2 </sub>does not rise appropriately. <span>&nbsp; </span><span>&nbsp;</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="19%">
  <p style="text-align:center;">Patient</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">FEV1</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">FEV1/FVC</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">TLC</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">DLCO/VA</p>
  </td>
 </tr>
 <tr>
  <td width="19%">
  <p style="text-align:center;">6</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">2.8 L (95%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">80%</p>
  </td>
  <td width="19%">
  <p style="text-align:center;">6.3 L (99%)</p>
  </td>
  <td width="20%">
  <p style="text-align:center;">1.9 (44%)</p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>A. Asthma</span></p>

<p><span>B.
Emphysema</span></p>

<p><span>C. Interstitial
lung disease</span></p>

<p><span>D. <span>Lymphangioleiomyomatosis</span></span></p>

<p><span>E.
Cirrhosis-associated hypoxemia</span></p>

<p><span>F.
Muscular dystrophy</span></p>

<p>Although pulmonary function
tests (PFTs) provide an array of measurements, only a few are needed to assess
a patient's condition. PFTs have five basic components: spirometry, lung
volumes, diffusing capacity, arterial blood gas, and flow-volume loops.&nbsp;</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=149 valign=top>
  <p>Pulmonary Function Tests</p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p>Spirometry</p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p>Lung volumes</p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p>Diffusing capacity</p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p>Arterial blood gas</p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p>Flow-volume loops</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>The following abbreviations
are used in this tutorial.</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=401 colspan=2 valign=top>
  <p style="text-align:center;">Common Abbreviations</p>
  </td>
 </tr>
 <tr>
  <td width=401 colspan=2 valign=top>
  <p style="text-align:center;"></p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>FEV<sub>1</sub></p>
  </td>
  <td width=315 valign=top>
  <p>Forced expiratory volume
  in the first second of expiration</p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>FVC</p>
  </td>
  <td width=315 valign=top>
  <p>Forced vital capacity</p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>TLC</p>
  </td>
  <td width=315 valign=top>
  <p>Total lung capacity</p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>DLCO/VA</p>
  </td>
  <td width=315 valign=top>
  <p>Diffusing capacity for
  carbon monoxide / alveolar volume</p>
  </td>
 </tr>
</table>

</div>

<p><b></b></p>

<p><b></b></p>

<p><b>Spirometry</b></p>

<p><b><u><o:p><span>&nbsp;</span></o:p></u></b></p>

<p>Spirometry measures air flow
and determines if obstruction is present. Obstruction is defined as an FEV<sub>1</sub>/FVC
less than 75%. The severity of obstruction is determined by the FEV<sub>1</sub>.</p>

<p><span>&nbsp;</span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=194 colspan=2 valign=top>
  <p style="text-align:center;">Severity of Obstruction</p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p></p>
  </td>
  <td width=108 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>FEV<sub>1</sub> &gt; 70%</p>
  </td>
  <td width=108 valign=top>
  <p>Mild</p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>FEV<sub>1</sub> 60-70%</p>
  </td>
  <td width=108 valign=top>
  <p>Moderate</p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>FEV<sub>1</sub> 50-60%</p>
  </td>
  <td width=108 valign=top>
  <p>Moderately severe</p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>FEV<sub>1</sub> 35-50%</p>
  </td>
  <td width=108 valign=top>
  <p>Severe</p>
  </td>
 </tr>
 <tr>
  <td width=86 valign=top>
  <p>FEV<sub>1</sub> &lt; 35%</p>
  </td>
  <td width=108 valign=top>
  <p>Very severe</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>Obstruction is considered
reversible if there is a <u>&gt;</u>12% increase in the FEV<sub>1</sub> after
bronchodilator challenge. </p>

<p></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Lung Volumes</b></p>

<p><b>&nbsp;</b></p>

<p>Restriction is defined as a
reduction in the total lung capacity (&lt;80% of the predicted value). The
severity of restriction is determined by the total lung capacity. &nbsp;</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=141 colspan=2 valign=top>
  <p style="text-align:center;">Severity of Restriction</p>
  </td>
 </tr>
 <tr>
  <td width=77 valign=top>
  <p></p>
  </td>
  <td width=64 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=77 valign=top>
  <p>TLC 70-80%</p>
  </td>
  <td width=64 valign=top>
  <p>Mild </p>
  </td>
 </tr>
 <tr>
  <td width=77 valign=top>
  <p>TLC 60-70%</p>
  </td>
  <td width=64 valign=top>
  <p>Moderate</p>
  </td>
 </tr>
 <tr>
  <td width=77 valign=top>
  <p>TLC &lt; 60%</p>
  </td>
  <td width=64 valign=top>
  <p>Severe</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>If a TLC is not ordered,
vital capacity (obtained by spirometry) can be used to determine the presence
of restriction, but TLC is an overall better predictor.</p>

<p><b></b></p>

<p><b></b></p>

<p><b>Diffusing Capacity</b></p>

<p><b></b></p>

<p>Diffusing capacity is the
ability of gas to move from the alveoli, across the interstitium, and into the
blood. The DLCO/VA provides a useful measure of diffusing capacity. (In the
laboratory, carbon monoxide is used to measure diffusion. The VA, or alveolar
volume, approximates the TLC and is used as a correction factor.) A normal
DLCO/VA is &gt;80% of the predicted value. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=176 valign=top>
  <p style="text-align:center;">Conditions that reduce DLCO/VA</p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p>Emphysema</p>
  <p>Interstitial lung disease</p>
  <p>Pulmonary vascular disease</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Pulmonary emboli</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Pulmonary vasculitis</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Pulmonary hypertension</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Pulmonary shunts</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<p><b>Arterial Blood Gas</b></p>

<p><b></b></p>

<p>Arterial blood gas analysis
determines the pH, PO<sub>2</sub>, and PCO<sub>2</sub> of the blood.<span>&nbsp; </span></p>

<p><b></b></p>

<p><b>Flow-Volume Loop</b></p>

<p><b></b></p>

<p>The flow-volume loop is used
mainly to assess upper airway obstruction (e.g., laryngeal cancer). </p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Physiologic Shunt Study&nbsp;</b></p>

<p><b></b></p>

<p>Physiologic shunt studies
are done if pulmonary shunting is suspected as a cause of hypoxemia. The
patient breathes 100% oxygen. If shunting is present, the PO<sub>2</sub> does
not rise appropriately. </p>

<p><u><o:p><span>&nbsp;</span></o:p></u></p>

<p><u><o:p><span>&nbsp;</span></o:p></u></p>

<p><b><u>Specific Conditions</u></b></p>

<p><b><u><o:p><span>&nbsp;</span></o:p></u></b></p>

<p><b>Asthma</b>. In asthma, the main problem is obstruction. There is no
reduction in lung volume and no impairment of gas transport from the alveoli to
the blood. PFTs show a reduced FEV1/FVC ratio, normal (or increased) TLC, and
normal (or increased) DLCO/VA. Typically, the obstruction improves with
bronchodilator challenge.</p>

<p><b></b></p>

<p><b>Emphysema</b>. In emphysema, there is obstruction and hyperinflation
with air trapping and impairment of gas transport. The PFTs show a reduced
FEV1/FVC ratio, an elevated TLC, and a reduced DLCO/VA. In “pure” emphysema,
obstruction is not reversible. In most patients with COPD, however, some
bronchial hyper-reactivity is present. </p>

<p><b></b></p>

<p><b>Interstitial lung disease</b>. Interstitial lung disease reduces lung
compliance, causing a restrictive pattern on PFTs. Lung volumes become
progressively smaller and gas transport is impaired. PFTs show a normal
FEV1/FVC ratio (no obstruction), a low TLC, and a low DLCO/VA.</p>

<p><b></b></p>

<p><b>Combined obstructive and restrictive lung disease. </b>Certain
conditions cause both obstruction and restriction: cystic fibrosis,
bronchiectasis, eosinophilic granuloma, lymphangioleiomyomatosis, and
interstitial disease <i>with</i> emphysema. </p>

<p><b><span></span></b></p>

<p><b><span>Chest bellows diseases</span></b><span>. In disorders that
affect the chest wall and muscles (e.g., kyphoscoliosis, neuromuscular
disease), the lungs are normal but cannot inflate maximally. The FEV1/FVC ratio
and the DLCO/VA are normal, but the TLC is reduced.<br clear=all>
</span></p>

<p><b><span>Answers</span></b></p>

<p><b><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><b><span>B.<span>&nbsp;&nbsp; </span></span></b><span>The patient in Case 1 has emphysema,
which is characterized by a low FEV<sub>1</sub>/FVC ratio, a high TLC, and a
low DLCO/VA.<span >&nbsp; </span><b></b></span></p>

<p><span><span>&nbsp;</span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><b></b></span></p>

<p><b><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><b><span>D.<span>&nbsp;&nbsp; </span></span></b><span>The patient in Case 2 has<b> </b>l<span>ymphangioleiomyomatosis, a condition associated with obstruction and
restriction. The low FEV<sub>1</sub>/FVC ratio indicates obstruction; the low
TLC indicates restriction.<span >&nbsp; </span></span><b><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></b></span></p>

<p><b><span></span></b></p>

<p><b><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><b><span>F.<span>&nbsp;&nbsp; </span></span></b><span>The patient in Case 3 has muscular
dystrophy, a chest bellows disorder. These disorders are associated with a
normal FEV<sub>1</sub>/FVC ratio, a low TLC, and a normal DLCO/VA ratio. <b></b></span></p>

<p><b><span></span></b></p>

<p><b><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><b><span>A.<span>&nbsp;&nbsp; </span></span></b><span>The patient in Case 4 has asthma, which
is characterized by a low FEV<sub>1</sub>/FVC ratio, a normal TLC, and a normal
DLCO/VA ratio.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><b><span>C.<span>&nbsp;&nbsp; </span></span></b><span>The patient in Case 5 has interstitial
lung disease, which is characterized by a<b>
</b>normal FEV<sub>1</sub>/FVC, a low TLC, and a low DLCO/VA ratio.<span>&nbsp; </span><b></b></span></p>

<p><b><span></span></b></p>

<p><b><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><b><span>E.<span>&nbsp;&nbsp; </span></span></b><span>The patient in Case 6 has
cirrhosis-associated hypoxemia, a condition characterized by small-vessel<b> </b>arteriovenous<b> </b>malformations, which cause pulmonary shunting. With shunting,
oxygen administration does not adequately reverse hypoxemia. <b><span>&nbsp;</span></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 52-year-old woman presents with a six-month history of gradually
progressive fatigue and shortness of breath on exertion. She denies fever,
chills, chest pain, and cough. Her past medical history is unremarkable. Her
temperature is 98.6</span><sup><span>o</span></sup><span>F, pulse is 88/minute,
blood pressure is 130/80 mm Hg, and respirations are 20/minute. The heart is
regular with a loud S2 at the left second intercostal space. A left parasternal
heave is present. Hepatojugular reflux is noted. The lungs are clear without
crackles or wheezes. Chest x-ray is normal. Echocardiogram reveals normal left
ventricular function, a hypertrophied right ventricle, and an estimated
pulmonary systolic pressure of 60 mmHg. Which of the following could be
associated with these cardiac findings? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>HIV
infection</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Scleroderma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Cirrhosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Amphetamine
use</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Obesity-hypoventilation</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Chronic
thromboembolism</span></p>

<p><span><span>G.<span>&nbsp;&nbsp; </span></span></span><span>All
of the above</span></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Pulmonary
hypertension (PH) is defined as an abnormal elevation of pulmonary artery
pressure (i.e., average resting pressure &gt; 25 mmHg). Fatigue and exertional
dyspnea may be the only symptoms, although angina, leg edema, and syncope can
occur with advanced disease. Physical findings include a loud S2 at the left
second interspace, a left parasternal heave (indicating right ventricular
hypertrophy), and hepatojugular reflux (indicating right heart failure). In
advanced cases, right heart failure manifested by jugular venous distension,
hepatomegaly, ascites, and peripheral edema may occur. Heart murmurs caused by
pulmonic and tricuspid regurgitation indicate advanced disease. </span></p>

<p><span></span></p>

<p><span>There are
four categories of pulmonary hypertension: arterial, venous, hypoxic, and
thromboembolic. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=293 valign=top>
  <p style="text-align:center;"><span>Pulmonary
  Hypertension</span></p>
  </td>
 </tr>
 <tr>
  <td width=293 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=293 valign=top>
  <p><span>Arterial</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Idiopathic</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>HIV infection</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Connective tissue disease (especially scleroderma)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Congenital heart disease (left-to-right shunt)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cirrhosis with portal hypertension</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Drugs (amphetamines, cocaine)</span></p>
  </td>
 </tr>
 <tr>
  <td width=293 valign=top>
  <p><span>Venous</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Left heart failure</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Mitral stenosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=293 valign=top>
  <p><span>Hypoxic</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Lung disease</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Sleep apnea</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Obesity-hypoventilation</span></p>
  </td>
 </tr>
 <tr>
  <td width=293 valign=top>
  <p><span>Thromboembolic</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer G is correct.<span>&nbsp; </span></span></b><span>Pulmonary
hypertension may be associated with </span><span>HIV infection,
scleroderma, cirrhosis, amphetamine use, obesity-hypoventilation, and chronic
thromboembolism.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 9-year-old girl is
admitted to the hospital with shortness of breath. She is agitated, her hips
and knees are painful and swollen, and she has an erythematous rash on her
trunk. A chest x-ray shows an enlarged heart and findings consistent with
pulmonary edema. The heart failure gets worse and she dies on the following
day. Infection of which of the following most likely preceded her admission?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Pharynx</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Lung</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Liver</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Skin</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Meninges</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Acute rheumatic fever (ARF)
is an autoimmune inflammatory process that develops as a sequela of
streptococcal infection. It follows pharyngeal infection with group A
streptococci and is characterized by nonsuppurative inflammation of the joints,
heart, subcutaneous tissue, and central nervous system. The risk of developing
rheumatic fever after an episode of streptococcal pharyngitis is estimated at
0.3-3%. Acute rheumatic fever may present with any of the following.</p>

<p></p>

<p><b><span>Polyarthritis</span></b><span>.<span >&nbsp; </span>Joint
involvement ranges from arthralgias to polyarthritis characterized by redness,
warmth, swelling, and tenderness. Frequently involved joints include the knees,
ankles, elbows, and wrists. The small joints of the hands and the spine are
rarely involved. Inflammation disappears within 2-4 weeks. The arthritis is
classically described as migratory, but, in many cases, new joints are affected
before the previously involved joints improve, leaving the appearance of an
additive arthritis. </span></p>

<p><span></span></p>

<p><b><span>Carditis</span></b><span>. This is the only manifestation of ARF with significant
potential to cause long-term disability and death. The pericardium, myocardium,
and endocardium may be involved (pancarditis). Signs may include new murmurs,
cardiac enlargement, heart failure, and pericardial friction rub. Mitral and
aortic regurgitation may occur acutely. Mitral stenosis and aortic stenosis may
develop after many years. </span></p>

<p><span></span></p>

<p><b><span>Erythema
marginatum</span></b><span>. These skin lesions are evanescent,
moving over the skin in serpiginous patterns. Likened to smoke rings, they have
a tendency to advance at the margins while clearing in the center. The lesions
may be macular and can disappear in minutes, appearing to change shape while
being examined. They are found on the trunk and proximal extremities and often
go unnoticed by patients.</span></p>

<p><span></span></p>

<p><b><span>Sydenham
chorea</span></b><span>. This is a neurological disorder
characterized by emotional lability, personality change, muscular weakness, and
uncoordinated, involuntary, purposeless movements. The patient may be unable to
sustain a tetanic contraction (e.g., clenched fist). Other findings include
dysarthria, gait problems, and poor fine-motor skills. </span></p>

<p><span></span></p>

<p><b><span>Subcutaneous
nodules</span></b><span>. These are uncommon and usually
associated with severe carditis. They are usually painless and are found
primarily over bony prominences and in tendon sheaths. Common sites include the
elbows, knees, wrists, ankles, Achilles tendons, back of the scalp, and spinous
processes of the vertebrae. </span></p>

<p><span></span></p>

<p><span>Other symptoms of ARF include fever, malaise, and abdominal
pain. The average duration of an untreated attack is 3
months. Chronic rheumatic fever, generally defined as disease persisting for
longer than 6 months, occurs in less than 5% of cases. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is correct</span></b><span>. Acute rheumatic fever is a sequela
of Group A streptococcal infection of the pharynx. </span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
32-year-old secretary has a routine chest x-ray before undergoing elective
surgery. It shows bilateral hilar lymphadenopathy and a 1-cm calcified nodule
in the left upper lobe. Physical examination shows no abnormalities. Her serum
calcium level is 11 mg/dL. Spirometry results are within normal limits.
Bronchoscopy and bronchoalveolar lavage yields 50% lymphocytes and 50%
macrophages. A bronchial biopsy specimen shows a non-necrotizing granuloma.
Stained sections of the specimen show no acid-fast bacilli or fungi. What is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Silicosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sarcoidosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tuberculosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Coccidioidomycosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wegener’s
granulomatosis</span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Sarcoidosis
is a disease of unknown cause characterized by the presence of noncaseating
granulomas in multiple organs. The lungs and the lymph nodes in the mediastinum
and hilum are the principal sites of involvement, but the disorder is systemic
and may affect other organs, such as the skin, eyes, nerves, heart, and joints.</span></p>

<p><span></span></p>

<p><span>The
clinical course ranges from asymptomatic to rapidly progressive. The peak age
at onset is in the 20s and 30s. Women are affected more often than men. 90% of
patients have intrathoracic involvement on chest radiograph. Well-defined,
noncaseating granulomas are found in the pulmonary parenchyma. The upper lobes
of the lung are more often affected than the lower lobes. Hilar and mediastinal
lymphadenopathy is usually bilateral and symmetric. Respiratory symptoms may
include shortness of breath, cough, and chest pain. A third of patients have
constitutional symptoms, including fever, weight loss, malaise, and fatigue. Up
to 20% have bilateral hilar adenopathy and erythema nodosum (<span>Lofgren's syndrome), which may be
accompanied by f</span>ever and arthralgias. </span></p>

<p><span></span></p>

<p><span>The
diagnosis of sarcoidosis is confirmed by the presence of well-formed
noncaseating granulomas in one or more organs. Special stains and cultures are
used to exclude mycobacterial and fungal infection. Patients with sarcoidosis
often have elevated levels of angiotensin-converting enzyme (ACE), produced by
epithelioid cells and macrophages in the granulomas. Hypercalcemia sometimes
occurs due to <a name=4-u1.0-B978-1-4160-2805-5..50100-2--p670></a>elevated
levels of 1,25-dihydroxyvitamin D (calcitriol), also produced by macrophages
within the granulomas.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=218 height=208
src="_%20Tutorials_files/image298.png" alt="Description: CXR" v:shapes="Picture_x0020_347244"></span><span></span></p>

<p style="text-align:center;"><span>Sarcoidosis: Bilateral hilar lymphadenopathy</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=253 height=191
src="_%20Tutorials_files/image300.png" alt="Description: S" v:shapes="Picture_x0020_347243"></span><span></span></p>

<p style="text-align:center;"><span>Sarcoidosis: Noncaseating granuloma with giant cell</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct. </span></b><span><span>&nbsp;</span>The presence of bilateral hilar
lymphadenopathy, hypercalcemia, and non-necrotizing granulomas suggest a
diagnosis of sarcoidosis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect. </span></b><span>Silicosis</span><span>
is a form of occupational lung disease caused by inhalation of crystalline
silica dust. It is characterized by inflammation, scarring, and nodule
formation in the lungs, particularly the upper lobes. Silicosis occurs only in
individuals exposed to silica dust (e.g., miners, sandblasters).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect. </span></b><span>Tuberculosis is characterized
by necrotizing granulomas. The bacteria can be seen using acid-fast stains.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect. </span></b><span>Coccidioidomycosis is
associated with granuloma formation. Special fungal stains allow detection of
fungal organisms. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect. </span></b><span>Wegener’s granulomatosis
is an autoimmune disease characterized by necrotizing vasculitis, necrotizing
granulomatous inflammation of the respiratory tract, and necrotizing
glomerulonephritis.<b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
52-year-old man presents to the hospital with dysarthria and right-sided
hemiplegia of one hour’s duration. He has not seen a doctor in 30 years and
takes no medicine. His blood pressure is 190/120 mm Hg (without orthostatic
change) and his pulse is 88/minute. There are no carotid bruits. The heart is
regular and the lungs are clear. Radial and femoral pulses are simultaneous.
The legs are not edematous. </span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span>Blood test
results: </span></p>

<p><span></span></p>

<p><span lang=PT-BR>Na<sup>+<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>145
mEq/L (normal: 136-145 mEq/L)</span></p>

<p><span lang=PT-BR>K<sup>+ <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>2.8
mEq/L (normal: 3.5-5.0 mEq/L)</span></p>

<p><span lang=PT-BR>Cl<sup>-<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>110
mEq/L (normal: 95-105 mEq/L)</span></p>

<p><span lang=PT-BR>HCO<sub>3</sub><sup>- <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>32
mEq/L (normal: 22-28 mEq/L)</span></p>

<p><span lang=PT-BR><span >&nbsp;&nbsp;&nbsp;
</span></span></p>

<p><span>What is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Essential
hypertension</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pheochromocytoma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hyperaldosteronism</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Coarctation
of the aorta</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Thyrotoxicosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypertension,</span> a chronic medical condition characterized by
elevation of systemic arterial blood pressure, is classified as primary
(essential) or secondary. About 90&#8211;95% of cases are “primary,” meaning
that the high blood pressure has no obvious cause. The remaining 5&#8211;10% of
cases are “secondary,” meaning that some indentifiable disorder is causing high
blood pressure. A thorough search for secondary causes is not cost-effective in
most patients with hypertension, but becomes critically important in two
circumstances: (1) when there is a compelling finding on the initial evaluation
and (2) when the hypertensive process is so severe that it is either refractory
to intensive multiple-drug therapy or requires hospitalization.</p>

<p></p>

<p style="text-align:center;"><b><span>GUIDE
TO EVALUATION OF SECONDARY HYPERTENSION</span></b></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Suspected
   Diagnosis</span></b></p>
   </td>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Clinical
   Clues</span></b></p>
   </td>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Diagnostic
   Testing</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td valign=top>
  <p><span>Renal parenchymal
  hypertension</span></p>
  <p><span>&nbsp;</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Reduced
  GFR</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Urine
  albumin-to-creatinine ratio ≥30 mg/g</span></p>
  <p><span></span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Renal
  ultrasonography</span></p>
  <p><span>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Renovascular disease</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>New
  elevation in serum creatinine</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Marked
  elevation in serum creatinine with initiation of ACEI or ARB </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Refractory
  hypertension </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Flash
  pulmonary edema </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Abdominal
  bruit</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Doppler
  ultrasonography</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Magnetic
  resonance angiography</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>CT
  angiography </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Invasive
  angiography</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Coarctation of the aorta</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Arm
  BP &gt; leg BP </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Chest
  bruits </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Rib
  notching on chest radiography</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Magnetic
  resonance imaging</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Aortography</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Primary aldosteronism</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Hypokalemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Metabolic
  alkalosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Refractory
  hypertension</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Plasma
  renin and aldosterone</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>24-hour
  urine potassium</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Adrenal
  CT </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Adrenal
  vein sampling</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Cushing's syndrome</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Truncal
  obesity</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Violaceous
  striae </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Muscle
  weakness</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>24-hour
  urine for cortisol</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Dexamethasone
  suppression test</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Adrenal
  CT</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Pheochromocytoma</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Paroxysmal
  hypertension</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Headaches,
  palpitations, perspiration, and pallor </span></p>
  <p><span></span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Plasma
  metanephrine and normetanephrine </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>24-hour
  urine catecholamines</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Adrenal
  CT</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Obstructive sleep apnea</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Loud
  snoring </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Daytime
  somnolence </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Obesity
  </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Large
  neck</span></p>
  </td>
  <td valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Sleep
  study</span></p>
  </td>
 </tr>
</table>

<p><u><span>Renal Parenchymal Hypertension </span></u></p>

<p><span>Chronic kidney disease is the most common cause of secondary
hypertension. Hypertension is present in more than 85% of patients with chronic
kidney disease and is a major factor causing their increased cardiovascular
morbidity and mortality. The mechanisms causing the hypertension include an
expanded plasma volume and peripheral vasoconstriction. The peripheral
vasoconstriction is caused by both activation of vasoconstrictor pathways
(renin-angiotensin and sympathetic nervous systems) and inhibition of vasodilator
pathways (nitric oxide). Renal insufficiency should be considered when there is
proteinuria by dipstick or when the serum creatinine level is greater than 1.2
mg/dL in hypertensive women or greater than 1.4 mg/dL in hypertensive men. </span></p>

<p><span></span></p>

<p><u><span>Renovascular Hypertension </span></u></p>

<p><span>The main causes of renal artery stenosis are atherosclerosis
(85% of cases), typically in older persons with other clinical manifestations
of systemic atherosclerosis, and fibromuscular dysplasia (15% of cases),
typically in women between the ages of 15 and 50 years. Renal artery stenosis
leads to underperfusion of the juxtaglomerular cells, thereby producing
renin-dependent hypertension. The following clinical clues increase the
suspicion of renovascular hypertension: any hospitalization for urgent or
emergent hypertension; recurrent “flash” pulmonary edema; recent worsening of
long-standing, previously well controlled hypertension; severe hypertension in
a young woman or in an older adult after the age of 50 years; precipitous and
progressive worsening of renal function in response to angiotensin-converting
enzyme (ACE) inhibition or angiotensin II receptor blockade; unilateral small
kidney; extensive peripheral arteriosclerosis; and a flank bruit.</span></p>

<p><span></span></p>

<p><u><span>Coarctation of the aorta</span></u><span> </span></p>

<p><span>Coarctation of the aorta typically occurs just distal to the
origin of the left subclavian artery, so the blood pressure is lower in the
legs than in the arms (opposite of the normal situation)<a
name=4-u1.0-B978-1-4160-2805-5..50071-9--intr></a>. The clue is that pulses are
weaker in the lower than in the upper extremities, indicating the need to
measure blood pressure in the legs as well as in both arms. Intercostal
collaterals can produce bruits on examination and rib notching on chest
radiograph. Coarctation can be cured with surgery or angioplasty.</span></p>

<p><span></span></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span>Primary Aldosteronism </span></u></p>

<p><span>The most common causes of primary aldosteronism are a
unilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia.
Because aldosterone is the principal ligand for the mineralocorticoid receptor
in the distal nephron, excessive aldosterone production causes excessive renal
Na<sup>+</sup>-K<sup>+</sup> exchange, often resulting in hypokalemia and an
elevated serum bicarbonate (</span><span>HCO<sub>3</sub><sup>-</sup></span><span>)
level. The diagnosis should always be suspected when hypertension is
accompanied by either unprovoked hypokalemia (serum potassium concentration
below 3.5 mmol/L in the absence of diuretic therapy)<a
name=4-u1.0-B978-1-4160-2805-5..50071-9--p437></a> or a tendency to develop
excessive hypokalemia during diuretic therapy (serum potassium concentration
below 3.0 mmol/L).<span >&nbsp; </span></span></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span>Cushing’s syndrome </span></u></p>

<p><span>Cushing's syndrome</span> is a condition associated with high serum
levels of cortisol. It can be caused by taking glucocorticoid drugs (e.g.,
prednisone), or by tumors that produce cortisol or adrenocorticotropic hormone
(ACTH). Cushing's disease refers to one specific cause of the syndrome, a tumor
(adenoma) in the pituitary gland that produces large amounts of ACTH, which in
turn elevates cortisol. It is the most common cause of Cushing's syndrome,
responsible for 70% of cases, excluding glucocorticoid-related cases. Findings in
Cushing’s syndrome include rapid weight gain, truncal obesity, “buffalo hump,”
“moon face,” excess sweating, telangiectasia, thinning of the skin, violaceous
striae, proximal muscle weakness, osteoporosis, amenorrhea, decreased libido,
infertility, hirsutism, psychological disturbance, and hyperglycemia. <a
href="http://en.wikipedia.org/wiki/Cushing's_syndrome#cite_note-1#cite_note-1"></a><u></u></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span>Pheochromocytoma </span></u></p>

<p><span>Pheochromocytomas are rare catecholamine-producing tumors of
the adrenal (or sometimes extra-adrenal) chromaffin cells. The diagnosis should
be suspected when hypertension is accompanied by frequent or refractory
headaches or by paroxysms of palpitations, perspiration, and pallor. In some
patients, pheochromocytoma is misdiagnosed as panic disorder. A family history
of early-onset hypertension may suggest pheochromocytoma as part of a multiple
endocrine neoplasia syndrome. If the diagnosis is missed, outpouring of
catecholamines from the tumor can cause unsuspected hypertensive crisis during
surgical or diagnostic procedures. In such cases, mortality exceeds 80%.</span></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span>Sleep Apnea</span></u></p>

<p><span>Clues to the presence of sleep apnea include obesity, l</span><span>oud snoring, daytime
somnolence, and obesity.<span >&nbsp; </span></span></p>

<p><a name=4-u1.0-B978-1-4160-2805-5..50071-9--cese></a><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span>Thyroid disease</span></u><span> </span></p>

<p><span>Both hyperthyroidism and hypothyroidism raise blood pressure.
Hyperthyroidism tends to cause systolic hypertension with a wide pulse
pressure, whereas hypothyroidism tends to cause mainly diastolic hypertension. </span></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span>Drugs </span></u></p>

<p>Drugs associated with hypertension include alcohol,
amphetamines, ecstasy (MDMA and derivatives), cocaine, corticosteroids,
cyclosporine, erythropoietin, estrogens (including birth control pills), and
nasal decongestants.</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b><span>Answer C is correct. </span></b><span><span>&nbsp;</span>The combination of hypertension,
hypokalemia, and an elevated serum bicrabonate level suggests a
high-aldosterone state. Primary hyperaldosteronism is the most likely
diagnosis. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Essential hypertension
does not cause hypokalemia or an elevated serum bicarbonate level.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect. </span></b><span>Pheochromocytoma
generally presents with episodic or sustained elevations of blood pressure,
accompanied by headache, palpitations, perspiration, and pallor. Hypokalemia is
not typical of this condition.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect. </span></b><span>Coarctation of the aorta
is unlikely given the simultaneousness of the radial and femoral pulses. Also,
coarctation is not associated with hypokalemia. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. This patient does not
have symptoms of thyrotoxicosis, which include weight loss, increased appetite,
anxiety, heat intolerance, tremor, and sweating.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
45-year-old African-American man is being evaluated for hypertension. He was
diagnosed with high blood pressure several years ago and was treated with
amlodipine. Since then, lisinopril and hydrochlorothiazide have been added to
his regimen, but his blood pressure remains elevated. He does not smoke, drink
alcohol, or use illegal drugs. He usually wakes up with a headache, and he is
tired and sleepy throughout the day. He has gained 50 lbs in the last few
years. Temperature is 98<sup>o</sup>F, pulse in 95/minute, blood pressure is
180/100 mm Hg, and weight is 350 lbs. Heart sounds are distant and lungs are
clear. Ankles are edematous. A complete blood count, chemistry profile, and
thyroid panel are normal. </span></p>

<p><span></span></p>

<p><span>What of
the following tests is most likely to confirm the diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Doppler
ultrasound of the renal arteries</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>24-hour
urine collection for cortisol</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>24-hour
urine collection for catecholamines and metanephrines</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Measurement
of plasma renin activity and plasma aldosterone concentration</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polysomnography</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>The principal causes of secondary hypertension are
listed below. </span></p>

<p><b><span></span></b></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=185 valign=top>
  <p style="text-align:center;"><span>Causes of Secondary Hypertension</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Drugs:
  alcohol, NSAIDs, steroids, decongestants</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Sleep apnea</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Renal
  artery stenosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Chronic
  renal disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Pheochromocytoma</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Hyperaldosteronism</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Cushing’s
  syndrome</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Hyperparathyroidism</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Acromegaly</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Hypothyroidism</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Hyperthyroidism</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Scleroderma</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><span>Obstructive
sleep apnea commonly presents with daytime fatigue and somnolence, morning
headache, and hard-to-treat hypertension. Patients are observed to be restless
sleepers, with snoring often accompanied by episodes of gasping, choking, and
interrupted breathing. Male gender and obesity are major risk factors.
Diagnosis is made by overnight sleep study (polysomnography).<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
E is correct. </span></b><span>Uncontrolled hypertension in a morbidly obese
patient with daytime sleepiness and morning headache suggests a diagnosis of
obstructive sleep apnea. Polysomnography can be used to establish the diagnosis
and to assess its severity. </span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Renal artery stenosis may be caused by fibromuscular dysplasia or
atherosclerosis. Fibromuscular dysplasia typically occurs in young women.
Atherosclerosis usually occurs in older patients with risk factors for vascular
disease. Patients with renal artery stenosis may present with hypertension
and/or renal insufficiency. An abdominal bruit is sometimes audible. Doppler
ultrasound of the renal arteries is usually the first step in diagnosis. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
Cushing’s syndrome is associated with hyperglycemia, hypertension, central
obesity, violaceous abdominal striae, thinning of the skin, easy bruising,
cataracts, osteoporosis, emotional disturbance, and sexual dysfunction.
Diagnosis can be made by measuring urinary free cortisol or with the dexamethasone
suppression test. </span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect</span></b><span>.
Patients with pheochromocytoma may present with recurrent episodes of headache,
palpitations, diaphoresis, and severe hypertension. Diagnosis is made by
measuring catecholamines and metanephrines in the urine.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Primary hyperaldosteronism may be caused by adrenal tumor or bilateral adrenal
hyperplasia. Patients usually present with hypertension and hypokalemia.
Diagnosis is made by measuring plasma renin activity and plasma aldosterone
concentration.</span></p>

<p><span>A
74-year-old woman with congestive heart failure (ejection fraction of 30%) and
COPD presents to the emergency department with a 1-week history of headache,
shortness of breath, dry cough, and swelling of the face and neck. She is
fatigued and has lost 20 lbs in three months. Her medications include
lisinopril, digoxin, furosemide, aspirin, and tiotropium. Family history is
positive for a ruptured abdominal aneurysm in the father. On physical exam,
temperature 36.0°C, pulse is 82/minute, blood pressure is 137/79 mm Hg, and
respirations are 22/minute. Her face is red and swollen; her neck veins are
distended. Heart is regular without murmurs, rubs, or gallops. Lungs are clear
without crackles or wheezes. Legs are non-edematous. Laboratory tests show mild
anemia and hypoalbuminemia. EKG shows normal sinus rhythm.<span>&nbsp; </span></span></p>

<p><span>Chest
X-ray is below:</span></p>

<p style="text-align:center;"><span><img border=0 width=231 height=240
src="_%20Tutorials_files/image302.png" alt="Description: cava-fig1" v:shapes="Picture_x0020_347242"></span><span></span></p>

<p><span></span></p>

<p><span>What is
the correct diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Angioedema
caused by the lisinopril</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Superior
vena cava syndrome</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulmonary
hypertension</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Aortic
aneurysm</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cardiac
tamponade</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer
B is correct.</span></b><span>
Superior vena cava (SVC) syndrome is usually a sign of advanced malignant
disease. Gradual narrowing of the SVC occurs because of tumor compression.
Lung, breast, and mediastinal neoplasms are the predominant cause of SVC
syndrome, with adenocarcinoma of the lung being the most common cause. Symptoms
may include cough, dyspnea, and dysphagia, as well as redness and swelling of
the face, neck, and upper extremities. Collateral venous circulation causes
distension of the superficial veins in the chest. SVC syndrome is a clinical
diagnosis. Tissue diagnosis is usually needed to guide therapy, which may
involve chemotherapy or radiation to shrink the tumor. The three-year survival
is less than 10%.</span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect.</span></b><span>
Angioedema is characterized by rapid swelling of the mouth, tongue, and throat.
The rest of the face and neck are usually spared. Stridor occurs in severe
cases. </span><a href="http://en.wikipedia.org/wiki/ACE_inhibitors"
title="ACE inhibitors"><span>ACE-inhibitors</span></a><span> (e.g., lisinopril) are
a common cause of angioedema. </span></p>

<p><span></span></p>

<p><b>Answer C is incorrect.</b>
Pulmonary hypertension is associated with <a
href="http://en.wikipedia.org/wiki/Shortness_of_breath"
title="Shortness of breath"><span>shortness of breath</span></a> and <a
href="http://en.wikipedia.org/wiki/Fatigue_(physical)"
title="Fatigue (physical)"><span>fatigue</span></a>. Physical examination shows a loud S2
at the left second interspace and a left parasternal heave. Jugular vein
distension, hepatomegaly, ascites, and pedal <a
href="http://en.wikipedia.org/wiki/Edema" title=Edema><span>edema</span></a> occur in advanced
cases.<span >&nbsp; </span></p>

<p></p>

<p><b><span>Answer
D is incorrect. </span></b><span>Aortic
aneurysms are usually asymptomatic, but they can rupture, causing severe pain
and internal hemorrhage. (Note: In this case, the chest X-ray shows a
supra-hilar lung mass, not an aneurysm.) </span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect.<span >&nbsp; </span></span></b><span>Pericardial tamponade is
an </span><a href="http://en.wikipedia.org/wiki/Medical_emergency"
title="Medical emergency"><span>emergency</span></a><span> condition caused by
fluid accumulation in the </span><a
href="http://en.wikipedia.org/wiki/Pericardium" title=Pericardium><span>pericardium</span></a><span>, which results in
reduced ventricular filling and hemodynamic compromise. Shortness of breath is
common. Extremities may be cool and clammy. Examination reveals jugular vein
distension, tachycardia, hypotension, and pulsus paradoxus. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section">Gastrointestinal</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Genitourinary</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Match the
condition with its classic presentation.</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
viral hepatitis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Biliary
colic </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acute
cholecystitis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Ascending
cholangitis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Duodenal
ulcer</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gastroesophageal
reflux</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
pancreatitis</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Irritable
bowel syndrome</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Intestinal
obstruction</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Appendicitis</span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>Diverticulitis</span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pyelonephritis</span></p>

<p><span><span>M.<span>&nbsp;
</span></span></span><span>Ureteral
colic</span></p>

<p><span><span>N.<span>&nbsp;&nbsp;
</span></span></span><span>Cystitis</span></p>

<p><span><span>O.<span>&nbsp;&nbsp;
</span></span></span><span>Chronic
mesenteric ischemia</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>22-year-old
man with fever, nausea, vomiting, and abdominal pain. The pain begins in the
peri-umbilical region and progresses to the right lower quadrant. The pain
improves with flexion and worsens with extension of the hip. Rebound tenderness
in elicited in the right lower quadrant. </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>29-year-old
woman with frequent urination associated with urgency and burning.<span>&nbsp; </span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>32-year-old
man with severe upper abdominal pain, nausea, and vomiting. Serum amylase and
lipase levels are elevated.</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>35-year-old
woman with bloating, cramping, and bouts of diarrhea alternating with periods
of constipation. Bowel movements relieve abdominal discomfort.</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>38-year-old
woman with fever, chills, rigors, jaundice, and right upper quadrant pain. She
becomes confused and hypotensive. Serum alkaline phosphatase and bilirubin
levels are elevated.<span >&nbsp; </span></span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>38-year-old
woman with fever, nausea, vomiting, and pain in the right upper quadrant.
Palpation beneath the right costal margin in the mid-clavicular line causes her
to wince with inspiration. </span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>38-year-old
woman with steady pain in the epigastrium and right upper quadrant that lasts
for several hours and resolves spontaneously. She had a similar episode last
week.<span >&nbsp; </span></span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>41-year-old
woman with a 5-day history of burning with urination develops fever, chills,
abdominal pain, vomiting, and tenderness over the left costovertebral angle.</span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>42-year-old
man with fever, malaise, muscle and joint aches, headache, nausea, vomiting,
abdominal pain, jaundice, and dark urine. AST and ALT are elevated.</span></p>

<p><span><span>10.<span>&nbsp; </span></span></span><span>46-year-old man with
spasms of severe abdominal pain and writhing. The pain radiates from the left
flank to the groin area and is associated with nausea and vomiting. Blood is
noted in the urine. </span></p>

<p><span><span>11.<span>&nbsp; </span></span></span><span>50-year-old man with
crampy mid-abdominal pain, vomiting, and inability to pass flatus or stool. His
abdomen is distended and tympanitic to percussion. </span></p>

<p><span><span>12.<span>&nbsp; </span></span></span><span>53-year-old man with a
“gnawing” pain in the epigastrium that improves with eating.<span>&nbsp; </span></span></p>

<p><span><span>13.<span>&nbsp; </span></span></span><span>60-year-old man with
heartburn and regurgitation.</span></p>

<p><span><span>14.<span>&nbsp; </span></span></span><span>68-year-old man with
fever and abdominal pain in the left lower quadrant. The white blood cell count
is elevated.<span >&nbsp; </span></span></p>

<p><span><span>15.<span>&nbsp; </span></span></span><span>66-year-old man presents
to the clinic with a 6-month history of intermittent abdominal pain that begins
30 minutes after eating a meal and resolves 2 hours later. The pain is located
in the periumbilical area.<span >&nbsp; </span>He has
lost weight and is afraid of eating. He has a 30 pack-year history of smoking,
hypertension, coronary artery disease, and peripheral vascular disease.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Answers</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>9.<span>&nbsp; </span>Acute viral hepatitis is characterized
by fever, malaise, muscle and joint aches, headache, nausea, vomiting,
abdominal pain, jaundice, and dark urine. The AST and ALT are very high.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.<span>&nbsp; </span>Biliary colic is characterized by steady
pain in the epigastrium and right upper quadrant that lasts for several hours
and resolves spontaneously. The word “colic” is a misnomer because the pain is
usually steady, not colicky. Pain occurs when a gallstone gets caught in the
cystic duct and contraction of the gall bladder results in increased pressure
in the gall bladder. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>6.<span>&nbsp;&nbsp; </span>Acute cholecystitis is
characterized by fever, nausea, vomiting, and pain in the right upper quadrant.
Murphy’s sign may be present. (Palpation beneath the right costal margin in the
mid-clavicular line causes the patient to wince with inspiration.) </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>5.
Ascending cholangitis is characterized by fever, chills, rigors, jaundice, and
right upper quadrant pain. Confusion and hypotension may occur if the patient
becomes septic. Serum alkaline phosphatase and bilirubin levels are elevated. <span>Ascending cholangitis</span> (sometimes
called <span>acute cholangitis) </span>is an
infection of the bile duct (cholangitis), usually caused by bacteria ascending
from the duodenum. It tends to occur if the bile duct is partially obstructed
by gallstones (often in the hepatopancreatic ampulla, or ampulla of Vater).<sup>
</sup>Cholangitis can be life-threatening and is regarded as a medical
emergency. Initial treatment is with intravenous fluids and antibiotics, but
there is often an underlying problem (such as gallstones) for which further
tests and treatment may be necessary. </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>12.<span>&nbsp; </span>Duodenal ulcer is characterized by a
“gnawing” pain in the epigastrium that improves with eating.</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>13.<span>&nbsp; </span>Gastroesophageal reflux is characterized
by heartburn and regurgitation. </span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>3.<span>&nbsp; </span>Acute pancreatitis is characterized by
severe upper abdominal pain, nausea, and vomiting. Serum amylase and lipase
levels are elevated. </span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>4.<span>&nbsp;&nbsp; </span>Irritable bowel syndrome is
characterized by bloating, cramping, and bouts of diarrhea alternating with
periods of constipation. Abdominal discomfort is relieved by bowel movements.</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>11.<span>&nbsp; </span>Intestinal obstruction is characterized
by crampy mid-abdominal pain, vomiting, and constipation. The abdomen is
distended and tympanitic to percussion.</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>1.<span>&nbsp; </span>Appendicitis is characterized by fever,
nausea, vomiting, and abdominal pain at McBurney’s point (the point that is
one-third of the distance from the right anterior superior iliac spine to the
umbilicus). The pain may improve with hip flexion and worsen with extension.</span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>14.
Diverticulitis is characterized by fever and left lower quadrant abdominal
pain. </span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8.<span>&nbsp; </span>Pyelonephritis is characterized by
burning with urination, fever, chills, abdominal pain, vomiting, and tenderness
over the costovertebral angle.</span></p>

<p><span><span>M.<span>&nbsp; </span></span></span><span>10.<span>&nbsp; </span>Ureteral colic, caused by urolithiasis,
is characterized by writhing and spasms of severe abdominal pain. The pain may
radiate from the flank to the groin area and may be associated with nausea and
vomiting. Hematuria may be present.</span></p>

<p><span><span>N.<span>&nbsp;&nbsp;
</span></span></span><span>2.<span>&nbsp; </span>Cystitis is characterized by urinary
frequency, urgency, and burning.</span></p>

<p><span><span>O.<span>&nbsp;&nbsp;
</span></span></span><span>15.
Chronic mesenteric ischemia should be suspected in patients with
atherosclerotic vascular disease who present with post-prandial periumbilical
abdominal pain. Classically, the pain begins 30 minutes after eating and
resolves 2 hours later. The condition can be diagnosed by Doppler ultrasound of
the mesenteric arteries.</span></p>

<p><span></span></p>

<p><span>Mrs. Smith
is a pregnant woman with a marked decrease in amniotic fluid. Mrs. Jones is a
pregnant woman with a marked increase in amniotic fluid. Which of the following
disorders could explain these findings? </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=180 valign=top>
  <p style="text-align:center;"><span>Mrs. Smith</span></p>
  </td>
  <td width=135 valign=top>
  <p style="text-align:center;"><span>Mrs. Jones</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=180 valign=top>
  <p><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>A</span></p>
  </td>
  <td width=180 valign=top>
  <p><span>Inadequate
  fusion of the maxillary and medial nasal prominences</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Congenital
  heart disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>B</span></p>
  </td>
  <td width=180 valign=top>
  <p><span>Maldevelopment
  of the dermis</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Erythroblastosis
  fetalis</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>C</span></p>
  </td>
  <td width=180 valign=top>
  <p><span>Failure
  of limb buds to grow</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Horseshoe
  kidney</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>D</span></p>
  </td>
  <td width=180 valign=top>
  <p><span>Bilateral
  renal agenesis</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Duodenal
  atresia</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>E</span></p>
  </td>
  <td width=180 valign=top>
  <p><span>Arrested
  migration of neural crest cells to the distal colon</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Neural
  tube defect</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Amniotic
fluid is <i>produced</i> mainly by fetal
urination, particularly during late gestation. The fetal kidneys start making
urine before the end of the first trimester. Urine production increases until
term gestation. Amniotic fluid also comes from the fetal lungs. The lungs
produce fluid that exits the trachea and is either swallowed or expelled into
the amniotic sac. Amniotic fluid is <i>removed</i>
mainly by fetal swallowing, which begins early in gestation. Some amniotic
fluid shifts into the fetal circulation through the placenta. (A large osmotic
gradient exists between the amniotic fluid and fetal blood).</span></p>

<p><span></span></p>

<p><span>Oligohydramnios</span><span>
is a deficiency of amniotic fluid. Fetal anomalies remain the most common
reason.<span >&nbsp; </span>Causes include:</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fetal
urinary tract anomalies, such as renal agenesis (Potter’s syndrome), polycystic
kidneys, or any urinary obstructive lesion (e.g., posterior urethral valves) </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>PROM
and chronic leakage of the amniotic fluid </span></p>

<p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Chorioamnionitis is an
additional important maternal complication from oligohydramnios due to rupture
of the membranes, which has an incidence of 21-74%. </span></p>

<p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>The earlier
chorioamnionitis occurs in pregnancy, the greater the fetal risk of
bronchopulmonary dysplasia (BPD), neurologic complications, pulmonary
hypoplasia, and, in severe cases, respiratory failure in the neonate. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Placental
insufficiency, as seen in pregnancy-induced hypertension (PIH), maternal
diabetes, or postmaturity syndrome when the pregnancy extends beyond 42 weeks'
gestation </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Maternal
use of prostaglandin synthase inhibitors or ACE inhibitors and angiotensin
receptor blockers (ARBs).<span >&nbsp; </span><i>ACE-inhibitors and ARBs are absolutely
contraindicated in pregnancy</i>.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Polyhydramnios</span> is an excess of amniotic fluid. The underlying
cause of the excessive amniotic fluid volume is obvious in some clinical
conditions and is not completely understood in others. Causes include the
following: </p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Twin
gestation with twin-to-twin transfusion syndrome (increased amniotic fluid in
the recipient twin and decreased amniotic fluid in the donor) or multiple
gestations </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fetal
anomalies that impair fetal swallowing, including esophageal atresia (usually
associated with a tracheoesophageal fistula), tracheal agenesis, duodenal
atresia, and other intestinal atresias </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>CNS
abnormalities and neuromuscular diseases that cause swallowing dysfunction
including anencephaly.</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenital
cardiac-rhythm anomalies associated with hydrops, fetal-to-maternal hemorrhage,
and parvovirus infection</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Poorly
controlled maternal diabetes mellitus (Oligohydramnios may also be seen if
severe vascular disease is present.)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chromosomal
abnormalities, most commonly trisomy 21, followed by trisomy 18 and trisomy 13.</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fetal
akinesia syndrome with absence of swallowing</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Idiopathic:<span>&nbsp; </span>the vast majority of cases of
polyhydramnios are idiopathic (historically up to 60%)</span></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer D is correct</b>. Mrs. Smith has a deficiency of amniotic fluid
(oligohydramnios). The main source of amniotic fluid is fetal urination, which
is absent in patients with bilateral renal agenesis. Mrs. Jones has an excess
of amniotic fluid (polyhydramnios). Most amniotic fluid is removed by fetal
swallowing, which is impaired in a variety of gastrointestinal disorders such
as duodenal atresia. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 42-year-old woman
presents with a 2-week history of low-grade fever and jaundice. Her medical
history is significant for diabetes mellitus, rheumatoid arthritis, and
Hashimoto’s thyroiditis. She takes metformin, plaquenil, and levothyroxine. She
traveled to Mexico six months ago and stayed for a week. On physical
examination, she has hepatomegaly and mild jaundice.</span></p>

<p><span></span></p>

<p><span>Her lab test results show:</span></p>

<p><span></span></p>

<p><span>AST <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>252
U/L</span></p>

<p><span>ALT<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>368
U/L</span></p>

<p><span>Alk phos<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>90
U/L</span></p>

<p><span>Total bilirubin: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3.2
mg/dl</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of the following
diagnostic tests would be most helpful?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Serum ceruloplasmin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Anti-nuclear antibody and anti-smooth muscle antibody</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>IgM antibody to hepatitis A</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Serum acetaminophen level</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Antimitochondrial antibodies</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Autoimmune hepatitis</span></b><span> is a chronic inflammatory disorder of the liver
of unknown cause. It is characterized by presence of autoantibodies, high
levels of serum immunoglobulins, and frequent association with other autoimmune
diseases. The disease is more common in women than men and typically has its
onset either in childhood and young adulthood or around the time of menopause.
Autoimmune hepatitis is one of the three major autoimmune liver diseases, along
with primary biliary cirrhosis and primary sclerosing cholangitis<a
name=4-u1.0-B978-1-4160-2805-5..50157-9--intr></a>. The pathogenesis of
autoimmune hepatitis is not known, but it is believed to be caused by
autoimmune reactions against normal hepatocytes. The disease seems to occur in
genetically predisposed individuals on exposure to as yet unidentified noxious
environmental agents that trigger an autoimmune process directed at liver
antigens. </span></p>

<p><span></span></p>

<p><span>Autoimmune hepatitis is
a heterogeneous disease with a wide spectrum of clinical features. It tends to
be more severe and florid in onset than chronic hepatitis B or C. Autoimmune
hepatitis is usually progressive and leads to end-stage liver disease if not
treated with immunosuppression. In some patients it is detected before the
onset of symptoms and jaundice if elevated serum aminotransferase levels are
found on a routine health evaluation. More typically, patients are first seen
because of jaundice and fatigue. Abnormalities in routine liver test results
are also similar to the abnormalities found in other forms of chronic hepatitis
with elevations in serum aminotransferase levels. Elevations in bilirubin or
alkaline phosphatase indicate more severe or advanced disease. Perhaps most
characteristic of autoimmune hepatitis are striking elevations in serum gamma
globulin and, specifically, immunoglobulin G (IgG), accompanied by
autoantibodies.</span></p>

<p><span></span></p>

<p><span>The presence of serum
autoantibodies is the basis for diagnosis of the two types of autoimmune
hepatitis: autoimmune hepatitis is characterized by the detection of
antinuclear (ANA) and anti&#8211;smooth muscle (SMA) antibodies. To meet
criteria for the diagnosis of autoimmune hepatitis, these antibodies should be
present in titers of at least 1:80 in adults and 1:20 in children. Liver biopsy
specimens in patients with autoimmune hepatitis show features characteristic of
chronic hepatitis. Plasma cell infiltrates, which are rare in other forms of
chronic hepatitis, are characteristic of autoimmune hepatitis.</span></p>

<p><span></span></p>

<p><span>Most typical of
autoimmune hepatitis is a rapid clinical response to corticosteroid therapy in
terms of resolution of clinical symptoms and improvement in serum
aminotransferase and serum bilirubin elevations.</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>. The patient most likely has autoimmune hepatitis, given her history of
other autoimmune diseases: diabetes, rheumatoid arthritis, and Hashimoto’s
thyroiditis. The presence of anti-nuclear antibody and anti-smooth muscle
antibodies would support the diagnosis of autoimmune thyroiditis.</span></p>

<p><span></span></p>

<p><b>Answer A is incorrect</b><span>. Wilson’s disease is an autosomal recessive
disorder characterized by the accumulation of copper in tissues. Patients may
present with liver disease, neurological disease, or psychiatric symptoms. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Hepatitis A is unlikely to occur six months after a trip to Mexico. The
incubation period for the virus is only 2-6 weeks.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Acetaminophen toxicity presents more acutely and is usually associated
with much higher AST and ALT levels (≥ 3000 U/L). </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Antimitochondrial antibodies are associated with primary biliary
cirrhosis. Patients with primary biliary cirrhosis have a disproportionate
elevation of the alkaline phosphatase and total bilirubin levels. This is known
as a “cholestatic” pattern. Patients with autoimmune hepatitis have a
disproportionate elevation of aminotransferases (AST and ALT). This is known as
a “hepatocellular” pattern. </span><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
21-year-old woman who breastfeeds her child develops a painful mass in the
upper outer quadrant of the right breast. The mass is tender and the overlying
skin is warm and erythematous. Pain and redness resolve with antibiotic
therapy. Several months later, the area is firm and the overlying skin is
dimpled. What is the most likely cause of these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Fibrocystic
change</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fibroadenoma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Traumatic
fat necrosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Breast
abscess with scarring</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Inflammatory
breast cancer</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>BREAST DISEASE</b></p>

<p><b></b></p>

<p><b>Mastitis</b> is an infection of the breast that usually occurs with
breast-feeding. A break in the skin </p>

<p>or an opening in the nipple
allows bacteria to enter the breast.<span >&nbsp;
</span>The ensuing inflammatory response causes redness, warmth, pain, and
swelling. The condition is treated with antibiotics. In some cases, a breast
abscess may form. An abscess should be suspected in a woman with a history of
mastitis who presents with a tender breast mass and warm, erythematous
overlying skin. Abscesses must be drained either surgically or by needle
aspiration. </p>

<p></p>

<p><b>Fibrocystic change</b> is the most common benign condition of the
breast, usually occurring in women of childbearing age. Microcysts in the
breast, which are too small to feel, can accumulate fluid and become palpable
macrocysts. Their growth compresses the surrounding breast tissue, causing
pain. Hormonal changes just before the menstrual period can cause cysts to grow
rapidly and cause associated discomfort.<span >&nbsp;
</span>These changes are typically best appreciated in the upper, outer
quadrants.</p>

<p><b></b></p>

<p><b>Fibroadenomas</b> are benign breast tumors composed of glandular and
stromal tissue. They are most common between the ages of 15 and 35.<span>&nbsp; </span>The etiology is unknown but a hormonal
relationship is likely since they persist during the reproductive years, can increase
in size during pregnancy or with estrogen therapy, and usually regress after
menopause. The tumors are usually round, mobile, firm, and non-tender. They may
be single or multiple and usually have a distinct border. Diagnosis can be made
by fine needle aspiration or core needle biopsy. Most fibroadenomas do not
increase the risk of breast cancer, but some do. The decision to surgically
remove a fibroadenoma must be individualized.</p>

<p></p>

<p><b><span>Fat necrosis</span></b> occurs
when an area of fatty breast tissue is damaged because of trauma, surgery, or
radiation. The damaged tissue is ultimately replaced by scar. Being firm, fat
necrosis with scarring can be difficult to distinguish from cancer. Diagnosis
may require needle biopsy or surgical excision.<span>&nbsp; </span></p>

<p><b></b></p>

<p><b>Inflammatory breast cancer</b>
is an uncommon and especially aggressive type of breast cancer. It is called
“inflammatory” because it presents with inflammatory changes, such as redness,
warmth, and swelling. Often no tumor is seen by mammography or ultrasound.
Rapid swelling with “peau d' orange” skin and nipple retraction may occur.
Inflammatory breast cancer may be confused with mastitis. Biopsy may be needed
to distinguish them. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b><span>Answer D is correct. </span></b><span>Breast abscess with
scarring is the most likely diagnosis. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 29-year-old woman with type 1 diabetes
mellitus and autoimmune thyroiditis presents with a 9-month history of fatigue,
bloating, abdominal pain, and intermittent diarrhea. She has greasy, malodorous
stools that float. Two weeks ago, she developed an itchy, blistering rash over
the elbows, knees, and buttocks. She has lost 30 lbs unintentionally. Lab tests
show a hemoglobin concentration of 9 g/dL with an MCV of 76. Which one of the
following is <i>not</i> likely to be true? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Her
symptoms are caused by an autoimmune disorder</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Avoiding
foods that contain wheat, barley, and rye is the mainstay of therapy for this
condition</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serum
levels of anti-tissue transglutaminase, anti-endomysium, and anti-gliadin
antibodies are likely to be elevated</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Biopsy
of the small intestine is likely to show villous atrophy</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Her
skin condition is called pyoderma gangrenosum<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Celiac disease, also known as gluten-sensitive
enteropathy or nontropical sprue, is an autoimmune condition characterized by
an inappropriate T cell-mediated response to gluten, which results in
inflammatory injury to the small intestine. (<span>Gluten</span> is a protein composite that appears in foods processed from
wheat, barley, and rye.) Many people with celiac disease are asymptomatic or minimally
symptomatic. Classic symptoms include fatigue, diarrhea, cramping, bloating,
and abdominal distension. Iron-deficiency anemia and malabsorption
(characterized by weight loss and greasy, malodorous stools) may occur.
Deficiency of fat-soluble vitamins can result in osteoporosis (vitamin D
deficiency) and coagulopathy (vitamin K deficiency). </span></p>

<p><span></span></p>

<p><span>Celiac disease is associated with dermatitis
herpetiformis, a skin condition characterized by intensely itchy,
papulovesicular eruptions, usually distributed symmetrically on extensor
surfaces (buttocks, back of neck, scalp, elbows, knees, and back). Patients
with celiac disease may have other autoimmune diseases, such as diabetes
mellitus type 1, autoimmune thyroiditis, and primary biliary cirrhosis. Celiac disease
predisposes patients to adenocarcinoma and lymphoma of the small intestine.
Serological tests show elevated levels of anti-tissue transglutaminase,
anti-endomysial, and anti-gliadin antibodies. Biopsy of the small intestine
shows villous atrophy. The mainstay of therapy is a gluten-free diet (i.e.,
avoiding foods derived from wheat, barley, and rye). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=234 height=288
src="_%20Tutorials_files/image304.png" alt="Description: DH" v:shapes="Picture_x0020_347283"></span><span></span></p>

<p style="text-align:center;"><span>Dermatitis herpetiformis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer E is correct. </span></b><span>Pyoderma gangrenosum is
a skin condition associated with Crohn’s disease and ulcerative colitis, not
celiac disease.</span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
45-year-old woman is diagnosed with cervical cancer. Which of the following is
the most important predisposing factor?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Smoking
history</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Family
history of cervical cancer</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Immunocompromised
state</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Low
socioeconomic status</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Human
papillomavirus infection</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>By far the most important
risk factor for cervical cancer is genital infection with human papillomavirus.
Human papillomavirus (HPV) is a small, double-stranded DNA virus that infects
epithelial cells and can induce a variety of benign and malignant tumors in
humans. Most HPV infections are asymptomatic and unrecognized, which is
conducive to high transmission rates. Transmission occurs through skin-to-skin
contact. Incubation periods range from weeks to years.</p>

<p><span>Manifestations
of infection range from benign genital warts (condyloma acuminata) to invasive
cervical cancer. Screening for “high-risk” oncogenic HPV serotypes is
associated with declining death rates from cervical cancer by about 2% a year.</span></p>

<p><span></span></p>

<p><span>More than
100 types of HPV have been described. Approximately 30 types are associated
with anogenital tract infections. Condyloma acuminata usually are caused by
“low-risk” HPV types 6 and 11. Invasive cervical cancer usually is associated
with “high-risk” HPV types 16 and 18. Oral infection with HPV increases the
risk of oropharyngeal cancer independent of tobacco and alcohol use. In the
United States, HPV is expected to replace tobacco as the main causative agent
for oral cancer. <span>Human papillomavirus</span>
(<span>HPV</span>) <span>vaccines can</span> prevent infection with serotypes associated with
cervical cancer and genital warts. Two HPV vaccines are available: Gardasil and
Cervarix. Both protect against types 16 and 18, which can cause cervical
cancer. Gardasil also protects against types 6 and 11, which can cause genital
warts. </span></p>

<p><span></span></p>

<p>The human papillomavirus
(HPV) encodes a protein, E6, which binds human p53 protein and inactivates it. <span>p53</span> (also known as <span>protein<b> </b>53</span> or <span>tumor protein 53</span>), is a tumor
suppressor protein. It regulates the cell cycle and helps to prevent cancer. As
such, p53 has been described as “the guardian of the genome,” the “guardian
angel gene,” and the “master watchman,” referring to its role in conserving
stability by preventing genome mutation. p53 has many mechanisms of anticancer
function, and plays a role in apoptosis, genomic stability, and inhibition of
angiogenesis. In its anti-cancer role, p53 works through several mechanisms:</p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
can activate DNA repair proteins when DNA has sustained damage. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
can induce growth arrest by holding the cell cycle at the G<sub>1</sub>/S
regulation point on DNA damage recognition (if it holds the cell here for long
enough, the DNA repair proteins will have time to fix the damage and the cell
will be allowed to continue the cell cycle). </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
can initiate apoptosis, the programmed cell death, if DNA damage proves to be
irreparable. </span></p>

<p><span></span></p>

<p><span>By
inactivating p53, the papillomavirus inhibits DNA repair, prevents growth arrest,
and. inhibits apoptosis. Moreover, some of the HPV &quot;early&quot; genes,
such as E6 and E7, are known to act as oncogenes that promote tumor growth and
malignant transformation. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct. </span></b><span>Human papillomavirus
infection is the most important predisposing factor for cervical carcinoma. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 66-year-old man presents to the clinic with a
6-month history of intermittent abdominal pain that begins 30 minutes after
eating a meal and resolves 2 hours later. The pain is located in the
periumbilical area.<span >&nbsp; </span>He has lost
weight and is afraid of eating. He has a 30 pack-year history of smoking,
hypertension, coronary artery disease, and peripheral vascular disease.
Physical examination reveals a non-tender abdomen. Lab tests show a serum
creatinine concentration of 2.5 mg/dL. Which of the following diagnostic tests
is most appropriate?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Upper
endoscopy</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Endoscopic
retrograde cholangiopancreatography (ERCP)</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Doppler
ultrasonography</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>CT
angiography</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Colonoscopy</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Patients with chronic mesenteric ischemia
commonly present with postprandial abdominal pain, sitophobia (fear of eating),
and weight loss. Often the abdominal examination is normal. Chronic mesenteric
ischemia typically occurs in patients with generalized atherosclerotic
disease.<span >&nbsp; </span>The patient in the
vignette has coronary artery disease and peripheral vascular disease. Even
without these conditions, one would suspect atherosclerotic disease based on
the history of smoking and hypertension. The mesenteric vessels can be
evaluated by Doppler ultrasound, CT angiography, or MR angiography. Doppler
ultrasound would be simplest and least expensive approach. The patient’s renal
insufficiency (serum creatinine of 2.5 mg/dL) would preclude the use of CT
angiography, which involves the administration of nephrotoxic radiocontrast. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. Chronic mesenteric
ischemia should be suspected in patients with atherosclerotic vascular disease
who present with post-prandial periumbilical abdominal pain. Classically, the
pain begins 30 minutes after eating and resolves 2 hours later. The condition can
be diagnosed by Doppler ultrasound of the mesenteric arteries. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
19-year-old man has severe intermittent bloody diarrhea and weight loss.
Colonoscopy shows numerous ulcers and inflammatory changes that extend from the
rectum to the mid-transverse colon. Biopsy specimens show acute and chronic
inflammation restricted to the mucosa. What is the most likely diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Necrotizing
enterocolitis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Allergic
colitis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>C. difficile</span></i><span>-associated colitis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><i><span>E. coli</span></i><span>-associated colitis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Crohn’s
disease</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ulcerative
colitis</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Ischemic
colitis</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Microscopic
colitis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Colitis is
an inflammation of the colon. It may be associated with enteritis (inflammation
of the intestine) and/or proctitis (inflammation of the rectum). </span><span>The most common types of colitis appear below.<span>&nbsp; </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Common
  Causes of Colitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p><span>Necrotizing enterocolitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p><span>Allergic colitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p><i><span>Clostridium
  difficile</span></i><span>-associated colitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p><span>Infectious colitis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Bacterial: E. Coli, Salmonella, Shigella</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Viral: Cytomegalovirus</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Parasitic: Entamoeba histolytica</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p><span>Inflammatory bowel disease</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Crohn’s disease</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Ulcerative colitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p><span>Ischemic colitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p><span>Microscopic colitis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Lymphocytic colitis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Collagenous colitis</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b><span>Necrotizing enterocolitis</span></b></p>

<p><b><span></span></b></p>

<p><span>Necrotizing enterocolitis (NEC) is a common cause of colitis
in newborns. Very small and ill preterm infants are particularly susceptible to
this condition. Hypoxic ischemia and aggressive enteral feedings may play a
role. </span><span>The
onset is often insidious, but illness may progress rapidly, resulting in
peritonitis, perforation, shock, and death. </span></p>

<p><span></span></p>

<p><b><span>Allergic colitis</span></b></p>

<p><b><span></span></b></p>

<p><span>In children aged 2 weeks to 1 year, the most common form of
colitis is allergic colitis, which usually results from hypersensitivity to
cow's milk and soy milk. The so-called “breast milk allergy” is a type of food
allergy induced by proteins (typically cow's milk proteins) ingested by the
mother and appearing in the breast milk. The condition</span><span> often presents with
blood and mucous in the stool, vomiting, and diarrhea after ingestion of milk.</span></p>

<p><span></span></p>

<p><b><i><span>Clostridium difficile</span></i></b><b><span>-associated colitis</span></b></p>

<p><b><span></span></b></p>

<p><em>Clostridium difficile</em>
is a spore-forming bacterium that causes disease in 1 out of 200 hospitalized
patients. It also causes disease in the outpatient setting. Prior antibiotic
exposure remains the most significant risk factor for developing the disease.
Several synonyms are used for diseases attributable to <em>C. difficile</em>
infections (CDI): <em>C. difficile</em> &#8211;associated diarrhea,
antibiotic-associated colitis, <em>C. difficile</em> colitis, and
pseudomembranous colitis. <em>C. difficile</em> accounts for up to 25% of
nosocomial antibiotic-associated diarrhea. The term “pseudomembranous” refers
to the exudate that appears in the colon. In the last decade, an increasing
number of CDIs have been reported, and the proportion of cases complicated by
severe outcomes has increased. This may be due to the spread of virulent
strains. </p>

<p></p>

<p><span>The condition is usually caused by antibiotic therapy.
Antibiotics favor overgrowth and colonization of the intestine by <i>Clostridium
difficile</i><span>, which</span> causes
damage by releasing toxins. Almost any antibiotic can lead to pseudomembranous
colitis. Fluoroquinolones, macrolides, clindamycin, beta-lactam/beta-lactamase
inhibitors, and all generations of cephalosporins have been associated with
CDI. Symptoms typically develop 5-10 days after initiation of antibiotic
therapy; however, symptoms can develop after a single day of antibiotic use or
can occur as late as 10 weeks after antibiotic cessation. Both increased length
of antimicrobial use and use of multiple antimicrobials increase the risk of
CDI. Some patients may develop CDI without a clearly identified antibiotic
exposure. </span></p>

<p><span></span></p>

<p><i>C. difficile</i> produces two similar toxins that disrupt the barrier
function of the colonic mucosa. Toxin A is an enterotoxin that binds to
receptors in the bowel wall, leading to activation of the inflammatory cascade
and disruption of the intercellular tight junctions, causing fluid secretion,
mucosal injury, edema, and inflammation. Toxin B is a cytotoxin that causes
mucosal injury and further activation of the inflammatory cascade.</p>

<p></p>

<p>The clinical presentation of
CDI ranges from self-limited diarrhea to severe colitis complicated by toxic
megacolon or colonic perforation. The classic presentation is cramping
abdominal pain with profuse, mucoid, malodorous, watery stools. Fever,
abdominal pain, and leukocytosis are common. Oral metronidazole and oral
vancomycin are used to treat CDI. Metronidazole, which is much less expensive
than vancomycin, is the drug of choice for mild-to-moderate CDI. Oral
vancomycin is the drug of choice for severe CDI.</p>

<p></p>

<p><b><span>Bacterial colitis</span></b></p>

<p><b><span></span></b></p>

<p><span>The organisms most commonly associated with bacterial
colitis are <i>Escherichia coli</i>, <i>Salmonella</i><span>,<i> </i>and <i>Shigella. </i></span></span></p>

<p><i><span></span></i></p>

<p><i><span>E coli</span></i><span> causes diarrhea by different mechanisms. Pathologic strains
have been classified as enteropathogenic, enterotoxic, enteroinvasive,
enteroaggregative, enteroadherent, and enterohemorrhagic. Enterohemorrhagic,
including O157:H7 and O26:H11, cause hemorrhagic colitis and systemic
complications (e.g., hemolytic uremic syndrome). The risk of developing
hemolytic uremic syndrome after infection with <i>E coli</i> O157 is estimated
to be 10-15%. <i></i></span></p>

<p><i><span></span></i></p>

<p><i><span>Salmonella</span></i><span> is typically spread by the fecal-oral route. Outbreaks are
associated with contaminated eggs, dairy products, and meats. Gastric acid is
usually lethal to the organism, but susceptibility to infection is increased
with decreased GI motility, rapid emptying of the stomach postgastrectomy,
large quantity of ingested bacteria, malnutrition, antibiotic use, and
achlorhydria. Salmonellae can penetrate the epithelial layer of the bowel and
evoke a leukocyte response. They cause diarrhea by producing toxins and
prostaglandins, stimulating the secretion of fluids and electrolytes. </span></p>

<p><i><span></span></i></p>

<p><i><span>Shigella</span></i><span> attaches to binding sites on the surface of intestinal
mucosal cells. The organism penetrates and proliferates in the cell, which
leads to cell destruction and produces mucosal ulcerations and bleeding.
Shigellae also elaborate the exotoxins that produce diarrhea. </span></p>

<p><b><span></span></b></p>

<p><b><span>Cytomegalovirus infection</span></b></p>

<p><span></span></p>

<p><span>Cytomegalovirus (CMV) colitis typically occurs in
immunocompromised individuals, such as patients with AIDS or organ recipients
receiving immunosuppressive treatment. </span><span>When the colon becomes infected, ulceration
occurs. As the body mounts an inflammatory response, watery diarrhea develops.
The ulcers can increase in depth, erode into blood vessels, can cause profuse
bloody diarrhea. </span><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Parasitic colitis</span></b></p>

<p><i><span></span></i></p>

<p><i><span>Entamoeba histolytica</span></i><span> is the world’s most common cause of parasitic colitis.
Transmission occurs through the ingestion of cysts, usually from water
contamination or person-to-person transmission (usually from poor
sanitation).<span >&nbsp; </span>After ingestion, the
cysts differentiate into the trophozoite stage.<span>&nbsp; </span>Trophozoites are labile outside of the
host and do not survive long in the environment.</span></p>

<p><b><span></span></b></p>

<p><b><span>Inflammatory bowel disease</span></b></p>

<p><span></span></p>

<p><span>Inflammatory bowel disease (IBD) includes two conditions:
Crohn’s disease and ulcerative colitis. Ulcerative colitis is characterized by
inflammation and ulceration confined to the colonic mucosa. Crohn’s disease is
manifested by transmural inflammation and granulomas affecting any segment of
the GI tract, including the colon. Ulcerative colitis invariably involves the
rectum and extends proximally without skipping segments. Crohn’s disease causes
discontinuous, patchy inflammation of the GI tract, usually involving the small
bowel, ileum, and colon. N</span><span>ewly diagnosed IBD has its peak incidence in the second
decade of life, with the vast majority of new cases occurring in people aged
15-40 years.</span><span></span></p>

<p></p>

<p>Crohn’s disease is an
idiopathic, chronic, transmural inflammatory process of the bowel that often
leads to fibrosis and obstructive symptoms and can affect any part of the
gastrointestinal tract from the mouth to the anus. Approximately 30% of Crohn’s
disease cases involve the small bowel, particularly the terminal ileum, another
30% involve the colon alone, and 40% involve both the small bowel and colon.
The characteristic presentation of Crohn’s disease is abdominal pain and
diarrhea, which may be complicated by intestinal fistulization, obstruction, or
both. Additional findings may include malnutrition and bone demineralization.
Unpredictable flares and remissions characterize the long-term course of this
disease. Microscopically, focal inflammatory infiltrates form around the
crypts. Ulceration of the superficial mucosa occurs and crypt abscesses
develop. Later, inflammatory cells invade the deep mucosal layers and form noncaseating
granulomas. The granulomas extend through all layers of the intestinal wall and
into the mesentery and regional lymph nodes. </p>

<p></p>

<p>Ulcerative colitis is a
chronic, idiopathic condition characterized by inflammation of the colon.
Patients typically have rectal bleeding, frequent stools, and mucous discharge
with or without tenesmus. Acute and chronic inflammation of the lamina propria,
crypt branching, and villous atrophy occur. There is discharge of mucus from
goblet cells. Ulcers appear and are soon covered by granulation tissue.
Excessive fibrosis is not a feature of the disease. Mucosal ulceration with
excessive granulation tissue results in polypoidal mucosal excrescences, called
“pseudopolyps.” </p>

<p><b><span></span></b></p>

<p><b><span>Ischemic colitis</span></b></p>

<p><span></span></p>

<p><span>Ischemic colitis</span> is a condition caused by an inadequate blood
supply to the colon. It affects elderly people primarily and may be due to
atherosclerotic disease, hypotension, or blood clot. Symptoms depend on the
severity of ischemia. The most common symptoms are abdominal pain (often left-sided)
and mild to moderate rectal bleeding. The pain may be out of proportion to
abdominal tenderness. In its mildest form, mucosal and submucosal edema and
hemorrhage occur, sometimes with mild necrosis and ulceration. With severe
ischemia, findings resembling inflammatory bowel disease (i.e. ulcerations,
crypt abscesses and pseudopolyps) may be present. Most patients are treated
supportively and recover; a minority develop sepsis and become critically ill. </p>

<p><b><span></span></b></p>

<p><b><span>Microscopic colitis</span></b></p>

<p><span></span></p>

<p><span>Microscopic colitis is </span>characterized by a triad of features:</p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic
watery diarrhea</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Normal
colonoscopy</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Characteristic
histopathology</span></p>

<p></p>

<p>Patients are usually
middle-aged women who present with a history of profuse watery diarrhea. They
have a higher-than-normal incidence of autoimmune diseases. </p>

<p></p>

<p>There are two types of
microscopic <span>colitis</span>: lymphocytic
and collagenous. Both are characterized by an increase in the number of
lymphocytes in the surface epithelium and lamina propria. Collagenous colitis
is additionally characterized by the presence of collagen in the subepithelium.</p>

<p><span>&nbsp;</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><b><span>Answer F is correct</span></b><span>. Ulcerative colitis is
usually diagnosed in young people and is characterized by rectal bleeding,
mucosal ulceration, no “skip” lesions, and the presence of acute and chronic
inflammatory cells confined to the mucosa.<span >&nbsp;
</span></span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Answer A is incorrect</span></b><span>. Necrotizing
enterocolitis is a condition that primarily affects preterm newborns.</span></p>

<p><span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Answer B is incorrect</span></b><span>. Allergic colitis is a
condition that affects infants. It is associated with milk allergy. </span></p>

<p><span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><b><span>Answer C is incorrect</span></b><span>. <i>C. difficile</i>-associated colitis occurs after antibiotic therapy and
may be associated with pseudomembranes.</span></p>

<p><span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Answer D is incorrect</span></b><span>. <i>E. coli</i>-associated colitis is an acute, not a chronic, inflammatory
condition. </span></p>

<p><span></span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Answer E is incorrect</span></b><span>. Crohn’s disease is
associated with transmural inflammation, skipped lesions, and noncaseating
granulomas.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><b><span>Answer G is incorrect</span></b><span>. Ischemic colitis
usually occurs in elderly people and is caused by decreased blood flow to the
bowel.</span></p>

<p><span></span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><b><span>Answer H is incorrect</span></b><span>. Microscopic colitis
has no grossly visible abnormalities on colonoscopy.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of the following is <i>incorrect</i> regarding Crohn’s disease?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
disease is characterized by transmural inflammation</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-Saccharomyces
cerevisiae antibodies (ASCA) are more common in Crohn’s disease than in
ulcerative colitis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Smoking
decreases the risk of Crohn’s disease</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Perinuclear
antineutrophil antibodies (p-ANCA) are more common in ulcerative colitis than
in Crohn’s disease</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
incidence of primary sclerosing cholangitis is increased in Crohn’s disease</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Crohn's disease</span>, also known as <span>regional enteritis<i>,</i></span> is an inflammatory disease that can
affect any part of the gastrointestinal tract from mouth to anus. </p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i>Crohn's ileocolitis</i>, which involves the
ileum and the colon, accounts for 50% of cases</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i>Crohn's ileitis</i>, which involves the ileum
only, accounts for 30% of cases</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i>Crohn's colitis</i>, which involves the colon
only, accounts for the 20% of cases (and may be hard to distinguish from
ulcerative colitis)</p>

<p></p>

<p>Crohn's disease is an
autoimmune disease and one type of inflammatory bowel disease. (The other major
type is ulcerative colitis.) Crohn’s disease is associated with transmural
inflammation of gastrointestinal tract. Non-caseating granulomas are seen in 50%
of cases. The condition is more common in Western industrialized nations,
suggesting an environmental link. Males and females are equally affected.
Smokers have an increased risk of developing Crohn's. (By contrast, smokers
have a <i>decreased </i>risk of developing
ulcerative colitis.) Crohn’s often presents in the teens and twenties, with
another peak incidence in the fifties to seventies. </p>

<p></p>

<p><span>The
principal symptoms of Crohn’s are abdominal pain, diarrhea (which may or may
not be bloody), vomiting, and weight loss. Intestinal inflammation</span><span> can lead to bowel stenosis and obstruction. Aphthous ulcers
may appear in the mouth. Rarely, the esophagus and stomach are involved,
causing dysphagia, abdominal pain, and vomiting. Itchiness or pain around the
anus may indicate inflammation, fistulization, abscess formation, or the
presence of an anal fissure. </span><span>Fistulae can develop between loops of bowel, between the
bowel and bladder, between the bowel and vagina, or between the bowel and skin.
People with extensive small bowel disease may have malabsorption and weight
loss. Those</span><span> who have had multiple surgeries
often develop short bowel syndrome. Crohn's disease and ulcerative colitis are
associated with primary sclerosing cholangitis. (The association is stronger
with ulcerative colitis than with Crohn’s.) </span></p>

<p><span></span></p>

<p><span>Crohn's
disease increases the risk of cancer in the area of inflammation. Individuals
with small bowel disease are at risk for small intestinal cancer. Those with
colitis are at high risk of developing colon cancer. Screening for colon cancer
with colonoscopy is recommended for anyone with Crohn's colitis.</span><span> </span></p>

<p><span></span></p>

<p><span>Two serological markers have
clinical utility<sup> </sup>in diagnosing inflammatory bowel disease and in
differentiating Crohn’s from<sup> </sup>ulcerative colitis: anti-<i>Saccharomyces
cerevisiae</i> antibody (ASCA) and perinuclear antineutrophil cytoplasmic
antibody (pANCA). ASCA is more prevalent in Crohn’s disease; pANCA is more
prevalent in ulcerative colitis. </span></p>

<p><span></span></p>

<p><span>Crohn’s
disease is characterized by periods of relapse and remission. The goal of
treatment is to control symptoms, maintain remission, and prevent relapse.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><img border=0 width=470 height=339
src="_%20Tutorials_files/image306.png" alt="Description: colon2" v:shapes="Picture_x0020_347282"></span><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>+</span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. Smokers have an
increased risk of developing Crohn’s disease and a decreased risk of developing
ulcerative colitis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
45-year-old man has a six-month history of difficulty swallowing associated
with chest pain. He has lost 10 lbs in the last three months. He has not
experienced heartburn. His hands are not sensitive to cold. His BMI is 20 kg/m<sup>2</sup>.
Physical examination shows no abnormalities. Barium swallow shows esophageal
dilation. Manometry shows high resting pressure at the lower esophageal
sphincter, which is unchanged with swallowing. Which is the most likely
diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Achalasia
</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Esophagitis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gastroesophageal
reflux</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Systemic
sclerosis (scleroderma)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Esophageal
diverticulum</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Dysphagia,
or difficulty swallowing, is caused by impeded movement of food or drink
anywhere from the pharynx to the stomach. It is distinct from globus, the
sensation of having a “lump in the throat,” which is unrelated to swallowing.
Dysphagia is classified as oropharyngeal or esophageal. </span></p>

<p><span></span></p>

<p><b><span>Oropharyngeal dysphagia (OPD)</span></b><span> results from a true
oropharyngeal swallowing dysfunction. Cerebrovascular accident, dementia,
myasthenia gravis, and amyotrophic lateral sclerosis are common causes of OPD
and are associated with a high morbidity and mortality risk. Dehydration,
malnutrition, choking, aspiration, pneumonia, sepsis, and death are all
potential consequences. When OPD is suspected, a modified barium swallow study
should be performed with the assistance of a speech therapist.<a
name=4-u1.0-B978-1-4160-2467-5..50051-8--f7></a></span></p>

<p><span></span></p>

<p><b><span>Esophageal dysphagia</span></b><span> results from disorders
affecting the tubular esophagus, including various mechanical obstructing
lesions and motility disorders. </span></p>

<p><span></span></p>

<p><i><span>Esophageal webs</span></i><span> are thin, eccentric
membranes consisting of mucosa and submucosal. They can occur anywhere in the
esophagus and hypopharynx. They can be associated with iron deficiency anemia,
although most patients are not anemic. </span></p>

<p><span></span></p>

<p><i><span>Esophageal rings</span></i><span> (e.g., Schatzki's
rings) are concentric rings of mucosal or muscular tissue that occur most commonly
in the distal esophagus and may be associated with gastroesophageal reflux
disease (GERD). Most patients are asymptomatic and do not require specific
treatment. Some patients may require esophageal dilation to relieve dysphagia
and acid-blocking therapy for GERD. </span></p>

<p><span></span></p>

<p><i><span>Benign</span></i><span> <i>esophageal
strictures</i> occur in a minority of patients with persistent GERD and erosive
esophagitis. Other causes include caustic ingestion, Crohn's disease, infection
(e.g., candidiasis), medication (e.g., NSAIDs), radiation therapy, and
scleroderma. Most strictures are located in the distal esophagus. </span></p>

<p><span></span></p>

<p><i><span>Malignant esophageal strictures</span></i><span> are usually caused by
adenocarcinoma of the esophagus. Initially, dysphagia occurs only with solid
foods, but it progresses to involve liquids as well.<span>&nbsp; </span>A primary or secondary malignancy should
be considered in patients with rapidly progressive dysphagia and weight loss. </span></p>

<p><a name=4-u1.0-B978-1-4160-2467-5..50051-8--f8></a><a
name=4-u1.0-B978-1-4160-2467-5..50051-8--f9></a><i><span></span></i></p>

<p><i><span>Esophageal diverticula</span></i><span> are outpouchings of the
mucosal wall of the esophagus. They lack a muscular wall and are caused by
pulsion forces secondary to esophageal motility disorders. Esophageal
diverticula are divided into four categories based on location: hypopharyngeal
(Zenker's diverticula), midesophageal diverticula, epiphrenic diverticula, and
intramural pseudodiverticulosis. Esophageal manometry is mandatory in patients
with diverticula to define the underlying esophageal motility disorder.
Surgical resection is often needed in patients with symptomatic diverticula.</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4160-2467-5..50051-8--f10></a><b><span>Esophageal dysmotility</span></b><span> <b>disorders</b>
include abnormalities of esophageal peristalsis and lower esophageal sphincter
(LES) function. They are best evaluated by esophageal manometry. </span></p>

<p><i><span>Diffuse esophageal spasm</span></i><span> is characterized by
intermittent chest pain (mild to severe) with <span after the ingestion of very hot or very cold foods. This condition is
often confused with heart disease, and patients often undergo a cardiac workup.
The classic finding on a barium esophagram is corkscrew appearance of the
esophageal body during contraction. </span></p>

<p><span></span></p>

<p><i><span>Nutcracker esophagus</span></i><span> presents with chest
pain and <span Distal esophageal peristaltic
amplitude higher than 180 mm Hg is required for diagnosis. The barium
esophagram is normal. </span></p>

<p><span></span></p>

<p><i><span>Achalasia</span></i><span> of the esophagus is characterized by loss of
esophageal peristalsis and incomplete relaxation of the LES. Its onset is
usually in the third to fifth decades. Most patients present with <span
 regurgitation, weight loss, chest pain, and
heartburn. Patients with achalasia tend to drink fluids and perform body-straightening
maneuvers to facilitate emptying of food into the stomach. Barium esophagrams
show a narrowing at the level of the gastroesophageal junction (bird beak) and
various degrees of esophageal dilation (see below). Upper endoscopy is required
to rule out the presence of a peptic stricture, esophageal or gastric tumor,
and gastroduodenal pathology. Esophageal manometry is the gold standard for
establishing the diagnosis of achalasia. The classic finding is absence of
esophageal peristalsis and a LES that fails to relax completely with
swallowing. Patients with achalasia are at an increased risk for developing of
squamous and adenocarcinoma of the esophagus.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=146 height=156
src="_%20Tutorials_files/image308.png" alt="Description: achalasia" v:shapes="Picture_x0020_347281"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=151 height=165
src="_%20Tutorials_files/image310.png" alt="Description: Achalasia1" v:shapes="Picture_x0020_347280"></span><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. Achalasia is an
esophageal motility disorder involving the smooth muscle layer of the esophagus
and the lower esophageal sphincter (LES). It is characterized by incomplete LES
relaxation, increased LES tone, and aperistalsis of the esophagus. Symptoms
include difficulty swallowing, regurgitation, and chest pain. Diagnosis is made
with barium swallow and esophageal manometry. Barium swallow shows esophageal
dilation and a bird’s beak deformity of the distal esophagus. Manometry shows
high resting pressure at the lower esophageal sphincter, which is unchanged or
minimally changed with swallowing. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
27-year-old woman is brought to the emergency room with abdominal pain and
light-headedness. Four days prior to her arrival, she began to have
intermittent vaginal bleeding and mild abdominal pain. This morning the pain
became severe and she became light-headed. Her last normal menstrual period was
three months ago. Abdominal examination shows moderate tenderness in the right
lower quadrant. Bimanual pelvic examination shows a 4-cm mass in the right
parametrium. Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Appendicitis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ovarian
cyst</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ovarian
cancer</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Ectopic
pregnancy</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Endometriosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>In
evaluating abdominal and pelvic pain, the clinician’s first duty is to exclude
life-threatening disease. The following “red flags” are of particular concern. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=121 valign=top>
  <p style="text-align:center;"><b><span>Red Flags</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=121 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=121 valign=top>
  <p><span>Severe
  pain</span></p>
  </td>
 </tr>
 <tr>
  <td width=121 valign=top>
  <p><span>Signs of
  shock</span></p>
  </td>
 </tr>
 <tr>
  <td width=121 valign=top>
  <p><span>Signs of
  peritonitis</span></p>
  </td>
 </tr>
 <tr>
  <td width=121 valign=top>
  <p><span>Signs of
  obstruction</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Severe
pain: early surgical consultation is often necessary</span></p>

<p><span><span>II.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Signs
of shock: tachycardia, hypotension, diaphoresis, confusion</span></p>

<p><span><span>a.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Vaginal
bleeding in a pregnant woman with an adnexal mass may suggest ectopic pregnancy</span></p>

<p><span><span>b.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tender
abdominal mass with back pain may suggest ruptured abdominal aortic aneurysm</span></p>

<p><span><span>c.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ecchymoses
of the costovertebral angles (Grey Turner’s sign) or of the umbilicus (Cullen’s
sign) may suggest hemorrhagic pancreatitis</span></p>

<p><span><span>III.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Signs
of peritonitis: severe abdominal pain exacerbated by movement; severe abdominal
tenderness with guarding and rebound; patient lying motionless</span></p>

<p><span><span>IV.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Signs
of obstruction: abdominal distension; high-pitched, rushing bowel sounds;
tympany to percussion<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>“Pelvic”
and “lower abdominal” pain can overlap. Both can be caused by gynecological and
non-gynecological conditions. Common gynecological causes of pelvic pain are
listed below.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=443 colspan=2 valign=top>
  <p style="text-align:center;"><b><span>Gynecological Causes
  of Pelvic Pain</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><i><span>Pain related to menstrual period</span></i></p>
  </td>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Dysmenorrhea</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Severe
  pain before and/or during menses</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Endometriosis</span></p>
  </td>
  <td width=221 valign=top>
  <p>Symptoms may include: </p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Dysmenorrhea &#8211; painful, sometimes disabling cramps
  during menses that may get worse over time </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Chronic pelvic pain &#8211; often accompanied by low back
  pain or abdominal pain </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Dyspareunia &#8211; painful sex </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Dysuria &#8211; painful voiding sometimes with urinary
  frequency and urgency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Dyschezia--painful defecation</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Fixed mass or tender nodules found on bimanual or rectal
  exam</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Mittelschmertz</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Sudden,
  severe pain at mid-cycle (during ovulation), often with light, spotty vaginal
  bleeding</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><i><span>Pain unrelated to menstrual period</span></i></p>
  </td>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Pelvic
  inflammatory disease</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Gradual
  onset of pain; mucopurulent cervical discharge; marked cervical motion
  tenderness; adnexal tenderness; may be associated with fever, dysuria,
  dyspareunia<span >&nbsp; </span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Ruptured
  ovarian cyst</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Sudden
  onset of pain, sometimes with vaginal bleeding, nausea, vomiting, and
  peritoneal signs</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Ruptured
  ectopic pregnancy</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Sudden
  onset of pain with vaginal bleeding; syncope and hemorrhagic shock may occur;
  tender adnexal mass may be present</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Acute
  degeneration of uterine fibroid</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Sudden
  onset of pain and vaginal bleeding; often during first 12 weeks of pregnancy
  or after delivery</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Adnexal
  torsion</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Sudden
  onset of severe pain, often with nausea, vomiting, peritoneal signs; risk
  factors include pregnancy, induction of ovulation, large ovary (&gt; 4cm)</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Uterine
  or ovarian cancer</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Gradual
  onset of pain; abnormal vaginal bleeding; sometimes pelvic mass</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Adhesions</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Gradual
  onset of pain or dyspareunia; history of abdominal surgery; sometimes nausea
  and vomiting</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Spontaneous
  abortion</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Vaginal
  bleeding with pelvic or back pain in early pregnancy accompanied by symptoms
  of early pregnancy like breast tenderness, nausea, and delayed menses</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer is D is correct</span></b><span>. Severe pain and
fainting are “red flag” signs. The absence of menses for three months suggests
possible pregnancy. Ectopic pregnancy is likely given the presence of vaginal
bleeding and a parametrial mass. An <span>ectopic
pregnancy</span> is a complication of pregnancy in which the embryo implants
outside the uterine cavity. With rare exceptions, ectopic pregnancies are not
viable. Furthermore, they are dangerous for the parent, since internal
hemorrhage is a life threatening complication. Most ectopic pregnancies occur
in the Fallopian tube (so-called <span>tubal
pregnancies</span>), but implantation can also occur in the cervix, ovaries,
and abdomen. An ectopic pregnancy is a potential medical emergency, and, if not
treated properly, can lead to death.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Appendicitis usually
presents with right lower quadrant pain. Tenderness may be present at
McBurney’s point (one-third of the distance from the anterior superior iliac
spine to the umbilicus). Guarding and rebound tenderness suggest peritonitis.
If the appendix is retrocecal, abdominal tenderness may be absent; if the
appendix lies entirely within the pelvis, abdominal rigidity may be absent,
though rectal examination may elicit tenderness in the rectovesicular pouch. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Ovarian cysts are
common in women of reproductive age. Most are asymptomatic and resolve on their
own. 95% are benign. Rare complications include cyst rupture, which may cause
severe abdominal pain and bleeding.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Patients with ovarian
cancer may be asymptomatic or may have any of the following: abdominal/pelvic
pain, abdominal mass, bloating,</span><a
href="http://en.wikipedia.org/wiki/Back_pain" title="Back pain"></a><span> back pain, urinary
urgency, constipation, fatigue, vaginal bleeding, or weight loss. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. In endometriosis,
endometrial-like cells appear outside the uterus, most commonly on the ovaries.
Like cells lining the uterine cavity, these cells are influenced by hormonal
changes. Typically the condition occurs during the reproductive years. The most
common symptom is pelvic pain, which may occur with menses.<b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
29-year-old woman has been unable to conceive for a year.<span>&nbsp; </span>Her cycles are regular, but she has very
painful periods despite use of non-steroidal anti-inflammatory drugs (NSAIDs).
She also reports painful intercourse. Her mother was diagnosed with ovarian
cancer at age 49. She has been married for five years. Physical examination
shows mild lower abdominal tenderness bilaterally. The uterus appears normal in
size. A small tender mass in noted in the left adnexal area. Pelvic ultrasound
shows a 5-cm complex cyst in the left ovary.<span>&nbsp; </span>What is the underlying pathophysiology
of this condition? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Chronic
inflammation of the uterus and cervix</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Malignant
transformation of epithelial cells of the ovary</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Endometrial
glands outside of uterine cavity</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Excessive
production of androgens by the ovaries</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Endometriosis</span></b></p>

<p><b><span></span></b></p>

<p><span>Endometriosis is the
presence of islands of endometrium (i.e., the tissue lining the inside of the
uterus) in locations outside of the uterus.<span>&nbsp; </span>Cyclic changes in these cells can be
associated with localized bleeding and resultant pain, inflammation, and/or
scarring.<span >&nbsp; </span>The exact reason for the
development of endometriosis is unknown but there appears to be a hereditary
component.<span >&nbsp; </span>Endometriosis typically
occurs during the reproductive years. It affects roughly 5-10% of women.</span></p>

<p><span></span></p>

<p><b><u><span>Symptoms </span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><span>The main symptoms of
endometriosis are pain and infertility, although not everyone gets these
symptoms.<span >&nbsp; </span>The most common pain from
endometriosis is pelvic pain which can be present at times other than the
menstrual flow, although the pain is usually noted to worsen with the menses
(dysmenorrhea).<span >&nbsp; </span>Pain with
intercourse is often present (dyspareunia).<span>&nbsp; </span>Endometriosis can cause rectal pain and
bleeding (dyschezia), and premenstrual back pain as well.<span>&nbsp; </span>Patients with relatively mild
endometriosis may have intense pain; alternatively, some patients with severe
disease can be relatively symptom-free.The mechanisms by which endometriosis
causes infertility are unknown.<span >&nbsp; </span>Adhesions
(scar tissue) and destruction of the fallopian tubes, ovarian cyst formation,
and distortion of the normal anatomical relationships can explain the pain and
infertility.<span >&nbsp; </span>In mild endometriosis,
proposed mechanisms causing pain and infertility include release of certain
chemicals by inflammatory cells that may be toxic to eggs, sperm, or embryos. Surgery
(usually a diagnostic laparoscopy) is the only way to diagnose
endometriosis.<span >&nbsp; </span></span></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span>Therapy</span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><span>Pain related to
endometriosis can be treated with either medication or an operation.<span>&nbsp; </span>A variety of different drugs have been
used to treat endometriosis but all of them aim to suppress stimulation to the
endometriotic implants.<span >&nbsp; </span>Treatment
with estrogen and progesterone combination hormone therapy (oral contraceptives)
has been used in order to create an environment similar to pregnancy.<span>&nbsp; </span>By establishing such a hormonal state,
endometriosis has been found to stop growing and symptoms have resolved
partially or completely.<span >&nbsp;&nbsp;
</span>Therapy with medication alone is most beneficial in mild to moderate
disease. For infertile women with endometriosis, the infertility evaluation
should be completed and factors contributing to infertility should be
addressed. Infertility due to endometriosis is usually treated surgically followed
by conventional infertility treatments.<span >&nbsp;
</span>Surgery alone is most effective if there is associated anatomical
distortion that can be corrected surgically.<span>&nbsp; </span>However, recurrence and formation of new
scar tissue limit the effectiveness of surgical therapy.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer C is correct. </b>In this vignette, the combination of
dysmenorrhea, dyspareunia, infertility, and lower abdominal tenderness suggest
a diagnosis of endometriosis. The complex ovarian cyst is most likely an
endometrioma.</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 60-year-old man with
alcoholic cirrhosis undergoes upper endoscopy and is found to have large
esophageal varices. He has no history of gastrointestinal bleeding or
encephalopathy. An abdominal ultrasound shows coarse hepatic echotexture, patent
portal and hepatic veins, and no ascites. Which one of the following is the
most appropriate primary prophylaxis for this gentleman?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nadolol</span><span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Norfloxacin</span><span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nitrates</span><span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Transjugular intrahepatic portosystemic shunt
(TIPS).</span><span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sclerotherapy of varices</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Esophageal varices</span> are dilated submucosal veins in the lower
esophagus. They are a consequence of portal hypertension, usually due to
cirrhosis, and they have a strong tendency to bleed.<span>&nbsp; </span></p>

<p><span>Most of the blood from the esophagus is drained
through the esophageal veins, which carry blood to the azygos vein, which in
turn drains into the superior vena cava. These veins are <i>not</i> responsible for the development of esophageal varices. The
remaining blood from the esophagus is drained into superficial veins lining the
mucosa, which drain into the left gastric vein, which in turn drains into the
portal vein. These superficial veins, which are normally only 1 millimeter in
diameter, can expand to 1-2&nbsp;centimeters when portal hypertension is
present. These dilated veins have thin walls and are called “varices.” </span></p>

<p><span></span></p>

<p><span>One of the most severe complications of
cirrhosis is esophageal variceal bleeding, which typically presents as
hematemesis (vomiting blood). In patients with advanced cirrhosis, high
pressure in the portal vein is transmitted to the left gastric vein. Branches
of the left gastric vein form varices in the lining of the esophagus. These
varices are prone to bleeding.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>In patients with portal hypertension, blood flow
though the portal system is redirected from the liver into areas of lower
venous pressure, i.e., the lower esophagus, stomach, abdominal wall, and
rectum. This redirection of blood flow can result in esophageal varices,
dilated veins over the anterior abdominal wall, and internal hemorrhoids.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=295 height=283
src="_%20Tutorials_files/image312.png" alt="Description: 200710291050_31783_000"
v:shapes="Picture_x0020_347279"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. Non-selective beta-blockers such as nadolol or propranolol are
recommended for patients with large varices to reduce the risk of variceal
bleeding. They </span><span>decrease
cardiac output through &#946;<sub>1</sub> blockade and decrease splanchnic
blood flow through &#946;<sub>2</sub> blockade. <span></span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Norfloxacin is used as prophylaxis for spontaneous bacterial
peritonitis in cirrhotic patients who have gastrointestinal bleeding or a
history of spontaneous bacterial peritonitis.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Nitrates can reduce portal pressure and may be used as an adjunct to
non-selective beta-blockers.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Transjugular intrahepatic portosystemic shunt (TIPS) is used in
patients with refractory gastrointestinal bleeding or ascites.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Sclerotherapy is used to treat bleeding esophageal varices. It is
generally not recommended for bleeding prophylaxis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Two chemicals are isolated
from the body. When administered at the same time, they induce gastric acid
secretion that is four times as great as that induced by either one alone. The
two chemicals are likely to be which of the following?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Acetylcholine and secretin</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Secretin and cholecystokinin</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Cholecystokinin and gastrin</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Gastrin and histamine</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Histamine and vasoactive intestinal polypeptide</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Gastric acid secretion by
the parietal cell is stimulated by three substances (acetylcholine, gastrin,
and histamine) and inhibited by one substance (somatostatin). The interaction
of these substances is shown in the figure below. A<span is
released from the vagus nerve. Gastrin is produced by G cells, histamine is
produced by ECL cells (enterochromaffin-like cells), and somatostatin is
produced by D cells.</span></span></p>

<p><span>The H<sup>+</sup>/K<sup>+</sup>-ATPase
in the parietal cell is the final common pathway for gastric acid secretion.
This enzyme allows the parietal cell to secrete hydrogen in exchange for
potassium. The exchange is electroneutral, but requires energy in the form of
adenosine triphosphate (ATP) because hydrogen is secreted against a gradient of
more than a million-fold. This huge energy requirement explains why parietal
cells have the largest mitochondrial content of any mammalian cell.</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=223 height=242
src="_%20Tutorials_files/image314.png"
alt="Description: http://www.mdconsult.com/books/bbmapAsset?appID=MDC&amp;isbn=978-1-4160-3675-3&amp;eid=4-u1.0-B978-1-4160-3675-3..50051-4..gr7&amp;assetType=full"
v:shapes="Picture_x0020_347278"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Gastric acid secretion
is stimulated by acetylcholine, gastrin, and histamine. Histamine directly
stimulates parietal cells to produce hydrochloric acid. Gastrin also directly
stimulates parietal cells to produce hydrochloric acid. In addition, gastrin stimulates
ECL cells to release histamine, thus magnifying the effect of the administered
histamine. Combined administration of gastrin and histamine has a synergistic
effect on acid release. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
10-year-old girl is brought to the emergency department because of abdominal
pain.<span >&nbsp; </span>Ultrasonography reveals
bilateral solid adnexal masses, 10cm x 10cm in size.<span>&nbsp; </span>The human chorionic gonadotropin (hCG)
level is elevated at 62 mIU/mL, and the lactate dehydrogenase (LDH) level is
elevated at 137 U/L.<span >&nbsp; </span>What is the
most likely diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Endodermal
sinus tumor</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Immature
teratoma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dysgerminoma</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Theca-lutein
cyst</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mature
cystic teratoma</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Germ cell tumors may be
benign or malignant. They usually occur in the gonads (ovaries and testes), but
may appear elsewhere. In females under the age of 21, 60% of ovarian tumors are
of the germ cell type, and up to one-third are malignant. </p>

<p></p>

<p>Germ cell tumors are
classified into two histological categories: germinomatous and
non-germinomatous. The survival rate for germinomatous tumors is higher, in
part, because these tumors are more sensitive to radiation and chemotherapy.
Non-germinomatous tumors, by contrast, tend to grow faster and have a lower
five-year survival rate. </p>

<h3><span><span><span></span></h3>

<table border=1 cellpadding=0>
 <tr>
  <td width=144>
  <p style="text-align:center;"><b><span>Tumor</span></b></p>
  </td>
  <td width=44>
  <p style="text-align:center;"><b><span>Peak</span></b></p>
  <p style="text-align:center;"><b><span>Age (yr)</span></b></p>
  </td>
  <td width=125>
  <p style="text-align:center;"><b><span>Benign or malignant</span></b></p>
  </td>
  <td width=117>
  <p style="text-align:center;"><b><span>Tumor marker</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=144>
  <p><span>Germinoma
  (<span>dysgerminoma</span> and <span>seminoma</span>)</span></p>
  </td>
  <td width=44>
  <p style="text-align:center;"><span>40-50</span></p>
  </td>
  <td width=125>
  <p style="text-align:center;"><span>Malignant</span></p>
  </td>
  <td width=117>
  <p><span>10%
  secrete hCG</span></p>
  </td>
 </tr>
</table>

<h3><span><span><span></span></h3>

<table border=1 cellpadding=0>
 <tr>
  <td width=144>
  <p style="text-align:center;"><b><span>Tumor</span></b></p>
  </td>
  <td width=44>
  <p style="text-align:center;"><b><span>Peak Age (yr)</span></b></p>
  </td>
  <td width=125>
  <p style="text-align:center;"><b><span>Benign or malignant</span></b></p>
  </td>
  <td width=117>
  <p style="text-align:center;"><b><span>Tumor marker</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=144>
  <p><span>Embryonal
  carcinoma</span></p>
  </td>
  <td width=44>
  <p style="text-align:center;"><span>20-30</span></p>
  </td>
  <td width=125>
  <p style="text-align:center;"><span>Malignant</span></p>
  </td>
  <td width=117>
  <p style="text-align:center;"><span>---</span></p>
  </td>
 </tr>
 <tr>
  <td width=144>
  <p><span>Endodermal
  sinus tumor (<span>yolk sac tumor)</span></span></p>
  </td>
  <td width=44>
  <p style="text-align:center;"><span>3</span></p>
  </td>
  <td width=125>
  <p style="text-align:center;"><span>Malignant</span></p>
  </td>
  <td width=117>
  <p><span>100%
  secrete AFP</span></p>
  </td>
 </tr>
 <tr>
  <td width=144>
  <p><span>Choriocarcinoma</span></p>
  </td>
  <td width=44>
  <p style="text-align:center;"><span>20-30</span></p>
  </td>
  <td width=125>
  <p style="text-align:center;"><span>Malignant</span></p>
  </td>
  <td width=117>
  <p><span>100%
  secrete hCG</span></p>
  </td>
 </tr>
 <tr>
  <td width=144>
  <p><span>Teratoma
  (mature teratoma, dermoid cyst, immature teratoma, teratoma with malignant
  transformation)</span></p>
  </td>
  <td width=44>
  <p style="text-align:center;"><span>0-3, 15-30</span></p>
  </td>
  <td width=125>
  <p><span>Mature
  teratoma and dermoid cyst are benign; others usually malignant</span></p>
  </td>
  <td width=117>
  <p style="text-align:center;"><span>---</span></p>
  </td>
 </tr>
</table>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b><span>Answer C is correct</span></b><span>. Dysgerminomas are the
most common malignant germ cell tumor, accounting for 50% of all cases. They
appear bilaterally in 10-15% of cases. They do not secrete alpha-fetoprotein
(which distinguishes them from endodermal sinus tumors). Some secrete hCG. They
are associated with elevated levels of LDH, which can be used as a tumor
marker.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Endodermal sinus
tumors are usually unilateral and do not secrete hCG. They <i>do</i> secrete alpha-fetoprotein.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Immature teratomas are
usually unilateral and do not secrete hCG. </span></p>

<p><span><span>&nbsp; </span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Theca-lutein cysts
result from ovarian hyperstimulation by gonadotropins. They are usually
bilateral and multicystic, contain serosanguinous fluid, and are associated
with significantly elevated hCG levels. Treatment is conservative, as they
usually regress spontaneously.<span >&nbsp;&nbsp;&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Mature cystic
teratomas are common ovarian neoplasms. They usually contain tissues derived
from all three germ layers (ectoderm, mesoderm, and endoderm), and may contain
cartilage, hair, or teeth. They are benign, appear bilaterally in 10-15% of
cases, and do not secrete hCG.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 29-year-old woman has a progressive increase in her serum &#946;-human
chorionic gonadotropin (&#946;-hCG) concentrations during a 6-week period. A
hydatidiform mole is removed, but the &#946;-hCG concentration continues to
increase. Which of the following is the most likely diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>A second non-invasive mole</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Choriocarcinoma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Pituitary adenoma</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Adrenal adenoma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Ectopic pregnancy</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Gestational trophoblastic disease</span> (GTD) or neoplasia is a generic
term for a group of pregnancy-related tumors that arise from trophoblasts.
Trophoblasts constitute the outer layer of the blastocyst (see figure). They
nourish the embryo and differentiate to form the placenta. Tumors arising from
these trophoblastic cells may be benign (e.g., hydatidiform mole) or malignant
(e.g., choriocarcinoma).<span >&nbsp; </span></p>

<p></p>

<p>GTD usually presents as a
hydatidiform mole (also known as a molar pregnancy), which includes abnormal
proliferation of the syncytiotrophoblast and replacement of normal placental
trophoblastic tissue by hydropic placental villi.<span>&nbsp; </span>They may be complete moles or partial
moles. Complete moles have chromosomes entirely of paternal origin as the
result of the fertilization of a blighted ovum by a haploid sperm that
reduplicates, or rarely, fertilization of a blighted ovum with two sperm.<span>&nbsp; </span>The karyotype of a complete mole is
usually 46XX.<span >&nbsp; </span>The fetus of a
partial mole is usually a triploid.<span >&nbsp;
</span>This consists of one haploid set of maternal chromosomes and two haploid
sets of paternal chromosomes, the consequence of dispermic fertilization of a
normal ovum.<span >&nbsp; </span>Complete moles are
more common than partial moles and more likely to undergo malignant
transformation. </p>

<p style="text-align:center;"><span><img border=0 width=240 height=348
src="_%20Tutorials_files/image316.png" v:shapes="_x0000_i1167"></span></p>

<p>Hydatidiform moles usually
present with painless vaginal bleeding in the first trimester. Blood tests show
very high levels of human chorionic gonadotropin (hCG) and the uterus is
usually larger than expected. Symptoms of hyperthyroidism may occur because hCG
can mimic the effects of thyroid-stimulating hormone (TSH). On ultrasound, the
mole has a “snowstorm” pattern (if it is a complete molar pregnancy).<span>&nbsp; </span>In cases of partial mole,
ultrasonography reveals an abnormally formed fetus without a heartbeat.<span>&nbsp; </span>Definitive diagnosis requires
histopathologic examination to differentiate between partial and complete molar
pregnancy and malignancy.<span >&nbsp; </span>Treatment
for either complete or partial molar pregnancy is dilation and curettage
followed by serial hCG levels until negative.</p>

<p></p>

<p>Choriocarcinomas are a
malignant transformation of trophoblastic tissue.<span>&nbsp; </span>Instead of hydropic chorionic villi, the
tumor has a red granular appearance on cut section and consists of intermingled
syncytiotrophoblastic and cytotrophoblastic elements with many abnormal
cellular forms.<span >&nbsp; </span>Clinically,
choriocarcinomas are characterized by rapid myometrial and uterine vessel
invasion and systemic metastases resulting from hematogenous embolization.<span>&nbsp; </span>Lung, vagina, central nervous system
(brain), kidney and liver are common metastatic locations.<span>&nbsp; </span>Choriocarcinoma may follow a molar
pregnancy (most common), normal-term pregnancy, abortion, or ectopic
pregnancy.<span >&nbsp; </span></p>

<p></p>

<p><span>2 to 3% of
hydatidiform moles develop into choriocarcinoma, a rapidly-growing, malignant
tumor. Choriocarcinoma is characterized by increased quantitative &#946;-hCG
levels. The tumor is exquisitely sensitive to chemotherapy (usually
methotrexate with other additional drugs), and the cure rate, even for
metastatic disease, is above 90%. </span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/7/72/Blastocyst_English.svg"><span><img border=0 width=290 height=241
src="_%20Tutorials_files/image318.png"
alt="Description: Description: File:Blastocyst English.svg" v:shapes="Picture_x0020_347276"></span></a></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>.<span>&nbsp; </span>A small fraction of hydatidiform moles
develop into choriocarcinoma, a rapidly-growing, malignant tumor characterized
by increasing levels of quantitative &#946;-hCG.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
14-month-old boy is brought to the emergency room because of rectal bleeding.
He does not appear distressed but has mild abdominal tenderness. Radionuclide
imaging (see below) reveals the diagnosis and surgery is recommended. What is
the most plausible explanation for this condition?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ectopic
gastric epithelium in a persistent omphalomesenteric duct</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Blockage
of the intestine due to folding of the distal ileum into the proximal colon</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bowel
rotation resulting in obstruction of the superior mesenteric artery</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hypertrophy
of smooth muscle in the gastric pylorus</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Esophagus
ending in a blind-pouch </span></p>

<p><span><span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=181 height=174
src="_%20Tutorials_files/image320.png"
alt="Description: http://www.uth.tmc.edu/radiology/publish/meckel_diverticulum/images/md05.jpg"
v:shapes="Picture_x0020_347275"></span><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Meckel’s diverticulum</span></b><span>, which results from
persistence of the omphalomesenteric duct (vitelline duct or yolk stalk), is
usually found in the mid-to-distal ileum and may end blindly or connect to the
umbilicus. Rectal bleeding with iron-deficiency anemia is the most common presentation
in children. The bleeding is not usually associated with severe pain.
Radionuclide imaging can detect ectopic gastric mucosa. Meckel’s diverticulum
is characterized by the “rule of 2s”: 2 inches long, 2 feet from the ileocecal
valve, occurs in 2% of the population, usually presents before age 2, may
contain 2 types of epithelium (gastric and pancreatic), only 2% of patients are
symptomatic, males are 2 times as likely to be affected as females, and 2% of
carcinoid tumors occur in Meckel’s diverticulum. </span></p>

<p><span></span></p>

<p><b><span>Intussusception</span></b><span> is the principal cause
of intestinal obstruction in children between the ages of 3 months and 6 years.
The condition involves “telescoping,” or prolapse, of one portion of the bowel
into an adjacent portion. Typically, the distal ileum folds into the proximal
colon. There is an outpouring of bloody mucus, resulting in “red currant jelly”
stool. The presentation is acute and severe, with screaming, vomiting,
diarrhea, and bloody bowel movements. The classic triad of colicky abdominal pain,
vomiting, and red “currant jelly” stools occurs in 20% of cases.<span>&nbsp; </span>Paroxysms of pain occur 10-20 minutes
apart, and the patient often feels well between episodes.<span>&nbsp; </span>A vertically oriented mass is sometimes
palpable in the right upper quadrant.<span >&nbsp;
</span>Most cases (90%) are idiopathic. The male-to-female ratio is
approximately 3:1. Contrast enema is diagnostic in 95% of cases, and usually
curative if administered within 24 hours of presentation.</span></p>

<p><span></span></p>

<p><b>Volvulus</b> is a bowel
obstruction that occurs when a loop of bowel twists on itself. Midgut volvulus
occurs in infants, who may be predisposed to volvulus because of intestinal
malrotation. The most common symptom is bilious vomiting (i.e., vomiting
greenish-yellow fluid). Severe abdominal pain and distension are typical.
Ischemia occurs in the distribution of the superior mesenteric artery. If
untreated, the condition may result in bowel necrosis and death. Acute volvulus
requires immediate surgical intervention. </p>

<p></p>

<p><b>Pyloric stenosis</b> is
caused by hypertrophy of smooth muscle in the gastric pylorus, resulting in
severe vomiting within the first few months of life. Vomiting is non-bilious
and &quot;projectile.&quot; Palpation of the abdomen may reveal a mass in the
epigastrium. Males are more commonly affected than females. Blood tests show
hypokalemic metabolic alkalosis. Surgery is curative. </p>

<p></p>

<p><b>Esophageal atresia</b> is
a congenital condition in which the esophagus ends in a blind pouch, rather
than connecting with the stomach. The pouch may or may not communicate with the
respiratory tract through a tracheoesophageal fistula. E<span>sophageal atresia</span> should be suspected when drooling in a newborn
is accompanied by choking, coughing, and sneezing. The infant may swallow
normally, but begins to cough as fluid returns through the nose and mouth.
Cyanosis may occur if fluid is aspirated into the trachea. Surgery is curative.
</p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer A is correct</b>. This patient most likely has Meckel’s
diverticulum.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Match each
of the following items with the statement that best describes its function. </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Secretin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gastrin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cholecystokinin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Gastric
inhibitory peptide (GIP)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Substance-P</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Motilin</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Somatostatin
</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Vasoactive
intestinal polypeptide</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Goblet
cell</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Parietal
cell</span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>Brunner’s
gland</span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chief
cell</span></p>

<p><span><span>M.<span>&nbsp;
</span></span></span><span>Peyer’s
patch</span></p>

<p><span><span>N.<span>&nbsp;&nbsp;
</span></span></span><span>Chyme</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Located
in the duodenum, it produces a mucus-rich alkaline secretion (containing
bicarbonate), which protects the duodenum from acidity provides an alkaline
environment for intestinal enzymes to be active.</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Located
in the stomach, it produces pepsinogen, the precursor of pepsin. (Pepsin is one
of three major proteolytic enzymes in the digestive system. The other two are
chymotrypsin and trypsin.) </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Semifluid
mass of partly digested food expelled by the stomach into the duodenum.</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Secreted
by cells lining the duodenum, it stimulates the pancreas to secrete digestive
enzymes and stimulates the gall bladder to contract and release bile.</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Released
from cells in the duodenum and jejunum, it inhibits stomach motility and acid
secretion and stimulates insulin release by the pancreas in a <span>glucose-dependent manner<i>.</i></span></span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Released
by cells in the stomach, duodenum, and pancreas, it stimulates gastric
contraction, hydrochloric acid secretion, histamine release, and pepsinogen
release.<span >&nbsp; </span></span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Part
of the mucosa of the small intestine, it secretes mucin, which dissolves in
water to form mucus, which in turn protects and lubricates the lining of the
intestine.</span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Secreted
by enterochromaffin cells in the duodenum and jejunum, it improves peristalsis
in the small intestine.</span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
produces gastric acid and intrinsic factor, a glycoprotein that binds with
dietary vitamin-B12 in the stomach and facilitates vitamin-B12 absorption in
the terminal ileum.</span></p>

<p><span><span>10.<span>&nbsp; </span></span></span><span>An organized lymphoid
nodule in the ileum.</span></p>

<p><span><span>11.<span>&nbsp; </span></span></span><span>Secreted by cells in the
duodenum, it stimulates bicarbonate secretion from the pancreas.</span></p>

<p><span><span>12.<span>&nbsp; </span></span></span><span>A peptide hormone, it
inhibits the release of pancreatic hormones (insulin and glucagon) and
gastrointestinal hormones (gastrin, cholecystokinin, secretin, motilin,
vasoactive intestinal polypeptide, gastric inhibitory polypeptide).</span></p>

<p><span><span>13.<span>&nbsp; </span></span></span><span>A neuropeptide
synthesized by enterochromaffin cells, it stimulates gastrointestinal motility
and transmits pain impulses in the nervous system.</span></p>

<p><span><span>14.<span>&nbsp; </span></span></span><span>It relaxes smooth muscle
and promotes water and electrolyte secretion by the jejunum, ileum, and colon.</span></p>

<p><span></span></p>

<p><b><span>Answers</span></b><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>11.
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Secretin
stimulates bicarbonate secretion by the pancreas.</span></p>

<p><span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>6.<span>&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Gastrin
stimulates gastric contraction, hydrochloric acid secretion, histamine release,
and pepsinogen release.</span></p>

<p><span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>4.
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Cholecystokinin
stimulates the pancreas to secrete digestive enzymes and the gall bladder to
contract and release bile.</span></p>

<p><span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>5.
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Gastric
inhibitory peptide (GIP) inhibits stomach motility and acid secretion and
stimulates insulin release by the pancreas in a <span>glucose-dependent manner.</span></span></p>

<p><span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>13.
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Substance-P
stimulates gastrointestinal motility and transmits pain impulses in the nervous
system.</span></p>

<p><span></span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8.
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Motilin
improves peristalsis in the small intestine.</span></p>

<p><span></span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>12.
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Somatostatin
inhibits the release of pancreatic hormones (insulin and glucagon) and
gastrointestinal hormones (gastrin, cholecystokinin, secretin, motilin,
vasoactive intestinal polypeptide, gastric inhibitory polypeptide).</span></p>

<p><span></span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>14.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Vasoactive
intestinal polypeptide relaxes smooth muscle and promotes water and electrolyte
secretion by the jejunum, ileum, and colon.</span></p>

<p><span></span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Goblet
cells secrete mucin, which dissolves in water to form mucus, which in turn
protects and lubricates the lining of the intestine.</span></p>

<p><span></span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Parietal
cells produce gastric acid and intrinsic factor, a glycoprotein that binds with
dietary vitamin-B12 in the stomach and facilitates vitamin-B12 absorption in
the terminal ileum.</span></p>

<p><span></span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Brunner’s
glands produce a mucus-rich alkaline secretion (containing bicarbonate), which
protects the duodenum from the acidic contents of chime, and which provides an
alkaline environment for intestinal enzymes.</span></p>

<p><span></span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Chief
cells produce pepsinogen, the precursor of pepsin.</span></p>

<p><span></span></p>

<p><span><span>M.<span>&nbsp;
</span></span></span><span>10.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Peyer’s
patches are organized lymphoid nodules in the ileum.</span></p>

<p><span></span></p>

<p><span><span>N.<span>&nbsp;&nbsp;
</span></span></span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Chyme
is a semifluid mass of partly digested food expelled by the stomach into the
duodenum.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Drug Z
constricts efferent arterioles but not afferent arterioles. Which combination
of effects is drug Z most likely to produce?</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>GFR</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>Filtration Fraction</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>Renal Blood Flow</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>A</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>B</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>C</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>D</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>E</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>F</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>G</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>H</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>The
afferent and efferent arterioles are the major resistance sites in the renal
microcirculation. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=415 height=312
src="_%20Tutorials_files/image322.png" alt="Description: rc2" v:shapes="Picture_x0020_347274"></span><span></span></p>

<p><span></span></p>

<p><span>H.P. = Hydrostatic
pressure</span></p>

<p><span>π<sub>b </sub>= Plasma
oncotic pressure</span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><i><span>Constriction of the afferent arteriole</span></i><span> increases resistance to
blood flow. The fall in pressure downstream decreases GFR and renal blood flow.
</span></p>

<p><span></span></p>

<p><i><span>Dilatation of the afferent arteriole</span></i><span> decreases resistance to
blood flow. The rise in pressure downstream increases GFR and renal blood flow.</span></p>

<p><span></span></p>

<p><i><span>Constriction of the efferent arteriole</span></i><span> increases resistance to
blood flow. The rise in pressure upstream increases GFR. The fall in pressure
downstream decreases renal blood flow. </span></p>

<p><span></span></p>

<p><i><span>Dilatation of the efferent arteriole</span></i><span> decreases resistance to
blood flow. The fall in pressure upstream decreases GFR. The rise in pressure
downstream increases renal blood flow. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Here’s a
summary.</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=155 valign=top>
  <p style="text-align:center;"><span>GFR</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>Renal blood flow</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=155 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>Afferent arteriolar constriction</span></p>
  </td>
  <td width=155 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>Afferent arteriolar dilatation</span></p>
  </td>
  <td width=155 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>Efferent arteriolar constriction</span></p>
  </td>
  <td width=155 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>Efferent arteriolar dilatation</span></p>
  </td>
  <td width=155 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>Filtration
fraction is the ratio of GFR to renal blood flow (GFR/RBF). Constriction of
efferent arterioles increases filtration fraction. Dilatation of efferent
arterioles decreases filtration fraction. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer G is correct</span></b><span>. Constriction of the
efferent arteriole increases resistance to blood flow. The rise in pressure
upstream increases GFR. The fall in pressure downstream decreases renal blood
flow. Filtration fraction, which is the ratio of GFR to renal blood flow, would
increase. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
5-week-old male infant is brought to the emergency room because of abdominal
distension. He has not had a bowel movement in 4 days. His mother says he has
been constipated since birth. Physical examination shows abdominal distension.
An X-ray shows distended loops of proximal bowel with an abrupt narrowing to a
small caliber of the distal 20-cm segment of colon. Which of the following
pathologic findings is most likely in a biopsy specimen of the distal rectum in
this patient? </span></span></p>

<p><span></span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman"'><span>A.<span>&nbsp;&nbsp;
</span></span></span></span><span style='font-family:"Times New Roman"'>Absent myenteric
ganglion cells</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman"'><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></span><span style='font-family:"Times New Roman"'>Abundant inspissated
mucus</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman"'><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></span><span style='font-family:"Times New Roman"'>Hypertrophy of the
muscle wall</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman"'><span>D.<span>&nbsp;&nbsp;
</span></span></span></span><span style='font-family:"Times New Roman"'>Nodular lymphoid
hyperplasia</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman"'><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></span><span style='font-family:"Times New Roman"'>Transmural coagulative
necrosis</span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span>Hirschsprung</span></span><span> disease, or congenital
aganglionic megacolon, is the most common cause of lower intestinal obstruction
in neonates. The disorder is caused by an absence of ganglion cells beginning
in the anal sphincter and extending proximally into the colon. <a
name=4-u1.0-B978-1-4160-2450-7..50331-5--p156></a>The ganglion cells are
missing because of an arrest of neuroblast migration from the proximal to
distal bowel. As a result, affected regions of bowel lack innervation.
Hirschsprung disease is usually sporadic. Males are affected more than females.
The aganglionic segment is limited to the rectosigmoid in 75% of patients; in
10%, the entire colon lacks ganglion cells. Symptoms begin at birth with the
delayed passage of meconium. Failure to pass stool leads to dilatation of the
proximal bowel. Surgery, the mainstay of therapy, should be undertaken before
complications occur. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=206 height=302
src="_%20Tutorials_files/image324.png" alt="Description: HIRSCHSPRUNG" v:shapes="Picture_x0020_347273"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span></span></b></span></p>

<p><span><span></span></b></span></p>

<p><span><span></span></b></span></p>

<p><span><span></span></b></span></p>

<p><span><span>Answer A is correct. </span></b></span><span>The
diagnosis of Hirschsprung disease should be suspected in an infant with
constipation and abdominal distension associated with distended loops of bowel
with abrupt, distal narrowing.<span >&nbsp; </span></span></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 30-year-old woman has anxiety about
episodes of abdominal pain that have alternated with diarrhea and constipation
over the past year. She often has these episodes when she is stressed or tired.
Physical examination and laboratory studies are within normal limits during
these episodes. Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Gastroenteritis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Generalized
anxiety disorder</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypochondriasis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Irritable
bowel syndrome</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Major
depressive disorder</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Somatization
disorder</span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Irritable bowel syndrome</b> (IBS) is one of the most commonly
diagnosed gastrointestinal (GI) conditions and also one of the most common
functional GI disorders seen in clinical practice. It is defined as chronic,
recurrent abdominal pain or discomfort that cannot be explained by structural
or biochemical abnormality, and is associated with at least two of the
following: improvement with defecation, onset associated with a change in
frequency of stool, and onset associated with a change in form (appearance) of
stool. Other symptoms that support the diagnosis include abnormal stool
frequency (≤3 bowel movements per week or &gt;3 bowel movements per day),
abnormal stool form (lumpy/hard or loose/watery), defecation straining,
urgency, or feeling of incomplete bowel movement, passing mucus, and bloating.
Three possible IBS subtypes include IBS with constipation, IBS with diarrhea,
and mixed IBS. </p>

<p></p>

<p>To date, no physiologic
mechanism unique to IBS has been identified. Rather, it is currently viewed as
a biopsychosocial disorder resulting from an interaction among a number of
factors: visceral hypersensitivity, enteric infection, low grade inflammation,
abnormal gut motility, and psychological factors. The treatment strategy is
based on the nature and severity of the symptoms, the character and degree of
functional impairment, and the presence of psychosocial difficulties affecting
the course of the illness. Patients with mild symptoms usually respond to
education, reassurance, and simple treatments not requiring prescription
medication. Some patients with moderate symptoms have more disability and
require pharmacologic therapy directed at altered gut physiology or
psychological treatments. A small group of patients with severe and refractory
symptoms seen more often at referral centers may benefit from antidepressant
therapy and psychological treatment.</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer D is correct. </b>Irritable bowel syndrome is one of the most
common GI disorders. The diagnosis should be suspected in patients with
recurrent abdominal pain and no structural or biochemical abnormalities.
Affected individuals may have diarrhea, constipation, or alternating bouts of
diarrhea and constipation. In an otherwise healthy 30-year-old woman with
recurrent bouts of abdominal pain and alternating diarrhea and constipation,
irritable bowel syndrome would be the most likely diagnosis.<span>&nbsp; </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
38-year-old woman presents to her physician with jaundice, generalized itching,
and pale stools. Her urine is dark. A blood test shows: </span></p>

<p><span></span></p>

<p><span>Aspartate
aminotransferase: <span>&nbsp; </span>52 U/L</span></p>

<p><span>Alanine
aminotransferase: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>54
U/L</span></p>

<p><span>Alkaline
phosphatase: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>279
U/L</span></p>

<p><span>Total
bilirubin: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.9
mg/dL</span></p>

<p><span>Conjugated
bilirubin: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.5
mg/dL</span></p>

<p><span></span></p>

<p><span>The most
likely cause of illness is:</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Intravascular
hemolysis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Extravascular
hemolysis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased
levels of UDP-glucuronyl transferase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Absence
of UDP-glucuronyl transferase</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Biliary
obstruction</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Jaundice</span>, also known as <span>icterus</span>,
is a yellowish pigmentation of the skin, conjunctivae, and other mucous
membranes caused by hyperbilirubinemia. Typically, the concentration of
bilirubin in the plasma must exceed 1.5 mg/dL, three times the usual value of
0.5 mg/dL, for the yellow color to be visible. </p>

<p></p>

<p>[Note: The conjunctivae are
among the first tissues to change color. The term “scleral icterus” is commonly
used, although the sclerae themselves are not icteric. The correct term is
“conjunctival icterus.”] </p>

<p></p>

<p>Jaundice is classified into
three categories: pre-hepatic, hepatic, and post-hepatic. </p>

<p><i><span></span></i></p>

<p><i><span>Pre-hepatic</span></i><span> jaundice is caused by
conditions associated with increased hemolysis, such as sickle cell disease,
spherocytosis, thalassemia, glucose-6-phosphate dehydrogenase deficiency,
hemolytic uremic syndrome, thrombotic thrombocytopenia purpura, and malaria.</span></p>

<p><span></span></p>

<p><span>Laboratory
findings include:</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serum:
increased unconjugated bilirubin</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urine
</span></p>

<p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Bilirubin absent
(because unconjugated bilirubin is not water-soluble)</span></p>

<p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Urobilinogen present
(because biliary drainage is not obstructed)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urine
color: normal (because bilirubin is absent)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Stool
color: normal (because biliary drainage is not obstructed)</span></p>

<p><i><span></span></i></p>

<p><i><span>Hepatic</span></i><span> jaundice is caused by
liver damage or by genetic defects. Conditions associated with liver damage
include alcoholic liver disease and viral hepatitis. Conditions caused by
genetic defects include Gilbert’s syndrome and Crigler-Najjar syndrome. </span></p>

<p><span></span></p>

<p><span>Laboratory
findings depend on the underlying disorder. Patients with alcoholic liver
disease or viral hepatitis have the following findings:</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serum:
increased unconjugated and conjugated bilirubin</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urine
</span></p>

<p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Bilirubin present
(because conjugated bilirubin is water-soluble)</span></p>

<p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Urobilinogen present
(because biliary drainage is not obstructed)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urine
color: dark (because bilirubin is present)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Stool:
normal (because biliary drainage is not obstructed)</span></p>

<p><span></span></p>

<p><i><span>Post-hepatic</span></i><span> jaundice, also called
obstructive jaundice, involves an interruption of bile flow. The most common
causes are choledocholithiasis (gallstones in the common bile duct) and cancer
of the head of the pancreas. The presence of acholic (pale or clay-colored)
stools and dark urine suggests an obstructive process, because feces get their
dark color from bile pigments. Patients with biliary obstruction may have
severe itching (pruritus) and high cholesterol levels. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Laboratory
findings include:</span></p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Serum: increased conjugated bilirubin</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Urine</p>

<p><span><span>o<span>&nbsp;&nbsp;
</span></span></span>Bilirubin present (because conjugated bilirubin
is water-soluble)</p>

<p><span><span>o<span>&nbsp;&nbsp;
</span></span></span>Urobilinogen absent (because biliary drainage is
obstructed)</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urine
color: dark (because bilirubin is present)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Stool
color: pale (because biliary drainage is obstructed)</span></p>

<p><span></span></p>

<p><span>No single
test can differentiate between the various types of jaundice. A combination of
tests is essential. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=145 valign=top>
  <p style="text-align:center;">Types of Jaundice</p>
  </td>
 </tr>
 <tr>
  <td width=145 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=145 valign=top>
  <p>Pre-hepatic (hemolytic)</p>
  <p>Hepatic</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Liver damage</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Genetic disorders</p>
  <p>Post-hepatic (obstructive)
  </p>
  </td>
 </tr>
</table>

</div>

<p><b></b></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>Pre-hepatic </span></p>
  <p style="text-align:center;"><span>Jaundice</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>Hepatic </span></p>
  <p style="text-align:center;"><span>Jaundice</span></p>
  </td>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>Post-hepatic </span></p>
  <p style="text-align:center;"><span>Jaundice</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>AST and ALT</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Alk Phos</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Unconjugated bilirubin</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Normal</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Conjugated </span></p>
  <p><span>bilirubin</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Total bilirubin</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Increased</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Urine color</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Normal </span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Dark </span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Dark </span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Urobilinogen</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Present</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Present</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Absent</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Urine bilirubin</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Not
  present</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Present</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Present</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Stool color</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=111 valign=top>
  <p><span>Pale</span></p>
  </td>
 </tr>
</table>

<p></p>

<p>Pearls: </p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Hemolytic anemia does <i>not</i> cause bilirubin to appear in the urine </p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Biliary obstruction is associated with acholic
(pale) stools</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Biliary obstruction can cause intense itching</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>Biliary obstruction is associated with decreased
or absent urobilinogen in the urine<span >&nbsp;
</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. Obstructive jaundice
is associated hyperbilirubinemia, predominantly in the form of conjugated
bilirubin. Itching is common, stools are typically pale (acholic), and the
urine is dark.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Intravascular
hemolysis is associated with unconjugated hyperbilirubinemia. Liver enzymes are
normal. Hemoglobinuria is present. Intravascular hemolysis is usually caused by
mechanical or toxic injury to red blood cells.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Extravascular
hemolysis is associated with unconjugated hyperbilirubinemia. Liver enzymes are
normal. Hemoglobinuria is <i>not </i>present.
Spherocytes are common. Extravascular hemolysis occurs because of defects in
the red blood cell membrane, which may be inherited or acquired.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Gilbert’s syndrome is
a very common, benign condition associated with decreased levels of
UDP-glucuronyl transferase. Unconjugated bilirubin levels are elevated. Liver
enzymes are normal. Jaundice occurs with stress or exercise.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Crigler-Najjar
syndrome type 1 is caused by absence of UDP-glucuronyl transferase. This
results in childhood kernicterus. Unconjugated bilirubin levels are extremely
high. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of the following is <i>not</i> true regarding the menstrual cycle?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Follicle-stimulating hormone (FSH) promotes</span><span> follicular growth by
binding to receptors in the granulosa cells of the follicle.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Ovulation
is triggered by a surge in luteinizing hormone (LH). </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>During
the follicular phase, estrogen inhibits the release of luteinizing hormone (LH)
through negative feedback.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Estrogen
stimulates endothelial growth and thickening of the vaginal wall. </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Progesterone converts
the endometrium to its secretory stage, preparing the uterus for implantation.<span></span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://en.wikipedia.org/wiki/File:MenstrualCycle2_en.svg"><span><img border=0 width=344 height=331
src="_%20Tutorials_files/image326.png"
alt="Description: http://upload.wikimedia.org/wikipedia/commons/thumb/2/2a/MenstrualCycle2_en.svg/350px-MenstrualCycle2_en.svg.png"
v:shapes="Picture_x0020_347272"></span></a><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>MENSTRUAL CYCLE</span></p>

<p style="text-align:center;"><span></span></p>

<p><span>Between menarche and
menopause, the reproductive organs undergo a series of changes at monthly
intervals. This “menstrual cycle” results from interactions of the
hypothalamic-pituitary-ovarian axis with target tissues (endometrium, cervix,
and vagina). The median length of a menstrual cycle is 28 days. Cycle lengths
are especially variable soon after menarche and before menopause. Menstrual
irregularities may result from abrupt changes in diet or exercise; serious
emotional disturbance; and parturition or abortion. The menstrual cycle is
divided into three phases: follicular, ovulatory, and luteal.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><span><img width=54 height=26
src="_%20Tutorials_files/image327.png" v:shapes="Straight_x0020_Connector_x0020_347286"></span><span><img width=26 height=54
src="_%20Tutorials_files/image328.png" v:shapes="Straight_x0020_Connector_x0020_347285"></span><span>

<table cellpadding=0 cellspacing=0>
 <tr>
  <td width=77 height=40 align=left valign=top bgcolor=white><span>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td>
    <div v:shape="Text_x0020_Box_x0020_347284"    <p style="text-align:center;">granulosa cells</p>
    </div>
    </td>
   </tr>
  </table>
  </span>&nbsp;</td>
 </tr>
</table>

</span><span><img border=0 width=235 height=220
src="_%20Tutorials_files/image330.png" alt="Description: ovary-04" v:shapes="Picture_x0020_347271"></span><span></span></p>

<p style="text-align:center;"><span>Ovarian Follicle</span></p>

<p><b><span></span></b></p>

<p><b><span>Follicular
(Preovulatory) Phase</span></b><span>
</span></p>

<p><span></span></p>

<p><span>The follicular phase
begins on the first day of menstrual bleeding, when estradiol, progesterone,
and LH are at their lowest levels.<span >&nbsp;
</span>In the early follicular phase, FSH promotes growth and development of
the follicles by binding to receptors in the granulosa cells, causing cell
division and differentiation. The granulosa cells secrete estrogen, which
stimulates endothelial growth. In the late follicular phase, FSH levels
decline, ensuring that only the most advanced follicle will proceed to
ovulation. </span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4160-2805-5..50261-5--f1></a><b><span>Ovulatory Phase</span></b><span> </span></p>

<p><span></span></p>

<p><span>Positive estrogen
feedback on the pituitary leads to an LH surge, which results in follicular
maturation and ovulation. During ovulation, an ovum is released from the mature
follicle. Some women experience brief, dull, unilateral pelvic pain near the
time of ovulation, termed <i>Mittelschmerz</i>, which may be due to leakage of
follicular fluid into the abdominal cavity. At peak LH levels, estrogen levels
begin to fall and progesterone levels begin to rise.</span></p>

<p><a name=4-u1.0-B978-1-4160-2805-5..50261-5--cese></a><b><span></span></b></p>

<p><b><span>Luteal
(Postovulatory) Phase</span></b><span>
</span></p>

<p><span></span></p>

<p><span>After ovulation, the
follicle transforms into the corpus luteum, which produces progesterone and
estradiol. Progesterone converts the endometrium to its secretory stage,
preparing the uterus for implantation. Progesterone levels peak a week after
the LH surge, and fall if pregnancy has not occurred. Similar (but smaller)
changes in estrogen occur.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>EFFECTS
ON TARGET ORGANS </span></p>

<p><b><span></span></b></p>

<p><b><span>Endometrium</span></b><span> </span></p>

<p><span></span></p>

<p><span>Menstrual bleeding
occurs when the corpus luteum stops secreting progesterone. After menses, the
basal layer of the endometrium regenerates the superficial layer of epithelial
cells lining the uterine cavity and an intermediate layer of spongiosa, both of
which are shed at each menstruation. Endometrial glands in these layers
proliferate under the influence of estrogen in the follicular phase so that the
mucosa thickens. In the luteal phase, under the influence of progesterone, the
glands become coiled and secretory. As both estradiol and progesterone decline
in the late luteal phase, endometrial necrosis occurs and bleeding ensues.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Cervix and Cervical
Mucus</span></b><span> </span></p>

<p><span></span></p>

<p><span>During the follicular
phase, cervical vascularity, congestion, and edema increase under the influence
of estrogen. The external cervical os opens to a diameter of 3 mm at ovulation
and then decreases to 1 mm. Cervical mucus increases in quantity (10- to
30-fold) and in elasticity. Under the influence of progesterone during the
luteal phase, cervical mucus thickens and loses its elasticity. </span></p>

<p><b><span></span></b></p>

<p><b><span>Vagina</span></b><span> </span></p>

<p><span></span></p>

<p><span>When estrogen levels are
low, the vaginal epithelium is pale and thin. During the follicular phase,
under the influence of estrogen, the epithelium thickens, and the number of
mature cornified cells increases. During the luteal phase, there is an increase
in cellular debris and clumping of shed desquamated cells.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Ovary</span></b><span> </span></p>

<p><span></span></p>

<p><span>During the reproductive
years, the ovaries regularly produce a single dominant follicle, which grows
and matures during the follicular phase. This process is governed by the
combined action of FSH and LH on the follicular wall. During ovulation, the LH
surge causes the release of a mature fertilizable oocyte. After ovulation, the
follicle wall transforms into the corpus luteum, which produces progesterone
and estradiol during the luteal phase. If implantation does not occur, the
corpus luteum undergoes luteolysis and hormone production ceases and it becomes
a corpus albicans. </span></p>

<p><b></b></p>

<p><b></b></p>

<p style="text-align:center;"><span><img border=0 width=282 height=193
src="_%20Tutorials_files/image332.png"
alt="Description: http://www.anselm.edu/homepage/jpitocch/genbio/follicledevelop.jpg"
v:shapes="Picture_x0020_347270"></span><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct.<span >&nbsp; </span></span></b></p>

<p><b><span></span></b></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>During
the follicular phase, estrogen <i>stimulates</i> the release of luteinizing
hormone (LH) through <i>positive</i> feedback.</span></p>

<p><span></span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Follicle-stimulating hormone (FSH) promotes</span><span> follicular growth by
binding to receptors in the granulosa cells of the follicle.</span></p>

<p><span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>O<span>vulation is triggered by a surge of luteinizing hormone (LH). </span></span></p>

<p><span></span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Estrogen
stimulates endothelial growth and thickening of the vaginal wall. [Note: </span><span>Endometrial hyperplasia</span><span> is a condition of excessive proliferation of the cells of
the endometrium. It usually results from high levels of estrogen, combined with
insufficient levels of progesterone. This may occur in a number of settings,
including obesity, estrogen producing tumors (e.g. granulosa cell tumors), and
certain formulations of estrogen replacement therapy. Endometrial hyperplasia
is a significant risk factor for the development of endometrial cancer, so
careful monitoring and treatment of women with this disorder is essential.]<span></span></span></p>

<p><span></span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Progesterone converts
the endometrium to its secretory stage, preparing the uterus for implantation.<span></span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 65-year-old man develops oliguria
and peripheral edema over a period of weeks. Urinalysis reveals hematuria and
proteinuria; examination of the urinary sediment reveals red cell casts.
Radiologic and ultrasound studies fail to demonstrate an obstructive lesion.
Renal biopsy shows many glomerular crescents. This presentation is most
suggestive of which of the following conditions?</span></span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Anti-glomerular
basement membrane disease</span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Diabetic
nephropathy</span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Hypertensive
nephropathy</span></span></p>

<p><span lang=EN-GB><span>D.<span>&nbsp;&nbsp;
</span></span></span><span lang=EN-GB>Minimal change disease</span></span><span
lang=EN-GB></span></p>

<p><strong><span lang=EN-GB>&nbsp; </span></strong><span lang=EN-GB></span></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><span>Rapidly
progressive glomerulonephritis (RPGN) is a disease of the kidney characterized
clinically by a rapid decrease in the glomerular filtration rate (GFR) of at
least 50% over a short period, from a few days to 3 months. The main pathologic
finding is extensive glomerular crescent formation. The ubiquitous pathological
feature of crescentic glomerulonephritis is a focal rupture of glomerular
capillary walls that can be seen by light microscopy and electron microscopy. </span></p>

<p><span></span></p>

<p><span>The term
rapidly progressive glomerulonephritis was first used to describe a group of
patients who had an unusually fulminant poststreptococcal glomerulonephritis
and a poor clinical outcome. Several years later, the antiglomerular basement
membrane (anti-GBM) antibody was discovered to produce a crescentic
glomerulonephritis in sheep, and, following this discovery, the role of
anti-GBM antibody in Goodpasture syndrome was elucidated. Soon afterward, the
role of the anti-GBM antibody in rapidly progressive glomerulonephritis
associated with Goodpasture disease was established. </span></p>

<p><span></span></p>

<p><span>In the
mid-1970s, a group of patients was described who fit the clinical criteria for
rapidly progressive glomerulonephritis but in whom no cause could be
established. Many of these cases were associated with systemic signs of
vascular inflammation (systemic vasculitis), but some cases were characterized
only by renal disease. A distinct feature of these cases was the virtual
absence of antibody deposition after immunofluorescence staining of the biopsy
specimens, which led to the label pauci-immune rapidly progressive
glomerulonephritis. More than 80% of patients with pauci-immune rapidly
progressive glomerulonephritis were subsequently found to have circulating
antineutrophil cytoplasmic antibodies (ANCAs). </span></p>

<p><span></span></p>

<p><span>Rapidly
progressive glomerulonephritis is classified into 3 categories: (1) anti-GBM
antibody disease (approximately 3% of cases), (2) immune complex disease (45%
of cases), and (3) pauci-immune disease (50% of cases). Immunologic
classification is based on the presence or absence of ANCAs.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Anti-GBM
antibody</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Goodpasture
syndrome (lung and kidney involvement)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-GBM
disease (only kidney involvement)</span></p>

<p><b><span>Immune
complex</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Postinfectious
(staphylococci/streptococci)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lupus
nephritis</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Henoch-Schönlein
purpura (immunoglobulin A and systemic vasculitis)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Immunoglobulin
A nephropathy (no vasculitis)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mixed
cryoglobulinemia</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Membranoproliferative
glomerulonephritis</span></p>

<p><b><span>Pauci-immune</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wegener
granulomatosis (WG)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Microscopic
polyangiitis (MPA)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Churg-Strauss
syndrome</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Note:
80-90% of patients are ANCA positive.</span></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB>Answer A is correct.</span></strong><span
 lang=EN-GB> This
patient has rapidly progressive glomerulonephritis (RPGN), as evidenced by the
presence of red blood cell casts and crescentic glomeruli. RPGN is usually due
to some form of vasculitis or to anti-glomerular basement membrane disease
(including Goodpasture syndrome and isolated anti-glomerular basement disease).
As vasculitis in not one of the options listed, the correct answer is
anti-glomerular basement membrane disease.<span >&nbsp;
</span></span></span></p>

<p><span></span></span></p>

<p><strong><span lang=EN-GB>Answer B is incorrect.</span></strong><span
 lang=EN-GB>&nbsp;Diabetic
nephropathy</span></span><strong><span lang=EN-GB> </span></strong><span lang=EN-GB>typically begins with microalbuminuria and
hypertension and progresses over a 10- to 20-year period to renal failure.</span></span><span
lang=EN-GB></span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><strong><span lang=EN-GB>Answer C is incorrect.</span></strong><span
 lang=EN-GB>
Hypertensive nephropathy</span></span><strong><span lang=EN-GB> </span></strong><span>typically presents with slowly
rising BUN and creatinine (unless the patient has malignant hypertension).</span></span></p>

<p><span lang=EN-GB></span></p>

<p><strong><span lang=EN-GB>Answer D is incorrect.</span></strong><span
 lang=EN-GB> Minimal
change disease typically presents with nephrotic syndrome and is not associated
with recognizable glomerular changes by light microscopy. Podocyte foot-process
fusion can be seen by electron microscopy.</span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><span>Combination
oral contaceptives contain an estrogen and a progestin. What is their principal
mechanism of action? </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=144 valign=top>
  <p style="text-align:center;"><span>Estrogen</span></p>
  </td>
  <td width=135 valign=top>
  <p style="text-align:center;"><span>Progestin</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=144 valign=top>
  <p><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>A</span></p>
  </td>
  <td width=144 valign=top>
  <p><span>Stimulates
  FSH secretion</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Stimulates
  LH secretion</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>B</span></p>
  </td>
  <td width=144 valign=top>
  <p><span>Inhibits
  FSH secretion</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Inhibits
  LH secretion </span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>C</span></p>
  </td>
  <td width=144 valign=top>
  <p><span>Stimulates
  LH secretion</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Stimulates
  FSH secretion </span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>D</span></p>
  </td>
  <td width=144 valign=top>
  <p><span>Inhibits
  LH secretion</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Inhibits
  FSH secretion</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>E</span></p>
  </td>
  <td width=144 valign=top>
  <p><span>Stimulates
  FSH secretion</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Inhibits
  LH secretion</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Combination
oral contraceptives contain both estrogen and progestin. The estrogen component
suppresses FSH secretion by the pituitary. (Ethinyl estradiol is the estrogen
in all combined contraceptives in the United States). Estrogen also potentiates
the action of progestin by increasing the intracellular pool of progesterone
receptors. The progestin component (e.g., norethindrone) inhibits LH secretion
by the pituitary, and by preventing an LH surge, inhibits the release of
oocytes from the ovary. In combined oral contraceptives, progestin is the
dominant component. It promotes endometrial atrophy and thickening of the
cervical mucus.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Oral
contraceptives decrease acne and hirsutism.<span>&nbsp; </span>Women normally have low serum levels of
testosterone, most of which is inactive due to binding with sex hormone-binding
globulin (SHBG).<span >&nbsp; </span>Only 1-2% of
testosterone is “free” and, therefore, able to cause acne and hirsutism
(conversion of villous hair to terminal hair in male-patterned areas, such as
lip, chin, and neck).<span >&nbsp; </span>Estrogen
increases SHBG production by the liver, allowing for greater binding of
testosterone, which lowers “free” testosterone levels and reduces acne and
hirsutism. By inhibiting LH secretion, progestins reduce the stimulus for
ovarian testosterone production. In addition, progestins inhibit
5&#945;-reductase, which converts testosterone to dihydrotestosterone, the
primary androgenic stimulus of hair follicles and pilosebaceous glands.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. Estrogen inhibits FSH
secretion, and progestin inhibits LH secretion. </span></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><span>A 28-year-old man dies in a motor vehicle
collision. At autopsy, the kidneys are enlarged bilaterally, and each weighs 3
kg. The external surface of the kidneys appears to be a mass of cysts.
Microscopic examination of the kidneys shows intact nephrons interspersed
between the cysts. The most likely cause of these changes in the kidneys
involves which of the following modes of inheritance?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Autosomal
dominant</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Autosomal
recessive</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mitochondrial</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>X-linked</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Polycystic kidney disease
(PKD) is a systemic hereditary disorder characterized by the formation of cysts
in the cortex and medulla of both kidneys. There are two types of PKD:
autosomal dominant polycystic kidney disease (ADPKD) and the much less-common autosomal
recessive polycystic kidney disease (ARPKD). </p>

<p><b></b></p>

<p><b>Autosomal dominant polycystic kidney disease.</b> </p>

<p></p>

<p>ADPKD is the most common
Mendelian disorder of the kidneys. It occurs in one in 1000 people. Disease
penetrance is 100%. Approximately 10% of individuals with end-stage renal
disease (ESRD) carry a diagnosis of ADPKD. 85% of cases are caused by a
mutation in the <span>PKD1</span> gene, and
15% of cases are caused by mutation in the <span>PKD2</span> gene. Polycystin 1 and polycystin 2 are the protein
products of PKD1 and PKD2. </p>

<p></p>

<p>ADPKD usually presents
between the ages of 30 and 40 and results in kidney failure by the fifth or
sixth decade. The condition is characterized by focal development of renal and
extrarenal cysts in an age-dependent manner, resulting in a slow, gradual, and massive
kidney enlargement. Typically kidney function does not decline until kidney
size is at least five times greater than normal. As the cysts accumulate fluid,
they enlarge, separate entirely from the nephron, compress the neighboring
renal parenchyma, and progressively compromise renal function. </p>

<p></p>

<p>Findings in ADPKD may
include hypertension, flank pain, palpable flank mass, hematuria, and urinary
frequency. Flank pain may be due to renal hemorrhage, passage of kidney stones,
or urinary tract infection. Extrarenal manifestations include liver cysts,
pancreatic cysts, splenic cysts, central nervous system arachnoid cysts, and
cerebral aneurysms. Individuals with ADPKD have an increased incidence of
diverticular disease and mitral valve prolapse.<a
name=4-u1.0-B978-0-323-05611-3..00025-2--u974></a><a
name=4-u1.0-B978-0-323-05611-3..00025-2--s456></a><a
name=4-u1.0-B978-0-323-05611-3..00025-2--st48></a><a
name=4-u1.0-B978-0-323-05611-3..00025-2--l314></a><a
name=4-u1.0-B978-0-323-05611-3..00025-2--l315></a></p>

<p><b></b></p>

<p><b>Autosomal recessive polycystic kidney disease</b>. </p>

<p></p>

<p>The clinical presentation of
ARPKD is highly variable. Signs and symptoms often appear shortly after birth.
Up to 50% of affected neonates die of pulmonary hypoplasia, the result of
oligohydramnios from severe intrauterine kidney disease. In those who survive,
the typical presentation is systemic hypertension with progression to end-stage
renal disease (ESRD) by the age 15. Unlike patients with ADPKD, individuals
with ARPKD generally do not have extrarenal cysts.</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer A is correct.<span >&nbsp; </span></b>The
most likely diagnosis is autosomal dominant polycystic kidney disease. </p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><span>An
18-year-old primigravid woman at 30 weeks’ gestation has a headache and mild
generalized edema. Her blood pressure, which was normal in early pregnancy, is
now 150/95 mm Hg. Urinalysis shows proteinuria. A 24-hour urine collection
shows 600 mg of protein. Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Nephrotic
syndrome</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acute
glomerulonephritis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Preeclampsia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Eclampsia<span>&nbsp;&nbsp; </span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Essential
hypertension</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Preeclampsia
is one of the most common causes of perinatal morbidity and mortality. The
cause of preeclampsia remains unknown. However, placental dysfunction can
initiate systemic vasospasm, ischemia, and thrombosis, which damage maternal
organs and cause placental infarction, fetal growth restriction, and death.</span></p>

<p><span></span></p>

<p>Preeclampsia complicates
approximately 5% to10% of all pregnancies. It occurs at both extremes of
reproductive age but is greatest in women younger than 20 years. Risk factors
appear below.</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=248 valign=top>
  <p style="text-align:center;">Risk Factors for Preeclampsia</p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p style="text-align:center;"></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Extremes of maternal age</p>
  <p>First pregnancy</p>
  <p>African-American race</p>
  <p>Multiple gestation</p>
  <p>Molar pregnancy</p>
  <p>Prior history of
  preeclampsia or eclampsia</p>
  <p>Family history of
  preeclampsia or eclampsia</p>
  <p>Pre-existing medical
  conditions (diabetes, hypertension, renal disease, connective tissue disease,
  vascular disease</p>
  <p></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>The disorder is typically
diagnosed when new-onset hypertension and proteinuria (greater than 300 mg in a
24-hour urine sample) is seen after the 20th week of gestation. Mild
preeclampsia consists of a systolic blood pressure rise of 30 mm Hg, a
diastolic blood pressure rise of 15 mm Hg, or an absolute reading of 140/90 mm
Hg in a pregnant woman with minimal proteinuria and nondependent edema. Severe
preeclampsia consists of a systolic blood pressure greater than 160 mm Hg or a
diastolic blood pressure greater than 110 mm Hg complicated by significant
proteinuria (greater than 5.0 g/day) and evidence of end-organ damage. Signs
and symptoms of severe preeclampsia include headache, visual disturbances,
confusion, right upper quadrant or epigastric pain, impaired liver function,
proteinuria, oliguria (less than 500 mL/24 hr), pulmonary <a
name=4-u1.0-B978-1-4160-2467-5..50031-2--p514></a>edema, microangiopathic
hemolytic anemia, thrombocytopenia, oligohydramnios, and intrauterine growth
retardation.</p>

<p></p>

<p>Treatment for mild
preeclampsia involves bed rest and surveillance. Delivery is delayed until
fetal maturity or the development of severe preeclampsia.<a
name=4-u1.0-B978-1-4160-2467-5..50031-2--para></a></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer C is correct</b>. Preeclampsia is diagnosed when new-onset
hypertension and proteinuria occur after the 20th week of gestation.
Proteinuria can lead to generalized edema. Young women in their first pregnancy
have a higher than normal risk of developing preeclampsia. </p>

<p><b></b></p>

<p><b>Answer A is incorrect</b>. Nephrotic syndrome is characterized by heavy
proteinuria (&gt;3.5 grams/day), low serum albumin levels, hyperlipidemia, and
anasarca (generalized edema). Patients may be normotensive or hypertensive.</p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect</span></b><span>. Acute
glomerulonephritis is characterized by sudden onset of hematuria, proteinuria,
and red blood cell casts, often accompanied by hypertension, edema, and
impaired renal function. It may be caused by primary renal or systemic
disease.&nbsp;</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=228 height=228
src="_%20Tutorials_files/image334.png" alt="Description: red blood cell cast"
v:shapes="Picture_x0020_347269"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Red blood cell cast</span></p>

<p><b>Answer D is incorrect</b>. <span>Eclampsia</span>
is an acute and life-threatening complication of pregnancy, characterized by
tonic-clonic seizures, usually in a patient with pre-eclampsia.</p>

<p><b></b></p>

<p><b>Answer E is incorrect</b>. Essential hypertension, also called primary
or idiopathic hypertension, is the most common type of hypertension. In this
patient, the appearance of high blood pressure and proteinuria in a pregnant
woman after the 20<sup>th</sup> week gestation suggests preeclampsia. </p>

<p></p>

<p><strong></strong></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
8-year-old boy has a viral upper respiratory tract infection. One week later,
he develops swelling of the face, hands, and feet. He is afebrile and
normotensive. Laboratory studies show:</span></p>

<p><span></span></p>

<p><span>Serum</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Albumin
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.8
g/dL</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Urea
nitrogen <span> </span>9.0 mg /dL</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Creatinine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0.8
mg/dL</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Cholesterol<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>270 mg mg/dL</span></p>

<p><span></span></p>

<p><span>Urine
protein<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4+
(by dipstick)</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4.5
grams/24 hours</span></p>

<p><span></span></p>

<p><span>Which of
the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Post-streptococcal
glomerulonephritis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Goodpasture
syndrome</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wegener
granulomatosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Polyarteritis
nodosa</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Minimal
change disease</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
patient in the vignette has diffuse edema (anasarca). The main causes of
anasarca are nephrotic syndrome, cirrhosis, and severe malnutrition/protein
deficiency.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=122 valign=top>
  <p><span><span>&nbsp;</span>Causes of Anasarca</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Nephrotic
  syndrome</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Cirrhosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Malnutrition</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>In this case,
the findings of heavy proteinuria, hypoalbuminemia, and hyperlipidemia are
consistent with nephrotic syndrome. Nephrotic syndrome is one of the major
renal syndromes.</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=479 colspan=3 valign=top>
  <p style="text-align:center;"><span>Major
  Renal Syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=153 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=203 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p style="text-align:center;"><span>Syndrome</span></p>
  </td>
  <td width=153 valign=top>
  <p style="text-align:center;"><span>Characteristics</span></p>
  </td>
  <td width=203 valign=top>
  <p style="text-align:center;"><span>Examples</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><span></span></p>
  </td>
  <td width=203 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Acute renal failure</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Abrupt decline in renal
  function resulting in retention of nitrogenous wastes (e.g., blood urea
  nitrogen and creatinine)</span></p>
  </td>
  <td width=203 valign=top>
  <p><span>Prerenal, intrarenal, and
  postrenal</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Acute nephritic syndrome</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Abrupt renal
  insufficiency with hematuria of glomerular origin (red blood cell casts
  and/or dysmorphic red blood cells in the urine)</span></p>
  </td>
  <td width=203 valign=top>
  <p><span>Poststreptococcal
  glomerulonephritis</span></p>
  <p><span>Systemic lupus
  erythematosus</span></p>
  <p><span>Cryoglobulinemia</span></p>
  <p><span>Goodpasture’s syndrome</span></p>
  <p><span>Wegener’s granulomatosis</span></p>
  <p><span>Henoch-Schonlein purpura</span></p>
  <p><span>Polyarteritis nodosa</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Nephrotic syndrome</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Massive proteinuria
  (&gt;3.5 grams/day) with edema, hypoalbuminemia, hyperlipidemia, and
  hyperlipiduria</span></p>
  </td>
  <td width=203 valign=top>
  <p><span>Minimal change disease</span></p>
  <p><span>Diabetic nephropathy</span></p>
  <p><span>Membranous
  glomerulonephropathy</span></p>
  <p><span>Focal glomerulosclerosis</span></p>
  <p><span>Amyloidosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Tubulointerstitial
  nephropathy</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Renal insufficiency with
  mild proteinuria and functional tubular defects</span></p>
  </td>
  <td width=203 valign=top>
  <p><span>Analgesic nephropathy</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Tubular defects</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Tubular transport
  defect(s) without renal insufficiency</span></p>
  </td>
  <td width=203 valign=top>
  <p><span>Renal tubular acidosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Asymptomatic urinary
  abnormalities</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Mild proteinuria or
  hematuria without renal insufficiency</span></p>
  </td>
  <td width=203 valign=top>
  <p><span>IgA nephropathy</span></p>
  <p><span>Alport’s syndrome</span></p>
  </td>
 </tr>
 <tr>
  <td width=122 valign=top>
  <p><span>Rapidly progressive renal
  failure</span></p>
  <p><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Rapid deterioration in
  renal function</span></p>
  </td>
  <td width=203 valign=top>
  <p><span>Rapidly progressive
  glomerulonephritis Malignant hypertension</span></p>
  <p><span>Obstructive uropathy</span></p>
  <p><span>TTP/HUS</span></p>
  <p><span>Multiple myeloma</span></p>
  <p><span>Scleroderma crisis</span></p>
  <p><span>Bilateral renal artery
  stenosis</span></p>
  <p><span>Atheromatous embolic
  disease</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=341 height=226
src="_%20Tutorials_files/image336.png" alt="Description: RBCCAST4" v:shapes="Picture_x0020_347268"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Red blood cell cast </span></p>

<p style="text-align:center;"><span>(a marker of nephritic syndrome)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. Minimal change disease
results in nephrotic syndrome, which is characterized by heavy proteinuria,
hypoalbuminemia, and hyperlipidemia. 90% of all children with nephrotic
syndrome have minimal change disease. The urinary sediment is bland. Renal
function and complement levels are normal. The kidney appears normal under
light microscopy. Electron microscopy shows effacement of the foot processes, a
marker of proteinuria. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>. Post-streptococcal
glomerulonephritis is associated with acute nephritic syndrome, which is
characterized by renal insufficiency (elevated BUN and creatinine) and
hematuria with red blood cell casts and/or dysmorphic red blood cells in the
urine. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. <span>Goodpasture syndrome,</span> also known as <span>anti-glomerular basement antibody
disease,<span >&nbsp; </span></span>is a rare disease
characterized by glomerulonephritis and hemorrhaging of the lungs. The
condition is associated with acute nephritic syndrome: renal insufficiency
(elevated BUN and creatinine) and hematuria with red blood cell casts and/or
dysmorphic red blood cells in the urine. Tests for anti-glomerular basement
membrane (anti-GBM) antibodies are useful for making the diagnosis. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. <span>Wegener granulomatosis</span> is a form of
vasculitis that affects the nose, lungs, kidneys and other organs. Due to its
end-organ damage, it is life-threatening and requires long-term
immunosuppression. The disease is associated with c-ANCAs (cytoplasmic
antineutrophil cytoplasmic antibodies). In the kidney, it causes acute
nephritic syndrome, which is characterized by renal insufficiency (elevated BUN
and creatinine) and hematuria with red blood cell casts and/or dysmorphic red
blood cells in the urine.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Polyarteritis nodosa
is associated with acute nephritic syndrome, which is characterized by renal
insufficiency (elevated BUN and creatinine) and hematuria with red blood cell
casts and/or dysmorphic red blood cells in the urine.</span></p>

<p><span></span></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><span>A
66-year-old man is admitted to the hospital with shortness of breath and leg
swelling. Physical examination shows jugular vein distension, an S3 at the
cardiac apex, bibasilar crackles in the lungs, and 2+ pitting edema of the
ankles and pretibial areas. He is given a dose of furosemide intravenously. Which
of the following physiologic changes is most likely to occur after the
administration of this medicine?</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>Na-K-2Cl transport in the thick ascending Loop
  of Henle</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>Osmolarity of the medullary interstitium</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>Water absorption in the descending Loop of
  Henle</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=140 valign=top>
  <p><span></span></p>
  </td>
  <td width=126 valign=top>
  <p><span></span></p>
  </td>
  <td width=154 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>A</span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>B</span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>C</span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>D</span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>E</span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>F</span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>G</span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>&#8595;<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>H</span></p>
  </td>
  <td width=140 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=126 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>&#8593;<b></b></span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=243 height=226
src="_%20Tutorials_files/image338.png" alt="Description: nephron" v:shapes="Picture_x0020_347267"></span><span></span></p>

<p>The <span>loop of Henle</span> is the portion of the nephron that extends from the
proximal convoluted tubule to the distal convoluted tubule. The loop has a
hairpin bend in the renal medulla. Its main function is to create a
concentration gradient in the medulla. By means of a countercurrent multiplier
system using sodium pumps, an area of high sodium concentration is created in
the medulla. This increases the tonicity of the medulla. The hypertonic medulla
then passively draws water from the filtrate, concentrating the urine. </p>

<p></p>

<p>The loop of Henle consists
of a descending and an ascending limb. The descending limb is permeable to
water. As the filtrate travels down the descending limb in the hypertonic
medulla, water flows out freely until the tonicity of the filtrate and
interstitium equilibrate. The thick ascending limb, by contrast, is impermeable
to water. It actively absorbs sodium from the filtrate and delivers it to the
medullary interstitium, raising its tonicity. The hypertonic interstitium then
passively draws water from the descending limb and collecting ducts.<span>&nbsp; </span></p>

<p></p>

<p>Cells in the thick ascending
loop of Henle use the <span>Na-K-2Cl<b> </b>transporter</span>
to reabsorb sodium. This transporter resides in the apical membrane of cells
lining the thick ascending limb. (The apical membrane is on the luminal side).
For each molecule of sodium absorbed, a molecule of potassium and two molecules
of chloride are also absorbed. Hence, the designation: Na-K-2Cl. (Na, K, and Cl
are transported in the same direction, i.e., from the filtrate into the cell.)<span>&nbsp; </span></p>

<p></p>

<p>Furosemide (Lasix) and other
loop diuretics inhibit the Na-K-2Cl transporter in the thick ascending limb of
the loop of Henle. This impairs sodium absorption, which is needed to raise the
tonicity of the medullary interstitium. By inhibiting sodium absorption,
furosemide decreases the tonicity (osmolarity) of the medullary interstitium.
Tonicity drives water absorption in the descending limb of the loop. By
decreased the tonicity of the medullary interstitium, furosemide decreases
water absorption in the descending limb.</p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer A is correct</b>. Furosemide inhibits the Na-K-2Cl transporter
in the thick ascending limb of the loop of Henle. This reduces sodium
absorption. Normally, sodium is absorbed and delivered to the medullary
interstitium, raising its osmolarity. By inhibiting sodium absorption,
furosemide reduces the osmolarity of the medullary interstitium. That
osmolarity drives passive water absorption from the descending limb of the
loop. When the osmolarity of the interstitium is reduced after administration
of furosemide, sodium absorption in the descending limb is reduced as well. </p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><span>A
38-year-old man notices dark urine after running a 15-km race. </span></p>

<p><span></span></p>

<p><span>Urinalysis
shows:</span></p>

<p><span></span></p>

<p><span>Specific
gravity: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.010</span></p>

<p><span>Dipstick</span></p>

<p><span>Glucose:<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span>Blood:<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>positive</span></p>

<p><span>Nitrates:<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span></span></p>

<p><span>Microscopic
examination</span></p>

<p><span>WBC
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span>RBC
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span></span></p>

<p><span>Which of
the following is the most likely cause of these findings?</span></p>

<p><span></span></p>

<p><span>A. Acute
glomerulonephritis</span></p>

<p><span>B.
Hypovolemia</span></p>

<p><span>C. Renal
infarct</span></p>

<p><span>D.
Urolithiasis</span></p>

<p><span>E.<span>&nbsp; </span>Rhabdomyolysis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>In this
vignette, the dipstick is positive for blood, but microscopic examination of
the urine shows no red blood cells. </span></p>

<p><span></span></p>

<p><span>Three
conditions cause the urine dipstick to register positive for blood: hematuria,
hemoglobinuria, and myoglobinuria. All three conditions can result in red or
brown urine. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=185 valign=top>
  <p style="text-align:center;"><span>Urine Dipstick: Blood (+)</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p style="text-align:center;"><span>Hematuria</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p style="text-align:center;"><span>Hemoglobinuria</span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p style="text-align:center;"><span>Myoglobinuria</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The first
step in evaluating a patient with blood on urine dipstick is to distinguish
hematuria from hemoglobinuria and myoglobinuria. In hematuria, red blood cells
are seen on microscopic examination of the urine; in hemoglobinuria and
myoglobinuria, they are not. </span></p>

<p><span></span></p>

<p><span>In this
vignette, microscopic examination of the urine shows no red blood cells;
therefore, hematuria is excluded. This leaves hemoglobinuria and myoglobinuria
as potential causes. Myoglobinuria due to rhabdomyolysis is the most likely
explanation in a long-distance runner, as extreme exertion can lead to muscle
breakdown with subsequent release of myoglobin into the blood.</span></p>

<p><span></span></p>

<p><i><span>Hematuria</span></i><span> can result from bleeding anywhere in the
urinary tract. Common causes include urinary tract infection, kidney stones,
renal injury, and cancer of the kidney, bladder, or prostate. </span></p>

<p><span></span></p>

<p><i><span>Hemoglobinuria</span></i><span> results from intravascular hemolysis. R<span>ed blood cells normally live about four months. At that
point they are trapped and disassembled in the spleen, bone marrow, and liver
(extravascular hemolysis). If red blood cells break down prematurely <i>within</i> the vascular system, however, the
components are set free in the blood (intravascular hemolysis). Free hemoglobin
binds to haptoglobin. If the hemoglobin level rises above the capacity of
haptoglobin to reclaim it, the hemoglobin appears in the urine. Conditions
associated with hemoglobinuria include malaria, sickle cell disease, hemolytic
uremic syndrome (HUS), thrombotic thrombocytopenia purpura (TTP), and
paroxysmal nocturnal hemoglobinuria (PNH). </span></span></p>

<p><i><span></span></i></p>

<p><i><span>Rhabdomyolysis </span></i><span>is the rapid breakdown
of skeletal muscle due to physical, chemical, or biological injury. Breakdown
products are released into the blood. Some of these products, such as
myoglobin, are harmful to the kidney and may cause acute renal failure.
Patients with rhabdomyolysis are treated with intravenous fluids (and dialysis
or hemofiltration if necessary). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. Heavy exertion (e.g.,
running a marathon) can cause muscle injury, resulting in rhabdomyolysis. This
condition is characterized by dark-colored urine (due to myoglobinuria), which
tests positive for blood on urine dipstick, but which does not show red blood
cells on microscopic examination. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. In acute
glomerulonephritis, red blood cells (including red blood cells casts) would be
seen on microscopic examination of the urine. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Hypovolemia would
result in a high urine specific gravity and a negative urine dipstick for
blood. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Renal infarction may
result in flank pain and hematuria. (Red blood cells would be seen on
microscopic examination of the urine.)</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Urolithiasis may
result in pain and hematuria. (Red blood cells would be seen on microscopic
examination of the urine.)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><span>A genetic male newborn has fully developed male sexual ducts and
recognizable fallopian tubes. Which of the following processes was most likely
disturbed during the embryonic period?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Production of estrogen by the embryonic testes</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Production of mullerian-inhibitory substance by the embryonic testes</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Production of testosterone by the embryonic testes</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Response of the paramesonephric (m&#369;llerian) ducts to estrogen</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Response of the paramedonephric (m&#369;llerian) ducts to testosterone</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Sexual differentiation</span><span> is the development of differences between males and females
from an undifferentiated zygote (fertilized egg).</span></p>

<p><span></span></p>

<p><b><span>Gonadal differentiation</span></b><span>.</span></p>

<p></p>

<p>Early in fetal life, germ
cells migrate from structures known as yolk sacs to the genital ridge. By week
6, undifferentiated gonads consist of germ cells, supporting cells, and
steroidogenic cells.</p>

<p>In a male, the <span>SRY</span> gene (sex-determining region Y)
and other genes induce differentiation of supporting cells into Sertoli cells
and steroidogenic cells into Leydig cells. These comprise the testes. The germ
cells become spermatogonia.</p>

<p>In a female, the absence of
the <i>SRY </i><span>gene causes</span>
supporting cells to differentiate into theca cells and steroidogenic cells into
granulosa cells. These comprise the ovaries. The germ cells become ovarian
follicles.</p>

<p><b></b></p>

<p><b>Hormonal differentiation</b>.</p>

<p></p>

<p>In a male fetus, testes
produce steroid and protein hormones essential for internal and external
anatomic differentiation. Leydig cells make testosterone by the end of the
second month of gestation. From then on, male fetuses have higher levels of
androgens in their systemic blood than females. Antimullerian hormone (AMH),
also called Mullerian regression factor, is a protein produced by Sertoli cells
that suppresses development of müllerian ducts in males, preventing development
of a uterus.</p>

<p>Fetal ovaries produce
estradiol, which supports follicular maturation but plays little part in other
aspects of prenatal sexual differentiation, as maternal estrogen floods fetuses
of both sexes.</p>

<p><b></b></p>

<p><b>Genital differentiation</b>. </p>

<p><i></i></p>

<p><i>Internal genital differentiation</i>. </p>

<p></p>

<p>Gonads are histologically
distinguishable by 6&#8211;8 weeks of gestation. A fetus of that age has both
mesonephric (wolffian) and paramesonephric (mullerian) ducts. Subsequent
development of one set and degeneration of the other depends on the presence or
absence of two testicular hormones: testosterone and Antimullerian hormone
(AMH). Disruption of typical development may result in the development of both,
or neither, duct system, which may produce morphologically intersexual
individuals.</p>

<p></p>

<p>Testosterone causes each
wolffian duct to develop into epididymis, vas deferens, and seminal vesicles.
Without male testosterone, wolffian ducts degenerate and disappear. Müllerian
ducts develop into a uterus, fallopian tubes, and upper vagina unless
Antimullerian hormone (AMH) induces degeneration of these ducts. (The presence
of a uterus is stronger evidence of absent testes than the state of the
external genitalia.)</p>

<p></p>

<p></p>

<p></p>

<h3><span></span></i></span></h3>

<h3><span>External genital differentiation</span></i></span><i><span></span></i></h3>

<p></p>

<p>By 7 weeks, a fetus has a
genital tubercle, urogenital groove and sinus, and labioscrotal folds. In
females, without excess androgens, these become the clitoris, urethra and
vagina, and labia.</p>

<p>Males become externally
distinct between 8 and 12 weeks, as androgens enlarge the phallus and cause the
urogenital groove and sinus to fuse in the midline, producing an unambiguous
penis with a phallic urethra, and a thinned, rugated scrotum.</p>

<p></p>

<p>A sufficient amount of any
androgen can cause external masculinization. The most potent is
dihydrotestosterone (DHT), generated from testosterone in skin and genital
tissue by the action of 5&#945;-reductase.* A male fetus may be incompletely
masculinized if this enzyme is deficient. In some disorders, androgens may be
present in high enough concentrations to cause partial or even complete
masculinization of the external genitalia of a genetically female fetus.</p>

<p></p>

<p>Further sex differentiation
of the external genitalia occurs at puberty, when androgen levels again become
disparate. Male levels of testosterone directly induce growth of the penis, and
indirectly (via DHT) the prostate.</p>

<p><span></span></span></p>

<p><span>*Differentiation
of the Wolffian duct into the male <i>internal
</i>reproductive tract requires testosterone, not dihydrotestosterone. By
contrast, formation of the <i>external</i>
reproductive tract &#8211; penis, prostate, and scrotum &#8211; requires
dihydrotestosterone. Consequently, congenital absence of 5&#945;-reductase,
which converts testosterone into dihydroxytestosterone, results in a male
internal reproductive tract, but feminized external genitalia.</span></span><b></b></p>

<p><b></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer B is correct</b>. At 6&#8211;8 weeks of gestation, a fetus has
both mesonephric (wolffian) and paramesonephric (mullerian) ducts. Subsequent
development of one set and degeneration of the other depends on the presence or
absence of two testicular hormones: testosterone and Antimullerian hormone
(AMH). Testosterone causes each wolffian duct to develop into epididymis, vas
deferens, and seminal vesicles. Without male testosterone, wolffian ducts
degenerate and disappear. Müllerian ducts develop into a uterus, fallopian
tubes, and upper vagina unless Antimullerian hormone (AMH) induces degeneration
of these ducts. In this vignette, the presence of male sexual ducts indicates
presence of testosterone. The simultaneous presence of female sexual ducts
(i.e., fallopian tubes) indicates deficiency or absence of Antimullerian
hormone (AMH), which causes degeneration and disappearance of female sexual
ducts.<span >&nbsp;&nbsp;&nbsp; </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
genotypic male (XY) is born with feminized external genitalia. The testes are
retained within the abdominal cavity, and the internal reproductive tracts
exhibit the normal male phenotype. Which of the following could account for
this abnormal development?</span></span></p>

<p><span></span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Complete androgen resistance</span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>5a-reductase deficiency</span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>17a-hydroxylase deficiency</span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Sertoli-only syndrome</span></span></p>

<p><span lang=EN-GB><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span lang=EN-GB>Testicular
dysgenesis</span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB><br>
<br>
</span><span lang=EN-GB>&nbsp; </span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB>Answer B is correct.</span></strong><span
 lang=EN-GB> Differentiation of the Wolffian ducts into the normal
male <i>internal</i> reproductive tract
requires testosterone, not dihydrotestosterone. On the other hand,
differentiation into the <i>external</i>
reproductive tract (penis, prostate, and scrotum) requires dihydrotestosterone.
Consequently, congenital absence of 5&#945;-reductase, which converts
testosterone to dihydroxytestosterone, results in a male internal reproductive
tract, but feminized external genitalia.</span></span><b></b></p>

<p><span lang=EN-GB></span></b></span></p>

<p><span lang=EN-GB>Answer A is incorrect.</span></b></span><span
 lang=EN-GB> With complete androgen resistance, the external
genitalia are feminized, but neither the male-type nor the female-type internal
tracts develop. In the absence of the androgen receptor, the Wolffian ducts
degenerate, and neither internal nor external male reproductive tracts develop.
The Müllerian ducts also degenerate because of continued production of Müllerian
regression factor (anti-Mullerian hormone) by the testes.</span></span></p>

<p><span lang=EN-GB></span></b></span></p>

<p><span lang=EN-GB>Answer C is incorrect.</span></b></span><span
 lang=EN-GB> With 17a-hydroxylase deficiency, the testes cannot
synthesize testosterone, resulting in feminization of the external genitalia
and degeneration of the Wolffian ducts. Normal secretion of Müllerian
regression factor causes degeneration of the Müllerian ducts. Because of the
excessive secretion of deoxycorticosterone by the adrenal cortex, these
individuals are usually hypertensive.</span></span></p>

<p><span lang=EN-GB></span></b></span></p>

<p><span lang=EN-GB>Answer D is incorrect.</span></b></span><span
 lang=EN-GB> </span></span><span>Sertoli
cell-only syndrome</span> (<span>germ cell
aplasia</span>) is a disorder characterized by male sterility with normal
secondary male features. Sertoli cells are found in the testes, but
seminiferous tubules are absent and spermatogenesis does not occur<span
 lang=EN-GB>.</span></span></p>

<p><span lang=EN-GB></span></b></span></p>

<p><span lang=EN-GB>Answer E is incorrect.</span></b></span><span
 lang=EN-GB> Testicular dysgenesis results in poor testicular
develop (in utero) with concomitantly decreased secretion of testosterone and
Müllerian regression factor. The Wolffian duct structures may degenerate and
the external genitalia may be feminized. Female-type internal tracts may
develop because of decreased secretion of Müllerian regression factor.</span></span><span
lang=EN-GB></span></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><span>A
60-year-old woman presents with urinary frequency and urge incontinence. Her
past medical history is unremarkable.<span >&nbsp;
</span>She takes no medication.<span >&nbsp;
</span>Pelvic and neurological examination is normal. Urine analysis is
negative. The post-void residual is normal. A cystometrogram shows uninhibited
detrusor contractions with bladder filling.<span>&nbsp; </span>Which of the following is the best
treatment for this condition?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Amitriptyline</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Oxybutynin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Topical
(vaginal) estrogen</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pseudoephedrine</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Kegel
exercises</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Urinary incontinence</span><span> is any involuntary leakage of urine. Continence and
micturition involve a balance between urethral closure and detrusor muscle
activity. Urethral pressure normally exceeds bladder pressure, allowing urine
to remain in the bladder. During normal urination, urethral pressure falls and
bladder pressure rises. </span></p>

<p><span></span></p>

<p><span>The
principal types of urinary incontinence appear below.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=104 valign=top>
  <p style="text-align:center;"><span>Types of urinary incontinence</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Stress</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Urge</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Overactive
  bladder</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Overflow</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Transient</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Functional</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><i>Stress urinary incontinence</i> is characterized by leakage of small
amounts of urine during movement (coughing, sneezing, and exercising). Physical
changes caused by pregnancy, childbirth, and menopause often lead to stress
incontinence. The urinary bladder is supported by the pelvic floor muscles, the
vagina, and various ligaments. If these structures weaken, the bladder moves
downward, pushing slightly out of the bottom of the pelvis toward the vagina.
This prevents muscles that ordinarily force the urethra shut from squeezing as
tightly as they should. As a result, urine can leak into the urethra during
moments of physical stress. </p>

<p style="text-align:center;"><span><img border=0 width=164 height=218
src="_%20Tutorials_files/image340.png"
alt="Description: Side view diagram of female urinary tract with labels pointing to the uterus, bladder, pelvic floor muscle, urethra, and vagina.  An inset shows an enlarged view of the pelvic floor muscles."
v:shapes="Picture_x0020_347266"></span></p>

<p><span>&nbsp;</span></p>

<p><i>Urge incontinence</i> is characterized by leakage of large amounts of
urine at unexpected times. It can mean that the bladder empties during sleep,
after the patient drinks a small amount of water, or when the patient hears
water running. The condition may be benign or may reflect neuromuscular disease
(e.g., stroke, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis).</p>

<p></p>

<p><i><span>Overactive bladder </span></i><span>is characterized by
urinary frequency and urgency, with or without urge incontinence. The term
“detrusor instability” refers to <span>involuntary
contraction of the detrusor muscle not associated with neurological disease.</span>
</span></p>

<p><i></i></p>

<p><i>Overflow incontinence</i> occurs when the bladder does not empty
properly. It is characterized by a high post-void residual. Nerve damage from
diabetes and other conditions can cause “neurogenic bladder” with overflow
incontinence. Urethral obstruction, which in men is usually due to an enlarged
prostate, can also cause overflow incontinence. </p>

<p><i></i></p>

<p><i>Transient incontinence</i> is temporary incontinence caused by a
passing disorder (e.g., urinary tract infection, new medication).</p>

<p><i></i></p>

<p><i>Functional incontinence </i>is untimely urination due to physical
disability, external obstacles, or problems in thinking or communicating that
prevent a person from reaching a toilet. Common causes of functional
incontinence include severe arthritis, Alzheimer’s disease, and wheelchair
confinement. </p>

<p><i><span></span></i></p>

<p><i><span>Mixed incontinence</span></i><span> is a combination of
stress incontinence and urge incontinence.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>. The patient in this
vignette has detrusor instability. Anticholinergics, such as oxybutynin, are
the mainstay of treatment for this condition. (The parasympathetic nervous
system stimulates detrusor muscle contraction by releasing acetylcholine, which
binds to muscarinic receptors. Anti-cholinergics inhibit this action.) </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Amitriptyline, a
tricyclic antidepressant, has anticholinergic properties, but the potential
side effects prevent it from being recommended as first-line therapy for
detrusor instability. Side effects include dry mouth, blurred vision,
constipation, fast heartbeat, and flushing (particularly at high doses). </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Vaginal estrogen is
used to treat atrophic vaginitis, not detrusor instability.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Pseudoephedrine has
alpha-adrenergic properties and may improve urethral tone, which might be
helpful for stress urinary incontinence, but not for detrusor instability.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Kegel exercises are
used in the treatment of stress urinary incontinence. The exercises strengthen
the muscles of the pelvic floor, decreasing urethral hypermobility. The pelvic
floor is comprised of two layers: a superficial layer (the urogenital
diaphragm) and a deep layer (the pelvic diaphragm). </span></p>

<p><span></span></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><span>A 64-year-old woman has had intermittent vaginal bleeding for the past
three months. Four years ago, she was diagnosed with breast cancer and was
treated with partial mastectomy, radiation therapy, and tamoxifen. Speculum and
bimanual examination are normal. Pap smear is also normal. Was it the most
likely source of bleeding? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Ovary</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Fallopian tube</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Uterine endometrium</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Cervical canal</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Vagina</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Vaginal bleeding</span><span>
may be physiological (menstrual cycle) or pathological. It may occur at any age
and always requires investigation in children, during pregnancy, and in the
postmenopausal period. Vaginal bleeding usually originates from the uterine
lining (endometrium) but may arise from the cervix, vagina, or (rarely)
fallopian tube.Bleeding during pregnancy is usually, but not always, related to
the pregnancy itself.</span></p>

<p><span></span></p>

<p><b><span>Bleeding
in Children</span></b></p>

<p><span>Bleeding
before menarche could be a sign of precocious puberty. Other causes include
foreign body in the vagina, molestation, vaginal infection (vaginitis), and,
rarely, tumor.</span></p>

<p><b><span></span></b></p>

<p><b><span>Premenopausal
women</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Exceptionally
heavy bleeding during periods is termed <span>menorrhagia</span>
or <span>hypermenorrhea</span>, while light
bleeding is called <span>hypomenorrhea</span>.
Bleeding between periods<span>
(intermenstrual bleeding) </span>is not necessarily pathological. Metrorrhagia
refers to unpredictable bleeding with no discernible period. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dysfunctional
uterine bleeding is a common cause of menorrhagia and irregular bleeding. It is
due to hormonal imbalance resulting in anovulation. Symptoms can be managed
with hormonal contraception.<span >&nbsp; </span>It is
a diagnosis of exclusion<span>.</span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Uterine
fibroids (leiomyoma) are benign tumors of the uterus<span> </span>that
present with menorrhagia, sometimes dysmenorrhea and potentially pressure
symptoms from enlarged irregular uterus. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cervical
cancer may occur in the premenopausal period and may present with &quot;contact
bleeding&quot; (e.g. after sexual intercourse, which is referred to as
post-coital bleeding). </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Uterine
cancer may lead to irregular and prolonged bleeding. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>In
women who have recently delivered a baby or had a miscarriage, vaginal bleeding
may be a sign of endometritis or retained products of conception. </span></p>

<p><b><span></span></b></p>

<p><b><span>Pregnant
women</span></b></p>

<p><span>During
pregnancy, mild blood loss may be due to rupture of a small vein on the outer
rim of the placenta. It can also herald a miscarriage or ectopic pregnancy and
rarely a molar pregnancy. Ultrasound is required to separate these conditions.
Bleeding in early pregnancy may be a sign of threatened or incomplete
miscarriage. In the second or third trimester, a placenta previa (placenta
partially or completely overlying the cervix) may bleed severely. Placental
abruption is often associated with uterine bleeding and pain.<span> </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Postmenopausal
women</span></b></p>

<p><span>All
postmenopausal women with vaginal bleeding should be assessed for endometrial
cancer. Other potential causes of bleeding include endometritis, endometrial
polyp, endometrial hyperplasia, cervical polyp, and vaginitis.</span></p>

<p><b><span></span></b></p>

<p><b><span>Diagnostic approach</span></b></p>

<p><span>The cause
of vaginal bleeding can sometimes be determined from the medical history and
physical examination. Pregnancy test, Pap smear, and transvaginal ultrasound
are often needed. If bleeding is excessive, testing for anemia may be
warranted. An abnormal endometrium may require further investigation by
hysteroscopy with biopsy or dilation and curettage.</span></p>

<p><b><span>Answer C is correct</span></b><span>. Vaginal bleeding can
originate from any part of the gynecological tract, but the most common source
is the uterine lining. In a post-menopausal woman, vaginal bleeding should
always be evaluated. Endometrial cancer is a common cause of post-menopausal
bleeding. Making the diagnosis is important as the condition can usually be
cured surgically. Tamoxifen increases the risk of endometrial cancer. The
patient in this vignette is post-menopausal, has a history of tamoxifen use,
and has no obvious source of bleeding on pelvic examination. She should be
evaluated for endometrial cancer<span> </span>with an
endometrial biopsy. </span></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><strong></strong></p>

<p><span>A 7-year-old boy has an intra-abdominal mass in the midline just above
the symphysis pubis. During surgery, a cystic mass is found attached to the
umbilicus and to the apex of the bladder. Which of the following is the most
likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Meckel’s
diverticulum</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Omphalocele</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gastroschisis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Bladder
exstrophy </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urachal
cyst</span></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Meckel's diverticulum</b>,
a true congenital diverticulum, is a small bulge in the small intestine,
present at birth. It is a vestigial remnant of the omphalomesenteric duct, also
called the vitelline duct or yolk stalk. (The omphalomesenteric duct is a long
narrow tube that joins the yolk sac to the midgut lumen of the developing
fetus. The yolk sac provides nourishment to the embryo before the placenta
develops.) </p>

<p></p>

<p>Meckel’s diverticulum is the
most frequent malformation of the gastrointestinal tract. A memory aid is
the,<span >&nbsp; </span>“rule of 2s”: <i>2%</i> (of
the population). <i>2</i> feet (from the ileocecal valve). <i>2</i> inches (in
length). <i>2%</i> are symptomatic. <i>2</i> types of common ectopic tissue
(gastric and pancreatic). <i>2</i> years is the most common age at clinical
presentation. <i>2</i> times <span>more boys
are affected.<i> </i></span></p>

<p></p>

<p>The condition is part of the
extrophy-epispadias spectrum of anomalies of the lower abdominal wall, bladder,
anterior bony pelvis, and external genitalia. The majority of individuals are
asymptomatic. The most common presenting symptom is painless rectal bleeding
(typically melena). The bleeding usually occurs without warning and stops
spontaneously. Some patients present with abdominal pain and distension due to
intestinal obstruction, volvulus, or intussusception.<span>&nbsp; </span>The diagnosis is made by a Meckle’s Scan,
which consists of intravenous infusion 99m technetium pertechnetate, which has
an affinity for gastric mucosa, and performing scintigraphy.<span>&nbsp;&nbsp; </span>Occasionally, the condition can
mimic acute appendicitis or present as an indirect hernia (usually right-sided).
</p>

<p></p>

<p>The diverticulum may be
attached to the umbilical region by the vitelline ligament, with the
possibility of vitelline cysts, or even a patent vitelline canal forming a
vitelline fistula. Torsion of the intestine around the viteeline ligament can
lead to obstruction, ischemia, and necrosis.</p>

<p></p>

<p><b><span>Umbilical
hernia</span></b><span>
is a small protrusion of bowel through the umbilical ring. The protrusion is
covered by skin. Umbilical hernias are often more apparent when the infant
cries or strains. Most close spontaneously by five years of age. They can occur
as isolated defects or as part of a larger syndrome.</span></p>

<p><b></b></p>

<p><b>Omphalocele </b>is a
herniation of bowel or other viscera (e.g., liver) through the umbilical ring.
It is caused by a defect in the abdominal wall muscles. The herniated segment
is formed from an outpouching of peritoneum and is covered by a thin membrane
that can easily rupture. (Normally the intestines protrude from the abdomen
into the umbilical cord until about the tenth week of pregnancy, after which
they return to the abdomen.) Omphaloceles can be mild, with only a small loop
of intestine outside the abdomen, or severe, containing most of the abdominal
organs. Omphaloceles are often associated with chromosomal abnormalities and
cardiac defects.</p>

<p><b><span></span></b></p>

<p><b><span>Gastroschisis</span></b><span> is a defect of the
anterior abdominal wall through which bowel protrudes without a covering sac.
The protrusion occurs between the rectus muscles just lateral to the umbilicus.
Unlike omphalocele, gastroschisis does not involve the umbilicus itself. The
defect is small and there is no overlying sac. Also, gastroschisis differs from
omphalocele in being less commonly associated with other abnormalities.
(Gastroschisis has not been correlated with chromosomal defects.)</span></p>

<p><b></b></p>

<p><b>Ectopia cordis</b> is a
birth defect in which the heart is abnormally located. Most commonly, the heart
protrudes outside the chest through a split sternum. In some cases, the heart
may be situated in the abdominal cavity or neck. Other birth defects may be
present. This condition is usually fatal in the first days of life; however,
sometimes surgical treatment is possible.</p>

<p><b><span></span></b></p>

<p><b><span>Pentalogy
of Cantrell</span></b><span>
(or <span>thoraco-abdominal syndrome</span>)
is a rare syndrome characterized by defects in the diaphragm, abdominal wall,
pericardium, heart, and lower sternum.</span></p>

<p><a
name=4-u1.0-B978-0-443-06811-9..10014-4--sec3></a><b></b></p>

<p><b>Bladder exstrophy</b> is
a congenital anomaly in which part of the urinary bladder is present outside
the body.<span >&nbsp; </span>It is part of a spectrum
of disorders of abdominal and pelvic fusion occurring in the first months of
embryogenesis and known collectively as the <span>exstrophy-epispadias complex</span>.<span >&nbsp;
</span>It results from failure of the abdominal wall and bony pelvis to close
during fetal development.<span >&nbsp; </span>It is
characterized by protrusion of the posterior bladder through the lower
abdominal wall and anomalies of the external genitalia.<span>&nbsp; </span>Other disorders in the
extrophy-epispadias complex are epispadias (in which the urethra ends in an
opening on the upper aspect (the dorsum) of the penis) and cloacal exstrophy
(which involves exstrophy of the bladder, large intestine and other lower
abdominal and genito-urinary complications)</p>

<p><b><span></span></b></p>

<p><b><span>Urachal cyst</span></b><span> is a fluid-filled structure between the
two obliterated ends of the urachus, i.e., the umbilicus and bladder dome. (The
<span>urachus</span> is a remnant of the
allantois, a canal that drains the fetal urinary bladder through the umbilical
cord.) In infancy, such cysts are rarely symptomatic, but may be detected as
incidental findings during bladder ultrasonography. More commonly, urachal cysts
are detected in early childhood or adolescence, when the patient presents with
suprapubic mass, abdominal pain, leakage of urine from the umbilicus, or signs
of urinary infection.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct.<span>&nbsp; </span></span></b><span>Urachal cysts are fluid-filled structures
derived from the urachus, a remnant of the allantois, which connects the fetal
bladder to the umbilicus. In this vignette, the location of the mass is
consistent with urachal cyst.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect. </span></b><span>Meckel's diverticulum </span><span>is a vestigial remnant of the omphalomesenteric duct, which
connects the midgut lumen to the yolk sac. About two inches in length, the
diverticulum protrudes from the ileum of the small bowel.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect. </span></b><span>Omphalocele<b> </b></span><span>is
a herniation of bowel or other viscera (e.g., liver) through the umbilical
ring. The herniated segment is surrounded by peritoneum, a thin membrane that
can rupture.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><span>Gastroschisis</span><span>
is a defect of the anterior abdominal wall through which bowel protrudes
without a covering sac. The protrusion occurs between the rectus muscles just
lateral to the umbilicus.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect.</span></b><span> <span>Bladder exstrophy</span> is a congenital anomality in which part of the
urinary bladder is present outside the body.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 65-year-old
man comes to the physician because he awakens to urinate several times per
night and has developed problems starting and stopping his stream of
urine.<span >&nbsp; </span>A biopsy of the prostate
shows enlargement and dilation of the prostatic glands but no dysplasia.<span>&nbsp; </span>Which of the following is the most
appropriate pharmacological treatment for this patient?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Finasteride</span></p>

<p><span>B.<span>&nbsp; </span>Flutamide</span></p>

<p><span>C.<span>&nbsp; </span>Ketoconazole</span></p>

<p><span>D.<span>&nbsp; </span>Spironolactone</span></p>

<p><span>E.<span>&nbsp; </span>Yohimbine</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=0 cellpadding=0 width="100%">
 <tr>
  <td
  width="0%"><p  <td></td>
  <td valign=top></td>
  <td
  width="93%"><p </tr>
 <tr>
  <td width="99%" colspan=4>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC072001></a><b><span>Benign Prostatic Hyperplasia </span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072002></a><span>Benign prostatic hyperplasia (BPH), a nonmalignant enlargement
    of the prostate gland, is a common condition in the aging male patient. It
    is estimated that more than 90% of all men will develop histologic evidence
    of BPH during the course of their lifetime; of those, greater than or equal
    to 50% will develop lower urinary tract symptoms (LUTS) that prompt them to
    seek medical care. Broadly speaking, LUTS can be divided into two groups:
    obstructive voiding symptoms and irritative voiding symptoms. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072003></a><span>Although most patients who seek medical care for BPH do so
    because of the associated LUTS, it is important to realize that these same
    symptoms can be the result of several different factors, including systemic
    illnesses such as diabetes mellitus, as well as neurologic conditions
    including spine disease, parkinsonism, multiple sclerosis, and
    cerebrovascular disease. It is important to to pay close attention to
    medication use because a number of medications used in the elderly
    population can result in various urologic symptoms. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC072002></a><span>Pathophysiology </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072004></a><span>Prostate growth and the subsequent development of BPH occur
    under the influence of testosterone and the more metabolically active
    dihydrotestosterone. Testosterone, which is produced by the testes and
    controlled through the hypothalamic-pituitary gonadal axis, is converted to
    dihydrotestosterone by the action of the enzyme 5&#945;-reductase.
    Dihydrotestosterone is the major intracellular androgen and is believed to
    be responsible for the development and maintenance of the hyperplastic cell
    growth characteristic of BPH. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072005></a><span>The development of BPH occurs predominantly in the
    periurethral prostatic tissue referred to as the <i>transition zone</i>.
    Tissue growth in this area leads to the phenomenon of bladder outlet
    obstruction (BOO), which leads to LUTS. BOO occurs as a result of two
    mechanisms: (1) mechanical obstruction, resulting from an increased tissue
    volume in the periurethral zone of the prostate; and (2) dynamic
    obstruction, which is the result of decreased bladder neck relaxation
    during voiding and increased smooth muscle tone in the bladder neck and
    prostate gland. Also important, but less well characterized, is the
    response of the bladder muscle to the increase in outlet resistance
    provided by the combination of mechanical obstruction and increased
    prostatic and bladder neck smooth muscle tone. As bladder outlet resistance
    increases, the bladder responds by increasing the force of contraction.
    Later during the course of the obstructive process, the bladder wall
    becomes thickened and loses compliance, which exacerbates symptoms.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><span></span></p>
  <p><a name=P072006></a><span></span></p>
  <p><a name=HC072003></a><a name=T072001></a><span></span></p>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="85%">
   <tr>
    <td width="100%">
    <p style="text-align:center;"><b><span>Lower Urinary Tract Symptoms</span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <div align=center>
  <table border=1 cellspacing=0 cellpadding=0 width="67%">
   <tr>
    <td valign=bottom>
    <p><a name=T072001.50></a><b><span>Irritative</span></b><span></span></p>
    </td>
    <td width="52%" valign=bottom>
    <p><b><span>Obstructive</span></b><span></span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><a name=T072001.100></a><span>Frequency</span></p>
    </td>
    <td width="52%" valign=top>
    <p><span>Hesitancy</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><a name=T072001.150></a><span>Nocturia</span></p>
    </td>
    <td width="52%" valign=top>
    <p><span>Slow stream</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><a name=T072001.200></a><span>Urgency</span></p>
    </td>
    <td width="52%" valign=top>
    <p><span>Stop-and-start voiding</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><a name=T072001.250></a><span>Urge incontinence</span></p>
    </td>
    <td width="52%" valign=top>
    <p><span>Sensation of incomplete emptying</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="90%">
   <tr>
    <td width="100%"></td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p style="text-align:center;"><a name=F072001></a><span><img border=0 width=243 height=189
    src="_%20Tutorials_files/image342.png"
    alt="Description: http://www.studentconsult.com/common/showimage.cfm?mediaISBN=9781416061090&amp;FigFile=S9781416061090-072-f001.jpg&amp;size=fullsize"
    v:shapes="Picture_x0020_347475"></span><span></span></p>
    </td>
   </tr>
   <tr>
    <td width="100%"></td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p style="text-align:center;"><a name=P072008></a><span></span></p>
    <p style="text-align:center;"><span>Causes of lower urinary tract symptoms. BPH, benign prostatic
    hyperplasia.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p style="text-align:center;"><a name=F072002></a><span><img border=0 width=346 height=196
    src="_%20Tutorials_files/image344.png"
    alt="Description: http://www.studentconsult.com/common/showimage.cfm?mediaISBN=9781416061090&amp;FigFile=S9781416061090-072-f002.jpg&amp;size=fullsize"
    v:shapes="Picture_x0020_347476"></span><span></span></p>
    </td>
   </tr>
   <tr>
    <td width="100%"></td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p style="text-align:center;"><a name=P072009></a><span></span></p>
    <p style="text-align:center;"><span>Zonal anatomy of the prostate gland.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072007></a><span>Diagnosis</span></p>
    <p><span></span></p>
    <p><span>The initial
    evaluation of a patient presenting with LUTS suggestive of BPH should
    include a detailed medical history, focusing on the patient's urinary
    symptoms, as well as the patient's past medical history, including comorbid
    conditions and any previous surgical procedures, general health conditions,
    and history of alcohol and tobacco use. A general physical examination
    should also be performed that includes a digital rectal examination (DRE)
    and a focused neurologic examination. Urinalysis, either by dipstick or
    microscopic examination of urine sediment, is also mandatory to rule out
    hematuria or evidence of urinary tract infection. Glycosuria can also be a
    significant finding, particularly if not previously identified. According
    to the same clinical practice guidelines, measurement of prostate-specific
    antigen (PSA) is optional during the initial evaluation. PSA can function
    as a surrogate for prostate volume measurement in addition to being a
    screening test for prostate cancer. PSA increases linearly with prostate
    volume.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=P072010></a><span></span></p>
  <p><span></span></p>
  <p><a name=P072011></a><span></span></p>
  <p><a name=P072012></a><span></span></p>
  <p><a name=P072013></a><span></span></p>
  <p><a name=HC072004></a><span></span></p>
  <p><a name=P072014></a><span></span></p>
  <p><a name=HC072005></a><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC072006></a><b><span>MEDICAL THERAPY </span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072015></a><span>Medical management is the preferred first-line treatment
    option for patients diagnosed with LUTS from BPH. Combination therapy with
    both a long-acting &#945; blocker and a 5&#945;-reductase inhibitor is more
    effective than single-agent therapy alone. In general, medical management
    is initiated for patients with moderate to severe symptoms. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC072007></a><b><i><span>&#945;-adrenergic Antagonists </span></i></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072016></a><span>&#945;-adrenergic antagonists, or &#945; blockers, are the
    most commonly prescribed medications for the treatment of LUTS associated
    with BPH. The bladder neck and prostate are richly innervated with
    &#945;-adrenergic receptors, specifically &#945;<sub>1a</sub> receptors,
    which constitute about 70% to 80% of the total number of &#945; receptors
    in these areas. &#945;<sub>1b</sub> receptors modulate vascular smooth
    muscle contraction and are located in the bladder neck and prostate to a
    lesser degree. Doxazosin, terazosin, tamsulosin, and extended-release
    alfuzosin are long acting &#945;-receptor antagonists. They are generally
    administered once daily, usually at bedtime to minimize the potential for
    orthostatic hypotension. These medications act through &#945;<sub>1</sub>
    receptors and can cause vasodilation resulting in transient hypotension and
    light-headedness. Tamsulosin is a selective &#945;<sub>1a</sub> receptor
    antagonist with a long half-life. It has a significantly lower degree of
    nonspecific &#945;-receptor binding compared with other &#945;-receptor
    antagonists. Therefore, side effects such as postural hypotension and
    dizziness are less common.<span >&nbsp; </span></span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><span></span></p>
  <p><a name=P072017></a><span></span></p>
  <p><a name=P072018></a><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC072008></a><b><i><span>5&#945;-reductase Inhibition (Finasteride and Dutasteride) </span></i></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072019></a><span>Finasteride and dutasteride block the intracellular conversion
    of testosterone to 5-dihydrotestosterone by inhibiting the action of the
    enzyme 5&#945;-reductase. This results in a reduction in prostate gland size
    over 6 to 12 months. It is most effective in reducing symptoms and
    preventing disease progression in patients with large prostate glands
    (&gt;40 mL). 5&#945;-reductase inhibition has also been shown to decrease
    the risk for urinary retention and subsequent surgical intervention, again,
    predominantly in those patients with larger glands. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=P072020></a><span></span></p>
  <p><a name=HC072009></a><span></span></p>
  <p><a name=P072021></a><span></span></p>
  <p><a name=P072022></a><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC072010></a><b><span>SURGICAL MANAGEMENT </span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=HC072011></a><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P072023></a><span>Although transurethral resection of the prostate (TURP)
    remains the gold standard for the surgical treatment of BPH, substantial
    effort has been devoted to the development of less invasive and less morbid
    methods of treating patients with symptomatic BPH. This has led to a
    proliferation of minimally invasive therapies, primarily using different
    methods of generating heat within the prostate gland, resulting in tissue
    destruction. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=P072024></a><span></span></p>
  <p><a name=P072025></a><span></span></p>
  <p><a name=P072026></a><span></span></p>
  <p><a name=HC072012></a><span></span></p>
  <p><span></span></p>
  <p><a name=P072027></a><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><a name=P072028></a><a name=T072002></a><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><a name=T072002.50></a><span></span></p>
  <p><span></span></p>
  <p><a name=P072029></a><span></span></p>
  <p><a name=R072009></a><span></span></p>
  <a name=R072010></a></td>
 </tr>
 <![if !supportMisalignedColumns]>
 <tr height=0>
  <td width=5></td>
  <td width=15></td>
  <td width=15></td>
  <td width=521></td>
 </tr>
 <![endif]>
</table>

</div>

<p><span></span></p>

<p><b><span>The correct answer is A.</span></b><span><span>&nbsp; </span>Benign prostatic hyperplasia (BPH) is a
common entity in men older than age 50.<span >&nbsp;
</span>Pathophysiologically, estradiol levels increase with age and they are
thought to sensitize the prostate to the effects of dihydrotestosterone (DHT),
causing the prostatic cells to grow.<span >&nbsp;
</span>Common symptoms of BPH include increased frequency of urination,
nocturia, problems with initiating and stopping urination, and pain on
urination.<span >&nbsp; </span>Finasteride is a
5&#945;-reductase inhibitor that inhibits conversion of testosterone to DHT,
therefore preventing further growth of the prostate, as well as promoting hair
growth.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect.</span></b><span><span>&nbsp; </span>Flutamide is a competitive inhibitor of
testosterone and its receptor and is used in the treatment of prostatic
carcinoma, not benign prostatic hypertrophy.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>Ketoconazole is a commonly used
antifungal that also has antiandrogen effects.<span>&nbsp; </span>In the latter capacity, it is used in
the treatment of polycystic ovarian syndrome to prevent hirsutism.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect.</span></b><span><span>&nbsp; </span>Spironolactone is a K<sup>+</sup>
sparing diuretic that also has antiandrogenic effects.<span>&nbsp; </span>In addition to use in the treatment of
hyperaldosteronism, hypokalemia, and congestive heart failure, it can be used
in preventing hirsutism in polycystic ovarian syndrome.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>Yohimbine is an &#945;-2-selective
inhibitor with questionable usage in the treatment of impotence.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
34-year-old African-American woman presents to the physician with abdominal
cramping that worsens during her menstrual period. <span>&nbsp;</span>The patient also says that her periods
often last for more than 7 days.<span >&nbsp; </span>An
ultrasound study shows multiple masses on the patient’s uterus.<span>&nbsp; </span>Which of the following
immunohistochemical stains would be the most appropriate for diagnosing this
patient’s condition?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Cytokeratin</span></p>

<p><span>B.<span>&nbsp; </span>Desmin</span></p>

<p><span>C.<span>&nbsp; </span>Glial fibrillary acid proteins</span></p>

<p><span>D.<span>&nbsp; </span>Neurofilament</span></p>

<p><span>E.<span>&nbsp; </span>Vimentin</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A&nbsp;<b>uterine fibroid</b>&nbsp;is
a&nbsp;leiomyoma&nbsp;(benign&nbsp;tumor&nbsp;from smooth muscle tissue) that
originates from the smooth muscle layer (myometrium) of the uterus. Fibroids
are often multiple and if the uterus contains too many leiomyomata to count, it
is referred to as&nbsp;<i>diffuse uterine leiomyomatosis</i>. The malignant
version of a fibroid is extremely uncommon and termed a&nbsp;leiomyosarcoma.</span></p>

<p><span><br>
Fibroids are the most common benign tumors in females and typically found
during the middle and later reproductive years. While most fibroids are
asymptomatic, they can grow and cause heavy and painful menstruation, painful
sexual intercourse, and urinary frequency and urgency. Some fibroids may
interfere with pregnancy, although this appears to be very rare.<sup> </sup>In
the&nbsp;United States, symptoms caused by uterine fibroids are a very frequent
indication for&nbsp;hysterectomy. </span></p>

<p><span></span></p>

<p><span>Fibroids, particularly when small,
may be entirely asymptomatic. Symptoms depend on the location of the lesion and
its size. Important symptoms include abnormal&nbsp;gynecologic hemorrhage,
heavy or painful periods, abdominal discomfort or bloating, painful defecation,
back ache, urinary frequency or retention, and in some
cases,&nbsp;infertility.&nbsp;There may also be pain during intercourse,
depending on the location of the fibroid. During&nbsp;pregnancy&nbsp;they may
also be the cause of&nbsp;miscarriage, bleeding,&nbsp;premature labor, or
interference with the position of the fetus.</span></p>

<p><span>Leiomyomata grossly appear as round,
well circumscribed (but not encapsulated), solid nodules that are white or tan,
and show whorled appearance on histological section. The size varies, from
microscopic to lesions of considerable size. Typically lesions the size of a
grapefruit or bigger are felt by the patient herself through the abdominal
wall.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=288 height=216
src="_%20Tutorials_files/image346.png"
alt="Description: File:Lipoleiomyoma2.jpg" v:shapes="Picture_x0020_347477"></span><span></span></p>

<p><span>.</span></p>

<p><span></span></p>

<p><span>Microscopically, tumor cells
resemble normal cells (elongated, spindle-shaped, with a cigar-shaped nucleus)
and form bundles with different directions (whorled). These cells are uniform
in size and shape, with scarce mitoses. </span></p>

<p style="text-align:center;"><a
href="http://en.wikipedia.org/wiki/File:Uterine_fibroids.png"><span><img border=0 width=155 height=160
src="_%20Tutorials_files/image348.png"
alt="Description: http://upload.wikimedia.org/wikipedia/commons/thumb/d/d0/Uterine_fibroids.png/220px-Uterine_fibroids.png"
v:shapes="Picture_x0020_347478"></span></a><span></span></p>

<p><span></span></p>

<p><span>Schematic drawing of various types of uterine fibroids:
a=subserosal fibroids, b=intramural fibroids, c=submucosal fibroid,
d=pedunculated submucosal fibroid, e=fibroid in statu nascendi, f=fibroid of
the broad ligament</span></p>

<p><span></span></p>

<p><span>Growth and location are the main
factors that determine if a fibroid leads to symptoms and problems.&nbsp;A
small lesion can be symptomatic if located within the uterine cavity while a
large lesion on the outside of the uterus may go unnoticed. Different locations
are classified as follows:</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Intramural fibroids are located
within the wall of the uterus and are the most common type; unless large, they
may be asymptomatic. Intramural fibroids begin as small nodules in the muscular
wall of the uterus. With time, intramural fibroids may expand inwards, causing
distortion and elongation of the uterine cavity.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Subserosal fibroids are located
underneath the mucosal (peritoneal) surface of the uterus and can become very large.
They can also grow out in a papillary manner to become pedunculated fibroids.
These pedunculated growths can actually detach from the uterus to become a
parasitic leiomyoma.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Submucosal fibroids are located in
the muscle beneath the endometrium of the uterus and distort the uterine
cavity; even small lesions in this location may lead to bleeding
and&nbsp;infertility. A pedunculated lesion within the cavity is termed an
intracavitary fibroid and can be passed through the cervix.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cervical fibroids are located in the
wall of the cervix (neck of the uterus). Rarely fibroids are found in the
supporting structures (round ligament,&nbsp;broad ligament, or uterosacral
ligament) of the uterus that also contain smooth muscle tissue.</span></p>

<p><span></span></p>

<p><span>Fibroids may be single or multiple. Most
fibroids start in an intramural location. With further growth, some lesions may
develop towards the outside of the uterus or towards the internal cavity.
Secondary changes that may develop within fibroids are hemorrhage, necrosis,
calcification, and cystic changes.</span></p>

<p><b><span></span></b></p>

<p><b><span>The correct answer is B.</span></b><span><span>&nbsp; </span>This vignette describes leiomyomas, or
fibroids, which are most often seen in African-American women.<span>&nbsp; </span>These tumors are benign and usually
present with menstrual pain and menorrhagia (increased bleeding).<span>&nbsp; </span>They are estrogen-sensitive, increasing
in size during pregnancy and decreasing with menopause.<span>&nbsp; </span>As their name suggests, leiomyomas are
composed of muscle fibers; thus, the appropriate stain is desmin.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>Cytokeratin staining would be most appropriate
for epithelial cells.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>Glial fibrillary acid protein staining
would be most appropriate for neuroglia.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect.</span></b><span><span>&nbsp; </span>Neurofilament staining would be most
appropriate for neurons.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>Vimentin staining would be most
appropriate for connective tissue.</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section">Endocrine,</span></p>

<p style="text-align:center;"><span
class="Section">Musculoskeletal,</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Integument</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
45-year-old man with AIDS is evaluated for fever and hypotension. He was
diagnosed with disseminated histoplasmosis three months ago and has been
treated with antifungal medication, as well as antiretroviral therapy.
Yesterday he had surgery for removal of an impacted wisdom tooth. Today he has
abdominal pain and is found to have a temperature of 102<sup>o</sup> F and a
blood pressure of 85/65 mm Hg. His blood tests show a serum sodium level of 125
mEq/L, a potassium level of 5.7 mEq/L, and a serum creatinine level of 1.9
mg/dL. He is started on empiric antibiotic therapy for possible bacterial
sepsis. What other diagnosis should be considered? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Malignant
hyperthermia</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Concomitant
aspergillosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Concomitant
mucormycosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Adrenal
crisis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Neuroleptic
malignant syndrome</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Adrenal insufficiency is
a condition in which the adrenal glands do not produce adequate amounts of steroid
hormones, primarily cortisol. The condition may be primary or secondary.
Primary adrenal insufficiency is caused by direct insult to the adrenal cortex.
Secondary adrenal insufficiency is caused by hypothalamic or pituitary
dysfunction.</span></p>

<p><span>Primary adrenal
insufficiency is associated with inadequate secretion of glucocorticoid and
mineralcorticoid hormones. Adrenocorticotropic hormone (ACTH) levels are high. </span></p>

<p><span>Autoimmune destruction
of the adrenal glands (Addison's disease) is the most common cause of primary
adrenal insufficiency in U.S. Tuberculosis is a common cause worldwide. Other
causes include bilateral adrenal hemorrhage, drugs (e.g., ketoconazole), and other
infectious diseases (e.g., HIV infection, disseminated histoplasmosis). </span></p>

<p><span></span></p>

<p><span>Secondary adrenal
insufficiency is associated with inadequate production of ACTH, which results
in glucocorticoid, but not mineralcorticoid deficiency. It is commonly caused
by discontinuation of prescribed glucocorticoids. Other causes include
pituitary macroadenomas and pituitary surgery or radiation. </span></p>

<p><a
name=4-u1.0-B978-1-4160-6643-9..00050-3--s002></a><span></span></p>

<p><span>Patients with primary
adrenal insufficiency experience fatigue, anorexia, nausea, vomiting, and
weight loss. Hypotension is almost always present. Because mineralcorticoid
levels are low, hyponatremia, hyperkalemia, and metabolic acidosis occur. Skin
hyperpigmentation, initially on the extensor surfaces, palmar creases, and
buccal mucosa, results from increased levels of ACTH. (Melanocyte-stimulating
hormone (MSH) production is a byproduct of ACTH synthesis.)</span></p>

<p><span></span></p>

<p><span>Secondary adrenal
insufficiency manifests more insidiously. Fatigue and hypoglycemia are typical
manifestations. Because mineralcorticoid levels are normal, hyperkalemia and
metabolic acidosis do not occur. Also, skin hyperpigmentation does not occur
because ACTH levels are low.<span >&nbsp; </span></span></p>

<p><a
name=4-u1.0-B978-1-4160-6643-9..00050-3--t001></a><a
name=4-u1.0-B978-1-4160-6643-9..00050-3--s004></a><span></span></p>

<p><span>When primary adrenal
insufficiency is suspected, computed tomography (CT) scanning of the adrenal
glands may help with the differential diagnosis. Enlarged adrenal glands or
calcifications suggest an infectious, hemorrhagic, or metastatic cause. When
secondary adrenal insufficiency is suspected, magnetic resonance imaging (MRI)
of the pituitary gland is indicated unless the cause is obvious (e.g., discontinuation
of glucocorticoid therapy).</span></p>

<p><a
name=4-u1.0-B978-1-4160-6643-9..00050-3--s005></a><i><span></span></i></p>

<p><i><span>Acute</span></i><span> adrenal insufficiency (<b><span>adrenal
crisis</span></b>) is a life-threatening emergency, which usually manifests
with nausea, vomiting, abdominal pain, and shock. Fever and abdominal
tenderness are common findings, and the patient may present with an acute
abdomen. (Surgical exploration without glucocorticoid coverage can be lethal.)
Hyponatremia, hyperkalemia, and metabolic acidosis may be noted on laboratory
tests. Adrenal crisis occurs in patients with undiagnosed or chronic adrenal
insufficiency who become acutely “stressed.” Common precipitating causes
include sepsis, surgery, and adrenal hemorrhage.</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4160-6643-9..00050-3--s006></a><a
name=4-u1.0-B978-1-4160-6643-9..00050-3--st00></a><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Acute development of
fever, abdominal pain, hypotension, hyponatremia, and hyperkalemia is consistent
with acute adrenal insufficiency (adrenal crisis). In this patient, HIV and
disseminated histoplasmosis might have caused primary adrenal insufficiency,
and the added stress of surgery or sepsis might have precipitated a full-blown
“crisis.” </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Malignant hyperthermia
is an inherited disorder characterized by hyperthermia, muscle rigidity, and
cardiovascular instability, usually triggered by halogenated gas or
succinylcholine administered during anesthesia for surgery. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Concomitant
aspergillosis would be very unusual. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Concomitant
mucormycosis would be very unusual.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Neuroleptic malignant
syndrome is characterized by hyperthermia, muscle rigidity, and delirium,
usually triggered by an antipsychotic medicine, such as haloperidol. Symptoms
begin within 1 to 3 days of drug initiation or dosage change. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 40-year-old woman has not had a
menstrual period in four months. Recently she has experienced headaches and
altered vision. She takes no medicine and she has not experienced hot flushes,
night sweats, or vaginal dryness. Her height is 5’6”. Her weight is 130 lbs.
Ophthalmologic examination shows bitemporal hemianopsia. Breast examination
shows expressible galactorrhea bilaterally. She has no acne or abnormal facial
hair growth. Pelvic examination is normal. </span></p>

<p><span></span></p>

<p><span>Laboratory tests show:</span></p>

<p><span></span></p>

<p><span>Beta-hCG<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span>Thyroid-stimulating hormone (TSH)<span> </span>1.0 &#956;U/mL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(N
= 0.5-5.0 &#956;U/mL)</span></p>

<p><span>Serum creatinine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0.8
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(N
= 0.6-1.2 mg/dL)</span></p>

<p><span>Follicle-stimulating hormone <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4
mIU/mL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(N =
4-30 mIU/mL)</span></p>

<p><span>Prolactin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>400
ng/mL<span >&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp; </span>(N &lt; 20 ng/mL)</span></p>

<p><span></span></p>

<p><span>Which is the most likely cause of amenorrhea
in this patient?</span></p>

<p><span></span></p>

<p><span>A. Hypothyroidism</span></p>

<p><span>B. Lactotroph tumor</span></p>

<p><span>C. Menopause</span></p>

<p><span>D. Pregnancy</span></p>

<p><span>E. Polycystic ovary syndrome<span></span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Amenorrhea, the absence of menstruation, is classified as primary or
secondary. Primary amenorrhea is defined as the absence of menarche by age 15.
Secondary amenorrhea is defined as cessation of menses after menses have begun.</span></p>

<p><span></span></p>

<p><span>Normally, the hypothalamus produces gonadotropin-releasing hormone (GnRH),
which stimulates the pituitary to produce gonadotropins: follicle-stimulating
hormone (FSH) and leutinizing hormone (LH). Gonadotropins stimulate the ovaries
to produce estrogen (mainly estradiol), androgens (mainly testosterone), and
progesterone. Estrogen causes endometrial proliferation. After ovulation, the
corpus luteum produces progesterone, which prepares the endometrium for embryo
implantation. If pregnancy does not occur, the endometrium breaks down and is
sloughed during menses. </span></p>

<p><span></span></p>

<p><span>Disruption of the hypothalamic-pituitary-ovarian axis results in
anovulatory amenorrhea.<span >&nbsp; </span>Amenorrhea
can also occur with normal ovulation (because of anatomic defects that prevent
normal menstrual flow). <i>Anovulatory</i>
amenorrhea, however, is by far the most common type of secondary amenorrhea. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=307 valign=top>
  <p style="text-align:center;"><span>Causes of Anovulatory Amenorrhea</span></p>
  </td>
 </tr>
 <tr>
  <td width=307 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=307 valign=top>
  <p><span><span>v<span>&nbsp; </span></span></span><span>Hypothalamic
  dysfunction</span></p>
  <p><span><span>v<span>&nbsp; </span></span></span><span>Pituitary dysfunction</span></p>
  <p><span><span>v<span>&nbsp; </span></span></span><span>Ovarian dysfunction</span></p>
  <p><span><span>v<span>&nbsp; </span></span></span><span>Other</span></p>
  <p><span><span>Ø<span>&nbsp;
  </span></span></span><span>Hypothyroidism/Hyperthyroidism</span></p>
  <p><span><span>Ø<span>&nbsp;
  </span></span></span><span>Obesity (excess estrogen)</span></p>
  <p><span><span>Ø<span>&nbsp;
  </span></span></span><span>Polycystic ovary disease (excess androgen)</span></p>
  <p><span><span>Ø<span>&nbsp;
  </span></span></span><span>Cushing’s syndrome (excess androgen)</span></p>
  <p><span><span>Ø<span>&nbsp;
  </span></span></span><span>Drugs (androgens, estrogens, progestins)</span></p>
  <p><span><span>Ø<span>&nbsp;
  </span></span></span><span>Neoplastic (tumors producing androgens, estrogens, or human
  chorionic gonadotropin)</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Certain findings suggest certain disorders.</span></p>

<p><span><span >&nbsp;</span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Finding</span></p>
  </td>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Disorder</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Galactorrhea</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Hyperprolactinemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Bitemporal
  hemianopsia and headache</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Pituitary
  tumor, most commonly with elevated prolactin levels</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Hot
  flushes, night sweats, vaginal dryness</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Estrogen
  deficiency (e.g., menopause)</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Virilization
  (acne, hirsutism, deepening voice)</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Androgen-producing
  tumor</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Obesity,
  hirsutism, acanthosis nigricans</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Polycystic
  ovary syndrome</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Fatigue,
  weight gain, cold intolerance</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Hypothyroidism</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Palpitations,
  tremor, heat intolerance</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Hyperthyroidism</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Moon
  face, buffalo hump, truncal obesity, thin extremities, violaceous abdominal
  striae</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Cushing’s
  syndrome</span></p>
  </td>
 </tr>
</table>

<p><span>Note: The first step in evaluating a patient with amenorrhea is to exclude
pregnancy. </span></p>

<p><b><span>Answer B is correct</span></b><span>. The patient in the
vignette has amenorrhea and galactorrhea. This combination suggests the
presence of elevated prolactin levels. Hyperprolactinemia is associated with
many conditions, most of which produce mild-to-moderate elevations in serum
prolactin. Prolactin-secreting pituitary adenomas produce high levels of
prolactin (&gt;200 ng/mL). In this clinical vignette, the prolactin level is
400 ng/mL. The cause is likely to be a lactotroph macroadenoma. Bitemporal
hemianopia results from disturbance of the optic chiasm, which is located above
the pituitary gland. Pituitary tumors are the most common cause of bitemporal
hemianopia.<span >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. The patient does not
have symptoms of hypothyroidism, and the thyroid-stimulating hormone (TSH)
level is normal. (It should be elevated in primary hypothyroidism). </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. The patient does not
have symptoms of menopause (hot flushes, night sweats, or vaginal dryness).
Also, the follicle-stimulating hormone (FSH) level is normal. (The FSH level
should be elevated in menopause.)</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Pregnancy is unlikely
with a negative beta-hCG. Also, it would not explain bitemporal hemianopia. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. The patient does not
have obesity, hirsutism, or acanthosis nigricans, which would suggest
polycystic ovary syndrome.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An infant is brought to the clinic because of an
itchy facial rash. The parents have asthma and allergic rhinitis. What is the
most likely diagnosis?</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=290 height=218
src="_%20Tutorials_files/image350.png"
alt="Description: 756148-762044-762045-1710117" v:shapes="Picture_x0020_347322"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Rosacea</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tinea
faciale</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Psoriasis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Erythema
infectiosum</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Atopic
dermatitis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Atopic dermatitis</span></b><span>, also called “infantile eczema,” is a pruritic disease that usually
starts in early infancy. It may be associated with other atopic (IgE-mediated)
disorders, such as asthma, allergic rhinitis, and urticaria. Severe itching is
typical. In infants, lesions usually appear on the cheeks, forehead, scalp, and
extensor surfaces of the legs. </span><span>The skin reacts abnormally to irritants, food, and
environmental allergens, and becomes red, flaky (eczematous), very itchy, and
vulnerable to bacterial infection.</span><span> </span><span><span>&nbsp;</span></span><span>The central face has a
characteristic pallor. </span><span>75%
of the cases improve by the time the child reaches adolescence; 25% have
difficulties through adulthood.<span></span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=190 height=124
src="_%20Tutorials_files/image352.png" alt="Description: n1510" v:shapes="Picture_x0020_347321"><img border=0 width=183 height=124
src="_%20Tutorials_files/image354.png" alt="Description: atopic_dermatitis"
v:shapes="Picture_x0020_347320"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Rosacea</span></b><span> is rare in infants.
Clinically, there is a combination of erythema, papules and pustules. There is
no scale. </span></p>

<p><span></span></p>

<p><b><span>Tinea faciale</span></b><span> is a superficial fungal
infection caused by dermatophytes. Lesions are usually asymmetric and exhibit
central clearing. </span></p>

<p><span></span></p>

<p><b><span>Psoriasis</span></b><span> can affect the face but
lesions have thicker silvery scale and pruritus is variable. Lesions tend to
involve the scalp too. </span></p>

<p><span></span></p>

<p><b><span>Erythema infectiosum</span></b><span>, or “fifth disease,” is
caused by parvovirus B19. Bright red cheeks are a defining characteristic of
the disease (hence the name &quot;slapped cheek disease&quot;) but lesions do
not have scales. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. The infant has atopic
dermatitis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following conditions is <i>least</i>
likely to cause nail clubbing?</span></p>

<p style="text-align:center;"><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Bronchogenic
carcinoma</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Emphysema</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lung
abscess</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Mesothelioma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tuberculosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Causes of Clubbing</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Pulmonary
  disease</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Bronchogenic carcinoma
  (mainly large cell)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Interstitial lung
  disease </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Tuberculosis </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Suppurative lung
  disease (lung abscess, empyema, bronchiectasis, cystic fibrosis) </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Mesothelioma</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Cardiac
  disease</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Congenital cyanotic
  heart disease</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Subacute bacterial
  endocarditis </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Atrial myxoma</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Gastrointestinal
  disease</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Crohn's disease and
  ulcerative colitis </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Primary biliary
  cirrhosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hepatopulmonary
  syndrome (a complication of cirrhosis)</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Other</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hyperthyroidism</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Thymoma</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>.<span>&nbsp; </span>Emphysema does not cause nail clubbing.
If a patient with emphysema is found to have clubbing, a search for
bronchogenic carcinoma should be undertaken. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
6-year-old girl presents with a painless mass in the midline of the neck just
below the hyoid bone. The mass appeared five months ago and has been growing.
Serum T4, T3, and TSH levels are normal. What is the most likely diagnosis?</span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Thyroglossal
duct cyst<span >&nbsp; </span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Brachial
cleft cyst</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dermoid
cyst</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Lipoma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ectopic
thyroid gland</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=160 height=156
src="_%20Tutorials_files/image356.png"
alt="Description: http://www.cssd.us/images/medicalinfo/thryglossalcyst.jpg"
v:shapes="Picture_x0020_347313"></span><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Congenital
neck masses are common in children but can occur in any age group. Classifying
these into midline or lateral location helps in the workup.</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Midline<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>a.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Thyroglossal duct cysts</span></i><span> are the most common anterior midline
neck masses in children. They are remnants of the descending tract of the
thyroid gland from the foramen cecum at the base of the tongue to its normal
position in the lower neck.<a name=4-u1.0-B978-1-4377-1160-8..10019-3--pg33></a>
Cysts or fistulas can occur anywhere along this tract and can intermittently
become infected. Physical examination usually reveals a 2-cm to 4-cm mass in
the anterior neck that moves with swallowing and elevates with tongue
protrusion. Treatment is surgical excision of the cyst and the tract. </span></p>

<p><a name=4-u1.0-B978-1-4377-1160-8..10019-3--f004></a><span><span>b.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Dermoid cysts</span></i><span> typically develop along midline embryonic
fusion planes and are composed of ectodermal and mesodermal embryonic remnants.
Their usual location in the neck is in the submental area. They are also found
frequently along the dorsum of the nose. Dermoid cysts tend not to move with
swallowing or elevate with tongue protrusion, unlike thyroglossal duct cysts.
Treatment is surgical excision.</span></p>

<p><span><span>c.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Ranulas</span></i><span> are cystic lesions that are usually present in the floor of
the mouth. They can extend through muscle planes into the upper midneck area. </span></p>

<p><a name=4-u1.0-B978-1-4377-1160-8..10019-3--s053></a><a
name=4-u1.0-B978-1-4377-1160-8..10019-3--cese></a><span></span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lateral<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>a.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Branchial cleft cysts</span></i><span> are common congenital abnormalities found in
the lateral neck area. They are caused by failure of obliteration of the
embryonic branchial clefts and can manifest as sinus tracts or fistulas. These
can become intermittently infected, especially after upper respiratory tract
infections.</span></p>

<p><span><span>b.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Lymphangiomas</span></i><span> (cystic hygromas) are congenital lymphatic
masses often found in the neck. They usually manifest during the first year of
life and often enlarge after upper respiratory tract infection. They are caused
by incomplete development and subsequent obstruction of the lymphatic system.
Most are found in the posterior triangle of the neck. </span></p>

<p><i><span><span>c.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Hemangiomas</span></i><span> are the most common congenital malformations.
Most are cutaneous, but they can appear in deep tissues. They are characterized
by appearance at or after birth, followed by a rapid proliferative phase at 6
to 18 months of age. They then reach a plateau phase, followed by a slow,
involutional phase over 6 to 8 years. Even large, uncomplicated lesions left
untreated usually undergo almost complete resolution. <i></i></span></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. Thyroglossal duct
cysts are the most common type of congenital midline neck mass. The thyroid
gland originates as the thyroid diverticulum at the base of the pharynx. During
development, it descends into the neck and remains connected to the tongue by the
thyroglossal duct. The duct eventually disappears, although part of it may
remain and form a cyst. These cysts are midline, painless, and usually located
near the hyoid bone. Surgical excision, which is recommended if the thyroid
gland is normal, prevents further growth and infection. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Brachial cleft cysts
are usually lateral in location and may be associated with fistulas or sinus
tracts. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Dermoid cysts, the
second most common midline neck mass, are usually located in the submental area
or on the dorsum of the nose.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Lipomas are more
common in adults than children and are rarely midline in location.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. An ectopic thyroid
gland occurs when the thyroid fails to descend during development.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 52-year old woman presents with a two-week
history of severe itching of the eyelids. What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=265 height=180
src="_%20Tutorials_files/image358.png" alt="Description: quiz010" v:shapes="Picture_x0020_347312"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Dermatomyositis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Seborrheic
dermatitis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Contact
dermatitis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Tinea
faciale</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Psoriasis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Contact dermatitis</b> is
caused by exposure to irritants (irritant contact dermatitis) or<span> </span>allergens (allergic contact
dermatitis). The condition is characterized by inflammation of the epidermis
and outer dermis. Symptoms include:</p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Red rash</span></b><span>. In irritant contact dermatitis, the rash appears
immediately; in allergic contact dermatitis, the rash appears 24&#8211;72 hours
after exposure. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Blisters or wheals</span></b><span>. Blisters, wheals (welts), and urticaria
(hives) often form in a pattern of skin exposure to the irritant or allergen. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Itchy, burning skin</span></b><span>. Irritant contact dermatitis tends to be
painful; allergic contact dermatitis tends to be itchy. </span></p>

<p><span></span></p>

<p><span>In irritant contact
dermatitis, a chemical (e.g., acid, alkali, solvent, oxidant, rubber, latex)
has a direct cytotoxic effect on epidermal cells. An example would be “diaper
dermatitis.” </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=111 height=146
src="_%20Tutorials_files/image360.png" alt="Description: 80m" v:shapes="Picture_x0020_347311"></span><span><span>&nbsp;</span></span><span></span></p>

<p><span></span></p>

<p><span>In allergic contact
dermatitis, the appearance of the rash is usually delayed. Exposure to plants
of the <span>Toxicodendron</span> genus
(e.g., poison ivy, poison oak, poison sumac) can cause allergic contact
dermatitis.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=227 height=164
src="_%20Tutorials_files/image362.png"
alt="Description: Poison-Ivy-Rash-Bubbles" v:shapes="Picture_x0020_347310"></span><span></span></p>

<p><span></span></p>

<p><span>Exposure to metal
alloys, sunscreens, cements, household cleaners, formaldehyde, dyes, and
rubbers can also cause allergic contact dermatitis. Involvement of the eyelids
alone suggests a cosmetic etiology.</span></p>

<p><span><span>&nbsp;</span></span></p>

<p style="text-align:center;"><span><img border=0 width=152 height=101
src="_%20Tutorials_files/image364.png" alt="Description: dermatitis-5" v:shapes="Picture_x0020_347309"></span><span><span>&nbsp; </span><span><img border=0 width=162 height=103
src="_%20Tutorials_files/image366.png" alt="Description: swollen-eyelids-rash"
v:shapes="Picture_x0020_347308"></span></span></p>

<p><span></span></p>

<p>Note: Allergic contact
dermatitis (ACD) occurs in two stages: an <span>induction phase</span>, which primes and sensitizes the immune system,
and an <span>elicitation phase</span>, in
which the response is triggered. </p>

<p></p>

<p>ACD is a Type IV delayed
hypersensitivity reaction involving a cell-mediated immune response. Contact
allergens are soluble haptens (low in molecular weight) that cross the stratum
corneum of the skin. They can elicit an immune response only as part of a
complete antigen, which requires their association with epidermal proteins to
form hapten-protein conjugates. These conjugates are recognized as foreign
bodies by Langerhans cells, which internalize the protein; transport it through
the lymphatic system to regional lymph nodes; and present it to T-lymphocytes.
This process is controlled by cytokines and chemokines. As the Langerhans cells
are transported to the lymph nodes, they differentiate into dendritic cells,
which are immunostimulatory. In lymph glands, dendritic cells present the
epitope to the T-lymphocytes, which differentiate and multiply so that they can
respond quickly and aggressively if the allergen appears again.</p>

<p><b></b></p>

<p><b>Dermatomyositis</b> is associated with a heliotrope rash, a violaceous
discoloration of the upper and lower eyelids and periorbital skin, usually with
edema. </p>

<p><b></b></p>

<p><b>Seborrheic dermatitis</b>
is an inflammatory disorder of the scalp, face, and trunk that produces red,
itchy, flaky skin. Rarely, the eyelids are the only site involved.</p>

<p><b></b></p>

<p><b>Tinea faciale</b> is a superficial fungal infection caused by
dermatophytes. Lesions are usually asymmetric and exhibit central clearing. </p>

<p><b><span></span></b></p>

<p><b><span>Psoriasis </span></b><span>can affect the face but
lesions have thicker silvery scale and pruritus is variable. Lesions tend to
involve the scalp too. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b><span>Answer C is correct</span></b><span>. The most likely
diagnosis is contact dermatitis. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
45-year-old man is found to have osteopenia on pre-operative chest x-ray. His
past medical history is significant for hypertension. Review of systems reveals
a 75 lb-weight gain in the past three years. His blood pressure is 170/105 mm
Hg. Exam findings include marked fullness of the lower face; supraclavicular
fat pads; and deep, wide, purple striae on the flanks and anterior abdominal
wall. Blood tests show a serum potassium level of 2.8 meq/L. The 24-hour
urinary free cortisol level is 520 &#956;g (normal &lt; 110 &#956;g). The serum
adrenocorticotropic hormone (ACTH) level is 30 pg/mL (normal: 10-20 pg/mL). A
high-dose dexamethasone suppression test lowers the serum cortisol level to
&lt;50% of the baseline value. MRI of the pituitary shows a 5 mm mass in the
anterior pituitary. Which of the following correctly explains the patient’s
high blood pressure and low serum potassium level? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>ACTH
binding to glucocorticoid receptors</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ACTH
binding to mineralcorticoid receptors</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cortisol
binding to glucocorticoid receptors</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Cortisol
binding to mineralcorticoid receptors </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

</div>

<span><br clear=all>
</span>

<div>The term
“Cushing syndrome” is used to describe a condition resulting from long-term
exposure to excessive glucocorticoids. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=257 valign=top>
  <p style="text-align:center;"><span>Clinical
  Features of Cushing Syndrome</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Sudden weight gain</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Central obesity</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Hypertension</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Facial plethora</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Proximal muscle weakness</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Glucose intolerance and
  diabetes mellitus</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Decreased libido or
  impotence</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Depression or psychosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Osteopenia or
  osteoporosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Easy bruising</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Hyperlipidemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Menstrual disorders</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Violaceous striae wider
  than 1 cm</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Recurrent opportunistic
  or bacterial infections </span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Acne</span></p>
  </td>
 </tr>
 <tr>
  <td width=257 valign=top>
  <p><span>Hirsutism</span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>Cushing
syndrome is most commonly caused by administration of exogenous
glucocorticoids. The term “Cushing disease” is reserved for Cushing syndrome
that is caused by excessive secretion of adrenocorticotropin hormone (ACTH) by
a pituitary tumor, usually an adenoma.</p>

<p></p>

<p>Cushing
disease is responsible for roughly two-thirds of the cases of endogenous
Cushing syndrome. The remaining endogenous cases are caused by ectopic
ACTH-secreting tumors and primary adrenal neoplasms. Cushing disease occurs
most frequently in women of reproductive age, but it can affect males and
females of any age.The pituitary tumors in Cushing disease are usually
microadenomas, which, by definition, are 10 mm or less in diameter.
Microadenomas generally do not cause symptoms by local mass effect. These
tumors are most often discovered when clinical manifestations of
hypercortisolism resulting from hypersecretion of ACTH prompt an appropriate
diagnostic work-up. Occasionally, microadenomas are found incidentally during
imaging performed for other reasons. Macroadenomas are uncommon in patients
with Cushing disease. These tumors cause mass effect when their size exceeds 15
mm in diameter. Suprasellar extension and optic chiasm compression, local bone
erosion, cavernous sinus compression, and panhypopituitarism may occur as a
macroadenoma enlarges. </p>

<p></p>

<p>Although
pituitary adenomas causing Cushing disease secrete excessive amounts of ACTH,
they generally retain some negative feedback responsiveness to high doses of
glucocorticoids. Ectopic sources of ACTH, usually in the form of extracranial
neoplasms, however, are generally not responsive to negative feedback with high
doses of glucocorticoids. A common effect of elevated ACTH levels (whatever the
source) is bilateral adrenocortical hyperplasia.</p>

<p><span>When
Cushing syndrome is suspected, initial laboratory testing is usually directed
at confirming excessive glucocorticoid production. This is best accomplished
through analysis of a 24-hour urine collection for urinary free cortisol
excretion. Values greater than 300 &#956;g/day are considered diagnostic for
Cushing syndrome.</span></p>

<p><span></span></p>

<p><span>Once
hypersecretion of cortisol is confirmed, the next step is to determine whether
the pathologic state is ACTH-dependent or ACTH-independent. This can be
accomplished through measurement of the late-afternoon ACTH level.
(Late-afternoon (after 4 p.m.) timing is important because ACTH levels are
normally low at that time.) If the plasma ACTH level is &gt; 10 pg/mL, then the
process is ACTH-dependent. If the ACTH level is &lt; 5 pg/mL, then the process
is ACTH-independent.</span></p>

<p><span></span></p>

<p><span>If the
process is ACTH-dependent, a high-dose dexamethasone suppression test combined
with cranial MRI studies may aid in localizing the site of ACTH overproduction.
In an 8-mg overnight dexamethasone suppression test, a single 8-mg dose of
dexamethasone is given at 11 p.m., and the serum cortisol level is measured at
8 a.m. the next morning. Suppression of the cortisol level to less than 50% of
baseline is considered indicative of Cushing disease (pituitary microadenoma).
Failure of dexamethasone to suppress cortisol levels to less than 50% of
baseline suggests an ectopic source of ACTH production (e.g. extracranial
neoplasm). </span></p>

<p><span></span></p>

<p><span>The
patient in this vignette has signs of Cushing syndrome: moon face,
supraclavicular fat pads, violaceous striae, hypertension, weight gain, and
osteopenia. A high urinary free cortisol level confirms the diagnosis of
Cushing syndrome. The high ACTH level indicates that the disorder is
ACTH-dependent. A positive high-dose dexamethasone test (suppression of serum
cortisol to &lt; 50% baseline) indicates that the patient most likely has
Cushing disease (a pituitary microadenoma secreting ACTH).<span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Excessive
ACTH production stimulates the adrenal glands to produce excessive cortisol.
Free cortisol passes easily through cellular membranes, where it binds to the
glucocorticoid receptor. The glucocorticoid receptor is expressed in almost
every cell in the body and regulates genes controlling the development,
metabolism, and immune response. Aldosterone, which is regulated mainly through
the renin-angiotensin system, also passes easily through cellular membranes. It
acts on mineralocorticoid receptors within the cells of the distal tubule and
the collecting duct of the kidney nephron. This activates the basolateral Na<sup>+</sup>/K<sup>+</sup>
pumps, which pump three sodium ions out of the cell and two potassium ions into
the cell. This results in reabsorption of sodium (Na<sup>+</sup>) ions and
water (which follows sodium) into the blood, and secreting potassium (K<sup>+</sup>)
ions into the urine (lumen of collecting duct). </span></p>

<p><span></span></p>

<p><span>The
mineralocorticoid receptor is activated by mineralocorticoids, such as
aldosterone and deoxycorticosterone, as well as glucocorticoids, such as
cortisol. Normally, the mineralocorticoid receptor is “protected” from
glucocorticoids by co-localization of an enzyme, 11ß-hydroxysteroid
dehydrogenase type 2 (11ß-HSD2), which converts cortisol to inactive cortisone.
In states of excess cortisol (Cushing syndrome), the enzymatic activity can be
overwhelmed such that bound cortisol is not metabolized and there is activation
of the mineralcorticoid receptor. Thus, cortisol will have mineralcorticoid
activity under this circumstance. </span></p>

<p><b><span>Answer D is correct.</span></b></p>

<p><b><span></span></b></p>

<p><span>Aldosterone
responsive epithelial tissues express the mineralocorticoid receptor, which
binds both cortisol and aldosterone. In fact, this mineralocorticoid receptor
binds cortisol 10 times more avidly than it binds aldosterone. The effect of
cortisol, however, is eliminated by the enzyme 11&#946;-hydroxysteroid
dehydrogenase 2, which metabolizes cortisol to inactive cortisone. In states of
excess cortisol, the enzymatic activity of 11&#946;-hydroxysteroid
dehydrogenase 2 can be overwhelmed such that bound cortisol is not metabolized
and there is activation of the mineralcorticoid receptor. Thus, cortisol will
have mineralcorticoid activity under this circumstance. The mineralocorticoid
activity causes a rise in blood pressure (due to the absorption of sodium and
water from tubules) and a drop in serum potassium levels. Inactivating
mutations of 11&#946;-hydroxysteroid dehydrogenase 2 give mineralocorticoid
activity that is mediated by cortisol, not aldosterone.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>A 12-year-old girl has a
3-week history of excessive thirst and urination. She takes no medication and
has no history of renal disease. Her blood sugar is normal. After an 8-hour
water deprivation test, she continues to produce large volumes of dilute urine.
When 5 units of ADH (vasopressin) is administered subcutaneously, she still
continues to produce large volumes of dilute urine. Her symptoms are most
likely due to a relative lack of which of the following proteins from the
apical membranes of collecting duct epithelial cells?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Epithelial Na<sup>+</sup> channel</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Na<sup>+</sup>-K<sup>+</sup>-ATPase</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>-</sup>
cotransporter</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Aquaporin</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Urea transporter</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Arginine vasopressin (AVP),
also known as antidiuretic hormone (ADH), is the primary determinant of free
water excretion in the body. Its main target is the kidney, where it acts by
altering the water permeability of the collecting tubules. Under the influence
of ADH, water is reabsorbed in the collecting tubules by osmotic equilibration
with the hypertonic interstitium. The water is returned to the systemic
circulation. </p>

<p></p>

<p><span>Diabetes insipidus</span> (<span>DI</span>)
is a condition associated with decreased production or decreased effectiveness
of ADH.<span >&nbsp; </span>It is characterized by
excessive thirst and large-volume excretion of dilute urine, irrespective of
fluid intake. </p>

<p></p>

<p>There are two major types of
DI: central DI, which is caused by decreased production of ADH, and nephrogenic
DI, which is caused by renal insensitivity to ADH. Central DI is usually caused
by hypothalamic disruption. Lesions of the posterior pituitary rarely cause
permanent DI because ADH is produced in the hypothalamus and can still be
secreted into the circulation. </p>

<p></p>

<p>Nephrogenic DI may be
hereditary or acquired. The hereditary form is usually caused by an X-linked
mutation, which impairs the function of the vasopressin receptor (also called
the V2 receptor). Less commonly, hereditary nephrogenic DI is caused by a mutation
in the aquaporin 2 gene. <span>Aquaporins</span>
are proteins that regulate the flow of water. They are imbedded in the cell
membrane and selectively conduct water molecules into and out of the cell,
while preventing the passage of ions and other solutes. The presence of these
water channels increases membrane permeability to water. Aquaporin 2 is
regulated by ADH.<span >&nbsp; </span></p>

<p></p>

<p>Acquired nephrogenic DI may
be caused by lithium toxicity, hypercalcemia, hypokalemia, or
tubulointerstitial disease. Lithium causes acquired diabetes insipidus by
decreasing the expression of the aquaporin 2 gene.</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer D is correct</b>. </p>

<p></p>

<p>Polyuria, the production of
abnormally large volumes of urine, may be caused by increased water intake,
diuretic use, diabetes mellitus, or diabetes insipidus. The patient in this
vignette takes no medication, excluding diuretic use as a possible cause. Also,
her blood sugar is normal, making diabetes mellitus unlikely. She continues to
produce large volumes of dilute urine despite water deprivation, excluding
excessive water intake as a cause. Consequently, diabetes insipidus (DI) is the
most likely diagnosis. </p>

<p></p>

<p>DI may be central or
nephrogenic. Central DI responds to the administration of ADH, which causes the
kidneys to reabsorb water. In this vignette, the patient does not respond to
ADH administration, suggesting a nephrogenic problem. Nephrogenic DI may be
hereditary or acquired. In an otherwise healthy young person, a hereditary
problem is most likely. Hereditary nephrogenic DI is usually X-linked
(affecting males only) and results in impaired functioning of the V2 receptor.
By contrast, mutation of the aquaporin 2 gene is usually autosomal recessive
and rarely autosomal dominant; both males and females can be affected. In this
vignette, an otherwise healthy young girl has nephrogenic DI. The most likely
explanation is mutation of the aquaporin 2 gene. <span>&nbsp;</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Which of
the following diabetes drugs causes neither weight gain nor hypoglycemia?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Glipizide
(Glucotrol)</span></p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Pioglitazone
(Actos)</span></p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Exenatide
(Byetta)</span></p>

<p><span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Insulin
glargine (Lantus)</span></p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Repaglinide
(Prandin)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellpadding=0 width="100%">
 <tr>
  <td colspan=5 valign=top><span><br clear=all>
  </span>
  <p style="text-align:center;"><b><span>MEDICATIONS FOR TYPE 2 DIABETES</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>Classification</span></b><span></span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><b><span>Medication</span></b><span></span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><b><span>Route</span></b><span></span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><b><span>Effects</span></b><span></span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><b><span>Side effects</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Sulfonylurea</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Glipizide</span></p>
  <p style="text-align:center;"><span>Glyburide</span></p>
  <p style="text-align:center;"><span><span >&nbsp;</span>Glimepiride</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Oral</span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><span>Stimulates insulin secretion</span></p>
  <p style="text-align:center;"><span>(glucose-independent)</span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><span>Hypoglycemia</span></p>
  <p style="text-align:center;"><span>Weight gain</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Biguanide</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Metformin</span></p>
  <p style="text-align:center;"><span>(Glucophage)</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Oral</span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><span>Inhibits hepatic gluconeogenesis</span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><span>Abdominal pain</span></p>
  <p style="text-align:center;"><span>Nausea</span></p>
  <p style="text-align:center;"><span>Diarrhea</span></p>
  <p style="text-align:center;"><span>Lactic acidosis</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Alpha-Glucosidase inhibitor</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Acarbose</span></p>
  <p style="text-align:center;"><span>(Precose)</span></p>
  <p style="text-align:center;"><span>Miglitol</span></p>
  <p style="text-align:center;"><span>(Glycet)</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Oral</span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><span>Delays carbohydrate absorption</span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><span>Abdominal pain</span></p>
  <p style="text-align:center;"><span>Nausea</span></p>
  <p style="text-align:center;"><span>Diarrhea</span></p>
  <p style="text-align:center;"><span>Elevated liver enzymes</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Thiazolidinedione</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Pioglitazone</span></p>
  <p style="text-align:center;"><span>(Actos)</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Oral</span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><span>Insulin sensitizer</span></p>
  <p style="text-align:center;"><span>(PPAR-&#947; agonist)</span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><span>Fluid retention</span></p>
  <p style="text-align:center;"><span>Weight gain</span></p>
  <p style="text-align:center;"><span>Heart failure</span></p>
  <p style="text-align:center;"><span>Edema</span></p>
  <p style="text-align:center;"><span>Anemia</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Meglitinide</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Repaglinide</span></p>
  <p style="text-align:center;"><span>(Prandin)</span></p>
  <p style="text-align:center;"><span>Nateglitinide</span></p>
  <p style="text-align:center;"><span>(Starlix)</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Oral</span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><span>Stimulates insulin secretion</span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><span>Hypoglycemia</span></p>
  <p style="text-align:center;"><span>Weight gain</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>DPP-4 inhibitor</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Sitagliptin</span></p>
  <p style="text-align:center;"><span>(Januvia) </span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Oral</span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><span>Increases insulin secretion</span></p>
  <p style="text-align:center;"><span>(glucose-dependent)</span></p>
  <p style="text-align:center;"><span>Decreases glucagon secretion</span></p>
  <p style="text-align:center;"><span>Slows gastric emptying</span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><span>None</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Incretin mimetic</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Exenatide</span></p>
  <p style="text-align:center;"><span>(Byetta)</span></p>
  <p style="text-align:center;"><span>Liraglutide</span></p>
  <p style="text-align:center;"><span>(Victoza)</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Injectable</span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><span>Increases insulin secretion</span></p>
  <p style="text-align:center;"><span>(glucose-dependent)</span></p>
  <p style="text-align:center;"><span>Decreases glucagon secretion</span></p>
  <p style="text-align:center;"><span>Slows gastric emptying</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><span>Nausea</span></p>
  <p style="text-align:center;"><span>Diarrhea</span></p>
  <p style="text-align:center;"><span>Weight loss</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Amylin analog</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Pramlintide</span></p>
  <p style="text-align:center;"><span>(Symlin)</span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Injectable</span></p>
  </td>
  <td width="26%" valign=top>
  <p style="text-align:center;"><span>Slows gastric emptying</span></p>
  <p style="text-align:center;"><span>Promotes satiety</span></p>
  <p style="text-align:center;"><span>Inhibits glucagon secretion</span></p>
  </td>
  <td width="19%" valign=top>
  <p style="text-align:center;"><span>Nausea</span></p>
  <p style="text-align:center;"><span>Anorexia</span></p>
  <p style="text-align:center;"><span>Hypoglycemia</span></p>
  </td>
 </tr>
</table>

<p><span>PPAR-&#947;:
</span><span>peroxisome
proliferator-activated receptor gamma</span></p>

<p><span>DPP-4:
</span><span>dipeptidyl
peptidase IV</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>.<span>&nbsp; </span>Exenatide is a synthetic version of
exendin-4, a hormone found in the saliva of the Gila monster. It displays
biological properties similar to human glucagon-like peptide-1 (GLP-1), a
regulator of glucose metabolism and insulin secretion.<span>&nbsp; </span>GLP-1 is an incretin hormone released
from the gut in response to eating.<span >&nbsp;
</span>It causes glucose-dependent insulin synthesis and release, meaning that
there is only an increase in insulin if the glucose is above a minimal
threshold.<span >&nbsp; </span>As glucose levels
decline, insulin release also declines. Because insulin secretion is
glucose-dependent, hypoglycemia does not occur. GLP-1 has the central effect
(at the hypothalamus) of reducing appetite. Delayed gastric emptying is another
effect of GLP-1. This results in weight loss in most patients.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>.<span>&nbsp; </span>Glipizide is a sulfonylurea agent that
works by binding to the sulfonylurea receptor on pancreatic &#946; cells.<span>&nbsp; </span>This closes the receptor, preventing
potassium efflux. Subsequent depolarization and calcium influx results in the
release of insulin. The net effect is an uncontrolled increase in circulating
insulin.<span >&nbsp; </span>During periods of reduced
or delayed caloric <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>intake,
hypoglycemia is possible. Anti-diabetic agents with the primary mechanism of
uncontrolled insulin release typically cause weight gain in proportion to the
extent of glycemic improvement.</span></p>

<p><span><span>&nbsp;</span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span>&nbsp; </span>Pioglitazone is thiazolidinedione agent
that selectively stimulates the nuclear receptor peroxisome
proliferator-activated receptor gamma (PPAR-&#947;), which results in increased
expression of GLUT1 and GLUT2 in peripheral tissues. GLUT1 and GLUT2 are
transmembrane carrier proteins that enable passive glucose movement across cell
membranes. By increasing expression of GLUT1 and GLUT2, pioglitazone decreases
insulin resistance. It does not cause hypoglycemia because it does not change
the amount of available insulin. Weight gain commonly occurs due to fluid
retention.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>.<span>&nbsp; </span>Insulin glargine, like all insulin
products, can cause weight gain and hypoglycemia.</span></p>

<p><span></span></p>

<p><b>Answer E is incorrect</b>. Repaglinide is a type of meglitinide.
Meglitinides bind to ATP-dependent K<sup>+</sup> (K<sub>ATP</sub>) channels on
the cell membrane of pancreatic &#946; cells in a similar manner to
sulfonylureas but at a separate binding site. This binding closes the receptor,
preventing potassium efflux. Subsequent depolarization and calcium influx
results in the release of insulin. Hypoglycemia and weight gain are potential
side effects of the medicine. </p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Match each
of the following diabetes medicines with its mechanism of action. </span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Glipizide</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Metformin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pioglitazone</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Acarbose</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Exenatide</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sitagliptin
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>1.
Inhibits dipeptidyl peptidase IV (DPP-IV), an enzyme that degrades incretins </span></p>

<p><span>2. Mimics
glucagon-like peptide 1, an incretin<span >&nbsp;
</span></span></p>

<p><span>3.
Inhibits alpha-glycosidase, an enzyme that breaks down carbohydrates </span></p>

<p><span>4.
Stimulates the nuclear receptor peroxisome proliferator-activated receptor
gamma (PPAR-&#947;), which modulates the transcription of insulin-sensitive
genes, thereby reducing insulin resistance in the liver and peripheral tissues</span></p>

<p><span>5. Reduces
gluconeogenesis, limits glucose absorption from the gut, and increases glucose
uptake in peripheral tissues</span></p>

<p><span>6.
Stimulates pancreas to produce insulin in glucose-<i>independent</i> manner</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>6.
Glipizide, a sulfonylurea, stimulates the pancreas to produce insulin in a
glucose-<i>independent </i>manner.<span>&nbsp; </span>Sulfonylureas bind the potassium channel
on the surface of beta cells, altering flux of potassium across the cell
membrane.<span >&nbsp; </span>This changes the activity
of voltage-dependent calcium channels, increasing intracellular calcium.<span>&nbsp; </span>This increased calcium through the
calcium channels induces insulin-containing secretory granules to undergo
exocytosis; thus, insulin is released.<span>&nbsp;&nbsp; </span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>5.
Metformin reduces gluconeogenesis, limits glucose absorption from the gut, and
increases glucose uptake in peripheral tissues</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>4.
Pioglitazone, a t<span>hiazolidinedione, s</span>timulates
the nuclear receptor peroxisome proliferator-activated receptor gamma
(PPAR-&#947;), ultimately reducing insulin resistance in the liver and
peripheral tissues</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>3.
Acarbose inhibits <span>alpha-glucosidase, an
enzyme that </span>breaks down carbohydrates</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>2.
Exenatide mimics glucagon-like peptide 1, an incretin<span>&nbsp; </span></span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>1.
Sitagliptin inhibits dipeptidyl peptidase IV (DPP-IV), an enzyme that degrades
incretins</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><!--[if supportFields]><span><span></span><span>&nbsp;</span>SEQ CHAPTER \h \r 1</span><![endif]--><!--[if supportFields]><span><span></span></span><![endif]--><span>A 52-year-old woman was diagnosed with type 2 diabetes
mellitus 18 years ago. Her physician recommended a diet, which she followed.
She lost 15 pounds and was able to maintain this weight for 3 years, during
which her blood sugar levels were normal. She then gained 20 pounds over 18
months and was started on metformin because her glycosylated hemoglobin level
had risen. Her blood sugar levels returned to normal, but 3 years later, they
rose again. At that time, glipizide was added to her regimen. Again, her blood
sugar levels returned to normal and her glycosylated hemoglobin levels ranged
from 6.5% to 7.0% over the ensuing years. Over the past 2 years, however, the
glycosylated hemoglobin level has remained above 10% despite adherence to her
medical regimen. Why are oral agents now failing to control her blood sugar
levels?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Metabolism
of oral agents accelerates over time. </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
patient is not truly adherent to her medical regimen.</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Failure
of these medications is expected as part of the natural history of type 2
diabetes mellitus.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br clear=all>
</span>

<p><span>Type 2
diabetes mellitus is characterized by two major metabolic defects: insulin
resistance and decreased insulin production. Insulin resistance precedes the
onset of diabetes, possibly by many decades. About 30% of Americans have
insulin resistance. This is defined as a decrease in the efficacy of insulin
(usually determined as removal of glucose from the peripheral blood) at any
given insulin level. Most people with insulin resistance do <i>not</i> have type 2 diabetes mellitus
because their pancreas is able to compensate for the resistance by producing
more insulin. In people who develop diabetes, however, the &#946; cells begin
to fail and insulin production declines. At the onset of type 2 diabetes
mellitus, about 50% of maximal insulin production is lost. At this stage,
patients may be treated of oral medicines, such as glipizide (which stimulates
&#946; cells to produce insulin) or metformin (which decreases insulin
resistance). Oral medicines may control blood sugar levels for years until
insulin secretion declines further. When insulin secretion falls to
approximately 10% of normal levels, oral medicines fail and patients require
exogenous insulin administration.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=377 height=268
src="_%20Tutorials_files/image368.png" alt="Description: natural_history"
v:shapes="Picture_x0020_347307"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>Type 2 diabetes mellitus
is characterized by progressive &#946;-cell dysfunction, which explains why
patients who once responded to lifestyle modification may require oral
medicines, and patients who once responded to oral medicines may require
insulin. </span></p>

<p><span>Therapy
must be advanced as &#946;-cell function deteriorates. </span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp; </span></span><span><span>

<table cellpadding=0 cellspacing=0>
 <tr>
  <td width=76 height=75 align=left valign=top bgcolor=white><span>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td>
    <div v:shape="Text_x0020_Box_x0020_347323"    <p    </div>
    </td>
   </tr>
  </table>
  </span>&nbsp;</td>
 </tr>
</table>

</span></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
32-year-old woman with type 1 diabetes mellitus develops a fever and cough. Her
appetite diminishes and she stops taking insulin because she is afraid to
administer it on an empty stomach. Her condition worsens and she is taken to
the emergency room. Her pulse is 120/minute, her blood pressure is 90/60 mm Hg,
and her respiratory rate is 28/minute. Blood tests show hyperglycemia,
metabolic acidosis, and ketosis. Urine tests show glucose and ketones. Which of
the following sets of hepatic findings is most likely in this patient?</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>cAMP</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>Protein Kinase A</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Phosphoprotein Phosphatase</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=45 valign=top>
  <p><span></span></p>
  </td>
  <td width=99 valign=top>
  <p><span></span></p>
  </td>
  <td width=86 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>A</span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>B</span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>C</span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>D</span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>E</span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>F</span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>G</span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>H</span></p>
  </td>
  <td width=45 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=99 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Diabetic ketoacidosis
(DKA), the most severe complication of type 1 diabetes mellitus, is
characterized by hyperglycemia, ketosis, and metabolic acidosis with an increased
anion gap. Rapid and aggressive treatment of DKA is essential, as metabolic
acidosis can result in cerebral edema, coma, and death.</span></p>

<p><span></span></p>

<p><span>The ketosis of DKA is
the result of insulin deficiency and unregulated glucagon secretion. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=167 valign=top>
  <p style="text-align:center;"><span>Effects of Insulin</span></p>
  </td>
  <td width=171 valign=top>
  <p style="text-align:center;"><span>Effects of Glucagon</span></p>
  </td>
 </tr>
 <tr>
  <td width=167 valign=top>
  <p><span></span></p>
  </td>
  <td width=171 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=167 valign=top>
  <p><span>Increases
  glycogen synthesis</span></p>
  </td>
  <td width=171 valign=top>
  <p><span>Increases
  glycogenolysis</span></p>
  </td>
 </tr>
 <tr>
  <td width=167 valign=top>
  <p><span>Increases
  lipid synthesis</span></p>
  </td>
  <td width=171 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=167 valign=top>
  <p><span>Increases
  amino acid uptake</span></p>
  </td>
  <td width=171 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=167 valign=top>
  <p><span>Increases
  potassium uptake</span></p>
  </td>
  <td width=171 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=167 valign=top>
  <p><span>Decreases
  proteolysis</span></p>
  </td>
  <td width=171 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=167 valign=top>
  <p><span>Decreases
  lipolysis</span></p>
  </td>
  <td width=171 valign=top>
  <p><span>Increases
  lipolysis</span></p>
  </td>
 </tr>
 <tr>
  <td width=167 valign=top>
  <p><span>Decreases
  gluconeogenesis</span></p>
  </td>
  <td width=171 valign=top>
  <p><span>Increases
  gluconeogenesis</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Glucagon stimulates
adipose tissue to release fatty acids stored in triglycerides. The free fatty
acids enter the circulation and are taken up by the liver where they undergo
fatty acid oxidation to acetyl CoA. Normally, acetyl CoA is completely oxidized
to CO<sub>2</sub> and H<sub>2</sub>O in the Krebs cycle. In DKA, however, fatty
acid oxidation is excessive and the liver cannot fully oxidize all the acetyl
CoA. It diverts the excess acetyl CoA into the ketogenesis pathway. The ketones
produced are &#946;-hydroxybutyrate and acetoacetate, with
&#946;-hydroxybutyrate being the most abundant. Acetoacetate is spontaneously
(non-enzymatically) decarboxylated to form acetone. Acetone is volatile and
released from the lungs, giving a sweet smell to the breath. Being acidic, the
ketones lower the pH of the blood producing a metabolic acidosis.</span></p>

<p><span>Glucose levels rise
because of gluconeogenesis and glycogenolysis in the liver.</span></p>

<p><span></span></p>

<p><span>1. Gluconeogenesis:
Triglyceride and protein catabolism is increased in skeletal muscle. This causes
release of glycerol (from triglycerides) and alanine (from protein) into the
circulation. These substances enter the liver where they are used as substrates
for gluconeogenesis. </span></p>

<p><span></span></p>

<p><span>2. Glycogenolysis:
Glucagon and epinephrine trigger glycogenolysis in the liver. </span></p>

<p><span>Glucose produced by the
liver is released into the circulation, producing hyperglycemia. </span></p>

<p><span>Hyperglycemia causes an
osmotic diuresis, whereby water and electrolytes are lost in the urine. As
ketones are excreted in the urine, there is an obligatory loss of Na<sup>+</sup>
and K<sup>+</sup>, and K<sup>+</sup> losses can be severe.</span></p>

<p><span></span></p>

<p><span>At the molecular level,
insulin, glucagon, and epinephrine function through the protein
kinase/phosphatase cascades (see below). DKA is characterized by insulin
deficiency and counterregulatory hormone (e.g., glucagon, epinephrine)
excess.<span >&nbsp; </span>Molecules activated by
glucagon and epinephrine are increased in DKA, whereas molecules activated by
insulin are decreased. <span>&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;</span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Protein
Kinase / Phosphatase Cascades</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=402 height=402
src="_%20Tutorials_files/image370.png" alt="Description: insulin3" v:shapes="Picture_x0020_347306"></span><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><b>Hormonal
Regulation of Protein Kinases and Protein Phosphatases</b></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=295 height=122
src="_%20Tutorials_files/image372.png" alt="Description: HormoneReg" v:shapes="Picture_x0020_347305"></span></p>

<p><b></b></p>

<p><b>I. Steps leading to
glycogen catabolism</b></p>

<p><span></span></p>

<p><span>Glucagon and epinephrine (adrenalin) bind
to receptors on the surface of liver and muscle cells.</span></p>

<p><span></span></p>

<p><span>The receptor-ligand complex activates
adenyl cyclase.</span></p>

<p><span></span></p>

<p><span>Adenyl cyclase converts ATP to cAMP, a
&quot;second messenger.&quot;</span></p>

<p><span></span></p>

<p><span>cAMP activates protein kinase A.</span></p>

<p><span></span></p>

<p><span>Protein kinase A phosphorylates:</span></p>

<p><span>1. phosphorylase kinase
(activating it)</span></p>

<p><span>2. glycogen synthase
(inactivating it)</span></p>

<p><span></span></p>

<p><span>Phosphorylase kinase phosphorylates
glycogen phosphorylase, activating it.</span></p>

<p><span></span></p>

<p><span>Phosphoprotein phosphatase (which removes
phosphates) is also phosphorylated, inactivating it.</span></p>

<p><b><span></span></b></p>

<p><b><span>II.
Steps leading to glycogen synthesis</span></b><span></span></p>

<p><span></span></p>

<p><span>To reverse
the above effects we need to dephosphorylate the proteins that were
phosphorylated in the above reactions. This occurs through activation of
phosphoprotein phosphatase. To achieve this, glucose must bind to glycogen
phosphorylase, releasing phosphoprotein phosphatase. Next, insulin-stimulated
protein kinase phosphorylates phosphoprotein phosphatase, activating it. The
active phosphoprotein phosphatase: </span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Removes
a phosphate group from glycogen phosphorylase, inactivating it </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Removes
a phosphate group from phosphorylase kinase, inactivating it </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Removes
a phosphate group for glycogen synthase, activating it</span></p>

<p><span></span></p>

<p><span>cAMP is
hydrolyzed to AMP by a phosphodiesterase. The destruction of the
&quot;messenger&quot; is necessary to reset the system to its normal metabolic
state and to make it responsive to the next set of hormonal signals. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer G is correct</span></b><span>. The patient in this
vignette has diabetic ketoacidosis. DKA is characterized by insulin deficiency
and counterregulatory hormone (e.g., glucagon, epinephrine) excess. Molecules
that are activated by glucagon and epinephrine (e.g., cAMP, protein kinase A)
will be increased, while molecules that are activated by insulin (e.g.,
phosphoprotein phosphatase) will be decreased. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 16-year-old girl is brought to the
emergency department after attempting suicide by cutting her wrist. The deepest
part of the wound is between the tendons of the flexor carpi radialis and the
flexor digitorum superficialis. This patient is most likely to have a deficit
of which of the following?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Adduction
and abduction of the fingers</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Extension
of the index finger</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Flexion
of the ring and small fingers</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Sensation
over the base of the small finger</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Opposition
of the thumb and other fingers</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><img border=0 width=490 height=291
src="_%20Tutorials_files/image374.png" alt="Description: gray422" v:shapes="Picture_x0020_347304"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Innervation of the Hand</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Median
Nerve </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Motor
</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Allows
for fine control of pincer grasp</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Innervates
thenar muscles and two radial lumbricals</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sensation
</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Radial
3.5 fingers, and their dorsal tips</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cutaneous
innervation image </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Course
</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Passes
via carpal tunnel through volar wrist</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Test
function </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Opposition
of thumb to each finger</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Observe
thenar muscles for contractions</span></p>

<p><span></span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ulnar
Nerve </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Motor
</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Allows
for power grip</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Innervates
all hand intrinsic muscles except: </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Does
not innervate two radial lumbricals</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Does
not innervate thenar muscles</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sensation
</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ulnar
1.5 fingers (palmar)</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Course
</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Passes
with ulnar artery via Guyon's Canal in wrist</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Test
function </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Finger
abduction against resistance</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Palpate
belly of first dorsal interosseus muscle</span></p>

<p><span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Radial
Nerve </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Motor
</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Innervates
extrinsic wrist and finger extensors</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Does
not innervate any intrinsic muscles</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sensation
</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dorsally
for 3.5 fingers</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Test
function </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wrist
and hand extension against resistance</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=376 height=282
src="_%20Tutorials_files/image376.png" alt="Description: NeuroMedianNerve"
v:shapes="Picture_x0020_347303"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=374 height=280
src="_%20Tutorials_files/image378.png" alt="Description: NeuroRadialNerve"
v:shapes="Picture_x0020_347302"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer E is correct. </span></b><span><span>&nbsp;</span>The median nerve lies between the tendons
of the flexor carpi radialis and the flexor digitorum superficialis
(subliminis). Injury to the median nerve would prevent opposition of the thumb
and other fingers. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect. </span></b><span><span>&nbsp;</span>The ulnar nerve is responsible for finger
adduction and abduction.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is incorrect.<span >&nbsp; </span></span></b><span>The radial nerve is
responsible for extension of the index finger.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is incorrect.<span >&nbsp; </span></span></b><span>The ulnar nerve is
responsible for flexion of the ring and small finger.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D
is incorrect.<span >&nbsp; </span></span></b><span>The ulnar nerve provides
sensation to the base of the small finger.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 72-year-old man presents with a painful rash (shown below). Which of
the following is <i>not</i> true regarding his condition?</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=265 height=180
src="_%20Tutorials_files/image380.png" alt="Description: quiz003" v:shapes="Picture_x0020_347301"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>The
rash is caused by the “chickenpox” virus</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
rash is caused by a virus that has a “dormant phase” in the dorsal root ganglia</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
condition is more common in adults than in children</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>The
pain may continue after the rash resolves</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
condition is highly contagious; exposed individuals may develop a similar rash</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Herpes zoster</span></b><span> is caused by varicella zoster virus
(VZV), a double-stranded DNA virus that belongs to the Herpes family. VZV
commonly infects children, causing </span><a
href="http://en.wikipedia.org/wiki/Chickenpox" title=Chickenpox><span>chickenpox</span></a><span>. After an episode of
chickenpox, the immune system eliminates the virus from most locations;
however, the virus remains dormant (latent) in the dorsal root ganglia. In
about 10-20% of cases, the virus is “reactivated” later in life, causing herpes
zoster. During reactivation, the virus leaves the nerve cell bodies and travels
along axons, causing infection of the skin in the region of the nerve
(dermatome). The rash usually heals within two to four weeks, although pain may
persist for months or years (postherpetic neuralgia). </span></p>

<p><span></span></p>

<p><span>The
earliest symptoms of herpes zoster &#8211; headache, fever, and malaise &#8211;
are nonspecific. These symptoms are often followed by pain, itching,
hyperesthesia (oversensitivity), or paresthesia (tingling, pricking, or
numbness) along the dermatome. The pain ranges from mild to extreme, and is
followed by a rash, usually on the torso, but sometimes on the face, eyes, or
extremities. </span></p>

<p><span></span></p>

<p><span>At first,
the rash resembles hives. Unlike hives, however, VZV spreads along a dermatome,
producing a rash with a unilateral, stripe-like distribution. The rash becomes
vesicular; small blisters fill with serous exudate. The vesicles become cloudy
or dark as they fill with blood. They crust over within ten days. Usually the
crust falls off and the skin heals, but scarring and discoloration occur in
severe cases. </span></p>

<p><span></span></p>

<p><span>Cranial
nerves can be affected. <i>Herpes zoster </i></span><a
href="http://en.wikipedia.org/wiki/Ophthalmic_nerve" title="Ophthalmic nerve"><i><span>ophthalmicus</span></i></a><span> involves the orbit of
the eye and is caused by reactivation in the ophthalmic division of the
trigeminal nerve. <i>Herpes zoster oticus</i><span>, which </span>can cause hearing loss and vertigo, occurs when the
virus spreads from the facial nerve to the vestibulocochlear nerve.</span></p>

<p><span></span></p>

<p><span>Herpes
zoster occurs only in people who have had chickenpox. Most patients are over
age fifty. Immunocompromised patients are especially predisposed to viral
reactivation. Symptoms of shingles cannot be transmitted from person to person;
however, during the blister phase, the virus can be transmitted to non-immune
persons, causing chickenpox. Repeated attacks of herpes zoster are rare, but
can occur. </span></p>

<p></span></p>

<p>A <span>vaccine for shingles was licensed in 2006. It reduces the
risk of shingles by about 50%. In people who develop shingles anyway, it
reduces the incidence and severity of post-herpetic neuralgia. A single dose of
the vaccine is recommended in adults 60 years of age and older.</span></span></p>

<p></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. Herpes zoster
(“shingles”) is caused by varicella (“chickenpox” virus). The virus has a
dormant phase in the dorsal root ganglia. The condition is more common in
adults than in children. Pain (referred to as “post-herpetic neuralgia”) may
persist long after the rash resolves. Symptoms of shingles cannot be
transmitted from person to person; however, during the blister phase, the virus
can be transmitted to non-immune persons, causing chickenpox. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><!--[if supportFields]><span><span></span><span>&nbsp;</span>SEQ CHAPTER \h \r 1</span><![endif]--><!--[if supportFields]><span><span></span></span><![endif]--><span>A 28-year-old woman has had excess facial hair since she was
21 years old. The problem has grown worse with time: She has gone from plucking
hairs once a week to shaving three times a week. The mustache area, chin, and
sideburns are most affected. Menarche occurred at age 12.<span>&nbsp; </span>Menstrual periods were regular until age
18; since then, they’ve been heavier and have occurred every two to three
months. She has gained 75 pounds in the past four years. She has been married
18 months and has not become pregnant despite unprotected intercourse.<span>&nbsp; </span>On physical examination, there are
numerous coarse, terminal hairs in the mustache, sideburn, and chin areas.
There has been no deepening of the voice, male-pattern balding, or clitoromegaly.</span></p>

<p><span></span></p>

<p><span>What
is the most likely cause of hirsutism? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Heterozygous
mutation in an enzyme in the pathway for cortisol synthesis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Heterozygous
mutation in an enzyme in the pathway for aldosterone synthesis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hyperinsulinemia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pituitary
tumor secreting ACTH</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span presence of excess terminal (coarse) hairs in androgen-dependent areas,
affects 5% to 15% of women. The upper lip, chin, chest, lower abdomen, and
extremities are principally affected. <span usually a sign of excessive androgen production (e.g., testosterone,
androstenedione, DHEA, or DHEA-S). </p>

<p></p>

<p>Hirsutism as an isolated
finding should be distinguished from <span>virilization,
which i</span>s associated with increased muscle mass, clitoral enlargement,
and deepening of the voice. These changes usually occur quickly (over months).
Virilization mandates a search for neoplasia. Testosterone elevation may
indicate an ovarian tumor; DHEAS elevation may indicate an adrenal tumor. Most
cases of hirsutism, however, do <i>not</i>
involve virilization. The most common causes of <span idiopathic and polycystic ovary syndrome (PCOS). Less common causes are
congenital adrenal hyperplasia and Cushing syndrome. </p>

<p></p>

<p>PCOS is characterized by
insulin resistance and hyperinsulinemia. (The pancreas produces high levels of
insulin to overcome resistance.) Insulin resistance is selective: Liver, fat,
and muscles are more insulin-resistant than ovaries. Insulin in high concentrations
binds to receptors in ovarian theca cells, stimulating androgen production. The
result is hirsutism.<span >&nbsp; </span></p>

<p></p>

<p>Women with PCOS typically
have abnormal menses, infertility, <span and obesity, all of which are related to androgen excess. PCOS is the
single most common endocrine abnormality of women of reproductive age. The
onset of symptoms is usually around menarche, but may occur after puberty. The
diagnosis is based on the presence of hyperandrogenism (e.g., hirsutism),
ovarian dysfunction (e.g., menstrual irregularity), and exclusion of other
conditions.</p>

<p><span></span></p>

<p><span>The
woman in this vignette has evidence of androgen excess (hirsutism). There is no
virilization (deepening of the voice, male-pattern baldness, or clitoromegaly)
to suggest an ovarian or adrenal tumor. PCOS should be suspected because of the
presence of menstrual irregularity, infertility, and obesity.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>PCOS is associated with
insulin resistance and hyperinsulinemia. Some patients have glucose intolerance
or even diabetes at diagnosis. For women with normal blood sugar levels, there
is a high risk of developing diabetes in the future. Women with PCOS are at
risk of developing other manifestations of the metabolic syndrome, such as
dyslipidemia, hypertension, and atherosclerosis. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answers A and B are
incorrect.</span></b><span>
Congenital adrenal hyperplasia may present in young adults with hirsutism,
irregular periods, and/or infertility.<span >&nbsp;
</span>The most common enzyme defect is 21-hydroxylase, which converts
17-hydroxyprogesterone to 11-deoxycortisol. The latter is converted to cortisol
by action of 11-hydroxylase.<span >&nbsp;
</span>Patients presenting in young adulthood have a partial blockade in
cortisol synthesis that can be overcome by a compensatory increase in ACTH.
This compensation, however, is at the expense of an increase in precursor
molecules, some of which have androgenic activity. This patient could have
21-hydroxylase deficiency (which would be confirmed by measuring
17-hydroxyprogesterone before and after the administration of synthetic ACTH);
however, a history of regular periods, which then become abnormal, is uncommon
in 21-hydroxylase deficiency. (Patients with this condition are more likely to
have <i>never</i> had normal menses.)<span>&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D</span></b><span> <b>is incorrect.</b> Cushing syndrome is associated with hirsutism,
obesity, and menstrual irregularity, but this patient lacks other clinical
findings of Cushing syndrome. (Besides, PCOS is much more common than Cushing
syndrome.)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
37-year-old man with schizophrenia presents with confusion, palpitations,
muscle rigidity, and sweating. His medicines include haloperidol and
acetaminophen, which he takes daily. His temperature is 40.2<sup>o</sup>C
(104.4<sup>o</sup>F), pulse is 105/minute, blood pressure is 165/85 mm Hg, and
respirations are 24/minute. The neck is supple, the skin is warm and moist, and
there is generalized muscle rigidity. Fundoscopic examination is normal. Deep
tendon reflexes are 2+ without clonus. Plantar reflexes are normal. The
thyroid-stimulating hormone (TSH) level is normal. Which is the most likely
diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Sepsis
</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Neuroleptic
malignant syndrome</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Graves’
disease</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Cerebral
hemorrhage</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Fever and
hyperthermia are distinct conditions associated with a rise in body
temperature. The two conditions are contrasted below. </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=235 valign=top>
  <p style="text-align:center;"><b><span>Fever</span></b></p>
  </td>
  <td width=234 valign=top>
  <p style="text-align:center;"><b><span>Hyperthermia</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=235 valign=top>
  <p><span>Increase in the
  hypothalamic “set point” </span></p>
  <p><span>(Rise in body’s
  thermostat)</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>No change in the
  hypothalamic “set point” (No change in body’s thermostat) </span></p>
  </td>
 </tr>
 <tr>
  <td width=235 valign=top>
  <p><span>Mediated by pyrogens</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Not mediated by pyrogens</span></p>
  </td>
 </tr>
 <tr>
  <td width=235 valign=top>
  <p><span>Antipyretics effective at
  lowering temperature</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Antipyretics not
  effective at lowering temperature</span></p>
  </td>
 </tr>
 <tr>
  <td width=235 valign=top>
  <p><span>Temperature elevation
  mild, moderate, or severe</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Temperature elevation
  usually severe</span></p>
  </td>
 </tr>
 <tr>
  <td width=235 valign=top>
  <p><span>Common</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Uncommon</span></p>
  </td>
 </tr>
 <tr>
  <td width=235 valign=top>
  <p><span>Associated with
  peripheral vasoconstriction and possibly shivering to preserve and generate
  heat</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Associated with
  peripheral vasodilation and sweating to eliminate heat</span></p>
  </td>
 </tr>
 <tr>
  <td width=235 valign=top>
  <p><span>Skin usually cool due to
  vasoconstriction</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Skin usually warm due to
  vasodilation</span></p>
  </td>
 </tr>
 <tr>
  <td width=235 valign=top>
  <p><span>Mild, moderate, or severe</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Life-threatening if not
  treated</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>Hyperthermia
is life-threatening and does not respond to anti-pyretics. The diagnosis is
suggested by preceding events. Selected causes of hyperthermia are described
below. </span></p>

<p><b><span></span></b></p>

<p><b><span>Heat
stroke </span></b><span>is a dangerous condition caused by heat exposure. It
is classified as exertional or non-exertional. Findings include hyperthermia,
confusion, and absent sweating. In the elderly, the condition may be exacerbated
by anti-cholinergic, antiparkinson, or diuretic drugs.<span>&nbsp; </span><b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Drug-induced
hyperthermia. </span></b><span>Internal body heat production can be increased by
certain drugs, such as cocaine, amphetamines, phencyclidine (PCP), lysergic
acid diethylamide (LSD), methylenedioxymethamphetamine (MDMA, or “ecstasy”),
monoamine oxidase inhibitors (MAOIs), and tricyclic anti-depressants (TCAs).<b>
</b></span></p>

<p><b><span></span></b></p>

<p><b><span>Neuroleptic
malignant syndrome</span></b><span>
is a life-threatening disorder caused by use of anti-psychotic drugs
(phenothiazines, haloperidol, prochlorperazine, metoclopramide) or withdrawal
from dopaminergic drugs. In both cases, the mechanism is inhibition of central
dopamine receptors in the hypothalamus, which results in increased heat
generation and decreased heat dissipation.The condition generally presents with
hyperthermia, delirium, muscle rigidity, extrapyramidal symptoms, and autonomic
instability.</span></p>

<p><b><span></span></b></p>

<p><b><span>Malignant
hyperthermia</span></b><span>
is a rare life-threatening condition triggered by exposure to inhalational
anesthetics, such as halothane, or to the neuromuscular-blocking agent,
succinylcholine. The condition is caused by a defect of skeletal muscle
sarcoplasmic reticulum, inherited as an autosomal dominant trait. In
susceptible individuals, the drug induces drastic and uncontrolled increase in
skeletal muscle oxidative metabolism, which leads to circulatory collapse and
death, if not treated quickly. </span></p>

<p><span><span>&nbsp;</span></span></p>

<p><b><span>Serotonin syndrome, </span></b><span>or serotonin storm,<b> </b>is a potentially life-threatening
condition caused by serotoninergic drugs, such as selective serotonin reuptake
inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). Symptoms include
hyperthermia, tremor, myoclonus, and diarrhea. </span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. Neuroleptic malignant
syndrome is suggested by high temperature, haloperidol use, and muscle
rigidity. Warm skin is consistent with hyperthermia. Of note, the temperature
is high despite daily use of acetaminophen. Anti-pyretics lower temperature in
febrile patients but not in hyperthermic patients.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>. Sepsis can be
associated with high fever and tachycardia, but muscle rigidity is not typical
and blood pressure is often low.<span >&nbsp;&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect</span></b><span>. Graves’ disease is an
autoimmune condition in which antibodies to the TSH receptor on the thyroid
activate the receptor, stimulating thyroid hormone synthesis and secretion. The
patient develops a diffusely enlarged goiter. Graves’ disease is associated
with hyperthyroidism (excess thyroid hormone in the blood) and thyrotoxicosis
(clinical syndrome resulting from excess thyroid hormone in the blood).
Hyperthermia may occur. In this case, Graves’ disease is unlikely because the
TSH level is normal. (It should be low in patients with primary
hyperthyroidism.) </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. Cerebral hemorrhage
may be associated with hyperthermia, but this diagnosis is unlikely given the
normal fundoscopic examination (no papilledema) and normal reflexes. <b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 67-year-old man has
frequent bowel movements, weight loss, and proximal muscle weakness. He has
become short-tempered with his family. His heart is irregularly irregular. An
electrocardiogram shows atrial fibrillation. Which of the following is the most
likely diagnosis?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Congestive
heart failure</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Cushing
syndrome</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Pheochromocytoma</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Mitral
valve prolapse</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>Hyperthyroidism
</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Classic symptoms of
hyperthyroidism include weight loss (despite a good appetite), heat
intolerance, palpitations, tremor, and hyperdefecation (increased frequency of
formed bowel movements). Hyperthyroidism is one of the few conditions in which
weight loss is accompanied by <i>increased </i>appetite.
The diagnosis can be missed if the patient presents with nonspecific symptoms
(e.g., fatigue, insomnia, anxiety, irritability, weakness, chest pain,
shortness of breath) or atypical symptoms (e.g., headache, periodic paralysis,
nausea and vomiting). Elderly patients may present with “apathetic”
hyperthyroidism, typified by weight loss unaccompanied by sympathomimetic
symptoms.</p>

<p></p>

<p>Signs of hyperthyroidism
include resting tachycardia; systolic hypertension; widened pulse pressure;
warm, moist skin with a velvety texture; onycholysis; and a staring gaze with
lid lag (noted when a rim of sclera is visible between the upper eyelid and the
superior margin of the iris on downward gaze). Cardiac examination may reveal a
prominent apical impulse and a systolic flow murmur. Atrial fibrillation may
occur. Neurologic findings include restlessness, irritability, pressured
speech, proximal muscle weakness, distal hand tremor, and brisk deep tendon
reflexes.</p>

<p></p>

<p>Common causes of
hyperthyroidism appear below. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=203 valign=top>
  <p>Common Causes of
  Hyperthyroidism</p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p>Graves’ disease</p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p>Toxic thyroid adenoma</p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p>Toxic multinodular goiter</p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p>Autoimmune thyroiditis
  (Hashimoto’s)</p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p>Subacute thyroiditis
  (DeQuervain’s)</p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p>Oral consumption of excess
  thyroid hormone tablets</p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p>Amiodarone</p>
  </td>
 </tr>
 <tr>
  <td width=203 valign=top>
  <p>Postpartum thyroiditis</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p><i>Graves’ disease</i> is characterized by a diffusely enlarged thyroid
with smooth contour. Sometimes a bruit can be heard over the gland. Graves’
disease is caused by autoantibodies that stimulate the TSH-receptor on the
thyroid, inducing synthesis and secretion of thyroid hormone. These antibodies
stimulate thyroid enlargement. Ophthalmopathy and dermopathy are unique to
Grave’s disease; they do no appear with other forms of hyperthyroidism. </p>

<p></p>

<p><i>Toxic multinodular goiter</i> may be associated with one or more
palpable nodules. </p>

<p></p>

<p>In <i>subacute thyroiditis</i>, the thyroid is firm, modestly enlarged, and
extremely tender. </p>

<p></p>

<p>A history of recent
pregnancy may suggest <i>postpartum
thyroiditis</i>. </p>

<p></p>

<p>Recent exposure to
amiodarone or surreptitious use of thyroid hormone may indicate <i>drug-induced</i> hyperthyroidism.</p>

<p><b><span>Answer E is correct</span></b><span>. Weight loss,
irritability, hyperdefacation, proximal muscle weakness, and atrial
fibrillation are consistent with a diagnosis of hyperthyroidism. </span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
43-year-old woman has a six-month history of fatigue, dry skin, and
constipation. Examination shows mild, diffuse thyroid enlargement. The thyroid
is non-tender. Serum studies show:</span></p>

<p><span></span></p>

<p><span>Thyroid-stimulating
hormone<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
µU/mL (Normal: 0.5-5 µU/mL)</span></p>

<p><span>Thyroxine
(T4)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.2
µg/dL<span >&nbsp; </span>(Normal: 5-12 µg/dL)<span>&nbsp; </span></span></p>

<p><span>Thyroid-peroxidase
antibody<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>9
IU/mL<span >&nbsp;&nbsp;&nbsp; </span>(Normal: 0-2
µg/dL)</span></p>

<p><span></span></p>

<p><span>Which is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diffuse
non-toxic goiter</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diffuse
toxic goiter (Graves’ disease)</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic
autoimmune (Hashimoto’s) thyroiditis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Subacute
granulomatous (de Quervain’s) thyroiditis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
patient in the vignette has symptoms of hypothyroidism: fatigue, dry skin, and
constipation. Hypothyroidism can present with any of the following symptoms. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=302 colspan=2 valign=top>
  <p style="text-align:center;"><span>Symptoms of Hypothyroidism</span></p>
  </td>
 </tr>
 <tr>
  <td width=302 colspan=2 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Fatigue</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Hair
  loss</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Cold
  intolerance</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Dry,
  coarse, cold skin</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Weakness</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Hoarse
  voice</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Lethargy</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Brittle
  nails</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Weight
  gain</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Periorbital,
  peripheral edema</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Constipation</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Delayed
  reflexes*</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Myalgias</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Slow
  reaction time</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Arthralgias</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Bradycardia</span></p>
  </td>
 </tr>
 <tr>
  <td width=140 valign=top>
  <p><span>Menstrual
  irregularities</span></p>
  </td>
  <td width=162 valign=top>
  <p><span>Pleural,
  pericardial effusions</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>*A delayed
relaxation phase of deep tendon reflexes is so characteristic of hypothyroidism
that this finding constitutes a bedside diagnostic test for
hypothyroidism.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
relationship between hypothyroidism and thyroid hormone levels appears
below.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=148 valign=top>
  <p><span></span></p>
  </td>
  <td width=48 valign=top>
  <p style="text-align:center;"><span>TSH</span></p>
  </td>
  <td width=54 valign=top>
  <p style="text-align:center;"><span>Free T<sub>4</sub></span></p>
  </td>
 </tr>
 <tr>
  <td width=148 valign=top>
  <p><span>Primary
  hypothyroidism</span></p>
  </td>
  <td width=48 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=54 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=148 valign=top>
  <p><span>Secondary
  hypothyroidism</span></p>
  </td>
  <td width=48 valign=top>
  <p style="text-align:center;"><span>&#8595; or Normal</span></p>
  </td>
  <td width=54 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span>&nbsp;</span></span></p>

<p><span>In this
patient, the diagnosis of primary hypothyroidism is confirmed my measuring
serum thyroid hormone levels. The patient’s TSH is high at 15 &#956;U/mL
(normal: 0.5-5.0 &#956;U/mL), and the thyroxine (T4) level is low at 2.2
&#956;g/dL (normal: 5-12 &#956;g/dL).</span></p>

<p><span></span></p>

<p><span>The
principal causes of hypothyroidism are listed below.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=325 valign=top>
  <p style="text-align:center;"><span>Causes of Primary Hypothyroidism</span></p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Autoimmune
  (Hashimoto’s) thyroiditis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Subacute (de Quervain’s)
  thyroiditis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Post-partum
  thyroiditis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Surgical removal of
  the thyroid</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Radiation treatment to
  the neck</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Radioactive iodine
  treatment of hyperthyroidism</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Iodine deficiency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Anti-thyroid medicine
  (propylthiouracil, methimazole)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Drugs (e.g.,
  amiodarone, lithium)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Congenital defects</span></p>
  </td>
 </tr>
</table>

</div>

<p><span>Chronic
autoimmune (Hashimoto’s) thyroiditis is the most common cause of hypothyroidism
(and goiter) in the U.S. This condition can be distinguished from other causes
of hypothyroidism, in part, my measuring thyroid antibodies in the blood. </span></p>

<p><span></span></p>

<p><span>The table
below lists commonly measured thyroid antibodies and the conditions that cause
them to be elevated.<span >&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 width=443>
 <tr>
  <td width=158 valign=top>
  <p style="text-align:center;"><span>Thyroid Antibody</span></p>
  </td>
  <td width=63 valign=top>
  <p style="text-align:center;"><span>Acronym</span></p>
  </td>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Present In</span></p>
  </td>
 </tr>
 <tr>
  <td width=158 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=63 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=221 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=158 valign=top>
  <p><span>Thyroid
  peroxidase antibody</span></p>
  </td>
  <td width=63 valign=top>
  <p style="text-align:center;"><span>TPOAb</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Hashimoto’s
  thyroiditis; Graves’ disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=158 valign=top>
  <p><span>Thyroglobulin
  antibody</span></p>
  </td>
  <td width=63 valign=top>
  <p style="text-align:center;"><span>TgAb</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Thyroid cancer;
  Hashimoto’s thyroiditis</span></p>
  </td>
 </tr>
 <tr>
  <td width=158 valign=top>
  <p><span>Thyroid
  stimulating hormone receptor antibody</span></p>
  </td>
  <td width=63 valign=top>
  <p style="text-align:center;"><span>TRAb</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Graves’
  disease</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>The
presence of thyroid peroxidase antibodies in a patient with hypothyroidism
suggests chronic autoimmune (Hashimoto) thyroiditis. </span></p>

<p><span></span></p>

<p><span>Chronic
autoimmune (Hashimoto) thyroiditis is characterized by lymphocytic infiltration
and destruction of the thyroid, resulting in goiter and hypothyroidism. The
thyroid gland is non-tender (unlike subacute thyroiditis, which is associated
with exquisite thyroid tenderness) and thyroid antibodies are present in high
titer. Early in the disease, thyroglobulin antibody is markedly elevated,
although it may disappear later. Thyroid peroxidase antibodies are present
early and generally remain present for years.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. Hashimoto’s
thyroiditis is the most common cause of hypothyroidism and goiter in the U.S.
TSH levels are high and T4 levels are low (primary hypothyroidism). The thyroid
gland is non-tender and thyroid antibodies (thyroid peroxidase antibody and
thyroglobulin antibody) are elevated.<span>&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>.<span>&nbsp; </span>Nontoxic goiter is defined as any
thyroid enlargement that is not associated with overt hyperthyroidism or
hypothyroidism and that does not result from inflammation or neoplasia. The
most common cause is iodine deficiency.<span >&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span>&nbsp; </span>Diffuse toxic goiter (Graves’ disease)
is the most common cause of hyperthyroidism in children and adolescents and the
most common cause of severe hyperthyroidism. Thyroid stimulating hormone
receptor antibody levels are elevated.<span >&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>.<span>&nbsp; </span>Subacute granulomatous (de Quervain’s)
thyroiditis, also called “painful thyroiditis,” is often preceded by a viral
upper respiratory tract infection. Symptoms include fever, neck pain, and
tenderness over the thyroid gland. A period of hyperthyroidism may precede a
period of hypothyroidism. </span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 30-year-old man comes to the emergency
department 1 hour after injuring his left knee in a volleyball game. He says he
twisted his left leg when he fell to the floor after he and a teammate
accidentally collided. He cannot bear weight on his left leg. Physical
examination shows tenderness and swelling of the left knee. When the patient
sits on the edge of the examination table, the left knee can be displaced
anteriorly at an abnormal degree. Which of the following is most likely injured
in this patient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Anterior
cruciate ligament</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fibular
collateral ligament</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Meniscofemoral
ligament</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Oblique
popliteal ligament</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Transverse
ligament of the knee</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=205 height=273
src="_%20Tutorials_files/image382.png" alt="Description: knee_anatomy" v:shapes="Picture_x0020_347300"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>The major
ligaments associated with the knee joint are the patellar ligament, the tibial
(medial) and fibular (lateral) collateral ligaments, and the anterior and
posterior cruciate ligaments.</span></p>

<p><a name=4-u1.0-B978-0-443-06952-9..00011-4--s147></a><span></span></p>

<p><b><span>Patellar ligament </span></b></p>

<p><span>The <span>patellar ligament</span> is basically the
continuation of the quadriceps femoris tendon inferior to the patella. It is
attached above to the margins and apex of the patella and below to the tibial
tuberosity.</span></p>

<p><a name=4-u1.0-B978-0-443-06952-9..00011-4--s148></a><span></span></p>

<p><b><span>Collateral ligaments</span></b><span></span></p>

<p><span>The
collateral ligaments, one on each side of the joint, stabilize the hinge-like
motion of the knee. <a name=4-u1.0-B978-0-443-06952-9..00011-4--f073></a>The
cord-like <span>fibular collateral ligament</span>
is attached superiorly to the lateral femoral epicondyle and inferiorly to the
lateral surface of the fibular head. The <span>tibial collateral ligament</span> is anchored superiorly to the medial
femoral epicondyle and inferiorly to the medial surface of the tibia.</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-0-443-06952-9..00011-4--s149></a><a
name=4-u1.0-B978-0-443-06952-9..00011-4--st14></a><b><span>Cruciate
ligaments</span></b><span></span></p>

<p><span>The two
cruciate ligaments are in the intercondylar region of the knee and interconnect
the femur and tibia. They are termed “cruciate” (Latin for “cross-shaped”)
because they cross each other<a name=4-u1.0-B978-0-443-06952-9..00011-4--o079></a>.
</span></p>

<p><span>The <span>anterior cruciate ligament</span> attaches to
the anterior part of the intercondylar area of the tibia and ascends
posteriorly to attach to the femur. The <span>posterior
cruciate ligament</span> attaches to the posterior aspect of the intercondylar
area of the tibia and ascends anteriorly to attach to the femur. <a
name=4-u1.0-B978-0-443-06952-9..00011-4--f074></a><span></span></span></p>

<p><span>The
anterior cruciate ligament prevents anterior displacement of the tibia relative
to the femur and the posterior cruciate ligament prevents posterior
displacement of the tibia relative to the femur.</span></p>

<p><b><span>Answer A
is correct. </span></b><span>The
anterior cruciate ligament prevents anterior displacement of the knee and leg. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 62-year-old man presents with the following skin lesion. </span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://en.wikipedia.org/wiki/File:Melanoma.jpg"><span><img border=0 width=171 height=114
src="_%20Tutorials_files/image384.png" alt="Description: 225px-Melanoma"
v:shapes="Picture_x0020_347299"></span></a><span></span></p>

<p><span></span></p>

<p><span>Which
of the following is <i>not</i> true
regarding his condition?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>If untreated,
metastasis and death may occur</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diagnosis is confirmed
by biopsy</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Excisional biopsy is
the treatment of choice</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>The presence of
tumor-infiltrating lymphocytes confers a poor prognosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Protection from
ultraviolet radiation may prevent such lesions from developing</span></p>

<p><span></span></p>

<p><span><span>&nbsp;</span></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Melanoma, </span>a malignant tumor of melanocytes, usually appears in the
skin, but may appear in the bowel or eye. Though less common than other types
of skin cancer, melanoma is responsible for 75% of deaths due to skin cancer.
The tumor begins as a proliferation of melanocytes at the dermis-epidermal
junction. During the radial growth phase, the tumor grows alongside the
junction. When it starts to grow vertically &#8211; into the epidermis and
papillary dermis &#8211; it begins to acquire the potential for metastasis.
Metastasis begins with the invasion of lymphatics and small blood vessels.</p>

<p><span></span></p>

<p><span>Early
signs of melanoma are summarized by the mnemonic, &quot;ABCDE&quot;:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A</span><span>symmetric </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span><span>order: irregular </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span><span>olor: variegated (multi-colored) </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>D</span><span>iameter: &gt;6&nbsp;mm more likely to be melanoma </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span><span>nlarging<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>These
criteria do not apply to the most dangerous form of melanoma, nodular melanoma,
which has its own mnemonic, “EFG”:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span><span>levated above the skin surface </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>F</span><span>irm to the touch </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>G</span><span>rowing </span></p>

<p></p>

<p>Most melanomas begin as an
alteration in the color and appearance of normal-looking skin. The patient may
notice a new dark spot or mole. Other melanomas form from an existing mole or
freckle. Nodular melanoma may appear as a new lump. In later stages, melanomas
may itch, ulcerate, or bleed. Minimizing exposure to ultraviolet radiation
(from the sun or sun beds) and wearing sun-protective clothing may prevent
development of melanoma. The diagnosis is made by biopsy. <span>Excisional biopsy</span> is the treatment of
choice. High-risk melanomas may require adjuvant therapy.</p>

<p><span></span></p>

<p><span>Prognosis
is affected by tumor thickness (Breslow's depth), depth related to skin
structures (Clark level), type of melanoma, presence of ulceration, presence of
lymphatic/perineural invasion, presence of tumor-infiltrating lymphocytes
(which confers a better prognosis), location of the lesion, presence of
satellite lesions, and presence of regional or distant metastasis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
D is correct. </span></b><span>The<b> </b></span><span>presence of tumor-infiltrating lymphocytes
improves prognosis.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>A
45-year-old woman comes to the physician for a routine health maintenance
examination. She says that she feels fine. She is 170 cm (5 ft 7 in) and weighs
86 kg (190 lb); BMI is 30 kg/m<sup>2</sup>. Her blood pressure is 132/87 mm Hg.
Physical examination shows no other abnormalities. Lab studies show:</p>

<p>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>105
mg/dL</p>

<p>Cholesterol, total<span>&nbsp; </span>210 mg/dL</p>

<p>Triglycerides<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>185
mg/dL</p>

<p>C-reactive protein<span> </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0.35
mg/L (N= 0.08-3.1 mg/L)</p>

<p></p>

<p>This
patient is at increased risk for developing which of the following conditions?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Atherosclerosis</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Chronic
lymphocytic (Hashimoto) thyroiditis </p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Systemic
lupus erythematosus</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Systemic
sclerosis (scleroderma)</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>Type
1 diabetes mellitus </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Metabolic
syndrome is a cluster of conditions &#8212; increased blood pressure, a high
blood sugar level, excess body fat around the waist, and abnormal cholesterol
levels &#8212; that occur together, increasing the risk of heart disease,
stroke, and diabetes. To be diagnosed with metabolic syndrome, the patient must
have three or more of the following metabolic disorders: </p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b>Abdominal waist circumference: </b><u><span>&gt;</span></u><b> </b>40 inches in men and <u><span>&gt;</span></u><span> </span>35 inches in women. Patients are typically overweight (BMI of
25-30 kg/m<sup>2</sup>) or obese (BMI <u>&gt;</u>30 kg/m<sup>2</sup>)</p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b>Increased blood pressure: </b>systolic blood
pressure <u>&gt;</u> 130 mm Hg or diastolic blood pressure measurement <u>&gt;</u>
85 mm Hg</p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b>Increased blood sugar level:</b> fasting
blood glucose <u>&gt;</u> 100 mg/dL</p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b>Abnormal lipid levels:</b> triglycerides <u>&gt;</u>
150 mg/dL and high-density lipoprotein (HDL) cholesterol <u>&lt;</u> 40 mg/dL
in men or <u>&lt;</u> 50 mg/dL in women</p>

<p><span></span></p>

<p><span>Individuals
with one component of the metabolic syndrome are more likely to have other
components. The more components the patient has, the greater is the health
risk. </span></p>

<p><span>Risk
factors for metabolic syndrome: </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Age.</span></b><span> Metabolic syndrome affects &lt; 10% of people in their 20s
and 40% of people in their 60s </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Race.</span></b><span> Hispanic and Asian</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Obesity.</span></b><span> BMI <u>&gt;</u> 25 kg/m<sup>2</sup> and abdominal obesity
(“apple” shape, rather than a “pear” shape)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>History of diabetes.</span></b><span> Personal history of gestational diabetes and
family history of type 2 diabetes</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Other conditions.</span></b><span> Hypertension, cardiovascular disease, and
polycystic ovary syndrome</span></p>

<p><span></span></p>

<p><span>Having
metabolic syndrome increases the likelihood of developing the following
conditions: </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Type 2 diabetes mellitus.</span></b><span> Metabolic syndrome is strongly
associated with insulin resistance. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><b><span>Cardiovascular disease.</span></b><span> High blood pressure and dyslipidemia
contribute to a buildup of plaques in the arteries (atherosclerosis), which
predispose the patient to heart attack and stroke.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>The patient has
metabolic syndrome. (She is obese and has an elevated blood pressure, blood
glucose, and triglycerides). She is at risk of developing type 2 diabetes
mellitus and atherosclerosis, which would predispose her to cardiovascular
disease (heart attack and stroke).<span >&nbsp; </span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span lang=EN-GB>A patient consults a physician because of a small lip
lesion that, on biopsy, proves to be a mucosal neuroma. The patient’s mother
had medullary carcinoma of the thyroid. In addition to being predisposed to
medullary carcinoma of the thyroid, to what others condition is the patient
predisposed? &nbsp; </span></p>

<p><span lang=EN-GB></span></p>

<p><span
lang=EN-GB><span>A.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Gastrinoma</span></p>

<p><span
lang=EN-GB><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Insulinoma</span></p>

<p><span
lang=EN-GB><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Parathyroid adenoma</span></p>

<p><span
lang=EN-GB><span>D.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Pheochromocytoma</span></p>

<p><span
lang=EN-GB><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Pituitary adenoma</span></p>

<p><span lang=EN-GB>&nbsp; </span></p>

<p><b><span lang=EN-GB><br>
<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB></span></b></p>

<p>The term <span>multiple endocrine neoplasia</span> (<span>MEN</span>) encompasses several distinct
syndromes involving tumors of endocrine glands. Tumors of nonendocrine tissues
also occur in some of these syndromes. MEN syndromes are inherited as autosomal
dominant disorders. The endocrine neoplasms may be expressed as hyperplasia,
adenoma, or carcinoma and may develop synchronously or metachronously. The
classification of <span>multiple endocrine
neoplasia</span> (<span>MEN</span>) syndromes
appears below:</p>

<p><span></span></p>

<p><span>MEN I
(Werner’s syndrome) </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pituitary tumors</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Enteropancreatic
neuroendocrine tumors (insulinoma, gastrinoma, glucagonoma)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Parathyroid tumors</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-0-323-07158-1..00003-1--li34></a><a
name=4-u1.0-B978-0-323-07158-1..00003-1--s104></a><a
name=4-u1.0-B978-0-323-07158-1..00003-1--st10></a><span><span>MEN II (Sipple’s syndrome)</span></span></p>

<p><span><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Medullary thyroid
carcinoma</span></span></p>

<p><span><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pheochromocytoma</span></span></p>

<p><span><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hyperparathyroidism</span></span></p>

<p><span><span></span></span></p>

<span></span>

<p><a name=4-u1.0-B978-0-323-07158-1..00003-1--o949></a><span>MEN III (Multiple
Mucosal Neuroma syndrome) </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Medullary thyroid
carcinoma</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pheochromocytoma</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Marfanoid habitus</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Multiple mucosal
neuromas</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span lang=EN-GB>Answer D is correct. </span></b><span lang=EN-GB>This patient has multiple endocrine neoplasia type </span><span
lang=EN-GB>III. Features include medullary carcinoma of the thyroid,
pheochromocytoma, and mucosal neuromas.</span></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB>Answer A is incorrect. </span></b><span lang=EN-GB>Gastrinomas are part of multiple endocrine neoplasia
type </span><span lang=EN-GB>II. <span></span></span></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB>Answer B is incorrect. </span></b><span lang=EN-GB>Insulinomas are part of multiple endocrine neoplasia
type </span><span lang=EN-GB>II. <span><span>&nbsp;</span></span></span></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB>Answer C is incorrect. </span></b><span lang=EN-GB>Parathyroid adenomas are part of multiple endocrine
neoplasia types I and </span><span lang=EN-GB>II.</span></p>

<p><b><span lang=EN-GB></span></b></p>

<p><b><span lang=EN-GB>Answer E is incorrect. </span></b><span lang=EN-GB>Pituitary adenomas are part of multiple endocrine
neoplasia type </span><span lang=EN-GB>I. </span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB><span>&nbsp;</span></span><span lang=EN-GB></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>The
nervous system increases the force of muscle contraction in a graded fashion
primarily by recruitment of motor units and by increasing which of the following?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Amplitude
of action potentials of single motor neurons</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Duration
of action potentials in single motor neurons</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Frequency
of firing of individual motor neurons</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Number
of active end-plates on the muscle fiber</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rate
of synthesis of acetylcholine at the motor nerve terminal</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>With
voluntary muscle contraction, the brain sends signals in the form of action
potentials through the nervous system to the motor neuron, which innervates
muscle fibers. While nerve impulse profiles are, for the most part, always the
same, skeletal muscles are able to produce varying levels of contractile force.
This phenomenon is explained by “<i>force
summation</i>.” Force summation is the addition of individual twitch
contractions to increase the intensity of overall muscle contraction. It is
achieved in two ways: by increasing the number and size of contractile units
simultaneously, called <i>recruitment of motor units</i><span>, </span>and by increasing the frequency at which action potentials are
sent to muscle fibers, called <i>temporal<span> summation</span></i>.</span></p>

<p><span></span></p>

<p><span>Recruitment of motor units: </span><span>A motor unit includes the motor neuron plus all
of the muscle fibers it innervates. The degree of contraction of a skeletal
muscle is influenced by the number of motor units being stimulated. Skeletal
muscles consist of numerous motor units and, therefore, stimulating more motor
units creates a stronger contraction. </span></p>

<p><span></span></p>

<p><span>Temporal summation:</span> An increase in the frequency with which a
muscle is stimulated increases the strength of contraction. With rapid
stimulation (so rapid that a muscle does not completely relax between
successive stimulations), a muscle fiber is re-stimulated while there is still
some contractile activity. As a result, there is a “summation” of the
contractile force. In addition, with rapid stimulation there isn’t enough time
between successive stimulations to remove all the calcium from the sarcoplasm.
So with several stimulations in rapid succession, calcium levels in the
sarcoplasm increase. More calcium means more active cross-bridges and,
therefore, a stronger contraction. (If a muscle fiber is stimulated so rapidly
that it does not relax at all between stimuli, a smooth, sustained contraction
called <span>tetanus</span> occurs.) </p>

<p></p>

<p>Skeletal muscles contract
according to the <i>sliding filament model</i><span> (Figure 1).</span></p>

<p></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>An
action potential originating in the brain reaches an alpha motor neuron, which
then transmits an action potential down the axon. </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
action potential propagates by activating voltage-gated sodium channels along
the axon toward the synapse. Eventually, the action potential reaches the motor
neuron terminal and causes a calcium ion influx through the voltage-gated
calcium channels. </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
Ca<sup>2+</sup> influx causes vesicles containing the neurotransmitter
acetylcholine to fuse with the plasma membrane, releasing acetylcholine into
the extracellular space. </span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
acetylcholine diffuses across the synapse and activates nicotinic cholinergic
receptors on the motor end plate of the muscle cell. Activation of the
nicotinic receptor opens its intrinsic sodium/potassium channel, causing sodium
to rush in and potassium to trickle out. Because the channel is more permeable
to sodium, the muscle fiber membrane depolarizes (the membrane potential
becomes more positive), triggering an action potential. </span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
action potential spreads through the muscle fiber’s network of T-tubules,
epolarizing the inner portion of the muscle fiber. </span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
depolarization activates voltage-dependent calcium channels (dihydropyridine
receptors) in the T tubule membrane, which are in close proximity to
calcium-release channels (ryanodine receptors) in the adjacent sarcoplasmic
reticulum. </span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>This
activation causes the sarcoplasmic reticulum to release calcium. </span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
calcium binds to the troponin C present on the actin-containing thin filaments
of the myofibrils. The troponin C then allosterically modulates the
tropomyosin. Under normal circumstances, the tropomyosin sterically obstructs
binding sites for myosin on the thin filament; however, once calcium binds to
troponin C and causes an allosteric change in the troponin protein, troponin T
allows tropomyosin to move, unblocking the binding sites. </span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Myosin
(which has ADP and inorganic phosphate bound to its nucleotide binding pocket
and is in a ready state) binds to the newly uncovered binding sites on the thin
filament (binding to the thin filament is very tightly coupled to the release
of inorganic phosphate). Myosin is now bound to actin in the strong binding
state. The release of ADP and inorganic phosphate are tightly coupled to the
power stroke, which pulls the Z-bands towards each other, thus shortening the
sarcomere and the I-band (Figure 2). </span></p>

<p><span><span>10.<span>&nbsp;
</span></span></span><a
href="http://en.wikipedia.org/wiki/Adenosine_triphosphate"
title="Adenosine triphosphate"><span>ATP</span></a><span> binds myosin, allowing
it to release actin and be in the weak binding state (a lack of ATP makes this
step impossible, resulting in rigor mortis). The myosin then hydrolyzes the ATP
and uses the energy to move into the &quot;cocked back&quot; conformation.<span>&nbsp; </span></span></p>

<p><span><span>11.<span>&nbsp;
</span></span></span><span>Steps
9 and 10 repeat as long as ATP is available and calcium is present on thin
filament. </span></p>

<p><span><span>12.<span>&nbsp;
</span></span></span><span>While
the above steps are occurring, calcium is actively pumped back into the
sarcoplasmic reticulum. When calcium is no longer present on the thin filament,
the tropomyosin changes conformation back to its previous state so as to block
the binding sites again. The myosin ceases binding to the thin filament, and
the contractions cease. </span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>Figure 1</span></p>

<p style="text-align:center;"><span><img border=0 width=304 height=596
src="_%20Tutorials_files/image386.png"
alt="Description: Muskel-molekulartranslation" v:shapes="Picture_x0020_347298"></span><span></span></p>

<p><span>Figure 2</span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/6/6e/Sarcomere.svg"><span><img border=0 width=373 height=290
src="_%20Tutorials_files/image388.png" alt="Description: File:Sarcomere.svg"
v:shapes="Picture_x0020_347297"></span></a><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>The force of muscle
contraction is increased by two mechanisms: recruitment of more motor units and
temporal summation (firing of individual motor neurons more frequently).</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>. The amplitude of
action potentials is constant.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect</span></b><span>. The duration of action
potentials does not change.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. The number of
endplates does not change.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect</span></b><span>. The rate of synthesis
of acetylcholine does not change.</span></p>

<p style="text-align:center;"><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 5-year-old boy is brought to the
physician by his parents because of an 8-month history of difficulty walking.
His parents say that he limps when he walks and has a waddling gait; he also
has difficulty standing. When getting up from a sitting position, he uses his
hands to walk up his thighs and push his body into a standing position. His
parents have not noticed any weakness of his arms. His mother is an only child,
but she has an uncle who became bedridden as a child and died of respiratory
arrest. Physical examination shows prominent calf muscles. Muscle strength is
4/5 at both hips but normal elsewhere. This patient most likely has a mutation
in the gene coding for which of the following proteins?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Actin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dystrophin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Frataxin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Myelin</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Myosin</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Duchenne muscular dystrophy</span><span> has long received attention from the general
and medical communities because it is a severe, currently untreatable,
relatively common disorder associated with relentless clinical deterioration<a
name=4-u1.0-B978-1-4160-3080-5..50015-8--intr></a>. The isolation of the gene
affected in this X-linked disorder <a
name=4-u1.0-B978-1-4160-3080-5..50015-8--p368></a>and the characterization of
its protein &#8211; dystrophin &#8211; have given insight into every aspect of
the disease, greatly improved the genetic counseling of affected families, and
suggested strategies for treatment.</span></p>

<p><span></span></p>

<p><a
name=4-u1.0-B978-1-4160-3080-5..50015-8--cese></a><span>Affected boys are normal for the first year or
two of life but develop muscle weakness at the age of 3 to 5 years, when they
begin to have difficulty climbing stairs and rising from a sitting position.
The child is confined to a wheelchair by the age of 12 years and is unlikely to
survive beyond the age of 20 years. Patients die of respiratory failure or,
because the myocardial muscle is also affected, of cardiac failure. In the
preclinical and early stages of the disease, the serum level of creatine kinase
is grossly elevated (50 to 100 times the upper limit of normal) because of its
release from diseased muscle. The brain is also affected; on average, there is
a modest decrease in IQ of about 20 points.</span></p>

<p></p>

<p>Duchenne muscular dystrophy,
a sex-linked recessive inherited trait, occurs in males (and in females with
Turner syndrome); carriers are female. It is reported to occur in one in 3500
live births. There is a family history in 70% of patients, and the condition
occurs as a spontaneous mutation in about 30% of patients. The disorder is the
result of a mutation in a region of the X chromosome that encodes the 400-kd
protein dystrophin. Dystrophin is important to the stability of the cell
membrane cytoskeleton. In patients with Duchenne muscular dystrophy, the total
absence of this protein results in progressive muscle degeneration and loss of
function.</p>

<p></p>

<p>Children with Duchenne
muscular dystrophy usually reach early motor milestones at appropriate times,
but independent ambulation may be delayed, and many are initially toe-walkers.
The disease usually becomes evident between 3 and 6 years of age. Clinical features
include large, firm calf muscles; the tendency to toe-walking; a widely based
stance; and a waddling gait. The diagnosis is usually obvious by the time the
child is 5 or 6 years old. A dramatically elevated level of creatine kinase (50
to 100 times normal) and DNA analysis of blood samples confirm the diagnosis.
Muscle biopsy shows variations in fiber size, internal nuclei, split fibers,
degenerating or regenerating fibers, and fibrofatty tissue deposition.
Dystrophin testing of the muscle biopsy specimen confirms the type of muscular
dystrophy </p>

<p></p>

<p>The degree of muscular
weakness depends on the age of the patient. Because the proximal musculature
weakens before the distal muscles, examination of the lower extremities shows
an early weakness of gluteal muscle strength. The weakness in the proximal
muscles of the lower extremity can be shown by a decrease in the ability to
rise from the floor without assistance of the upper extremities (Gower sign).
Calf pseudohypertrophy is caused by infiltration of the muscle by fat and
fibrosis, giving the calves the feel of hard rubber (see image). </p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=273 height=451
src="_%20Tutorials_files/image390.png"
alt="Description: http://www.mdconsult.com/books/bbmapAsset?appID=MDC&amp;isbn=978-0-323-03329-9&amp;eid=4-u1.0-B978-0-323-03329-9..50035-0..gr7&amp;assetType=full"
v:shapes="Picture_x0020_347296"></span></p>

<p style="text-align:center;">Calf
“pseudohypertrophy” in Duchenne muscular dystrophy</p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct. </span></b><span>Duchenne muscular dystrophy is an X-linked
disorder caused by mutation of the gene that codes for the protein, dystrophin.
Dystrophin is important to the stability of the cell membrane cytoskeleton.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 52-year-old woman with diabetes mellitus
presents to the clinic with malformed toenails. Which of the following tests
will most likely reveal the correct diagnosis? </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=265 height=181
src="_%20Tutorials_files/image392.png" alt="Description: quiz019" v:shapes="Picture_x0020_347295"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Wood’s
lamp examination</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nail
biopsy</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Blood
chemistries</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Potassium
hydroxide smear</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fungal
culture</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Onychodystrophy, or malformation of the nails,
may be congenital, traumatic, infectious, inflammatory, or drug-induced. The
most common cause of nail deformity is fungal infection, or onychomycosis
(about half of all cases). Toenails are affected more often than fingernails.
The nail plate is often yellow and thick, may become rough and crumbly, and can
separate from the nail bed. Dermatophytes are the fungi most commonly
responsible for onychomycosis. The diagnosis is made with a potassium hydroxide
(KOH) smear. Before obtaining a specimen, the nail is clipped and cleansed with
alcohol. A positive KOH smear shows fungal hyphae.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=207 height=146
src="_%20Tutorials_files/image394.png" alt="Description: KOHdermatophyte"
v:shapes="Picture_x0020_347294"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>A negative smear does not rule out
onychomycosis. Direct microscopy may be negative in up to 10% of cases, and
culture may be negative in up to 30% of cases. An effective treatment for
onychomycosis is oral terbinafine.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>.<span>&nbsp; </span>Microscopic examination of a potassium
hydroxide smear is the most useful test for diagnosing onychomycosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
65-year-old woman is diagnosed with osteoporosis of the spine. She has a 30
pack-year smoking history. Last year, she underwent a three-vessel coronary
artery bypass graft, and five years ago, she underwent total abdominal
hysterectomy with bilateral salpingo-oophorectomy for benign uterine disease.
Which of the following is the most appropriate pharmacologic therapy for her
osteoporosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Conjugated
equine estrogens (Premarin)</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Conjugated
equine estrogens and medroxyprogesterone acetate (Prempro)</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Raloxifene
hydrochloride (Evista)</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Alendronate
sodium (Fosamax)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Osteoporosis</span><span>
is a disease of bones that leads to an increased risk of fracture. In
osteoporosis the bone mineral density (BMD) is reduced and bone
microarchitecture deteriorates. Osteoporosis is defined by the World Health
Organization (WHO) as a bone mineral density that is 2.5 standard deviations or
more below the mean peak bone mass (average of young, healthy adults) as
measured by DXA.The disease may be classified as primary type 1, primary type
2, or secondary. The form of osteoporosis most common in women after menopause
is referred to as primary type 1 or <span>postmenopausal
osteoporosis</span>. Primary type 2 osteoporosis or <span>senile osteoporosis</span> occurs after age 75 and is seen in both
females and males at a ratio of 2:1. Finally, secondary osteoporosis may arise at
any age and affects men and women equally. This form of osteoporosis results
from chronic predisposing medical problems or disease, or prolonged use of
medications such as glucocorticoids.</span></p>

<p><span></span></p>

<p><span>The
underlying mechanism in all cases of osteoporosis is an imbalance between bone
resorption and bone formation. In normal bone, there is constant matrix
remodeling of bone; up to 10% of all bone mass may be undergoing remodeling at
any point in time. Bone is resorbed by osteoclasts (which derive from the </span><a
href="http://en.wikipedia.org/wiki/Bone_marrow" title="Bone marrow"><span>bone marrow</span></a><span>), after which new bone
is deposited by osteoblasts. The three main mechanisms by which osteoporosis
develops are an inadequate <span>peak bone
mass</span> (the skeleton develops insufficient mass and strength during
growth), excessive bone resorption by osteoclasts, and inadequate formation of
new bone ny osteoblasts during remodeling. An interplay of these three
mechanisms underlies the development of fragile bone tissue.</span></p>

<p><span></span></p>

<p><span>A
number of medications are available for the treatment of osteoporosis:<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Bisphosphonates.</span></b><span> Bisphosphonates are the
mainstay of therapy for osteoporosis. They inhibit bone breakdown, preserve
bone mass, and increase bone density in the spine and hip, reducing the risk of
fracture. Examples include alendronate (Fosamax), risedronate (Actonel),
ibandronate (Boniva), and zoledronic acid (Reclast). Bisphosphonates are
indicated for treatment of osteoporosis in post-menopausal women, adult men,
and people with steroid-induced osteoporosis. They are also used
prophylactically in post-menopausal women and in people receiving long-term
glucocorticoid therapy. Side effects include nausea, abdominal pain, difficulty
swallowing, and increased risk of inflamed esophagus or esophageal ulcer. Rare
side effects include osteonecrosis of the jaw, visual disturbance, and atypical
fractures (subtrochanteric and diaphyseal femur fractures).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b>Raloxifene (Evista).</b>
Raloxifene is a selective estrogen receptor modulator (SERM). It has estrogenic
effects on bone (i.e., it reduces bone loss) and anti-estrogenic effects on
uterus and breast (i.e., it reduces the risk of breast and uterine cancer).
Raloxifene is used for treatment and prevention of osteoporosis in
postmenopausal women. <span>In patients with coronary
artery disease, it may increase the risk of stroke, and it is </span>contraindicated
in individuals with a history of venous thromboembolic events, including deep
vein thrombosis and pulmonary embolism. Hot flashes are a common side effect. </p>

<p></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Calcitonin.</span></b><span> A hormone produced by
the thyroid gland, calcitonin reduces bone resorption. It may prevent spine
fractures and relieve pain from compression fractures. It is usually
administered as a nasal spray and may cause nasal irritation. It is not as
potent as the bisphosphonates, and is usually reserved for people who cannot
tolerate these medicines.</span></p>

<p><span></span></p>

<p><b><span>Teriparatide
(Forteo).</span></b><span>
An analog of parathyroid hormone, t<span>eriparatide</span>
works by stimulating new bone growth, rather than by preventing further bone
loss. It is given once daily by injection under the skin. Long-term effects are
being studied.</span></p>

<p><span></span></p>

<p><b><span>Hormone
therapy. </span></b><span>Estrogen,
especially when started soon after menopause, helps to maintain bone density.
It may, however, increase the risk of blood clots, endometrial cancer, and breast
cancer. Due to safety concerns, hormone therapy is not considered first-line
treatment for osteoporosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>.<span>&nbsp; </span>Bisphosphonates are the mainstay of
therapy for osteoporosis. The patient in this vignette has a history of
cardiovascular disease and is, therefore, not a candidate for hormone therapy
or raloxifene therapy. The Women’s Health Initiative (WHI), one of the largest
clinical trials, was designed to assess the effects of hormone replacement
therapy (HRT), dietary change, and calcium and vitamin D supplementation on
heart disease, osteoporotic fractures, and breast and colorectal cancer risk.
Early data showed that combinations of estrogen and progesterone increase the
risk of breast cancer, myocardial infarction, stroke, and blood clots. Data
also showed that estrogen alone increases the risk of blood clots and stroke,
and does not reduce the risk of myocardial infarction. Based on these results,
the American Heart Association has recommended that women with pre-existing
coronary artery disease consider non-hormonal options for the treatment of
osteoporosis. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Breast carcinomas
often cause the skin of the breast to become puffy and pitted, resembling
orange peel. The pits most likely correspond with which of the following?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Attachment
of suspensory ligaments (retinacula cutis) to the dermis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diffuse
scarring in subcutaneous fibrous tissue</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Focal
invasion of the dermis by neoplastic cells</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Openings
of sebaceous glands</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Openings
of sweat glands</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=244 height=244
src="_%20Tutorials_files/image396.png"
alt="Description: peau-d-orange-cellulite-ceinture-ventre-plat-regime-minceur-mincir-maigrir-sudation-sauna"
v:shapes="Picture_x0020_347293"></span><span></span></p>

<p style="text-align:center;"><span>Peau d’orange</span></p>

<p><span></span></p>

<p><span>A change
in the color or texture of the skin of the breast or areola is an important
symptom of breast carcinoma. The presence of dimpling, puckering, or scaliness
warrants further investigation. The presence of unusually prominent pores,
indicative of edema of the skin, is an important sign of malignancy. This
clinical sign is called <span d'orange</i></span>
because of its orange-peel appearance. During the early stages of breast
carcinoma, the lymphatic vessels of the breast are dilated and contain
occasional emboli of carcinoma cells. Limited <span over the lower half of the areola is present. As the disease
progresses, more lymphatic vessels become filled with carcinoma cells that
block them, creating more generalized edema. The pits in <i>peau d’orange</i> represent spots where the retinacula cutis attach to
the dermis. (The retinacula cutis are small fibrous strands that attach the
deep surface of the dermis to the underlying deep fascia. The extent of their
attachment determines the mobility of skin over the deep structures. These are
particularly well-developed over the breast where they are known as suspensory
ligaments of the breast. They are also well-developed, but short, in the palms
and soles.)</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. The pits in <i>peau d’orange</i> represent spots where the
retinacula cutis attach to the dermis. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>A 64-year-old man has
episodes of headache, heart palpitations, and sweating. He has lost 22 lbs in
the past 3 months. During one episode, his blood pressure was found to be
210/100 mm Hg. Urine studies show increased catecholamine concentrations. CT of
the abdomen shows a right adrenal mass. This tumor most likely originates from
which part of the adrenal gland?<span >&nbsp; </span></p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Medulla</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Zona
glomerulosa</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Zona
fasciculata</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Zona
reticularis</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>A <span>pheochromocytoma</span> is a neuroendocrine tumor of the medulla of the
adrenal glands (originating in the chromaffin cells) that secretes excessive
amounts of catecholamines, usually noradrenaline (norepinephrine) and
adrenaline (epinephrine). The most common presentation is headache, excessive
sweating, increased heart rate, and increased blood pressure with the attack
subsiding in less than one hour. Palpitations, anxiety, pallor, weight loss,
and hyperglycemia are common. A pheochromocytoma can also cause resistant
arterial hypertension and may be fatal if it produces “malignant hypertension”
(severely high blood pressurer). The tumor is usually unilateral, but may be
bilateral; it is usually benign, but maybe malignant; and it is usually
sporadic, but may be hereditary. The diagnosis can be established by measuring
catecholamines and metanephrines in blood or through a 24-hour urine
collection. Care should be taken to rule out other causes of adrenergic excess
like hypoglycemia, stress, exercise, and drugs. Pheochromocytomas occur most
often during young-adult to mid-adult life.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Answer A is correct.<span >&nbsp; </span></b>Pheochromocytomas
originate from chromaffin cells in the adrenal medulla. The adrenal medulla is
the core of the adrenal gland, and is surrounded by the adrenal cortex. It
secretes approximately 20% norepinephrine and 80% epinephrine. The chromaffin
cells of the medulla, named for their characteristic brown staining with
chromic acid salts, are the body's main source of the circulating catecholamines:
adrenaline (epinephrine) and noradrenaline (norepinephrine). Catecholamines are
derived from the amino acid tyrosine and these water-soluble hormones are the
major hormones underlying the fight-or-flight response. To carry out its part
of this response, the adrenal medulla receives input from the sympathetic
nervous system through preganglionic fibers originating in the thoracic spinal
cord (from T5 -T11). These fibers release acetylcholine, which stimulate the
adrenal medulla to produce catecholamines. Because it is innervated by
preganglionic nerve fibers, the adrenal medulla can be considered as a
specialized sympathetic ganglion. Unlike other sympathetic ganglia, however,
the adrenal medulla lacks distinct synapses and releases its secretions directly
into the blood.</p>

<p></p>

<p><b>Answer B is incorrect. </b>The outermost part of the adrenal cortex,
the zona glomerulosa, is the main site for production of mineralocorticoids,
mainly aldosterone, which is largely responsible for the long-term regulation
of blood pressure. Aldosterone's effects are on the distal convoluted tubule
and collecting duct of the kidney where it causes increased reabsorption of
sodium and increased excretion of both potassium and hydrogen ions. The major
stimulus to produce aldosterone is angiotensin II, while ACTH from the
pituitary only produces a transient effect. </p>

<p></p>

<p><b><span>Answer C is incorrect. </span></b><span>Situated between the
glomerulosa and reticularis, the zona fasciculata is responsible for producing
glucocorticoids, such as 11-deoxycorticosterone, corticosterone, and cortisol
in humans. Cortisol is the main glucocorticoid under normal conditions and its
actions include mobilization of fats, proteins, and carbohydrates.
Additionally, cortisol enhances the activity of other hormones including
glucagon and catecholamines. The zona fasciculata secretes a basal level of
cortisol but can also produce bursts of the hormone in response to
adrenocorticotropic hormone (ACTH) from the anterior pituitary. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect. </span></b><span>The inner most cortical
layer, the zona reticularis, produces androgens, mainly dehydroepiandrosterone
(DHEA), DHEA sulfate (DHEA-S), and androstenedione (the precursor to
testosterone).<span >&nbsp; </span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>A 24-year-old man visits the
clinic for a regular check-up. His father died of a heart attack at the age of
52. Physical examination shows a tendon xanthoma on the elbow. The serum
cholesterol level is 360 mg/dL. A mutation is most likely to be found in which
of the following genes?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Lipoprotein
lipase</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>ApoC2</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>LDL
receptor</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>ARH</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>ApoE</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Fats and cholesterol are
lipid-soluble and therefore cannot travel “alone” in the blood. They must be
placed in a water-soluble “capsule” for transport. That water-soluble capsule
is a lipoprotein. </p>

<p>Below is an example of a
lipoprotein. </p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=258 height=201
src="_%20Tutorials_files/image398.png" alt="Description: Lipoprotein" v:shapes="Picture_x0020_347292"></span></p>

<p></p>

<p>Inside the lipoprotein are
molecules of cholesterol (C) and triglyceride (T). These molecules are
surrounded by a phospholipid monolayer (represented in green). Within the
monolayer are various apoproteins (Apo A, B, C, and E), which interact with
structures outside the capsule to direct the transport of cholesterol and
triglyceride into and out of the capsule. </p>

<p></p>

<p>Lipoproteins are divided
into four major classes based on density: chylomicrons, VLDL (very low density
lipoprotein), LDL (low density lipoprotein), and HDL (high density
lipoprotein). Density depends on fat-to-protein ratio. Fat is “light”; so high
fat-to-protein ratios mean low density.<span></span></p>

<p><a
name=4-u1.0-B978-1-4160-2911-3..50038-8--spar></a></p>

<p></p>

<p>Dyslipidemia (abnormal
levels of lipoprotein in the blood) occurs when production or clearance of
lipoproteins is altered. Many factors contribute to dyslipidemia, including
defects in apoproteins, defects in receptors to which apoproteins bind, and
defects in enzymes that digest lipids. </p>

<p></p>

<p>Dyslipidemia may be
classified as primary or secondary. Primary dyslipidemia results from genetic
defects that directly affect lipoproteins. Secondary dyslipidemia is caused by
conditions, such as diabetes or hypothyroidism, which indirectly affect
lipoproteins.</p>

<p></p>

<p><span>The most
common primary dyslipidemia is familial hypercholesterolemia, an autosomal
dominant disorder in which mutation of the LDL receptor gene results in high
LDL cholesterol levels. LDL cholesterol normally circulates in the body for 2.5
days, and subsequently binds to the LDL receptor on liver cells, undergoes
endocytosis, and is digested. LDL is removed, and synthesis of cholesterol by
the liver is suppressed in the HMG-CoA reductase pathway. In familial hypercholesterolemia,
LDL receptor function is reduced or absent, and LDL circulates for an average
duration of 4.5 days, resulting in significantly increased level of LDL
cholesterol in the blood (with normal levels of other lipoproteins). This
increase occurs because the enzyme, 3-hydroxy-3-methylglutaryl (HMG)-CoA
reductase, which is involved in cholestrol synthesis, is not repressed. </span></p>

<p><span></span></p>

<p><span>[Repression
of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase is an effective means of
lowering serum cholesterol levels. In fact, the most effective and commonly
used cholesterol-lowering drugs are “statins,” or 3-hydroxy-3-methylglutaryl
(HMG)-CoA reductase inhibitors.]<span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>About 1 in
500 persons carries a mutation for familial hypercholesterolemia. About 1 in 20
survivors of a myocardial infarction is heterozygous for a mutation of this
gene.<span >&nbsp; </span>There are several hundred
known mutations resulting in the phenotype.<span>&nbsp; </span>Persons homozygous for mutations in the
LDL receptor have total serum cholesterol levels around 2000 mg/dl and can have
myocardial infarctions as young as age 3 or 4.<span>&nbsp; </span>A liver transplant results in
normalization of serum cholesterol levels since the transplanted liver has
normal cell surface expression of LDL particle receptors. HMG Co-A reductase
inhibitors (so called “statins”) block the rate-limiting enzyme in cholesterol
synthesis, lowering LDL-cholesterol levels.</span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span>Physical
findings of familial hypercholesterolemia may include xanthelasmata and tendon
xanthomas. Affected individuals develop premature vascular disease and have a
family history of early atherosclerotic vascular disease. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=230 height=128
src="_%20Tutorials_files/image400.png" alt="Description: Xanthelasmata" v:shapes="Picture_x0020_347291"></span><span></span></p>

<p style="text-align:center;"><span>Xanthelasmata</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=152 height=121
src="_%20Tutorials_files/image402.png"
alt="Description: image_gallery?img_id=1318242&amp;t=1222359119603" v:shapes="Picture_x0020_347290"></span><span></span></p>

<p></p>

<p style="text-align:center;"><span>Tendon xanthomas (elbow)</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. Familial
hypercholesterolemia, the most common primary dyslipidemia, is caused by a
mutation in the LDL receptor gene. The disorder is autosomal dominant and is
associated with high LDL cholesterol levels. Physical findings include
xanthelasmata, tendon xanthomas, and premature vascular disease. Patients
typically have a family history of early atherosclerotic vascular disease.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>. Familial lipoprotein
lipase deficiency is a rare autosomal recessive disorder associated with high
chylomicron and VLDL cholesterol levels. Blood tests show high triglyceride
levels. Eruptive xanthomas and pancreatitis may occur.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect</span></b><span>. Familial ApoC2
deficiency is similar to familial lipoprotein lipase deficiency in its clinical
manifestations. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. Autosomal recessive
hypercholesterolemia is similar to familial (autosomal dominant)
hypercholesterolemia in its clinical manifestations, but it is much rarer.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect</span></b><span>. Familial type III
hyperlipoproteinemia is caused by a mutation in the ApoE gene and is associated
with high VLDL levels. Blood tests show high cholesterol and triglyceride
levels. Physical findings include palmar xanthomas, tuberous xanthomas, and
premature atherosclerosis.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
32-year-old man is referred for evaluation of uncontrolled hypertension. He was
first told he had high blood pressure at age 25. He reports no symptoms except
dry mouth after starting clonidine.<span >&nbsp;
</span>In the past he took a “water pill,” but it was discontinued because it
lowered his serum potassium level. He is presently taking metoprolol 50 mg
twice daily, amlodipine 10 mg once daily, and clonidine 0.2 mg three times
daily. Arteriolar narrowing is seen on fundoscopic examination. Blood pressure
is 175/95 mm Hg in both arms; pulse is 62/ minute. Blood pressure over the
thighs is 185/108 mm Hg. There is no orthostatic drop in blood pressure with
standing.<span >&nbsp; </span>Blood tests show a serum
sodium level of 147 mEq/L (normal: 136-145 mEq/L) and a potassium level of 3.7
mEq/L (normal: 3.5-5.0 mEq/L).<span >&nbsp;&nbsp;
</span></span></p>

<p><span></span></p>

<p><span>Blood is
drawn in the morning to measure the serum aldosterone level and plasma renin
activity, both before and after administration of a 25-mg dose of captopril.
The result shows suppressed plasma renin activity and a high serum aldosterone
level. A diagnosis of primary hyperaldosteronism is made (Conn’s syndrome). CT
of the abdomen shows a 2-cm right adrenal adenoma. Adrenal venous sampling
demonstrates high levels of aldosterone emerging from the right adrenal gland.
The patient undergoes right adrenalectomy.<span >&nbsp;
</span>After surgery, the blood pressure falls to 135/78 mm Hg off all
medications. Plasma renin activity and aldosterone levels are found to be
normal when they are measured two months later.</span></p>

<p><span></span></p>

<p><span>What
series of pathophysiologic events led to the high serum sodium in this patient?
</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Increased extracellular volume,
increased cardiac output as described by the Starling curve, increased
perfusion pressure in the kidneys, increased loss of both sodium and free water
in the distal tubule, but relatively more water than sodium </span></p>

<p><span>B.<span>&nbsp; </span>Vasodilatation, decreased effective
blood volume, suppressed atrial natriuretic peptide, suppressed arginine
vasopressin, increased resorption of sodium in the kidneys</span></p>

<p><span>C.<span>&nbsp; </span>Increased extracellular volume,
increased atrial natriuretic peptide, suppressed arginine vasopressin, loss of
free water</span></p>

<p><span>D.<span>&nbsp; </span>Decreased extracellular volume,
increased arginine vasopressin, loss of free water and sodium, but relatively
more free water loss</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

</div>

<span><br clear=all>
</span>

<div><span>Primary
hyperaldosteronism is a relatively common cause of secondary hypertension. 8%
to 12% of all persons with hypertension have primary hyperaldosteronism.<span>&nbsp; </span>Most patients have bilateral
hyperplasia, which is treated with anti-hypertensive medicines, including an
aldosterone blocker. Proper identification and treatment of these patients is
important because without aldosterone blockade outcomes are worse (more
myocardial infarctions and strokes).<span >&nbsp;
</span>Adrenal adenomas producing aldosterone are generally treated by surgical
removal (as in the patient described).<span >&nbsp;
</span>Among patients with resistant hypertension (i.e., patients on at least 3
medications without adequate blood pressure control), primary
hyperaldosteronism is especially common. </span></p>

<p><span></span></p>

<p><span>Screening
for primary hyperaldosteronism can be accomplished with paired serum
measurements (in the morning) of plasma renin activity and serum aldosterone in
the morning. Aldosterone levels are high and plasma renin activity is
suppressed, even after administration of Captopril.</span></p>

<p><span></span></p>

<p><span>A common
finding in untreated primary hyperaldosteronism is mild hypernatremia. Patients
have increased intravascular volume (due to the effects of aldosterone), which
causes a rise in atrial natriuretic peptide levels. Arginine vasopressin levels
are suppressed, which leads to free water loss and hypernatremia.<span>&nbsp; </span>Thus, these patients are “dehydrated,”
defined by an elevated sodium level, despite having increased extracellular
volume. This highlights the fact that dehydration and volume depletion are two
different things. Dehydration is the loss of free water from both the
extracellular and intracellular spaces; serum sodium levels are increased.
Volume depletion, by contrast, is a loss of salt (sodium) and water from the
extracellular space; serum sodium levels may be low, normal, or high. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer
C is correct. </span></b><span>The
pathophysiologic events leading to the high serum sodium are increased
extracellular volume, increased atrial natriuretic peptide, suppressed arginine
vasopressin, loss of free water.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
25-year-old woman presents with weakness and fatigue.<span>&nbsp; </span>Her delivery four months ago was
complicated by postpartum hemorrhage and profound hypotension, requiring a
blood transfusion of 4 units.<span >&nbsp; </span>She
has been amenorrheic since the hemorrhage and has not been able to breastfeed
her baby due to inadequate milk production. In which of the following hormones
is she <i>least</i> likely to be deficient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Prolactin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Follicle-stimulating
hormone (FSH)</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Vasopressin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Adrenocorticotropic
hormone (ACTH)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Thyroid-stimulating
hormone (TSH)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Sheehan syndrome</span><span>,
also known as <span>postpartum
hypopituitarism</span> or <span>postpartum
pituitary necrosis</span>, is caused by blood loss and hypovolemic shock during
and after childbirth.</span></p>

<p><span></span></p>

<p><span>After a
severe postpartum hemorrhage with hypovolemia, the pituitary gland may become
necrotic. In normal uncomplicated pregnancies, the pituitary enlarges because
of hyperplasia of the lactotrophs and is more sensitive to changes in blood
flow. A sudden decrease in blood flow can lead to complete pituitary necrosis
or partial necrosis with preservation of pituitary function.<span>&nbsp; </span></span></p>

<p><span>In severe
cases, extreme headache, nausea, and vomiting may occur and may be confused
with subarachnoid hemorrhage. If the blood supply to the pituitary is only
marginally affected, the patient may be relatively asymptomatic until some
stress such as infection or surgery precipitates adrenal crisis. </span></p>

<p><span></span></p>

<p><span>An orderly
progression of events typically occurs in Sheehan syndrome. Initially,
prolactin production decreases, causing failure to lactate. In most cases,
gonadotropins (FSH and LH) are affected, leading to hypogonadism and menstrual
disturbance (typically, absent or infrequent menses). Vasomotor symptoms,
dyspareunia, atrophic vaginitis, and osteopenia may result from estrogen
deficiency. Loss of pubic and axillary hair may be attributable to low androgen
levels. Fatigue and decreased muscle mass may result from decreased growth
hormone levels. </span></p>

<p><span></span></p>

<p><span>Secondary
adrenal insufficiency (which is associated with weakness, fatigue,
hypoglycemia, and dizziness) should be suspected when cortisol and ACTH levels
are low and fail to increase during an insulin tolerance test. Secondary
hypothyroidism may result from TSH deficiency.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. Vasopressin, which is
secreted by the posterior pituitary, is usually preserved in Sheehan syndrome.
The posterior pituitary is a direct extension of the hypothalamus. Its blood
supply is less dependent on the portal vasculature. Diabetes insipidus usually
does not occur in Sheehan syndrome.<span >&nbsp;
</span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 60-year-old man has tenderness in the
region distally between the tendons of the extensor pollicis longus and
extensor pollicis brevis after falling on the palm of his right hand. A
fracture of which of the following carpal bones is most likely in this patient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Hamate</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lunate</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Scaphoid</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Trapezium</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Triquetrum</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Fracture
of the scaphoid bone (also called the navicular bone) is the most common type
of wrist fracture. It usually causes pain, swelling, and tenderness at the base
of the thumb and in the anatomic “snuffbox.”* It is diagnosed by X-ray;
however, not all scaphoid fractures are apparent initially. Consequently,
patients with snuffbox tenderness following wrist trauma are often casted for
7&#8211;10 days, at which point a second set of X-rays is taken. The scaphoid
has its own blood flow unlike other carpal bones. It receives blood primarily
from lateral and distal branches of the radial artery. If blood flow is
disrupted, the bone may not heal and surgery may be required.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=297 height=166
src="_%20Tutorials_files/image404.png" alt="Description: en_carpalbones2"
v:shapes="Picture_x0020_347289"></span><span></span></p>

<p style="text-align:center;"><span>Carpal bones</span></p>

<p style="text-align:center;"><span><img border=0 width=228 height=280
src="_%20Tutorials_files/image406.png" alt="Description: IMAGE002" v:shapes="Picture_x0020_347288"></span><span></span></p>

<p style="text-align:center;"><span>Anatomical snuffbox</span></p>

<p style="text-align:center;"><span><img border=0 width=175 height=218
src="_%20Tutorials_files/image408.png"
alt="Description: 230px-Scaphoid_waist_fracture" v:shapes="Picture_x0020_347287"></span><span></span></p>

<p style="text-align:center;"><span>Scaphoid fracture</span></p>

<p><span></span></p>

<p><span>*The <span>anatomical snuffbox</span> is a triangular
deepening on the dorsoradial aspect of the hand. The scaphoid and trapezium
bones form the floor of the snuffbox. The snuffbox is bounded by the extensor
pollicis longus on one side and the abductor pollicis longus and extensor
pollicis brevis on the other. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>This patient has
tenderness over the anatomic snuffbox. Fracture of the scaphoid bone should be
suspected. </span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
36-year-old woman presents to the physician with amenorrhea.<span>&nbsp; </span>She reports an increase in her ring and
shoe sizes over the past year, increase sweating, and increased fatigue.<span>&nbsp; </span>Physical examination shows a blood
pressure of 150/90 mm Hg and coarse facial features with mild
macroglossia.<span >&nbsp; </span>Which of the
following is most appropriate for this patient? </span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Finasteride</span></p>

<p><span>B.<span>&nbsp; </span>Leuprolide</span></p>

<p><span>C.<span>&nbsp; </span>Octreotide</span></p>

<p><span>D.<span>&nbsp; </span>Recombinant growth hormone</span></p>

<p><span>E.<span>&nbsp; </span>Somatrem</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><b><span>Acromegaly and
  Gigantism </span></b></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P065015></a><span>In childhood, GH
  hypersecretion leads to gigantism; in adults whose long bone epiphyses are
  fused, GH excess causes acromegaly with local overgrowth of bone in the acral
  areas. GH hypersecretion is almost always caused by a GH-secreting pituitary
  adenoma. About 70% of patients with acromegaly have macroadenomas. Ectopic
  GHRH secretion can occur with pancreatic islet cell tumors and bronchial or
  intestinal carcinoids.<span >&nbsp; </span></span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC065010></a><b><i><span>Clinical
  Features </span></i></b></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P065016></a><span>The clinical features
  of acromegaly are insidious, and it may take several years for the
  disfiguring features to be diagnosed. The most classic clinical feature is
  acral enlargement, exhibited as a widening of the hands and feet and a
  coarsening of the facial features; the frontal sinuses enlarge, leading to
  prominent supraorbital ridges, and the mandible grows downward and forward,
  resulting in prognathism and wide spacing of the teeth. Ring, glove, and shoe
  sizes increase as a result of soft tissue and bony enlargement of hands and
  feet. The bony and soft tissue changes are accompanied by endocrine,
  metabolic, and systemic manifestations.</span></p>
  <p style="text-align:center;"><b><span></span></b></p>
  <p style="text-align:center;"><b><span>Acromegaly</span></b></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=HC065011></a><span></span></p>

<p><a name=T065003></a><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0 width="90%">
 <tr>
  <td valign=bottom>
  <p><a name=T065003.50></a><b><span>Change</span></b><span></span></p>
  </td>
  <td valign=bottom>
  <p><b><span>Manifestations</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td colspan=2 valign=top>
  <p><a name=T065003.100></a><b><span>Somatic Changes</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.150></a><span>Acral changes</span></p>
  </td>
  <td valign=top>
  <p><span>Enlarged hands and feet</span></p>
  </td>
 </tr>
 <tr>
  <td rowspan=5 valign=top>
  <p><a name=T065003.200></a><span>Musculoskeletal
  changes</span></p>
  </td>
  <td valign=top>
  <p><span>Arthralgias</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.250></a><span>Prognathism</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.300></a><span>Malocclusion</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.350></a><span>Carpal tunnel syndrome</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.400></a><span>Proximal myopathy</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.450></a><span>Skin changes</span></p>
  </td>
  <td valign=top>
  <p><span>Sweating</span></p>
  </td>
 </tr>
 <tr>
  <td rowspan=2 valign=top>
  <p><a name=T065003.500></a><span>Colon changes</span></p>
  </td>
  <td valign=top>
  <p><span>Polyps</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.550></a><span>Carcinoma</span></p>
  </td>
 </tr>
 <tr>
  <td rowspan=2 valign=top>
  <p><a name=T065003.600></a><span>Cardiovascular
  symptoms</span></p>
  </td>
  <td valign=top>
  <p><span>Cardiomegaly</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.650></a><span>Hypertension</span></p>
  </td>
 </tr>
 <tr>
  <td rowspan=3 valign=top>
  <p><a name=T065003.700></a><span>Visceromegaly</span></p>
  </td>
  <td valign=top>
  <p><span>Tongue</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.750></a><span>Thyroid</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.800></a><span>Liver</span></p>
  </td>
 </tr>
 <tr>
  <td colspan=2 valign=top>
  <p><a name=T065003.850></a><b><span>Endocrine-Metabolic
  Changes</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td rowspan=3 valign=top>
  <p><a name=T065003.900></a><span>Reproduction</span></p>
  </td>
  <td valign=top>
  <p><span>Menstrual abnormalities</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.950></a><span>Galactorrhea</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.1000></a><span>Decreased libido</span></p>
  </td>
 </tr>
 <tr>
  <td rowspan=2 valign=top>
  <p><a name=T065003.1050></a><span>Carbohydrate
  metabolism</span></p>
  </td>
  <td valign=top>
  <p><span>Impaired glucose tolerance</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.1100></a><span>Diabetes mellitus</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><a name=T065003.1150></a><span>Lipids</span></p>
  </td>
  <td valign=top>
  <p><span>Hypertriglyceridemia</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width="90%">
 <tr>
  <td width="100%"></td>
 </tr>
</table>

</div>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P065017></a><b><i><span>Treatment</span></i></b><span></span></p>
  <p><span></span></p>
  <p><span>Trans-sphenoidal
  microsurgery is the initial therapy of choice, resulting in rapid reduction
  of GH levels with a low rate of surgical morbidity. Radiotherapy is an
  effective method of reducing GH hypersecretion; however, it may take as long
  as 20 years for GH levels to fall after radiotherapy, and the incidence of
  hypopituitarism is high. Medical management involves the use of drugs that
  decrease GH secretion from the pituitary tumor (somatostatin analogues,
  dopamine agonists) or block the peripheral action of GH at the hepatic
  receptor (GH receptor antagonists). Octreotide acetate, a long-acting
  somatostatin analogue, is effective in reducing GH and IGF-I levels to normal
  in 40% to 65% of patients and shrinks tumor mass in about 50% of cases. Side
  effects of octreotide include diarrhea, abdominal cramps, flatulence, and
  gallstone formation. </span></p>
  </td>
 </tr>
</table>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p></b></p>

<p><b><span>The correct answer is C.<span>&nbsp; </span></span></b><span>This patient presents with acromegaly, the
clinical syndrome that is a result of excessive growth hormone (GH) secretion
in adults (after closure of the physes).<span >&nbsp;
</span>Octreotide is a somatostatin analog that acts at the anterior pituitary
to suppress GH secretion, and is used in the treatment of acromegaly.<span>&nbsp; </span>Surgical and radiotherapeutic approaches
are also an option, depending on the etiology.<span>&nbsp; </span>Somatostatin is normally secreted by the
hypothalamus to help regulate basal GH secretion.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is Incorrect. </span></b><span><span>&nbsp;</span>Finasteride is a 5-&#945;-reductase
inhibitor that suppresses the conversion of testosterone to dihydrotestosterone
and is used in the treatment of benign prostatic hypertrophy.</span></p>

<p><span></span></p>

<p><b><span>Answer B in incorrect.</span></b><span><span>&nbsp; </span>Leuprolide is a gonadotropin-releasing
hormone analog that can exhibit both agonist and antagonist actions, depending
on the timing of administration.<span >&nbsp; </span>It
is used to treat infertility, prostate cancer, and uterine fibroids.<span>&nbsp; </span>Adverse effects include antiandrogen
actions (e.g., gynecomastia, decreased libido), nausea, and vomiting.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect.</span></b><span><span>&nbsp; </span>Like somatrem, recombinant GH is useful
in the treatment of GH deficiency, but would exacerbate the condition of a
patient with acromegaly.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>Somatrem is a somatotropin, or GH
analog, that stimulates the release of somatomedin/insulin-like growth factor-l
from the liver and is useful in the treatment of GH deficiency.<span>&nbsp; </span>It would exacerbate the condition of a
patient with acromegaly.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 14-year-old boy presents with complaints of right knee pain of
approximately 2 months' duration. He remembers falling during soccer training 2
months ago, but the trauma was not severe enough to seek medical attention.
Shortly afterward, he started having pain at night or after soccer practice.
The pain would initially subside with rest and over-the-counter medication.
However, for the past 2 weeks the pain has increased in intensity, causing him
to limp. His mother has noticed his right thigh is slightly larger than the
left. It is also warm and tender to touch. X-ray of the knee shows an
osteolytic and osteoblastic tumor in the distal femur. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=237 height=283
src="_%20Tutorials_files/image410.png"
alt="Description: http://www.cancerindex.org/images/osteosarcoam_radiograph.jpeg"
v:shapes="Picture_x0020_347255"></span><span></span></p>

<p><span></span></p>

<p><span>Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Chondrosarcoma</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ewing’s sarcoma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Metastasis to bone </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Osteochondroma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Osteosarcoma</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Primary
Bone Tumors</span></b></p>

<p><b><span></span></b></p>

<p><a
name=4-u1.0-B978-1-4377-1604-7..00208-6--s001></a><span>Primary
bone malignancies are relatively uncommon tumors (0.2% of all neoplasms) that
arise from cells that are normal components of bone tissues and that have the
potential to metastasize. Malignant tumors are to be distinguished from a
variety of more common benign bone lesions, such as osteochondromas and
enchondromas, which lack the ability to metastasize.</span></p>

<p><span></span></p>

<p><b><span>Clinical Manifestations and
Diagnosis</span></b></p>

<p><span></span></p>

<p><span>Patients with primary malignant and benign bone tumors
present with pain, swelling and occasionally pathologic fracture of the
involved bone. If radiologic studies suggest a malignant primary bone tumor, an
orthopedic oncologist should be consulted before carrying out a biopsy because
improper biopsy technique may compromise subsequent surgical care, particularly
limb-sparing surgery. Staging of patients with bone tumors generally requires
computed tomography (CT) scans of the chest, abdomen, and pelvis to assess for
metastatic disease. Characterization of the primary bone tumor may benefit from
magnetic resonance imaging (MRI) assessment of soft tissue extension or CT scan
assessment of cortical bone involvement, or both.</span></p>

<p><a
name=4-u1.0-B978-1-4377-1604-7..00208-6--s002></a><span></span></p>

<p><a name=4-u1.0-B978-1-4377-1604-7..00208-6--s003></a><a
name=4-u1.0-B978-1-4377-1604-7..00208-6--st00></a><b><span>Osteosarcoma</span></b></p>

<p><span></span></p>

<p><i><span>Osteosarcoma</span></i><span>&nbsp;is
the most common malignant sarcoma of bone, representing about 35% of cases. It
has a bimodal age distribution, with highest incidence in patients younger than
20 years, most likely related to the normal rapid bone growth that occurs
during adolescence. In this age group, most tumors arise in the metaphyseal
areas of the long bones of the extremities, particularly around the knee. </span><span>Over 90% of tumors are located in the metaphysis (the growing ends of
the bone) the most common sites are the bones around the knee which account for
80% of cases. </span><span>Males are affected more commonly
than females at a ratio of 3:2. A second peak of incidence occurs in adults
older than 60 years. The sites of origin in these older patients are somewhat
more heterogeneous, with craniofacial and pelvic bones each accounting for 20%
of tumors. Radiographically, osteosarcomas usually present as mixed
osteoblastic and osteolytic lesions, although pure forms of either appearance
can occur. Periosteal elevation (Codman's triangle), cortical destruction, and
tumor extension into soft tissue are common on plain films or MRI.</span></p>

<p><span></span></p>

<p><span>The incidence of osteosarcoma is increased in families that
carry germline deletion of retinoblastoma (<i>Rb</i>),&nbsp;<i>p53</i>&nbsp;(Li-Fraumeni),
or&nbsp;<i>RecQ</i>&nbsp;DNA helicase genes. Consistent with these
observations, although most younger patients with osteosarcomas have no
apparent predisposing factor or family history of bone tumors, alterations in
the&nbsp;<i>p53</i>&nbsp;and&nbsp;<i>Rb</i>&nbsp;genes of such sporadic tumors
occur in 40% and 60%, respectively. In older patients, a variety of conditions
may predispose patients to osteosarcoma, most convincingly antecedent Paget's
disease or prior radiation therapy.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Chondrosarcoma</span></b></p>

<p><span></span></p>

<p><i><span>Chondrosarcoma</span></i><span>, a
malignant tumor characterized by hyaline cartilage differentiation, is the
second most common sarcoma of bone, representing 25% of bone sarcomas. The peak
incidence is in the fifth to seventh decades of life. The most common primary
sites are in the pelvis, proximal femur, and proximal humerus. Patients present
with long-standing complaints of swelling, pain, or both. Radiographically,
chondrosarcoma is detected as an area of radiolucency with variable punctate
mineralization, with frequent cortical bone erosion or thickening, sometimes
with extension into adjacent soft tissue. Distinguishing low-grade
chondrosarcomas from benign central enchondromas can be difficult. Location in
the axial skeleton and size greater than 5&nbsp;cm favor malignancy.</span></p>

<p><span></span></p>

<p><b><span>Ewing's Sarcoma</span></b></p>

<p><span></span></p>

<p><span>Ewing's sarcoma and primitive neuroectodermal tumor (PNET)
are a family of small round cell sarcomas that represent 16% of primary bone
sarcomas. As with osteosarcoma, the peak incidence occurs during the second
decade of life, but unlike osteosarcoma, the incidence of Ewing's is unimodal,
being distinctly unusual in older adults and in nonwhites. Ewing's sarcoma
tends to arise in the diaphyseal region of long bones, in the pelvis, or in
ribs. Ewing's tumors are characterized radiologically by a permeative or
“moth-eaten” appearance of the affected bone, with a multilayered “onion-skin”
periosteal reaction. MRI studies frequently document a significant soft tissue
mass associated with the bone lesion. Unlike other sarcomas of bone, Ewing's
sarcoma may present with symptoms of an inflammatory systemic illness, with
intermittent fevers, anemia, leukocytosis, and an increased sedimentation rate.</span></p>

<p><span></span></p>

<p><b><span>Metastatic Tumors
to Bone</span></b></p>

<p><span></span></p>

<p><span>Tumors metastatic to bone are important
causes of cancer-related morbidity. Effective prevention and treatment of
skeleton-related metastases are an important part of clinical care for many
cancer patients. The most common tumors to metastasize to bone are breast in
women and prostate in men, followed by lung, kidney, gastrointestinal tract,
and thyroid.</span></p>

<p><span>Bone metastases typically present as
localized or referred pain and less commonly as a fracture. Plain radiographs
may demonstrate blastic or lytic lesions. Although prostate cancer is generally
blastic and multiple myeloma usually lytic, most other tumors have a mixed
appearance. In patients with one documented bone metastasis or in patients with
widely metastatic disease and bone pain, a radiologic survey can identify bone
metastases that may ultimately place the patient at risk for a pathologic
fracture. Technetium diphosphonate bone scans are useful to delineate the extent
of bony metastases and in following response to therapy. However, a negative
study must be interpreted cautiously for tumors that are potentially purely
lytic because these may be undetectable by bone scan. In such tumors (e.g.,
multiple myeloma), a skeletal survey is therefore preferable. Routine screening
for bone metastases is not indicated for cancer patients with no symptoms or
signs of bone involvement.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct. </span></b><span>A tumor with
osteoblastic and osteolytic lesions near the knee of a teenager is most likely
to be osteosarcoma.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
18-year-old woman is referred to a specialist because she has never had a
period. She reports occasional bouts of nausea, vomiting, and generalized
weakness.<span >&nbsp; </span>Her blood pressure is
160/99 mm Hg; laboratory studies show a serum K<sup>+</sup> level of 2.2 mEq/L.
There is no breast development and no pubic and axillary hair. There are no
signs of virilization (<span </span></span><span>enlargement, increased muscle strength,
acne,<span frontal hair
thinning, or deepening of the voice.)</span>This patient suffers from a
condition that affects the production of two of the three adrenal hormones,
leaving only one functioning hormone.<span >&nbsp;
</span>In which area of the adrenal gland is this one hormone produced?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Capsule</span></p>

<p><span>B.<span>&nbsp; </span>Medulla</span></p>

<p><span>C.<span>&nbsp; </span>Zona fasciculata</span></p>

<p><span>D.<span>&nbsp; </span>Zona glomerulosa</span></p>

<p><span>E.<span>&nbsp; </span>Zona reticularis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=0 cellpadding=0 width="100%">
 <tr>
  <td
  width="0%"><p  <td></td>
  <td valign=top></td>
  <td
  width="94%"><p </tr>
 <tr>
  <td width="99%" colspan=4>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC067005></a><b><span>Congenital Adrenal Hyperplasia </span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P067021></a><span>Congenital adrenal hyperplasia (CAH) refers to disorders of
    adrenal steroid biosynthesis that result in glucocorticoid and
    mineralocorticoid deficiencies. Because of deficient cortisol biosynthesis,
    a compensatory increase in ACTH occurs, inducing adrenal hyperplasia and
    overproduction of the steroids that precede blockage of enzyme production. </span></p>
    <p><span></span></p>
    <p style="text-align:center;"><span><img border=0 width=428 height=370
    src="_%20Tutorials_files/image412.png"
    alt="Description: http://www.studentconsult.com/common/showimage.cfm?mediaISBN=9781416061090&amp;FigFile=S9781416061090-067-f002.jpg&amp;size=fullsize"
    v:shapes="Picture_x0020_347256"></span><span></span></p>
    <p><span></span></p>
    <p><span>Five major types of
    CAH exist, and the clinical manifestations of each type depend on which
    steroids are in excess and which are deficient. All these syndromes are
    transmitted in an autosomal recessive pattern. </span></p>
    <p><span></span></p>
    <p><span>21-Hydroxylase
    (CYP21) deficiency is the most common of these disorders and accounts for
    about 95% of patients of CAH. In this condition, there is a failure of
    21-hydroxylation of 17-hydroxyprogesterone and progesterone to
    11-deoxycortisol and 11-deoxycorticosterone, respectively, with deficient
    cortisol and aldosterone production. Cortisol deficiency leads to increased
    ACTH release, causing overproduction of 17-hydroxyprogesterone and
    progesterone. Increased ACTH production also leads to increased biosynthesis
    of androstenedione and DHEA, which can be converted to testosterone. </span></p>
    <p><span>Patients with
    21-hydroxylase deficiencies can be divided into two clinical phenotypes:
    classic 21-hydroxylase deficiency, usually diagnosed at birth or during
    childhood, and late-onset 21-hydroxylase deficiency, which develops during
    or after puberty. Patients with classic 21-hydroxylase deficiency have
    various degrees of mineralocorticoid deficiency (salt-losing form) and
    virilization. The most useful measurement for the diagnosis of classic
    21-hydroxylase deficiency is that of plasma 17-hydroxyprogesterone. A value
    greater than 200 ng/dL is consistent with the diagnosis. Late-onset
    21-hydroxylase deficiency usually develops around the time of puberty with
    signs of virilization (hirsutism and acne) and amenorrhea or
    oligomenorrhea. This diagnosis should be considered in women with
    unexplained hirsutism and menstrual abnormalities or infertility. The aim
    of treatment for classic 21-hydroxylase deficiency is to replace
    glucocorticoids and mineralocorticoids, suppress ACTH and androgen
    overproduction, and allow for normal growth and sexual maturation in
    children.<span></span></span></p>
    <p><span></span></p>
    <a name=P067023></a></td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=P067022></a><span></span></p>
  <p><a name=P067024></a><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P067025></a><span>11&#946;-Hydroxylase (CYP11B1) deficiency accounts for about
    5% of the patients with CAH. In this syndrome, the conversions of
    11-deoxycortisol to cortisol and 11-deoxycorticosterone to corticosterone
    (the precursor to aldosterone) are blocked. Affected patients usually have
    hypertension and hypokalemia because of increased amounts of precursors
    with mineralocorticoid activity. Virilization occurs, as with
    21-hydroxylase deficiency, and a late-onset form exhibiting as androgen
    excess also occurs. The diagnosis is made from the finding of elevated
    plasma 11-deoxycortisol levels, either basally or after ACTH stimulation. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P067026></a><span>Rare forms of CAH are 3&#946;-HSD type II,
    17&#945;-hydroxylase (CYP17), and steroidogenic acute regulatory protein
    deficiencies. </span></p>
    </td>
   </tr>
  </table>
  </td>
 </tr>
 <![if !supportMisalignedColumns]>
 <tr height=0>
  <td width=5></td>
  <td width=13></td>
  <td width=13></td>
  <td width=526></td>
 </tr>
 <![endif]>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>The correct answer is D.</span></b><span><span>&nbsp; </span>17-&#945;-Hydroxylase deficiency, a form
of congenital adrenal hyperplasia, is characterized by deficits in
glucocorticoid and sex steroid synthesis.<span >&nbsp;
</span>This is coupled with increased mineralocorticoid production due to the
increased flow of precursors, such as pregnenolone and progesterone, through
mineralocorticoid-yielding pathways. The resultant low serum cortisol and sex
steroid levels with elevated mineralocorticoid levels manifest clinically with
hypertension, hypokalemia, and a female phenotype with no sexual
maturation.<span >&nbsp; </span>Aldosterone is produced
in the zona glomerulosa.<span >&nbsp;
</span>Aldosterone synthesis requires 21-&#946;-hydroxylase but not
17-&#945;-hydroxylase.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>The capsule does not produce any
hormones.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect.</span></b><span><span>&nbsp; </span>The medulla produces catecholamines;
neither 17-&#945;-hydroxylase nor 21-&#946;-hydroxylase is required for the
synthesis of catecholamines.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>Cortisol is produced in the zona
fasciculata of the adrenal cortex.<span >&nbsp;
</span>Cortisol synthesis requires 21-&#946;-hydroxylase and
17-&#945;-hydroxylase.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>Sex hormones are produced in the zona
reticularis.<span >&nbsp; </span>Synthesis of the sex
hormones requires 17-&#945;-hydroxylase but not 21-&#946;-hydroxylase.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A patient
undergoes successful thyroidectomy for Graves’ disease and returns to a
euthyroid state with the use of levothyroxine supplementation.<span>&nbsp; </span>In a follow-up examination, the patient reports
resolution of all prior symptoms except for anxiety and irritability.<span>&nbsp; </span>She also reports frequent muscle
spasms.<span >&nbsp; </span>On physical examination,
tapping over the facial nerve elicits facial muscle spasm.<span>&nbsp; </span>An ECG shows QT prolongation.<span>&nbsp; </span>Which of the following most likely
describes the current laboratory values of this patient?</span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=65>
  <p style="text-align:center;"><span>Choice</span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span>Calcium</span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span>Phosphate</span></p>
  </td>
  <td width=67>
  <p style="text-align:center;"><span>Parathyroid</span></p>
  <p style="text-align:center;"><span>Hormone</span></p>
  </td>
 </tr>
 <tr>
  <td width=65>
  <p style="text-align:center;"><span>A</span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span><span><img width=12 height=21
  src="_%20Tutorials_files/image413.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347257"></span></span><span></span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span><img width=12 height=23
  src="_%20Tutorials_files/image414.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347258"></span><span></span></p>
  </td>
  <td width=67>
  <p style="text-align:center;"><span><span><img width=12 height=21
  src="_%20Tutorials_files/image415.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347259"></span></span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=65>
  <p style="text-align:center;"><span>B</span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span><img width=12 height=21
  src="_%20Tutorials_files/image416.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347260"></span><span></span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span><img width=12 height=24
  src="_%20Tutorials_files/image417.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347261"></span><span></span></p>
  </td>
  <td width=67>
  <p style="text-align:center;"><span><img width=12 height=24
  src="_%20Tutorials_files/image418.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347262"></span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=65>
  <p style="text-align:center;"><span>C</span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span><img width=12 height=25
  src="_%20Tutorials_files/image419.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347263"></span><span></span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span><img width=12 height=21
  src="_%20Tutorials_files/image420.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347469"></span><span></span></p>
  </td>
  <td width=67>
  <p style="text-align:center;"><span><span><img width=12 height=21
  src="_%20Tutorials_files/image421.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347470"></span></span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=65>
  <p style="text-align:center;"><span>D</span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span><img width=12 height=24
  src="_%20Tutorials_files/image422.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347471"></span><span></span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span><img width=12 height=21
  src="_%20Tutorials_files/image423.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347472"></span><span></span></p>
  </td>
  <td width=67>
  <p style="text-align:center;"><span><img width=12 height=23
  src="_%20Tutorials_files/image424.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347473"></span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=65>
  <p style="text-align:center;"><span>E</span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span>Normal</span></p>
  </td>
  <td width=65>
  <p style="text-align:center;"><span>Normal</span></p>
  </td>
  <td width=67>
  <p style="text-align:center;"><span>Normal</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>A</span></p>

<p><span>B.<span>&nbsp; </span>B</span></p>

<p><span>C.<span>&nbsp; </span>C</span></p>

<p><span>D.<span>&nbsp; </span>D</span></p>

<p><span>E.<span>&nbsp; </span>E</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><b><span>Hypocalcemia</span></b></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC074020></a><span>SYMPTOMS AND SIGNS</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074030></a><span>Hypocalcemia leads to
  a reduction in the potential difference across cell membranes, which leads to
  hyperexcitability, particularly of cells of the neuromuscular class. Hence
  neuromuscular cells spontaneously fire and produce spontaneous seizures,
  paresthesias, and skeletal muscle contractions (referred to as&nbsp;<i>carpal
  spasm, pedal spasm</i>, or&nbsp;<i>tetany</i>). Two physical signs are
  observed on examination: Trousseau sign, which is spontaneous contraction of
  the forearm muscles in response to application of a blood pressure cuff
  around the upper arm and inflation to above systolic pressure, and Chvostek
  sign, which is twitching of the facial muscles with gentle tapping of the
  facial nerve as it exits the parotid gland. An electrocardiographic sign is a
  prolonged QTc interval. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC074021></a><span>PATHOPHYSIOLOGY</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074031></a><span>Hypocalcemia may
  result from five general mechanisms: (1) a reduction in serum binding
  proteins (albumin), (2) an increase in serum phosphate with a resultant
  increase in the calcium-phosphate solubility product, (3) an increase in
  renal calcium excretion, (4) a reduction in intestinal calcium absorption, or
  (5) a loss of calcium from the ECF into the skeleton. In practice, several of
  these factors are operative in several disorders. For example, in
  hypoparathyroidism, a reduction in intestinal calcium absorption combines
  with an inability to reabsorb calcium from the distal tubule to cause
  hypocalcemia; or, in breast cancer with extensive osteoblastic metastases,
  increases in osteoblast activity remove calcium from the ECF, and anorexia
  leads to a reduction in intestinal calcium intake. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=HC074022></a><span></span></p>

<p><a name=P074032></a><a name=T074002></a><span></span></p>

<p><span></span></p>

<p><a name=T074002.50></a><a name=T074002.100></a><a name=T074002.150></a><a
name=T074002.200></a><a name=T074002.250></a><a name=T074002.300></a><a
name=T074002.350></a><a name=T074002.400></a><a name=T074002.450></a><a
name=T074002.500></a><a name=T074002.550></a><a name=T074002.600></a><a
name=T074002.650></a><a name=T074002.700></a><a name=T074002.750></a><a
name=T074002.800></a><a name=T074002.850></a><a name=T074002.900></a><a
name=T074002.950></a><a name=T074002.1000></a><a name=T074002.1050></a><a
name=T074002.1100></a><a name=T074002.1150></a><a name=T074002.1200></a><a
name=T074002.1250></a><a name=T074002.1300></a><a name=T074002.1350></a><a
name=T074002.1400></a><a name=T074002.1450></a><a name=T074002.1500></a><a
name=T074002.1550></a><a name=T074002.1600></a><a name=T074002.1650></a><a
name=T074002.1700></a><a name=T074002.1750></a><a name=T074002.1800></a><a
name=T074002.1850></a><a name=T074002.1900></a><a name=T074002.1950></a><a
name=T074002.2000></a><a name=T074002.2050></a><a name=T074002.2100></a><a
name=T074002.2150></a><a name=T074002.2200></a><a name=T074002.2250></a><a
name=T074002.2300></a><a name=T074002.2350></a><a name=T074002.2400></a><a
name=T074002.2450></a><a name=T074002.2500></a><a name=T074002.2550></a><a
name=T074002.2600></a><a name=T074002.2650></a><a name=T074002.2700></a><a
name=T074002.2750></a><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC074023></a><b><span>Hypoparathyroidism</span></b></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074033></a><span>Hypoparathyroidism
  causes hypocalcemia as a result of a decrease in intestinal calcium
  absorption (a result of low circulating 1,25[OH]<sub>2</sub>D concentrations,
  which are a result of low circulating PTH), combined with reduced renal
  calcium reabsorption in the distal tubule (as a result of decreased
  circulating PTH). Hypoparathyroidism may be idiopathic or autoimmune,
  occurring either in isolation or as part of the polyglandular failure
  syndrome in association with Graves hyperthyroidism, Hashimoto thyroiditis,
  Addison disease, type 1 diabetes, vitiligo, mucocutaneous candidiasis, and
  other autoimmune disorders. Hypoparathyroidism may also be commonly
  encountered as surgical hypoparathyroidism in patients who have undergone
  thyroid, parathyroid, or laryngeal surgery for multinodular goiter or Graves
  disease, for parathyroid hyperplasia, or for carcinoma of the larynx or
  esophagus. Surgical and autoimmune hypoparathyroidism together account for
  most patients with hypoparathyroidism. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074034></a><span>The diagnosis is made
  by finding a low serum ionized calcium level in a patient with an
  inappropriately reduced serum PTH concentration. In general, the phosphorus concentration
  is high normal or frankly elevated, and plasma 1,25(OH)<sub>2</sub>D
  concentrations are reduced.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074035></a><span>Treatment is normally
  directed at increasing intestinal calcium absorption through the use of large
  doses of calcium and the active form of vitamin D, 1,25(OH)<sub>2</sub>D, in
  normal replacement amounts. The goal is to induce sufficient intestinal
  calcium hyperabsorption to overwhelm the ability of the kidney to excrete it.
  </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><b><span>The correct answer is D.</span></b><span><span>&nbsp; </span>Causes of hypoparathyroidism include
thyroidectomy, metastatic cancer, and DiGeorge’s syndrome.<span>&nbsp; </span>Signs and symptoms of hypoparathyroidism
include anxiety and irritability, neuromuscular excitability, tetany,
intracranial calcifications, dental abnormalities, and cardiac conduction
abnormalities.<span >&nbsp; </span>Laboratory values
reflect a state of hypocalcemia and hyperphosphatemia with low parathyroid
hormone levels.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>These laboratory values are seen in
primary hyperparathyroidism.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect.</span></b><span><span>&nbsp; </span>The patient would be hypoparathyroid;
however, hypoparathyroidism causes hypocalcemia and hyperphosphatemia, not
hypercalcemia and hypophosphatemia as indicated in this answer choice.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>These laboratory values are seen in
secondary hyperparathyroidism.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>This patient’s history of radioactive
iodine therapy and signs and symptoms of irritability, neuromuscular
excitability, positive Chvostek’s sign, and QT prolongation all point to a
diagnosis of hypocalcemia secondary to hypoparathyroidism.<span>&nbsp; </span>It is unlikely that his calcium,
phosphate, and parathyroid hormone levels are normal.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
60-year-old woman with a 55-pack-year history of smoking presents to the
emergency department with nausea and vomiting, headache, malaise, and diffuse
aches.<span >&nbsp; </span>A CT scan shows a solitary
nodule in the right upper lobe of the lung.<span>&nbsp; </span>Laboratory studies are significant for a
serum calcium level of 14.2 mg/dL, a serum phosphate level of 1.5 mg/dL, and a
serum alkaline phosphate activity of 81 U/L.<span>&nbsp; </span>The factors that account for this
patient’s laboratory findings act primarily at which of the following
locations?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Adrenal cortex and intestines</span></p>

<p><span>B.<span>&nbsp; </span>Adrenal cortex and renal tubules</span></p>

<p><span>C.<span>&nbsp; </span>Intestines and bones</span></p>

<p><span>D.<span>&nbsp; </span>Renal tubules and bones</span></p>

<p><span>E.<span>&nbsp; </span>Renal tubules and pancreas</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><b><span>Malignancy-Associated
  Hypercalcemia</span></b></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074006></a><span>The most common cause
  of hypercalcemia among hospitalized patients is cancer. Hypercalcemia occurs
  late in the course of cancer, and rapid progression to more severe
  hypercalcemia and rapid death is the rule. In general, hypercalcemia is only
  encountered in patients with large tumor burdens. Conversely, small, occult
  cancers rarely cause hypercalcemia. The exceptions to this rule are small
  tumors of the neuroendocrine variety, such as islet cell tumors and bronchial
  carcinoids. Certain tumors are common causes of hypercalcemia, including
  breast, renal, squamous, and ovarian carcinomas, as well as multiple myeloma
  and lymphoma. Conversely, certain other common cancers are not commonly
  associated with hypercalcemia, exemplified by colon, prostate, and gastric
  carcinoma.</span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><span>Cancer may lead to
    hypercalcemia through several mechanisms, the most common of which is&nbsp;<i>humoral
    hypercalcemia of malignancy</i>&nbsp;(HHM). HHM accounts for about 80% of
    patients with malignancy-associated hypercalcemia (MAHC) and is the result
    of secretion by tumors of parathyroid hormone-related protein (PTHrP).
    PTHrP mimics the actions of parathyroid hormone (PTH) on the kidney to
    prevent calcium excretion and on the skeleton to activate osteoclasts and
    induce bone resorption. Tumors classically associated with the HHM
    mechanism are breast cancer, squamous carcinomas of any site (including
    larynx, lung, cervix, and esophagus), renal carcinomas, and ovarian
    carcinomas. These observations, together with histologic evidence for
    aggressive bone resorption at sites within the skeleton not involved by
    tumor, make clear that HHM is indeed the result of a tumor-derived&nbsp;<i>humor</i>&nbsp;or
    hormone. In addition to hypercalcemia, these patients display reductions in
    PTH, reductions in 1,25-dihydroxyvitamin D (1,25[OH]<sub>2</sub>D),
    elevations in PTHrP, and reductions in serum phosphorus.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P074008></a><span>A second form of MAHC is that caused by local tumor invasion of
    the skeleton, a process referred to as&nbsp;<i>local osteolytic
    hypercalcemia</i>&nbsp;(LOH). LOH accounts for about 20% of patients with
    MAHC. In these patients, in contrast to those with HHM, the skeletal
    metastatic or primary tumor burden is large, and the offending tumor is
    most often a breast cancer or a hematologic neoplasm such as multiple
    myeloma, leukemia, or lymphoma. These patients display reductions in both
    PTH and PTHrP, as well as 1,25(OH)<sub>2</sub>D, and generally have normal
    to elevated serum phosphorus values.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P074009></a><span>A third form of MAHC is due to&nbsp;<i>secretion of 1,25(OH)<sub>2</sub>D
    by lymphomas and dysgerminomas</i>. These instances are unusual and are
    interesting from a mechanistic standpoint. The increase in 1,25(OH)<sub>2</sub>D
    leads to intestinal calcium hyperabsorption as well as to systemically
    driven bone resorption. Thus, this condition is in essence a malignant
    version of the hypercalcemia that occurs in sarcoidosis. The fact that
    macrophages produce 1,25(OH)<sub>2</sub>D and that overproduction of
    1,25(OH)<sub>2</sub>D occurs in some lymphomas is now well documented. </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P074010></a><span>Finally, although most instances of HHM are due to PTHrP,
    several well-documented case reports of&nbsp;<i>ectopic secretion of
    authentic PTH</i>&nbsp;have come to light. These case reports have included
    a colon carcinoma, a squamous carcinoma of the lung, a small cell carcinoma
    of the ovary, and a neuroendocrine tumor.</span></p>
    </td>
   </tr>
  </table>
  </td>
 </tr>
</table>

<p><a name=T074001></a><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>The correct answer is D.</span></b><span><span>&nbsp; </span>This vignette describes a patient
suffering from hypercalcemia secondary to malignancy.<span>&nbsp; </span>The laboratory data show hypercalcemia
coupled with hypophosphatemia in the setting of an elevated serum alkaline
phosphatase activity.<span >&nbsp; </span>This is
consistent with hypercalcemia due to the actions of PTHrP, which produces
physiologic effects that mimic those of PTH:<span>&nbsp; </span>increased bone resorption and increased
renal absorption of calcium, resulting in elevated levels of these electrolytes
in the serum.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>PTH and PTHrP do not act at the adrenal
cortex or the intestines.<span >&nbsp; </span>The
adrenal cortex is the primary site of action for ACTH and ACTH-like peptide;
the intestines are the primary site of action for
1,25-dihydroxycholecalciferol.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect.</span></b><span><span>&nbsp; </span>PTH and PTHrP have no action at the
adrenal cortex.<span >&nbsp; </span>ACTH and ACTH-like
peptide (both of which can be elaborated by neoplastic cells, resulting in
Cushing’s syndrome) act primarily at the adrenal cortex.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>The intestines and bones are primary
sites of action for 1,25-dihydroxycholecalciferol (vitamin D).<span>&nbsp; </span>While PTH and PTHrP stimulate production
of 1,25-dihydroxycholecalciferol, producing secondary effects at the
intestines, these hormones do not act primarily on the intestines.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>PTH and PTHrP act primarily at the renal
tubules and bones to increase serum calcium levels.<span>&nbsp; </span>These hormones do not influence the
pancreas, although pancreatic tumors have been shown to occasionally secrete
PTHrP.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
27-year-old woman presents to a new physician with muscle cramping and
spasm.<span >&nbsp; </span>On physical examination, the
physician notes shortened fourth and fifth metacarpals and metatarsals, short
stature, a round face, and abnormal teeth.<span >&nbsp;
</span>Her facial muscles twitched when her facial nerve was tapped, and her
wrist twitched with the use of a blood pressure cuff.<span>&nbsp; </span>Laboratory studies show a decreased
serum calcium level and a significantly elevated parathyroid hormone
level.<span >&nbsp; </span>There is no evidence of
renal disease, thus decreasing the likelihood of renal osteodystrophy.<span>&nbsp; </span>Which of the following is the most
common mode of inheritance of this patient’s disease?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Autosomal dominant</span></p>

<p><span>B.<span>&nbsp; </span>Autosomal recessive</span></p>

<p><span>C.<span>&nbsp; </span>Mitochondrial</span></p>

<p><span>D.<span>&nbsp; </span>X-linked dominant</span></p>

<p><span>E.<span>&nbsp; </span>X-linked recessive</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><b><span>Pseudohypoparathyroidism</span></b></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074036></a><span>Pseudohypoparathyroidism
  refers to a group of disorders that have in common resistance to the actions
  of PTH. In most cases, the resistance is due to different types of
  inactivating mutations in the signal-transducing protein Gs-&#945;. Patients
  may be resistant only to PTH, or they may be resistant to multiple peptide
  hormones, including thyroid-stimulating hormone (with hypothyroidism) and
  follicle-stimulating hormone and luteinizing hormone (with hypogonadism). The
  most common form of the syndrome, type Ia, is associated with multiple
  hormone resistance and a phenotype referred to as&nbsp;<i>Albright hereditary
  osteodystrophy</i>, which includes short stature, shortened fourth and fifth
  metacarpals and metatarsals, obesity, mental retardation, subcutaneous
  calcifications, and café-au-lait spots. Because the disorder is hereditary, a
  clear family history of this phenotype is often present, as well as a family
  history of hypocalcemia or seizures.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074037></a><span>Biochemically, these
  patients resemble those with hypoparathyroidism; they are hypocalcemic and
  have hyperphosphatemia. The diagnosis is made by the finding of an elevated
  circulating PTH in a patient with hypocalcemia and hyperphosphatemia in whom
  other causes of hypocalcemia and secondary hypoparathyroidism have been
  excluded.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P074038></a><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>The correct answer is A.</span></b><span><span>&nbsp; </span>This patient had
pseudohypoparathyroidism.<span >&nbsp; </span>In all
forms of pseudohypoparathyroidism, there is a defect in the peripheral organ
response to PTH, leading to increased PTH levels.<span>&nbsp; </span>There are several types of
pseudohypoparathyroidism, which vary in clinical presentation.<span>&nbsp; </span>This is an autosomal dominant disease,
and penetrance is variable.<span >&nbsp;
</span>Pseudohypothyroidism is caused by kidney unresponsiveness to PTH.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.</span></b><span><span>&nbsp; </span>Pseudohypoparathyroidism is an autosomal
dominant disease, and penetrance is variable.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>Pseudohypoparathyroidism is an autosomal
dominant disease, and penetrance is variable.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect.</span></b><span><span>&nbsp; </span>Pseudohypoparathyroidism is an autosomal
dominant disease, and penetrance is variable.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>Pseudohypoparathyroidism is an autosomal
dominant disease, and penetrance is variable.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
39-year-old woman is seen by a physician because of a lump in the front of her
neck.<span >&nbsp; </span>Physical examination reveals
a swollen thyroid gland.<span >&nbsp; </span>A biopsy
of the enlarged but painless thyroid gland is found to contain psammoma bodies
and thin projections of epithelium surrounding a fibrovascular core.<span>&nbsp; </span>The nuclei of many cells are optically
clear.<span >&nbsp; </span>Which of the following risk
factors is most commonly associated with her diagnosis?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Chronic cigarette smoking</span></p>

<p><span>B.<span>&nbsp; </span>Preexisting Graves’ disease</span></p>

<p><span>C.<span>&nbsp; </span>Presence of HLA-DR5 receptors</span></p>

<p><span>D.<span>&nbsp; </span>Prior radiotherapy to the head or neck</span></p>

<p><span>E.<span>&nbsp; </span>Recent pregnancy</span></p>

<p></span></p>

<p border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC066038></a><b><span>Solitary
  Thyroid Nodules</span></b></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P066058></a><span>Thyroid nodules are
  common. Benign thyroid nodules are usually follicular adenomas, colloid
  nodules, benign cysts, or nodular thyroiditis. Patients may have one
  prominent nodule on clinical examination, but thyroid ultrasound evaluation
  may reveal multiple nodules. Although most nodules are benign, a small
  percentage are malignant. In addition, most thyroid cancers are low-grade
  malignancies. History, physical examination, and laboratory tests can be
  helpful in differentiating benign from malignant lesions. For example, lymph
  node involvement or hoarseness is strongly suggestive of a malignant tumor.</span></p>
  <p><span></span></p>
  <p style="text-align:center;"><b><span>High-Risk Factors for Malignancy in a Thyroid Nodule</span></b><span></span></p>
  </td>
 </tr>
</table>

<p><a name=T066006></a><span></span></p>

<p><span></span></p>

<p><a name=T066006.50></a><a name=T066006.100></a><a name=T066006.150></a><a
name=T066006.200></a><a name=T066006.250></a><a name=T066006.300></a><a
name=T066006.350></a><a name=T066006.400></a><a name=T066006.450></a><a
name=T066006.500></a><a name=T066006.550></a><a name=T066006.600></a><a
name=T066006.650></a><a name=T066006.700></a><a name=T066006.750></a><a
name=T066006.800></a><a name=T066006.850></a><a name=T066006.900></a><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=279 valign=top>
  <p><b><span>History</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Head and neck
  irradiation</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Exposure to nuclear
  radiation</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Rapid growth</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Recent onset</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Young age</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Male sex</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Familial incidence
  (medullary and about 5% of papillary)</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><b><span>Physical Examination</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Hard consistency of
  nodule</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Fixation of nodule</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Lymphadenopathy</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Vocal cord paralysis</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Distant metastasis</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><b><span>Laboratory and Imaging</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Elevated serum
  calcitonin</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><i><span>Cold</span></i><span>&nbsp;nodule on technetium scan</span></p>
  </td>
 </tr>
 <tr>
  <td width=279 valign=top>
  <p><span>Solid lesion with
  microcalcifications on ultrasonography</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width="90%">
 <tr>
  <td width="100%"></td>
 </tr>
</table>

</div>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P066059></a><span></span></p>
  <p><span>The major etiologic
  factor for thyroid cancer is childhood or adolescent exposure to head and
  neck radiation. Previously, radiation was used to treat an enlarged thymus,
  tonsillar disease, hemangioma, or acne. Recently, exposure to radiation from
  nuclear plants (e.g., Chernobyl, Ukraine) has contributed to an increased
  incidence of thyroid cancer. Patients with a history of irradiation should
  have a baseline thyroid ultrasound and their thyroid carefully palpated every
  1 to 2 years.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P066060></a><span>A dominant nodule
  (&gt;1-1.5 cm) or nodules with ultrasound features compatible with neoplasia
  should undergo FNA, which is a safe procedure that has reduced the need for
  surgical excision. In addition, malignant lesions (5% of biopsies), such as
  papillary, anaplastic, and medullary carcinoma, can be specifically
  identified. Follicular neoplasms, however, cannot be diagnosed as benign or
  malignant by FNA; a cytology report of follicular neoplasia, along with
  &quot;suspicious&quot; cytology, requires surgical excision. .</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=8 cellpadding=0 width="100%">
 <tr>
  <td width="96%">
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P066061></a><b><span>Thyroid Carcinoma</span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P066062></a><span>The types and characteristics of thyroid carcinomas are
    presented below. Papillary carcinoma is associated with local invasion and
    lymph node spread. Poor prognosis is associated with thyroid capsule
    invasion, size greater than 2.5 cm, age at onset older than 45 years, tall
    cell variant, and lymph node involvement. Follicular carcinoma is slightly
    more aggressive than papillary carcinoma and can spread by local invasion
    of lymph nodes or hematogenously to bone, brain, or lung. Many tumors show
    both papillary and follicular cell types. Patients may exhibit metastases
    before diagnosis of the primary thyroid lesion. Anaplastic carcinoma tends
    to occur in older individuals, is very aggressive, and rapidly causes pain,
    dysphagia, and hoarseness.</span></p>
    </td>
   </tr>
  </table>
  <p><a name=T066007></a><span></span></p>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0>
   <tr>
    <td>
    <p><b><span>Characteristics of
    Thyroid Cancers</span></b></p>
    </td>
   </tr>
  </table>
  </div>
  <p><a name=T066007.300></a><a name=T066007.250></a><a name=T066007.200></a><a
  name=T066007.150></a><a name=T066007.100></a><a name=T066007.50></a><span></span></p>
  <div align=center>
  <table border=1 cellspacing=0 cellpadding=0>
   <tr>
    <td valign=bottom>
    <p><b><span>Type of Cancer</span></b><span></span></p>
    </td>
    <td valign=bottom>
    <p><b><span>Percentage of
    Thyroid Cancers</span></b><span></span></p>
    </td>
    <td valign=bottom>
    <p><b><span>Age of Onset (yr)</span></b><span></span></p>
    </td>
    <td valign=bottom>
    <p><b><span>Treatment</span></b><span></span></p>
    </td>
    <td valign=bottom>
    <p><b><span>Prognosis</span></b><span></span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Papillary</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>80</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>40-80</span></p>
    </td>
    <td valign=top>
    <p><span>Thyroidectomy,
    followed by radioactive iodine ablation</span></p>
    </td>
    <td valign=top>
    <p><span>Good</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Follicular</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>15</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>45-80</span></p>
    </td>
    <td valign=top>
    <p><span>Thyroidectomy,
    followed by radioactive iodine ablation</span></p>
    </td>
    <td valign=top>
    <p><span>Fair to good</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Medullary</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>3</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>20-50</span></p>
    </td>
    <td valign=top>
    <p><span>Thyroidectomy and
    central compartment lymph node dissection</span></p>
    </td>
    <td valign=top>
    <p><span>Fair</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Anaplastic</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>1</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>50-80</span></p>
    </td>
    <td valign=top>
    <p><span>Isthmusectomy
    followed by palliative x-ray treatment</span></p>
    </td>
    <td valign=top>
    <p><span>Poor</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Lymphoma</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>1</span></p>
    </td>
    <td valign=top>
    <p style="text-align:center;"><span>25-70</span></p>
    </td>
    <td valign=top>
    <p><span>X-ray therapy and/or
    chemotherapy</span></p>
    </td>
    <td valign=top>
    <p><span>Fair</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="90%">
   <tr>
    <td width="100%"></td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P066063></a><span></span></p>
    <p><span>Medullary thyroid
    carcinoma is derived from calcitonin-producing parafollicular cells and is
    more malignant than papillary or follicular carcinoma. It is multifocal and
    spreads both locally and distally. It may be either sporadic or familial. When
    familial, it is inherited in an autosomal dominant pattern and is part of
    multiple endocrine neoplasia type IIA (medullary carcinoma of the thyroid,
    pheochromocytoma, and hyperparathyroidism) or multiple endocrine neoplasia
    type IIB (medullary carcinoma of the thyroid, mucosal neuromas, intestinal
    ganglioneuromas, marfanoid habitus, and pheochromocytoma). Elevated basal
    serum calcitonin levels confirm the diagnosis. Evaluation for&nbsp;<i>RET</i>&nbsp;proto-oncogene
    mutations should be performed in patients with medullary carcinoma, and, if
    present, all first-degree relatives of the patients should be examined.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=HC066040></a><span></span></p>
  <p><a name=P066064></a><span></span></p>
  <p><a name=P066065></a><span></span></p>
  <p><a name=P066066></a><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P066067></a><span>The prognosis for well-differentiated thyroid carcinomas is
    good. The patient's age at the time of diagnosis and sex are the most
    important prognostic factors. Men older than 40 years of age and women
    older than 50 years of age have higher recurrence and death rates than do
    younger patients. The 5-year survival rate for invasive medullary carcinoma
    is 50%, whereas the mean survival for anaplastic carcinoma is 6 months.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=B066001></a><span></span></p>
  <p><a name=PB066001></a><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><a name=R066001></a><span></span></p>
  <p><a name=R066002></a><span></span></p>
  <p><a name=R066003></a><span></span></p>
  <p><a name=R066004></a><span></span></p>
  <p><a name=R066005></a><span></span></p>
  <a name=R066006></a></td>
 </tr>
</table>

<p><span></span></p>

<p><b><span>The correct answer is D.</span></b><span><span>&nbsp; </span>Papillary thyroid carcinoma is the most
common type of thyroid cancer.<span >&nbsp; </span>It
is always distinguished by its finger-like projections of epithelium
surrounding a central fibrovascular core, calcified spheres (psammoma bodies),
optically clear “Orphan Annie” nuclei, and molding of the nuclei.<span>&nbsp; </span>Patients often have a prior history of
radiation to the head or neck.<span >&nbsp;
</span>Papillary thyroid carcinoma carries a better prognosis than the other
forms of thyroid cancer.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=264 height=200
src="_%20Tutorials_files/image426.png"
alt="Description: http://medsci.indiana.edu/c602web/602/c602web/602image/38_2.jpg"
v:shapes="Picture_x0020_347474"></span><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>Smoking would certainly increase this
patient’s risk for lung, oropharyngeal, esophageal, pancreatic, and
bladder.<span >&nbsp; </span>However, smoking is not
specifically a risk factor for developing thyroid carcinoma.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.</span></b><span><span>&nbsp; </span>Graves’s disease is an autoimmune
disorder in which antibodies to the thyroid hormone-stimulating receptor
stimulate increased release of thyroid hormone.<span>&nbsp; </span>Symptoms of Graves’ disease include the
clinical features of hyperthyroidism (restlessness, tremor, tachycardia, heat
intolerance) as well as a tendency to develop exophthalmos and pretibial
myxedema.<span >&nbsp; </span>Patients with Graves’
disease are not at a significantly increased risk of papillary thyroid
carcinoma.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>Individuals with HLA-DR5 receptors have
an increased incidence of Hashimoto’s thyroiditis, and autoimmune form of
hypothyroidism.<span >&nbsp; </span>The biopsy of a
patient with Hashimoto’s thyroiditis would show substantial lymphocytic
infiltration into the gland along with characteristic eosinophilic Hurthle
cells.<span >&nbsp; </span>Like patients with Graves’
disease, patients with Hashimoto’s thyroiditis often have concurrent autoimmune
conditions, but they are not at increased risk for papillary thyroid carcinoma.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>Postpartum thyroiditis presents with a
painless enlarged thyroid and symptoms of hyperthyroid function.</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section">Blood </span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Vascular</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
80-year-old woman has fatigue and shortness of breath. Physical examination is
normal. A chest radiograph is normal. Laboratory tests show:</span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>8 g/dL</span></p>

<p><span>Hematocrit<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>25%</span></p>

<p><span>Mean
corpuscular volume (MCV)<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>72µm<sup>3</sup>
</span></p>

<p><span></span></p>

<p><span>Which of
the following is the most likely cause of her condition?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Chronic
blood loss</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#946;-thallasemia
minor</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acquired
hemolytic anemia </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Folic
acid deficiency</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pernicious
anemia</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Anemia</span></b><span>, a reduction in red blood cell mass, may
reflect decreased production of erythrocytes, either because of primary
hematological disease or in response to systemic illness, or it may reflect increased
cell turnover from hemolysis. Symptoms reflect the speed with which the red
blood cell mass has declined. Patients with acute hemorrhage or massive
hemolysis may present with hypovolemic shock. Patients who develop anemia
slowly, however, may have few symptoms. Symptoms may include fatigue,
palpitations, shortness of breath, and decreased exercise tolerance. Physical
findings in patients with anemia may include pallor, tachycardia, and heart
murmur. Jaundice and splenomegaly may be seen in patients with hemolysis. The
mean corpuscular volume (MCV) is a helpful tool in the diagnosis of anemia.
Using the MCV, anemia can be classified as microcytic, normocytic, and
macrocytic. The differential diagnosis of anemia based on MCV appears below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=232 valign=top>
  <p style="text-align:center;"><span>Differential
  Diagnosis of Anemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=232 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=232 valign=top>
  <p><span>Microcytic (MCV &lt; 80)</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Iron deficiency</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Thalassemia minor</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Sideroblastic anemia</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Lead poisoning</span></p>
  </td>
 </tr>
 <tr>
  <td width=232 valign=top>
  <p><span>Normocytic<span>&nbsp; </span>(MCV 80-100)</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Early iron
  deficiency</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Anemia of chronic
  disease</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Chronic renal
  failure</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Hemolysis</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Aplastic anemia</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Myelophthisic
  disorder</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Mixed nutritional
  disorder (iron and B12<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span>deficiency)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></p>
  </td>
 </tr>
 <tr>
  <td width=232 valign=top>
  <p><span>Macrocytic (MCV &gt;100)</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Megaloblastic</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Folate deficiency</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Vitamin B<sub>12</sub> deficiency</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Drug-induced megaloblastosis</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Non-megaloblastic</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Liver disease</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Hypothyroidism</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Hemolysis (with brisk reticulocytosis)</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Iron
deficiency is the leading cause of anemia worldwide.<span>&nbsp; </span>Early iron deficiency presents as a
normocytic anemia. Late iron deficiency presents as a microcytic anemia. The
most frequent cause of iron deficiency is occult blood loss. All men and
postmenopausal women who are found to be iron deficient should be evaluated for
a source of gastrointestinal bleeding, regardless of whether occult blood is
found in the stool. In premenopausal women, iron deficiency is usually due to
menstruation or pregnancy. Dietary deficiency of iron is most commonly seen in
young children whose growth outstrips their intake of iron, or in babies who
drink mostly milk at the expense of iron-containing food.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. The patient in this
vignette has a microcytic anemia (MCV= 70). Microcytic anemia in an older
person should raise concern for iron deficiency resulting from occult
gastrointestinal bleeding. This patient should be tested for iron deficiency
and undergo workup for occult gastrointestinal bleeding. Typical laboratory
findings in iron deficiency anemia include low serum iron level, high total
iron-binding capacity (TIBC), low transferrin saturation level (&lt;10%), and
low serum ferritin level (&lt;12ng/ml). </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span>&nbsp; </span>&#946;-thallasemia minor usually
presents as an asymptomatic, mild microcytic anemia. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.<span>&nbsp; </span></span></b><span>Hemolysis results in a normocytic or macrocytic
anemia. (Hemolysis is accompanied by reticulocytosis, and reticulocytes are
larger than mature red blood cells.) <b></b></span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect.<span>&nbsp; </span></span></b><span>Folic acid deficiency results in a macrocytic
anemia.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>.<span>&nbsp; </span>Pernicious anemia, which is due to
vitamin B<sub>12</sub> deficiency, is a type of macrocytic anemia.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
65-year-old woman with mitral stenosis develops atrial fibrillation. Which of
the following drugs is most appropriate for long-term prevention of stroke? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Aspirin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Heparin,
unfractionated</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Warfarin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Streptokinase</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Atrial
fibrillation predisposes to thrombus formation, which can lead to embolization.
Embolization to the cerebral arteries causes stroke. </span></p>

<p><span></span></p>

<p><b><span>Warfarin</span></b><span>, which inhibits gamma-carboxylation of vitamin
K-dependent clotting factors, is used for chronic anti-coagulation of patients
with atrial fibrillation who are at high-risk of stoke. High-risk patients
include those with valvular heart disease (e.g., rheumatic heart disease,
prosthetic heart valve) and those with two or more CHADS criteria. (CHADS is an
acronym for congestive heart failure, hypertension, age &gt; 75 years, diabetes
mellitus, and stroke history). The patient described above is at high risk for
stroke because of mitral stenosis and should be anticoagulated with warfarin.</span></p>

<p><span></span></p>

<p><b><span>Aspirin </span></b><span>irreversibly inhibits cyclo-oxygenase, which
prevents conversion of arachadonic acid to prostaglandins. This inhibits
platelet aggregation. Aspirin is used in low-risk patients with atrial
fibrillation. Low-risk patients are those with normal valves who meet fewer
than two of the CHADS criteria. The patient described above is at high risk for
stroke and should be treated with warfarin.</span></p>

<p><span></span></p>

<p><span>Unfractionated
<b>heparin</b>, a parenteral anticoagulant
that potentiates antithrombin III, is typically used for short-term
anti-coagulation.</span></p>

<p><span></span></p>

<p><b><span>Streptokinase</span></b><span> is a thrombolytic agent that breaks down
existing clots. In the setting of acute myocardial infarction, it is used to
lyse the thrombus that forms after plaque rupture in a coronary artery. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>Warfarin is used for
chronic anti-coagulation of patients with atrial fibrillation who are at
high-risk of stoke, such as persons with mitral stenosis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An 18-year-old woman injured her left knee while
playing basketball. She is scheduled for arthroscopic knee surgery.
Preoperative laboratory tests show a platelet count of 268,000/mm<sup>3</sup>,
an INR of 1.0, and an activated partial thromboplastin time (aPTT) of 67
seconds (normal: 25-40 seconds). When she was five years old, her tonsils were
removed without excessive bleeding. Several years later, four wisdom teeth were
pulled without significant bleeding. She has no history of heavy menstrual flow
and she has never been anemic. Her family history is negative for bleeding
disorders. The orthopedic surgeon is concerned about her lab test results and
asks for advice. What is the most appropriate response?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Explain that the patient
is a hemophilia carrier, has a deficiency of factor VIII, and will need an
infusion of factor VIII before surgery.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Explain that the aPTT is
high because not enough blood was collected in the citrate-containing vacuum
tube (laboratory error). </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Ask the laboratory to
mix the woman’s plasma with normal plasma (50-50 mixing study) and re-measure
the aPTT.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Tell the surgeon that
the patient has been surreptitiously injecting heparin.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p><b>Coagulation Tests</b></p>

<p></p>

<p>The activated partial
thromboplastin time (aPTT) assesses the “intrinsic” and common coagulation
pathways. The prothrombin time (PT) assesses the “extrinsic” pathway. A normal
aPTT requires the presence of the following coagulation factors: I, II, V, VIII,
IX, X, XI, &amp; XII. A prolonged aPTT indicates heparin use, coagulation
factor deficiency (e.g. hemophilia), or the presence of antiphospholipid
antibody (especially lupus anticoagulant, which paradoxically <i>increases</i>
the propensity for thrombosis). </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=154 valign=top>
  <p><span>Causes
  of Increased aPTT</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Heparin
  use</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Coagulation
  factor deficiency</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Antiphospholipid
  antibody</span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>To distinguish these, mixing
tests are performed in which the patient's plasma is mixed (at a 50:50
dilution) with normal plasma. If the aPTT remains abnormal, the patient’s
plasma is said to contain an &quot;inhibitor&quot; (heparin, antiphospholipid
antibodies, or coagulation factor-specific inhibitors). If the aPTT returns to
normal, factor deficiency is more likely. Deficiencies of factors VIII, IX, XI
and XII can cause a prolonged aPTT, which will return to normal upon “mixing.” </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=160 valign=top>
  <p style="text-align:center;">Disorder</p>
  </td>
  <td width=151 valign=top>
  <p style="text-align:center;">Results of Mixing Study</p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p></p>
  </td>
  <td width=151 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p>Coagulation factor
  deficiency (usually Factor VIII, IX, XI or XII)</p>
  </td>
  <td width=151 valign=top>
  <p>aPTT normalizes</p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p>Antiphospholipid antibody </p>
  </td>
  <td width=151 valign=top>
  <p>aPTT does not normalize</p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p>Heparin use</p>
  </td>
  <td width=151 valign=top>
  <p>aPTT does not normalize</p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p>Coagulation
  factor-specific inhibitor</p>
  </td>
  <td width=151 valign=top>
  <p>aPTT does not normalize</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p style="text-align:center;"><span><img border=0 width=393 height=502
src="_%20Tutorials_files/image428.png" v:shapes="Picture_x0020_347357"></span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct</span></b><span>.
A prolonged aPTT can result from a deficiency of clotting factors VIII, IX, XI,
or XII. If one of these factors is deficient, mixing the patient’s blood with
normal plasma will return the aPTT to normal. If, instead, the blood contains
an antiphospholipid antibody (e.g., lupus anticoagulant), mixing will <i>not</i>
return the aPTT to normal. (The aPTT will remain high). Lupus anticoagulant is
an antiphospholipid antibody that may be present in healthy individuals.<span>&nbsp; </span><i>In vivo</i>, it interacts with
platelet membrane phospholipids, increasing adhesion and aggregation of
platelets. Thus, lupus anticoagulant is not really an anticoagulant. It is <i>prothrombotic</i>.
It is called “anti-coagulant” because, <i>in vitro</i>, it inhibits lipids in
the aPTT assay, causing prolongation of the aPTT. (The term “anticoagulant” is
a misnomer.)<span >&nbsp; </span>Lupus anticoagulant
and heparin have the same effect on aPTT: They prolong it. But heparin is a
real anticoagulant, whereas lupus anticoagulant is a prothrombotic agent. If
the patient in this vignette has a mixing study and the aPTT does not
normalize, we assume that lupus anticoagulant is present and that there is no
increased risk of bleeding during surgery. If the aPTT normalizes with mixing,
factor deficiency should be assumed and surgery should be postponed.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Hemophilia occurs almost exclusively in males because it is an X-linked
disorder. Women who carry hemophilia trait can have low levels of factor VIII,
a prolonged aPTT, and a bleeding diathesis. The patient in this vignette has no
family history of male “bleeding” to suggest hemophilia. Had there been a
family history of bleeding, testing would still be needed to determine the
exact cause. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect. </span></b><span>Insufficient
blood in the citrate-containing tube can prolong the aPTT, but other
explanations must be considered.<span >&nbsp; </span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Surreptitious
injection of heparin will elevate the aPTT, but other explanations must be
considered. Note: Heparin works by activating antithrombin III, which then
inactivates thrombin and other proteases involved in blood clotting, most
notably factor Xa.</span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 1-day-old neonate has hemolytic disease of
the newborn. Both parents are Rh-positive. IgG isohemagglutinins are found in
the mother's blood. Which of the following parental blood types is most likely?</span></p>

<p><span></span></p>

<p><b><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Mother<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Father</span></b></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span>A <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>O</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span>AB <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>O</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span>B <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>A</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span>B <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>O</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span>O <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>AB</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The <b>ABO antigens</b> are carbohydrates
linked to cell surface proteins and lipids. They are synthesized by polymorphic
glycosyltransferase enzymes, which vary in activity depending on the inherited
allele</span>. The ABO antigens were the first alloantigen system to be defined
in mammals. </p>

<p></p>

<p>All normal individuals
synthesize the O antigen, which is attached to plasma membrane proteins. Most
individuals possess a fucosyltransferase that adds a fucose moiety to the O
antigen, resulting in an H antigen. A single gene on chromosome 9 encodes a
glycosyltransferase enzyme, which further modifies the H antigen. There are
three allelic variants of this gene. The O allele gene product is devoid of
enzymatic activity. The A allele-encoded enzyme transfers a terminal <span>N</span>-acetylgalactosamine moiety, and the
B allele gene product transfers a terminal galactose moiety. </p>

<p></p>

<p>Individuals who are
homozygous for the O allele cannot attach terminal sugars to the H antigen and
express only the H antigen. In contrast, individuals who possess an A allele
(AA homozygotes, AO heterozygotes, or AB heterozygotes) form the A antigen by
adding terminal <span>N</span>-acetylgalactosamine
to some of their H antigens. Similarly, individuals who express a B allele (BB
homozygotes, BO heterozygotes, or AB heterozygotes) form the B antigen by
adding terminal galactose to some of their H antigens. AB heterozygotes form
both A and B antigens from some of their H antigens. The terminology has been
simplified so that OO individuals are said to be blood type O; AA and AO
individuals are blood type A; BB and BO individuals are blood type B; and AB
individuals are blood type AB. </p>

<p><span></span></p>

<p><span>Individuals who express a particular ABO
antigen are tolerant to that antigen, but individuals who do not express that
antigen produce natural antibodies that recognize the antigen.</span>
Individuals who express A or B antigens are tolerant to these molecules and do
not produce anti-A or anti-B antibodies, respectively. However, bacteria
present in the GI tract contain antigens similar to the A and B blood group
antigens, therefore blood group O and A individuals produce anti-B IgM
antibodies, and blood group O and B individuals produce anti-A IgM antibodies. </p>

<p><span></span></p>

<p><span>In clinical transfusion, the choice of blood
donors for a particular recipient is based on the expression of blood group
antigens and the antibody responses to them.</span> If a patient receives a
transfusion of red blood cells from a donor who expresses the antigen not
expressed on self red blood cells, a transfusion reaction may result. It
follows that AB individuals can tolerate transfusions from all potential donors
and are therefore called universal recipients; similarly, O individuals can
tolerate transfusions only from O donors but can provide blood to all
recipients and are therefore called universal donors. In general, differences
in <i>minor</i> blood groups lead to red
cell lysis only after repeated transfusions trigger a secondary antibody
response.</p>

<p></p>

<p>ABO antigens are expressed
on many other cell types in addition to blood cells, including endothelial
cells. For this reason, ABO typing is critical to avoid hyperacute rejection of
certain solid organ allografts. ABO incompatibility between mother and fetus
generally does not cause problems for the fetus because most of the
anti-carbohydrate antibodies are IgM and do not cross the placenta. Individuals
with blood group O, however, can produce IgG antibodies against A and B
antigens, which can cross the placenta and can cause intrauterine hemolysis in
the fetus, although clinically significant hemolysis related to ABO
incompatibility is rare. </p>

<p>The <b>Rhesus (Rh) antigens</b>, named after the monkey species in which they
were originally identified, are another clinically important group of blood
group antigens. Rh proteins are encoded by two tightly linked genes, but only
one of them, called RhD, is commonly considered in clinical blood typing. This
is because up to 15% of the population has an alteration of the RhD allele.
These people, called Rh negative, are not tolerant to the RhD antigen and will
make antibodies to the antigen if they are exposed to Rh-positive blood cells.</p>

<p></p>

<p>The major clinical
significance of anti-Rh antibodies is related to hemolytic reactions associated
with pregnancy that are similar to transfusion reactions. Rh-negative mothers
carrying an Rh-positive fetus can be sensitized by fetal red blood cells that
enter the maternal circulation, usually during childbirth. Since the Rh antigen
is a protein, as opposed to the carbohydrate ABO antigens, class-switched IgG
antibodies are generated in Rh-negative mothers. Subsequent pregnancies in
which the fetus is Rh positive are at risk because the maternal anti-Rh IgG
antibodies can cross the placenta and mediate the destruction of the fetal red
blood cells. This causes <span>erythroblastosis
fetalis</span> (hemolytic disease of the newborn) and can be lethal for the
fetus. </p>

<p></p>

<p>Rh alloimmunization in
Rh-negative women can be prevented by administration of anti-RhD antibodies to
the mother at 28 weeks of gestation, after amniocentesis or chorionic villus
sampling, after vaginal bleeding or within 72 hours of birth of an Rh-positive
baby. The treatment prevents the baby's Rh-positive red blood cells that
entered the mother's circulation from inducing the production of anti-Rh
antibodies in the mother. The exact mechanism of action of the administered
antibodies is not clear. </p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct. </b>Hemolytic disease of the newborn
(erythroblastosis fetalis) occurs when IgG antibodies from the mother cross the
placenta and attack red blood cells of the fetus or newborn. The condition may
be caused by ABO or Rh incompatibility between mother and child. In this case,
we are told that the mother is Rh positive; therefore, hemolysis is not caused
by Rh incompatibility. (For hemolysis to be due to Rh incompatibility the
mother would have to be Rh negative and the child Rh positive.) Rather,
hemolysis must be due to ABO incompatibility. Most antibodies directed against
ABO antigens are of the IgM class and do not cross the placenta. However,
individuals with type O blood group can produce IgG antibodies that cross the
placenta and cause hemolysis. “E” is the correct answer because the mother in
“E” has type O blood group. She most likely has IgG antibodies against A and B,
which can cross the placenta.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 60-year-old woman with polycythemia vera
presents with 3-day history of progressive abdominal pain and distension. She
does not consume alcoholic beverages and has no risk factors for viral
hepatitis. Physical examination shows tender hepatomegaly and severe ascites.
Liver enzymes are moderately elevated. Which one of the following diagnostic
tests would be most helpful?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Octreotide
scan</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hepatic
venography</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serum
ferritin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serum
alpha-fetoprotein</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Endoscopic
retrograde cholangiopancreatography (ERCP)</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b>Budd-Chiari syndrome</b> (hepatic vein obstruction)<span> prevents blood from flowing out of the liver and back to
the heart. The blockage can cause liver damage</span>. Findings include
vomiting, tender hepatomegaly, a<span>bdominal swelling,
elevated liver enzymes, and jaundice. The condition occurs is a </span>number
of thrombogenic disorders. Listed in decreasing order of frequency, they are:</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Polycythemia vera </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pregnancy </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Post-partum state </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Oral contraceptive use</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Paroxysmal nocturnal
hemoglobinuria </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hepatocellular carcinoma</span></p>

<p><span></span></p>

<p><span>Hepatic venography is the best test for
diagnosing hepatic vein occlusion.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. Hepatic vein
thrombosis (Budd-Chiari syndrome) should be suspected in a patient with
polycythemia vera who develops abdominal pain and distension, tender
hepatomegaly, and ascites. Hepatic venography is the best test for diagnosing
hepatic vein occlusion.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect. </span></b><span>An <span>octreotide<b> </b>scan<b> </b></span>is a
type of nuclear scan used to find carcinoid and other tumors. Octreotide, a
drug similar to somatostatin, is radiolabeled with indium-111. After injection
into a vein, it travels through the bloodstream and attaches to tumor cells
that have receptors for somatostatin.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect.<span>&nbsp; </span></span></b><span>Serum ferritin levels are high in patients with
hemochromatosis.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is
incorrect.<span >&nbsp; </span></span></b><span>Serum alpha-fetoprotein
levels are elevated in patients with hepatocellular carcinoma. <b></b></span></p>

<p><b></b></p>

<p><b>Answer E is incorrect.<span >&nbsp; </span></b>Endoscopic
retrograde cholangiopancreatography (ERCP) is a technique that combines the use
of endoscopy and fluoroscopy to diagnose and treat certain problems of the
biliary or pancreatic ductal systems. Through the endoscope, the physician can
see the inside of the stomach and duodenum and inject dyes into the ducts in
the biliary tree and pancreas so they can be seen on x-rays. ERCP is used primarily
to diagnose and treat conditions of the bile ducts, including gallstones,
inflammatory strictures (scars), leaks (from trauma and surgery), and cancer.
ERCP can be performed for diagnostic and therapeutic reasons, although the
development of safer and relatively non-invasive investigations such as
magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound
has meant that ERCP is now rarely performed without therapeutic intent.</p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>A 53-year-old woman with cancer is being treated with a hematopoietic
growth factor. Leukocyte differentials before and after treatment are shown:</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=95 valign=top>
  <p><span></span></p>
  </td>
  <td width=99 valign=top>
  <p><span>Before treatment</span></p>
  </td>
  <td width=90 valign=top>
  <p><span>After treatment</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span></span></p>
  </td>
  <td width=99 valign=top>
  <p><span></span></p>
  </td>
  <td width=90 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span>Leukocyte count</span></p>
  </td>
  <td width=99 valign=top>
  <p><span>1,000/mm<sup>3</sup></span></p>
  </td>
  <td width=90 valign=top>
  <p><span>10,000/mm<sup>3</sup></span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Eosinophils</span></p>
  </td>
  <td width=99 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp; </span>1%</span></p>
  </td>
  <td width=90 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp; </span>1%</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Lymphocytes</span></p>
  </td>
  <td width=99 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp; </span>90%</span></p>
  </td>
  <td width=90 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp; </span>9%</span></p>
  </td>
 </tr>
 <tr>
  <td width=95 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp;
  </span>Neutrophils</span></p>
  </td>
  <td width=99 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp; </span>9%</span></p>
  </td>
  <td width=90 valign=top>
  <p><span><span >&nbsp;&nbsp;&nbsp;&nbsp; </span>90%</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span>The growth factor is most likely to be which of the following?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Granulocyte
colony-stimulating factor</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Macrophage
colony-stimulating factor</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Interleukin
1</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Interleukin
6</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Interleukin
12</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Interleukin
17</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Colony-stimulating
factors</b><b> (CSFs)</b> are glycoproteins
that stimulate hemopoietic stem cells to proliferate and differentiate into
specific kinds of blood cells (usually white blood cells). CSFs can be
synthesized and administered exogenously, although exogeous molecules differ
slightly from their endogenous counterparts because the latter undergo
posttranslational modification.</p>

<p></p>

<p>The term
&quot;colony-stimulating factor&quot; refers to the method of discovery.
Hemopoietic stem cells are cultured on a matrix that prevents cells from
moving, so that if a single cell starts to proliferate all cells derived from
it remain clustered around it. These cells, originating from a common
precursor, are called “colonies.” By adding various substances to cultures of
hemopoietic stem cells, it is possible to determine which colonies are
stimulated by these substances.</p>

<p></p>

<p>The substance that
stimulates formation of colonies of macrophages is called macrophage
colony-stimulating factor. The substance that stimulates formation of colonies
of granulocytes is called granulocyte colony-stimulating factor.</p>

<p></p>

<p>The principal
colony-stimulating factors are:</p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Granulocyte
colony-stimulating factors (G-CSF) </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Macrophage
colony-stimulating factor </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Granulocyte macrophage
colony-stimulating factors (GM-CSF) </span></p>

<p><span></span></p>

<p><span>Granulocyte
colony-stimulating factor </span>(G-CSF) stimulates stems cells to proliferate
and differentiate into mature granulocytes (principally neutrophils). It also
mobilizes stem cells, sending them from the bone marrow into the bloodstream. </p>

<p></p>

<p>In oncology and hematology,
a recombinant form of G-CSF is used in certain cancer patients to accelerate
recovery from neutropenia after chemotherapy, allowing higher-intensity
treatment regimens. (Chemotherapy can cause myelosuppression and unacceptably
low levels of white blood cells, making patients prone to infections.) G-CSF is
also used to increase the number of hematopoietic stem cells in the blood of a
stem cell donor, and may be given to stem-cell receivers to compensate for
“conditioning” regimens (chemotherapy or irradiation given before transplantation).
</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer A is correct</b>. Granulocyte colony-stimulating factor is used
in cancer patients who have become neutropenic from chemotherapy. It stimulates
hematopoietic stem cells to proliferate and differentiate into granulocytes,
principally neutrophils. The result is an increase in the white blood cell
count and an increase in the number and proportion of neutrophils. </p>

<p><b></b></p>

<p><b>Answer B is incorrect</b>. Macrophage colony-stimulating factor
stimulates stem cells to proliferate and differentiate into macrophages.</p>

<p></p>

<p><b>Answers C, D, E, and F are incorrect</b>. Interleukins 1, 6, 12, and 17
are important cytokine mediators of acute and chronic inflammation, as shown
below. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Cytokine</span></b></p>
   </td>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Principal
   Sources</span></b></p>
   </td>
   <td width=138 valign=bottom>
   <p style="text-align:center;"><b><span>Principal
   Actions in Inflammation</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width=380 colspan=3 valign=top>
  <p><b><span></span></b></p>
  <p style="text-align:center;"><b><span>ACUTE
  INFLAMMATION</span></b></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>TNF</span></p>
  </td>
  <td width=178 valign=top>
  <p><span>Macrophages, mast cells,
  T lymphocytes</span></p>
  </td>
  <td width=138 valign=top>
  <p><span>Stimulates expression of
  endothelial adhesion molecules and secretion of other cytokines; systemic
  effects</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>IL-1</span></p>
  </td>
  <td width=178 valign=top>
  <p><span>Macrophages, endothelial
  cells, some epithelial cells</span></p>
  </td>
  <td width=138 valign=top>
  <p><span>Similar to TNF; greater
  role in fever</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>IL-6</span></p>
  </td>
  <td width=178 valign=top>
  <p><span>Macrophages, other cells</span></p>
  </td>
  <td width=138 valign=top>
  <p><span>Systemic effects
  (acute-phase response)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Chemokines</span></p>
  </td>
  <td width=178 valign=top>
  <p><span>Macrophages, endothelial
  cells, T lymphocytes, mast cells, other cell types</span></p>
  </td>
  <td width=138 valign=top>
  <p><span>Recruitment of leukocytes
  to sites of inflammation; migration of cells to normal tissues</span></p>
  </td>
 </tr>
 <tr>
  <td width=380 colspan=3 valign=top>
  <p><b><span></span></b></p>
  <p style="text-align:center;"><b><span>CHRONIC
  INFLAMMATION</span></b></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>IL-12</span></p>
  </td>
  <td valign=top>
  <p><span>Dendritic cells,
  macrophages</span></p>
  </td>
  <td width=138 valign=top>
  <p><span>Increased production of
  IFN-&#947;</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>IFN-&#947;</span></p>
  </td>
  <td valign=top>
  <p><span>T lymphocytes, NK cells</span></p>
  </td>
  <td width=138 valign=top>
  <p><span>Activation of macrophages
  (increased ability to kill microbes and tumor cells)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>IL-17</span></p>
  </td>
  <td valign=top>
  <p><span>T lymphocytes</span></p>
  </td>
  <td width=138 valign=top>
  <p><span>Recruitment of
  neutrophils and monocytes</span></p>
  </td>
 </tr>
</table>

</div>

<p style="text-align:center;">TNF=
tumor necrosis factor; IL = interleukin; IFN = interferon</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><span>A
55-year-old woman presents with a 1-month history of right leg swelling. Her
medical history is significant for ovarian cancer for which she underwent radical
hysterectomy and chemotherapy. Physical examination reveals edema of the right
lower extremity with induration of the overlying skin. Which of the following
is the most likely cause of edema?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Decreased
capillary hydrostatic pressure</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increased
capillary oncotic pressure</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased
capillary permeability</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Lymphatic
obstruction</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Edema</span></b></p>

<p><span></span></p>

<p><span>Several
factors determine whether fluid will be filtered or reabsorbed in a capillary
bed. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Capillary hydrostatic
pressure tends to produce filtration since a higher pressure in the capillary
will force more fluid to leave the capillary. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Interstitial fluid
hydrostatic pressure will have the opposite effect since higher pressure in the
interstitium will force fluid to move from the interstitium into the capillary.
</span></p>

<p><span></span></p>

<p><span>The net
osmotic pressure in capillaries, also termed oncotic pressure, is primarily
created by the presence of the non-diffusible protein albumin. It is important
to realize, though, that the total osmotic pressure in the capillary is created
mainly by electrolytes because their concentration is far higher than the
concentration of albumin. The reason electrolytes are not important for fluid
transport across a capillary is that the electrolyte concentrations are similar
in the capillary and interstitium, so that there is no net drive for diffusion.
</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Capillary oncotic
pressure tends to draw fluid into the capillary</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Interstitial fluid
oncotic pressure tends to draw fluid into the interstitium. </span></p>

<p><span></span></p>

<p><span>Under
normal circumstances the capillary hydrostatic pressure and capillary oncotic
pressures are relatively high and the other two pressures are relatively low,
the net result being that some fluid leaves the typical capillary. This fluid
returns to the circulation via the lymphatic system.</span></p>

<p><span>If too
much fluid leaves the capillary, then the result is edema. Edema can be caused
by anything that affects the four factors mentioned above so that the net
effect is more fluid leaving the capillary. Common causes of edema include
diseases that increase capillary hydrostatic pressure.</span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>In congestive heart
failure, venous pressure increases because of an inadequate cardiac output. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous thrombosis also
increases venous pressure proximal to the obstruction (that is, on the
capillary side of the obstruction), leading to edema in the vascular bed
affected. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Renal retention of salt
and water increases capillary hydrostatic pressure simply because the vascular
system is more “full” of fluid. </span></p>

<p><span></span></p>

<p><span>Some
disease states (e.g., cirrhosis, nephrotic syndrome) produce hypoalbuminemia
which reduces capillary oncotic pressure. This reduces the osmotic pressure of
fluid within the capillary, resulting in less drive for fluid to return to the
capillary. The result is edema.</span></p>

<p><span></span></p>

<p><span>Lymphatic
obstruction or surgical removal of lymph nodes produces edema by reducing the
drainage of fluid from the interstitium. Although interstitial fluid
hydrostatic pressure increases in this situation which reduces the drive for
fluid movement from capillary to interstitium, the pressures forcing pressure
out of the capillary still exceed the pressures favoring fluid movement into
the capillary.</span></p>

<p><span></span></p>

<p><span>Finally,
edema can be produced by conditions that damage capillaries and thus increase
capillary permeability.</span></p>

<span><br clear=all>
</span>

<p><span>The
principal mechanisms of edema are summarized below.<span>&nbsp; </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=419 colspan=3 valign=top>
  <p style="text-align:center;"><span>Edema</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
  <td width=156 valign=top>
  <p><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p style="text-align:center;"><span>Mechanism</span></p>
  </td>
  <td width=156 valign=top>
  <p style="text-align:center;"><span>Cause</span></p>
  </td>
  <td width=153 valign=top>
  <p style="text-align:center;"><span>Characteristics</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span></span></p>
  </td>
  <td width=156 valign=top>
  <p><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Increased
  capillary hydrostatic pressure</span></p>
  </td>
  <td width=156 valign=top>
  <p><span>Heart
  failure</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Pitting
  edema</span></p>
  <p><span>Jugular
  vein distension</span></p>
  <p><span>Hepatojugular
  reflux</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Increased
  capillary hydrostatic pressure </span></p>
  </td>
  <td width=156 valign=top>
  <p><span>Renal
  failure</span></p>
  <p><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Pitting
  edema</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Increased
  capillary hydrostatic pressure </span></p>
  </td>
  <td width=156 valign=top>
  <p><span>Deep
  vein thombosis</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Pitting
  edema</span></p>
  <p><span>Limited
  to area of blockage</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Decreased
  capillary oncotic pressure</span></p>
  </td>
  <td width=156 valign=top>
  <p><span>Cirrhosis
  </span></p>
  <p><span>Nephrotic
  syndrome </span></p>
  <p><span>Severe
  malnutrition</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Pitting
  edema</span></p>
  <p><span>Generalized
  (anasarca)</span></p>
  <p><span>Peri-orbital
  edema</span></p>
  <p><span>&#8595;
  Serum albumin</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Lymphatic
  obstruction</span></p>
  </td>
  <td width=156 valign=top>
  <p><span>Removal
  of lymph nodes</span></p>
  <p><span>Radiation</span></p>
  <p><span>Tumor</span></p>
  <p><span>Injury</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Non-pitting
  edema</span></p>
  <p><span>Limited
  to area of blockage</span></p>
  <p><span>Indurated
  skin</span></p>
  </td>
 </tr>
 <tr>
  <td width=111 valign=top>
  <p><span>Increased
  capillary permeability</span></p>
  </td>
  <td width=156 valign=top>
  <p><span>Allergic
  reactions</span></p>
  <p><span>Burns</span></p>
  <p><span>Snake bites</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Variable</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Lymphedema should be
considered in a patient who has undergone regional lymph node resection and who
presents with localized swelling of the corresponding extremity. Lymphedema is
usually non-pitting and may appear months or years after lymph node resection.
The overlying skin may be indurated. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Increased, not
decreased, capillary hydrostatic pressure causes edema in congestive heart
failure and venous stasis. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Decreased, not
increased, capillary oncotic pressure causes edema in cirrhosis and nephrotic
syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Increased, not
decreased, capillary permeability causes edema in allergic reactions and burns.
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year-old woman with type 1 diabetes mellitus
has had progressive renal failure over the past 2 years. She has not yet
started dialysis. Her hemoglobin concentration is 9 g/dL, hematocrit is 28%,
and mean corpuscular volume is 94 &#956;m3. A blood smear shows normochromic,
normocytic cells. What is the most likely cause of anemia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
blood loss</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic
lymphocytic leukemia</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Erythropoietin
deficiency</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Immunohemolysis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Microangiopathic
hemolysis</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sickle
cell disease</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Sideroblastic
anemia</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>&#946;-Thalassemia
trait</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The total mass of red blood cells in the
circulatory system is regulated within very narrow limits so that an adequate
number of red blood cells is available to provide sufficient tissue oxygenation
and, yet, so that the cells do not become so concentrated that they impede
blood flow. Any condition that causes the quantity of oxygen transported to the
tissues to decrease ordinarily increases the rate of red blood cell production.
Thus, when a person becomes extremely anemic as a result of hemorrhage, for example,
the bone marrow immediately begins to produce large quantities of red blood
cells. </span></p>

<p><span></span></p>

<p><span>The principal factor that stimulates red
blood cell production is a circulating hormone called <b>erythropoietin</b> (a glycoprotein). In the absence of erythropoietin,
hypoxia has either no effect or very little effect in stimulating red blood
cell production. On the other hand, when the erythropoietin system is
functional, hypoxia causes marked increase in erythropoietin production, and
the erythropoietin in turn enhances red blood cell production until hypoxia is
relieved. </span></p>

<p><span></span></p>

<p><span>In a normal person, 80-90% of all
erythropoietin is formed in the kidneys; the remainder, mainly in the liver.
Individuals with <b>chronic kidney disease</b>
(CKD) invariably become anemic because the 10-20% of the normal erythropoietin
formed in other tissues (mainly the liver) is insufficient to stimulate
production of adequate numbers of red blood cells. In normal subjects, serum
erythropoietin levels increase in response to a reduction in red blood cell mass
(i.e., anemia). In CKD, erythropoietin concentrations are inappropriately low
for the degree of anemia. The adequacy of erythropoietin production in response
to anemia appears to decline in rough proportion to the degree of reduction in
nephron mass. </span></p>

<p><span></span></p>

<p><span>Anemia in CKD can develop because of any
of the hematologic diseases that may affect individuals without kidney disease,
such as iron, vitamin B<sub>12</sub></span><a
href="http://www.mdconsult.com.webproxy.ouhsc.edu/books/linkTo?type=bookPage&amp;isbn=978-1-4160-6193-9&amp;eid=4-u1.0-B978-1-4160-6193-9..10056-9--bib202&amp;appID=MDC"></a><span>, or folic acid
deficiency. But the form of anemia most common in CKD is a normocytic,
normochromic (or slightly hypochromic) anemia with insufficient production of
erythrocytes, due primarily to erythropoietin deficiency. The greatest proof
that erythropoietin deficiency is the primary cause of renal anemia is the
consistent success of treating renal anemia with recombinant human
erythropoietin (rHuEPO). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C
is correct. </span></b><span>The
principal cause of anemia in patients with chronic kidney disease is
erythropoietin deficiency. This typically presents as a normochromic,
normocytic anemia. White blood cell and platelet counts remain unaffected. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A healthy
18-year-old man is undergoing an exercise stress test. Which of the following
is occurring in this man’s skeletal muscle during exercise? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Increased
arteriolar diameter</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increased
vascular resistance</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased
capillary hydrostatic pressure</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Increased
oxygen concentration</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased
metabolite concentration</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>During
exercise, blood flow to muscle must increase to meet the greater demand for
nutrients and oxygen. This is achieved primarily through arteriolar dilatation,
which lowers vascular resistance and increases blood flow.</span></p>

<p><span></span></p>

<p><span>Poiseuille's
equation:</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=60 height=34
src="_%20Tutorials_files/image430.png"
alt="Description: 58a785aa20836091240538adaaefe0ee" v:shapes="Picture_x0020_347356"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>R = resistance</span></p>

<p><span>&#951; = viscosity</span></p>

<p><span>l = length of vessel</span></p>

<p><span>r = radius of vessel</span></p>

<p><span></span></p>

<p><span>Resistance
falls dramatically as blood vessel radius increases. </span></p>

<p><span></span></p>

<p><span>As
resistance falls, blood flow increases:</span></p>

<p style="text-align:center;"><span>Q = P / R</span></p>

<p><span>Q = blood flow</span></p>

<p><span>P = pressure</span></p>

<p><span>R = resistance</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span><span>&nbsp;</span>During exercise, blood flow to muscle
increases due to arteriolar dilatation.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect. </span></b><span>Arteriolar dilatation
decreases vascular resistance (Poiseuille's equation). </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><span>As blood flow increases,
capillary hydrostatic pressure increases.<span >&nbsp;
</span>Flow = Pressure x Resistance. (The capillaries cannot control resistance
as arterioles can.)<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>An exercising muscle
uses oxygen to burn fuel. Oxygen levels decrease. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect. </span></b><span>Metabolites produced by
burning fuel increase during exercise. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A husband and wife are in your office.<span>&nbsp; </span>Their daughter developed a deep vein
thrombosis during the third trimester of pregnancy and was told she has the
Factor V Leiden mutation. She was also told that her whole family needed to be
screened for the trait. <span >&nbsp;</span>The couple
is in excellent health and has three other children and eight
grandchildren.<span >&nbsp; </span>None of them have
had a deep vein thrombosis (DVT) or pulmonary embolism. Two uncles have had
heart attacks before age 60 and several elderly family members have had strokes.
Which of the following is most appropriate? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Explain
that factor V Leiden testing is often abnormal during pregnancy and needs to be
repeated.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Recommend
complete testing for hypercoagulability on the entire family, including protein
C, protein S, antithrombin III, prothrombin mutation 20210, and Factor V
Leiden.</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Test
the family for Factor V Leiden and place all members with the mutation on
warfarin.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Educate
the parents about Factor V Leiden and about the signs and symptoms of deep vein
thrombosis and pulmonary embolism.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><b><span>Factor V Leiden (FVL) mutation</span></b><span> is the most common inherited disorder leading to venous
  thromboembolism (VTE). About 5% of individuals with European ancestry are
  heterozygous for FVL. The FVL mutation occurs at a site where activated
  protein C (APC) cleaves and inactivates normal factor Va (Arg506); abolition
  of this cleavage site results in APC resistance. Failure to inactivate the
  mutant factor Va allows the prothrombinase complex to be relatively uninhibited
  and leads to increased thrombin generation and a thrombophilic phenotype.
  About one fourth of patients with an initial occurrence of VTE or PE will
  have heterozygous FVL, and this percentage increases to nearly 60% in those
  with recurrent VTE or a strong family history of VTE or PE. APC resistance
  can be demonstrated by specialized clotting tests showing that the addition
  of APC fails to prolong the partial thromboplastin time (PTT). Genotyping can
  then confirm whether FVL is present and whether heterozygous or homozygous.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P054011></a><span>Inheritance of
  heterozygous FVL conveys an about seven-fold increased risk for VTE or PE.
  However, at 50 years of age, only 25% of persons with heterozygous FVL have
  had VTE or PE compared with much higher percentages in persons with other
  inherited thrombophilias. It is with concomitant&nbsp;<i>acquired</i>&nbsp;risk
  factors such as immobilization, pregnancy, or oral contraceptive use that the
  risk for VTE or PE in persons with FVL becomes more significant.<span>&nbsp; </span>Homozygotes for FVL have an increased
  risk for VTE that is estimated to be between 20- and 80-fold. Only occasional
  reports exist of patients with homozygous FVL who are asymptomatic into old
  age. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
D is correct</span></b><span>.<span>&nbsp; </span>The family needs to know the signs and symptoms
of deep vein thrombosis (leg pain, swelling, redness) and of pulmonary embolism
(shortness of breath and chest pain).<span >&nbsp;
</span>If any of these symptoms occur, medical care should be sought regardless
of mutation status. Hip and knee replacements increase the risk of DVT in all
patients. Anyone undergoing these procedures should receive DVT prophylaxis.
Screening asymptomatic family members for Factor V Leiden is controversial.
Treatment of asymptomatic carriers with warfarin is never indicated.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is incorrect</span></b><span>.<span>&nbsp; </span>Factor V Leiden is a genetic mutation.
It is not affected by pregnancy.</span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><b>Answer
B is incorrect</b>.<span >&nbsp; </span>There is no
need for such extensive testing in asymptomatic individuals. </span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect. </span></b><span>In
this vignette, it is not surprising that no one else in the family has had a
DVT. Factor V Leiden is often only one of many risk factors (e.g., surgery,
pregnancy, leg injury) for thrombosis.<span >&nbsp;
</span>Warfarin carries a 1-3% chance of serious bleeding each year and should
not be used in asymptomatic Factor V Leiden carriers. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An otherwise healthy 20-year-old man of Mediterranean descent is given
sulfamethoxazole to treat a bladder infection. Three days after beginning the
antibiotic, he becomes jaundiced and his urine becomes dark. His hemoglobin
concentration is 7 gm/dL. On blood smear examination, Heinz bodies are detected
in numerous red blood cells. His condition worsens until day 6 of antibiotic
therapy, when it begins to improve. Symptoms are gone by day 9 of continued
antibiotic therapy. Which of the following conditions is the most likely
explanation for these findings? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Aplastic
anemia</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytochrome-<i>b<sub>5</sub></i> reductase deficiency</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Glucose-6-phosphate
dehydrogenase deficiency</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pyruvate
kinase deficiency</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sepsis
successfully treated with antibiotics</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Glucose-6-phosphate
dehydrogenase (G6PD) deficiency</b> is the most common human enzyme defect,
affecting more than 400 million worldwide. People of African, Middle Eastern,
South Asian, and Mediterranean descent are predominantly affected. G6PD
deficiency is an X-linked disorder characterized by abnormally low levels of
glucose-6-phosphate dehydrogenase, an enzyme involved in the pentose phosphate
pathway, which is especially important in red blood cell metabolism.
Individuals with the disease exhibit nonimmune hemolytic anemia in response to
a number of causes, most commonly infection or exposure to certain medications
or chemicals. G6PD deficiency is closely linked to <span>favism</span>, a disorder characterized by a hemolytic response to broad
bean consumption. (The name is derived from the Italian name for broad bean: <i>fava</i>).
Most individuals with G6PD deficiency are asymptomatic. Symptomatic patients
are usually male (due to an X-linked pattern of inheritance), but female
carriers can be clinically affected due to unfavorable Lyonization, where
random inactivation of an X-chromosome in certain cells creates a population of
G6PD-deficient red blood cells coexisting with normal red cells.</p>

<p><span></span></p>

<p><span>Many
substances are potentially harmful to people with G6PD deficiency. Certain
antimalarial drugs (e.g. primaquine, pamaquine and chloroquine) can cause
hemolysis in people with G6PD deficiency. Sulfonamides (e.g. sulfamethoxazole),
methylene blue, and naphthalene should also be avoided by people with G6PD
deficiency, as should certain analgesics (e.g. aspirin) and a few non-sulfa
antibiotics (nalidixic acid, nitrofurantoin, isoniazid, and dapsone). Glucose-6-phosphate
dehydrogenase is an enzyme in the pentose phosphate pathway. It converts
glucose-6-phosphate to 6-phosphoglucono-&#948;-lactone, and it is the
rate-limiting enzyme in this pathway. The pentose phosphate pathway supplies
reducing equivalents to cells by maintaining the level of nicotinamide adenine
dinucleotide phosphate (NADPH). NADPH, in turn, maintains the supply of reduced
glutathione, which is used to mop up free radicals that cause oxidative damage.
The G6PD / NADPH pathway is the <i>only</i> source of biochemical reductant
needed to maintain reduced glutathione in red blood cells. The role of red
cells as oxygen carriers puts them at substantial risk of damage from oxidizing
free radicals except for the protective effect of G6PD/NADPH/glutathione.</span></p>

<p></p>

<p>People with G6PD deficiency
are at risk of hemolytic anemia in states of oxidative stress. Oxidative stress
can result from infection, chemical exposure, medication, or certain foods.
When reduced glutathione is consumed, enzymes and other proteins (including
hemoglobin) are damaged by oxidants. Damaged red cells are phagocytosed and
sequestered in the spleen; the hemoglobin is metabolized to bilirubin, which
may cause jaundice at high concentrations. </p>

<p><span>The
diagnosis should be suspected when patients from certain ethnic groups (e.g.,
people of Mediterranean descent) develop hemolysis after an oxidative
challenge, especially when there is a positive family history. Findings include
anemia, elevated reticulocyte counts, Heinz bodies in red blood cells (seen on
blood smear), elevated bilirubin levels, elevated lactate dehydrogenase levels
(from hemolysis), low haptoglobin levels (from hemolysis), and negative Coombs’
test (because hemolysis is not immune-mediated). “Bite cells” may be seen.
(“Bite cells” are red blood cells whose Heinz bodies have been “bitten out” by
macrophages in the spleen). </span></p>

<p></p>

<p>The most important step in
managing patients with this disease is prevention. Affected individuals should
avoid drugs and foods that cause hemolysis. Also, they should be vaccinated
against pathogens (e.g. hepatitis A and B) that can induce attacks. </p>

<p><b>Answer C is correct. </b><span >&nbsp;</span><span>Heinz bodies</span> are small round
inclusions of denatured (“damaged”) hemoglobin in red blood cells, usually
caused by oxidative stress or genetic mutation.<span>&nbsp; </span>The abnormal hemoglobin results in
reactive oxygen species (ROS) formation, which damages the cell. This causes
premature lysis of red blood cells, as damaged cells are cleared by macrophages
in the spleen. Acute development of anemia, jaundice, and dark urine in this
patient suggests a hemolytic process. G6PD deficiency should be suspected when
hemolysis occurs in a person of Mediterranean descent after administration of a
sulfa antibiotic. G6PD deficiency is the most common enzyme deficiency in the
world. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
3-year-old boy is brought to your office with a 3-day history of abdominal
pain, vomiting, and diarrhea. The parents are worried because the diarrhea
became bloody this morning and the boy has not been urinating. The family ate
hamburgers at a cook-out last weekend, after which the mother and sister
developed mild abdominal pain and diarrhea. On physical examination, the boy is
pale and irritable. Lab tests show: </span></p>

<p><span></span></p>

<p><span>Hemoglobin
<span>&nbsp;&nbsp;&nbsp; </span>7.0 g/dL</span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>8,500/mm3</span></p>

<p><span>Platelets <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>37,000/mm3</span></p>

<p><span></span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>40
mg/dL</span></p>

<p><span>Creatinine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4.8
mg/dL<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Examination
of the blood smear shows decreased platelet numbers, fragmented red blood
cells, and polychromatophilic red cells (reticulocytes). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=192 height=144
src="_%20Tutorials_files/image432.png" alt="Description: Schistocytes" v:shapes="Picture_x0020_347355"></span><span></span></p>

<p><span></span></p>

<p><span>You admit
the boy to the hospital. Which of the following diagnostic and therapeutic
approaches is most appropriate? </span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>A.
Stool culture for bacterial pathogens (Salmonella and Shigella species);
administer antibiotics</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>B.
Stool culture for bacterial pathogens (Salmonella and Shigella species);
perform kidney biopsy</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>C.
Stool culture with sorbitol-MacConkey and ELISA assay for stool Shiga toxin;
manage with supportive care, including hemodialysis if necessary</span></p>

<p><span>D.
Stool culture with sorbitol-MacConkey and ELISA assay for stool Shiga toxin;
manage with plasma exchange</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Hemolytic-uremic syndrome (HUS)</span></b><span> is associated with
microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure.
The presence of fragmented red blood cells indicates a microangiopathic process
in which red cells are forced through partially occluded vessels. The abdominal
pain and bloody diarrhea are consistent with enterohemorrhagic colitis caused
by Shiga toxin-secreting bacteria. The most common of these bacteria is <i>E. coli</i> O157:H7.<span>&nbsp; </span><i>E.
coli</i> O157:H7 is part of the normal intestinal flora of cattle, and is
commonly acquired by eating undercooked meat. Children are more susceptible to
infection than adults.<span >&nbsp; </span>Shiga toxin
causes microvascular thrombosis in the kidneys, which results in red cell
fragmentation and platelet consumption (causing thrombocytopenia).
Reticulocytes and nucleated red cells appear, indicating increased red blood
cell production as a response to hemolysis. Most children recover spontaneously
and completely. About half may require hemodialysis until renal failure
resolves.<b></b></span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p style="text-align:center;"><span>Conditions associated with microangiopathic hemolysis</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Microangiopathic Hemolysis</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Hemolytic-uremic
  syndrome (HUS)</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Thrombotic
  thrombocytopenic purpura (TTP)</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Pre-eclampsia</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Malignant
  hypertension</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Disseminated
  microvascular metastases of carcinoma</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. <i>E. coli</i> O157:H7 can be cultured on sorbitol-MacConkey agar. An
ELISA assay can detect Shiga toxin in the stool. Supportive care is the
mainstay of management. Dialysis may be needed in some patients.<span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Hemolytic-uremic
syndrome is caused predominantly by <i>E.
coli</i> O157:H7. Antibiotics are not needed.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Hemolytic-uremic
syndrome is caused predominantly by <i>E.
coli</i> O157:H7. Kidney biopsy is unnecessary and inappropriate. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Plasma exchange is
recommended for thrombotic thrombocytopenic purpura (TTP), not hemolytic-uremic
syndrome (HUS). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
25-year-old male presents to his primary care provider with a slowly enlarging,
nonpainful right neck mass. He denies recent upper respiratory tract
infections, fevers, night sweats, or unintentional weight loss. He is otherwise
healthy. Social history and family history are unremarkable. On examination he
is afebrile with normal vital signs. Pertinent findings include a 3-cm, firm,
round, nontender, mobile mass in the mid-right neck. There is no other
peripheral lymphadenopathy. The liver and spleen are not enlarged. Biopsy of
the mass shows large numbers of the following cell type:</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=152 height=122
src="_%20Tutorials_files/image434.png" alt="Description: HP-Home-Image" v:shapes="Picture_x0020_347354"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>What is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hodgkin
lymphoma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Non-Hodgkin
lymphoma</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Toxoplasmosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tuberculosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Hodgkin lymphoma</b><span> </span>is a type of cancer that originates
from lymphocytes. It is characterized by the orderly spread of disease from one
lymph node group to another and by the development of systemic symptoms with
advanced disease. Multinucleated Reed-Sternberg cells are the characteristic
histopathologic finding. Hodgkin lymphoma may be treated with radiation
therapy, chemotherapy, or hematopoietic stem cell transplantation, the choice
of treatment depending on the stage, bulk, and histological subtype of the
disease.</p>

<p></p>

<p>The disease occurrence shows
two peaks: the first in young adulthood (age 15&#8211;35) and the second in
those over 55 years old. The 10-year overall survival rate is more than 90% for
any stage, though early diagnosis may help. Since many patients are young, they
often live 40 years or more after treatment. It is now known that approximately
half of cases of Hodgkin lymphoma are related to Epstein-Barr virus (EBV).
Patients with a history of infectious mononucleosis due to Epstein-Barr virus
have a slightly increased risk of Hodkin lymphoma.</p>

<p><span></span></p>

<p><span>The most
common presentation of Hodgkin’s lymphoma is painless cervical and/or
supraclavicular lymphadenopathy. Axillary and inguinal lymphadenopathy is less
common. The mediastinum is frequently involved; symptoms may include shortness
of breath and/or cough. Approximately 30% of patients present with B symptoms,
defined as unexplained, recurrent fevers ≥100.4°F (38°C), drenching night
sweats requiring change of bed clothes, or ≥10% weight loss in the last 6
months. B symptoms are more common in patients with advanced disease. Other
systemic symptoms not categorized as B symptoms include generalized pruritus
and alcohol-induced pain at the site of a tumor mass. </span></p>

<p></p>

<p>Hodgkin lymphoma must be
distinguished from other types of cancer, as well as from non-cancerous
(generally, infectious) causes of lymph node swelling. Definitive diagnosis is
by lymph node biopsy, usually excisional biopsy with microscopic examination.
Microscopic examination of the lymph node biopsy reveals complete or partial
effacement of the lymph node architecture by scattered large malignant cells
known as Reed-Sternberg cells. Reed-Sternberg cells are large and are either
multinucleated or have a bilobed nucleus (thus resembling an “owl’s eye”) with
prominent eosinophilic inclusion-like nucleoli. In approximately 50% of cases,
the Reed-Sternberg cells are infected by the Epstein-Barr virus. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer B is correct.</b> This is a classic presentation of Hodgkin’s
lymphoma with Reed-Sternberg cells seen on microscopic examination of a lymph
node biopsy. </p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 1-week-old neonate develops marked unconjugated
hyperbilirubinemia and dies the following week. Lab tests show no evidence of
hemolysis. Liver enzymes are normal. What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Gilbert’s
syndrome</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rotor
syndrome</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dubin-Johnson
syndrome</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Crigler-Najjar
syndrome, type 1</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<h3><span></span></h3>

<h3><span>Bilirubin</span><span> is produced by the breakdown of
red blood cells. When erythrocytes get old or damaged, they are disposed of in
the spleen. This releases hemoglobin, which is broken down to heme and “globin”
protein. The heme is then turned into unconjugated bilirubin in the
reticuloendothelial cells of the spleen. This unconjugated bilirubin is not
soluble in water. It binds to albumin and is sent to the liver. </span></h3>

<h3><span></span></h3>

<h3><span>In the liver it
is conjugated with glucuronic acid by the enzyme glucuronyltransferase, making
it soluble in water. Much of it goes into the bile, which travels through the
biliary system into the bowel. In the colon, some of the conjugated bilirubin
is metabolized by colonic bacteria to urobilinogen, which is further
metabolized to stercobilinogen, and finally oxidized to stercobilin. This
stercobilin gives feces its brown color. Some of the urobilinogen is reabsorbed
and excreted in the urine. Normally, only a tiny amount of bilirubin, if any,
is excreted in the urine. </span></h3>

<h3><span></span></h3>

<h3><span>If the liver’s
function is impaired or if biliary drainage is blocked, some of the conjugated
bilirubin leaks out of the hepatocytes and appears in the urine, turning it
dark amber. However, in disorders involving hemolytic anemia, an increased
number of red blood cells are broken down, causing an increase in the amount of
unconjugated bilirubin in the blood. The unconjugated bilirubin is not water
soluble, and thus will not appear in the urine. Because there is no problem
with the liver or biliary system in hemolytic anemia, the excess unconjugated
bilirubin will go through the normal processing mechanisms (e.g., conjugation,
excretion in bile, metabolism to urobilinogen, reabsorption) and will show up
as an increase in urine urobilinogen. </span></h3>

<h3><span></span></h3>

<h3><span>Therefore, urine
bilirubin is increased when the liver is impaired or when biliary drainage is
blocked, but not in hemolytic anemia. Urobilinogen, by contrast, is increased
in hemolytic anemia and decreased when biliary drainage is blocked.<span>&nbsp; </span></span></h3>

<p><span></span></p>

<p><span>There are five known hereditary defects in
bilirubin metabolism: Crigler-Najjar syndrome types 1 and type II, Gilbert’s
syndrome, Dubin-Johnson syndrome, and Rotor syndrome.<span>&nbsp; </span>Crigler-Najjar syndrome and Gilbert
syndrome cause <i>unconjugated</i>
hyperbilirubinemia. Crigler-Najjar syndrome is life-threatening; Gilbert
syndrome is benign. Dubin-Johnson syndrome and Rotor syndrome cause <i>conjugated</i> hyperbilirubinemia.
Dubin-Johnson syndrome is differentiated from Rotor syndrome by the presence of
black pigmentation in the liver. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct. </span></b><span>Of the four hereditary
disorders listed, only Crigler-Najjar syndrome and Gilbert syndrome cause <i>unconjugated</i> hyperbilirubinemia.
Crigler-Najjar syndrome is life-threatening; Gilbert syndrome is benign. This
neonate has Crigler-Najjar syndrome.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Five days
after undergoing a right total hip replacement, a 68-year old man experiences
sharp chest pain and shortness of breath. He has a low-grade fever and
tachycardia. His right leg is swollen and painful. Which of the following would
predispose him to this event?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Overproduction
of protein C </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mutation
of Factor V gene</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Low
serum homocysteine levels</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>von
Willebrand factor deficiency</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Factor
VIII deficiency</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Risk factors for deep venous thrombosis (DVT)</span></p>

<p style="text-align:center;"><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Genetic</span></p>
  </td>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Acquired</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
  <td width=221 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Factor V
  Leiden*</span></p>
  <p><span>Prothrombin
  G20210A mutation</span></p>
  <p><span>Antithrombin
  III deficiency</span></p>
  <p><span>Protein
  S deficiency</span></p>
  <p><span>Protein
  C deficiency</span></p>
  <p><span></span></p>
  <p><span>*Suspect
  genetic cause if patient has…</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Unexplained DVT</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Recurrent DVT</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>FMH of DVT</span></p>
  <p><span></span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Surgery/Trauma</span></p>
  <p><span>Immobilization</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Bedridden &gt; 3
  days</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Air flights &gt; 6-8
  hours</span></p>
  <p><span>Obesity</span></p>
  <p><span>Venous
  stasis</span></p>
  <p><span>Pregnancy</span></p>
  <p><span>Stroke</span></p>
  <p><span>Congestive
  heart failure</span></p>
  <p><span>Nephrotic
  syndrome</span></p>
  <p><span>Cancer</span></p>
  <p><span>Medicine:
  OCs, HRT</span></p>
  <p><span>Antiphospholipid
  antibody syndrome</span></p>
  <p><span>Hyperhomocysteinemia</span></p>
  </td>
 </tr>
</table>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>* Factor V Leiden is the most common hereditary
hypercoagulability disorder.</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. The clinical scenario
is most consistent with deep vein thrombosis and pulmonary embolism. Factor V
Leiden, the most common hereditary hypercoagulability disorder, is a mutation
of the Factor V gene that prevents Factor V from being deactivated by protein
C. Unopposed Factor V leads to a hypercoagulable state that may result in deep
venous thrombosis and pulmonary embolism. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Proteins C and S
inhibit the coagulation cascade. Deficiency, not overproduction of these
proteins, leads to a hypercoagulable state. </span></p>

<p><b></b></p>

<p><b>Answer C is incorrect</b>. High, not low, levels of homocysteine are
associated with a hypercoagulable state. <span>Hyperhomocysteinemia</span> is a medical condition characterized by an
abnormally large level of homocysteine in the blood. As a consequence of the
biochemical reactions in which homocysteine is involved, deficiencies of the
vitamins pyridoxine (B<sub>6</sub>), folic acid (B<sub>9</sub>), or B<sub>12</sub>
can lead to high homocysteine levels. Supplementation with pyridoxine, folic
acid, or B<sub>12</sub> reduces the concentration of homocysteine in the
bloodstream. A high level of homocysteine makes a person more prone to
endothelial injury, which leads to vascular inflammation, which in turn may
lead to atherogenesis, which can result in ischemic injury. </p>

<p></p>

<p>Hyperhomocysteinemia is a
risk factor for blood clots, heart attacks, and strokes. It can cause
miscarriage and is associated with pre-eclampsia. Hyperhomocysteinemia usually
occurs in people with at least one defective gene that affects breakdown of
homocysteine. Defects in methylenetetrahydrofolate reductase (MTHFR) or
methioninesynthetase are associated with hyperhomocysteinemia. Both enzymes are
involved in the conversion of homocysteine to methionine. Consequently,
individuals with hyperhomocysteinemia often have decreased levels of
methionine. </p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. Von Willebrand
deficiency predisposes to bleeding, not hypercoagulability. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Factor VIII deficiency
(hemophilia A) predisposes to bleeding, not hypercoagulability. </span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Blood flow is studied in an anesthetized animal. After an initial control
period, a tourniquet is placed around one extremity to occlude blood flow for
exactly 1 minute. When the tourniquet is released, blood flow increases
abruptly and exceeds the control value for several minutes (reactive
hyperemia). After an appropriate recovery period, the procedure is repeated,
but this time, the extremity is actively exercised during the period of
occlusion. How will the reactive hyperemia after the second occlusion compare
with the reactive hyperemia after the first? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Abolished</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Unchanged</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increased</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>“Hyperemia”</b><span> is increased blood flow to </span>a
particular area of the body. It may be “<em><span>active” or</span></em><i> </i>“<em><span>reactive,”
and it is typically associated with </span></em>erythema.<span
 </span></p>

<p><i><span></span></i></p>

<p><i><span>Active</span></i><span> hyperemia is increased blood flow caused by <span>increased metabolic activity.</span> During
skeletal muscle contraction, for example, vasoactive substances are released
that dilate resistance vessels and increase blood flow. Similarly, blood flow
is increased in the gastrointestinal tract during digestion and in the coronary
arteries during periods of increased heart rate. Under normal circumstances
total blood flow to the brain is relatively constant due to autoregulation, but
regional brain blood flow can vary depending on metabolic activity. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=190 height=157
src="_%20Tutorials_files/image436.png"
alt="Description: Relationship between skeletal muscle blood flow and oxygen consumption"
v:shapes="Picture_x0020_347353"></span><span></span></p>

<p><span></span></p>

<p><span>The figure
above shows that basal oxygen consumption is associated with a resting blood
flow rate. As oxygen consumption increases, there is a near-linear increase in
blood flow until the vessels are maximally dilated. A 50-fold increase in
muscle blood flow may occur during heavy exercise. Active hyperemia is caused
by tissue hypoxia and by the release of vasodilators (e.g., adenosine, nitric
oxide, carbon dioxide, <span>potassium ion)</span>.</span></p>

<p></p>

<p><i><span>Reactive</span></i><span>
hyperemia is increased blood flow that <em><span>occurs after a brief period of ischemia.</span></em>
For example, reactive hyperemia occurs after a tourniquet is removed from the
arm, after a clamp is removed from an artery during surgery, or after a
stenosed coronary artery is recanalized.</span></p>

<p><span></span></p>

<p><span><img border=0 width=453 height=176
src="_%20Tutorials_files/image438.png"
alt="Description: reactive hyperemia in skeletal muscle" v:shapes="Picture_x0020_347352"></span><span></span></p>

<p><span></span></p>

<p>Figure 2 <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Figure
3</p>

<p>Figure 2 shows the effects
of a 2-minute arterial occlusion on blood flow. Blood flow goes to zero during
arterial occlusion. When the occlusion is released, blood flow rises rapidly
and the excess flow lasts for several minutes. Hyperemia occurs because, during
the period of occlusion, tissue <em><span>hypoxia</span></em> and vasodilators (e.g., <em><span>adenosine</span></em>) dilate arterioles and
decrease vascular resistance. When perfusion pressure is restored, blood flow
is increased because of reduced vascular resistance. </p>

<p></p>

<p>During hyperemia, the tissue
becomes reoxygenated and the vasodilators are washed away. This causes vessels
to regain their normal <em><span>vascular tone</span></em>, with blood flow returning to normal. Longer
periods of occlusion create a greater metabolic stimulus for vasodilation,
resulting in greater and more prolonged hyperemia (Figure 3).&nbsp; </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b><span>Answer D is correct. </span></b><span>Hyperemia may be triggered by increased metabolic activity
(active) or by ischemia (reactive).<span >&nbsp;
</span>In this vignette, the animal’s extremity is occluded twice. Both
occlusions result in <i>reactive</i>
hyperemia after the tourniquet is released. During the second occlusion,
however, the extremity is actively exercised, adding a component of <i>active</i> hyperemia to the <i>reactive</i> hyperemia already in place.
Exercise increases oxygen consumption, and oxygen consumption is strongly
correlated with blood flow. The combined effects of exercise and ischemia
during the second occlusion will increase the metabolic stimulus for
vasodilation and increase hyperemia beyond the level seen after the first
occlusion. <b></b></span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
66-year-old man with alcohol dependence and cirrhosis is admitted to the
hospital with abdominal pain. Three months ago he was hospitalized with
bleeding esophageal varices. On physical examination, he is somnolent. Spider
angiomas are noted on his chest. His abdomen is remarkable for tense ascites.
The liver and spleen are not palpable through the fluid. Deep tendon reflexes
are hyperactive and asterixis is present.<span >&nbsp;
</span>Lab tests show:</span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>10.2 g/dL</span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>3,750/mm<sup>3</sup></span></p>

<p><span>Platelets <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>52,000/mm<sup>3</sup></span></p>

<p><span></span></p>

<p><span>Examination
of the blood smear reveals target cells, normal white blood cell morphology,
and decreased platelets.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=183 height=137
src="_%20Tutorials_files/image440.png" alt="Description: Target" v:shapes="Picture_x0020_347351"></span><span></span></p>

<p><span></span></p>

<p><span>What is
the most important cause of thrombocytopenia in this patient?</span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>A.
Increased pooling of platelets in the spleen</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>B.
Marrow suppression of platelet production by alcohol</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>C.
Thrombopoietin deficiency</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>D.
Thalassemia minor</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span><img border=0 width=431 height=326
src="_%20Tutorials_files/image442.png" v:shapes="Picture_x0020_347483"></span></b><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Advanced
cirrhosis is associated with portal hypertension, and portal hypertension leads
to splenomegaly, hypersplenism, and thrombocytopenia. The splenic sinusoids
become congested, which results in platelet pooling, or <b>“sequestration.”</b><span >&nbsp; </span>In
normal people, one-third of circulating platelets are pooled in the sinusoids.
This is because platelets, the smallest of blood elements, drift into the
sluggish sinusoidal circulation rather than moving directly from arteriole to
venule.<span >&nbsp; </span>Platelets in the spleen are
freely exchangeable with circulating platelets. Under stress, epinephrine
contracts the sinusoids, increasing the number of circulating platelets. In
patients with congestive splenomegaly, the spleen can accommodate more
platelets; 90% of platelets may be pooled in the sinusoids. Platelet
sequestration is typical of patients with advanced cirrhosis and portal
hypertension. <b></b></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>.<span>&nbsp; </span>Increased pooling of platelets in the
spleen is the most important cause of thrombocytopenia in this patient.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Rarely, severe alcohol
toxicity can cause marrow suppression, but this would not be the principal
cause of thrombocytopenia in this patient. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Thrombopoietin, a
hormone required for platelet production, is synthesized in the liver.
Thrombopoietin deficiency may contribute to this patient’s thrombocytopenia,
but it is not the main cause.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. “Target” cells are
seen in thalassemia and liver disease. Thalassemia is not associated with thrombocytopenia.
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
34-year-old woman visits her physician because of “tiny spots” that have
appeared on her legs. She has no other symptoms. Examination shows petechiae on
the legs. Laboratory tests show:</span></p>

<p><span></span></p>

<p><span>Hemoglobin:
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>14.0
g/dL</span></p>

<p><span>Mean
corpuscular volume: <span>&nbsp;&nbsp;&nbsp; </span>84
&#956;m3 </span></p>

<p><span>Leukocyte
count: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>8,000/mm3</span></p>

<p><span>Neutrophils <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>65%</span></p>

<p><span>Lymphocytes <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>30%</span></p>

<p><span>Monocytes <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5%</span></p>

<p><span>Platelet
count <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>18,000/mm3</span></p>

<p><span></span></p>

<p><span>A
peripheral blood smear shows normal red cell morphology. A bone marrow smear
shows</span></p>

<p><span>mature
megakaryocytic hyperplasia. Which of the following conditions is most likely?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Cirrhosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aplastic
anemia</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Immune
thrombocytopenic purpura</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Thrombotic
thrombocytopenic purpura</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The most
salient findings in this case are petechiae and <b>thrombocytopenia</b>. Petechiae are small, non-blanching red or purple
spots on the skin or mucous membranes caused by minor bleeding. Bleeding
beneath the skin is classified by the size of the discoloration. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Petechia<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1-3
mm</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Purpura <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3
mm-1 cm</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Ecchymosis<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;1 cm</span></p>

<p><span></span></p>

<p><span>Any of the
following factors may predispose a patient to bleeding.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Platelet deficiency or
dysfunction</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Coagulation disorders</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Increased capillary
fragility</span></p>

<p><span></span></p>

<p><span>In this
vignette, the cause of the bleeding is suggested by the low platelet count. A
normal platelet count is 150,000 &#8211; 450,000/mm<sup>3</sup>.
Thrombocytopenia is defined as a platelet count less than 150,000/ mm<sup>3</sup>.Generally,
bleeding caused by minor trauma is not observed until the platelet count falls
below 50,000/ mm<sup>3</sup>. Spontaneous bleeding usually occurs when the
count falls below 10,000/ mm<sup>3</sup>. </span></p>

<p><span></span></p>

<p><span>Thrombocytopenia
may cause bleeding in the skin or mucous membranes. Common presentations
include gingival bleeding, epistaxis, menorrhagia, and minor bleeding of the
gastrointestinal or genitourinary tracts. In the absence of trauma, gross
hematuria and major gastrointestinal bleeding are rare. By contrast, patients
with a coagulation disorder may present with deep muscular bleeding,
hemarthrosis, or retroperitoneal bleeding.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=146 valign=top>
  <p style="text-align:center;"><b><span>Thrombocytopenia</span></b></p>
  </td>
  <td width=146 valign=top>
  <p style="text-align:center;"><b><span>Coagulation disorders</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=146 valign=top>
  <p><span>Easy
  bruising</span></p>
  <p><span>Mucosal
  bleeding </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Gum bleeding </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Epistaxis </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>GI bleeding (mild)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>GU bleeding (mild)</span></p>
  <p><span></span></p>
  </td>
  <td width=146 valign=top>
  <p><span>Deep
  muscular bleeding </span></p>
  <p><span>Hemarthrosis
  </span></p>
  <p><span>Retroperitoneal
  bleeding</span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span>&nbsp;</span></span></p>

<p><span>Usually,
patients with a consumptive process (immune thrombocytopenic purpura,
hypersplenism) have a lower risk of bleeding than patients with impaired
platelet production. Intracranial bleeding, though extremely rare, is the most
common cause of death from thrombocytopenia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i><span>Acute</span></i><span> ITP is a transient, mostly postinfectious
disorder characterized by platelet destruction. It occurs mainly in children
with a peak age between 2 and 5 years. <i>Chronic
</i>immune thrombocytopenic purpura (ITP) is an immune-mediated
thrombocytopenia occurring primarily in adults (although children may be
affected). Platelets coated with IgG autoantibodies undergo accelerated
clearance by macrophages, predominantly in the spleen and liver. The condition
is more common in women than men. ITP is a diagnosis of exclusion. The criteria
for diagnosing ITP appear below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=255 valign=top>
  <p style="text-align:center;"><b><span>Criteria for ITP</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>Thrombocytopenia
  (with large platelets)</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>Normal
  hemoglobin concentration</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>Normal
  leukocyte count</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>No
  adenopathy or splenomegaly</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>Normal
  or increased numbers of megakaryocytes in bone marrow</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>No other
  explanation for thrombocytopenia</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span><span>&nbsp;</span></span></p>

<p><a name=4-u1.0-B0-323-03748-8..50048-8--para47></a><a
name=4-u1.0-B0-323-03748-8..50048-8--celist10></a><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct.<span>&nbsp; </span></span></b><span>Several findings suggest a diagnosis of immune
thrombocytopenic purpura (ITP): severe thrombocytopenia, normal hemoglobin
concentration, normal leukocyte count, no adenopathy, no splenomegaly, and no
symptoms of systemic disease. The presence of megakaryocytic hyperplasia in the
bone marrow suggests platelet destruction (as opposed to decreased production)
as a cause of thrombocytopenia.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>.<span>&nbsp; </span>Cirrhosis may be associated with portal
hypertension, splenomegaly, and hypersplenism, resulting in thrombocytopenia.
Typically, the thrombocytopenia is not severe. Examination may show
splenomegaly and stigmata of chronic liver disease. Anemia may be present and
target cells may be seen on examination of the peripheral blood smear.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span>&nbsp; </span>Patients with aplastic anemia typically
present with pancytopenia. The bone marrow is unable to produce enough new
cells to maintain normal blood cell counts. Megakaryocytic hyperplasia does not
occur.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect. </span></b><span>Thrombotic thrombocytopenia
purpura (TTP) is characterized by microangiopathic hemolytic anemia and
thrombocytopenia. Fever, neurological dysfunction, and renal insufficiency may
be present. Microangiopathic hemolysis results in schistocytes (fragmented red
blood cells), which are visible on examination of the peripheral blood smear. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Match each
of the following vignettes with the most likely type of leukemia. </span></p>

<p><span></span></p>

<p><span>1. A
62-year-old man visits his doctor for a routine physical. He denies any complaints,
such as fever or chills, weight loss, or fatigue. Of note, his blood tests show
an elevated white blood cell count of 16,000/mm<sup>3</sup>. 80% of the white
blood cells are mature lymphocytes.</span></p>

<p><span></span></p>

<p><span>2. A
54-year-old man has a 2-month history of fever, malaise, and weight loss. He
also reports abdominal fullness, early satiety, and frequent nosebleeds. On
exam, he is found to have splenomegaly. Cytogenetic analysis reveals a t(9;22)
chromosomal translocation.</span></p>

<p><span></span></p>

<p><span>3. A
38-year-old man has a 1-month history of fatigue, nosebleeds, and weight loss.
Physical examination shows mild pallor and petechial hemorrhages over his lower
limbs. He has multiple, widespread small lymph nodes that are palpable and mild
splenomegaly. Peripheral blood smear shows numerous “blast” cells.</span></p>

<p><span></span></p>

<p><span>4. A
58-year-old man has fatigue, bruising on his legs, and aching bones. On
examination, he is pale and has bony tenderness over the sternum and tibia.
Petechiae are present on the legs. There are no palpable lymph nodes. The liver
and spleen are not palpable. Bone marrow biopsy shows Auer rods are seen in the
cytoplasm of “blast” cells.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute lymphoblastic leukemia</span><span> </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acute myeloid leukemia</span><span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic<span> lymphoid leukemia</span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Chronic myelogenous leukemia</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Chronic<span> lymphoid leukemia</span>
(CLL)</b> is the most common type of leukemia. It affects B cell lymphocytes,
which originate in the bone marrow, develop in lymph nodes, and normally fight
infection by producing antibodies. In CLL, the DNA of a B cell is damaged, so
that it cannot produce antibodies; patients are often immunocompromised as a
result. B cells grow out of control and accumulate in the bone marrow and
blood, where they crowd out healthy blood cells. CLL usually presents in
adults; most newly diagnosed patients are over the age of 50. Affected
individuals are often symptomatic. The clue to the diagnosis may be an abnormal
blood test; patients typically have a high white blood cell count with a
preponderance of mature lymphocytes. As CLL progresses, lymphadenopathy,
splenomegaly, hepatomegaly, and eventually anemia and infections occur. Early
CLL is typically not treated; late CLL is treated with chemotherapy and other
modalities. Molecular<span >&nbsp; </span>analysis has
distinguished two major types of CLL with different survival times. CLL lacking
somatic hypermutation of the immunoglobulin heavy chain gene is usually
positive for the marker ZAP-70 has an average survival of 5 years. CLL with
somatic hypermutation of the immunoglobulin heavy chain gene is negative for
ZAP-70 and has an average survival of more than 25 years. Many patients,
especially older ones, with slowly progressing disease can be reassured that
they may not need any treatment in their lifetime.</p>

<p><b></b></p>

<p><b>Chronic myelogenous
leukemia</b><b> (<span>CML</span>)</b> is a form of leukemia characterized by the increased and
unregulated growth of predominantly myeloid cells in the bone marrow and the
accumulation of these cells in the blood. CML is a clonal bone marrow stem cell
disorder in which proliferation of mature granulocytes (neutrophils,
eosinophils, and basophils) and their precursors is the main finding. It is a
type of myeloproliferative neoplasm associated with a characteristic
chromosomal translocation called the Philadelphia chromosome. Patients are
often asymptomatic at diagnosis, presenting incidentally with an elevated white
blood cell count on a routine laboratory test. Symptoms of CML may include
left-sided abdominal pain due to an enlarged spleen, malaise, joint or hip
pain, anemia, and thrombocytopenia with easy bruising (although an <i>increased</i>
platelet count may also occur). CML is often suspected on the basis of an
abnormal blood count, which shows increased granulocytes of all types,
typically including mature myeloid cells. Basophils and eosinophils are almost
always increased. A bone marrow biopsy is performed as part of the evaluation.
CML is diagnosed by detecting the Philadelphia chromosome. The <span>Philadelphia chromosome</span> is specific
for CML. It is the result of a reciprocal translocation between chromosome 9
and 22. The genes involved are <i>abl1</i>
(Abelson protoncogene) on chromosome 9, a tyrosine kinase, and <i>bcr</i> (breakpoint cluster region) on
chromosome 22; the resulting fusion gene leads to dysregulation of the abl
tyrosine kinase. CML is now largely treated with tyrosine kinase inhibitors
(TKIs) such as imatinib mesylate (Gleevec), which have led to dramatically
improved survival rates.</p>

<p style="text-align:center;"><span><img border=0 width=240 height=186
src="_%20Tutorials_files/image444.png"
alt="Description: philadelphia_chromosome" v:shapes="Picture_x0020_347350"></span></p>

<p></p>

<p><b><span>Acute
lymphoblastic leukemia</span></b><b><span> (<span>ALL</span>)</span></b><span> is a form of leukemia characterized by
excess lymphoblasts. It is most common in childhood with a peak incidence at
2-5 years of age, and another peak in old age. The overall cure rate in
children is about 80%. “<span>Acute”</span>
refers to the relatively short time course of the disease, being fatal in as
little as a few weeks if untreated. Findings may include fatigue, anemia,
weight loss, loss of appetite, excessive bruising, bone pain, joint pain,
breathlessness, enlarged lymph nodes, hepatomegaly, splenomegaly, and petechiae
(due to thrombocytopenia).<span >&nbsp; </span>Symptoms
are so general that many other diseases must be considered in the differential
diagnosis. Typically, the higher the white blood cell count, the worse the
prognosis. Blast cells are seen on blood smears in majority of cases.
Definitive diagnosis is made by flow cytometry on peripheral blood or bone
marrow. Important prognostic factors include age, WBC count and cytogenetic
analysis. The majority of cases are composed of immature B lineage cells (B
lymphoblastic leukemia or precursor B-cell ALL); a minority are composed of
immature T lineage cells (T lymphoblastic or precursor T-cell ALL). Treatment
is prolonged (2.5 to 3 years) and includes a long maintenance phase. Central
nervous system relapse is common if prophylactic treatment is not used.</span></p>

<p><b></b></p>

<p><b>Acute myeloid leukemia</b>
is a cancer of the myeloid line of blood cells, characterized by the rapid
growth of immature myeloid cells that accumulate in the bone marrow and
interfere with the production of normal mature blood cells. AML is the most
common acute leukemia affecting adults. Symptoms are caused by replacement of
normal bone marrow with leukemic cells, which causes a drop in red blood cells,
platelets, and normal white blood cells. These symptoms include fatigue,
shortness of breath, easy bruising and bleeding, bone pain, joint pain, and
increased risk of infection. As an acute leukemia, AML progresses rapidly and
is typically fatal within weeks or months if untreated. Enlargement of the
spleen may occur but is usually mild and asymptomatic. Lymph node swelling is
rare, in contrast to acute lymphoblastic leukemia. The first clue to a
diagnosis of AML is typically an abnormal blood count.<span>&nbsp; </span>While an excess of abnormal white blood
cells (leukocytosis) is a common finding, and leukemic blasts are sometimes
seen, AML can also present with <i>low</i> white blood cell count. Definitive
diagnosis usually requires an adequate bone marrow aspiration and biopsy. Auer
rods, which are specific for AML, may be seen. Auer rods are clumps of
azurophilic granular material that form elongated needles seen in the cytoplasm
of leukemic blasts. Important prognostic factors include age, results of
cytogenetic analysis, and more recently the presence of specific genetic
mutations.</p>

<p style="text-align:center;"><span><img border=0 width=293 height=204
src="_%20Tutorials_files/image446.png" alt="Description: stains1" v:shapes="Picture_x0020_347349"></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/f/f1/Myeloblast_with_Auer_rod_smear_2010-01-27.JPG"><span><img border=0 width=353 height=265
src="_%20Tutorials_files/image448.png"
alt="Description: Description: File:Myeloblast with Auer rod smear 2010-01-27.JPG"
v:shapes="Picture_x0020_347348"></span></a></p>

<p style="text-align:center;">Auer
rods in a patient with AML</p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p>Answers</p>

<p><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>An
elevated white blood cell count, comprised mainly of mature lymphocytes, is
consistent with CLL.</p>

<p><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>The
Philadelphia chromosome is specific for CML. </p>

<p><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>The
presence of lymphadenopathy and blasts in the blood is consistent with ALL. </p>

<p><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Auer
rods are specific for AML. </p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
52-year-old woman has adenocarcinoma of the left breast. Resection of the tumor
is scheduled, and the physician plans to obtain samples of the draining nodes.
To find these nodes, a radiotracer is injected adjacent to the tumor and images
are obtained. The first draining sentinel node in this patient is most likely
found at which of the following locations?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Contralateral
neck</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Ipsilateral axilla</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ipsilateral
mediastinum</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Ipsilateral
supraclavicle</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Medial
contralateral breast</span></p>

<p><span></span></p>

<p><span>A
12-year-old boy is brought to the physician by his father because of redness
and swelling of his left foot for 24 hours. Three days ago the boy scraped his
foot while wading in a drainage ditch. Examination of the left foot shows a
purulent abrasion with edema, erythema, and tenderness on the lateral side.
&nbsp;Infection is most likely to next spread from the lateral side of the foot
to the regional lymph nodes in which of the following areas? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Lateral surface of the thigh</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Medial malleolus, posteriorly</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Popliteal fossa</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Sole of the foot</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Superficial inguinal area</span></p>

<span><br clear=all>
</span>

<p><b><span>Head and Neck</span></b></p>

<p><b><span></span></b></p>

<p><span>The
lymphatic drainage system of the head and neck is shown below. Nodes in the
neck are located either in the anterior triangle (anterior to the
sternocleidomastoid) or posterior triangle (posterior to the
sternocleidomastoid). Please note that lung cancer, gastrointestinal cancer,
and genitourinary cancers can present with supraclavicular lymphadenopathy. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=453 height=311
src="_%20Tutorials_files/image450.png" alt="Description: afp20021201p2103-f1"
v:shapes="Picture_x0020_347347"></span><span></span></p>

<p><span></span></p>

<p><b><span>Breast</span></b><span> <b>and
upper extremity</b></span></p>

<p><span></span></p>

<p><span>Lymph
drainage of the breast and upper extremity is shown below. Approximately 75% of
the lymph from the breast travels to ipsilateral axillary lymph<i> </i>nodes; 25% travels to the internal
thoracic nodes, to the contralateral breast, and to the abdominal lymph nodes.
The <i>axillary lymph nodes</i> include the
anterior (pectoral), posterior (subscapular), medial (apical), lateral
(brachial), and central lymph-node groups. The lymphatic drainage of the
breasts is especially relevant to oncology, because breast cancer cells can be
dispersed through the lymphatic system. Usually, the first place to which
breast cancer spreads is the ipsilateral axillary nodes. </span></p>

<p><span></span></p>

<p><span><img border=0 width=358 height=271
src="_%20Tutorials_files/image452.png" alt="Description: image002" v:shapes="Picture_x0020_347346"></span><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><span>The
lymph glands of the upper extremity are divided into two sets, <span>superficial</span> and <span>deep. Superficial lymph glands</span> include
the <span>supratrochlear glands</span> and
the <span>deltopectoral glands. The</span> <i><span>supratrochlear
glands</span></i> are above the medial epicondyle of the humerus. Their
afferents drain the middle, ring, and little fingers, the medial portion of the
hand, and the superficial area over the ulnar side of the forearm. The <i><span>deltopectoral
glands </span></i><span>collect lymph from
the lateral side of the hand, forearm, and arm. Ultimately, these superficial
lymph channels drain into deeper channels. All upper extremity lymph flows
toward the <i>axillary nodes</i>. </span></span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Chest<a name="thoracic_duct"></a></span></b></p>

<p><b><span></span></b></p>

<p><span>The <i>thoracic duct</i> is the <span>largest lymphatic channel</span> in the body.
It extends from the <span>1st lumbar vertebra</span>
to the <span>root of the neck, and drains t</span>he
<span>left arm</span>, <span>left neck</span> and <span>head</span>, <span>left thorax</span>, <span>left upper abdomen</span> (to umbilicus), <span>both sides</span> of the <span>abdomen below the umbilicus,</span> and <span>both lower limbs.</span> The thoracic duct is
located anterior to the vertebral bodies, posterior to the esophagus, and to
the right of the descending aorta.<span >&nbsp;
</span>It terminates at the junction of the left internal jugular and left
subclavian veins.<span >&nbsp; </span>On the right, a
similar lymph channel, the <i>right
lymphatic duct</i>, receives lymph from the right upper chest, the right side
of the head, and the right upper limb.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=320 height=317
src="_%20Tutorials_files/image454.png" alt="Description: 91776-1" v:shapes="Picture_x0020_347345"></span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Abdomen and Pelvis</span></b></p>

<p><b><span></span></b></p>

<p><span>Lymph from
organs below the diaphragm flows toward the paraaortic nodes. Lymph carrying
nutrients from the mid-gut and hind-gut (organs supplied by the superior
mesenteric and inferior mesenteric arteries) flows toward the liver.
Consequently, cancer of the pancreas, intestine, and colon can easily
metastasize to the liver. (The liver then sends lymph to the paraaortic,
mediastinal, axillary, and umbilical nodes). Lymph from the gonads travels
through lymphatic vessels near the vertebral bodies. Consequently, gonadal
cancer can easily metastasize to bone.</span></p>

<p><span></span></p>

<p><b><span>Lower extremity </span></b></p>

<p><b><span></span></b></p>

<p><span>The lymph
glands of the lower extremity consist of the <span>anterior tibial gland,</span> the <span>popliteal</span>
glands, and the <span>inguinal glands. </span>The
<i><span>anterior
tibial gland</span></i> is small and inconstant. The <i><span>popliteal lymph glands</span></i>,
small in size, are imbedded in the fat contained in the popliteal fossa. They receive
lymph drainage from the lateral aspect of the foot. The <i><span>inguinal glands </span></i>are
situated at the upper part of the femoral triangle and receive lymph from the
lower extremity and scrotum. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Question 1. Answer B is correct.</span></b><span> Most lymph from the
breast travels to the ipsilateral axillary lymph nodes.</span></p>

<p><span></span></p>

<p><b><span>Question 2. Answer C is correct. </span></b><span>Lymph from the lateral
aspect of the foot travels first to the popliteal nodes in the popliteal fossa.</span></p>

<p><span><span>&nbsp;</span><span></span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
72-year-old man presents to the clinic with low back pain of two months
duration. His blood tests show:</span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>10.5 g/dL</span></p>

<p><span>Hematocrit<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>30%</span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>40
mg/dL</span></p>

<p><span>Creatinine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.0
mg/dL</span></p>

<p><span>Calcium <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>11
mg/dL</span></p>

<p><span>Albumin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3.0
g/dL</span></p>

<p><span>Total
protein<span>&nbsp;&nbsp; </span>8.4 g/dL</span></p>

<p><span>Urine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4+
protein</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Bone
marrow examination is most likely to show uncontrolled proliferation of which
of the following cells?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span><img border=0 width=122 height=125
src="_%20Tutorials_files/image456.png"
alt="Description: http://www.oncolink.org/coping/images/neutrophil.jpg" v:shapes="Picture_x0020_347344"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=121 height=121
src="_%20Tutorials_files/image458.png"
alt="Description: http://sashiimii.files.wordpress.com/2010/08/lymphocyte-01a.jpeg"
v:shapes="Picture_x0020_347343"></span><span></span></p>

<p><span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=122 height=122
src="_%20Tutorials_files/image460.png"
alt="Description: http://www.profelis.org/neu/ap2/jpegs/basophil-01a.jpeg"
v:shapes="Picture_x0020_347342"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span><img border=0 width=121 height=115
src="_%20Tutorials_files/image462.png"
alt="Description: http://www.phartoonz.com/wp-content/uploads/2010/11/eosinophil4.jpg"
v:shapes="Picture_x0020_347341"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=123 height=169
src="_%20Tutorials_files/image464.png"
alt="Description: http://pathology.mc.duke.edu/website/images/grad/Histo_course/plasmacell.jpg"
v:shapes="Picture_x0020_347340"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Multiple myeloma</b> is a cancer of plasma cells. The malignant cells
accumulate in bones, where they cause bone lesions, and in bone marrow where
they interfere with the production of normal blood cells. Most patients produce
an abnormal antibody called a “paraprotein,” which causes renal disease and
interferes with normal antibody production. </p>

<p></p>

<p>A tetrad of findings is
common in myeloma: hypercalcemia, renal failure, normocytic anemia, and bone
disease. The mnemonic, CRAB, is often used for this tetrad: C = calcium
(hypercalcemia), R = renal failure, A = anemia, B = bone lesions. Because
paraproteins enter the blood and spill into urine, most patients have high
serum protein levels (despite having low serum albumin levels) and proteinuria.
</p>

<p></p>

<p><span>Hypercalcemia and Bone lesions</span></p>

<p><b></b></p>

<p><span>Multiple
myeloma is unique in its propensity to cause osteolysis. Most patients suffer
progressive bone destruction, especially of the spine and ribs. Osteolysis is
caused by osteoclast activation, and commonly results in hypercalcemia, severe
and unremitting bone pain, pathologic fractures, and spinal cord compression.
The hypercalcemia may be mild to life-threatening. Osteolysis produces </span>&quot;punched-out&quot;
bone lesions (see radiograph of “pepper pot&quot; skull below). <span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span>Renal failure</span></p>

<p><b><span></span></b></p>

<p><span>Renal
failure, which may be acute or chronic, is commonly caused by hypercalcemia.
Some patients with myeloma produce abnormal light chains, called Bence-Jones
proteins, which damage renal tubules. </span></p>

<p><span></span></p>

<p><span>Anemia</span></span></p>

<p><b><span></span></b></p>

<p>The anemia of multiple
myeloma is usually normocytic and normochromic. It results from marrow
replacement by malignant cells and by cytokine-mediated inhibition of
hematopoiesis.</p>

<p></p>

<p><span>Infection</span></p>

<p><b></b></p>

<p>Patients with myeloma are
predisposed to infection because of immunodeficiency. (Normal antibody
production is suppressed). The most common infections are pneumonia and
pyelonephritis.<span >&nbsp; </span></p>

<p></p>

<p></p>

<p>The presence of unexplained
hypercalcemia, bone pain, renal failure, and anemia should prompt further
testing for multiple myeloma, especially in the presence of high serum protein
levels and low serum albumin levels. Serum and urine protein electrophoresis
should be undertaken to look for a “monoclonal spike,” evidence of a
paraprotein (see figures below). </p>

<p></p>

<p>Myelomas can produce all
classes of immunoglobulin, IgG being the most common. Some myelomas produce
light and/or heavy chains (&#954;- or &#955;-light chains or any of the five
types of heavy chains: &#945;, &#947;, &#948;, &#949; or &#956;).</p>

<p>Multiple myeloma is the
second most common hematological malignancy, constituting 1% of all cancers. </p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=162 height=108
src="_%20Tutorials_files/image466.png"
alt="Description: wcd spep normal c graph" v:shapes="Picture_x0020_347339"></span></p>

<p style="text-align:center;">Normal
serum protein electrophoresis</p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span><img border=0 width=162 height=108
src="_%20Tutorials_files/image468.png"
alt="Description: wcd spep monoclonal iga" v:shapes="Picture_x0020_347338"></span></p>

<p style="text-align:center;">Serum
electrophoresis with “monoclonal spike”</p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span><img border=0 width=213 height=205
src="_%20Tutorials_files/image470.png" alt="Description: myeloma_skull+xray"
v:shapes="Picture_x0020_347337"></span></p>

<p style="text-align:center;">“Punched
out” skull lesions in multiple myeloma</p>

<p style="text-align:center;"></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct</b>.
Multiple myeloma is a cancer of plasma cells (white blood cells that produce
antibodies). Image E depicts a plasma cell. (Other images: A = neutrophil, B =
lymphocyte, C = basophil, D = eosinophil.)<span >&nbsp;
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
quaternary structure of hemoglobin adapts to the chemical environment of the
blood. In its relaxed (R) form, hemoglobin has a high affinity for oxygen; in
its taut (T) form, hemoglobin has a lower affinity for oxygen. At a given
partial pressure of oxygen, which of the following will increase the amount of
taut hemoglobin?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Excess
carbon monoxide </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreasing
pH</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increasing
the number of oxygen molecules bound to hemoglobin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Decreasing
2,3-DPG (diphosphoglycerate) in RBCs </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased
binding of carbon dioxide to hemoglobin </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=360 height=350
src="_%20Tutorials_files/image472.png"
alt="Description: Oxygen dissociation curve" v:shapes="Picture_x0020_347336"></span><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><span>The <b>oxygen-hemoglobin dissociation curve</b>
shows the saturation of hemoglobin as a function of pO<sub>2</sub>. The
sigmoidal shape of the curve indicates that as pO<sub>2</sub> increases,
binding of O<sub>2</sub> to hemoglobin increases until a plateau is reached.
This effect is due to the structure of hemoglobin. </span></p>

<p><span></span></p>

<p><span>Hemoglobin
is a tetramer. Each of the four monomers consists of a heme group that binds O<sub>2</sub>
and a globin chain. In the absence of O<sub>2</sub> the four chains interact in
such a way that the affinity for O<sub>2</sub> is very low; this state of
hemoglobin is termed the taut or tensed (T) state. Once some O<sub>2</sub>
molecules have bound to hemoglobin, the four monomers reduce their affinity for
each other which facilitates the binding of more O<sub>2</sub>; this state of
hemoglobin is termed the relaxed (R) state. </span></p>

<p><span></span></p>

<p><span>The four
binding sites in a hemoglobin molecule are said to express cooperativity,
because at low pO<sub>2</sub> levels there is not much binding of O<sub>2</sub>
to hemoglobin, but as pO<sub>2</sub> increases the binding of O<sub>2</sub> to
hemoglobin increases. The pO<sub>2</sub> in arterial blood is normally about
100 mm Hg, which means hemoglobin saturation is about 97.5%. The pO<sub>2</sub>
in venous blood is normally about 40 mm Hg, which means that hemoglobin
saturation is about 75%.</span></p>

<p><span></span></p>

<p><span>Several
factors can alter the O<sub>2</sub> binding affinity of hemoglobin. As
temperature, the concentration of 2,3-diphosphoglycerate (2,3-DPG), [H<sup>+</sup>],
and/or CO<sub>2</sub> increase, the O<sub>2</sub> binding affinity of
hemoglobin decreases, resulting in a rightward shift of the oxygen-hemoglobin
dissociation curve. The result is that more O<sub>2</sub> is unloaded from
hemoglobin. Decreases in these same factors, or the presence of carbon monoxide
(CO), increase the O<sub>2</sub> binding affinity of hemoglobin. The result is
that unloading of O<sub>2</sub> is reduced.</span></p>

<p><span></span></p>

<p><span>Are the
factors that can change affinity of O<sub>2</sub> to hemoglobin physiologically
significant? Yes. A metabolically active tissue requires more O<sub>2</sub>.
Metabolism produces heat which increases temperature and produces a reduction
in pH (increased [H<sup>+</sup>]) and increase in CO<sub>2</sub>. Each of these
factors shifts the oxygen-hemoglobin dissociation curve to the right, reducing
the O<sub>2</sub> affinity of hemoglobin, which facilitates the unloading of
more O<sub>2</sub> to the metabolizing tissue. In contrast, in the lungs CO<sub>2</sub>
is excreted which reduces CO<sub>2</sub> and [H<sup>+</sup>], and the
temperature is lower because of less metabolism. Each of these factors shifts
the curve to the left which enhances O<sub>2</sub> affinity of hemoglobin,
facilitating O<sub>2</sub> uptake.</span></p>

<p><span></span></p>

<p><span>2,3-DPG is
a product of metabolism in red blood cells (RBCs) that binds to hemoglobin,
inhibiting the binding of O<sub>2</sub>. Low pO<sub>2</sub> (hypoxia) enhances
the metabolism in RBCs which increases the blood level of 2,3-DPG. This does
inhibit the loading of O<sub>2</sub> onto hemoglobin, but this effect is
modest. More importantly, at the tissue level the rightward shift of the curve
increases unloading of O<sub>2</sub> to tissues in the hypoxic state.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>. Factors that increase
the amount of taut hemoglobin are those that shift the oxygen dissociation
curve to the right. Shifting the curve to the right facilitates oxygen
unloading; shifting the curve to the left facilitates oxygen uptake. Factors
that shift the curve to the right include binding of carbon dioxide to
hemoglobin, increased temperature, increased 2,3-DPG, and increased acidity
(lower pH). Factors that shift the curve to the left include binding of oxygen
to hemoglobin, decreased temperature, decreased 2,3-DPG, decreased acidity
(higher pH), and carbon monoxide binding to hemoglobin.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
58-year-old man with a 40 pack-year smoking history presents with exertional
leg pain of six months duration. He experiences cramping in both calves with
walking. The pain is relieved by rest. Six months ago, he could walk 5 blocks before
the onset of pain. Now he can only walk 3 blocks. Which of the following
vascular structures is most likely diseased in this man?</span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Arteries</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Arterioles</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Capillaries</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Venules</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Veins</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Peripheral
artery disease (PAD)</span></b><span> is a narrowing of the peripheral arteries, most
commonly in the pelvis and lower extremities.</span><span> PAD is similar to coronary artery
disease (CAD) and carotid artery disease in that all three conditions are
caused by atherosclerotic narrowing of arteries in critical regions of the
body. Atherosclerosis of the coronary arteries restricts blood flow to the
heart; atherosclerosis of the carotid arteries restricts blood flow to the
brain; and atherosclerosis of the arteries in the pelvis and lower extremities
restricts blood flow to the thighs, legs, and feet. </span></p>

<p><span></span></p>

<p><span>The classic symptom of PAD is pain, cramping, or tiredness in the leg or
hip muscles that occurs with walking and subsides with rest (claudication);
however, p</span><span>atients
with mild PAD are usually asymptomatic. Patients with moderate-to-severe PAD
may have any of these findings: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Claudication &#8211;
exertional pain, cramping, or tiredness in affected muscles</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Weak or absent arterial
pulses in the lower extremities </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Sores, wounds, or ulcers
that heal slowly or not at all </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pallor, cyanosis, or
coolness of the affected extremity </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Shiny skin or diminished
hair and nail growth</span></p>

<p></p>

<p>The first diagnostic test
usually performed in patients with suspected PAD is the ankle brachial index
(ABI). The ABI is calculated by dividing the systolic blood pressure at the
ankle by the systolic blood pressures in the arm. When the systolic blood
pressure in the ankle is lower than the pressure in the arm, PAD is suspected.
A normal ABI is 1.0-1.2. An ABI less than 0.9 is consistent with PAD; values
below 0.5 indicate severe PAD. If the ABI is abnormal, the next step is usually
a Doppler ultrasound examination to determine the location and extent of
atherosclerosis.</p>

<p></p>

<p>People with PAD have a
4-to-5-fold greater risk of having a myocardial infarction or stroke. If
severe, PAD can lead to gangrene and amputation of the leg or foot. Major risk
factors for PAD include smoking, diabetes, hypertension, and dyslipidemia. Complications
of PAD include thromboembolism. Rupture of an atherosclerotic plaque can
trigger clot formation, and the newly formed thrombus can further narrow the
artery, block the artery, or embolize distally. </p>

<p></p>

<p>Management of PAD includes
the following: </p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Risk factor management</span></p>

<p><span><span>o<span>&nbsp;&nbsp;
</span></span></span><span>Smoking
cessation</span></p>

<p><span><span>o<span>&nbsp;&nbsp;
</span></span></span><span>Diabetes
management </span></p>

<p><span><span>o<span>&nbsp;&nbsp;
</span></span></span><span>Hypertension
management</span></p>

<p><span><span>o<span>&nbsp;&nbsp;
</span></span></span><span>Lipid
management </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Antiplatelet drugs
(i.e., aspirin, clopidogrel)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Exercise: Regular
exercise improves walking</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Medicine: Cilostazol may
improve symptoms of claudication</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Revascularization:
reserved for severe cases</span></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer A is correct. </b>This patient has classic leg claudication,
which suggests a diagnosis of peripheral artery disease (PAD). Smoking is a
major risk factor for PAD, a condition in which large arteries become narrowed
by atherosclerotic plaque. The ankle-brachial index (ABI) should be measured to
confirm the diagnosis. Smoking cessation (and management of other risk factors)
is essential. A regular exercise program (e.g., treadmill walking) should be
recommended if the diagnosis is confirmed. Daily aspirin should also be
recommended, and revascularization (angioplasty, stent placement, or bypass
grafting) may be needed if the condition becomes severe. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Match each
of the following clinical scenarios with the corresponding peripheral blood
smear.</span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>72-year
old man with multiple myeloma</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>43-year
old woman with thrombotic thrombocytopenia purpura</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>67-year
old man with myelofibrosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>4-year
old boy with hereditary spherocytosis<span >&nbsp;
</span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>42-year
old woman with iron deficiency anemia</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>12-year
old girl with sickle cell anemia</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>68-year
old man with cirrhosis</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>42-year
old man whose spleen has been removed </span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>6-year
old boy with lead poisoning</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>52-year
old woman with vitamin B12 deficiency</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=236 height=161
src="_%20Tutorials_files/image474.png"
alt="Description: http://labmed.hallym.ac.kr/hematol/Hematol-Cell-Lists/basophilicstippling.jpg"
v:shapes="Picture_x0020_347335"></span><span></span></p>

<p><span></span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=235 height=178
src="_%20Tutorials_files/image476.png"
alt="Description: http://www.ezhemeonc.com/wp-content/uploads/2009/02/howell-jolly-bodies-100x-website-arrow.jpg"
v:shapes="Picture_x0020_347334"></span><span><span>&nbsp;&nbsp;</span></span></p>

<p><span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=236 height=178
src="_%20Tutorials_files/image478.png"
alt="Description: http://ahdc.vet.cornell.edu/clinpath/modules/hemogram/images/target.jpg"
v:shapes="Picture_x0020_347333"></span><span></span></p>

<p><span></span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img width=20 height=23
src="_%20Tutorials_files/image479.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347365"></span><span><img border=0 width=235 height=152
src="_%20Tutorials_files/image481.png"
alt="Description: C:\Users\sblevins\Desktop\untitled.bmp" v:shapes="Picture_x0020_347332"></span><span></span></p>

<p><span></span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img width=31 height=18
src="_%20Tutorials_files/image482.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347364"></span><span><img border=0 width=235 height=157
src="_%20Tutorials_files/image484.png"
alt="Description: http://t0.gstatic.com/images?q=tbn:ANd9GcSz5JG6CoaL7QBp0kZVp4MANX84oQ2w_2gxPFsk5NlSZ_ABY__q&amp;t=1"
v:shapes="Picture_x0020_347331"></span><span></span></p>

<p><span></span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=234 height=148
src="_%20Tutorials_files/image486.png"
alt="Description: C:\Users\sblevins\Desktop\loadBinary.jpg" v:shapes="Picture_x0020_347330"></span><span></span></p>

<p><span></span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=234 height=155
src="_%20Tutorials_files/image488.png"
alt="Description: http://medlibes.com/uploads/Screen%20shot%202010-07-05%20at%2012.53.27%20PM.png"
v:shapes="Picture_x0020_347329"></span><span></span></p>

<p><span></span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img width=26 height=12
src="_%20Tutorials_files/image489.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347363"></span><span><img width=27 height=12
src="_%20Tutorials_files/image490.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347362"></span><span><img width=24 height=12
src="_%20Tutorials_files/image491.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347361"></span><span><img border=0 width=234 height=177
src="_%20Tutorials_files/image493.png"
alt="Description: C:\Users\sblevins\Desktop\t.jpg" v:shapes="Picture_x0020_347328"></span><span></span></p>

<p><span></span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span><img border=0 width=234 height=157
src="_%20Tutorials_files/image495.png"
alt="Description: http://4.bp.blogspot.com/__lUCvLqUwYk/S0yIIB9JQWI/AAAAAAAAADU/7Ve-MCSVuKQ/s200/schistocytes400.jpg"
v:shapes="Picture_x0020_347327"></span><span></span></p>

<p><span></span></p>

<p><span><span>10.<span>&nbsp;
</span></span></span><span><img width=29 height=12
src="_%20Tutorials_files/image496.png" v:shapes="Straight_x0020_Arrow_x0020_Connector_x0020_347360"></span><span><img border=0 width=234 height=178
src="_%20Tutorials_files/image498.png"
alt="Description: http://www.med-ed.virginia.edu/courses/path/innes/images/wcdjpeg/wcd%20rouleaux%20pc%20x50.jpeg"
v:shapes="Picture_x0020_347326"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Answers.</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>10.<span>&nbsp; </span>Multiple myeloma is associated with
Rouleaux (red blood cells stacked like coins.)</span></p>

<p><span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>9.
Schistocytes are broken red blood cells that occur in microangiopathic
hemolytic anemia, such as thrombotic thrombocytopenia purpura.</span></p>

<p><span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8.
Teardrop cells occur <span>in marrow disorders (e.g.,
myelofibrosis) associated with extramedullary hematopoiesis. </span></span></p>

<p><span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>7.
Spherocytes occur in patients with hereditary spherocytosis. [<span>Hereditary spherocytosis</span> is an
autosomal dominant condition characterized by production of red blood cells
that are sphere-shaped rather than bi-concave-disk-shaped. The cells are
osmotically fragile and, therefore, prone to hemolysis. Hemolysis results in
anemia, pallor, fatigue, jaundice (from hyperbilirubinemia), and splenomegaly.</span><a
href="http://en.wikipedia.org/wiki/Hereditary_spherocytosis#cite_note-isbn0-7216-0187-1-0#cite_note-isbn0-7216-0187-1-0"></a><span></span></p>

<p><span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>6.
Iron deficiency anemia is characterized by hypochromic, microcytic red blood
cells.</span></p>

<p><span></span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>4.
Sickle cells can be seen in patients with sickle cell anemia.</span></p>

<p><span></span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>3.
Target cells occur in patients with advanced liver disease. They are also
associated with a variety of hemoglobinopathies.</span></p>

<p><span></span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>2.
Howell-Jolly bodies are basophilic nuclear remnants in red blood cells. They
are usually removed by the spleen and can be seen in asplenic patients. </span></p>

<p><span></span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>1.
Basophilic stippling occurs in patients with lead poisoning. </span></p>

<p><span></span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>5.
Hypersegmented neutrophils are associated with vitamin B12 and folic acid
deficiency. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 57-year-old man develops a deep vein
thrombosis in his right lower extremity. He has sustained no injury to his leg
nor taken any long flights. He is a nonsmoker. His only medicines are aspirin
and lisinopril. He works as a medical technician and enjoys good health. His
hemogram shows the following: </span></p>

<p><span></span></p>

<p><span>Hemoglobin <span>&nbsp;&nbsp;&nbsp; </span>20
g/dL</span></p>

<p><span>Hematocrit <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>60%
</span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>18,000/mm<sup>3</sup></span></p>

<p><span>Platelet<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>890,000/mm<sup>3</sup></span></p>

<p><span></span></p>

<p><span>His chest x-ray is negative.<span>&nbsp; </span>Treatment with low-molecular-weight
heparin and warfarin is initiated. What should be ordered next?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Blood
tests for protein C, protein S, antithrombin III, Factor V Leiden, and
prothrombin mutation 20210 </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>CT
of the chest, abdomen, and pelvis to search for occult malignancy</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bone
marrow examination</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Blood
test for a mutation of the Janus kinase 2 (JAK2) gene</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<table border=0 cellspacing=8 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><b><span>Polycythemia Vera</span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC048004></a><span>ETIOLOGY AND PATHOGENESIS</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=T048001></a><span></span></p>
  <p><span></span></p>
  <p><a name=T048001.100></a><a name=T048001.50></a><span></span></p>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="90%">
   <tr>
    <td width="100%"></td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P048004></a><span>PV, literally meaning<span
    red blood cells in
    the blood,</i><span a syndrome
    of increased red blood cell mass in the peripheral blood resulting from a
    clonal multipotent hematopoietic stem cell defect. When patients are first
    diagnosed with an elevated hemoglobin per unit volume<span
       evaluation should focus on
    whether this increase reflects an enhanced red cell mass (i.e.,<span
    erythrocytosis or
    polycythemia</i>) or a normal red cell mass in the presence of a decreased
    plasma volume (i.e.,<span    erythrocytosis</i><span by
    dehydration or other causes). The latter condition is not true
    polycythemia. Polycythemia or absolute erythrocytosis is defined as<span
    absolute increase in red
    cellmass caused by increased red blood cell production.</i><span
    normal conditions, the
    body's ability to increase red blood cell production in states of
    hypoxemia, anemia, hemolysis, and acute blood loss ensures continuous
    oxygen delivery to tissues. In response to physiologic stimuli, pluripotent
    stem cell precursors are activated by erythropoietin (EPO) to differentiate
    into erythroid progenitor cells and eventually hemoglobin-carrying
    erythrocytes. When numbers of mature red blood cells are adequate, a
    negative feedback mechanism suppresses further EPO production, and the
    serum hemoglobin level remains normal.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P048006></a><span>PV is a primary clonal stem cell
    disorder of unknown origin that is characterized by predominant erythrocytosis
    associated with other hematopoietic abnormalities. Although one half of all
    patients have concurrent leukocytosis or thrombocytosis, erythrocytosis is
    the hallmark and the cause of the most serious clinical complications of
    this disease. Diagnosis of PV was formerly one of<span
       on an elevated red cell
    mass, splenomegaly, thrombocytosis, leukocytosis, lack of hypoxemia and
    other secondary causes of polycythemia, and elevated levels of leukocyte
    alkaline phosphatase and serum vitamin B<sub>12</sub>-binding protein
    levels. More recent information on the disease pathophysiology has led to
    new diagnostic criteria based on the discovery of JAK2 mutations in
    virtually all patients with PV. Identification of low serum EPO levels and
    EPO-independent erythroid colony growth are now regarded as the only
    secondary criteria helpful in establishing a primary PV diagnosis.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC048005></a><span>CLINICAL FEATURES AND LABORATORY
    STUDIES</span></p>
    </td>
   </tr>
  </table>
  <p><a name=T048002></a><span></span></p>
  <p><span></span></p>
  <p><a name=T048002.100></a><a name=T048002.50></a><span></span></p>
  <p><span></span></p>
  <p><a name=T048003></a><span></span></p>
  <p><span></span></p>
  <p><a name=T048003.150></a><a name=T048003.100></a><a name=T048003.50></a><span></span></p>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="90%">
   <tr>
    <td width="100%"></td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P048007></a><span>The median age at onset of 65
    years. Early recognition and treatment of PV are important because
    untreated patients with PV suffer significant morbidity and mortality from
    thromboembolic disease in the cerebral, coronary, and mesenteric
    circulations. Twenty percent of patients show symptoms of arterial and
    venous thrombosis, and thrombosis remains the most common cause of death.
    Typically, patients complain of headache, visual problems, mental clouding,
    and pruritus after bathing. Occlusive vascular events such as stroke,
    transient ischemic attacks, myocardial ischemia, and digital pain, paresthesias,
    or gangrene are common. In addition, pulmonary, deep vein, hepatic, and
    portal vein thromboses may occur. Paradoxically, patients are also
    predisposed to hemorrhagic events, which are presumably caused by abnormal
    platelet function, and such patients may exhibit gastrointestinal bleeding.
    Physical examination often shows retinal vein occlusion, ruddy cyanosis,
    and splenomegaly.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P048011></a><span><span>&nbsp; </span></span></p>
    <p><span>Peripheral blood often appears microcytic, with or without
    iron deficiency. Bone marrow examination shows a hypercellular marrow with
    pronounced hyperplasia of erythroid lineage cells. Cytogenetic features at
    the time of diagnosis are usually normal; the development of clonal
    cytogenetic abnormalities heralds transformation in the later stages of
    disease. The incidence of the JAK2 V617F mutation in patients with PV
    ranges up to 97% in various studies.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC048006></a><span>TREATMENT</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P048012></a><span>Without treatment, one half of
    all patients with PV die of thrombotic complications within 18 months of
    diagnosis. With therapy, PV is a chronic, progressive disease. Patients
    with advanced age, prior history of thrombosis, and high hematocrit values
    are at high risk for subsequent vascular events. Therefore, intermittent
    phlebotomy is the mainstay of treatment and usually results in iron
    deficiency anemia, which further reduces the rate of red blood cell
    production. </span></p>
    </td>
   </tr>
  </table>
  </td>
 </tr>
</table>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>.<span>&nbsp; </span>The patient has elevated red blood cell,
white blood cell, and platelet counts, suggestive of polycythemia vera. The
vast majority of patients with polycythemia vera have a mutation in the JAK2
gene.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>.<span>&nbsp; </span>Inherited risk factors for thrombosis
would not explain the abnormal hemogram. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Occult solid
malignancy would not explain the abnormal hemogram.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Bone marrow
examination is unlikely to provide a diagnosis.</span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 60-year-old woman
with alcoholic cirrhosis has ascites and esophageal varices. Which of the
following contributes to the development of ascites?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Increased hepatic lymph flow</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Increased capillary hydrostatic pressure</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Increased plasma oncotic pressure</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Increased plasma albumin concentration</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Decreased plasma ephinephrine and norephinephrine</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><span>PORTAL HYPERTENSION</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P045011></a><span>The normal portal
  venous pressure is low (5 to 10 mm Hg), and the hepatic venous pressure
  gradient (HVPG), which reflects sinusoidal pressure, is less than 5 mm Hg. In
  cirrhosis, the distortion of hepatic architecture by fibrous tissue and
  regenerative nodules, as well as a dynamic component caused by an increase in
  intrahepatic vascular tone, leads to increased resistance to portal venous
  flow, resulting in increased portal venous pressure (&gt;10 mm Hg). The HVPG
  is measured using a transvenous approach by subtracting free hepatic venous
  pressure from the wedged hepatic venous pressure.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P045012></a><span>Although cirrhosis is
  the most important cause of portal hypertension, any process leading to
  increased resistance to portal blood flow into (presinusoidal) or through
  (sinusoidal) the liver or to hepatic venous outflow from the liver
  (postsinusoidal) may result in portal hypertension. In addition, cirrhosis is
  associated with increased cardiac output, which leads to greater splanchnic
  blood flow, further aggravating portal hypertension. It is important to
  recognize that the HVPG is reliably increased only in sinusoidal portal
  hypertension.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P045013></a><span>In an attempt to
  decompress the portal system, venous collaterals form between the portal and
  systemic circulations. Major sites of collateral vessel formation include the
  gastroesophageal junction, retroperitoneum, rectum, and falciform ligament of
  the liver (abdominal and periumbilical collaterals). Clinically, the most
  important collaterals are those connecting the portal vein to the azygos vein
  through dilated, tortuous veins (varices) in the submucosa of the gastric
  fundus and esophagus.</span></p>
  </td>
 </tr>
</table>

<p><a name=T045003></a><span></span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p style="text-align:center;"><b><span>Causes of Portal Hypertension</span></b></p>
  </td>
 </tr>
</table>

<p><a name=T045003.50></a><a name=T045003.100></a><a name=T045003.150></a><a
name=T045003.200></a><a name=T045003.250></a><a name=T045003.300></a><a
name=T045003.350></a><a name=T045003.400></a><a name=T045003.450></a><a
name=T045003.500></a><a name=T045003.550></a><a name=T045003.600></a><a
name=T045003.650></a><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0 width="68%">
 <tr>
  <td width="100%" valign=top>
  <p><b><span>Increased Resistance to Flow</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><b><i><span>Presinusoidal</span></i></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><i><span>Extrahepatic</span></i><span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Portal or splenic vein
  occlusion (thrombosis, sclerosis, tumor)</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><i><span>Intrahepatic</span></i><span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Schistosomiasis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Congenital hepatic
  fibrosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Sarcoidosis</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><b><i><span>Sinusoidal</span></i></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><span>Cirrhosis (many causes)</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><span>Alcoholic hepatitis</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><b><i><span>Postsinusoidal</span></i></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><i><span>Intrahepatic</span></i><span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Veno-occlusive disease</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><i><span>Extrahepatic</span></i><span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Budd-Chiari syndrome</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Cardiac causes:
  constrictive pericarditis</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><b><span>Increased Portal Blood Flow</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><span>Splenomegaly not caused by liver disease</span></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign=top>
  <p><span>Arterioportal fistula</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span>Answer
B is correct</span></b><span>. Ascites in patients with cirrhosis is caused by
portal hypertension, and portal hypertension is associated with increased
hydrostatic pressure in the splanchnic capillaries. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
37-year-old woman with diabetes mellitus undergoes an abdominal
hysterectomy.<span >&nbsp; </span>Twenty-four hours
postoperatively, she develops chest pain and difficulty breathing. The pain is
“sharp like a knife” and worse with inspiration.<span>&nbsp; </span>Her temperature is 38ºC (100.4ºF), pulse
is 110/minute, blood pressure is 90/60 mm Hg, and respirations are 18/minute.
She appears anxious and her breathing is shallow. The heart is regular and the
lungs are clear. Pulse oximetry shows an oxygen saturation of 80%. What is the
most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Pulmonary
embolus</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Septic
shock</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Musculoskeletal
disease</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pneumothorax</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Myocardial
infarction</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=0 cellspacing=8 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><b><span>Pulmonary Thromboembolic Disease</span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P019002></a><span>Pulmonary embolism is a
    relatively common entity. It is usually a complication of venous
    thrombosis. The deep veins of the femoral and popliteal systems of the
    lower extremities are most often affected, but right atrial, right
    ventricular, and upper extremity thromboses can also embolize to the lung.
    In view of this, predisposing factors for pulmonary embolism are the same
    as those for venous thrombosis and include venous stasis,
    hypercoagulability, and endothelial injury. Congenital or acquired
    procoagulant disorders (e.g., activated protein C deficiency) are also considered
    predisposing factors.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P019003></a><span>After a clot dislodges from the
    lower extremity circulation, it travels to the pulmonary circulation, where
    it can obstruct a branch of the pulmonary artery. The affected lung segment
    develops an increased ventilation-perfusion ratio (V/Q). This increases
    overall dead space ventilation, which leads to an inefficient excretion of
    partial pressure of carbon dioxide in arterial blood (Pa<span>co</span><sub>2</sub>). In addition, blood
    flow is shifted from the obstructed site to other areas, which may include
    areas of low V/Q, thereby leading to shunting and hypoxemia. Pulmonary
    infarction of the area distal to the occlusion is rare because of the
    redundancy of the pulmonary circulation and because of oxygenation of lung
    parenchyma by bronchial arteries and by alveolar oxygen.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC019002></a><span>CLINICAL PRESENTATION</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=T019001></a><span></span></p>
  <p><span></span></p>
  <p><a name=T019001.250></a><a name=T019001.200></a><a name=T019001.150></a><a
  name=T019001.100></a><a name=T019001.50></a><span></span></p>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="90%">
   <tr>
    <td width="100%"></td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P019004></a><span>The classic presentation of
    acute pulmonary embolism includes acute shortness of breath accompanied by
    chest pain, hemoptysis, severe hypoxemia, and circulatory collapse as a
    result of shock. However, more often than not, the presentation is subtle,
    and the diagnosis might be difficult to make without a high level of
    suspicion, particularly in young individuals with otherwise healthy lungs.
    Dyspnea on exertion and atypical chest pain might be the only symptoms on
    initial presentation. Therefore, a careful history is paramount when
    evaluating patients for thromboembolic disease, especially those at high
    risk for this disorder as a result of stasis, malignancy, and previous
    history of venous thrombosis as well as other risk factors. The physical
    examination might reveal abnormalities in lung auscultation ranging from
    isolated crackles to diffuse wheezing. Pleural effusions might be
    underlying areas of dullness to percussion during the physical examination.
    Edema of the extremities, especially if the edema is asymmetrical, might
    point to venous thrombosis. In deep vein thrombosis, dorsiflexion of the
    foot may cause calf pain as a result of stretching the calf muscles and
    deep veins (Homan sign). Signs of pulmonary hypertension and right
    ventricular strain, such as increased pulmonary component of the second
    heart sound or right ventricular heave, are not usually appreciated unless
    there is a massive pulmonary embolus or preexisting heart or lung disease.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC019003></a><span>EVALUATION</span><span></span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P019010></a><span>In severe cases, arterial blood
    gas measurement may show acidemia, hypoxemia, and hypercapnia, but subtle
    changes such as mild alkalosis might be the only abnormalities. A normal Pa<span>co</span><sub>2</sub><span
    a patient with tachypnea and
    presumably hyperventilation suggests increased dead space and, in the
    appropriate setting, might point to the diagnosis. However, a normal
    alveolar-arterial oxygen-tension gradient (A-aD<span>o</span><sub>2</sub>) does not exclude acute pulmonary
    embolism. An elevated level of lactic dehydrogenase (LDH) might be the
    result of tissue infarction, but this test is also insensitive and
    nonspecific. Some have advocated the use of plasma D-dimer levels in
    patients who might have pulmonary thromboembolism, but these are not
    specific either because they are elevated in patients with several
    unrelated medical conditions such as congestive heart failure, chronic
    illness, and connective tissue disorders. The main usefulness of plasma
    D-dimer levels is its negative predictive value.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=F019001></a><span></span></p>
  <p><a name=P019011></a><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P019012></a><span>The electrocardiogram may show atrial
    tachyarrhythmias or evidence of right heart strain as evidenced by a new
    right bundle branch block, right ventricular strain pattern, and the S<sub>I</sub>Q<sub>II</sub>T<sub>III</sub><span
    that mimics inferior
    myocardial infarction. The chest radiograph is often normal but may show
    atelectasis, isolated infiltrates, or a small pleural effusion. </span></p>
    <p><span></span></p>
    <p><span>Three diagnostic methods are used for the diagnosis of
    pulmonary embolism: the V/Q scan, chest computed tomography (CT), and
    pulmonary arteriography. The V/Q scan compares lung ventilation by
    radiolabeled tracer gas with lung perfusion by radiolabeled micro-occlusive
    particles. The usefulness of the V/Q scan depends greatly on the pre-test
    probability of the disease, which, in turn, is dependent on the expertise
    of the clinician and his or her level of certainty. A<span
       scan is characterized by lobar
    or multilobar perfusion defects that coincide with areas of normal or
    relatively normal ventilation and is more than 90% accurate in diagnosing
    pulmonary embolism. A<span    scan shows no perfusion or
    ventilation defects and can exclude pulmonary embolism in essentially all
    cases. However, the test is less reliable when interpreted as<span
    intermediate,</i><span
          </span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><a name=T019002></a><span></span></p>
  <p><span></span></p>
  <p><a name=T019002.400></a><a name=T019002.350></a><a name=T019002.300></a><a
  name=T019002.250></a><a name=T019002.200></a><a name=T019002.150></a><a
  name=T019002.100></a><a name=T019002.50></a><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P019013></a><span>Spiral CT angiography provides a
    noninvasive and sensitive way to evaluate for pulmonary emboli. Pulmonary
    arteriography is the gold standard and should be considered in patients
    without contraindications to the procedure when other tests are
    inconclusive and a high likelihood of pulmonary embolism exists. </span></p>
    </td>
   </tr>
  </table>
  <p></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=HC019004></a><span>MANAGEMENT</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P019014></a><span>Pulmonary embolism is treated
    with supportive measures directed at sustaining organ function (e.g., fluid
    replacement for hypotension, mechanical ventilation for respiratory
    failure). To date, the only mechanical way to dislodge reliably a pulmonary
    artery clot is with surgical thromboembolectomy, a procedure with high
    mortality that requires a high level of expertise. Thromboembolectomy is
    only used for proximal clots that are long-standing (<i>chronic
    thromboembolism syndrome</i>). Consequently, medical treatments are
    preferred, and these are directed to prevent further clotting or to
    dissolve an existing clot. Anticoagulation with regular or
    low-molecular-weight heparin is recommended in patients without major
    contraindications to anticoagulation (e.g., upper gastrointestinal
    bleeding, hemorrhagic stroke). The use of thrombolytic medications (e.g.,
    tissue plasminogen activator) is usually reserved for patients with
    increased risk for mortality as a result of circulatory collapse caused by
    obstruction to the flow in large or multiple pulmonary vessels.</span></p>
    </td>
   </tr>
  </table>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. Sudden onset chest
pain and shortness of breath with hypoxemia in a young person who recently
underwent surgery suggests a diagnosis of pulmonary embolism. <b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect</span></b><span>. In sepsis,
hyperventilation (as compensation for metabolic acidosis) may cause the patient
to feel short of breath.<span >&nbsp; </span>Confusion
and disorientation may be present, along with tachycardia and paradoxical
hypothermia. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Musculoskeletal
disease causes chest discomfort that may worsen with movement.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Spontaneous
pneumothorax may present with chest pain, shortness of breath, and absent
breath sounds on the affected side.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Chest pain associated
with myocardial ischemia is often “heavy” or “squeezing.”<span>&nbsp; </span>Dyspnea is common. The pain may radiate
to the neck, jaw, back, or upper extremity.<span>&nbsp; </span>In patients with diabetes mellitus,
chest discomfort may be diminished or absent due to neuropathy.<span>&nbsp; </span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
4-year-old boy is brought to the emergency room with severe left-sided
abdominal pain. Physical examination shows pallor, tachycardia, and
hypotension. The spleen tip is palpated 6 cm below the left costal margin. Lab
studies show:</span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Hemoglobin
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5.0
g/dL </span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Hematocrit<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15%</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>White
blood cell (WBC) count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4,000/mm<sup>3</sup></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Platelet
count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>70,000/mm<sup>3</sup></span></p>

<p><span></span></p>

<p><span>A
photomicrograph of a Wright-stained peripheral blood smear is shown below:</span></p>

<p><span></span></p>

<p style="text-align:center;"><!--[if mso & !supportInlineShapes & supportFields]><span></span><span>&nbsp;</span>SHAPE <span>&nbsp;</span>\* MERGEFORMAT <span></span><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><v:shape
 id="_x0000_i1085" type="#_x0000_t75">
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span></span><![endif]--><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span>Which
of the following most likely explains the patient’s condition?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Cirrhosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aplastic
crisis <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Autoimmune
hemolysis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Splenic
sequestration</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
peripheral blood smear in this patient shows sickle cells, target cells, and
reticulocytes. The presence of “sickling” suggests a diagnosis of sickle-cell
disease. </span></p>

<p><span></span></p>

<p><span>The
term sickle-cell disease refers to a group of related hemoglobinopathies. In
humans, the hemoglobin molecule is an assembly of four globular protein
subunits: 2 &#940; chains and 2 &#946; chains. Each chain is tightly associated
with a non-protein heme group. The heme group consists of an iron ion held in a
ring, known as a porphyrin.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=227 height=194
src="_%20Tutorials_files/image501.png" alt="Description: hemoglobin" v:shapes="Picture_x0020_347325"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Sickle
cell disease results from a genetic mutation in the &#946;-globin gene, which
codes for the &#946;-protein subunit. Specifically, there is an
adenine-to-thymidine substitution in codon 6 of the &#946;-globin gene, which
results in replacement of glutamic acid by valine. This change results in an
abnormal type of hemoglobin, hemoglobin S (HbS), which polymerizes when
deoxygenated. This causes red blood cell sickling. The term <i>sickle cell</i> <i>anemia</i> refers to patients who are homozygous for the sickle-cell
mutation (HbSS). Sickle cell anemia is, therefore, one of many types of
sickle-cell disease, all of which are characterized by varying degrees of red
blood cell sickling, hemolytic anemia, vasculopathy, vaso-occlusion, acute and
chronic organ damage, and reduced lifespan. Sickle-cell anemia is the most
severe type of sickle cell disease.</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4160-2805-5..50172-5--spar></a><span></span></p>

<p><span>The
main features of sickle cell disease appear below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=185 valign=top>
  <p style="text-align:center;"><span >Features of
  Sickle-Cell Disease</span></span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p style="text-align:center;"><span ></span></span></p>
  </td>
 </tr>
 <tr>
  <td width=185 valign=top>
  <p><span>Sickle-Cell
  “Crises”</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Painful
  episodes</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Acute
  chest syndrome</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Aplastic
  crisis</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Splenic
  sequestration</span></span></p>
  <p><span>Complications</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Sepsis</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Stroke</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Retinopathy</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Cardiac
  disease</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Pulmonary
  hypertension</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Gallstones</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Splenic
  infarction</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Renal
  disease</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Bone
  disease (osteomyelitis, osteonecrosis, osteopenia)</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Leg
  ulcers</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Priapism</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><span>Placental
  insufficiency</span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Nutritional
  deficiencies</span></span><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>In
patients with sickle cell anemia, the hemoglobin concentration usually ranges
between 6 and 10 g/dL. The anemia may be microcytic, normocytic, or macrocytic.
Microcytic anemia usually indicates concomitant iron deficiency or thalassemia.
Macrocytic anemia occurs when the reticulocyte count is high. (Reticulocytes
are larger than mature red blood cells.) The presence of nucleated red cells
(erythroblastosis) indicates a regenerative response by the marrow to anemia
&#8211; a response that leads to reticulocytosis. </span></p>

<p><span></span></p>

<p><span>Target
cells are often seen in sickle-cell disease.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=246 valign=top>
  <p style="text-align:center;"><span>Conditions Associated with Target Cells</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Sickle-cell
  disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Hemoglobin
  C disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Liver
  disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Thalassemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Iron
  deficiency anemia (severe)</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Asplenia
  (anatomic or functional)</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The
patient in the clinical vignette has a large painful spleen with signs of
circulatory compromise. This suggests a complication of sickle-cell disease
called “splenic sequestration,” in which rapid pooling of blood in the spleen
is accompanied by splenic enlargement, pancytopenia (due to hypersplenism), and
hypovolemia. If untreated, the patient may die of circulatory collapse. </span></p>

<p><span></span></p>

<p><span>It is
useful to remember that splenomegaly, defined as a spleen size greater than 12
cm, has many potential causes.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=333 colspan=2 valign=top>
  <p style="text-align:center;"><span>Causes of
  Splenomegaly</span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p><span></span></p>
  </td>
  <td width=243 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p style="text-align:center;"><span>Type</span></p>
  </td>
  <td width=243 valign=top>
  <p style="text-align:center;"><span>Examples</span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p><span></span></p>
  </td>
  <td width=243 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p><span>Congestive</span></p>
  </td>
  <td width=243 valign=top>
  <p><span>Cirrhosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p><span>Infectious </span></p>
  </td>
  <td width=243 valign=top>
  <p><span>Acute </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Infectious
  mononucleosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Subacute
  bacterial endocarditis</span></p>
  <p><span></span></p>
  <p><span>Chronic </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Malaria
  </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Miliary
  tuberculosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p><span>Inflammatory</span></p>
  </td>
  <td width=243 valign=top>
  <p><span>Connective tissue
  disorders</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Systemic lupus erythematosus</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Rheumatoid arthritis</span></p>
  <p><span></span></p>
  <p><span>Other</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Sarcoidosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Secondary amyloidosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p><span>Neoplastic</span></p>
  </td>
  <td width=243 valign=top>
  <p><span>Myeloproliferative</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Polycythemia vera</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Chronic myelogenous leukemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Primary thrombocythemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Myelofibrosis with myeloid metaplasia</span></p>
  <p><span></span></p>
  <p><span>Lymphoproliferative</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Lymphoma</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Chronic lymphocytic leukemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p><span>Hemolytic</span></p>
  </td>
  <td width=243 valign=top>
  <p><span>RBC shape disorders</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Hereditary spherocytosis</span></p>
  <p><span></span></p>
  <p><span>RBC enzyme disorders</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Pyruvate kinase deficiency</span></p>
  <p><span></span></p>
  <p><span>Hemoglobinopathies</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Hemoglobinopathies</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Sickle-cell variants</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Sickle-cell anemia with splenic sequestration crisis</span></p>
  </td>
 </tr>
 <tr>
  <td width=90 valign=top>
  <p><span>Storage diseases</span></p>
  </td>
  <td width=243 valign=top>
  <p><span>Gaucher, Niemann-Pick</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span>Most
causes of splenomegaly are not associated with rapid and painful enlargement of
the spleen. Splenic sequestration from sickle cell disease, however, <i>does</i> have this effect. </span></p>

<p><span></span></p>

<p><span>Pancytopenia,
defined as a reduction in red blood cell, white blood cell, and platelet
counts, has many potential causes. </span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=338 colspan=2 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>Causes of
  Pancytopenia</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p style="text-align:center;"><span>Type</span></p>
  </td>
  <td width=234 valign=top>
  <p style="text-align:center;"><span>Examples</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=234 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Congenital </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Fanconi’s anemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Metabolic </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Gaucher, Niemann-Pick</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Nutritional </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Folate and B12
  deficiency (severe)</span></p>
  <p><span>Anorexia nervosa</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Hematologic </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Aplastic anemia </span></p>
  <p><span>Myelodysplastic
  syndrome</span></p>
  <p><span>Myelofibrosis </span></p>
  <p><span>Paroxysmal nocturnal
  hemoglobinuria</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Infectious </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Viral (HIV,
  parvovirus)</span></p>
  <p><span>Bacterial</span></p>
  <p><span>Mycobacterial</span></p>
  <p><span>Fungal</span></p>
  <p><span>Protozoal</span></p>
  <p><span>Sepsis</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Inflammatory </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Systemic lupus
  erythematosus</span></p>
  <p><span>Sarcoidosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Toxic </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Drugs
  (anti-neoplastic, anti-epileptic)</span></p>
  <p><span>Toxins (benzene,
  arsenic)</span></p>
  <p><span>Irradiation</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Neoplastic </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Lymphoma</span></p>
  <p><span>Leukemia </span></p>
  <p><span>Multiple myeloma</span></p>
  <p><span>Polycythemia vera</span></p>
  <p><span>Myelophthisis</span></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top>
  <p><span>Hypersplenism </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Cirrhosis </span></p>
  <p><span>Sickle-cell disease with
  splenic sequestration</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>In this
clinical vignette, the presence of sickling and an enlarged spleen suggests
splenic sequestration as the cause of pancytopenia. </span></p>

<p><span></span></p>

<p><span>Sickle
cell anemia is clinically heterogeneous. Some patients have almost all known complications;
others have almost none but die suddenly; still others skip one or more phases
of disease but suffer intensely from others. Although sickle-cell disease is a
prototypic Mendelian, single-gene disorder, it behaves clinically as a
multigenic trait with phenotypic variability.</span></p>

<p>Hemolysis is mainly
extravascular due to erythrophagocytosis by reticuloendothelial cells, which
recognize the damaged sickle cells. In some patients, intravascular hemolysis
occurs, liberating excessive amounts of hemoglobin into the circulation.
Certain complications, such as pulmonary hypertension, priapism, leg ulcer, and
stroke, are closely linked to the intensity of hemolysis, whereas other
complications, such as painful episodes, acute chest syndrome, and osteonecrosis,
are linked to high blood viscosity and the interactions among sickle cells,
leukocytes, and the endothelium.</p>

<p><a name=4-u1.0-B978-1-4160-2805-5..50172-5--cese></a><span><span></span></b></span></p>

<p><span><span>Painful Crisis</span></b></span><span><span> </span></b></span></p>

<p></p>

<p>Pain caused by sickle
vaso-occlusion often starts in young children as the hand-foot syndrome:
painful swelling of the hands and feet caused by inflammation of the metacarpal
and metatarsal periosteum. Acute painful episodes are the most common
vaso-occlusive events. What triggers them is usually unknown. They are usually
severe and last from hours to days. These attacks of acute pain must be
distinguished from chronic pain caused by osteonecrosis of the hips and
shoulders, neuropathic pain, and milder non-specific pains that are often
present between episodes. Painful crises are usually stereotypical, affecting
individuals in the same manner from episode to episode. Because patients often
manage these events at home, hospital visits may underestimate the frequency of
events.</p>

<p><span><span></span></b></span></p>

<p><span><span>Acute Chest Syndrome</span></b></span><span><span> </span></b></span></p>

<p></p>

<p>Acute chest syndrome is
characterized by fever, chest pain, wheezing, cough, hypoxia, and lung
infiltrate. It is clinically indistinguishable from pneumonia and can be
lethal. It is second only to painful crisis as a cause of hospitalization, and
it is more common in children. The course is often mild in children and severe
in adults. </p>

<p><b><span></span></b></p>

<p><b><span>Aplastic crisis<i></i></span></b></p>

<p><span></span></p>

<p><span>Aplastic
crisis is usually triggered by parvovirus B19, which invades and destroys red
blood cell precursors. Red blood cell production is arrested for two to three
days. In normal individuals, this would be of little consequence, but in patients
with sickle-cell disease, it is life-threatening (because red blood cell life
is shortened). Reticulocyte counts drop dramatically and patient becomes
severely anemic, resulting in fatigue, pallor, and tachycardia. The crisis
takes about a week to resolve. </span></p>

<p><b><span></span></b></p>

<p><b><span>Splenic sequestration crisis</span></b></p>

<p><span></span></p>

<p><span>Splenic sequestration is characterized by </span><span>sudden pooling of blood
in the spleen; acute, painful enlargement of the spleen; and hypovolemia, which
results in tachycardia and hypotension. It is a medical emergency; if
untreated, the patient may die within hours of circulatory collapse.<span>&nbsp; </span></span></p>

<h4><span>In patients with sickle cell
anemia, splenic infarction usually occurs by age 10. A “functional asplenia”
ensues, increasing the patient’s risk of infection with encapsulated organisms.
Howell-Jowell bodies (indicative of an asplenic state) are often present in the
blood at this time. Once splenic infarction has occurred, the patient is no
longer predisposed to splenic sequestration. (Sequestration requires a
functioning spleen.)</span></h4>

<p><span></span></p>

<p><span><span>Sepsis</span></b></span></p>

<p><span></span></span></p>

<p><span>Functional
asplenia predisposes patients to infection by encapsulated organisms, such as <i>Streptococcus pneumoniae</i> and <i>Hemophilus influenzae</i>. Patients benefit
from routine vaccination for <i>H. influenzae</i>, <i>S. pneumoniae</i>, and <i>Neisseria
meningitidis</i>.<span><span></span></span></p>

<p><span><span>Stroke</span></b></span><span><span> </span></b></span></p>

<p></p>

<p>A major complication of
sickle cell anemia in early life is stroke caused by stenosis and occlusion of
large vessels. Ischemic stroke predominates in children; hemorrhagic stroke
predominates in adults. Subclinical neurologic events and silent cerebral infarction
are even more common than stroke. </p>

<p><b></b></p>

<p><b>Retinopathy</b></p>

<p></p>

<p>Proliferative sickle
retinopathy is more common in HbSC disease that in sickle-cell anemia (HbSS).
Vitreal hemorrhage and retinal detachment can cause vision loss. </p>

<p><b></b></p>

<p><b>Cardiac disease</b></p>

<p></p>

<p>In sickle-cell disease, the
heart may be enlarged. Typically, the precordium is hyperactive and a systolic
ejection is present. Myocardial infarction is rare. Sudden death is usually due
to arrhythmia.<span >&nbsp;&nbsp; </span></p>

<p><span><span></span></b></span></p>

<p><span><span>Pulmonary Hypertension</span></b></span><span><span> </span></b></span></p>

<p></p>

<p>Pulmonary hypertension is
found in 30 to 40% of adult patients with sickle cell anemia. It is often
asymptomatic and occurs primarily in patients above the age of 35 years. Half
of all patients with pulmonary hypertension die within 2 years of diagnosis. </p>

<p><span><span></span></b></span></p>

<p><span><span>Gallstones</span></b></span><span><span> </span></b></span></p>

<p></p>

<p>Cholelithiasis is a consequence
of hemolysis and increased bilirubin production. More than half of adults are
affected. </p>

<p><b></b></p>

<p><b>Renal disease</b></p>

<p></p>

<p>Sickle cell disease, which
can affect any part of the kidney, may result in hematuria, proteinuria,
hyposthenuria (inability to concentrate the urine), acidosis, and renal
failure. </p>

<p><b></b></p>

<p><b>Bone disease</b></p>

<p></p>

<p>Osteonecrosis of the hips
and shoulders is a common occurrence. Its onset is insidious and progressive.
Most patients with early-stage disease progress to collapse of the femoral head
within two years. Advanced disease may be visible on plain radiographs; early
disease may require magnetic resonance imaging for diagnosis. Osteomyelitis,
which is often difficult to distinguish from bone infarction, is usually caused
by <i>Staphylococcus aureus</i> or
salmonella infection. <a name=4-u1.0-B978-1-4160-2805-5..50172-5--intr></a></p>

<p><span><span></span></b></span></p>

<p><span><span>Leg Ulcers</span></b></span><span><span> </span></b></span></p>

<p></p>

<p>About 5 to 10% of patients
with sickle cell anemia above the age of 10 years develop leg ulcers. </p>

<p><span><span></span></b></span></p>

<p><span><span>Priapism</span></b></span><span><span> </span></b></span></p>

<p></p>

<p>Priapism, a prolonged
painful erection, may be seen in men with sickle cell anemia. Affected patients
have a higher incidence of stroke, pulmonary hypertension, renal failure, leg
ulcers, and premature death than individuals without priapism.</p>

<p><b></b></p>

<p><b>Pregnancy</b></p>

<p></p>

<p>There is no absolute
contraindication to pregnancy for patients with sickle cell anemia. Rates of
pyelonephritis, pre-eclampsia, spontaneous abortion, and intrauterine growth
retardation are increased.<span >&nbsp; </span></p>

<p><b></b></p>

<p><b>Nutritional deficiencies</b></p>

<p></p>

<p>Sickle cell disease routinely
causes growth retardation.<a name=4-u1.0-B978-1-4160-2805-5..50172-5--para></a></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer D is correct. </b>The presence of sickling, splenic enlargement,
pancytopenia, and circulatory compromise suggests splenic sequestration. </p>

<p><b></b></p>

<p><b>Answer A is incorrect. </b>Cirrhosis can cause portal hypertension and
splenomegaly, which may lead to hypersplenism. Hypersplenism may present as
thrombocytopenia or pancytopenia. Target cells are commonly seen in the
peripheral blood smear of patients with cirrhosis. Cirrhosis, however, would
not cause sickling or rapid enlargement of the spleen. </p>

<p><b></b></p>

<p><b>Answer B is incorrect. </b>Aplastic crisis is associated with worsening
anemia, but not splenic enlargement. Reticulocytosis does not occur in aplastic
crisis.<span >&nbsp; </span><b></b></p>

<p><b></b></p>

<p><b>Answer C is incorrect. </b>Autoimmune hemolysis is associated with
anemia and reticulocytosis. It is not, however, associated with sickling,
target cells, leukopenia, or thrombocytopenia.<span>&nbsp; </span><b></b></p>

<p><b></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following causes of thrombocytopenia is associated with arterial and venous
thrombosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Hypersplenism</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Quinidine-induced
thrombocytopenia</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sulfa-induced
thrombocytopenia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Heparin-induced
thrombocytopenia</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Idiopathic
thrombocytopenia purpura</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Thrombocytopenia, defined as
an abnormally low platelet concentration, may be due to decreased platelet
production, increased platelet destruction, or abnormal platelet distribution
(hypersplenism). Assuming normal platelet function, the symptoms and signs
expected with various platelet counts appear below.</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=136 valign=top>
  <p style="text-align:center;">Platelet Count</p>
  </td>
  <td width=234 valign=top>
  <p style="text-align:center;">Signs and
  Symptoms</p>
  </td>
 </tr>
 <tr>
  <td width=136 valign=top>
  <p style="text-align:center;"></p>
  </td>
  <td width=234 valign=top>
  <p style="text-align:center;"></p>
  </td>
 </tr>
 <tr>
  <td width=136 valign=top>
  <p>&gt; 50,000/&#956;L</p>
  </td>
  <td width=234 valign=top>
  <p>No symptoms or signs, although patients may bleed
  longer with major trauma</p>
  </td>
 </tr>
 <tr>
  <td width=136 valign=top>
  <p>25,000 to 50,000/&#956;L</p>
  </td>
  <td width=234 valign=top>
  <p>Petechiae and bruising with minor trauma</p>
  </td>
 </tr>
 <tr>
  <td width=136 valign=top>
  <p>10,000 to 25,000/&#956;L</p>
  </td>
  <td width=234 valign=top>
  <p>Spontaneous petechiae and bruising greater on the
  lower extremities; menorrhagia</p>
  </td>
 </tr>
 <tr>
  <td width=136 valign=top>
  <p>&lt; 10,000/&#956;L</p>
  </td>
  <td width=234 valign=top>
  <p>Prominent bruising, mucosal bleeding (epistaxis,
  gum bleeding, gastrointestinal,<span >&nbsp;
  </span>or genitourinary bleeding), and possibly central nervous system
  bleeding</p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Selected
causes of thrombocytopenia are discussed below.</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B0-323-03748-8..50048-8--cesectit></a><b><span>Chronic liver disease</span></b><span></span></p>

<p><span></span></p>

<p><span>Thrombocytopenia
is a common complication of chronic liver disease. <a
name=4-u1.0-B0-323-03748-8..50048-8--p507></a>The primary cause is portal
hypertension with congestive splenomegaly and platelet sequestration. Also,
patients with cirrhosis have reduced levels of thrombopoietin, which is mainly
produced by the liver and is the main regulator of thrombopoiesis. </span></p>

<p><b><span></span></b></p>

<p><b><span>Idiopathic
thrombocytopenic purpura (ITP)</span></b></p>

<p><span></span></p>

<p><i><span>Acute</span></i><span> ITP is a transient, mostly postinfectious
disorder characterized by platelet destruction. It occurs mainly in children. <i>Chronic </i>immune thrombocytopenic purpura
(ITP) is an immune-mediated thrombocytopenia occurring primarily in adults.
Platelets coated with IgG autoantibodies undergo accelerated clearance by
macrophages, predominantly in the spleen and liver. The condition is more
common in women than men. ITP is a diagnosis of exclusion. The criteria for diagnosing
ITP appear below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=255 valign=top>
  <p style="text-align:center;"><b><span>Criteria for ITP</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>Thrombocytopenia
  (with large platelets)</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>Normal
  hemoglobin concentration</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>Normal
  leukocyte count</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>No
  adenopathy or splenomegaly</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>Normal
  or increased numbers of megakaryocytes in bone marrow</span></p>
  </td>
 </tr>
 <tr>
  <td width=255 valign=top>
  <p><span>No other
  explanation for thrombocytopenia</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Disease-associated
immune<span> </span>thrombocytopenia</span></b><span> </span></p>

<p><span></span></p>

<p><span>Autoimmune <span>thrombocytopenia</span> is most commonly seen
in patients with collagen vascular or lymphoproliferative disorders. <span>Thrombocytopenia</span> is noted in 14 to 26%
of patients with systemic lupus erythematosus<a
name=4-u1.0-B978-1-4160-2805-5..50184-1--p129></a>. Splenomegaly and mild
adenopathy are relatively common. Laboratory findings show increased numbers of
megakaryocytes in the bone marrow. <a
name=4-u1.0-B978-1-4160-2805-5..50184-1--cese></a></span></p>

<p><span>A low platelet count is
commonly seen in patients with lymphoproliferative disorders. In most cases it
is due to decreased platelet production because of marrow infiltration or the
effects of treatment. However, immune <span>thrombocytopenia</span>
is sometimes noted, particularly in individuals with chronic lymphocytic
leukemia and non-Hodgkin's lymphoma.</span></p>

<p><b><span></span></b></p>

<p><b><span>Post-transfusion
purpura</span></b><span>
</span></p>

<p><a name=4-u1.0-B978-1-4160-2805-5..50184-1--para></a><span></span></p>

<p><span>This rare
disorder almost always occurs in women and appears about 7 to 10 days after
transfusion. There is usually a history of either a previous transfusion or
pregnancy, and most cases occur in multiparous women after their first blood transfusion.</span><span> </span></span><span is </span></span><span>usually severe, and about 10% of cases
have intracranial hemorrhage.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Drug-induced
thrombocytopenia</span></b></p>

<p><span></span></p>

<p><span>Drug-induced
thrombocytopenia is common and usually immune-mediated<b>.</b> The drugs most
commonly implicated are heparin, quinine, quinidine, chlorothiazide,
penicillin, sulfa drugs, linezolid, rifampin, cimetidine, and anticonvulsants.
Thrombocytopenia typically occurs 2 to 3 weeks after initial drug exposure and
resolves within 10 days of discontinuation of the drug. Of note, glycoprotein
IIb/IIIa receptor inhibitors can cause platelet counts to fall within a few
hours of exposure.</span></p>

<p><span></span></p>

<p><b><span>Heparin-induced
thrombocytopenia (HIT)</span></b></p>

<p><span></span></p>

<p><span>Heparin-induced thrombocytopenia (HIT) is different than other types of d</span><span>rug-induced
thrombocytopenia. In HIT, thrombosis is the most feared complication;
significant bleeding rarely occurs. <span>Heparin-induced
thrombocytopenia<b> </b></span>may result in potentially lethal arterial and
venous thromboses. IgG antibodies form against a complex of heparin and
platelet factor 4. A <span decline in platelet count may be
seen in patients previously exposed to heparin. The condition can be severe.</span>
Even small doses of heparin (the amount used in an intravenous line flush) can
cause significant thrombocytopenia and thrombosis.</span><a
name=4-u1.0-B0-323-03748-8..50048-8--para107></a><span </span></span><span>Although
unfractionated heparin is 10 times more likely to cause HIT than low molecular
weight heparin, almost all patients with HIT display cross-reactivity.
Consequently, low molecular weight heparin should be avoided in patients with a
history of HIT.</span></span><b><span></span></b></p>

<p><span></span></p>

<p><b><span>Infection</span></b></p>

<p><span></span></p>

<p><a name=4-u1.0-B0-323-03748-8..50048-8--para56></a><span>Thrombocytopenia
associated with some viral infections, such as rubella, mumps, infectious
mononucleosis, and cytomegalovirus<a
name=4-u1.0-B978-1-4160-2805-5..50184-1--intr></a>, is primarily
immune-mediated and closely mimics acute ITP. In HIV, thrombocytopenia is due
to both immune-mediated platelet destruction and decreased platelet production,
probably secondary to infection of megakaryocytes.<span Sepsis is a
common and often overlooked cause of thrombocytopenia in the critically ill. </span></span></p>

<p><b><span></span></b></p>

<p><span>Thrombotic
Microangiopathies: T</span></b></span><a
name=4-u1.0-B0-323-03748-8..50048-8--para55></a><a
name=4-u1.0-B0-323-03748-8..50048-8--para30></a><a
name=4-u1.0-B0-323-03748-8..50048-8--celist5></a><b><span>hrombotic thrombocytopenic purpura (TTP)
and </span></b></p>

<p><b><span>Hemolytic-uremic
syndrome (HUS)</span></b></p>

<p><span></span></p>

<p><span>The
thrombotic microangiopathies are characterized by excessive platelet
aggregation, which leads to microvascular occlusion, thrombocytopenia, and
mechanical injury to erythrocytes (microangiopathic hemolytic anemia). In TTP,
platelet aggregation occurs primarily in the systemic microvasculature; in HUS,
it occurs predominantly in the renal circulation. Distinguishing these two
conditions is not always possible. TTP may be associated with medication,
cancer, chemotherapy, bone marrow transplantation, or HIV infection. HUS is
usually caused by <i>Escherichia coli</i> (<i>E. coli</i> 0157).</span></p>

<p><span></span></p>

<p><span>TTP is a
life-threatening condition. HUS occurs primarily in children; proteinuria,
hematuria, and elevated blood urea nitrogen and creatinine levels reflect the
degree of renal failure.<span >&nbsp; </span></span></p>

<p><sup><span></span></sup></p>

<p><b><span>Disseminated
intravascular coagulation (DIC)</span></b></p>

<p><span></span></p>

<p><span>Disseminated
intravascular coagulation (DIC) is characterized by systemic activation of
coagulation cascade, which leads to the intravascular formation of fibrin,
thrombotic occlusion of small and medium-sized vessels, and organ ischemia. The
process depletes platelets and coagulation factors, which can result in
hemorrhage. DIC is a disorder associated with many disease states, most
commonly infection, cancer, burns, trauma, and pregnancy. While
microangiopathic hemolysis is invariably present in TTP and HUS, it is only
sometimes present in DIC. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><a name=4-u1.0-B0-323-03748-8..50048-8--para90></a><a
name=4-u1.0-B0-323-03748-8..50048-8--celist21></a><a
name=4-u1.0-B0-323-03748-8..50048-8--spara4></a><b><span>Answer D
is correct</span></b><span>.
Heparin-induced thrombocytopenia is associated with arterial and venous
thrombosis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
37-year-old woman presents to the emergency department with a 3-day history of
abdominal pain, nausea, and diarrhea. Lab tests show: </span></p>

<p><span></span></p>

<p><span>Hemoglobin
<span>&nbsp;&nbsp;&nbsp; </span>9.5 g/dL</span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>7,500/mm<sup>3</sup></span></p>

<p><span>Platelet<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>10,000/mm<sup>3</sup></span></p>

<p><span></span></p>

<p><span>Examination
of the blood smear confirms severe thrombocytopenia and shows fragmented red
blood cells and numerous polychromatophilic red cells (reticulocytes).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=236 height=178
src="_%20Tutorials_files/image503.png" alt="Description: Schistocytes" v:shapes="Picture_x0020_347324"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>EDTA-dependent
pseudothrombocytopenia</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic
blood loss</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Idiopathic
thrombocytopenic purpura (ITP)</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Thrombotic
thrombocytopenia purpura (TTP) </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Thrombotic
thrombocytopenia purpura (TTP) is classically associated with a pentad of
findings: fever, neurologic symptoms, renal failure, thrombocytopenia, and
microangiopathic hemolytic anemia. However, many patients with TTP are not
acutely ill on presentation and do not have fever, neurologic symptoms, or
renal failure. In such cases, the diagnosis is made solely by the presence of
microangiopathic hemolytic anemia and thrombocytopenia. The most common
presenting symptoms in TTP are gastrointestinal &#8211; abdominal pain,
vomiting, and diarrhea. Severe thrombocytopenia is confirmed by examination of
the blood smear. Microangiopathic hemolysis is evident by the presence of
fragmented red blood cells. </span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><span>TTP may be congenital
  or acquired. In patients with congenital or familial TTP, mutations in the
  vWF-cleaving protease, ADAMTS-13, abrogate its activity. Patients with
  acquired TTP without a family history usually have an antibody, often
  immunoglobulin G (IgG) that blocks the normal function of this vWF-cleaving
  protease to less than 10% of normal. Ultralarge vWF multimers released by endothelial
  cells normally anchor to endothelial cells through P-selectin and form long
  strings that adhere and aggregate platelets in the microcirculation.
  ADAMTS-13 downregulates the size of these multimers. Deficient cleaving
  protease function in TTP leads to higher circulating levels of the larger,
  high-molecular-weight vWF multimers; these, in turn, cause increased platelet
  adhesion and clearance&nbsp;<i>without</i>&nbsp;activating the coagulation
  cascade. Therefore, both the PT and PTT are normal in TTP, unlike DIC. TTP
  after chemotherapy (mitomycin C) and in association with pregnancy, stem cell
  transplantation, lupus, or HIV infection appears to have a similar pathogenic
  mechanism of thrombosis. Thrombocytopenia (often severe) is accompanied by
  microangiopathy with schistocytes on the peripheral smear and increased serum
  lactate dehydrogenase. Microvascular occlusions in multiple organs cause many
  of the symptoms, especially in the kidney and brain. The classic pentad of
  signs (fever, thrombocytopenia, microangiopathic hemolysis, neurologic
  symptoms, and renal insufficiency) is present in fewer than 25% of patients
  with TTP. The diagnosis is generally made on the clinical assessment of
  thrombocytopenia and microangiopathic hemolytic anemia; assays for ADAMTS-13
  activity and inhibitor are not yet widely available and do not have a rapid
  turn-around time.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P054026></a><span>Treatment of familial
  TTP is based on replenishment of cleaving protease activity with plasma
  transfusion; acquired TTP additionally requires removal of the antibody. The
  latter is accomplished by plasma exchange, whereby patient plasma is removed
  (plasmapheresis) and replaced with fresh-frozen plasma, often
  &quot;cryo-poor&quot; to reduce ultralarge vWF multimers in transfused
  plasma. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>.<span>&nbsp; </span>The diagnosis of TTP is suggested by the
combination of anemia, thrombocytopenia, and fragmented red blood cells.
Patients with TTP commonly present with gastrointestinal symptoms. This patient
should be admitted to the hospital and treated with plasma exchange.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. EDTA-dependent
“pseudothrombocytopenia” is, basically, a laboratory error. The lab reports a
low platelet count, but the true platelet count is actually normal.
EDTA-dependent “pseudothrombocytopenia” occurs in 1 in 1,000 normal adults.
These individuals have autoantibodies that cause platelet agglutination in the
presence of EDTA, an anticoagulant used in certain blood tubes.
Pseudothrombocytopenia has no clinical significance, except that it can trick
the doctor into believing that the patient is thrombocytopenic, leading to
unnecessary tests. In this vignette, the patient’s thrombocytopenia is real, as
confirmed by the blood smear.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Chronic blood loss
does not cause thrombocytopenia. (It often causes an increased platelet count.)</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Idiopathic
thrombocytopenia purpura is not associated with microangiopathic hemolysis and,
therefore, does not result in fragmented red blood cells. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 66-year-old man was diagnosed with deep vein thrombosis in his left leg
two years ago. He has since had persistent swelling of that leg. Physical
examination reveals leg edema up to the knee with mild thickening and
hyperpigmentation of the skin. Which of the following is true?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>His
condition is due to “incompetent” valves.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Arterial
hypertension plays a pathophysiologic role.</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>He is at
increased risk of developing exquisitely painful ulcers.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>He is at
reduced risk of developing cellulitis.</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Antihypertensive
drugs are the treatment of choice.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Chronic venous insufficiency</span> occurs when valves in the veins
(usually of the legs) become damaged, or &quot;incompetent,&quot; because of
deep vein thrombosis (DVT) or phlebitis. DVT is the most common cause of
chronic venous insufficiency. Damage to the valves results in venous
hypertension, which causes chronic leg swelling and calf discomfort. Symptoms
can last a lifetime. Physical findings may include varicosities, leg and ankle
swelling, lymphedema, and ulceration. (Unlike ulcers due to arterial
compromise, venous stasis ulcers are not exquisitely painful.) The involved
skin is often dry, pruritic, thickened, and hyperpigmented. The patient is at
increased risk of developing cellulitis. Vascular compression stockings can
improve venous hemodynamics, reduce edema, and minimize skin discoloration. </p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer A is correct</b><span>. </span>The condition is due to incompetent
valves.</p>

<p><b></b></p>

<p><b>Answer B is incorrect</b>. Venous hypertension resulting from
incompetent valves plays a pathophysiologic role, not arterial hypertension.</p>

<p><b></b></p>

<p><b>Answer C is incorrect</b>. He may develop ulcers, but they are not
exquisitely painful. </p>

<p><b></b></p>

<p><b>Answer D is incorrect</b>. He is at increased, not decreased, risk of
developing cellulitis.</p>

<p><b></b></p>

<p><b>Answer E is incorrect</b>. Vascular compression stockings are the
treatment of choice.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
60-year-old woman with a past medical history of hypertension and colon cancer
presents to the emergency department with sudden onset of shortness of breath.
She was diagnosed with colon cancer last week and underwent partial colectomy.
On physical examination, temperature is 98.5<sup>o</sup>F, pulse is 125
/minute, blood pressure is 98/72 mm Hg, and respirations are 32/minute. The
oxygen saturation is 84% on room air. The heart is regular without murmurs,
rubs, or gallops. The lungs are clear without rhonchi, crackles, or wheezes.
The patient is placed on oxygen by nasal cannula. An EKG shows sinus
tachycardia with no ischemic changes.<span >&nbsp;
</span>Brain natriuretic peptide is 80 ng/L. Electrolytes, TSH, and complete
blood count are normal. Cardiac enzymes are drawn. Arterial blood gases show a
pH of 7.48, PO<sub>2</sub> of 58 mm Hg, and PCO<sub>2</sub> of 20 mm Hg on room
air (F<sub>I</sub>O<sub>2</sub> of 21%). Which of the following is the best
test to confirm the diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>D-Dimer</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>CT
Angiography</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Venous
Doppler of the lower extremities</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Chest
X-ray</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cardiac
catheterization</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>This
patient is at high risk for pulmonary embolism (PE) because of her recent
hospitalization and cancer. Sudden onset of shortness of breath, tachycardia,
hypoxemia, and respiratory alkalosis are consistent with PE. Patients with PE
may have a relatively normal EKG and chest X-ray. A contrast-enhanced CT scan
(CT angiography) would be the best noninvasive test for making the diagnosis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. This
patient most likely has pulmonary embolism. A contrast-enhanced CT scan (CT
angiography) would be the best noninvasive test for making the diagnosis. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.<span>&nbsp; </span></span></b><span>The D-dimer test can be used to
screen for DVT and PE when the pre-test probability of either is low. A normal
D-dimer essentially rules out thromboembolism. An elevated D-dimer, however, is
non-specific and of no diagnostic benefit.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Doppler
ultrasound of the veins of the lower extremities can be used to diagnose deep
vein thrombosis (DVT), but will not confirm the presence of pulmonary emboli. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Chest
x-ray is helpful to rule out other causes of shortness of breath, but is not
sensitive for pulmonary embolism.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Urgent
cardiac catheterization is recommended in patients with acute myocardial
infarction, but not in patients with pulmonary embolism. </span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 19-year-old woman has had heavy menstrual
periods and anemia since menarche. She has increased bruising if she takes
aspirin.<span >&nbsp; </span>Her sister is also
anemic.<span >&nbsp; </span>Her hemoglobin
concentration is 8 g/dL (normal: 12-16 g/dL) and her mean corpuscular volume
(MCV) is 67 &#956;m<sup>3</sup> (normal is 80-100 &#956;m<sup>3</sup>).<span>&nbsp; </span>The white count and platelet count are
normal.<span >&nbsp; </span>Her prothrombin time (PT)
is normal. Her activated partial thromboplastin time (aPTT) is mildly prolonged
at 46 seconds (normal: 25-40 seconds). Her bleeding time is mildly prolonged at
9 minutes (normal: 2-7 minutes). What is the most appropriate next step? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Consult
a gynecologist</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Order
platelet aggregation studies</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Test
for von Willebrand disease</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Order
Factor VIII and IX levels</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Von
Willebrand disease is the most common inherited bleeding disorder. It is caused
by a qualitative or quantitative deficiency of von Willebrand factor (vWF). The
condition may be associated with bruising, nosebleeds, gum bleeds, and heavy
menses. Severe internal bleeding and joint bleeding are rare. The von
Willebrand protein has a dual role: 1) It is a carrier protein for Factor
VIII.<span >&nbsp; </span>If von Willebrand protein
levels are low, more factor VIII circulates unbound and unprotected from rapid
degradation. Factor VIII levels drop and the aPTT increases.<span>&nbsp; </span>2) It tethers platelets to the site of
vessel injury.<span >&nbsp; </span>Without functional
von Willebrand protein, platelet plug formation is poor and prolonged bleeding
may occur.<span >&nbsp; </span>If surgery is required,
concentrates containing von Willebrand protein can be given.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
following table shows the effect of various conditions on the prothrombin time,
partial thromboplastin time, bleeding time, and platelet count. </span></p>

<p><span></span></p>

<table border=1 cellpadding=0>
 <thead>
  <tr>
   <td width=127>
   <p style="text-align:center;"><span>Condition</span></p>
   </td>
   <td width=80>
   <p style="text-align:center;"><span>Prothrombin time
   (PT)</span></p>
   </td>
   <td width=116>
   <p style="text-align:center;"><span>Partial
   thromboplastin time (aPTT)</span></p>
   </td>
   <td width=89>
   <p style="text-align:center;"><span>Bleeding time</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Platelet count</span></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width=127>
  <p><span>Aspirin</span></p>
  </td>
  <td width=80>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=116>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=89>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>N</span></p>
  </td>
 </tr>
 <tr>
  <td width=127>
  <p><span>Disseminated
  intravascular coagulation (DIC)</span></p>
  </td>
  <td width=80>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=116>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=89>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=127>
  <p><span>Hemophilia</span></p>
  </td>
  <td width=80>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=116>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=89>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>N</span></p>
  </td>
 </tr>
 <tr>
  <td width=127>
  <p><span>Liver
  failure, end-stage</span></p>
  </td>
  <td width=80>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=116>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=89>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=127>
  <p><span>Thrombocytopenia</span></p>
  </td>
  <td width=80>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=116>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=89>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=127>
  <p><span>Vitamin
  K deficiency or warfarin</span></p>
  </td>
  <td width=80>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=116>
  <p style="text-align:center;"><span>N or &#8593;</span></p>
  </td>
  <td width=89>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>N</span></p>
  </td>
 </tr>
 <tr>
  <td width=127>
  <p><span>von
  Willebrand disease</span></p>
  </td>
  <td width=80>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=116>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=89>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>N</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer
C is correct.</span></b><span><span>&nbsp; </span>Von Willebrand disease would explain the
propensity for bleeding (resulting in heavy menstrual periods, chronic blood
loss, and iron deficiency anemia) and an elevated aPTT. <b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is incorrect</span></b><span>.<span>&nbsp; </span>The underlying bleeding disorder should
be evaluated before consulting the gynecologist. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect.</span></b><span><span>&nbsp; </span>Platelet abnormalities do not prolong
the aPTT.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Hemophilia A (due to Factor VIII deficiency) and hemophilia B (due to Factor IX
deficiency) occur almost exclusively in males because they are X-linked
disorders. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section">Neuroscience
</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Psychiatry</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 54-year-old man presents to the
emergency department with intense pain of sudden onset in his right eye.
Examination reveals injection surrounding the limbus and elevated intraocular
pressure in the same eye. After obtaining a careful history, the emergency room
physician concludes that this episode was triggered by which of the following
agents?</span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Amitriptyline</span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Cimetidine</span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Diazepam</span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Malathion</span></span></p>

<p><span lang=EN-GB><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span lang=EN-GB>Propranolol</span></span><span lang=EN-GB></span></p>

<p><span>&nbsp; </span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><b><span>Acute angle-closure glaucoma</span></b><span>. Acute elevations in
intraocular pressure can occur when the outflow of aqueous humor from the
ciliary body to the angle is suddenly blocked. (The condition is more common in
Asians and people who are farsighted but may occur in any patient.) An acute angle-closure
attack may follow an episode of emotional or physical stress, dilation of the
pupil in dim lighting, or rarely, after instillation of dilating eyedrops. A
patient having an acute attack usually has severe ocular pain and redness,
blurred vision, rainbow-colored halos around lights, and often nausea and
vomiting. On examination, the eye is usually red, the pupil is dilated and
poorly reactive, and intraocular pressure is greatly elevated. Generally, only
one eye is affected. Corneal clouding or corneal edema may be present in
advanced cases. An acute episode of angle-closure glaucoma is an ocular
emergency and requires immediate treatment to lower intraocular pressure to
prevent permanent visual loss. Acute angle-closure glaucoma can be caused by adrenergic
agents, either locally (phenylephrine drops, nasal ephedrine) or systemically
(epinephrine for anaphylactic shock). It can also be caused by drugs with
anticholinergic properties (e.g., tricyclic anti-depressants).</span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB></span></strong></p>

<p><strong><span lang=EN-GB>Answer A is correct.</span></strong><span
 lang=EN-GB><span>&nbsp; </span>The patient described is suffering from
an attack of acute or narrow angle glaucoma (also called angle-closure
glaucoma). Attacks can be precipitated by drugs with anticholinergic actions
because muscarinic receptors on the pupillary constrictor muscle of the iris
are blocked. This causes pupillary dilation, which further “narrows” the angle
in the anterior chamber of the eye. Amitriptyline is a tricyclic antidepressant
with significant anticholinergic side effects.</span></span><span lang=EN-GB></span></p>

<p><span
lang=EN-GB>&nbsp;</span></p>

<p><strong><span
lang=EN-GB>Answer B is incorrect.</span></strong><span
 lang=EN-GB> Cimetidine
is an H<sub>2</sub> antagonist that reduces gastric acid release. </span></span></p>

<p><span
 lang=EN-GB></span></span></p>

<p><strong><span
lang=EN-GB>Answer C is incorrect.</span></strong><span
 lang=EN-GB> Diazepam
is a benzodiazepine. </span></span><span lang=EN-GB></span></p>

<p><span
lang=EN-GB>&nbsp;</span></p>

<p><strong><span
lang=EN-GB>Answer D is incorrect.</span></strong><span
 lang=EN-GB> Malathion
is an organophosphorus cholinesterase inhibitor that is used as an insecticide.
This agent would increase levels of acetylcholine, thereby widening the angle.</span></span><span
lang=EN-GB></span></p>

<p><span
lang=EN-GB>&nbsp;</span></p>

<p><strong><span lang=EN-GB>Answer E is incorrect.</span></strong><span
 lang=EN-GB>
Propranolol is a non-selective, beta-adrenergic antagonist. </span></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span>A
59-year-old man was hospitalized after an acute myocardial infarction. The day
after his discharge, he is readmitted with sudden difficulty speaking. He
understands the speech of others and is able to speak clearly and fluently, but
he has trouble naming objects and finding the appropriate words. He often makes
paraphasic errors (i.e., incorrect substitution of a similar-sounding word
&#8211; as “giss” for “kiss” &#8211; or a word with similar meaning, as “hug”
for “kiss”). His ability to repeat words and phrases is greatly impaired. </span></p>

<p><span></span></p>

<p><span>What type
of aphasia is he exhibiting?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anomic</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Broca’s</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Conduction</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wernicke’s</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Global</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>There are
two types of acquired speech defect: impaired articulation (dysarthria) and
impaired language (aphasia). Dysarthria is limited to the spoken word; aphasia
affects oral and written language. Dysarthria usually indicates motor
dysfunction; aphasia represents dysfunction of the language system. </span></p>

<p><span></span></p>

<p><span>All
aphasic syndromes are characterized by difficulty recalling words and naming
objects. This difficulty is not limited to a single sensory modality. For
example, a patient who cannot identify a set of keys will have trouble whether
he sees the keys, feels them, or hears them jangle. In right-handed persons,
aphasia is almost always rooted in the left cerebral hemisphere (usually in the
cortex). More than half of left-handed aphasics have had damage to the left
hemisphere; the others have right hemispheric or bilateral damage. </span></p>

<p><span></span></p>

<p><span>If a
patient’s only language deficit is recalling words or naming objects, the
aphasia is described as “anomic.” Anomia implies dysfunction somewhere in the
left hemispheric language system. Other language disturbances allow a more
precise anatomic localization. </span></p>

<p><span></span></p>

<p><span>Two
cortical areas adjacent to the left sylvian fissure are especially important
for language: Broca’s area, which is located anteriorly, and Wernicke’s area,
which is located posteriorly (Figure 10-1). These areas are connected by the
arcuate fasciculus (a bundle of white matter). Broca’s area, Wernicke’s area,
and the pathways connecting these two areas constitute the perisylvian core of
the language system. The perisylvian core includes inferior portions of the
left frontal and parietal lobes and a superior portion of the left temporal
lobe. </span></p>

<p><span></span></p>

<p><span>Wernicke’s
area is important for language reception and comprehension. Broca’s area is
important for reproduction of speech. Damage to Wernicke’s area causes poor
comprehension. Damage to Broca’s area causes decreased fluency. A lesion in any
part of the perisylvian core impairs repetition (see table below).</span></p>

<p><span></span></p>

<p><span>The
patient in this vignette has trouble naming objects, which occurs in all types
of aphasia. His inability to repeat words indicates a lesion in the perisylvian
core. His comprehension is normal, indicating that Wernicke’s area is intact,
and his speech is fluent, indicating that Broca’s area is intact. The lesion
must lie, therefore, in the conduction pathways between these two locations.
Such aphasia is termed “conduction” aphasia. </span></p>

<p><span></span></p>

<p><span>In this
patient, a CT scan showed an embolic infarct in the inferior left parietal
lobe.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=313 height=244
src="_%20Tutorials_files/image505.png" v:shapes="Picture_x0020_347383"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>Aphasic syndrome</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>Naming (Language system)</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>Repetition (Perisylvian core)</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>Fluency (Anterior)</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>Comprehension (Posterior)</span></p>
  </td>
 </tr>
 <tr>
  <td width=89 valign=top>
  <p><span></span></p>
  </td>
  <td width=89 valign=top>
  <p><span></span></p>
  </td>
  <td width=89 valign=top>
  <p><span></span></p>
  </td>
  <td width=89 valign=top>
  <p><span></span></p>
  </td>
  <td width=89 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=89 valign=top>
  <p><span>Anomic</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>N</span></p>
  </td>
 </tr>
 <tr>
  <td width=89 valign=top>
  <p><span>Broca’s</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>N</span></p>
  </td>
 </tr>
 <tr>
  <td width=89 valign=top>
  <p><span>Conduction</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>N</span></p>
  </td>
 </tr>
 <tr>
  <td width=89 valign=top>
  <p><span>Wernicke’s</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>N</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
 </tr>
 <tr>
  <td width=89 valign=top>
  <p><span>Global</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><span>I</span></p>
  </td>
 </tr>
</table>

<p><span><span>&nbsp;</span></span></p>

<p><span>N = normal</span></p>

<p><span>I =
impaired </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. The patient is
exhibiting conduction aphasia.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following figures best illustrates the relationship between blood flow and
mean arterial pressure (MAP) in a vascular bed that demonstrates autoregulation
of blood flow?</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=434 height=214
src="_%20Tutorials_files/image507.png" v:shapes="Picture_x0020_347382"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Autoregulation</span></b><span> is the <span>intrinsic ability of an organ to maintain a constant blood flow despite
changes in perfusion pressure</span>. This occurs in the absence of neural and
hormonal influences and is, therefore, intrinsic to the organ. </span></p>

<p><span></span></p>

<p><span>If
perfusion pressure decreases in a <i>passive</i>
vascular bed, i.e., one that does <i>not</i>
show autoregulation, a rapid and sustained fall in blood flow occurs. Passive
constriction of the arterioles will cause increased vascular resistance. If,
however, perfusion pressure decreases in a vascular bed that <i>is</i> capable of autoregulatory behavior,
the initial drop in pressure and flow triggers arteriolar dilation, which
increases blood flow over the next few minutes. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=301 height=179
src="_%20Tutorials_files/image509.png" alt="Description: hyper1" v:shapes="Picture_x0020_347381"></span><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>CBF = cerebral blood flow</span></p>

<p style="text-align:center;"><span>MAP = mean arterial pressure </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The figure
above shows the relationship between blood flow and perfusion pressure in an
autoregulating and non-autoregulating vascular bed. In the autoregulating
vascular bed (designated “normal”) flow changes relatively little despite a
large change in perfusion pressure. In the non-autoregulating bed (designated
“absent”) flow drops significantly as pressure drops.</span></p>

<p><span></span></p>

<p><span>Different
organs display varying degrees of autoregulatory behavior. The renal, cerebral,
and coronary circulations show excellent autoregulation, whereas skeletal
muscle and splanchnic circulations show moderate autoregulation. The cutaneous
circulation shows little or no autoregulatory capacity. Autoregulation ensures
that critical organs have an adequate blood flow and oxygen delivery.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct.</span></b><span> In the autoregulating
vascular bed, flow changes relatively little despite a large change in
perfusion pressure.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
8-year-old girl has bilateral peripheral vision defects. CT scan shows
calcification of the pituitary fossa. MRI shows a sellar and suprasellar mass
with high signal intensity on T1 images. Which of the following is the most
likely origin of her brain tumor?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ventricular
lining</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Vascular
endothelium</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rathke’s
pouch</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Fourth
ventricle neuroectoderm</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Adenohypophyseal
lactotrophs</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=157 height=176
src="_%20Tutorials_files/image511.png" alt="Description: craniopharyngioma.jpg"
v:shapes="Picture_x0020_347380"></span><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p>Primary central nervous
system (CNS) tumors are a heterogeneous group of diseases that are,
collectively, the second most common malignancy in childhood and adolescence.
The treatment approach is multimodal. Surgery with complete resection, if
feasible, is the foundation, with radiation therapy and chemotherapy utilized
according to the diagnosis, patient age, and other factors.</p>

<p></p>

<p><a name=4-u1.0-B978-1-4377-0755-7..00491-7--s001></a><a
name=4-u1.0-B978-1-4377-0755-7..00491-7--st00></a><span style='font-family:"Times New Roman"'>Childhood brain tumors
occur at any location within the central nervous system. The relative frequency
of different histologic types and the anatomic distribution are shown below. </span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p style="text-align:center;"><span><img border=0 width=452 height=341
src="_%20Tutorials_files/image513.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0755-7&amp;eid=4-u1"
v:shapes="Picture_x0020_347379"></span><span style='font-family:"Times New Roman"'></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. In children,
craniopharyngioma is the most common tumor to arise from the sella turcica.
Findings may include headache, pituitary dysfunction, and bitemporal
hemianopsia (due to impingement of the optic chiasm). Craniopharyngiomas are
derived from Rathke’s pouch, an embryological structure that buds from the roof
of the mouth to form the anterior pituitary. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=403 height=128
src="_%20Tutorials_files/image515.png"
alt="Description: http://www.cytochemistry.net/endocrine_system/pitdraw2.jpg"
v:shapes="Picture_x0020_347378"></span><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Ependymomas arise from
cells lining the ventricles. Usually they appear in the fourth ventricle, where
they may block the flow of cerebrospinal fluid, causing hydrocephalus. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Hemangioblastomas
arise from vascular endothelium, usually in the cerebellum or spinal cord.
Symptoms include cerebellar ataxia and motor/sensory dysfunction.
Hemangioblastomas may be sporadic or part of von Hippel-Lindau disease, an
autosomal dominant disease associated with pheochromocytoma, pancreatic cysts,
and cerebellar and retinal hemangioblastomas. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Medulloblastomas arise
from neuroectoderm of the fourth ventricle. Hydrocephalus results from blockage
of cerebrospinal fluid. Findings include headache, vomiting, and head
tilt.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Pituitary adenomas are
rare in children. The most common types in adults are non-secreting tumors, prolactinomas
(derived from lactotrophs that secrete prolactin, causing galactorrhea and
amenorrhea), growth-hormone secreting tumors (derived from somatotrophs,
causing acromegaly), and ACTH-producing tumors (derived from corticotrophs,
causing Cushing’s syndrome).<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 58-year-old woman is admitted to the hospital because of
metastatic breast cancer. She begs her best friend to stay with her at the
hospital because she is afraid of being left alone. Which of the following
defense mechanisms explains this behavior? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Denial</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Displacement</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Regression</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Repression</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sublimation</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Defense mechanisms are subconscious “protective” techniques used
by individuals to distance themselves from unpleasant thoughts, feelings, or
behaviors. The most common defense mechanisms appear below.</span></p>

<p><span></span></p>

<p><b><span>1. Denial</span></b><span></span></p>

<p><span>Denial is the refusal to accept reality. Example: An alcoholic
denies he has a drinking problem.</span></p>

<p><b><span></span></b></p>

<p><b><span>2. Regression</span></b><span></span></p>

<p><span>Regression is the reversion to an earlier stage of development
in the face of unacceptable thoughts. Example: An adult with a terminal illness
begs a friend to stay with her overnight. </span></p>

<p><b><span></span></b></p>

<p><b><span>3. Acting Out</span></b><span></span></p>

<p><span>Acting out is performing an extreme behavior to express a
thought or feeling. Example: A boy throws a book at someone instead of saying,
“I’m mad at you.” </span></p>

<p><b><span></span></b></p>

<p><b><span>4. Dissociation</span></b><span></span></p>

<p><span>Dissociation is a temporary, </span><span>drastic modification of one’s personal identity.
Example: A victim of spousal abuse imagines herself as a beloved princess. </span></p>

<p><b><span></span></b></p>

<p><b><span>5. Compartmentalization </span></b><span></span></p>

<p><span>Compartmentalization is a form of dissociation in which a part
of oneself is “mentally separated” from another part. Example: An honest person
cheats on his income tax return and does not “see” that he has behaved dishonestly.</span></p>

<p><b><span></span></b></p>

<p><b><span>6. Projection</span></b><span></span></p>

<p><span>Projection is the misattribution of one’s own undesired thoughts
onto another person. Example: A woman expresses anger at her husband for “not
listening,” but does not listen herself.<span >&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>7. Reaction formation</span></b><span></span></p>

<p><span>Reaction formation is the converting of unwanted thoughts into
their opposite. Example: A woman who is angry with her boss is overly kind and
generous toward him.</span></p>

<p><b><span></span></b></p>

<p><b><span>8. Repression</span></b><span></span></p>

<p><span>Repression is the unconscious blocking of unacceptable thoughts.
Example: A physician subconsciously blocks his memories of medical school.</span></p>

<p><span></span></p>

<p><b><span>9. Displacement</span></b><span></span></p>

<p><span>Displacement is the redirection of thoughts about one person so
they are “aimed” at another person. Example: A man who is angry at his boss
yells at his wife instead. </span></p>

<p><b><span></span></b></p>

<p><b><span>10. Intellectualization</span></b><span></span></p>

<p><span>Intellectualization is the overemphasis on thinking and the
abandonment of normal emotion. Example: A man who has just been diagnosed with
terminal cancer focuses on the details of the medical procedures he has
undergone. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>11. Rationalization</span></b><span></span></p>

<p><span>Rationalization is offering a different explanation for one’s
perceptions. Examples: A boy who fails an examination decides that the test was
poorly written. </span></p>

<p><b><span></span></b></p>

<p><b><span>12. Undoing</span></b><span></span></p>

<p><span>Undoing is the attempt to take back or counteract an
unacceptable thought or act. Example: A man praises his wife’s intelligence
after calling her “dumb.”</span></p>

<p><b><span></span></b></p>

<p><b><span>13. Sublimation</span></b><span></span></p>

<p><span>Sublimation is the channeling of unacceptable thoughts into
acceptable ones. Example: A man who is angry over an injustice writes a book
about injustice. </span></p>

<p><b><span></span></b></p>

<p><b><span>14. Compensation</span></b><span></span></p>

<p><span>Compensation is the process of counterbalancing perceived
weaknesses with perceived strengths. Example: A man who is unsuccessful at his
career tells himself that he’s a good husband and father.</span></p>

<p><b><span></span></b></p>

<p><b><span>15. Assertiveness</span></b><span></span></p>

<p><span>Assertiveness is the expression of a person’s needs in a manner
that is respectful, direct, and firm. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C
is correct. </span></b><span>Regression is the reversion to an earlier stage of development
in the face of unacceptable thoughts.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is incorrect. </span></b><span>Denial is the refusal to accept reality.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is incorrect. </span></b><span>Displacement is the redirection of thoughts about one person so
they are “aimed” at another person. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D
is incorrect. </span></b><span>Repression is the unconscious blocking of unacceptable thoughts.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E
is incorrect.</span></b><span> Sublimation is the channeling of unacceptable thoughts into
acceptable ones.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
78-year-old man is admitted to the intensive care unit after sustaining a burn
over 20% of his body. The following day he cannot recall why he is in the
hospital, and he accuses the staff of torturing him. He is disoriented to place
and date. His wife says he was “normal” before the burn. What is the most
likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Major
depressive disorder</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Delirium</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dementia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Mania</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Schizophrenia</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Delirium</span></b><span> is an acute confusional state. It is not a
disease but a syndrome with many potential causes. The principal symptoms are
clouding of consciousness, difficulty maintaining or shifting attention,
disorientation, delusions, hallucinations, abnormal behavior, and fluctuating
levels of consciousness. Disturbance of the sleep-wake cycle manifested by
insomnia, daytime drowsiness, or disturbing dreams or nightmares may occur.
Symptoms tend to fluctuate over the course of the day, with improvement during
the daytime and worsening at night. Often patients cannot remember why they are
in the hospital or what happened while they were delirious. </span></p>

<p><span></span></p>

<p><span>Emotional
disturbances such as depression, anxiety, fear, and irritability are sometimes
seen. </span></p>

<p><span>Many
medical disorders, intoxications, and medicines can cause delirium. Often
delirium is multifactorial, and the physician must investigate each
contributing cause. Common causes include hypoxia, hypoglycemia, hyperthermia,
anticholinergic medicine, alcohol or sedative withdrawal, infection, fluid and
electrolyte abnormality, hepatic and renal failure, cerebral hypoperfusion,
structural lesion of the brain, postoperative state, vitamin deficiency
(especially thiamine and cyanocobalamin), and endocrinopathy. Medications can
cause delirium in elderly people even at therapeutic doses. Dementia is a
strong risk factor for delirium; dysphoria and depression are also major risk
factors.</span></p>

<p><span></span></p>

<p><span>Delirium
is a medical emergency associated with increased morbidity and mortality. It is
transient, appears rapidly, and is usually reversible. The diagnosis is made
clinically; laboratory and imaging tests do not establish the diagnosis.
Delirious patients are often given an incorrect diagnosis of dementia,
depression, mania, or schizophrenia due to the presence of overlapping
features.</span></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer B is correct</b>. Delirium is the
most likely diagnosis.<b></b></p>

<p><b></b></p>

<p><b>Answer A is incorrect</b>. <span>Major depressive disorder</span> is a
syndrome characterized by low mood, low self-esteem, and loss of interest or
pleasure in normally enjoyable activities. It is a disabling condition that
adversely affects sleep and appetite; work, school, and family life; and
general health.</p>

<p><b></b></p>

<p><b>Answer C is incorrect</b>. <span
 is characterized by a progressive decline in
memory and at least one other cognitive function, such as attention,
orientation, judgment, abstract thinking, or personality.&nbsp; Delirium and
dementia are the most common causes of cognitive dysfunction (defined as the
inability to acquire, retain, and use knowledge normally). Although these
conditions may occur together, they are quite different. Delirium begins
suddenly, causes fluctuations in mental function, and is usually reversible. Dementia
begins gradually, is slowly progressive, and is usually irreversible.<span>&nbsp;&nbsp; </span>Delirium affects mainly attention;
dementia affects mainly memory. Both are more common in older people.</p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. <span>Mania</span> is characterized by excessive
elevation <span>of mood that is disproportionate to the situation</span>.</span> Mania
may be caused by drugs (e.g., cocaine, methamphetamine), medication (e.g.,
glucocorticoids), and malignancy, but is most commonly associated with bipolar
disorder, where episodes of mania alternate with episodes of major depression.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect</span></b><span>. <span>Schizophrenia<b> </b></span>is a severe,
persistent, and debilitating condition characterized by disintegration of
thought and poor emotional responsiveness. Common symptoms include auditory
hallucinations, paranoid and bizarre delusions, and disorganized speech and
thinking. The onset of symptoms typically occurs in young adulthood, with a
global lifetime prevalence of about 0.3&#8211;0.7%.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 74-year-old man has a two-year history of progressive change in
behavior. He writes everything down on a notepad; otherwise, he forgets. He
cannot remember the names of his cousins or his birthday. His blood test
results are normal, including thyroid hormone and vitamin B12 levels. A drug
from which of the following classes is most likely to improve symptoms? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acetylcholinesterase
inhibitor</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Benzodiazepine</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Opioid
receptor antagonist</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Phenothiazine</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tricyclic
antidepressant</span></p>

<p><span></span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Dementia</b> is a serious
loss of cognitive ability in a previously unimpaired person, beyond what might
be expected from normal aging. It may be static, the result of a unique global
brain injury, or progressive, resulting in long-term decline due to damage or
disease in the body. Although dementia is far more common in the geriatric
population, it can occur before the age of 65, in which case it is termed
“early onset dementia.” </p>

<p></p>

<p>Dementia is a syndrome
(i.e., set of signs and symptoms) in which affected areas of cognition may be
memory, attention, language, and problem solving. It is normally required to be
present for at least 6 months to be diagnosed. In all types of general
cognitive dysfunction, higher mental functions are affected first in the
process.Dementia reduces the ability to learn, reason, retain or recall past
experiences. There is also loss of patterns of thoughts, feelings and
activities. As dementia worsens individuals may neglect themselves and may
become disinhibited or incontinent. Especially in the later stages of the
condition, affected persons may be disoriented in time (not knowing what day of
the week, day of the month, or even what year it is), in place (not knowing
where they are), and in person (not knowing who they, or others around them, are).
</p>

<p>Dementia, though often
treatable to some degree, is usually due to causes that are progressive and
incurable. </p>

<p></p>

<p>Symptoms of dementia can be
classified as either reversible or irreversible. Less than 10% of cases of
dementia are due to causes that may presently be reversed with treatment.
Without careful assessment of history, the short-term syndrome of delirium
(often lasting days to weeks) can easily be confused with dementia, because they
have all symptoms in common, save duration. Some mental illnesses, including
depression and psychosis, may produce symptoms that must be differentiated from
both delirium and dementia. </p>

<p></p>

<p>There are many specific
types (causes) of dementia, often showing slightly different symptoms. However,
the symptom overlap is such that it is impossible to diagnose the type of
dementia by symptomatology alone, and in only a few cases are symptoms enough
to give a high probability of some specific cause. Certainty cannot be attained
except with brain biopsy during life or at necropsy in death. Some of the most
common forms of dementia are: Alzheimer disease, vascular dementia,
frontotemporal dementia, semantic dementia, and dementia with Lewy bodies. </p>

<p><span></span></p>

<p><span>Currently,
there are no medications that are clinically proven to be preventative or
curative of dementia. Although some medications are approved for use in the
treatment of dementia, these treat the behavioral and cognitive symptoms of
dementia, but have no effect on the underlying pathophysiology.
Acetylcholinesterase inhibitors -- Tacrine (Cognex), donepezil (Aricept),
galantamine (Razadyne), and rivastigmine (Exelon) -- are approved for treatment
of dementia induced by Alzheimer disease. They may be useful for other similar
diseases causing dementia such as Parkinson disease or vascular dementia.
Acetylcholinesterase inhibitors aim to increase the amount of the
neurotransmitter acetylcholine, which is deficient in people with dementia.
This is done by inhibiting the action of the enzyme acetylcholinesterase, which
breaks down acetylcholine as part of normal brain function. Though these
medications are commonly prescribed, in a minority of patients these drugs can
cause side effects including bradycardia and syncope. </span></p>

<p><span></span></p>

<p><b>Answer A is correct. </b>Dementia is associated with acetylcholine
deficiency. Symptoms may improve with use of an acetylcholinesterase inhibitor,
which would increase levels of acetylcholine.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Part 1.
Ms. Streetwise is a 58-year old homeless widow brought to the Emergency
Department after jumping off an overpass in an apparent suicide attempt.
Fortunately, she fell on a grassy bank and sustained only superficial cuts.<span>&nbsp; </span>She is alert and fully oriented. Psychomotor
activity and speech are slow.<span >&nbsp; </span>She
is tearful and states that she has felt despondent and alone for quite some
time. She decided it was time to end her suffering. Her energy is low, she has
lost 15 pounds due to poor appetite, and she does not sleep well.<span>&nbsp; </span>She has not enjoyed life lately. She
left her senior retirement center because she felt she didn’t deserve such a
good place. She believes that she has caused great suffering in the world, as
she has not attended church to pray for others in two years.<span>&nbsp; </span>Prior to retiring five years ago, she
was a successful school teacher who regularly won teaching awards.</span></p>

<p><span></span></p>

<p><span>Which of
the following tests would be <i>least</i>
helpful at this time?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Thyroid
function tests</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urine
drug screen</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serum
vitamin B12, folate, and thiamine levels</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Functional
MRI to assess brain metabolism</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>CT
to rule out head injury</span></p>

<p><span></span></p>

<p><span>Part 2.
You order thyroid function tests, a urine drug screen, a head CT, and serum
levels of vitamin B12, folate, and thiamine.<span>&nbsp; </span>All results are normal. You believe that
Ms. Streetwise’s suicide attempt was the result of a mental disorder. What is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Schizoaffective
Disorder</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Major
Depression</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Malingering</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Alcoholism</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Delusional
Disorder</span></p>

<p><span></span></p>

<p><span>Part 3.
How would you treat Ms. Anderson?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Start
a tricyclic antidepressant and refer her to a shelter</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Start
an SSRI (selective serotonin reuptake inhibitor) and place her in the care of
concerned family members </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Start
a second-generation antipsychotic and refer her to a community mental health
center</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hospitalize
her in a psychiatric inpatient unit</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Keep
her under observation status for 24 hours in the emergency department</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Part 1</span></p>

<p><span></span></p>

<p><b><span>Answer D is correct.</span></b><span><span>&nbsp; </span>Although functional MRI may be abnormal
in chronic mood disorders, dementia, and other brain conditions, it is costly,
unnecessary, and not available in most medical centers.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect. </span></b><span>Thyroid function tests
would be helpful because untreated hypothyroidism can cause depressed mood.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect.<span>&nbsp; </span></span></b><span>Urine drug screen would be helpful because CNS
depressants, such as benzodiazepines and alcohol, can cause depressed mood.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.<span>&nbsp; </span></span></b><span>Deficiencies of vitamin B12, folate, and
thiamine can adversely affect mood.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect. </span></b><span>Because of her fall, a
head CT should be ordered to exclude intracranial bleed. </span></p>

<p><b><span></span></b></p>

<p><span>Part 2</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct. </span></b><span>Ms. Anderson has more
than 5 of the 9 criteria required to make the diagnosis of major depression:
depressed mood, low energy, decreased appetite and weight loss, suicidality,
loss of interest, sleep disturbance, and excessive guilt. She has major
depression with psychotic features.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>Ms. Anderson has been highly functional
in the past, which argues against schizoaffective disorder. There is no known
history of at least two weeks of psychosis <i>outside</i>
of a mood disturbance, which could suggest schizoaffective disorder. Also, her
delusional guilt appears to be mood congruent.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect.</span></b><span> Malingering involves
faking illness for secondary gain. There is no evidence that Ms. Anderson is
seeking secondary gain.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect.</span></b><span> The negative urine drug
screen makes alcoholism unlikely. The urine drug test can detect alcohol
several days after consumption.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect.</span></b><span> Delusional disorder
involves having a delusion <i>about
something that is feasible.</i> (Causing the world’s problems is not feasible.)
Also, delusional disorder would not be associated with a predominant mood
disturbance.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><span>Part 3</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct. </span></b><span>After a significant
suicide attempt, hospitalization is indicated to ensure the patient’s safety
and compliance with treatment. Discharging a suicidal patient can lead to
adverse consequences (not to mention a malpractice suit).</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect. </span></b><span>Tricyclics are fatal in
overdose. A shelter cannot provide adequate monitoring.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect. </span></b><span>Family members should
not be entrusted to care for an actively suicidal patient.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect. </span></b><span>A second-generation
antipsychotic would not be the primary treatment for depression, but might be
indicated adjunctively for her psychosis. Outpatient treatment at a community
mental health center is not acceptable.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect. </span></b><span>Nothing is gained by
24-hour observation. Moreover, an attendant would be necessary to ensure that
no further suicide attempts occur.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
children of a 67-year-old woman ask their family physician for advice about
their mother's behavior 4 weeks after the death of her husband of 40 years.
They are concerned because she weeps whenever she comes upon an object in her
home that she associates with him. Her appetite has decreased, and she has had
a 2-kg (4.4-lb) weight loss. She awakens 1 hour before the alarm goes off each
morning. She is able to care for herself. Although she does not leave her home
for any social activities, she does enjoy visits from her family. Which of the
following is the most likely explanation for her symptoms and the most
appropriate management?</span></p>

<p><span>&nbsp;</span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Normal
grief reaction, and she requires no medical attention</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Normal
grief reaction, and she would benefit from an antidepressant</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Major
depression, and she should be treated with an antidepressant</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Pathologic
grief reaction, and she should be treated with psychotherapy</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pathologic
grief reaction, and she should be encouraged to move in with one of her
children</span></p>

<p><span>&nbsp;</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i><span>Grief</span></i><span>&nbsp;</span></span><span>may be defined as
the physical and emotional pain precipitated by a significant loss. The loss
may be of a person or pet, but it can also be of a meaningful place, job, or
object. A term closely related to grief is<span means to be robbed by death. Many subtypes of grief have been
suggested; some of the more commonly used subtypes appear below.</span><span></span></p>

<p></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td valign=top>
  <p><span>Anticipatory grief</span></p>
  </td>
  <td valign=top>
  <p><span>A grief reaction that
  occurs in anticipation of an impending loss; its symptoms include anger,
  guilt, anxiety, irritability, sadness, feelings of loss, and a decreased
  ability to perform usual tasks.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Acute grief</span></p>
  </td>
  <td valign=top>
  <p><span>The first stage of the
  process of bereavement. Symptoms may begin immediately following the loss, or
  may be delayed.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Delayed grief</span></p>
  </td>
  <td valign=top>
  <p><span>The absence of the
  expression of grief at the time of a loss.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Unresolved grief</span></p>
  </td>
  <td valign=top>
  <p><span>Grief symptoms that reach
  extremes of intensity, duration, or tenacity.</span><a
  href="http://www.mdconsult.com.webproxy.ouhsc.edu/books/linkTo?type=bookPage&amp;isbn=978-0-323-04743-2&amp;eid=4-u1.0-B978-0-323-04743-2..50040-8--bib2&amp;appID=MDC"><sup><span>[2]</span></sup></a><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Complicated grief</span></p>
  </td>
  <td valign=top>
  <p><span>Unresolved grief plus
  clinical complications (e.g., physical symptoms) that interfere with daily
  function.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=319 height=390
src="_%20Tutorials_files/image517.png" v:shapes="Picture_x0020_347495"></span><span></span></p>

<p><span></span></p>

<p><b><span>Answer
A is correct.</span></b><span> The patient is having a normal grief reaction and
requires no medication. </span><span></span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect.</span></b><span><span>&nbsp; </span>Normal grief reactions are time limited
(less than 2 months) and do not warrant antidepressant therapy.</span></p>

<p><span></span></p>

<p><b><span>Answer
C and D are incorrect. </span></b><span>Bereavement may become a Major Depressive Episode or a
pathologic grief reaction if it persists for more than 2 months or includes
marked impairment, morbid preoccupation with worthlessness, suicidal ideation,
psychotic symptoms, hallucinatory experiences (other than thoughts of hearing
the voice of, or transiently seeing, the deceased person), or psychomotor
retardation. Major Depression may be treated with an antidepressant, and both
depression and pathologic grief may respond to psychotherapy.</span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect.</span></b><span>
Moving in with children is not generally recommended by physicians unless
patients cannot care for themselves, whether for physical or mental health
problems. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 4-month-old boy is brought to the
physician by his mother for a well-child examination. He is at the 98th
percentile for head circumference. Physical examination shows dilation of the
scalp veins and spasticity of the lower extremities. The physician suspects
excessive cerebrospinal fluid accumulation in the ventricular system of the
brain. The source of this fluid is most likely which of the following?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Choroid
plexus</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dura
mater</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pia
mater</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Roof of the third
ventricle<span></span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hydrocephalus</span> is a medical condition in which there is an abnormal
accumulation of cerebrospinal fluid (CSF) in the ventricles of the brain. This
may cause increased intracranial pressure inside the skull and progressive
enlargement of the head, convulsion, tunnel vision, mental disability, and
death. The clinical presentation of hydrocephalus varies with chronicity. </p>

<p>Acute dilatation of the
ventricular system is more likely to manifest with the signs and symptoms of
increased intracranial pressure, such as headache, vomiting, papilledema,
sleepiness, or coma. </p>

<p></p>

<p>Elevated intracranial
pressure may result in uncal and/or cerebellar tonsil herniation, with
resulting life threatening brain stem compression. By contrast chronic
dilatation (especially in the elderly population) may have a more insidious
onset, presenting, for instance, with Hakim's triad: gait instability, urinary
incontinence and dementia. This triad is typical of the condition, normal
pressure hydrocephalus (NPH). In infants with hydrocephalus, CSF builds up in
the central nervous system, causing the fontanelle to bulge and the head to be
larger than expected. </p>

<p></p>

<p>Early symptoms may also
include downward gaze, irritability, seizures, sleepiness, vomiting, and
spasticity of the extremities.<span >&nbsp; </span></p>

<p><span></span></p>

<p><span>Hydrocephalus
can be caused by impaired CSF flow, impaired CSF reabsorption, or excessive CSF
production.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>The most common cause of
hydrocephalus is CSF flow obstruction, hindering the free passage of
cerebrospinal fluid through the ventricular system and subarachnoid space (e.g.,
stenosis of the cerebral aqueduct or obstruction of the interventricular
foramina secondary to tumor, hemorrhage, infection, or congenital
malformation). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=243 height=271
src="_%20Tutorials_files/image519.png" alt="Description: csf" v:shapes="Picture_x0020_347377"></span><span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hydrocephalus can also
be caused by overproduction of cerebrospinal fluid (e.g., papilloma of choroid
plexus). The choroid plexus consists of a layer of cuboidal epithelial cells
surrounding a core of capillaries and loose connective tissue. The epithelial
layer is continuous with the ependymal cell layer that lines the ventricles,
but unlike the ependyma, the choroid plexus layer has tight junctions in
between cells on the side facing the ventricle (apical surface). These tight
junctions prevent the majority of substances from crossing the cell layer into
the CSF; thus, the choroid plexus acts as a blood-CSF barrier. The choroid
plexus folds into many villi around each capillary, creating frond-like
processes that project into the ventricles. These villi greatly increase the
surface area of the choroid plexus. CSF is formed as plasma is filtered from
the blood through the epithelial cells. In addition to CSF production, the
choroid plexus acts as a filtration system, removing metabolic waste, foreign
substances, and excess neurotransmitters. In this way, the choroid plexus has
an important role in helping to maintain the delicate extracellular environment
required by the brain to function optimally.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>Enlarged head, dilated
scalp veins, and lower extremity spasticity are consistent with hydrocephalus
and increased intracranial pressure. Hydrocephalus can be caused by obstruction
of CSF flow or by overproduction of CSF by the choroid plexus (e.g. choroid
plexus papilloma). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Normal
infant development involves timely acquisition of specific cognitive, social,
and motor skills. Which of the following skills would <i>not</i> be expected in a 7-month old infant? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Recognizes
and prefers mother</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Explores
with hands and mouth </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Uses
voice to express joy and displeasure </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Transfers
object from hand to hand </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulls
self up to stand </span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Important milestones for an infant at 2 months,
6 months, and 1 year of age appear below. </span></b></p>

<p><b><span></span></b></p>

<p><b><u><span>2 MONTHS</span></u></b><u><span>:</span></u></p>

<p><span></span></p>

<p><b><span>Social and Emotional</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Begins
to smile responsively</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Responds
to familiar voices</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Recognizes
mother</span></p>

<p><b><span>Gross Motor Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>When
on stomach, able to lift head almost 45 degrees</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Less
flexing of the arms and legs while lying on the stomach</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Disappearance
of stepping reflex (baby appears to dance or step when placed upright on solid
surface) </span></p>

<p><b><span>Fine Motor Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Grasp
reflex (grasping a finger) starts to disappear</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hands
are fisted 50% of the time</span></p>

<p><b><span>Language Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Turns
to sounds</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Coos</span></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span>6 MONTHS:</span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><span>Social and Emotional</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Removes
a covering over face (start of the peekaboo game)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Vocalizes
to own image in a mirror and in response to toys</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Recognizes
and prefers mother</span></p>

<p><b><span></span></b></p>

<p><b><span>Gross Motor Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Able
to roll from back to stomach (rolled from stomach to back at age 4 months)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Able
to sit alone while propped on hands</span></p>

<p><b><span>Fine Motor Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Able
to drop and object and pick it up again</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rakes
a small object with hand to pick it up</span></p>

<p><b><span>Language Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Babbles
with consonants (“bababa, gagaga”)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Listens
then vocalizes when adult stops</span></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span>12 months:</span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><span>Social and Emotional</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Separation
anxiety (Cries when mother or father leaves)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Has
stranger anxiety that developed around 9 months of age (Shy or anxious with
strangers)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Enjoys
imitating people in his/her play </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Shows
specific preferences for certain people and toys </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Shows
objects to parent to share interest </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Points
to get desired object</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>**lack
of these Social/Emotional milestones by 12 months are “red flags” for autism
spectrum disorders**</span></p>

<p><b><span>Gross Motor Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Stands
alone (with arms help high and legs splayed)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Takes
independent steps</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulled
to stand at 9 months and cruised around furniture holding on with hands at 10
months</span></p>

<p><b><span>Fine Motor Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Has
a fine pincer grasp (can pick up a small object with thumb and forefinger)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Scribbles
with a crayon after demonstration</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Attempts
to build a tower of two</span></p>

<p><b><span>Language Development</span></b></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Says
one word in addition to “dada” and “mama” </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Responds
to “no” </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Uses
simple gestures, such as shaking head for “no” </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Waves
“bye-bye”</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tries
to imitate words </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. “Pulling self up to
stand” is a 9-month milestone.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>. “Recognizing mother”
is a 3-month milestone. “Preferring mother” is a 6-month milestone. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect</span></b><span>. “Explores with hands
and mouth” is a 3-4 month milestone.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect</span></b><span>. “Using voice to
express joy and displeasure” is a 4-5-month milestone.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. “Transferring object
from hand to hand” is a 6-month milestone.</span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
23-year-old woman has a 7-year history of unilateral, throbbing, increasingly
severe headaches. The headaches last about 8 hours, are associated with nausea
and vomiting, and are exacerbated by loud noises. Physical examination shows no
abnormalities. Which of the following medicines is most likely to provide pain
relief if administered soon after the onset of headache?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Propranolol</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Amitriptyline</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Divalproex</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Topiramate</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sumatriptan</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Migraine headaches may be
unilateral or bilateral and may occur with or without an aura. The headache
typically lasts from 4-72 hours. Pain intensity is usually moderate to severe
and intensifies with movement or physical activity. Many patients prefer to lie
quietly in a dark room. The pain usually subsides gradually within a day or
after sleep. A majority of patients feel tired or weak afterward. Nausea and
vomiting usually occur, and photophobia and/or phonophobia are common findings.
</p>

<p></p>

<p>Many patients report
premonitory symptoms that occur hours to days before the onset of </p>

<p>headache. These include
heightened sensitivity to light, sound, or odors; lethargy or yawning; food
cravings; or mental and mood changes. Many patients also describe an aura (a
complex of neurologic symptoms preceding or accompanying the headache). Auras
usually develop over 5-20 minutes and last less than 60 minutes. They can be
visual, sensory, or motor. Most are visual, and the most common visual
phenomenon is the scintillating scotoma, which is an arc of absent vision with
a shimmering, zigzag border. Common migraine triggers include food, hormonal
changes, physical exertion, fatigue, and medication.</p>

<p></p>

<p>Migraine treatment involves
acute (abortive) and preventive (prophylactic) therapy, as well as avoiding
migraine triggers. Acute treatment aims to eliminate or halt progression of the
headache. Preventive treatment aims to reduce the frequency and severity of
migraine attacks.<span >&nbsp; </span></p>

<p>Abortive therapies include
acetaminophen and non-steroidal anti-inflammatory drugs for mild to moderate
headache, and triptans for moderate to severe headache. The triptans work by
binding to serotonin 5-HT receptors in nerve endings and on cranial blood
vessels (causing vasoconstriction). They are most effective when taken at the
beginning of a migraine. The safety of triptans is well established, and the
risk of coronary vasospasm is exceedingly rare. Still, triptans should not be
taken by patients with known or suspected coronary artery disease, as they may
increase risk of cardiovascular and cerebrovascular events. </p>

<p></p>

<p>Migraine prophylaxis should
be considered in patients with frequent or prolonged headaches. First-line
drugs for prophylaxis include beta-blockers such as propranolol, tricyclic
antidepressants such as amitriptyline, and anticonvulsants such as divalproex and
topiramate.<span >&nbsp; </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer E is correct. </b>Sumatriptan belongs to the triptan class.
Triptans are useful as abortive therapy for migraines, especially when taken
soon after the headache begins.<span >&nbsp; </span></p>

<p><b></b></p>

<p><b>Answer A is incorrect. </b>Propranolol is a beta-blocker. Beta-blockers
are useful for prophylactic (not abortive) therapy of migraines. </p>

<p><b></b></p>

<p><b>Answer B is incorrect. </b>Amitriptyline is a tricyclic
anti-depressant. Tricyclic anti-depressants are useful for prophylactic (not
abortive) therapy of migraines. </p>

<p><b></b></p>

<p><b>Answer C is incorrect</b>. Divalproex is an anti-convulsant drug that
is useful for prophylactic (not abortive) therapy of migraines. </p>

<p><b></b></p>

<p><b>Answer D is incorrect</b>. Topiramate is an anti-convulsant drug that
is useful for prophylactic (not abortive) therapy of migraines. </p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
34-year-old woman presents with a one-week history of decreased vision in the
right eye. She can see objects in the peripheral field, but not directly in
front of her. She has experienced pain behind the right eye that worsens with
eye movement. Her vision is clear in the left eye, and she has no blurred
vision. Two years ago, she went through a “spell” in which she had trouble
climbing stairs. She would drag her right leg while walking. Also, she could
not feel warm or cold water in the left leg when she took a bath. The lower
extremity symptoms improved after a few weeks. </span></p>

<p><span></span></p>

<p><span>On
physical examination, visual acuity is 20/200 in the right eye and 20/20 in the
left. Visual field testing shows central loss of vision in the right eye. The
pupillary responses are sluggish when light is directed into the right eye, but
normal when light is directed into the left eye. Swinging the light from the
left to the right eye causes both pupils to enlarge. Fundoscopic examination is
normal. There is mild weakness and increased tone in the right lower extremity.
The right knee and ankle reflexes are hyperactive; other reflexes are normal.
Babinski sign is present on the right. Pinprick sensation is slightly decreased
in the left leg. </span></p>

<p><span></span></p>

<p><span>What is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Intracranial
hemorrhage</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Occipital
lobe tumor</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Amyotrophic
lateral sclerosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Multiple
sclerosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ocular
migraine</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
pathway for the pupillary light reflex begins in the retina (Figure 6-2). The
axons from the retinal ganglion cell (RET) run through the optic nerve (ON),
optic chiasm (CHI), and optic tract (OT). They synapse in the pretectal nucleus
(PTN) of the midbrain at the level of the oculomotor nerve. Fibers then run
from the pretectal nucleus to both Edinger-Westphal nuclei (EWN) of the
oculomotor nerve complex. The nerve fibers from the Edinger-Westphal nuclei run
in the oculomotor nerve to the ciliary ganglion (CG) and then through short
ciliary nerves to the iris sphincter. </span></p>

<p><span></span></p>

<p><span>When light
is directed into one eye, the information regarding light brightness is
summated in the pretectal region of the midbrain. That information goes to both
Edinger-Westphal nuclei equally. Consequently, both pupils constrict equally
when a bright light is directed into one eye. If for some reason (e.g., optic
nerve lesion, retinal detachment, opacified cornea), less light is “conveyed”
through the optic nerve, the pretectal region will detect this, both
Edinger-Westphal nuclei will receive less input, and the pupillary response
will be bilaterally sluggish or absent. However, when light is projected into
the normal eye, both pupils will constrict briskly.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>In this
vignette, light directed into the right eye causes both pupils to react
sluggishly, whereas light directed into the left eye causes both pupils to
constrict briskly. The efferent arc (oculomotor nerve) of the light reflex is,
therefore, normal. The lesion must be in the afferent limb of the reflex arc.
Fibers carrying information on light brightness cross at the optic chiasm.
Since the patient has a uniocular deficit, the lesion must be anterior to the
optic chiasm. This afferent pupillary defect is called the Marcus Gunn
pupillary sign. Because the cornea, lens, ocular media, and macula appear
normal, the lesion must be in the optic nerve.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Lower
extremity findings include right-sided weakness and left-sided loss of pinprick
and temperature sensation (Figure 6-4). These findings are consistent with a
lesion in the right half of the spinal cord. Such a lesion would affect
corticospinal fibers to the right lower extremity and spinothalamic fibers from
the left lower extremity. If the dorsal columns were involved, loss of
vibratory sensation and proprioception would be present on the ipsilateral
side. Because the lower, but not the upper, extremities are affected, the
lesion must be caudal to T1 and rostral to L2 (spinal levels). (The upper
extremities are innervated by spinal nerves C5 to T1; the lower extremities are
innervated by spinal nerves L2 to S1. For a lesion to “miss” the upper
extremities and “hit” the lower extremities, it must be located below T1 and
above L2.)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>

<table cellpadding=0 cellspacing=0 align=left>
 <tr>
  <td width=68 height=0></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=298 height=371 src="_%20Tutorials_files/image521.png" v:shapes="Picture_x0020_347400"></td>
 </tr>
</table>

</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><span><img width=416 height=644
src="_%20Tutorials_files/image523.png" v:shapes="Picture_x0020_347399"></span></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<br clear=ALL>

<p><b><span>Answer D is correct. </span></b><span>This patient has two
separate sites of neurological involvement &#8211; the right optic nerve and
the right spinal cord. The most likely diagnosis in a 34-year old woman is
multiple sclerosis. Multiple sclerosis is a demyelinating disease that, by
definition, affects more than one CNS site. (Myelin is a substance that
provides “electrical insulation.” It forms a layer, the myelin sheath, which is
usually around only the axon of a neuron. Schwann cells supply the myelin for
peripheral neurons, whereas oligodendrocytes myelinate the axons of the central
nervous system.) Demyelination of the optic nerve (optic neuritis) explains the
visual findings and demyelination of the spinal cord explains the lower
extremity findings. The diagnosis of multiple sclerosis requires the presence
of multiple CNS lesions, a history of relapse and remission, involvement of
white matter, and exclusion of other diagnoses. The most common cause of optic
neuritis is multiple sclerosis. Up to 50% of patients with multiple sclerosis
will develop optic neuritis, and in 20-30% of cases, optic neuritis is the
presenting sign.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Drug X applied to a nerve axon decreases
the duration of the action potential without affecting the resting potential or
peak amplitude of the action potential. Which of the following is the most
likely mechanism of action of Drug X?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Blockade
of voltage-gated Na<sup>+</sup> channels</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decrease
in the rate of Na<sup>+</sup> inactivation</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decrease
in rate of opening of voltage-gated Na<sup>+</sup> channels</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Increase
in the rate of opening of voltage-gated K<sup>+</sup> channels</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Inhibition
of the Na<sup>+</sup>/K<sup>+</sup>-ATPase pump</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Nerve fibers conduct “messages” in the
form of action potentials. An action potential is an electrical current that
travels down a nerve fiber. An action potential can occur only when opposite
charges exist on two sides of a cell membrane. Nerve fibers are positively
charged on the outside and negatively charged on the inside. An action
potential represents a brief reversal of that charge (positive on the inside
and negative on the outside) as it travels down the nerve fiber. </span></p>

<p><span></span></p>

<p><span>Neurons use Na<sup>+</sup> and K<sup>+</sup>
to maintain polarity. Na<sup>+</sup> is highly concentrated outside the cell
and K<sup>+</sup> is highly concentrated inside the cell. When a nerve is
resting (not transmitting an electrical message), Na<sup>+</sup> and K<sup>+</sup>
move down their concentration gradients through <i>potassium-sodium leak channels</i> to opposite sides of the membrane.
These leak channels are always open. Na<sup>+</sup> travels from outside to
inside the nerve, and K<sup>+</sup> travels from inside to outside the nerve.
This continuous process is possible because the cell membrane contains a <i>Na<sup>+</sup>/K<sup>+</sup> ATPase</i> <i>pump</i>, which returns Na<sup>+</sup> and K<sup>+</sup>
to their original positions. The pump moves Na<sup>+</sup> from inside to
outside the nerve and K<sup>+</sup> from outside to inside the nerve. This
requires energy in the form of ATP. For every 3 Na<sup>+</sup> pumped out of
the cell, 2 K<sup>+</sup> are pumped in. This 3-to-2 discrepancy allows the
inside of the neuron to be negatively charged relative to the outside. This
“charged” state is called the <b>resting
potential.</b> </span></p>

<p><span></span></p>

<p><span>The first step in sending an electrical
signal (action potential) is called depolarization. During <b>depolarization</b>, <i>voltage-gated
Na<sup>+</sup> channels</i> open, allowing Na<sup>+</sup> to “rush” into the
cell, causing the inside of the nerve to become positive. During <b>repolarization</b>, the cell must return to
its resting potential. This is achieved by opening <i>voltage-gated K<sup>+</sup> channels</i>, which allow K<sup>+</sup> to
rush out of the cell, causing the outside of the neuron to become positive.
Once again, the resting potential is restored. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=416 height=205
src="_%20Tutorials_files/image525.png" alt="Description: biological-membrane"
v:shapes="Picture_x0020_347376"></span><span></span></p>

<p><span></span></p>

<p><span>The figure above shows different types of
transmembrane proteins in a cell membrane.<span >&nbsp;
</span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Channel
protein (always open): Example: potassium-sodium leak channel</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gated
channel proteins (open or closed): Examples: voltage-gated Na<sup>+</sup>
channel and voltage-gated K<sup>+</sup> channel</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Transport
protein: Na<sup>+</sup>/K<sup>+</sup> pump ATPase pump</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=329 height=169
src="_%20Tutorials_files/image527.png" alt="Description: ActionPotential"
v:shapes="Picture_x0020_347375"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Phases of an
action potential</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=342 height=191
src="_%20Tutorials_files/image529.png" alt="Description: ap3" v:shapes="Picture_x0020_347374"></span><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>The opening
and closing of voltage-gated channels causes ion shifts during an action
potential</span></p>

<p><span></span></p>

<p><span>Also, see demonstration at: </span><a
href="http://outreach.mcb.harvard.edu/animations/actionpotential.swf"><span>http://outreach.mcb.harvard.edu/animations/actionpotential.swf</span></a><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is correct. </span></b><span>Increasing
the rate of opening of voltage-gated K<sup>+</sup> channels would speed
repolarization and shorten the action potential. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is incorrect. </span></b><span>Blocking
voltage-gated Na<sup>+</sup> channels would prevent an action potential from
occurring. This is how many anesthetics work. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is incorrect. </span></b><span>Slowing
the rate at which Na<sup>+</sup> channels close (i.e., Na<sup>+</sup>
inactivation) would lengthen the time during which Na<sup>+</sup> could enter
the cell, thereby increasing the peak amplitude of the action potential and
delaying the onset of repolarization.<span >&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is incorrect.</span></b><span>
Decreasing the rate of opening of voltage-gated Na<sup>+</sup> channels would
inhibit depolarization and lengthen the action potential. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E
is incorrect.</span></b><span>
Inhibition of the Na<sup>+</sup>/K<sup>+</sup>-ATPase pump would depolarize the
neuron and prevent the establishment of a resting potential. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 35-year-old man sustained
an injury to his left leg. Examination shows left foot drop with numbness and
paresthesias over the lateral leg and dorsal foot. Injury to which of the
following nerves is most likely? </p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Femoral</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Lateral femoral cutaneous nerve</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Posterior tibial</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Common fibular (peroneal)</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Sciatic</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Nerves traveling from the
spinal cord to the extremities may become entrapped due to injury or
inflammation. The most common entrapment neuropathies appear below. </p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=443 colspan=2 valign=top>
  <p style="text-align:center;"><span>Entrapment Neuropathy</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span></span></p>
  </td>
  <td width=248 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Nerve(s)</span></p>
  </td>
  <td width=248 valign=top>
  <p style="text-align:center;"><span>Symptoms</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span></span></p>
  </td>
  <td width=248 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Brachial plexus and/or subclavian artery or vein (<i>Thoracic outlet syndrome</i>)</span></p>
  <p><span></span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness, and
  paresthesias along the ulnar aspect of the forearm, hand, and 4<sup>th</sup>
  and 5<sup>th</sup> fingers</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Swelling and pain in
  the arm</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Episodic cramping of
  the hand, especially with arm elevation</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Axillary
  nerve </span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness, and
  paresthesias over<span >&nbsp; </span>the outer
  shoulder </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Shoulder weakness </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Difficulty lifting
  objects </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Difficulty lifting arm
  above the head</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Radial
  nerve </span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness, and
  paresthesias of the forearm, the “thumb side&quot; of the dorsal hand, and
  the 2<sup>nd</sup> and 3<sup>rd</sup> fingers</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Difficulty extending
  the elbow </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Difficulty extending
  the wrist </span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Median
  nerve (<i>Carpal tunnel syndrome</i>)</span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness and
  paresthesias over the<span >&nbsp; </span>wrist,
  palm, thumb, and<span >&nbsp; </span>2<sup>nd</sup>
  and 3<sup>rd</sup> fingers<span >&nbsp;&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Difficulty with finger
  coordination </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Wasting of thenar
  eminence (in advanced cases) </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Weak grip</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Ulnar
  nerve</span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness, and
  paresthesias in the 4th and 5th fingers, usually on the palm side </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Weak grip</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Difficulty with finger
  coordination</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Muscle wasting (in
  advanced cases)</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Femoral
  nerve </span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness, and
  paresthesias of the medial thigh and anteromedial calf</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Weakness of the
  quadriceps muscle (knee extension) </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Difficulty walking up
  and down stairs, especially down</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Feeling knee
  &quot;give way&quot;</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Decreased patellar
  reflex</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Lateral femoral cutaneous nerve<span>&nbsp; </span>(<i>Meralgia
  paresthetica</i>)</span><span></span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness, and
  paresthesias over the anterolateral thigh</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Posterior tibial nerve (<i>Tarsal tunnel syndrome</i>)</span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness, and
  paresthesias over the plantar surface of the foot</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Common
  peroneal nerve </span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness, and
  paresthesias over the dorsal foot and lateral leg<span>&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>&quot;Slapping&quot;
  gait (walking pattern in which each step makes a slapping noise) </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Foot drop</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Toes dragging while
  walking</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span>Sciatic
  nerve </span></p>
  </td>
  <td width=248 valign=top>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Pain, numbness,
  paresthesias ranging from the lower back and upper buttock to the back of the
  thigh and leg</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Decreased ankle reflex</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Common peroneal nerve
dysfunction is associated with foot drop and numbness and paresthesias of the
lateral leg and dorsal foot. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Femoral nerve
dysfunction is associated with decreased patellar reflex, numbness of the
medial thigh and anteromedial calf, and weakness of the quadriceps muscle (knee
extension).</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Dysfunction of the
lateral femoral cutaneous nerve is associated with pain, numbness, and
paresthesias over the anterolateral thigh.</span></p>

<p><b></b></p>

<p><b>Answer C is incorrect</b>. Posterior tibial nerve dysfunction causes
tarsal tunnel syndrome, which is associated with pain and numbness over the
plantar surface of the foot.<span >&nbsp; </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect</span></b><span>. Sciatic nerve
dysfunction is associated with decreased ankle reflex and pain anywhere from
the lower back and upper buttock to the back of the thigh and leg.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
32-year-old college student is having trouble at school. He cannot complete his
experiments in the laboratory because he worries about germs. He spends two
hours each day cleaning his workbench with alcohol to reduce his anxiety. He is
studying <i>E. Coli</i> in the lab and has
persistent, intrusive worries about becoming infected. He gets angry when
others use his workbench. Which of the following is the most appropriate
pharmacotherapy for this patient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ciprofloxacin<span>&nbsp;&nbsp; </span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chlorpromazine</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Phenytoin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Fluoxetine</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Amitriptyline</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Obsessive-compulsive
disorder (OCD) is an anxiety disorder that causes significant distress and
functional impairment. OCD is characterized by obsessive thoughts and/or
repetitive compulsive actions. Obsessions are recurrent and persistent thoughts
that are intrusive, inappropriate, and not merely excessive worries about
real-life problems. Affected individuals try to suppress or ignore these
thoughts, recognizing them as abnormal. Compulsions are repetitive behaviors
(e.g., hand washing, ordering, checking) or mental acts (e.g., praying,
counting, repeating words silently) in response to an obsession or according to
rules that must be applied rigidly. These behaviors are aimed at reducing
distress or preventing some dreaded event; however, they are either excessive
or unrelated to the problem at hand.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><span>Obsessions
and their related compulsions often fall into one of the following categories. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=193 valign=top>
  <p style="text-align:center;"><b><span>Obsessions </span></b><span></span></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><b><span>Associated Compulsions </span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=193 valign=top>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=193 valign=top>
  <p><span>Fear of
  contamination</span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Washing,
  cleaning</span></p>
  </td>
 </tr>
 <tr>
  <td width=193 valign=top>
  <p><span>Need for
  symmetry or precise arranging</span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Ordering,
  arranging, balancing, straightening until &quot;just right&quot;</span></p>
  </td>
 </tr>
 <tr>
  <td width=193 valign=top>
  <p><span>Unwanted
  sexual or aggressive thoughts or images</span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Checking,
  praying, “undoing” actions, asking for reassurance</span></p>
  </td>
 </tr>
 <tr>
  <td width=193 valign=top>
  <p><span>Doubts
  (e.g., gas jets off, doors locked)</span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Repeated
  checking behaviors</span></p>
  </td>
 </tr>
 <tr>
  <td width=193 valign=top>
  <p><span>Concerns
  about throwing away something valuable</span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Hoarding</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p>Obsessive-compulsive
disorder can usually be treated in an outpatient setting. The mainstays of
treatment include serotoninergic antidepressant medications, behavior therapy,
education, and family interventions.<span >&nbsp;
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Fluoxetine is an
antidepressant medication of the selective serotonin reuptake inhibitor (SSRI)
class. Medicines in this class are effective in the treatment of
obsessive-compulsive disorder. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 48-year-old man has a 1-month history of progressive headache.
Funduscopic examination shows:</span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/1/1a/Papilledema.jpg"><span><img border=0 width=210 height=202
src="_%20Tutorials_files/image531.png" alt="Description: File:Papilledema.jpg"
v:shapes="Picture_x0020_347373"></span></a><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is the most likely cause of these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Acute occlusion of the retinal artery</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Increased intracranial pressure</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Inflammation of the anterior chamber</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Inflammation of the optic nerve</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Papilledema</span><span>
is optic disc swelling that is caused by increased intracranial pressure. The
swelling is usually bilateral and can occur over a period of hours to weeks.
When papilledema is found on fundoscopy, further evaluation is warranted as
vision loss can result if the underlying condition </span></p>

<p><span>is not
treated. Further evaluation with a CT or MRI of the brain is usually performed.
Papilledema may be asymptomatic or present with headache in the early stages. </span></p>

<p><span></span></p>

<p><span>The signs
of papilledema that are seen using an ophthalmoscope include</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>venous
engorgement (usually the first signs) </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>loss
of venous pulsation </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>hemorrhages
over and / or adjacent to the optic disc </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>blurring
of optic margins </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>elevation
of optic disc </span></p>

<p><span></span></p>

<p><span>Checking
the eyes for signs of papilledema should be carried out whenever there is a
clinical suspicion of raised intracranial pressure, and is recommended in
new-onset headaches. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct. </span></b><span>Venous engorgement,
blurred optic margins, and hemorrhages adjacent to the optic disc suggest
papilledema, a sign of increased intracranial pressure. Patients with increased
intracranial pressure often present with headache. (By contrast, patients with
central retinal artery occlusion, optic neuritis, or anterior uveitis are more
likely to present with eye/visual changes.)<span>&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect. </span></b><span>With central retinal
artery occlusion, there is complete loss of vision in the eye. The entire
retina (with the exception of the fovea) becomes pale and swollen and opaque
while the central fovea still appears reddish. This is the basis of the famous
&quot;cherry red spot&quot; seen on fundoscopy.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><span>Anterior uveitis</span><span>
usually presents with eye pain, eye redness, photophobia, and, to a variable
degree, decreased vision. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>Optic neuritis is
usually due to multiple sclerosis. Symptoms include sudden loss of vision or
sudden blurred or &quot;foggy&quot; vision and pain on movement of the affected
eye.<b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year-old man with schizophrenia develops difficulty walking while
taking haloperidol. Physical examination shows diffuse muscular rigidity. The
patient is slow in initiating movement and walks with a shuffling gait. Which
of the following drug properties is most likely responsible for this effect? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Anti-adrenergic </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Anti-dopaminergic</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Anti-histaminergic </span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Anti-muscarinic</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Anti-serotoninergic </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Parkinsonism</span><span>
(also known as <span>Parkinson syndrome)</span>
is a neurological syndrome characterized by tremor, hypokinesia, rigidity, and
postural instability. The underlying causes of parkinsonism are numerous, and
diagnosis can be complex.</span><a
href="http://en.wikipedia.org/wiki/Parkinsonism#cite_note-1#cite_note-1"></a><span> While the
neurodegenerative condition Parkinson disease (PD) is the most common cause of
parkinsonism, a wide-range of other etiologies can lead to a similar set of
symptoms, including some toxins, a few metabolic diseases, and a handful of
non-PD neurological conditions. Its most common cause is as a side effect of
medications, mainly neuroleptic antipsychotics, especially the phenothiazines
(such as perphenazine and chlorpromazine), thioxanthenes (such as flupenthixol
and zuclopenthixol), and butyrophenones (such as haloperidol), and piperazines
(such as ziprasidone). </span></p>

<p><span></span></p>

<p><span>Parkinson disease</span> is a degenerative disorder of the central
nervous system. The motor symptoms of Parkinson disease result from the death
of dopamine-generating cells in the substantia nigra, a region of the midbrain;
the cause of this cell death is unknown. Early in the course of the disease,
the most obvious symptoms are movement-related; these include shaking,
rigidity, slowness of movement and difficulty with walking and gait. Later,
cognitive and behavioral problems may arise, with dementia commonly occurring
in the advanced stages of the disease. Other symptoms include sensory, sleep,
and emotional problems. PD is more common in the elderly, with most cases
occurring after the age of 50.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct. </span></b><span>Neuroleptic
antipsychotics cause parkinsonism through their anti-dopaminergic properties. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
34-year-old woman is brought to the emergency room after slitting her wrists
with a sharp object. She is incarcerated and serving a life sentence for
murder. Once she is stabilized, she demands to be hospitalized until she is
completely “healed.” She threatens to harm the attending physician if he writes
for her discharge. Which of the following is the most likely diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Schizoid
personality disorder</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Antisocial
personality disorder</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Borderline
personality disorder</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Narcissistic
personality disorder</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Obsessive-compulsive
personality disorder</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Personality disorders</span><span>, formerly known as <span>character
disorders</span>, are characterized by &quot;an enduring pattern of inner
experience and behavior that deviates markedly from the expectations of the
culture.&quot; The behavior pattern is chronic, inflexible, and associated with
considerable personal and social disruption. </span></p>

<p><span></span></p>

<p><span>Personality
disorders are classified into three major “clusters.”</span></p>

<p><span></span></p>

<p><span>Cluster A (odd or eccentric)</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Paranoid personality disorder:</span><span> irrational suspicion
and mistrust of others </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Schizoid personality disorder:</span><span> lack of interest in
social relationships; seeing no point in sharing time with others; anhedonia;
introspection </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Schizotypal personality disorder:</span><span> social withdrawal; odd
behavior; magical thinking </span></p>

<p><span></span></p>

<p><span>Cluster B (dramatic or emotional)</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Antisocial personality disorder:</span><span> pervasive disregard for
the law and the rights of others </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Borderline personality disorder:</span><span> extreme &quot;black and
white&quot; thinking; mood instability; suicidal or self-mutilating behavior;
unstable and intense relationships; impulsivity; anger control problems;
disturbed self-image </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Histrionic personality disorder:</span><span> pervasive
attention-seeking, including inappropriate sexual seductiveness and shallow or
exaggerated emotions </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Narcissistic personality disorder:</span><span> pervasive pattern of
grandiosity; need for admiration; lack of empathy </span></p>

<p><span></span></p>

<p><span>Cluster C (anxious or fearful)</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Avoidant personality disorder:</span><span> social inhibition;
feelings of inadequacy; extreme sensitivity to negative evaluation; avoidance
of social interaction. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dependent personality disorder:</span><span> pervasive psychological
dependence on others </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Obsessive-compulsive personality disorder (not the
same as obsessive-compulsive disorder):</span><span> rigid conformity to rules, moral codes, and
excessive orderliness </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>.<span>&nbsp; </span>This patient has anti-social personality
disorder, characterized by disregard for the law and the rights of others. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Part 1</span></p>

<p><span></span></p>

<p><span>Mr. Jones
is a 32-year-old man who is brought to the emergency room by police because he
was standing in the street proclaiming to passersby that he is a messenger of
God. <a name=31419></a><span >&nbsp;</span>On
examination, he is alert and oriented to person, place, time, and
situation.<span >&nbsp; </span>His hygiene is poor. He
is malodorous and appears not to have shaved or bathed in days.<span>&nbsp; </span>He has trouble sitting still through the
interview and is at times physically intrusive. He fails to maintain normal
social space between himself and others. His speech is rapid and loud; his
thought process is tangential. He describes his “religious insights” in
grandiose terms, but avoids details because he believes that the examining
psychiatrist is part of a conspiracy to keep him from spreading his divine
word.<span >&nbsp; </span>He denies suicidal or
homicidal ideation.<span >&nbsp; </span>He has little
insight into his delusional nature.<span >&nbsp;
</span>His judgment is impaired. The remainder of the physical examination is
normal, including the pulse and blood pressure.</span></p>

<p><span></span></p>

<p><span>Which of
the following tests should be ordered first? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Urine
drug screen</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>CT
scan to rule out head trauma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Thyroid
function tests</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>24-hour
urine sample for metanephrine and catecholamines</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Erythrocyte
sedimentation rate (ESR) </span></p>

<p><span></span></p>

<p><span>Part 2</span></p>

<p><span></span></p>

<p><span>Blood tests, a urine drug screen, and a head CT
are normal.<span >&nbsp; </span>Mr. Jones is
hospitalized in an inpatient psychiatric facility.<span>&nbsp; </span>Which of the following medicines is most
useful in treating his condition?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Lithium</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Valproate</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Carbamazepine</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Lamotrigine</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
second-generation antipsychotic medicine</span></p>

<span><br clear=all>
</span>

<p><span>Part 1</span></p>

<p><b><span>Answer
A is correct.</span></b><span><span>&nbsp; </span>A urine drug screen can detect
stimulants (e.g., methamphetamines) and other drugs (illicit or prescribed)
that cause hyperactivity and psychosis.</span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect.</span></b><span>
A CT scan is costly and should not be ordered as a preliminary test, especially
given the normal physical exam and the absence of a history of head
trauma.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect.</span></b><span>
Thyroid function tests (TSH, T4) can detect thyrotoxicosis &#8211; and
thyrotoxicosis when extreme (thyroid storm) can be associated with
hyperactivity and psychosis. Thyrotoxicosis, however, is associated with
elevated pulse and blood pressure. (In this patient, the pulse and blood
pressure are normal.) Also, urine drug screen results can be obtained more
quickly than thyroid function test results.</span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect.</span></b><span><span>&nbsp; </span>A 24-hour urine sample for metanephrines
and catecholamines is useful for making the diagnosis of pheochromocytoma, but
this diagnosis is unlikely given the normal pulse and blood pressure. </span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect.</span></b><span><span>&nbsp; </span>A normal erythrocyte sedimentation rate
(ESR) helps to exclude active inflammation, such as would occur with autoimmune
disease (e.g., systemic lupus erythematosus). Autoimmune diseases are more
common in women than in men. Sometimes they cause psychosis, but this occurs
less commonly than drug-induced psychosis. </span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span>Part
2</span></p>

<p><b><span>Answer
E is correct.</span></b><span><span>&nbsp; </span>Second-generation antipsychotics are
approved for treatment of bipolar disorder and schizophrenia. Their efficacy as
anti-psychotics and as mood stabilizers make them doubly suited for Mr. Jones.</span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect. </span></b><span>Lithium
is useful as a mood stabilizer, but not as an anti-psychotic. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect.</span></b><span>
Valproate is useful as a mood stabilizer, but not as an anti-psychotic.</span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect. </span></b><span>Carbamazepine
is useful as a mood stabilizer, but not as an anti-psychotic.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
D is incorrect. </span></b><span>Lamotrigine
is useful as a mood stabilizer, but not as an anti-psychotic.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year-old woman visits the emergency room because she thinks she has
had a heart attack. One hour ago, she developed sudden onset chest pain, heart
pounding, shortness of breath, nausea, dizziness, and flushed skin. The episode
lasted 30 minutes. She now feels better. Last week, she had two similar
episodes, which convinced her to limit her activity. Physical examination is
normal. Which of the following is the most appropriate nonpharmacologic
therapy?<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Psychoanalysis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Cognitive-behavioral therapy</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Psychodynamic therapy</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Group therapy</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic therapy</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Psychotherapy</span> aims to increase the individual’s sense of
well-being. Most forms of psychotherapy use spoken conversation. Some use other
forms of communication such as the written word, artwork, drama, narrative
story, or music. Psychotherapy with children often involves play, dramatization
(i.e. role-play), and drawing. Psychotherapy occurs within a structured
encounter between a trained therapist and client. Purposeful,
theoretically-based psychotherapy began in the 19th century with
psychoanalysis. Since then, scores of other approaches have appeared. There are
several broad systems of psychotherapy:</p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Psychoanalysis,
the first practice to be called “psychotherapy,” encourages verbalization of
the patient’s thoughts, including free associations, fantasies, and dreams. From
these, the analyst formulates the nature of the unconscious conflicts that are
causing the patient’s symptoms. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cognitive-behavioral
therapy (CBT) is based on the idea that our feelings and behaviors are rooted
in thoughts. We can change the way we feel and act by changing the content of
our thoughts. There is empirical evidence that CBT is effective for a variety
of mood, anxiety, personality, eating, and substance abuse disorders. Treatment
is often brief, direct, and “tailored” to the specific problem. CBT can be used
in individual and group settings. Many techniques have been adapted for
self-help applications.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Psychodynamic
therapy attempts to reveal the unconscious content of a person’s psyche in an
effort to alleviate psychic tension. Its roots are in psychoanalysis, but
psychodynamic therapy tends to be briefer and less intensive than traditional
psychoanalysis. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Existential
therapy is based on the idea that human beings are alone in the world, and that
isolation leads to feelings of meaninglessness that can be overcome by creating
one’s own set of values and meanings. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Humanistic
therapy emphasizes the growth and fulfillment of the individual
(self-actualization) through self-mastery, self-examination, and creative
expression. Freedom of choice in creating one’s experience is at the core of
this form of therapy.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>“Brief
therapy” focuses on a specific problem and aims at direct intervention. It is
solution-based rather than problem-oriented. It is less concerned with how a
problem arose than how it is sustained. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Systemic
therapy addresses people in the context of their relationships. Family therapy
and marriage counseling are included in this category.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Transpersonal
therapy is based on a spiritual understanding of consciousness. It draws from
the spiritual traditions, including eastern philosophies (e.g., Buddhism and
the Yogic traditions of India) and the Western contemplative traditions. These
traditions are integrated with contemporary psychology.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Body
psychotherapy assumes that problems of the mind are related to problems of the
body, including aberrant physiology, posture, breathing, muscularity, and
sexuality. Massage and exercise therapy are included in this category. </span></p>

<p></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer B is correct</b>. <span>Panic
attacks</span> are characterized by sudden, intense, and relatively brief
periods of fear and apprehension. Patients often think they are having a heart
attack or nervous breakdown. They may report a fear of dying or of “going
crazy.” The attacks involve activation of the sympathetic nervous system.
Symptoms may include trembling, shortness of breath, palpitations, chest pain,
hot flashes, sweating, nausea, dizziness, and paresthesias.
Cognitive-behavioral therapy (CBT) is an effective therapeutic approach. The
first part of CBT is informational. Patients benefit from learning what a panic
attack is and how common it is. They also benefit from knowing that their
symptoms are not due to heart disease or some other dangerous pathology.
Ultimately they learn to replace inappropriate thoughts, which provoke anxiety,
with appropriate thoughts that reflect a correct understanding of the
condition. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=231 height=135
src="_%20Tutorials_files/image533.png" v:shapes="Picture_x0020_347372"></span></p>

<p>Tyramine is a drug that
causes adrenergic neurons to release norepinephrine. The circles above
represent the size of a patient’s pupils without treatment and following
treatment with tyramine and with epinephrine. Which of the following is
compatible with findings shown for the left eye?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Blockade
of &#945;-adrenergic receptors</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Blockade
of &#946;-adrenergic receptors</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Blockade
of muscarinic receptors<span >&nbsp; </span></p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Inhibition
of cholinesterase</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>Sympathetic
denervation </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Two types of muscle control
the size of the iris: circular muscle and radial muscle. Circular muscle is
innervated by the parasympathetic nervous system; radial muscle is innervated
by the sympathetic nervous system. Sympathetic stimulation of &#945;<sub>1</sub>
adrenergic receptors causes the contraction of the radial muscle and subsequent
dilation of the pupil (mydriasis). </p>

<p>Parasympathetic stimulation
of M3 muscarinic receptors causes contraction of the circular muscle and
constriction of the pupil (miosis). In the normal operation of the autonomic
nervous system, action potentials cause neurons to release their
neurotransmitters.<span >&nbsp; </span>Following
release, the neurotransmitters interact with receptors on the effector to
produce a response, in this instance contraction or dilation of the pupil.<span>&nbsp; </span>Pupillary responses can be used to
predict the effects of agonists or antagonists of autonomic receptors.<span>&nbsp; </span></p>

<p></p>

<p><b>Pupillary diameter</b> is determined by a balance of parasympathetic
and sympathetic activation.<span >&nbsp; </span>The
parasympathetic control dominates under most conditions.<span>&nbsp; </span>Increasing parasympathetic activity will
produce enhanced pupillary constriction and decreasing parasympathetic activity
will produce pupillary dilation.<span >&nbsp;
</span>The reverse is true for decreasing and increasing sympathetic activity,
respectively.<span >&nbsp; </span>Therefore, pupillary
dilation can be elicited in two ways: blockade of muscarinic receptors or
excitation of alpha<sub>1</sub> receptors.<span >&nbsp;
</span>Drugs that produce either one of these effects are used to dilate eyes
for an ophthalmological exam.<span >&nbsp;
</span>Analogously, pupillary constriction can be elicited by exciting
muscarinic receptors or blocking alpha<sub>1</sub> receptors.</p>

<p></p>

<p>Administration of a drug
that stimulates alpha<sub>1</sub> receptors, such as norepinephrine or
epinephrine, will produce pupillary dilation; a drug that stimulates muscarinic
receptors will produce pupillary constriction.<span>&nbsp; </span>These effects will occur regardless of
whether the autonomic nervous system is intact because the drugs bypass the
nervous system to act directly on the receptors.<span>&nbsp; </span>Tyramine is a drug that produces
sympathoexcitation by causing the release of norepinephrine from sympathetic
postganglionic nerve terminals.<span >&nbsp; </span>It
does this by displacing norepinephrine from the storage vesicles.<span>&nbsp; </span>Because tyramine must act through the
sympathetic nervous system, it is classified as an indirect sympathomimetic
drug.<span >&nbsp; </span>If there is damage to
sympathetic postganglionic neurons so that they are not functional or do not
contain norepinephrine in vesicles, then tyramine will not have an effect.<span>&nbsp; </span>If this situation occurs, administration
of norepinephrine or epinephrine can still have an effect because they do not
require the presence of an intact sympathetic nervous system to produce an
effect.</p>

<p></p>

<p>In this vignette, the left
pupil is smaller than the right. (We are not told which pupil is normal).
Treatment with epinephrine causes the left pupil to dilate, which would be
expected because epinephrine stimulates &#945;<sub>1</sub> adrenergic
receptors, causing contraction of the radial muscle and dilation of the pupil
(mydriasis). Contrary to expectation, however, treatment with tyramine has no
effect on left pupillary size. Normally, tyramine should stimulate neuronal
release of norepinephrine, causing pupillary dilation. If this is not
happening, the neuron must be dysfunctional. Nerves that release norepinephrine
belong to the sympathetic nervous system; therefore, sympathetic denervation
would explain the inability of the nerves to release norepinephrine in response
to tyramine. </p>

<p></p>

<p></p>

<p></p>

<p>In other words, epinephrine
is effective because it stimulates the &#945;<sub>1</sub> adrenergic receptor <i>directly</i>. Tyramine works <i>indirectly</i> by stimulating the
sympathetic nerves to release norepinephrine. If the sympathetic system is not
functioning (i.e., because of denervation), then norepinephrine is not released
and the &#945;<sub>1</sub> adrenergic receptor is not stimulated. Notice that
in the right eye (where sympathetic nerves are intact), tyramine causes
pupillary dilation. The subsequent administration of epinephrine has no effect
because the &#945;-receptors have already been stimulated.</p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct. </b>Left-sided sympathetic denervation explains
the pupillary findings. Epinephrine acts directly on the &#945;1 adrenergic
receptor, causing pupillary dilation, even when the sympathetic nerves are not
functioning. Tyramine, by contrast, relies on an intact sympathetic nervous
system to release norepinephrine, stimulating &#945;1 adrenergic receptors.
Sympathetic denervation prevents this effect.<span>&nbsp;&nbsp; </span></p>

<p><b></b></p>

<p><b>Answer A is incorrect.</b> If &#945;1 adrenergic receptors were
blocked, neither epinephrine nor tyramine would cause pupillary dilation. The
fact that epinephrine is effective at causing pupillary dilation indicates that
&#945;-blockade is not present. </p>

<p><b></b></p>

<p><b>Answer B is incorrect. </b>&#946;-blockade would have no effect on
pupillary size. Pupillary size is mediated by &#945; receptors (dilation) and
muscarinic receptors (constriction).<span >&nbsp;
</span><b></b></p>

<p><b></b></p>

<p><b>Answer C is incorrect. </b>Muscarinic blockade would cause pupillary
dilation, not constriction. This patient’s left pupil is constricted in the
untreated state. Furthermore, epinephrine and tyramine would have no effect on muscarinic
receptors, which are part of the parasympathetic nervous system.<span>&nbsp;&nbsp; </span></p>

<p><b></b></p>

<p><b>Answer D is incorrect. </b>Inhibition of cholinesterase would increase
acetylcholine levels. (Acetylcholine stimulates muscarinic receptors, causing
pupillary constriction.) At first, this seems like a plausible explanation for
the small left pupil. But cholinesterase inhibition would not explain the
failure of tyramine to produce pupillary dilation. That failure, as explained
above, is due to sympathetic denervation.<span >&nbsp;
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 36-year-old woman comes to the
physician because of a 10-month history of difficulty falling asleep due to a
crawling sensation in her legs. She has to get up several times during the
night to relieve the feeling. The symptoms started shortly after she delivered
her son 1 year ago. She says her husband complains because she has become a
“jumpy” sleeper, and her movements sometimes wake him up. Physical examination
shows no abnormalities. Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Amyotrophic
     lateral sclerosis</span></li>
 <li><span>Multiple
     sclerosis</span></li>
 <li><span>REM
     sleep behavior disorder</span></li>
 <li><span>Restless
     legs syndrome</span></li>
 <li><span>Sleep
     myoclonus<span></span></span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Restless
legs syndrome</span></b><b><span> (<span>RLS</span>)</span></b><span> is a neurological disorder characterized
by an irresistible urge to move in order to stop an uncomfortable or odd
sensation. It most commonly affects the legs, but can affect the arms, torso,
and even phantom limbs. Movement of the affected body part provides temporary
relief. More than half of RLS cases are familial and are inherited in an
autosomal dominant fashion with variable penetrance. RLS affects an estimated
7% to 10% of the general population in North America and Europe. A minority of
sufferers experience daily or severe symptoms. </span></p>

<p></p>

<p>RLS sensations are sometimes
compared to an itching or tickling in the muscles. The sensations typically
begin or intensify when the patient is at rest (relaxing, reading, studying, or
trying to sleep). Symptoms are generally worse in the evening or at night, and
improve with activity. Most individuals with RLS have limb-jerking during
sleep, which is associated with sleep disruption. Some people experience only a
minor annoyance, while others experience major disruptions of sleep and
significant impairment in quality of life. </p>

<p><span></span></p>

<p><span>RLS may be
primary or secondary. Primary, or idiopathic, RLS usually begins slowly before
age 45, and progresses with age. Secondary RLS often has a sudden onset after
age 40, and may be associated with specific medical conditions or the use of
certain drugs. Most research on RLS has focused on the dopamine and iron
systems. (Iron and levodopa, a prodrug that can center the CNS, where it is
metabolized to dopamine) can be used to treat RLS. Differences in dopamine- and
iron-related markers have also been demonstrated in the cerebrospinal fluid of
individuals with RLS. </span></p>

<p><span></span></p>

<p><span>Conditions
associated with RLS include varicose veins, folate deficiency, magnesium
deficiency, fibromyalgia, sleep apnea, uremia, diabetes, thyroid disease,
peripheral neuropathy, Parkinson disease, and certain auto-immune disorders
such as Sjögren syndrome, celiac disease, and rheumatoid arthritis. Symptoms of
RLS may worsen during pregnancy. </span></p>

<p><span></span></p>

<p><span>Certain
drugs can also worsen symptoms of RLS:</span></p>

<ul type=disc>
 <li><span>antiemetics (with
     antidopaminergic properties) </span></li>
 <li><span>antihistamines<span>&nbsp; </span></span></li>
 <li><span>antidepressants
     (both tricyclics and selective serotonin reuptake inhibitors)</span></li>
 <li><span>antipsychotics </span></li>
 <li><span>anticonvulsants</span></li>
</ul>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct.</span></b><span> The patient’s symptoms
are classic for restless legs syndrome. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Part 1</span></p>

<p><span></span></p>

<p><span>Mr. Alioto
is a 19-year old man brought to the Emergency Department after he was found
camped out under a bridge in sub-freezing weather.<span>&nbsp; </span>He was malnourished, cold, and unable to
care for himself. He said he would not go to a shelter because the CIA was waiting
there to arrest him for having angry thoughts about the current national
administration and the economic downturn. His speech is normal, but his affect
is inappropriate. Thought production is goal directed. He hears angry voices
telling him to beware of government agents.<span>&nbsp; </span>Because he is guarded and will not offer
much information, you contact his parents, who tell you that he has been
hospitalized a year ago for similar symptoms. They tell you that he was shy but
otherwise normal until age 15, when he began to withdraw. He has become
increasingly reclusive.<span >&nbsp; </span>Although
his mood has been relatively normal, he has not been able to work or attend
college since his first hospitalization.<span >&nbsp;
</span>Physical examination is otherwise normal and basic lab tests, including
urine drug screen, are normal.<span >&nbsp; </span>He
has no history of medical illnesses.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><span>What is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Schizoaffective
disorder</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Schizophreniform
disorder</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Delusional
disorder</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Schizophrenia</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Substance-induced
psychotic disorder</span></p>

<p><span></span></p>

<p><span>Part 2</span></p>

<p><span></span></p>

<p><span>Which is
the next most appropriate step? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Start
a second-generation antipsychotic and refer to a community mental health
center.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Start
a first-generation (typical) antipsychotic and observe for 24 hours in the
emergency department.</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hospitalize
(with an emergency order of detention) so that an appropriate antipsychotic can
be started.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Have
him transported to a shelter with a 2-week supply of an antipsychotic medicine
and have the social worker arrange for an appointment with a community mental
health center.</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Start
rapid neuroleptization with haloperidol in the E.R.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Part 1</span></p>

<p><span></span></p>

<p><b><span>Answer
D is correct</span></b><span>.
Schizophrenia presents with two or more psychotic symptoms in a one-month
period, with deterioration in functioning lasting at least six months.
Substance abuse, medical disorders, and other psychiatric disorders must be
ruled out. Mr. Alioto has premorbid withdrawal (which is common in
schizophrenia), delusions, and auditory hallucinations. Because he lacks
disorganized or catatonic symptoms, his schizophrenia is of the paranoid
subtype.</span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Schizoaffective disorder includes mood disturbance (not present in Mr. Alioto,
according to his family) and psychotic symptoms for at least two weeks <i>outside</i> a mood disturbance.</span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
Schizophreniform disorder may present similarly to schizophrenia, but lasts for
only one to six months.</span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect</span></b><span>.
In delusional disorder, “non-bizarre” delusions are present, hallucinations are
absent, and there is no deterioration in functioning as in schizophrenia.</span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect</span></b><span>.
The drug screen is negative. A positive screen would <i>not</i> have ruled out
schizophrenia, as a dual diagnosis is common in people with schizophrenia.
(Drug-induced psychosis and schizophrenia can occur concurrently.)</span></p>

<p><span></span></p>

<p><span>Part 2</span></p>

<p><span></span></p>

<p><b><span>Answer
C is correct.</span></b><span><span>&nbsp; </span>Mr. Alioto is unable to care for himself
and he is in danger of developing hypothermia (and dying) if he returns to the
streets. An Emergency Order of Detention (EOD) should be initiated and Mr.
Alioto should be hospitalized. (In his current state, Mr. Jones is not
competent to sign himself in voluntarily for treatment.) Antipsychotic
medication should be initiated. </span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect. </span></b><span>Starting
an antipsychotic medicine on an outpatient basis is unacceptable, as Mr. Alioto
is unable to care for himself.</span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect. </span></b><span>First-generation
antipsychotics are cheaper than second-generation antipsychotics, but they take
longer to have effect and have major side effects. Mr. Jones needs closer
attention than can be provided in an emergency department. </span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect. </span></b><span>Shelters
do not provide adequate structure or guidance with medication in patients who
are acutely psychotic. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
E is incorrect. </span></b><span>Rapid
“neuroleptization” requires multiple doses of medicine, such as haloperidol or
risperdol, given orally or intramuscularly. This should be undertaken in
patients who are violent due to psychotic illnesses. Mr. Alioto is not violent.
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Mrs. Smith is a 43-year-old married woman
with a history of depression previously responsive to antidepressant therapy.
She presents to Dr. Jones with a 6-month history of lack of motivation and
fatigue.<span >&nbsp; </span>Recent stressors include
financial and family problems: Her husband lost his job and her daughter may be
using drugs. Dr. Jones restarts her on the same antidepressant medicine she
responded to in the past. At a follow up visit six weeks later, she reports no
improvement in her motivation or energy level. Also, she continues to
experience weight gain and constipation. </span></p>

<p><span></span></p>

<p><span>Which of
the following is the most appropriate course of action at this time?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Switch
to a different antidepressant medicine &#8211; one with a different mechanism
of action</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increase
the dose of the antidepressant medicine</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Reconsider
the diagnosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Refer
Mrs. Smith to a therapist for treatment of depression</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Secondary depression</span></b></p>

<p><span></span></p>

<p><span>True
medical illness is often missed in patients with a history of psychiatric
disease because it is assumed that all symptoms are of psychiatric origin. In
the case of Mrs. Smith, Dr. Jones assumes that “lack of motivation and fatigue”
are due to depression because Mrs. Smith has a history of depression. A careful
history would have uncovered weight gain and constipation in addition to “lack
of motivation and fatigue.” Also, a careful history would have noted the
absence of other symptoms of depression (e.g., depressed mood). While it is
tempting to attribute weight gain and constipation to the antidepressant
medicine, the patient says she <i>has
continued to experience</i> these symptoms &#8211; i.e., they were present
before the antidepressant medicine was started. Common medical causes of
“depression” include hypothyroidism, vitamin B12 deficiency, and anemia. Mrs.
Smith may well have hypothyroidism. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct.<span>&nbsp; </span></span></b><span>Hypothyroidism should be considered as a
diagnosis. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.<span>&nbsp; </span></span></b><span>Based on the information provided in the
vignette, there is no reason to think that the patient wouldn’t respond to the
same antidepressant medicine <i>if she truly
had depression</i>. (What worked in the past is likely to work again.) Had the
diagnosis turned out to be depression, increasing the dose of the current
medication would likely have been a better choice than switching medicines.
Patients are often switched from one antidepressant to another without an
adequate trial (not enough time is allowed or the dose is too low). This
results in so-called “treatment failures,” which demoralize the patient, making
it harder to find appropriate treatment in the future.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect. </span></b><span>While increasing the
dose of the antidepressant medicine may be a better choice than switching
medications, the more appropriate course of action is to re-assess the
diagnosis. The patient has symptoms of hypothyroidism.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect.</span></b><span> While referring Mrs.
Smith to a therapist would be appropriate if she truly had depression, it is
more likely that her symptoms are non-psychiatric.<span>&nbsp; </span>Referral for psychotherapy would likely
frustrate the patient and embarrass Dr. Jones when he learns that Mrs. Smith is
not truly depressed.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An 8-year-old boy is brought to the
physician by his mother because he is not paying attention in class. His mother
says that his teacher has described his in-school behavior as &quot;frequently
stopping what he is doing and then blinking and making chewing movements.&quot;
His mother has noticed that he sometimes &quot;stares off into space&quot; and
seems to be daydreaming. Physical examination shows no abnormalities. An EEG
during one of the episodes shows generalized spike-and-wave bursts at 3 Hz per
second. This patient most likely has which of the following types of seizures?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Absence</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Akinetic</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Complex
partial</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Generalized
tonic-clonic</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Myoclonic</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Seizures</span></b><span> are divided into two
broad categories: generalized and partial. Generalized seizures are produced by
electrical impulses from throughout the entire brain; partial seizures are
produced (at least initially) by electrical impulses in a relatively small part
of the brain. The part of the brain generating the seizures is sometimes called
the focus. The most common types of seizures are listed below:</span></p>

<p><span></span></p>

<table border=1 cellspacing=1 cellpadding=0>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Generalized Seizures</span><span> <br>
  <![if !supportLineBreakNewLine]><br>
  <![endif]></span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Symptoms</span><span> </span></p>
  </td>
 </tr>
 <tr>
  <td nowrap>
  <p><span>1. &quot;Grand Mal&quot; or Generalized
  tonic-clonic</span><span>
  </span></p>
  </td>
  <td>
  <p><span>Unconsciousness,
  convulsions, muscle rigidity</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>2. Absence</span><span> </span></p>
  </td>
  <td>
  <p><span>Brief
  loss of consciousness</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>3. Myoclonic</span><span> </span></p>
  </td>
  <td>
  <p><span>Sporadic
  (isolated), jerking movements</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>4. Clonic</span><span> </span></p>
  </td>
  <td>
  <p><span>Repetitive,
  jerking movements</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>5. Tonic</span><span> </span></p>
  </td>
  <td>
  <p><span>Muscle
  stiffness, rigidity</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>6. Atonic</span><span> </span></p>
  </td>
  <td>
  <p><span>Loss of
  muscle tone</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>Generalized Seizures</span><span> </span></p>

<p><span></span></p>

<p><span>There are
six types of <span>generalized seizures</span>.
The most common and dramatic is the generalized convulsion, also called the <span>grand-mal seizure</span>. In this type of
seizure, the patient loses consciousness and usually collapses. The loss of
consciousness is followed by generalized body stiffening (called the “tonic”
phase of the seizure) for 30 to 60 seconds, then by violent jerking (the
“clonic” phase) for 30 to 60 seconds, after which the patient goes into a deep
sleep (the “postictal” or after-seizure phase). During grand-mal seizures,
injuries and accidents may occur, such as tongue biting and urinary
incontinence.</span></p>

<p><span></span></p>

<p><span>Absence seizures</span><span>
cause a short loss of consciousness (just a few seconds) with few or no
symptoms. The patient, most often a child, typically interrupts an activity and
stares blankly. These seizures begin and end abruptly and may occur several
times a day. Patients are usually not aware that they are having a seizure,
except that they may be aware of “losing time.”</span></p>

<p><span></span></p>

<p><span>Myoclonic seizures</span><span>
consist of sporadic jerks, usually on both sides of the body. Patients
sometimes describe the jerks as brief electrical shocks. When violent, these
seizures may result in dropping or involuntarily throwing objects.</span></p>

<p><span></span></p>

<p><span>Clonic seizures</span><span>
are repetitive, rhythmic jerks that involve both sides of the body at the same
time.</span></p>

<p><span></span></p>

<p><span>Tonic seizures</span><span>
are characterized by stiffening of the muscles.</span></p>

<p><span></span></p>

<p><span>Atonic seizures</span><span>
consist of a sudden and general loss of muscle tone, particularly in the arms
and legs, which often results in a fall.</span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=1 cellpadding=0>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><span>Partial Seizures</span><span> <br>
  <![if !supportLineBreakNewLine]><br>
  <![endif]></span></p>
  </td>
  <td valign=top>
  <p style="text-align:center;"><span>Symptoms</span><span> </span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>1. Simple</span><span><br>
  <![if !supportLineBreakNewLine]><br>
  <![endif]></span></p>
  <p><span>a. <span>Motor</span><br>
  b. <span>Sensory</span></span></p>
  <p><span>c. Autonomic</span><span></span></p>
  <p><span>d. <span>Psychological</span></span></p>
  </td>
  <td>
  <p><span></span></p>
  <p><span></span></p>
  <p><span><span>a.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Jerking, muscle rigidity, spasms, head-turning</span></p>
  <p><span><span>b.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Unusual sensations affecting either the senses</span></p>
  <p><span><span>c.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Nausea, diarrhea, incontinence, tachycardia</span><span></span></p>
  <p><span><span>d.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Memory or emotional disturbances</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>2. Complex</span><span> <br>
  <![if !supportLineBreakNewLine]><br>
  <![endif]></span></p>
  </td>
  <td>
  <p><span>Automatisms
  such as lip smacking, chewing, fidgeting, walking and other repetitive,
  involuntary but coordinated movements</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>3. Secondary generalization</span><span> </span></p>
  </td>
  <td>
  <p><span>Symptoms
  that are initially associated with a preservation of consciousness that then
  evolves into a loss of consciousness and convulsions.</span></p>
  </td>
 </tr>
</table>

<p><span>Further Reading:</span></p>

<p><span><span>·</span></span><a
href="http://www.webmd.com/epilepsy/understanding-epilepsy-basics"><span>The Basics of
Epilepsy</span></a><span> </span></p>

<p><span><span>·</span></span><a
href="http://www.webmd.com/epilepsy/epilepsy-convulsive-disorders"><span>Epilepsy / Convulsive
Disorders</span></a><span> </span></p>

<p><span><span>·</span></span><a
href="http://www.webmd.com/epilepsy/guide/types-epilepsy"><span>Types of Epilepsy</span></a><span> </span></p>

<p><span><span>·</span></span><a
href="http://www.webmd.com/epilepsy/news/20070322/best-first-choice-drugs-epilepsy-idd"><span>Best First-Choice
Drugs for Epilepsy ID'd</span></a><span> </span></p>

<p><span><span>·</span></span><a
href="http://www.webmd.com/epilepsy/guide/epilepsy-causes-index"><span>Epilepsy: Causes</span></a><span> </span></p>

<p><span><span>·</span></span><a
href="http://www.webmd.com/epilepsy/guide/epilepsy-living-coping"><span>Epilepsy: Living
and Coping</span></a><span> </span></p>

<p><span><span>·</span></span><a
href="http://www.webmd.com/epilepsy/guide/epilepsy-non-surgical-treatments"><span>Epilepsy:
Non-Surgical Treatments</span></a><span> </span></p>

<p><span><span>·</span></span><a
href="http://www.webmd.com/epilepsy/epilepsy-types-directory"><span>See All Epilepsy
Types Topics</span></a><span> </span></p>

<p><span></span></p>

<p><span>Partial Seizures</span><span>
</span></p>

<p><span></span></p>

<p><span>Partial seizures</span><span>
are divided into simple, complex, and those that evolve into secondary
generalized seizures. During simple partial seizures, patients retain
awareness; during complex partial seizures, they lose awareness. <span>Simple partial seizures</span> are further
subdivided into four categories: motor, sensory, autonomic, and psychological.
Motor symptoms include movements such as jerking and stiffening. Sensory
symptoms involve unusual sensations affecting any of the five senses (vision,
hearing, smell, taste, or touch). When simple partial seizures cause sensory
symptoms only (and not motor symptoms), they are called &quot;auras.&quot;
Autonomic symptoms include nausea, diarrhea, incontinence, and tachycardia.
Simple partial seizures with psychological symptoms are characterized by various
experiences involving memory (the sensation of deja-vu), emotions (such as fear
or pleasure), or other complex psychological phenomena.</span></p>

<p><span></span></p>

<p><span>Complex partial seizures</span><span>, by definition, include impairment of awareness. Patients
seem to be “out of touch,” “out of it,” or “staring into space” during these
seizures. There may also be some “complex” symptoms called automatisms.
Automatisms consist of involuntary but coordinated movements that tend to be
purposeless and repetitive. Common automatisms include lip smacking, chewing,
fidgeting, and walking.</span></p>

<p><span></span></p>

<p><span>The third
kind of partial seizure is one that begins as a focal seizure and evolves into
a generalized convulsive (“grand-mal”) seizure. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct. </span></b><span>The patient’s symptoms
are consistent with a diagnosis of absence seizures. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Part 1</span></p>

<p><span></span></p>

<p><span>Ms.
Anderson, a 29-year old mother of two children, is referred to your primary
care practice by a colleague, who told her after treating her for five years
that “maybe Dr. X can help you &#8211; I don’t seem to be able to.” Her medical
records, which she brings with her, are thick and contain many appropriate
laboratory studies and medical procedures, all negative.<span>&nbsp; </span>She is unable to work, and now she
states that her medical problems affect her ability to take care of her
household.<span >&nbsp; </span>She appears genuinely
upset that she can’t work or complete her housework.<span>&nbsp; </span>She has an elementary school teaching credential
and would like to resume teaching, an enjoyable career for her. She is upset that
her medical bills are high, and she does not like to depend on physicians, but
she wants to be well and independent.</span></p>

<p><span></span></p>

<p><span>Today she
states that one of her biggest problems is continuing pain &#8211; pain in her
muscles, headache, abdominal pain, and pain during urination.<span>&nbsp; </span>Moreover, she has intermittent nausea,
vomiting, and a sensation of abdominal bloating. She reports that she vomited
constantly throughout her pregnancies. She has experienced double vision and
periods of deafness, but has had normal evaluations by an ophthalmologist and
an audiologist. </span></p>

<p><span></span></p>

<p><span>She is
neatly groomed, but appears distressed by her symptoms. She is alert and fully
oriented. Intellect and abstract concept formation are normal. Despite her many
symptoms, her mood is generally good. She sleeps well, her energy level is
normal, and she does not have significant anxiety.<span>&nbsp; </span>Speech is normal in rate and rhythm;
thought production is goal-directed.</span></p>

<p><span></span></p>

<p><span>What is
the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Factitious
disorder</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypochondriasis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Malingering</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Somatization
disorder</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pain
disorder</span></p>

<p><span></span></p>

<p><span>Part 2</span></p>

<p><span></span></p>

<p><span>What is
the most helpful approach to treating Ms. Anderson?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Tell her not to worry: Her medical
     evaluation reveals no medical illness and her symptoms are “all in her
     head.” </span></li>
 <li><span>Tell her that her medical evaluation is
     normal and schedule her for a return visit in one year.</span></li>
 <li><span>Advise her that you will conduct more tests
     because some medical problems are elusive. </span></li>
 <li><span>Refer her to a psychiatrist because she has
     a mental disorder, not a medical disorder.</span></li>
 <li><span>Tell her that while her medical evaluation
     shows no medical illness, her symptoms are real.<span>&nbsp; </span>Schedule her for regular
     appointments to reassure her, and refer her to a mental health
     practitioner to help her “cope with stress.”</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span>Part 1</span></p>

<p><span></span></p>

<p><b><span>Answer D is correct. </span></b><span>Ms. Anderson presents
with hallmark symptoms of somatization disorder, in which patients seek
treatment for many physical complaints before age 30 and have significant
functional impairment. She fulfills criteria of having at least 4 pain
symptoms, 2 gastrointestinal symptoms, 1 sexual symptom, and 1
pseudo-neurological symptom. She has had complete evaluations which have ruled
out a medical problem, and her symptoms don’t appear to have been intentionally
produced.<span >&nbsp; </span>Somatization disorder can
be frustrating for physicians and very costly to patients and society.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect. </span></b><span>With factitious
disorder, physical symptoms are intentionally feigned in order to assume a sick
role. Our patient wants to be well and independent.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect. </span></b><span>In hypochondriasis, fear
predominates &#8211; fear of having a serious disease based on
misinterpretation of bodily symptoms. This fear does not respond to medical
evaluation and reassurance. Ms. Anderson denies anxiety and we don’t see the
excessive worry about having a serious disease that characterizes
hypochondriasis.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect. </span></b><span>With malingering,
physical symptoms are intentionally produced for secondary gain, such as
avoiding a duty or seeking financial compensation.<span>&nbsp; </span>There is no evidence that Ms. Anderson
is seeking secondary gain. She wants to work.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect. </span></b><span>In pain disorder, the
predominant focus is pain in one or more body areas resulting in distress and
impairment. Psychological factors appear to have a role in the onset or
maintenance of symptoms. Ms. Anderson has a diffuse array of symptoms of which
pain is only a part. <b></b></span></p>

<p align=right><span></span></p>

<p><span>Part 2</span></p>

<p><span></span></p>

<p><b><span>Answer E is correct.</span></b><span><span>&nbsp; </span>Scheduling regular appointments and
acknowledging that symptoms are real can be reassuring to patients with
somatization disorder. This helps to establish trust, which can facilitate the
patient’s acceptance of psychiatric referral later on. Patients often accept
that their symptoms are related to stress and that they may benefit with help
in coping. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>Although reassurance is helpful, telling
the patient that her problem is “all in her head” is disrespectful and damages
the therapeutic relationship. The patient is not purposefully creating
symptoms, is distressed about them, and has incurred considerable medical
expense.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.</span></b><span> Putting off the patient
for a year does not address the issue. The patient will likely call for more
frequent appointments or seek another physician.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect. </span></b><span>Although it is tempting
to take on a hero role, performing additional testing at this time is wasteful
and reinforces the patient’s concerns.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect. </span></b><span>Although referral to a
psychiatrist may helpful later, this abrupt referral is unlikely to be accepted
by the patient, who will likely believe that you are minimizing or dismissing
her problems.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
67-year-old man develops a tremor in his fingers. The tremor is most pronounced
when he reaches for a cup of coffee or points to an object. A disorder of which
of the following is most likely?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Substantia
nigra</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cerebellum</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Thyroid</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Liver
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A <span>tremor</span> is an involuntary, somewhat
rhythmic, muscle contraction and relaxation involving to-and-fro movements
(oscillations or twitching) of one or more body parts. It is the most common of
all involuntary movements and can affect the hands, arms, eyes, face, head,
vocal cords, trunk, and legs. Most tremors occur in the hands. There are three
basic types of tremor: resting, intention, and postural. </span></p>

<p><span></span></p>

<p><span>A resting
(or static) tremor is most prominent at rest and decreases or disappears with
voluntary movement. An example is the relatively slow, fine, pill-rolling
tremor of Parkinson’s disease.</span></p>

<p><span></span></p>

<p style="text-align:center;"><!--[if mso & !supportInlineShapes & supportFields]><span></span><span>&nbsp;</span>SHAPE <span>&nbsp;</span>\* MERGEFORMAT <span></span><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><v:shape
 id="_x0000_i1069" type="#_x0000_t75">
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span></span><![endif]--><span></span></p>

<p style="text-align:center;"><span>Resting tremor</span></p>

<p style="text-align:center;"><span></span></p>

<p><span>Intention
tremors appear with activity and often get worse as the target is neared.
Disorders of the cerebellar hemispheres commonly cause intention tremors.<span></span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=150 height=212
src="_%20Tutorials_files/image536.png" v:shapes="Picture_x0020_347371"></span><span></span></p>

<p style="text-align:center;"><span>Intention tremor</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Postural
tremors appear when a certain posture (e.g., holding the hand still and prone
in front of the body) is maintained. Examples include the fine, rapid tremor of
hyperthyroidism and the tremors of anxiety and fatigue. Some postural tremors
are familial. Asterixis is a postural tremor characterized by nonrhythmic,
flapping movements of wide amplitude. To detect asterixis, the patient is asked
to hold both hands forward with hands cocked up and fingers spread. The
extended wrist or fingers flex suddenly and briefly, and then return to their
original position. Causes of asterixis include liver failure, renal failure,
and pulmonary insufficiency. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=191 height=93
src="_%20Tutorials_files/image538.png" v:shapes="Picture_x0020_347370"></span><span></span></p>

<p style="text-align:center;"><span>Postural tremor</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=172 height=138
src="_%20Tutorials_files/image540.png" v:shapes="Picture_x0020_347369"></span><span></span></p>

<p style="text-align:center;"><span>Asterixis</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct. </span></b><span>Intention tremors are
usually caused by cerebellar dysfunction. These tremors appear with activity
and worsen as the target is approached. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect. </span></b><span>Parkinson’s disease is
caused by death of dopamine-producing cells in the substantia nigra, located in
the midbrain. The classic tremor is a relatively slow, fine, pill-rolling
tremor, which occurs at rest.<span >&nbsp; </span><b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><span>Hyperthyroidism produces
a fine, rapid tremor. This is an example of postural tremor. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. Liver failure can
result in asterixis, which is a specific type of postural tremor. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
71-year-old man visits his family doctor. A routine blood test shows:</span></p>

<p><span></span></p>

<p><span>Hemoglobin:
10 g/dL</span></p>

<p><span>Hematocrit:
30%</span></p>

<p><span>Mean
corpuscular volume (MCV): 104 &#956;m<sup>3</sup></span></p>

<p><span>WBC count:
5,000/mm<sup>3</sup></span></p>

<p><span>Platelet:
160,000/mm<sup>3 </sup><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span>The serum
methylmalonic acid level is elevated. A peripheral blood smear shows the
following: </span></p>

<p><span></span></p>

<p><span><img border=0 width=434 height=290
src="_%20Tutorials_files/image542.png"
alt="Description: hypersegmented neutrophil" v:shapes="Picture_x0020_347368"></span><span></span></p>

<p><span></span></p>

<p><span>Failure to
treat this condition may result in which of the following neurological
symptoms?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Lethargy and
     syncope </span></li>
 <li><span>Ataxia and
     paresthesias</span></li>
 <li><span>Diplopia and
     dysarthria</span></li>
 <li><span>Tremor,
     bradykinesia, rigidity, and postural instability</span></li>
</ol>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Both folic
acid and vitamin B12<b> </b>deficiency can
produce a macrocytic anemia, characterized by an elevated mean corpuscular
volume (MCV). Examination of a peripheral blood smear may show hypersegmented
neutrophils (as shown in the image). Folic acid deficiency is associated with
elevated homocysteine levels; vitamin B12 deficiency is associated with both
elevated homocysteine and elevated methylmalonic acid levels. Folic acid
deficiency does not have neurologic sequela; vitamin B12 deficiency <i>can</i> result in neurologic sequela. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>. Macrocytic anemia with
hypersegmented neutrophils suggests either folic acid or vitamin B12
deficiency. Only vitamin B12 deficiency produces neurologic symptoms. The
symptoms are due to impaired myelin synthesis. The posterior and lateral spinal
columns are primarily affected, causing paresthesias and diminished
proprioception. </span></p>

<p><span></span></p>

<p><b><span>Answer A</span></b><span> <b>is
incorrect</b>. Syncope results from cerebral hypoperfusion. </span></p>

<p><span></span></p>

<p><b><span>Answer C</span></b><span> <b>is
incorrect</b>. Diplopia and dysarthria can be caused by cerebrovascular
accident (stroke), among other things. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Parkinson’s disease is
characterized by tremor, bradykinesia, rigidity, and postural instability.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
52-year-old man has gradually progressive weakness in the hands. Physical
examination shows normal sensorium, normal sensation, and the following
abnormalities: atrophy of the forearm muscles, fasciculations of the muscles of
the upper extremities, hyperreflexia of the lower extremities, and extensor
plantar reflexes bilaterally (Babinski sign). Which diagnosis is most likely?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Botulism</span></li>
 <li><span>Myasthenia
     gravis<span >&nbsp; </span></span></li>
 <li><span>Amyotrophic lateral
     sclerosis</span></li>
 <li><span>Multiple sclerosis</span></li>
 <li><span>Guillain-Barré
     syndrome</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The first
step in evaluating a weak patient is to exclude life-threatening disease.<span>&nbsp; </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=311 valign=top>
  <p style="text-align:center;"><span>“Red
  Flag” Signs</span></p>
  </td>
 </tr>
 <tr>
  <td width=311 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=311 valign=top>
  <p><span>Rapid onset of weakness</span></p>
  </td>
 </tr>
 <tr>
  <td width=311 valign=top>
  <p><span>Dyspnea</span></p>
  </td>
 </tr>
 <tr>
  <td width=311 valign=top>
  <p><span>Inability to raise head
  against gravity</span></p>
  </td>
 </tr>
 <tr>
  <td width=311 valign=top>
  <p><span>Bulbar symptoms
  (difficulty chewing, talking, or swallowing)</span></p>
  </td>
 </tr>
 <tr>
  <td width=311 valign=top>
  <p><span>Loss of ambulation</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The major
mechanisms of weakness appear below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=428 colspan=2 valign=top>
  <p style="text-align:center;"><span>Mechanisms
  of Weakness</span></p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p style="text-align:center;"><span>Mechanism</span></p>
  </td>
  <td width=279 valign=top>
  <p style="text-align:center;"><span>Findings</span></p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p><span></span></p>
  </td>
  <td width=279 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p><span>Upper motor neuron</span></p>
  </td>
  <td width=279 valign=top>
  <p><span>Spasticity (increase
  muscle tone)</span></p>
  <p><span>Hyperreflexia</span></p>
  <p><span>Extensor plantar reflex
  (Babinski sign)</span></p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p><span>Lower motor neuron</span></p>
  </td>
  <td width=279 valign=top>
  <p><span>Flaccidity (decreased
  muscle tone)</span></p>
  <p><span>Hyporeflexia</span></p>
  <p><span>Fasciculations</span></p>
  <p><span>Muscle atrophy
  (eventually)</span></p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p><span>Peripheral polyneuropathy</span></p>
  </td>
  <td width=279 valign=top>
  <p><span>Distal muscles affected
  more than proximal muscles </span></p>
  <p><span>Lower extremities
  affected more than upper extremities<span >&nbsp;
  </span></span></p>
  <p><span>Lower motor neuron
  pattern</span></p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p><span>Neuromuscular junction</span></p>
  </td>
  <td width=279 valign=top>
  <p><span>Fluctuating weakness </span></p>
  <p><span>(worse with activity;
  better with rest)</span></p>
  </td>
 </tr>
 <tr>
  <td width=149 valign=top>
  <p><span>Muscle</span></p>
  </td>
  <td width=279 valign=top>
  <p><span>Proximal muscles affected
  more than distal muscles</span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span>&nbsp;</span></span></p>

<p><span>Certain
findings are especially useful.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Disorder</span></p>
  </td>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Findings</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Brain lesion (stroke,
  tumor, abscess) </span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Unilateral weakness</span></p>
  <p><span>Upper motor neuron
  pattern</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Cervical myelopathy due
  to spondylosis</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Progressive quadriplegia</span></p>
  <p><span>Upper motor neuron
  pattern</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Botulism</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Weakness preceded by
  gastroenteritis</span></p>
  <p><span>Acute generalized
  weakness</span></p>
  <p><span>Bulbar symptoms</span></p>
  <p><span>Extraocular muscle palsy</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Myasthenia gravis</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Fatigability with
  eye-blinking</span></p>
  <p><span>Extraocular muscle palsy</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Amyotrophic lateral
  sclerosis</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Dysarthria</span></p>
  <p><span>Dysphagia</span></p>
  <p><span>Tongue fasciculations</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span>Multiple sclerosis</span></p>
  </td>
  <td width=221 valign=top>
  <p><span>Relapses and remissions</span></p>
  <p><span>Visual changes (optic
  neuritis)</span></p>
  <p><span>Internuclear
  ophthalmoplegia</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span>Amyotrophic lateral sclerosis</span></b><span> <b>(ALS)</b>. ALS is a disease that affects upper and lower motor neurons.
Most patients present with spasticity and hyperreflexia (upper motor neuron
signs) and progressive muscle weakness and atrophy (lower motor neuron signs).
Cognitive function, bowel and bladder function, and eye movements are usually
preserved. The disease is relentless and progressive: Affected individuals lose
control of voluntary movements, and respiratory paralysis ensues. Sensory and
autonomic nerves are usually spared. ALS may be familial or acquired. The two
forms are clinically and pathologically indistinguishable.<span>&nbsp;&nbsp; </span><b><span >&nbsp;</span></b></span></p>

<p><span></span></p>

<p><b><span>Botulism. </span></b><span>Botulism is a rare, toxin-mediated,
paralytic disease. The toxin is produced by the bacterium <i>Clostridium botulinum</i>. The disease may be acquired by bacterial
colonization of the digestive tract, by direct ingestion of toxin, or by wound
contamination. Paralysis typically starts with the cranial nerves and spreads
to the limbs. The patient may present with double vision, drooping of the
eyelids, loss of facial expression, or difficulty with swallowing or talking.
The weakness then spreads to the arms (starting in the shoulders and proceeding
to the forearms) and legs (starting with the thighs and proceeding to the
feet). The autonomic nervous sytem may be affected, causing dry mouth and
throat, postural hypotension, and constipation. Nausea and vomiting may occur,
and, in severe forms, respiratory paralysis ensues. </span></p>

<p><span></span></p>

<p><b><span>Myasthenia gravis</span></b><span>. <span>Myasthenia gravis</span> is an autoimmune
neuromuscular disease that causes fluctuating muscle weakness and fatigability.
Weakness is caused by circulating antibodies that block acetylcholine receptors
at the post-synaptic neuromuscular junction. The hallmark of myasthenia gravis
is fatigability: Muscles become weaker with activity and stronger with rest.
Especially susceptible are the muscles that control eye and eyelid movements,
facial expression, chewing, talking, and swallowing. Presenting symptoms
include ptosis, diplopia, dysarthria, dysphagia, and change in facial expression.
Neck and limb movements may be affected, gait may be unsteady, and breathing
may be impaired.</span></p>

<p><span></span></p>

<p><b><span>Multiple sclerosis</span></b><span>. Multiple sclerosis is
an inflammatory disease in which the myelin sheaths around the axons of the
brain and spinal cord are damaged, leading to demyelination and scarring. (The
myelin sheath is usually around only the axon of a neuron. Schwann cells supply
the myelin for peripheral neurons, whereas oligodendrocytes myelinate the axons
of the central nervous system.) Multiple sclerosis usually begins in young
adults. Women are more commonly affected than men. Patients can have almost any
neurological finding,<span >&nbsp; </span>including
fatigue, visual changes, altered sensation, pain, muscle weakness, difficulty with
movement or balance, problems with speech or swallowing, and bowel or bladder
dysfunction. Cognitive and mood changes may occur. Uhthoff’s phenomenon
(exacerbation of symptoms with exposure to heat) and Lhermitte’s sign (an
electrical sensation running down the back when bending the neck) are characteristic
but not specific for multiple sclerosis. Symptoms may progress gradually or
alternate between relapse and remission.<span >&nbsp;
</span><sup><span >&nbsp;</span></sup></span></p>

<p><span></span></p>

<p><b><span>Guillain-Barré syndrome</span></b><span>. Guillain-Barré
syndrome is an <span>acute inflammatory
demyelinating polyneuropathy</span> (AIDP), an autoimmune disorder affecting
the peripehral nervous system, usually triggered by an acute infectious
process. Typically, the patient experiences ascending paralysis, in which leg
weakness spreads to the upper limbs and<span >&nbsp;
</span>face. There is complete loss of deep tendon reflexes. With prompt
treatment, the majority of patients recover. Death may result, however, from
respiratory or autonomic nervous system dysfunction.</span></p>

<p><b><span>Answer C is correct.</span></b><span> The combination of
upper motor neuron findings (hyperreflexia and extensor plantar reflexes) and
lower motor neuron findings (fasciculations and atrophy) suggests a diagnosis
of amyotrophic lateral sclerosis. Normal sensorium and normal sensation are
typical of ALS.<span >&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
60-year-old man developed sudden clumsiness in his right hand and arm while he
was watering the garden. His hand, which was holding a hose, shook
uncontrollably as he reached toward his plants. The shaking stopped when he put
his hand down. He maintained a strong grip on the nozzle, which felt cold
against his right hand, but not against his left hand. He became nauseated and
dizzy, and felt as if the garden were spinning around him. When he tried to
walk, he staggered, falling toward the right.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>On examination,
his voice is hoarse and his walking is unbalanced. He tends to fall to the
right. Standing with his feet together, he is equally unsteady with eyes opened
and closed. The right eyelid is somewhat droopy. Pupil diameter is 2 mm on the
right and 5 mm on the left. Horizontal nystagmus is noted on lateral gaze.
Touching the right cornea causes neither eye to blink; touching the left causes
blinking bilaterally. Pinprick is less sharp on the right side of the face.
Sweating is present on the left but not the right side of the face. Right
palatal paralysis is noted with the gag reflex. There is decreased sensation to
pinprick and temperature on the left side of the body, but proprioceptive and
vibratory sensation is normal. The right arm and leg are hypotonic, but with
normal strength. The right patellar tendon reflex is pendular (i.e., the leg
continues to swing after the tendon is struck). Movements of the right limbs
are dysmetric, and fine motor movements are clumsy. </span></p>

<p><span></span></p>

<p><span>A lesion
in which of the following areas would explain these findings?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Right thalamus</span></li>
 <li><span>Left thalamus</span></li>
 <li><span>Right midbrain</span></li>
 <li><span>Left midbrain</span></li>
 <li><span>Right pons</span></li>
 <li><span>Left pons</span></li>
 <li><span>Right medulla</span></li>
 <li><span>Left medulla</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Loss of
sensation to the face can occur at three different levels (Figure 5-2). The
first-order neuron has its cell body in the trigeminal nerve ganglion. Its
dendrites are sensory receptors and its axon enters the spinal trigeminal
nucleus, which extends from the upper pons to the C2 level of the spinal cord.
Second-order neurons, whose cell bodies lie in the spinal trigeminal nucleus,
send their axons to the contralateral side, where they ascend in the
contralateral medial lemniscus and synapse with the third-order neurons in the
thalamus. The third-order neurons send their neurons to the somatosensory
cortex in the parietal lobe. A lesion anywhere along this pathway can decrease
pain and temperature sensation on the right side of the face and cause a loss
of the corneal reflex. </span></p>

<p><span></span></p>

<p><span>Decreased
pain and temperature sensation on the left side of the body indicates
involvement of the spinothalamic tract. The only place where the spinothalamic
tract receiving input from the left side of the body approximates the trigeminal
system from the right side of the body is in the right brainstem between the
upper pons and C2 (These are the upper and lower limits of the spinal
trigeminal nucleus).<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Hoarseness
and an abnormal gag reflex further localize the lesion (Figure 5-3). Hoarseness
is caused by vocal cord dysfunction. The vocal cords are innervated by the
vagus nerve from the nucleus ambiguus. The gag reflex involves cranial nerves
IX and X. The afferent limb is supplied by the glossopharyngeal nerve and the
efferent limb is supplied by the vagus nerve. Thus, dysfunction of the nucleus
ambiguus and the vagus nerve on the right side will cause hoarseness and right
palatal paralysis. The nucleus ambiguus is located in the upper medulla. </span></p>

<p><span></span></p>

<p><span>The
patient has clumsiness and incoordination. These could be due to loss of
position sense, weakness, vestibular dysfunction, or cerebellar dysfunction.
The findings of ataxia (gross lack of coordination), dysmetria (inability to
judge distance with the water hose), and intention tremor (right hand shaking
when holding the water hose, but not at rest) suggest ipsilateral cerebellar
dysfunction. We already suspect a lesion in the upper medulla due to the
patient’s hoarseness and palatal paralysis. The inferior cerebellar peduncle is
located in the upper medulla; therefore, a lesion in the upper medulla could
explain the cerebellar findings (Figure 5-4).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
patient also has vertigo, nausea, and nystagmus, which suggest vestibular
dysfunction. Vestibular input is conveyed from the labyrinth of the inner ear
to the vestibular nucleus in the lower pons and upper medulla. </span></p>

<p><span></span></p>

<p><span>Romberg’s
sign is absent. This sign is elicited by asking the patient to stand with his
feet together and with his eyes open, and then closed. If unsteadiness
increases when the eyes are closed, the patient is said to have Romberg’s sign,
which suggests proprioceptive or vestibular dysfunction. If unsteadiness does
not change, Romberg sign is said to be absent. Cerebellar dysfunction is
associated with an absent Romberg sign: Unsteadiness is equally severe with the
eyes opened and closed. </span></p>

<p><span></span></p>

<p><span>Finally,
the patient has Horner’s syndrome &#8211; ptosis, miosis, and hemifacial
anhidrosis &#8211; which indicates dysfunction of the sympathetic nervous
system. Horner’s syndrome can result from damage to first-, second-, or
third-order neurons ipsilaterally. </span></p>

<p><span></span></p>

<ul type=disc>
 <li><i><span>First-order neuron:</span></i><span> Central lesions
     that involve the hypothalamospinal pathway (e.g., transection of the
     cervical spinal cord). </span></li>
 <li><i><span>Second-order
     neuron:</span></i><span>
     Preganglionic lesions (e.g., compression of the sympathetic chain by lung
     tumor). </span></li>
 <li><i><span>Third-order neuron:</span></i><span> Postganglionic
     lesions at the level of the internal carotid artery (e.g., a tumor in the
     cavernous sinus). </span></li>
</ul>

<p><span></span></p>

<p><span>In this
case, dysfunction of the first-order neuron, which travels through the upper
medulla, could explain the findings. </span></p>

<p><span></span></p>

<p><span>Of note,
ptosis occurs with oculomotor dysfunction and with Horner’s syndrome. Oculomotor
dysfunction usually leads to <i>complete</i>
ptosis and an unreactive pupil. Horner’s syndrome usually leads to <i>incomplete</i> ptosis and a constricted
pupil. The partial ptosis of Horner’s syndrome is due to weakness of the tarsal
muscle of M&#369;ller, which is innervated by the sympathetic nerves. The
levator is still intact and prevents the eyelid from drooping completely. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span>

<table cellpadding=0 cellspacing=0 align=left>
 <tr>
  <td width=0 height=5></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=419 height=623 src="_%20Tutorials_files/image544.png" v:shapes="Picture_x0020_347396"></td>
 </tr>
</table>

</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>

<table cellpadding=0 cellspacing=0 align=left>
 <tr>
  <td width=18 height=8></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=404 height=644 src="_%20Tutorials_files/image546.png" v:shapes="Picture_x0020_347395"></td>
 </tr>
</table>

</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<br clear=ALL>

<p style="text-align:center;"><span><img border=0 width=302 height=280
src="_%20Tutorials_files/image548.png" alt="Description: Gray677" v:shapes="Picture_x0020_347367"></span><span></span></p>

<p style="text-align:center;"><span>Figure 5-4</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer G is correct. </span></b></p>

<p><span></span></p>

<p><span>The
patient in this vignette has lateral medullary syndrome (also called Wallenberg
syndrome or posterior inferior cerebellar artery syndrome). Lateral medullary
syndrome results from occlusion of the posterior inferior cerebellar artery
(PICA) or one of its branches or of the vertebral artery. Symptoms are caused
by infarction of the lateral part of the medulla oblongata. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellpadding=0>
 <tr>
  <td width=435 colspan=2>
  <p style="text-align:center;"><b><span>Wallenberg
  Syndrome</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=435 colspan=2>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><b><span>Dysfunction</span></b><span></span></p>
  </td>
  <td width=210>
  <p style="text-align:center;"><b><span>Effects</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Vestibular nuclei</span></p>
  </td>
  <td width=210>
  <p><span>Vomiting, </span><a
  href="http://en.wikipedia.org/wiki/Vertigo_(medical)"
  title="Vertigo (medical)"><span>vertigo</span></a><span>, </span><a
  href="http://en.wikipedia.org/wiki/Pathologic_nystagmus"
  title="Pathologic nystagmus"><span>nystagmus</span></a><span></span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Inferior cerebellar
  peduncle</span></p>
  </td>
  <td width=210>
  <p><span>Ipsilateral </span><a
  href="http://en.wikipedia.org/wiki/Ataxia"><span>ataxia</span></a><span>, dysmetria (past pointing),
  dysdiadokokinesia</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Lateral spinothalamic
  tract</span></p>
  </td>
  <td width=210>
  <p><span>Contralateral loss of
  pain and temperature sensation from body</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Spinal trigeminal nucleus</span></p>
  </td>
  <td width=210>
  <p><span>Ipsilateral loss of pain
  and temperature sensation from face</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Nucleus ambiguus (which
  affects </span><a href="http://en.wikipedia.org/wiki/Vagus_nerve"><span>vagus </span></a><span>and
  </span><a href="http://en.wikipedia.org/wiki/Glossopharyngeal_nerve"><span>glossopharyngeal nerve</span></a><span>s)</span></p>
  </td>
  <td width=210>
  <p><span>Ipsilateral laryngeal,
  pharyngeal, and palatal hemiparesis; </span><a
  href="http://en.wikipedia.org/wiki/Dysphagia"><span>dysphagia</span></a><span>, </span><a
  href="http://en.wikipedia.org/wiki/Hoarseness" title=Hoarseness><span>hoarseness</span></a><span>,
  diminished </span><a href="http://en.wikipedia.org/wiki/Gag_reflex"
  title="Gag reflex"><span>gag reflex</span></a><span></span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><span>Sympathetic fibers
  (descending)</span></p>
  </td>
  <td width=210>
  <p><span>Ipsilateral </span><a
  href="http://en.wikipedia.org/wiki/Horner%27s_syndrome"><span>Horner's syndrome</span></a><span> (ptosis, miosis, and anhydrosis)</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
70-year-old man is brought to the emergency room because he is unable to walk.
Several weeks ago, he began dragging his right leg while walking. He had to
lean on a chair to stand, and he pushed the chair around in order to walk. When
the right leg became so weak that he could not get out of bed, he allowed his
daughter to bring him to the emergency room. During the same period of time,
his right upper extremity became increasingly weak. He would drop objects from
his right hand and could not raise his hand above his head. His left eyelid
began to droop until it closed completely. When he manually lifted his left
eyelid, he saw double. </span></p>

<p><span></span></p>

<p><span>He is
alert, oriented, and cooperative. His speech is well articulated and fluent.
Naming, repetition, and comprehension are normal. Visual fields are full. The
right pupil is 3 mm in diameter and reacts normally to light. The left pupil is
7 mm in diameter and unreactive to light. He cannot adduct, elevate, or depress
the left eye; abduction, however, is normal.<span>&nbsp; </span>Looking down results in counterclockwise
rotation of the left eye. Right eye movements are full. A complete drooping of
the left eyelid is noted. The lower part of the right face does not move as
well as the left. Both sides of the forehead wrinkle well. Pinprick, proprioceptive,
and vibratory sensation are normal. Weakness, increased muscle tone, and
hyperreflexia are noted in the right upper and lower extremity. Babinski’s sign
is present on the right. The finger-to-nose test shows no ataxia or tremor on
the left. The right arm is too weak to test. The patient cannot walk due to
weakness in the right leg.</span></p>

<p><span></span></p>

<p><span>A lesion
in which of the following areas would explain these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Right
cerebral hemisphere </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Left
cerebral hemisphere</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Right
midbrain</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Left
midbrain</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Right
pons</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Left
pons</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Right
medulla</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Left
medulla</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Weakness,
increased tone, hyperreflexia, and Babinski’s sign indicate a lesion of the
corticospinal system (Figure 1-2). The weakness is right-sided; therefore, a
lesion above the pyramidal decussation would have to be left-sided; a lesion
below the pyramidal decussation would have to be right-sided. Also, the lesion
must be above the level of C4 because the arm is involved.<span>&nbsp; </span>(The upper extremity is innervated by
spinal nerves C5 to T1. The biceps reflex involves C5 and C6.)</span></p>

<p><span></span></p>

<p><span>Weakness
of the lower face is consistent with an upper motor neuron lesion. (A lower
motor neuron lesion would cause weakness of the upper and lower face.) Upper
motor neurons that supply the right lower face originate in the left cerebral
hemisphere and travel through the left cerebral peduncle of the midbrain before
crossing in the pons to the right facial nerve nucleus (Figure 3-3). Thus, a
lesion that affects both the corticospinal tract and the corticobulbar fibers to
the right facial nucleus must be located on the left side at or above the level
of the lower pons. </span></p>

<p><span></span></p>

<p><span>The
patient’s inability to adduct, elevate, or depress the left eye indicates
dysfunction of the oculomotor nerve, which supplies the superior rectus, medial
rectus, inferior rectus, and inferior oblique muscles. The oculomotor nerve
also innervates the levator palpebrae muscle and carries the efferent limb of
the papillary light reflex. Therefore, nerve dysfunction results in ptosis and
an unreactive pupil, as seen in this patient. The patient has normal intorsion
of the left eye, which indicates normal function of the superior oblique muscle
and the trochlear nerve. Also, the patient has normal abduction of the eye,
indicating normal function of the lateral rectus muscle and the abducens
nerve.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
oculomotor nerve arises from the anterior aspect of the midbrain (Figure 3-4).
Therefore, a lesion of the left midbrain would explain the ocular, facial, and
extremity findings in this patient.<span >&nbsp;
</span>A CT scan ultimately showed a tumor in the left cerebral peduncle of the
midbrain. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span><img width=466 height=1290
src="_%20Tutorials_files/image551.png" v:shapes="Picture_x0020_347394 Picture_x0020_347393"></span></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<br clear=ALL>

<p><span><span><img width=398 height=661
src="_%20Tutorials_files/image553.png" v:shapes="Picture_x0020_347392"></span></span><span><span>&nbsp;</span><b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. A lesion in the left
midbrain would explain these findings. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
65-year-old man is brought to the emergency room because of sudden difficulty
with walking. He fell while trying to get out of bed this morning. He was able
to get back up but later dragged his right leg while walking. He noticed
weakness in his right arm when he tried to grasp objects for support. His
family notes that he has been drooling from the left side of his mouth and that
his speech is slurred. He has noticed no change in vision or loss of sensation.
</span></p>

<p><span></span></p>

<p><span>On
physical examination, the patient is alert, oriented, and cooperative. His
speech is slurred but fluent. Speech and reading comprehension are normal. The
pupils are 3mm in diameter and reactive to light. He can look conjugately to
the right, up, and down, but not to the left. Visual fields are intact. When he
speaks and tries to smile, the left side of his face does not move. When he is
asked to close his eyes tightly, the eyelashes on the right become buried but
those on the left remain visible. Wrinkling on the left side of the forehead is
less pronounced. The tongue protrudes and the palate elevates in the midline.
Pinprick, proprioceptive, and vibratory sensations are intact. The right upper
and lower extremities are weak and hyperreflexic. Babinski’s sign is present on
the right. The right upper extremity is slightly flexed at the elbow, and the
right lower extremity is slightly extended. The right lower extremity moves
slowly and stiffly when he tries to walk. </span></p>

<p><span></span></p>

<p><span>A lesion
in which of the following areas would explain these findings?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Right internal
     capsule</span></li>
 <li><span>Left internal
     capsule</span></li>
 <li><span>Right midbrain</span></li>
 <li><span>Left midbrain</span></li>
 <li><span>Right pons</span></li>
 <li><span>Left pons</span></li>
 <li><span>Right medulla</span></li>
 <li><span>Left medulla</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hyperreflexia
and Babinski’s sign indicate a lesion of the corticospinal system (Figure 1-2).
The abnormalities of the patient’s gait are typical of hemiparesis and
consistent with an upper motor neuron lesion. The upper motor neuron, or
corticospinal pathway, runs the entire length of the CNS. Muscles of the upper
extremity are innervated by the C4-T1 spinal cord segments. Therefore, a lesion
above the C4 level would explain upper extremity weakness. The biceps reflex is
supplied by C5 and C6. Hyperactivity of that reflex indicates a lesion at or
above the C4 level. </span></p>

<p><span></span></p>

<p><span>Each
facial nerve nucleus is functionally divided into two separate regions, one
that supplies the muscles of the upper face and one that supplies the muscles
of the lower face (Figure 2-3). The part that supplies the upper face receives
input from both cerebral hemispheres, while the part that supplies the lower
face receives only contralateral input. Therefore, a lower motor neuron lesion
would result in loss of innervation to the upper and lower face. This is known
as a “peripheral” type of facial weakness. A lesion of the contralateral
hemisphere would result in a loss of innervation to the lower face. (The upper
face would still be innervated by the intact ipsilateral hemisphere.) The patient
would be able to move the upper but not the lower face. This is known as a
“central” type of facial weakness. </span></p>

<p><span></span></p>

<p><span>In this
vignette, both upper and lower parts of the face are affected, consistent with
a peripheral pattern. The lesion could be in the facial nucleus, the facial
nerve fasciculus (the portion of the facial nerve within the brainstem), the
peripheral nerve, the neuromuscular junction, or the muscle. Knowing that the
corticospinal tract is involved, the lesion must be in the CNS. Therefore, the problem
must lie in the facial nucleus or fasciculus, not in the peripheral nerve,
neuromuscular junction, or muscle</span></p>

<p><span></span></p>

<p><span>Only a
lesion in the left pons could cause left facial weakness and right arm and leg
weakness (Figure 2-4), as the facial nucleus and fasciculus are located in the
pons. This is an example of “crossed paralysis” in which there is cranial nerve
weakness on one side of the body and extremity weakness on the other side.
Crossed paralysis indicates a brainstem lesion. The slurred speech is caused by
facial weakness. (Certain sounds like “me” and “pa” require closure of the
obicularis oris, which is affected in facial paralysis.)</span></p>

<p><span></span></p>

<p><span>The system
involved in moving the eyes conjugately to the left originates in the right
frontal eye field of the cerebral cortex (Figure 2-5). Fibers descend through
the internal capsule to the right side of the midbrain. Here, fibers cross to
the left side at the level of the lower midbrain. These fibers then descend to
the lower pontine level and synapse in an area called the paramedian pontine
reticular formation (PPRF). Fibers then leave the PPRF and synapse in the
ipsilateral abducens nucleus. There are two populations of neurons in the
abducens nucleus: motor neurons, which run to the lateral rectus muscle to
abduct the ipsilateral eye, and interneurons, which cross the midline at the
level of the abducens nucleus to ascend in the contralateral medial
longitudinal fasciculus (MLF) and synapse in the medial rectus subnucleus of
the oculomotor nucleus. When the PPRF activates the abducens nucleus, the eyes
move conjugately to the ipsilateral side by innervating the ipsilateral lateral
rectus and contralateral medial rectus muscles. A lesion of the PPRF or closely
adjacent abducens nucleus produces horizontal gaze palsy when the patient tries
to look toward the side of the lesion (as in this case).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>In this
vignette, we have established that the lesion is in the left pons, because of
the presence of left facial weakness and right upper and lower extremity
weakness. The left pons contains the PPRF and abducens nucleus, which upon
being damaged result in left gaze paresis (Figure 2-6). </span></p>

<p><span></span></p>

<p><span>This
patient was ultimately found to have an infarct in the left pons. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><img
width=462 height=1154 src="_%20Tutorials_files/image556.png" v:shapes="Picture_x0020_347391 Picture_x0020_347390"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span><img width=439 height=659
src="_%20Tutorials_files/image558.png" v:shapes="Picture_x0020_347389"></span></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>

<table cellpadding=0 cellspacing=0 align=left>
 <tr>
  <td width=26 height=0></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=382 height=628 src="_%20Tutorials_files/image560.png" v:shapes="Picture_x0020_347388"></td>
 </tr>
</table>

</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span><img width=452 height=667
src="_%20Tutorials_files/image562.png" v:shapes="Picture_x0020_347387"></span></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<br clear=ALL>

<p><b><span>Answer F is correct</span></b><span>. A lesion in the left
pons would explain these findings. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
38-year-old man with a history of Hodgkin’s disease presents with right hand
weakness. Four weeks prior to his visit, he began having trouble opening jars.
Occasionally he would drop objects from his right hand. His left leg and,
later, his left hand began to go numb. His wife noticed that he seemed to drag
his right leg and to have trouble climbing stairs. </span></p>

<p><span></span></p>

<p><span>Physical
examination shows decreased proprioception and vibratory sensation in the toes,
ankles, and fingers on the right side. Pinprick and temperature sensation are
diminished in the left arm, trunk, and leg, but not on the neck and face. Mild
weakness without wasting or fasciculation is noted in the right arm and leg.
Grip and finger abduction are weaker in the right hand than in the left, but shoulder
abduction, as well as elbow flexion and extension, are normal. Right hip
flexion and ankle dorsiflexion are weak. Tendon reflexes (biceps, triceps,
knee, and ankle) are increased on the right side. Babinski’s sign is present on
the right. </span></p>

<p><span></span></p>

<p><span>Injury to which
of the following areas would explain these findings? </span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Right thalamus</span></li>
 <li><span>Left thalamus</span></li>
 <li><span>Right spinal cord
     at C3</span></li>
 <li><span>Left spinal cord at
     C3</span></li>
 <li><span>Right spinal cord
     at C7</span></li>
 <li><span>Left spinal cord at
     C7</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
presence of hyperreflexia and Babinski’s sign indicates an upper motor neuron
lesion, i.e., a lesion of the corticospinal (pyramidal) system. In this case,
hyperreflexia is noted as high as the biceps, which is innervated by the C5 and
C6 spinal segments. Therefore, the lesion must be above the C5 level. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=293 colspan=2 valign=top>
  <p style="text-align:center;"><span>Deep Tendon Reflexes</span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span></span></p>
  </td>
  <td width=117 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Biceps
  reflex</span></p>
  </td>
  <td width=117 valign=top>
  <p><span>C5, C6</span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Brachioradialis
  reflex</span></p>
  </td>
  <td width=117 valign=top>
  <p><span>C5, C6,
  C7</span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Triceps
  reflex</span></p>
  </td>
  <td width=117 valign=top>
  <p><span>C6, C7,
  C8</span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Patellar
  reflex or knee-jerk reflex</span></p>
  </td>
  <td width=117 valign=top>
  <p><span>L2, L3,
  L4</span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Ankle
  jerk reflex (Achilles reflex)</span></p>
  </td>
  <td width=117 valign=top>
  <p><span>S1, S2</span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Plantar
  reflex or Babinski’s reflex</span></p>
  </td>
  <td width=117 valign=top>
  <p><span>L5, S1,
  S2</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The
involved corticospinal tract begins in the left frontal lobe and descends in
the left cerebral peduncle of the midbrain and the left basis pontis (Figure
1-2). In the pyramids of the medulla, it crosses to the right side and descends
in the right lateral funiculus of the spinal cord. The corticospinal fibers
synapse with second-order neurons in the ventral horn of the spinal cord. Axons
of these neurons innervate muscles on the right side of the body. </span></p>

<p><span></span></p>

<p><span>Numbness
in the left upper and lower extremities suggests involvement of the
spinothalamic tract (Figure 1-3). This is confirmed by the absence of pinprick
and temperature sensation on the left side.<span>&nbsp; </span>The first-order neuron has its cell body
in the dorsal root ganglion and enters the spinal cord via the dorsal root. It
synapses with the second-order neuron in the dorsal horn of the spinal cord.
The second-order neuron then crosses to the other side of the spinal cord
through the anterior white commissure. It ascends in the lateral funiculus to
synapse in the ventral posterior lateral nucleus of the thalamus. From there,
the third-order neuron ascends to the somatosensory area of the cerebral
cortex. </span></p>

<p><span></span></p>

<p><span>The only
anatomic site where a single small lesion can affect both the corticospinal and
spinothalamic tracts and produce the symptoms seen in this patient is on the
right side below the pyramidal decussation and above the C5 level of the spinal
cord. </span></p>

<p><span></span></p>

<p><span>The
ascending fibers in the spinal cord are laminated such that fibers entering
from the lower levels are more lateral and superficial. These fibers are more
vulnerable to compression by an extrinsic lesion. As an extrinsic lesion
expands, more fibers are involved and the sensory symptoms appear to ascend.
Fibers of the corticospinal system are similarly laminated, and progressive
spinal cord compression can cause an ascending pattern of weakness. (This
pattern is sometimes confused with the ascending symptoms of Guillain-Barré
syndrome.)</span></p>

<p><span></span></p>

<p><span>Vibratory
and proprioceptive sensation is mediated by the dorsal column-medial lemniscal
pathway (Figure 1-4). The first-order neuron, whose cell body is in the dorsal
root ganglion, enters the spinal cord via the dorsal root. It ascends in the
ipsilateral dorsal column of the spinal cord without synapsing or crossing to
the other side. In the medulla, the first-order neurons from spinal segments
below T6 synapse in the nucleus gracilis, while those from rostral spinal
segments synapse in the nucleus cuneatus. The second-order neuron axons cross
to the other side to form the medial lemniscus. These fibers then ascend to
synapse with the third-order neurons in the thalamus. The thalamic neuron axons
ascend to the somatosensory areas in the parietal lobe cortex.</span></p>

<p><span></span></p>

<p><span>The
proposed lesion &#8211; a right-sided lesion located between the pyramidal
decussation and the C5 level of the spinal cord &#8211; would account not only
for the patient’s right-sided weakness and left-sided loss of pinprick
sensation, but also for the loss of right-sided vibratory and proprioceptive
sensation. The patient has symptoms and signs of a hemispinal cord lesion
(lesion of one-half of the spinal cord). This is known as the Brown-Sequard
syndrome. In this case, the patient was found to have right-sided spinal cord
compression at the level of C3. The cause was Hodgkin’s lymphoma. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>

<table cellpadding=0 cellspacing=0 align=left>
 <tr>
  <td width=4 height=0></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=462 height=1345 src="_%20Tutorials_files/image565.png" v:shapes="Picture_x0020_347386 Picture_x0020_347385"></td>
 </tr>
</table>

</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>

<table cellpadding=0 cellspacing=0 align=left>
 <tr>
  <td width=20 height=0></td>
 </tr>
 <tr>
  <td></td>
  <td><img width=430 height=663 src="_%20Tutorials_files/image567.png" v:shapes="Picture_x0020_347384"></td>
 </tr>
</table>

</span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<br clear=ALL>

<p><b><span>Answer C is correct</span></b><span>. A lesion in the right
spinal cord at C3 would explain these findings. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
12-year-old girl presents to the clinic with fatigue, sadness, and
uncontrollable shaking. Physical examination reveals gold-colored deposits in
the corneas and a Parkinson-like tremor. Lab tests show mild elevation of liver
enzymes. Which of the following would you expect? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Decreased
urinary copper excretion</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased
serum ceruloplasmin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increased
serum ferritin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Decreased
serum alpha-1 antitrypsin</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increased
iron saturation</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Wilson’s disease is an autosomal recessive
disorder of copper metabolism that results in copper accumulation in various
organs. Patients usually present in childhood or adolescence with liver
disease, neurological disease (e.g., movement disorder) or psychiatric disease.
Copper deposition in Descemet’s membrane of the cornea results in
Kayser-Fleischer rings, which are pathognomic for the disease. Laboratory tests
show decreased serum ceruloplasmin levels, increased tissue copper levels, and
increased urinary excretion of copper. The mainstay of therapy is copper
chelation (using D- penicillamine). Liver transplantation is curative.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=290 height=193
src="_%20Tutorials_files/image569.jpg" alt="Description: Kayser-Fleischer_ring"
v:shapes="Picture_x0020_347366"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Kayser-Fleischer rings
are gold-colored rings that appear to encircle the iris of the eye. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>. The neuropsychiatric
findings in this patient, along with Kayser-Fleischer rings, point to a
diagnosis of Wilson’s disease, which is associated with low ceruloplasmin
levels. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section">Nutrition</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Pharmacology</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 45-year-old man is brought to the
emergency room after suffering a seizure during his first day at an alcohol
treatment center. The seizure lasted one minute and resolved spontaneously. The
patient had been drinking a fifth of bourbon and 6 to 12 beers daily for many
years. The seizure occurred 36 hours after his last drink. On examination, the
patient is sweaty, anxious, and tremulous, but oriented to person, place, and
time. Temperature is 100.1<sup>o</sup>F, blood pressure is 180/100 mm Hg, and
pulse is 113/minute. The urine toxicology screen is negative. The blood alcohol
level is zero. The patient is given a loading dose of phenytoin and admitted to
the hospital for general medical observation. Eight hours later, he becomes agitated,
diaphoretic, and disoriented. He screams that his room is infested with bugs
that are crawling on top of him. What is the most likely cause of the patient’s
altered sensorium?</span></p>

<p><b><span></span></b></p>

<ol start=1 type=A>
 <li><span>Alcohol
     withdrawal delirium</span></li>
 <li><span>Status
     epilepticus</span></li>
 <li><span>Schizophrenia</span></li>
 <li><span>Thyroid
     storm</span></li>
 <li><span>Adverse
     reaction to phenytoin</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Alcohol withdrawal delirium,
also known as delirium tremens (DT), u<span>sually
develops 48&#8211;72 hours after discontinuation of alcohol, peaks around day
4, and may persist for 2 weeks. A</span> functional decrease in GABA (<span>&#947;-aminobutyric acid)</span> when alcohol
is no longer being consumed leads to loss of the inhibitory control of
excitatory neurotransmitters, such as norepinephrine, glutamate, and dopamine.
Symptoms of DT include fever, tachycardia, hypertension, confusion, agitation,
disorientation, hallucinations, and diarrhea. DT is life-threatening emergency.
It occurs most often in those who drink large quantities of alcohol daily
(e.g., 4 - 5 pints of wine; 7 - 8 pints of beer; 1 pint of &quot;hard&quot;
liquor), and in those with a history of habitual alcohol use for more than 10
years. Of note, withdrawal from sedative-hypnotics, such as benzodiazepines or
barbiturates, can also result in seizures, DT, and death if not properly
managed. </p>

<p>Patients with DT should be
admitted to the intensive care unit and treated aggressively with
benzodiazepines. Benzodiazepines are the treatment of choice because they have
similar GABA-potentiating effects to alcohol.<span>&nbsp; </span>In addition, benzodiazepines have
excellent anticonvulsant effects. Antipsychotics (e.g., haloperidol) may be
required to control extreme agitation. Before the advent of ICUs and modern
pharmacotherapy, mortality rates for DT approached 35%.</p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b><span>Answer A
is correct.<span >&nbsp; </span></span></b><span>Alcohol withdrawal is
the most likely cause of the patient’s altered sensorium.</span></p>

<p><b></b></p>

<p><b>Answer B is incorrect</b>. Although definitions vary, status
epilepticus is often defined as a continuous, unremitting seizure lasting
longer than 30 minutes, or as recurrent seizures without intervening
consciousness lasting more than 30 minutes. Status elipepticus is a medical
emergency. </p>

<p><b></b></p>

<p><b>Answer C is incorrect</b>. Psychiatrists are often called to evaluate
patients for “schizophrenia” who turn out to have delirium.<span>&nbsp; </span>Hallucinations are common in delirium
and do not suggest underlying schizophrenia.<b></b></p>

<p><b></b></p>

<p><b>Answer D is incorrect</b><span>. </span>Thyroid storm is a medical emergency
<span>characterized by </span>fever, tachycardia,
arrhythmia, heart failure, nausea/vomiting, diarrhea, confusion, and
disorientation. The patient in this vignette has many symptoms compatible with
thyroid storm, but DT is a more likely given the medical history.</p>

<p><b></b></p>

<p><b>Answer E is incorrect</b>. The patient’s symptoms are not due to
phenytoin use. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 30-year-old man presents to his physician with the sense that his heart
occasionally races, and this sense occurs more frequently when he is
exercising.<span >&nbsp; </span>Treadmill testing with
ECG analysis indicates that his AV node has enhanced automaticity.<span>&nbsp; </span>Which of the following drugs could be
prescribed to treat this man because it slows conduction, prolongs refractory
period, and decreases automaticity in the sinoatrial and atrioventricular
nodes?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dofetilide<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Flecainide</span></p>

<p><span>C. <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Lidocaine</span></p>

<p><span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Procainamide</span></p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Verapamil</span></p>

<p><span></span></p>

<p><span></span></p>

<b><span><br clear=all>
</span></b>

<p><span>Antiarrhythmic
drugs are classified based on the mechanism of action of the drugs.<span>&nbsp; </span>The advantage of the system is that it
allows prediction for pharmacological effect, therapeutic use and side effects.<span>&nbsp; </span>The classification is not precise.<span>&nbsp; </span>Some drugs may have multiple mechanisms
and may overlap several classes.<span >&nbsp;
</span>There are other antiarrhythymic drugs that do not fall into any of these
classes.</span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Class
I &#8211; Na<sup>+</sup> channel blockers (local anesthetics)</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Class
II &#8211; Sympatholytic agents (&#61538;-blockers)</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Class
III &#8211; Prolonged repolarization (potassium channel blockers)</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Class
IV &#8211; Calcium channel blockers</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Class
V &#8211; Other mechanisms</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>“Some
Block Potassium Channels” is a pneumonic to remember the first four classes.</span></p>

<p><span></span></p>

<p><u><span>S</span></u><span>ome (Class I - sodium
channel blockers) </span></p>

<p><u><span>B</span></u><span>lock (Class II - beta
blockers) </span></p>

<p><u><span>P</span></u><span>otassium (Class III -
potassium channel blockers) </span></p>

<p><u><span>C</span></u><span>hannels (Class IV -
calcium channel blockers)</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 width=469>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>Class</span></b></p>
  </td>
  <td width=133 valign=top>
  <p style="text-align:center;"><b><span>Examples</span></b></p>
  </td>
  <td width=298 valign=top>
  <p><b><span>Mechanism</span></b></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>Ia</span></b></p>
  </td>
  <td width=133 valign=top>
  <ul type=disc>
   <li><a
       href="http://en.wikipedia.org/wiki/Quinidine" title=Quinidine><span>Quinidine</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Procainamide" title=Procainamide><span>Procainamide</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Disopyramide" title=Disopyramide><span>Disopyramide</span></a><span> </span></li>
  </ul>
  </td>
  <td width=298 valign=top>
  <p><a
  href="http://en.wikipedia.org/wiki/Sodium_channel" title="Sodium channel"><span>Na<sup>+</sup>-channel</span></a><span> blocker (intermediate
  association/dissociation)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>Ib</span></b></p>
  </td>
  <td width=133 valign=top>
  <ul type=disc>
   <li><a
       href="http://en.wikipedia.org/wiki/Lidocaine" title=Lidocaine><span>Lidocaine</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Phenytoin" title=Phenytoin><span>Phenytoin</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Mexiletine" title=Mexiletine><span>Mexiletine</span></a><span></span></li>
   <li><span>Tocainide</span></li>
  </ul>
  </td>
  <td width=298 valign=top>
  <p><a href="http://en.wikipedia.org/wiki/Sodium_channel"
  title="Sodium channel"><span>Na<sup>+</sup>-channel</span></a><span> blocker (fast
  association/dissociation)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>Ic</span></b></p>
  </td>
  <td width=133 valign=top>
  <ul type=disc>
   <li><a
       href="http://en.wikipedia.org/wiki/Flecainide" title=Flecainide><span>Flecainide</span></a><span> </span></li>
   <li><span>Encainide</span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Propafenone" title=Propafenone><span>Propafenone</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Moricizine" title=Moricizine><span>Moricizine</span></a><span> </span></li>
  </ul>
  </td>
  <td width=298 valign=top>
  <p><a href="http://en.wikipedia.org/wiki/Sodium_channel"
  title="Sodium channel"><span>Na<sup>+</sup>-channel</span></a><span> blocker (slow
  association/dissociation)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>II</span></b></p>
  </td>
  <td width=133 valign=top>
  <ul type=disc>
   <li><a
       href="http://en.wikipedia.org/wiki/Propranolol" title=Propranolol><span>Propranolol</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Esmolol" title=Esmolol><span>Esmolol</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Timolol" title=Timolol><span>Timolol</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Metoprolol" title=Metoprolol><span>Metoprolol</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Atenolol" title=Atenolol><span>Atenolol</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Bisoprolol" title=Bisoprolol><span>Bisoprolol</span></a><span></span></li>
  </ul>
  </td>
  <td width=298 valign=top>
  <p><span>B</span><a
  href="http://en.wikipedia.org/wiki/Beta_blocker" title="Beta blocker"><span>eta-block</span></a><span>er<br>
  <![if !supportLineBreakNewLine]><br>
  <![endif]></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>III</span></b></p>
  </td>
  <td width=133 valign=top>
  <ul type=disc>
   <li><a
       href="http://en.wikipedia.org/wiki/Amiodarone" title=Amiodarone><span>Amiodarone</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Sotalol" title=Sotalol><span>Sotalol</span></a><span>* </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Ibutilide" title=Ibutilide><span>Ibutilide</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Dofetilide" title=Dofetilide><span>Dofetilide</span></a><span> </span></li>
  </ul>
  </td>
  <td width=298 valign=top>
  <p><a href="http://en.wikipedia.org/wiki/Potassium_channel_blocker"
  title="Potassium channel blocker"><span>K<sup>+</sup>-channel
  blocker</span></a><span><span>&nbsp; </span>(*</span><a
  href="http://en.wikipedia.org/wiki/Sotalol" title=Sotalol><span>Sotalol</span></a><span> is also a </span><a
  href="http://en.wikipedia.org/wiki/Beta_blocker" title="Beta blocker"><span>beta-blocker</span></a><span>)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>IV</span></b></p>
  </td>
  <td width=133 valign=top>
  <ul type=disc>
   <li><a
       href="http://en.wikipedia.org/wiki/Verapamil" title=Verapamil><span>Verapamil</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Diltiazem" title=Diltiazem><span>Diltiazem</span></a><span> </span></li>
  </ul>
  </td>
  <td width=298 valign=top>
  <p><a href="http://en.wikipedia.org/wiki/Calcium_channel_blocker"
  title="Calcium channel blocker"><span>Ca<sup>2+</sup>-channel
  blocker</span></a><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p style="text-align:center;"><b><span>V</span></b></p>
  </td>
  <td width=133 valign=top>
  <ul type=disc>
   <li><a
       href="http://en.wikipedia.org/wiki/Adenosine" title=Adenosine><span>Adenosine</span></a><span> </span></li>
   <li><a
       href="http://en.wikipedia.org/wiki/Digoxin" title=Digoxin><span>Digoxin</span></a><span> </span></li>
  </ul>
  </td>
  <td width=298 valign=top>
  <p><span>Other
  mechanisms</span></p>
  </td>
 </tr>
</table>

<p><b><span></span></b></p>

<p><b><span>Class I</span></b></p>

<p><span></span></p>

<p><span>Class I
antiarrhythmic drugs block Na<sup>+</sup> conduction through voltage-gated Na<sup>+</sup>
channels.<span >&nbsp; </span>These drugs are in the
class of local anesthetics (LAs).<span >&nbsp;
</span>Class I drugs are the oldest of the antiarrhythmic drugs and still in
wide use.</span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span>Local
anesthetics in the <b>charged form</b> <b>bind to the pore of the voltage-gated Na<sup>+</sup>
channels and block Na<sup>+</sup> conductance through the channel</b>.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Class I
drugs have broad spectrum antiarrhythmic activity and are used for
supraventricular and ventricular arrhythmias, atrial fibrillation, and atrial
flutter.</span></p>

<p><span></span></p>

<p><b><span>Class II</span></b></p>

<p><span></span></p>

<p><b><span>The acute antiarrhythmic effects of the <span><img border=0 width=8 height=11
src="_%20Tutorials_files/image571.png" alt="Description: betalower" v:shapes="Picture_x0020_347425"></span><i>-</i>blockers
are primarily due to the inhibition of abnormal automaticity of the SA and AV
nodes or a portion of a reentry loop.</span></b><span><span >&nbsp; </span><b>They also help to inhibit ventricular
response to atrial tachycardia by decreasing conduction through the AV node. </b><span>&nbsp;</span>These drugs can also reduce ventricular
ectopic beats, particularly if the ectopic activity has been precipitated by
catecholamines.<span >&nbsp; </span>They are also
useful in suppressing exercise-induced tachycardias.<span>&nbsp; </span><span>Beta</span><span>-</span>blockers are also useful in chronic
antiarrhythmic therapy.<span >&nbsp; </span><span>They </span>decrease the likelihood of sudden cardiac
death after myocardial infarction, but the mechanism is not well understood.</span></p>

<p><span></span></p>

<p><b><span>Class III</span></b><span></span></p>

<p><span></span></p>

<p><span>The class
III antiarrhythmic drugs include those agents that specifically prolong
refractoriness in atrial and ventricular tissue.<span>&nbsp; </span>The drugs share the common effect of <b>delaying repolarization by blocking the
rapidly activating delayed rectifier potassium channels (I<sub>Kr</sub>)
responsible for phase 2 and phase 3 repolarization</b>.<span>&nbsp; </span>Most drugs in this class prolong the QT
interval.<span >&nbsp; </span>The common side effect of
all class III agents is that they may also be proarrhythmic in the form of <b>provoking early afterdepolarizations</b> by
blocking potassium channels and delaying repolarization.</span></p>

<p><span></span></p>

<p><b><span>Class IV</span></b></p>

<p><span></span></p>

<p><span>Class IV is comprised of
the <b>non-dihydropyridine</b> calcium
channel blockers, <b>verapamil and
diltiazem</b>.<span >&nbsp; </span><b>The primary site of action of these drugs is the slow response action
potentials in the SA and AV nodes.</b><span >&nbsp;
</span><b>Both verapamil and diltiazem
block L-type calcium channels and slow conduction, prolong refractoriness, and
decrease automaticity in the calcium-dependent tissue in the SA and AV nodes.</b><span>&nbsp; </span>These agents are effective in automatic
or reentrant tachycardias, which arise from or use the SA or AV nodes. <span>&nbsp;</span>These drugs will slow ventricular
response during atrial fibrillation by slowing AV conduction.<span>&nbsp; </span>This class of drugs is also effective in
exercise-triggered tachycardias or tachycardias triggered by automaticity since
calcium may play a role in these arrhythmias.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Other antiarrythmic
drugs</span></b></p>

<p><span></span></p>

<p><span>Adenosine</span></p>

<p><span></span></p>

<p><b><span>Administered as an acute
IV bolus for treatment of reentrant supraventricular arrhythmias.<span>&nbsp; </span></span></b><span>Adenosine binds to a specific adenosine receptor
and also <b>activates the
acetylcholine-sensitive K<sup>+</sup> channel in the atrium, SA and AV nodes</b>.<span>&nbsp; </span>This causes a shortening of the action
potential duration, hyperpolarization and slowing of automaticity.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Digitalis</span></p>

<p><span></span></p>

<p><b><span>Digitalis has vagotonic
effects</span></b><span>
by causing an inhibition of Ca<sup>++</sup> currents in the AV node and
activation of acetylcholine-sensitive K<sup>+</sup> currents in the atrium.
This results in a hyperpolarization, shortening of atrial action potentials and
increase in the refractory period of the AV node.<span>&nbsp; </span><b>Digitalis
is used in patients with reentry arrhythmias in the AV node and atrial
fibrillation.</b></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct.<span>&nbsp; </span></span></b><span>Verapamil is a class IV antiarrhythmic drug that
blocks Ca<sup>++</sup> channels to produce its therapeutic effects. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
3-year-old girl presents with a temperature of 101<sup>o</sup>F, nasal
discharge, and severe paroxysms of coughing. She is diagnosed with whooping
cough (pertussis), and erythromycin is prescribed. How does this antibiotic
work?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Inhibits
the interaction between the bacterial 50S ribosomal subunit and tRNA</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Inhibits
the formation of peptidoglycan cross-links</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Inhibits
DNA gyrase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Inhibits
DNA topoisomerases</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Inhibits
synthesis of ergosterol</span></p>

<p><span></span></p>

<p><span></span></p>

<span><br clear=all>
</span>

<p><span></span></p>

<p><span></span></p>

<p><img width=163 height=550
src="_%20Tutorials_files/image573.png" align=left v:shapes="Text_x0020_Box_x0020_47 Line_x0020_48 Group_x0020_46 Text_x0020_Box_x0020_44 Line_x0020_42 Group_x0020_40 Line_x0020_38 Group_x0020_36 Text_x0020_Box_x0020_34 Line_x0020_32 Group_x0020_30 Line_x0020_28 Group_x0020_26 Text_x0020_Box_x0020_24 Line_x0020_22 Group_x0020_20 Line_x0020_17 Group_x0020_15 Text_x0020_Box_x0020_13 Line_x0020_10 Group_x0020_11 Text_x0020_Box_x0020_7 Group_x0020_347426 Picture_x0020_3 Group_x0020_18 Text_x0020_Box_x0020_9 Group_x0020_12 Line_x0020_14 Text_x0020_Box_x0020_16 Group_x0020_19 Text_x0020_Box_x0020_21 Group_x0020_23 Line_x0020_25 Text_x0020_Box_x0020_27 Group_x0020_29 Text_x0020_Box_x0020_31 Group_x0020_33 Line_x0020_35 Text_x0020_Box_x0020_37 Group_x0020_39 Text_x0020_Box_x0020_41 Group_x0020_43 Line_x0020_45"><span></span></p>

<p><span>The
primary function of the ribosome is protein synthesis. Protein synthesis occurs
in distinct phases: initiation, elongation, and termination.</span></p>

<p><span></span></p>

<p><span>Initiation
involves association of the mRNA with the smaller subunit of the ribosome that
is bound by an initiating aminoacyl-tRNA (i.e., tRNA bound to an amino acid).
The large ribosomal subunit then binds to form an initiation complex. The
initiating aminoacyl-tRNA “pairs up” with the mRNA codon AUG, which signals the
beginning of the polypeptide.</span></p>

<p><span></span></p>

<p><span>In the
elongation phase, amino acids are successively linked through the formation of
covalent peptide bonds, thereby lengthening the polypeptide chain. Each of the
incoming amino acids is attached to its respective tRNA. The codon on the mRNA
is recognized and bound by the anticodon of the tRNA portion of the
aminoacyl-tRNA. </span></p>

<p><span></span></p>

<p><span>[Binding
occurs on the “A” site of the ribosome, where the aminoacyl-tRNA #4 binds in
step 1 of the figure. In step 2, the peptide bond is formed between residues 3
and 4, which releases tRNA #3 from its amino acid. This enzymatic activity is
coupled with the translocation of tRNA #3 to site “E”, and tRNA #4, which is
still linked to its respective amino acid, is translocated from the “A” site to
the “P” site.<span >&nbsp; </span>In step 3, tRNA #3
dissociates from the ribosome. The process begins again with the association of
tRNA #5.] </span></p>

<p><span></span></p>

<p><span>Lastly,
termination of synthesis of the polypeptide chain occurs when a stop codon is
encountered in the mRNA. </span></p>

<span><br clear=all>
</span>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. Erythromycin, a
macrolide antibiotic, binds selectively to the 50S ribosomal subunit in
bacteria, interfering with the transfer of aminoacyl-tRNA from the “A” site to
the “P” site of the rRNA complex. As a result, the “A” site cannot accept
another aminoacyl-tRNA, thereby preventing extension of the protein chain. A
notable difference between prokaryotic and eukaryotic cells is the structure
and composition of their ribosomes. There are several classes of antibiotics
(e.g., macrolides, aminoglycosides) that block the action of the bacterial
ribosome with no effect on eukaryotic ribosomes.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.</span></b><span> Beta-lactam antibiotics
(i.e., penicillins, cephalosporins, carbapenems, and monobactams) inhibit the
formation of peptidoglycan cross-links, which are necessary in the synthesis of
bacterial cell walls. Beta-lactams and macrolides are used extensively to treat
gram-positive infections.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C and D are incorrect.</span></b><span> Quinolones inhibit DNA
replication and transcription by inhibiting DNA gyrase and DNA topoisomerases.
For many Gram-negative bacteria, DNA gyrase is the target; for many
Gram-positive bacteria, topoisomerase IV is the target. (Eukaryotic cells do
not contain DNA gyrase or topoisomerase IV). DNA gyrase is necessary for the
unwinding DNA prior to replication. DNA topoisomerases relieve torsional strain
that results from DNA replication and transcription. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.</span></b><span> Azole antifungal drugs
(e.g., ketoconazole, fluconazole, clotrimazole) inhibit the enzyme that
converts lanosterol to ergosterol. Depletion of ergosterol disrupts the
structure of the fungal membrane, leading to inhibition of fungal growth.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i>Escherichia coli</i> strains X and Y are both resistant to ampicillin.
Ampicillin resistance is stable in strain X when it is grown for multiple
generations in the absence of antibiotic. However, strain Y loses ampicillin
resistance when it is grown in media without the antibiotic. Which of the
following best explains the acquisition of ampicillin susceptibility in strain
Y?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Downregulation
of the resistance gene</p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span>Insertion of a transposon into the resistance
gene<span></span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span>Loss of a plasmid carrying the resistance gene<span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span>Point mutations in the resistance gene<span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span>Recombination with a defective copy of the
resistance gene<span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Antibiotic resistance</span><span>
is a quality that allows microorganisms to survive exposure to antibiotics.
Bacteria acquire resistance either by mutation of the bacterial genome or by by
horizontal gene transfer. <span>Horizontal
gene transfer</span>, also called <span>lateral
gene transfer</span>, is a process by which an organism incorporates genetic
material from another organism without being the offspring of that organism. By
contrast, <span>vertical transfer</span>
occurs when an organism receives genetic material from its ancestor. </span></p>

<p><span></span></p>

<p><span>The
principal mechanisms of horizontal gene transfer are:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Conjugation: transfer of
genetic material from one bacterium to another through cell-to-cell contact </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Transduction: viral
(bacteriophage) transport of genetic material from one bacterium to another </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Transformation:
alteration of a cell by introducing foreign genetic material</span></p>

<p><span></span></p>

<p><span>Through
horizontal gene transfer, genes that confer antibiotic resistance can be
shared. Evolutionary stress (such as exposure to antibiotics) selects for
antibiotic-resistant bacteria. If a bacterium carries several resistance genes,
it is called multiresistant or, informally, a <span>superbug</span> or <span>super-bacterium</span>.
The high prevalence of antibiotic-resistance is due to widespread antibiotic
use.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>There are
four major mechanisms of antibiotic resistance:</span></p>

<p><span></span></p>

<ol start=1 type=1>
 <li><span>Drug deactivation
     (e.g., some bacteria produce &#946;-lactamase, which deactivates p<span>enicillin</span>). </span></li>
 <li><span>Alteration of the
     target site (e.g., MRSA can alter PBP, the binding site of penicillin). </span></li>
 <li><span>Alteration of a
     metabolic pathway (e.g., some bacteria do not require para-aminobenzoic
     acid to synthesize folic acid and nucleic acids. These bacteria are
     resistant to sulfonamides.) </span></li>
 <li><span>Reduced drug
     accumulation (e.g., some bacteria alter the permeability of their cell
     surface to antibiotics; others increase the efflux of antibiotic across
     the cell surface). </span></li>
</ol>

<p><span></span></p>

<p><span>Beta-lactamases</span> are enzymes produced by some bacteria that are
responsible for their resistance to beta-lactam antibiotics like penicillins,
cephalosporins, cephamycins, and carbapenems. These antibiotics have a common
element in their molecular structure: a four-atom ring known as a beta-lactam.
The lactamase enzyme breaks that ring open, deactivating the molecule's
antibacterial properties. </p>

<p></p>

<p>Genes that encode
beta-lactamases are widespread in the bacterial kingdom and are found on the
chromosome and on plasmids. The <span of gram-positive bacteria (e.g. <i>Staphylococcus aureus</i>) are released into
the extracellular environment. The <span of gram-negative bacteria remain within the
periplasm.<b> </b><span>(The<b> </b>periplasm</span>
is the space between the peptidoglycan cell wall and the external outer
membrane of gram-negative bacteria.) Hundreds of different <span
 enzymes
have been described. All have the same function but with differing amino acid
sequences that influence their affinity for different <span </p>

<p></p>

<p>Some enzymes specifically
target penicillins or cephalosporins, while others are especially broadly
attack most <span compounds (i.e.
extended-spectrum <span ESBLs). </p>

<p><span>Many
antibiotic resistance genes reside on plasmids. A <span>plasmid</span> is a DNA molecule that is separate from, and can replicate
independently of, the chromosomal DNA. Plasmids are double-stranded and, in
many cases, circular. Unlike viruses, plasmids are “naked” DNA and do not
encode genes necessary to encase the genetic material for transfer to a new
host.</span></p>

<p></p>

<p>Plasmids provide a mechanism
for horizontal gene transfer within a population of microbes and typically
provide a selective advantage under a given environmental state. They can be
classified by function:</p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fertility
plasmids, which are capable of conjugation </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Resistance
plasmids, which confer resistance to antibiotics or poisons </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Col
plasmids, which produce bactericidal proteins </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Degradative
plasmids, which enable digestion of foreign substances </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Virulence
plasmids, which render the bacterium pathogenic</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct.</span></b><span> Bacteria acquire
antibiotic resistance either by mutation of the bacterial genome or by
horizontal gene transfer. Mutation of the bacterial genome is unlikely to
explain changing patterns of resistance based on antibiotic exposure. Through
horizontal gene transfer, however, a plamid carrying a gene conferring
resistance can enter and leave the cell, altering its resistance pattern. <i>Escherichia coli</i> strain Y most likely
has a plasmid that confers resistance to ampicillin. When selective pressure is
removed from the strain (i.e., growth in a media without antibiotics), loss of
the plasmid renders the organism susceptible to ampicillin. By contrast, <i>Escherichia coli</i> strain X retains its
resistance to ampicillin even when selective pressure is removed from that
strain (i.e., the resistance is “stable.”) Consequently, in strain X, the gene
conferring resistance may well reside on the bacterial chromosome itself. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>In the
figure below, drug X causes a rise in blood pressure. Drug Y is added, which
has little effect on blood pressure. Drug X is then readministered, which
causes a drop in blood pressure. Which are drugs X and Y, respectively? </span></p>

<p><span></span></p>

<p><span><img border=0 width=215 height=94
src="_%20Tutorials_files/image575.png" v:shapes="Picture_x0020_347424"></span><span></span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Phenylephrine,
     phentolamine</span></li>
 <li><span>Phenylephrine,
     metoprolol</span></li>
 <li><span>Norepinephrine,
     propranolol</span></li>
 <li><span>Isoproterenol,
     clonidine</span></li>
 <li><span>Epinephrine,
     phentolamine</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Relative </span><span><span>a</span></span><span> and </span><span><span>b</span></span><span> effects of catecholamines</span></p>

<p style="text-align:center;"><span></span></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><u><span>Selective
</span></u><u><span><span>a</span></span></u><u><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;</span></span></u><u><span><span>a</span></span></u><u><span>=</span></u><u><span><span>b</span></span></u><u><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Selective
</span></u><u><span><span>b</span></span></u><u><span></span></u></p>

<p><span></span></p>

<p><span>phenylephrine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>norepinephrine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>epinephrine<span>&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span>dobutamine</span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>isoproterenol</span></p>

<p style="text-align:center;"><span></span></p>

<p><span>The list
above shows the relative efficacies of several autonomic agonist drugs in
stimulating alpha- and beta-adrenergic receptors. Thus, phenylephrine
selectively activates alpha receptors and isoproterenol selectively activates
beta receptors. Epinephrine effectively stimulates both receptor subtypes.
Norepinephrine more effectively stimulates alpha receptors than beta receptors,
and dobutamine more effectively stimulates beta receptors than alpha receptors.</span></p>

<p><span></span></p>

<p><span>Clonidine
is unique because it stimulates alpha<sub>2</sub>-adrenergic receptors in the
brain, resulting in vasodilation.</span></p>

<p><span></span></p>

<p><span>Major
effects of stimulating adrenergic receptors are presented below.</span></p>

<p style="text-align:center;"><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=192 valign=top>
  <p style="text-align:center;"><span>Alpha-adrenergic receptor</span></p>
  </td>
  <td width=210 valign=top>
  <p style="text-align:center;"><span>Beta-adrenergic receptor</span></p>
  </td>
 </tr>
 <tr>
  <td width=192 valign=top>
  <p><span></span></p>
  </td>
  <td width=210 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=192 valign=top>
  <p><span>Vasoconstriction
  (&#945;<sub>1</sub>)</span></p>
  <p><span>Pupillary
  dilation (&#945;<sub>1</sub>)</span></p>
  <p><span>Intestinal
  relaxation (&#945;<sub>1</sub>)</span></p>
  <p><span>Pilomotor
  contraction (&#945;<sub>1</sub>)</span></p>
  <p><span>Bladder
  sphincter contraction(&#945;<sub>1</sub>)</span></p>
  <p><span>Glycogenolysis
  and gluconeogenesis (&#945;<sub>1</sub>)</span></p>
  <p><span>Lipolysis
  (&#945;<sub>1</sub>)</span></p>
  <p><span>Ejaculation
  (&#945;<sub>1</sub>)</span></p>
  <p><span>Renin
  secretion (&#945;<sub>1</sub>)</span></p>
  </td>
  <td width=210 valign=top>
  <p><span>Cardiac
  acceleration (&#946;<sub>1</sub>&gt; &#946;<sub>2</sub>)</span></p>
  <p><span>Increased
  myocardial contractility (&#946;<sub>1</sub>&gt; &#946;<sub>2</sub>)</span></p>
  <p><span>Vasodilation
  (&#946;<sub>2</sub>)</span></p>
  <p><span>Intestinal
  relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Uterus
  relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Bronchodilation
  (&#946;<sub>2</sub>)</span></p>
  <p><span>Bladder
  wall relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Glycogenolysis
  and gluconeogenesis (&#946;<sub>2</sub>)</span></p>
  <p><span>Lipolysis
  (all &#946; receptors)</span></p>
  <p><span>Renin
  secretion (&#946;<sub>1</sub>)</span></p>
  </td>
 </tr>
</table>

</div>

<p style="text-align:center;"><b><span></span></b></p>

<p><span>An example
of a drug that selectively blocks alpha-adrenergic receptors is phentolamine. A
drug that selectively blocks beta<sub>1</sub>-adrenergic receptors is
metoprolol. A drug that non-selectively blocks beta-adrenergic receptors is
propranolol. </span></p>

<p><span></span></p>

<p><span>The
effects of administering multiple drugs are predictable based on their agonist
and antagonist properties. An alpha blocking drug would block the effects of an
alpha agonist but have no effects on responses to beta agonists, and a beta
blocker would block the effects of a beta agonist but not an alpha agonist. A
beta<sub>1</sub>-selective blocker would block the beta<sub>1</sub>-mediated
effects of a non-selective beta agonist, but beta<sub>2</sub>-mediated effects
would still occur. For example, metoprolol would block the increases in heart
rate and contractility that occur with epinephrine, but bronchodilation would
still occur. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Epinephrine
effectively stimulates both alpha- and beta-adrenergic receptors. An alpha
antagonist would block the alpha-mediated effects of administering epinephrine
but have no effect on the beta-mediated responses, and a beta blocker would
block the beta-mediated effects but have no effect on the alpha-mediated
responses.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. Epinephrine is a
non-selective agonist of &#945; and &#946; adrenergic receptors. &#945;<sub>1</sub>
receptor stimulation causes vasoconstriction and increased systemic vascular
resistance. &#946;<sub>1</sub> stimulation causes increased heart rate and
contractility. &#946;<sub>2</sub> stimulation causes vasodilation. When
epinephrine is administered, there is an increase in blood pressure because of
&#945;<sub>1</sub> and &#946;<sub>1</sub> stimulation. (The effect of &#946;<sub>2</sub>
stimulation is minimal.) Phentolamine blocks &#945; receptors, so when
epinephrine is readministered after phentolamine has been given, the &#946;
response is unopposed. Blood pressure drops because of &#946;<sub>2</sub> stimulation.
</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Phenylephrine is an
&#945;-agonist. Administration causes a rise in blood pressure. Phentolamine
blocks the &#945; effect, lowering blood pressure and preventing a rise in
blood pressure when phenylephrine is re-administered. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span>&nbsp; </span>Phenylephrine is an &#945;-agonist.
Administration causes a rise in blood pressure. Metoprolol, a &#946;-blocker,
lowers blood pressure. It does not inhibit the effect of phenylephrine, so
readministration of phenylephrine would raise blood pressure once again.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Norepinephrine, which
has a predominantly &#945; effect, causes blood pressure to rise. Propranolol,
a &#946;-blocker, lowers blood pressure. It does not inhibit the &#945;
stimulatory effect of norepinephrine, so readministration of norepinephrine would
raise blood pressure once again. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Isoproterenol, which
has a predominantly &#946; effect, causes blood pressure to drop (&#946;<sub>2 </sub>effect).
Clonidine, an &#945;<sub>2</sub> agonist, also causes blood pressure to drop
(central CNS effect). Readministration of isoproterenol would drop blood
pressure even further. </span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><b><span></span></b></p>

<p><span of grapefruit juice increases the bioavailability of many drugs,
including felodipine, midazolam, saquinavir, and verapamil. After oral
administration of any one of these drugs, which of the following is most likely
to be increased in the presence of grapefruit juice?</span></p>

<p><span><span>&nbsp;&nbsp;
</span></span></span><span drug
metabolism</span></p>

<p><span>&nbsp;&nbsp;&nbsp;
</span></span></span><span CYP3A4 activity</span></p>

<p><span>&nbsp;&nbsp;&nbsp;
</span></span></span><span serum concentration</span></p>

<p><span>&nbsp;&nbsp;
</span></span></span><span of distribution</span></p>

<p><span>&nbsp;&nbsp;&nbsp;
</span></span></span><span body clearance</span></p>

<p><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span defined as the fraction of the drug reaching the systemic circulation after
administration. When a drug is administered by IV injection, the entire dose
enters the circulation and bioavailability is 100%. However, this is not true
for most drugs administered by other routes, especially drugs given orally. The
bioavailability of a drug is a function of its absorption and ultimate entry
into the systemic circulation. Factors that affect <span listed below.</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=278 valign=top>
  <p style="text-align:center;">Factors affecting bioavailability</p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>Drug properties
  (solubility, hydrophobicity, pKa)</p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>Drug formulation
  (immediate-release, delayed-release)</p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>Drug interactions (with
  foods or other drugs) </p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>Drug metabolism (by
  intestinal or liver cells)</p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>Drug efflux (from
  enterocyte by protein transporters)</p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>Structural disorders of
  the GI tract</p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>Motility disorders of the
  GI tract</p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>Age of patient (neonate,
  elderly)</p>
  </td>
 </tr>
 <tr>
  <td width=278 valign=top>
  <p>“First-pass” metabolism in
  the liver</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>Factors that increase drug
absorption (and, therefore, bioavailability) will increase peak serum drug
concentration. Factors that decrease drug absorption will decrease peak serum
drug concentration. </p>

<p></p>

<p>Bioavailability is usually
assessed by determining the maximum (peak) plasma drug concentration, peak time
(when maximum plasma drug concentration occurs), and area under the plasma
concentration&#8211;time curve.</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=166 height=115
src="_%20Tutorials_files/image577.png"
alt="Description: Representative plasma concentration&#8211;time relationship after a single oral dose of a hypothetical drug."
v:shapes="Picture_x0020_347423"></span></p>

<p></p>

<p>Grapefruit juice is a potent
inhibitor of the cytochrome P450 CYP3A4 enzyme, which is one of the most
important enzymes involved in the metabolism of drugs. The enzyme exists in
enterocytes and hepatocytes, where it deactivates and facilitates the excretion
of certain drugs before they enter the systemic circulation, thus reducing
their bioavailability. By inhibiting this enzyme, grapefruit juice increases
the bioavailability of these drugs. Rarely, this can lead to drug toxicity and
death, as has occurred with astemizole and terfenadine. </p>

<p></p>

<p></p>

<p></p>

<p><b>Answer C is correct</b>. Grapefruit juice increases the bioavailability
of many drugs by inhibiting the cytochrome P450 CYP3A4 enzyme. This is one of
the most important enzymes involved in the metabolism of drugs. It exists in
enterocytes and in liver cells. It functions prinicipally by deactivating and
facilitating the excretion of drugs before they enter the systemic circulation.
Grapefruit juice, by inhibiting this enzyme, prevents drug deactivation and
elimination, allowing more drug to enter the systemic circulation. Thus,
bioavailability and peak serum drug concentration rise.<span>&nbsp; </span></p>

<p></p>

<p><b>Answer A is incorrect</b>. Grapefruit juice decreases (not increases)
intestinal drug metabolism. This allows more drug to be delivered to the
systemic circulation. Bioavailability is increased. </p>

<p></p>

<p><b>Answer B is incorrect. </b>Grapefruit juice inhibits intestinal <span
 activity. It does not increase hepatic CYP3A4 activity.</span></p>

<p><b></b></p>

<p><b>Answer D is incorrect. </b>Grapefruit juice would not affect volume of
distribution. </p>

<p><b></b></p>

<p><b>Answer E is incorrect. </b>Grapefruit juice would not increase total
body clearance. </p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Which of
the following is true regarding breast milk? </span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Breast milk is a
     major source of immunoglobulin G (IgG)</span></li>
 <li><span>Most ingested drugs
     that are soluble in maternal blood do not cross into breast milk</span></li>
 <li><span>Breast milk
     contains large amounts of iron</span></li>
 <li><span>Prolactin
     stimulates milk production and breast development</span></li>
 <li><span>Breast milk is a
     good source of Vitamin K</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Human milk
is recognized by the American Academy of Pediatrics as an optimal feeding for
all infants, which is why the academy recommends exclusive breastfeeding in the
first six months of life.<span >&nbsp;
</span>Physicians can influence a patient’s feeding choice, and prenatal
education is important in the initiation and maintenance of breastfeeding.<span>&nbsp; </span>Studies have shown that women are more
likely to initiate breastfeeding if their physicians or nurses encourage it.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Breastfeeding
is good for the mother and the baby. For the mother, breastfeeding triggers the
hypothalamus to produce oxytocin, which is secreted by the posterior pituitary.
Oxytocin increases uterine contractions, which decreases uterine blood loss.
For the infant, breast milk is a major source of IgA (but not IgM or IgG). IgA
helps to prevent newborns from developing gastrointestinal infections. Breast
milk is very low in iron, which must be supplemented. It is also not a good
source of vitamin K. Most drugs taken by the mother will enter breast milk;
therefore, caution must be taken before prescribing medicine to a breastfeeding
mother. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Prolactin stimulates
milk production and breast development.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect. </span></b><span>Breast milk is a major
source of IgA, not IgG.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect. </span></b><span>Most ingested drugs that
are soluble in maternal blood <i>do</i>
cross into breast milk.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><span>Breast milk is low in
iron.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect. </span></b><span>Breast milk is a poor
source of Vitamin K. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>A 62-year-old man is being treated with
cisplatin for small cell carcinoma of the lungs. The efficacy of cisplatin
depends on interaction with which of the following?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>DNA</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>DNA
polymerase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Growth
factor receptors</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Reverse
transcriptase</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ribosomes</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
majority of chemotherapeutic drugs can be divided in to alkylating agents,
antimetabolites, </span><a href="http://en.wikipedia.org/wiki/Anthracycline"
title=Anthracycline><span>anthracyclines</span></a><span>, plant alkaloids,
topoisomerase inhibitors, and other antitumor agents. All of these drugs affect
cell division or DNA synthesis and function in some way. Some newer agents do
not directly interfere with DNA. These include monoclonal antibodies and the new
tyrosine kinase inhibitors, e.g. </span><a
href="http://en.wikipedia.org/wiki/Imatinib" title=Imatinib><span>imatinib mesylate</span></a><span> (Gleevec), which
directly target a molecular abnormality in certain types of cancer (e.g.,
chronic myelogenous leukemia). These are examples of targeted therapies. In
addition, some drugs that modulate tumor cell behavior without directly
attacking those cells may be used. Hormone treatments fall into this category.</span></p>

<p><b><span></span></b></p>

<p><b><span>Alkylating
agents </span></b></p>

<p><span></span></p>

<p><span>Alkylating
agents chemically modify the cell’s DNA, usually by forming covalent bonds with
the amino, carboxyl, sulfhydryl, or phosphate groups in DNA. Examples include
cisplatin, cyclophosphamide, and chlorambucil.</span></p>

<p><b><span></span></b></p>

<p><b><span>Anti-metabolites</span></b><i><span></span></i></p>

<p><span></span></p>

<p><span>Anti-metabolites
masquerade as purines (e.g., azathioprine, mercaptopurine) or pyrimidines. They
prevent these substances from becoming incorporated into DNA during the
&quot;S&quot; phase of the cell cycle, stopping normal development and
division. They also affect RNA synthesis. </span></p>

<p><b><span></span></b></p>

<p><b><span>Plant
alkaloids and terpenoids </span></b></p>

<p><span></span></p>

<p><span>Plant
alkaloids block cell division by preventing microtubule function. Microtubules
are vital for cell division, and, without them, cell division cannot occur. The
main examples are vinca alkaloids (e.g., vincristine) and taxanes.</span></p>

<p><b><span></span></b></p>

<p><b><span>Topoisomerase
inhibitors </span></b></p>

<p><span></span></p>

<p><span>Topoisomerases
(e.g., etoposide) are essential enzymes that maintain the topology of DNA.
Inhibition of type I or type II topoisomerases interferes with both
transcription and replication of DNA by upsetting proper DNA supercoiling. </span></p>

<p><b><span></span></b></p>

<p><b><span>Cytotoxic
antibiotics </span></b></p>

<p><span></span></p>

<p><span>These
include </span><a href="http://en.wikipedia.org/wiki/Actinomycin"
title=Actinomycin><span>actinomycin</span></a><span>, anthracyclines (e.g.,
doxorubicin), </span><a href="http://en.wikipedia.org/wiki/Bleomycin"
title=Bleomycin><span>bleomycin</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Plicamycin" title=Plicamycin><span>plicamycin</span></a><span>, and </span><a
href="http://en.wikipedia.org/wiki/Mitomycin" title=Mitomycin><span>mitomycin</span></a><span>.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is correct</span></b><span>.
As an alkylating agent, cisplatin chemically modifies the cell’s DNA.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A normal
chest x-ray is shown below. Which chamber of the heart is delineated by “E”?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Left atrium</span></li>
 <li><span>Left ventricle</span></li>
 <li><span>Right atrium</span></li>
 <li><span>Right vetricle</span></li>
</ol>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=443 height=295
src="_%20Tutorials_files/image579.png" alt="Description: newpicturenb5" v:shapes="Picture_x0020_347422"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. The right atrium is
delineated by “E.” See image below. </span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=260 height=327
src="_%20Tutorials_files/image581.png" alt="Description: CXRNLPA385" v:shapes="Picture_x0020_347421"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Which of the
following represents the precision of the estimate of the association between
the exposure and outcome in a harm study?</span></p>

<p></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Relative risk</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Absolute risk increase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Confidence interval</span><span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Number-needed-to-harm</span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p><span>Epidemiologic studies use a quantitative
approach to describing both exposures and outcomes. Whether RCT, cohort study,
or case-control study, all of these studies attempt to present their results as
a single number, usually referred to as the point estimate, that quantifies the
relationship between the exposure and the outcome. This number is an estimate
of the truth rather than the truth itself because each study, however large,
includes only a sample of all the people who are affected by the exposure-outcome
relationship. The point estimate expresses the strength of the association
between the exposure and outcome. In an RCT or a cohort study, the point
estimate is the <b>relative risk</b> (RR).
Risk in the study subjects is the number of cases or outcomes that occur over
time. The RR is simply the risk of disease (or other outcome) among the exposed
or treated subjects divided by the risk in the unexposed subjects. A
case-control study does not measure risk directly but calculates its results as
an<span ratio</b><span
 which is generally equivalent to
an RR from a cohort study<a name=4-u1.0-B978-0-323-06986-1..00005-6--t001></a>.</span></p>

<p style="text-align:center;"><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td valign=top>
  <p><span>RRs and ORs &lt; 1.0
  indicate protection from outcome.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>RRs and ORs &gt; 1.0
  indicate risk of outcome.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>RRs and ORs = 1.0
  indicate no association to outcome.</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><a
name=4-u1.0-B978-0-323-06986-1..00005-6--sp00></a><span></span></p>

<p><span>If there is no association at all between
the exposure and outcome, then the RR or OR would be 1.0. RRs and ORs greater
than 1.0 indicate an increased risk of the outcome. RRs and ORs less than 1.0
indicate a decreased risk of the outcome. For both RRs and ORs, the further
away the value is from 1.0, the stronger the relationship between the exposure
and the outcome. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=289 height=227
src="_%20Tutorials_files/image583.png" v:shapes="Picture_x0020_347498"></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="99%">
 <tr>
  <td width="97%" valign=top>
  <p><a
  name=4-u1.0-B978-0-323-06986-1..00005-6--f001></a><span  <p><span  5-2&nbsp;</b></span><span  of point estimates (<i>open circles</i>) and
  confidence intervals (<i>between the crossbars</i>) of two studies with
  reduced risk and two studies with increased risk. If the confidence interval
  overlaps 1.0, the change in risk is statistically insignificant.</span></p>
  </td>
  <td valign=top>
  <p mso & !supportInlineShapes & supportFields]><span></span><span>&nbsp;</span>SHAPE <span>&nbsp;</span>\* MERGEFORMAT <span></span><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><v:shape
   id="_x0000_i1056" type="#_x0000_t75">
   <v:imagedata croptop="-65520f" cropbottom="65520f"/>
  </v:shape><span></span><![endif]--><span></span></p>
  </td>
 </tr>
</table>

<p><span style='font-family:"Times New Roman"'></span></span></p>

<p><span>The RR is based on results from the people in a particular
study and not the entire population possible, thus there is always a
possibility of sampling error. The quantitative description of the study
results needs to include a measure of this uncertainty. The <b>confidence interval</b> is widely used to
express the precision of the point estimate; a wide confidence interval
indicates less precision, and a narrow confidence interval indicates more. In
general, the larger the study, the narrower the confidence interval. There are
several cautions about interpreting confidence intervals correctly. First, the
confidence interval indicates only uncertainty that is due to the play of
chance; it does not inform us about uncertainty in the results because of other
factors, such as confounders that have not been controlled for, or of
peculiarities of the population that was studied, or poor study quality.
Second, a wide confidence interval does not mean there is no association
between the exposure </span><span>and the outcome; even an imprecise point estimate
remains the best explanation of </span><span>the relationship until a larger or better study is performed. Finally,
confidence intervals are often drawn as a straight line around the point
estimate to show the width of their range; this might seem to suggest that the
location of the true point estimate would be equally likely to fall anywhere
within that interval. In fact, the confidence interval could better be shown as
a bell-shaped curve centered on the point estimate.</span></p>

<p><span>Relative risk estimates do not take into
account the incidence or the importance of the problem being evaluated. A
relative risk of 4 says that the outcome increases 400% in exposed individuals
compared with unexposed individuals. This increase often causes great worry or
excitement (particularly in the media). However, the relative risk must be
interpreted in the context of the frequency of the outcome. For instance, the
incidence of venous thromboembolism (VTE) in young women without using oral
contraceptives is about 1 in 10,000, and the incidence while using oral
contraceptives is 4 in 10,000; thus, the relative risk is 4. However, the <b>absolute risk</b> of VTE is still low in
both groups of women with a difference in risk of 3 in 10,000. The risk in the
exposed minus the risk in the unexposed is the risk difference. The<span
 difference</i><span
 the size of the effect in
absolute terms. This is also called<span it is very
useful for putting large relative risks into a clinically useful perspective.
This is also called the<span reduction</i><span a benefit
is identified, and the<span increase</i><span a harm is
identified.</span></p>

<p><span></span></p>

<p><span>For clinicians and patients, even the
calculation of absolute risk differences in a population may not be helpful in
assessing possible risks or benefits. An alternative calculation looks at the
complementary concept: how many patients need to be treated to observe one
benefit or one adverse event? The<span to treat (NNT)</b>, the number of patients who need to be treated to
achieve an additional positive outcome, is the reciprocal of the <b>absolute risk reduction</b> (the risk
difference for good outcomes). If the effect is dangerous, the value is called
the <b>number needed to harm (NNH)</b>. The
number of patients who, if they received the treatment, would lead to one
additional patient being harmed, compared with patients not receiving the
treatment, is the reciprocal of the absolute risk increase (the risk difference
for bad outcomes). Thus, using the example of oral contraceptives, with a risk
of VTE of 4 in 10,000, the number needed to harm (NNH)&#8212;that is, to experience
one extra VTE&#8212;is 3333, the reciprocal of 3 in 10,000, which is the <b>absolute risk increase</b>.</span></p>

<p></span></p>

<p></span></p>

<p><span>Answer C is correct. </span></b><strong><span>Confidence intervals </span></strong><span>quantify uncertainty in measurement. In a sense, they represent <strong><span>a range of
plausible values</span></strong><span>. A narrow confidence
interval implies high precision (i.e., we can specify plausible values to
within a tiny range). A wide interval implies poor precision (i.e., we can only
specify plausible values to a broad and uninformative range). </span><span>&nbsp;</span></span></p>

<p><span></span></b></p>

<p><span>Answer A is incorrect. </span></b><span>Relative risk is the risk of an event
relative to exposure. Specifically, it is the ratio of the probability of the
event occurring in the exposed group versus a control group.<span>&nbsp; </span></span></p>

<p></span></p>

<p style="text-align:center;"><span><img border=0 width=111 height=34
src="_%20Tutorials_files/image585.png"
alt="Description: RR= \frac {p_\text{exposed}}{p_\text{non-exposed}} " v:shapes="Picture_x0020_347420"></span><span></span></p>

<p><span></span></b></p>

<p><span>Answer B is incorrect. </span></b><span>Absolute risk increase, or excess risk, is
the absolute difference between the event rate in the exposed group and the
event rate in the control group. Specifically, it is difference between the
proportion of subjects in a population with a particular disease who were
exposed to a specified risk factor and the proportion of subjects with that
same disease who were not exposed. Absolute risk increase is the inverse of
“the number needed to treat” (the average number of patients who need to be
treated to prevent one additional bad outcome).<span>&nbsp; </span></span></p>

<p><span></span></b></p>

<p><span>Answer D is incorrect</span></b><span>. Number-needed-to-harm is the number of
people who need to be exposed to a risk factor over a specific period to cause
harm in one patient who would otherwise not have been harmed. It is the
reciprocal of the absolute risk increase.</span></p>

<p></span></p>

<p><span></span></b></p>

<p></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A study
was conducted to determine if one method of measuring pain intensity, the
Verbal Rating Scale (VRS), could be substituted for another method, the Visual
Analog Scale (VAS). 85 patients with chronic pain were surveyed using both the
VRS and VAS. The results appear below. Which of the following values most
likely represents the correlation coefficient?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>&#8211; 0.9</span></li>
 <li><span>&#8211; 0.2</span></li>
 <li><span><span>&nbsp;&nbsp; </span>0</span></li>
 <li><span>+ 0.2</span></li>
 <li><span>+ 0.9</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=367 height=257
src="_%20Tutorials_files/image587.png" v:shapes="Picture_x0020_347419"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The <span>correlation coefficient</span> (r) measures
the strength and direction of a linear relationship between two
variables.&nbsp;The correlation coefficient ranges from &#8722;1 to +1. &nbsp; </span></p>

<p><span><br>
<i>Positive correlation</i><span>:</span>
&nbsp;&nbsp; If <span>x</span> and <span>y</span> have a strong positive linear
correlation, <span>r</span> is close to
+1.&nbsp; An <span>r</span><span> </span>value of exactly +1 indicates a
perfect positive fit.&nbsp;Positive values indicate that as <span>x</span> increases, <span>y </span>also increases. </span></p>

<p><span><br>
<i>Negative correlation</i><span>:</span>
&nbsp; If <span>x</span> and <span>y</span> have a strong negative linear
correlation, <span>r</span> is close to
&#8722;1.&nbsp; An <span>r</span><span> </span>value of exactly &#8722;1 indicates a
perfect negative fit.&nbsp;Negative values indicate that as <span>x</span> increases, <span>y</span> decreases. </span></p>

<p><span></span></p>

<p><i><span>No
correlation</span></i><span>:</span><span>&nbsp; If there is no linear correlation between x and y, <span>r</span> is 0.&nbsp; A value of zero means
that there is a random, nonlinear relationship between the two variables.</span></p>

<p><span><br>
A <span>perfect</span> correlation of +1 or
&#8722;1 occurs only when all data points lie exactly on a straight line.&nbsp;
If <span>r</span> is +1, the slope of the
line is positive.&nbsp; If <span>r</span> is
&#8722;1, the slope of the line is negative.&nbsp; </span></p>

<p><span></span></p>

<p><span>A
correlation greater than 0.8 is generally considered “<span>strong</span>”; a correlation less than 0.5 is generally considered “<span>weak</span>.”&nbsp; (This depends, however,
on the type of data being examined.)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://en.wikipedia.org/wiki/File:Correlation_examples.png"><span><img border=0 width=302 height=128
src="_%20Tutorials_files/image589.png"
alt="Description: 400px-Correlation_examples" v:shapes="Picture_x0020_347418"></span></a><span></span></p>

<p><span></span></p>

<p><span>The figure
above shows several sets of data (<i>x</i>,&nbsp;<i>y</i>) points, with the
correlation coefficient listed above each set. Note that the correlation
coefficient reflects the “noisiness” and direction of a linear relationship
(top row), but not the slope of the relationship (middle), nor many aspects of
nonlinear relationships (bottom). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct. </span></b><span>A correlation
coefficient of +0.9 indicates a strong positive correlation between the VAS and
VRS for measuring pain intensity. <b><span>&nbsp;</span></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
abdominal CT is done on a normal 50-year-old man. An image from the scan is shown
below. What structure is labeled “8”?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Adrenal gland</span></li>
 <li><span>Aorta</span></li>
 <li><span>Inferior vena cava</span></li>
 <li><span>Lymph node</span></li>
 <li><span>Superior vena cava</span></li>
</ol>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=209 height=178
src="_%20Tutorials_files/image591.png" alt="Description: Abdomen04" v:shapes="Picture_x0020_347417"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
following structures are depicted: </span></p>

<p><span></span></p>

<ol start=1 type=1>
 <li><span>Liver</span></li>
 <li><span>Spleen </span></li>
 <li><span>Pancreas</span></li>
 <li><span>Gall bladder</span></li>
 <li><span>---</span></li>
 <li><span>Left adrenal gland</span></li>
 <li><span>Inferior vena cava</span></li>
 <li><span>Aorta</span></li>
 <li><span>Portal vein</span></li>
 <li><span>Superior mesenteric
     artery</span></li>
 <li><span>Ascending colon</span></li>
 <li><span>Descending colon</span></li>
 <li><span>Transverse colon</span></li>
 <li><span>Stomach</span></li>
 <li><span>Distal stomach</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. “8” indicates the
aorta.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A chest CT
is done on a normal 50-year-old man. An image from the scan is shown below.
What structure is labeled “22”?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Aorta</span></li>
 <li><span>Esophagus</span></li>
 <li><span>Inferior vena cava</span></li>
 <li><span>Lymph node</span></li>
 <li><span>Superior vena cava </span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=327 height=204
src="_%20Tutorials_files/image593.png" alt="Description: Med10" v:shapes="Picture_x0020_347416"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
following structures are depicted:</span></p>

<p><span></span></p>

<ol start=1 type=1>
 <li><span>Trachea</span></li>
 <li><span>Esophagus</span></li>
</ol>

<p><span>18. Sternum</span></p>

<p><span>19. Aortic arch</span></p>

<p><span>22. Superior vena cava</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct. </span></b><span>“22” indicates the
superior vena cava.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
72-year-old woman with diabetes and hypertension is taking three medications:
metformin, lisinopril, and amitriptyline. She feels well. Her blood pressure is
125/75 mm Hg and her HbA1c is 6.5. Her husband dies suddenly of a heart attack
and she becomes severely depressed. Her physician prescribes paroxetine 20 mg
daily for her depression. Her mood improves but she begins to experience
blurred vision, dry mouth, dizziness, and difficulty with urination. What is
the most likely cause of her symptoms? </span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Excessive dose of
     paroxetine</span></li>
 <li><span>Drug interaction
     with metformin</span></li>
 <li><span>Drug interaction
     with lisinopril</span></li>
 <li><span>Drug interaction
     with amitriptyline</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
patient presents with classic anticholinergic symptoms: blurred vision, dry
mouth, dizziness, and difficulty with urination. Tricyclic drugs, such as
amitriptyline, are a common cause of anticholinergic symptoms (which is why
they should be used cautiously in the elderly). This patient was feeling well
until paroxetine was added to her regimen, which suggests that paroxetine may
be involved in her symptomatology. Understanding drug metabolism can clarify
the issue.</span></p>

<p><span></span></p>

<p><span>A basic
purpose of drug metabolism is to make drugs water-soluble so they can be
excreted in the urine or bile. Many drugs are metabolized by the cytochrome
P450 (CYP) system of enzymes, which predominate in the liver. Such drugs are
considered “substrates” of the CYP system. In addition, many drugs can induce
or inhibit the enzymes. “Inducers” will accelerate the metabolism of a
substrate, while “inhibitors” will interfere with metabolism. If a patient
receives a CYP “substrate” and a CYP “inhibitor” concomitantly, enzyme
inhibition will cause the level of the substrate to rise. If a patient receives
a CYP “substrate” and a CYP “inducer” concomitantly, enzyme induction will
cause the level of the substrate to fall.</span></p>

<p><span></span></p>

<p><span>In this
case, amitriptyline is a substrate for CYP and paroxetine is an inhibitor of
CYP. By inhibiting CYP, paroxetine can cause the level of amitriptyline to
rise, resulting in anticholinergic symptoms.</span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span><img border=0 width=505 height=638
src="_%20Tutorials_files/image595.png" v:shapes="Picture_x0020_347415"></span></b><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. In this patient, the
addition of paroxetine to the medical regimen caused amitriptyline levels to
rise, resulting in anti-cholinergic side effects. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
70-year-old woman with chronic kidney disease is diagnosed with pneumonia. She
is treated with levofloxacin. How would her dosing regimen differ from the
dosing regimen of someone with normal kidney function?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Lower loading dose,
     lower maintenance dose </span></li>
 <li><span>Lower loading dose,
     same maintenance dose</span></li>
 <li><span>Lower loading dose,
     higher maintenance dose</span></li>
 <li><span>Same loading dose,
     lower maintenance dose</span></li>
 <li><span>Same loading dose,
     same maintenance dose</span></li>
 <li><span>Same loading dose,
     higher maintenance dose</span></li>
 <li><span>Higher loading
     dose, lower maintenance dose</span></li>
 <li><span>Higher loading
     dose, same maintenance dose</span></li>
 <li><span>Higher loading
     dose, higher maintenance dose</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Chronic
kidney disease is defined as the presence of kidney damage or a reduction in
the glomerular filtration rate (GFR) for three months or longer. <span>Inappropriate dosing in patients with chronic kidney
disease can lead to toxicity. In particular, older patients (especially those
taking many medicines) are at a high risk of complications due to age-related
decline in renal function. </span></p>

<p><span></span></p>

<p><span>Chronic kidney disease can affect glomerular filtration,
tubular secretion and reabsorption, and renal metabolism. Drug absorption,
bioavailability, protein binding, distribution volume, and non-renal clearance
may be altered. Physicians should be careful when considering drug therapies
because toxic metabolites may accumulate and contribute to exaggerated
pharmacologic effects or adverse drug reactions. </span></p>

<p><span></span></p>

<p><span>The loading dose does <i>not</i>
need to be adjusted in patients with chronic kidney disease.<span>&nbsp; </span>Maintenance dosing, however, <i>should</i> be adjusted. Such an adjustment
may include dose reduction, lengthening the dosing interval, or both. Dose
reduction allows for a more stable drug concentration, but carries a higher
risk of toxicity if the dosing interval is not changed. Lengthening the dosing
interval, by contrast, carries a lower risk of toxicity because time is allowed
for drug elimination. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Levofloxacin is
excreted by the kidney. The presence of chronic kidney disease will not affect
the loading dose but will necessitate a reduction in the maintenance dose. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Match each
of the following adverse effects with the drug most likely to cause it.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Uterine cancer</span></li>
 <li><span>Ototoxicity</span></li>
 <li><span>Disulfiram-like
     reaction</span></li>
 <li><span>Tardive dyskinesia</span></li>
 <li><span>Diabetes insipidus</span></li>
 <li><span>Hemorrhagic
     cystitis</span></li>
 <li><span>Tendon rupture</span></li>
 <li><span>Drug-induced lupus</span></li>
 <li><span>Muscle pain</span></li>
 <li><span>Teeth discoloration
     </span></li>
 <li><span>Gingival
     hyperplasia</span></li>
 <li><span>Gynecomastia</span></li>
 <li><span>Pulmonary fibrosis</span></li>
 <li><span>Cough</span></li>
 <li><span>Megaloblastic
     anemia</span></li>
 <li><span>Hemolysis in
     patients with glucose-6-phosphate dehydrogenase deficiency</span></li>
 <li><span>Gray baby syndrome</span></li>
 <li><span>Dilated
     cardiomyopathy</span></li>
 <li><span>Flushing</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<ol start=1 type=1>
 <li><span>Niacin</span></li>
 <li><span>Doxorubicin</span></li>
 <li><span>Chloramphenicol</span></li>
 <li><span>Sulfonamide</span></li>
 <li><span>Methotrexate</span></li>
 <li><span>Captopril</span></li>
 <li><span>Bleomycin</span></li>
 <li><span>Spironolactone</span></li>
 <li><span>Phenytoin</span></li>
 <li><span>Tetracycline</span></li>
 <li><span>Lovastatin</span></li>
 <li><span>Procainamide</span></li>
 <li><span>Ciprofloxacin</span></li>
 <li><span>Cyclophosphamide</span></li>
 <li><span>Lithium</span></li>
 <li><span>Haloperidol</span></li>
 <li><span>Metronidazole</span></li>
 <li><span>Gentamicin</span></li>
 <li><span>Tamoxifen</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Selected Drug Reactions</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=147 valign=top>
  <p style="text-align:center;"><span>System</span></p>
  </td>
  <td width=153 valign=top>
  <p style="text-align:center;"><span>Drug Reaction</span></p>
  </td>
  <td width=142 valign=top>
  <p style="text-align:center;"><span>Drug</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 valign=top>
  <p><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><span></span></p>
  </td>
  <td width=142 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=5 valign=top>
  <p><span>Cardiovascular</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Anti-cholinergic<sup>1</sup></span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Tricyclics
  </span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Coronary
  vasospasm</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Sumatriptan</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Flushing</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Niacin </span></p>
  <p><span>Vancomycin
  </span></p>
  <p><span>(red man
  syndrome)<sup>2</sup></span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Dilated
  cardiomyopathy</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Doxorubicin</span></p>
  <p><span>Daunorubicin</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Torsades
  de Pointes<sup>3</sup></span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Class IA
  anti-arrhythmics (quinidine)</span></p>
  <p><span>Class
  III anti-arrhythmics</span></p>
  <p><span>(sotalol)</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=8 valign=top>
  <p><span>Hematologic</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Agranulocytosis<sup><span>4</span></sup></span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Phenytoin</span></p>
  <p><span>Carbamazepine</span></p>
  <p><span>Propylthiouracil</span></p>
  <p><span>Methimazole</span></p>
  <p><span>Clozapine</span></p>
  <p><span>Colchicine</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Aplastic
  anemia</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Phenytoin</span></p>
  <p><span>Carbamazepine
  </span></p>
  <p><span>Propylthiouracil</span></p>
  <p><span>Methimazole</span></p>
  <p><span>Chloramphenicol</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Direct
  Coombs-positive </span></p>
  <p><span>Hemolytic
  Anemia</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Methyldopa</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Thrombocytopenia</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Heparin</span></p>
  <p><span>Quinidine</span></p>
  <p><span>Penicillin</span></p>
  <p><span>Sulfa</span></p>
  <p><span>NSAIDs</span></p>
  <p><span>Anti-convulsants</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Gray
  baby syndrome<sup><span>5</span></sup></span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Chloramphenicol</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Hemolysis
  in G6PD-deficient patients</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Aspirin</span></p>
  <p><span>NSAIDs
  (ibuprofen)</span></p>
  <p><span>Sulfonamides</span></p>
  <p><span>Nitrofurantoin</span></p>
  <p><span>Primaquine</span></p>
  <p><span>Isoniazid
  </span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Megaloblastic
  anemia</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Methotrexate</span></p>
  <p><span>Phenytoin</span></p>
  <p><span>Sulfa
  drugs</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Thrombosis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Estrogens</span></p>
  <p><span>Progestins</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=2 valign=top>
  <p><span>Pulmonary</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Cough</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>ACE-inhibitors</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Pulmonary
  fibrosis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Bleomycin</span></p>
  <p><span>Busulfan</span></p>
  <p><span>Amiodarone</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=4 valign=top>
  <p><span>GI</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Acute
  cholestasis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Macrolides
  (erythromycin)</span></p>
  <p><span>Penicillins</span></p>
  <p><span>Nitrofurantoin</span></p>
  <p><span>Anabolic
  steroids</span></p>
  <p><span>Oral
  contraceptives</span></p>
  <p><span>Cimetidine</span></p>
  <p><span>Chlorpromazine</span></p>
  <p><span>Prochlorperazine</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Acute
  hepatic necrosis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Acetaminophen</span></p>
  <p><span>Halothane</span></p>
  <p><span>Valproic
  acid</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Hepatitis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Isoniazid</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Pseudomembranous
  enterocolitis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Antibiotics
  (any)</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=3 valign=top>
  <p><span>Endocrine</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Adrenocortical
  insufficiency</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Glucocorticoid
  withdrawal</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Gynecomastia</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Spironolactone</span></p>
  <p><span>Digitalis</span></p>
  <p><span>Cimetidine</span></p>
  <p><span>Alcohol
  (chronic use)</span></p>
  <p><span>Estrogens</span></p>
  <p><span>Ketoconazole</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Hot
  flashes</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Tamoxifen</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=9 valign=top>
  <p><span>Musculoskeletal/Connective
  tissue</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Gingival
  hyperplasia</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Phenytoin</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Teeth
  discoloration<sup><span>6</span></sup></span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Tetracycline</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Muscle
  pain/injury</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Statins</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Gout</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Diuretics
  (by causing hyperuricemia)</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Osteoporosis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Corticosteroids</span></p>
  <p><span>Heparin</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Photosensitivity</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Sulfonamides</span></p>
  <p><span>Amiodarone</span></p>
  <p><span>Tetracycline</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Stevens-Johnson
  syndrome<sup><span>7</span></sup></span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Penicillin</span></p>
  <p><span>Sulfa
  drugs</span></p>
  <p><span>Phenytoin</span></p>
  <p><span>Carbamazepine</span></p>
  <p><span>Phenobarbital</span></p>
  <p><span>Ethosuximide</span></p>
  <p><span>Lamotrigine</span></p>
  <p><span>Allopurinol</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Lupus-like
  syndrome</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Hydralazine</span></p>
  <p><span>Isoniazid</span></p>
  <p><span>Procainamide</span></p>
  <p><span>Phenytoin</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Tendon
  rupture</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Fluoroquinolones</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=3 valign=top>
  <p><span>Renal</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Acute
  tubular necrosis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Aminoglycosides</span></p>
  <p><span>Amphotericin</span></p>
  <p><span>Radiographic
  contrast media</span></p>
  <p><span>Cyclosporin</span></p>
  <p><span>Cisplatin</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Interstitial
  nephritis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Penicillins</span></p>
  <p><span>Sulfa
  drugs</span></p>
  <p><span>Thiazides</span></p>
  <p><span>Loop
  diuretics</span></p>
  <p><span>NSAIDs</span></p>
  <p><span>Long-term
  use of analgesics (acetaminophen, aspirin, NSAIDs)</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Hemorrhagic
  cystitis</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Cyclophosphamide</span></p>
  <p><span>Ifosfamide</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=5 valign=top>
  <p><span>Neurologic</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Cinchonism<sup>8</sup></span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Quinidine,
  quinine</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Diabetes
  insipidus</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Lithium</span></p>
  <p><span>Demeclocycline</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Parkinson-like
  syndrome</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Haloperidol</span></p>
  <p><span>Chlorpromazine</span></p>
  <p><span>Metoclopramide</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Seizures</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Bupropion</span></p>
  <p><span>Imipenem/cilastatin</span></p>
  <p><span>Isoniazid</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Tardive
  dyskinesia<sup>9</sup></span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Anti-psychotics</span></p>
  </td>
 </tr>
 <tr>
  <td width=147 rowspan=3 valign=top>
  <p><span>Other</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Disulfiram-like
  reaction<sup>10</sup></span></p>
  <p><span>(severe
  symptoms after alcohol consumption)</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Metronidazole</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Ototoxicity
  </span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Aminoglycosides</span></p>
  <p><span>Vancomycin</span></p>
  <p><span>Loop
  diuretics</span></p>
  <p><span>Cisplatin</span></p>
  </td>
 </tr>
 <tr>
  <td width=153 valign=top>
  <p><span>Uterine
  cancer</span></p>
  </td>
  <td width=142 valign=top>
  <p><span>Tamoxifen</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><sup><span>1</span></sup><span>Anti-cholinergic side
effects include dry mouth, dry eyes, dry skin, blurred vision, hyperthermia,
tachycardia, constipation, urinary retention, ataxia, and confusion</span></p>

<p><span></span></p>

<p><sup><span>2</span></sup><b><span> </span></b><span>Red man syndrome,</span><span>
or <span>red neck syndrome, is associated
with vancomycin use. It </span>is characterized by flushing and/or an
erythemaous rash on the face, neck, and upper torso. The syndrome usually
appears within 4&#8211;10 minutes after the start of vancomycin infusion (or
soon after completion of the infusion). Symptoms may be treated (and prevented)
with antihistamines and a slower infusion rates.</span></p>

<p><span></span></p>

<p><sup><span>3</span></sup><span> Torsades de Pointes<b> </b>is
a French term that means &quot;twisting of the points.&quot; It refers to
a<span >&nbsp; </span>rapid, <span>polymorphic ventricular tachycardia</span> with a characteristic twist
of the QRS complex around the isoelectric baseline.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=263 height=68
src="_%20Tutorials_files/image597.png" alt="Description: torsades" v:shapes="Picture_x0020_347414"></span><span></span></p>

<p><span><span>&nbsp;</span></span></p>

<p><sup><span>4</span></sup><span>Agranulocytosis </span><span>is an acute condition of
severe and dangerous leukopenia, most commonly involving neutrophils.</span></p>

<p><sup><span>5</span></sup><span>Gray baby syndrome</span><span> is a serious side
effect that occurs in newborn infants (especially premature babies) following
the intravenous administration of chloramphenicol. Findings include vomiting,
ashen gray color of the skin, limp body tone, hypotension, cyanosis, hypothermia,
and cardiovascular collapse.<span >&nbsp; </span></span></p>

<p><sup><span>6</span></sup><span>Tetracyclines can
cause permanent discoloration of the teeth (yellow-gray-brown) if given to
children under the age of eight. Tetracycline consumption during pregnancy may
stain the teeth of the fetus.</span></p>

<p><sup><span>7</span></sup><b><span> </span></b><span>Stevens&#8211;Johnson syndrome</span><span> is a life-threatening
condition affecting the skin and mucous membranes in which the epidermis
separates from the dermis. Although most cases are idiopathic, the main class
of known causes is medications, followed by infections and (rarely) cancers.</span></p>

<h2><sup><span>8</span></sup><span>Cinchonism is a pathological condition
caused by an overdose of quinine. S<span include </span>flushed
and sweaty skin, blurred vision, ringing of the ears, impaired hearing,
confusion, dizziness, headache, abdominal pain, vomiting, diarrhea, and rash.</span></h2>

<p><sup><span>9</span></sup><span>Tardive dyskinesia</span><span>
is a difficult-to-treat form of dyskinesia (disorder resulting in involuntary,
repetitive body movements) that often appears after long-term or high-dose use
of antipsychotic drugs. Tardive dyskinesia is characterized by repetitive,
involuntary, purposeless movements, such as grimacing, tongue protrusion, lip
smacking, puckering and pursing of the lips, and rapid eye blinking. </span></p>

<p><sup><span>10</span></sup><span>A disulfiram-like
reaction occurs with consumption of small amounts of alcohol. Symptoms include
headache, confusion, flushing, blurred vision, chest pain, shortness of breath,
nausea, vomiting, weakness, and anxiety.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answers</span></b><span> </span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>19</span></li>
 <li><span>18</span></li>
 <li><span>17</span></li>
 <li><span>16</span></li>
 <li><span>15</span></li>
 <li><span>14</span></li>
 <li><span>13</span></li>
 <li><span>12</span></li>
 <li><span>11</span></li>
 <li><span>10</span></li>
 <li><span>9</span></li>
 <li><span>8</span></li>
 <li><span>7</span></li>
 <li><span>6</span></li>
 <li><span>5</span></li>
 <li><span>4</span></li>
 <li><span>3</span></li>
 <li><span>2</span></li>
 <li><span>1</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 37-year-old woman presents
to the emergency room with a 12-hour history of nausea, vomiting, and right
upper quadrant abdominal pain. She attempted suicide three days ago by taking
“lots of pills.” Today she is jaundiced. Which of the following drugs is most
likely to have caused her symptoms? </p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Aspirin</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Acetaminophen</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Amitriptyline</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Alprazolam</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Diphenhydramine</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Acetaminophen intoxication
is a relatively common form of drug poisoning. Patients may at first be
asymptomatic or have nausea and abdominal pain. Disease progression can result
in liver failure, which may be manifested by jaundice, elevated transaminases,
hypoglycemia, acidosis, easy bruising, and encephalopathy. Some patients
improve spontaneously; others progress; some ultimately die. Liver damage is
not caused by the acetaminophen itself, but by a metabolite, <i>N</i>-acetyl-<i>p</i>-benzoquinoneimine
(NAPQI), which depletes the liver’s natural antioxidant, glutathione. Risk
factors for acetaminophen toxicity include excessive alcohol intake, fasting or
anorexia nervosa, and use of certain drugs such as isoniazid. Treatment
includes removing acetaminophen from the body and replacing the depleted
glutathione. Administration of acetylcysteine, a precursor of glutathione, is a
mainstay of therapy. </p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer B is correct</b>. Acetaminophen intoxication most likely caused
the patient’s symptoms. <b></b></p>

<p><b></b></p>

<p><b>Answer A is incorrect</b><span>. Aspirin overdose,</span> or <span>salicylism,</span>
may be acute or chronic. Mild intoxication produces nausea and vomiting,
abdominal pain, tinnitus, and dizziness. Severe poisoning causes hyperthermia,
tachypnea, metabolic acidosis, and coma. </p>

<p><b></b></p>

<p><b>Answer C is incorrect</b>. Amitriptyline is a tricyclic
anti-depressant. Tricyclics have a narrow therapeutic index. Overdose produces
anti-cholinergic symptoms, such as dry mouth, nausea and vomiting, urinary
retention, constipation, tachycardia, and confusion. Severe complications
include dysrhythmia, hypotension, and seizure. Common electrocardiographic
abnormalities include tachycardia and prolongation of the QRS complex.<span>&nbsp; </span></p>

<p><b></b></p>

<p><b>Answer D is incorrect</b>. Alprazolam is a benzodiazepine. Overdose can
cause fatigue, drowsiness, ataxia, and slurred speech. Severe symptoms include
respiratory depression and coma. </p>

<p><b></b></p>

<p><b>Answer E is incorrect</b>. Diphenhydramine is an antihistaminic and
anticholinergic drug. Overdose can cause fatigue, somnolence, dry mouth, nausea
and vomiting, urinary retention, constipation, tachycardia, ataxia, and
delirium. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
60-year-old woman has a prosthetic heart valve. She takes warfarin daily. Which
of the following antibiotics can be safely prescribed without additional
monitoring of the INR or adjustment of the warfarin dose?<span>&nbsp; </span></span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Ciprofloxacin</span></li>
 <li><span>Erythromycin</span></li>
 <li><span>Metronidazole </span></li>
 <li><span>Trimethoprim-sulfamethoxazole</span></li>
 <li><span>None of the above</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Recognizing
drug-drug interactions is a daily challenge for physicians. Most pharmacies
have drug-interaction software programs; however, these programs tend to
&quot;flag&quot; all interactions, making it difficult for the pharmacist to
interpret clinical significance. </span></p>

<p><span></span></p>

<p><span>The
following table lists many of the most important drug interactions. </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=479 colspan=3 valign=bottom>
  <p style="text-align:center;"><b><span>Serious Drug Interactions</span></b></p>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=bottom>
  <p style="text-align:center;"><b><span>Interaction</span></b><b><span></span></b></p>
  <div align=center><b><span>
  <hr size=1 width="100%" noshade align=center>
  </span></b></div>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td width=160 valign=bottom>
  <p style="text-align:center;"><b><span>Potential
  effect</span></b><b><span></span></b></p>
  <div align=center><b><span>
  <hr size=1 width="100%" noshade align=center>
  </span></b></div>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td width=160 valign=bottom>
  <p style="text-align:center;"><b><span>Comments</span></b></p>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Warfarin<span>&nbsp; </span><i>plus<span>&nbsp;&nbsp; </span></i></span></p>
  <p><span></span></p>
  <p><span>ciprofloxacin, </span></p>
  <p><span>erythromycin,</span></p>
  <p><span>clarithromycin, </span></p>
  <p><span>metronidazole, </span></p>
  <p><span>or </span></p>
  <p><span>TMP-SMZ </span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased effect of warfarin</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Select alternative antibiotic.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Warfarin<span>&nbsp; </span><i>plus </i></span></p>
  <p><span>acetaminophen</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased bleeding, increased INR</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Use lowest possible acetaminophen
  dosage and monitor INR.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Warfarin<span>&nbsp; </span><i>plus </i></span></p>
  <p><span>acetylsalicylic acid (aspirin)</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased bleeding, increased INR</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Limit aspirin dosage to 100 mg per
  day and monitor INR.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Warfarin<span>&nbsp; </span><i>plus\</i></span></p>
  <p><span>NSAID</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased bleeding, increased INR</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Avoid combination if possible; if
  not, use a COX-2 inhibitor and monitor INR.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Fluoroquinolone<span>&nbsp; </span><i>plus </i></span></p>
  <p><span>sucralfate </span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Decreased absorption of
  fluoroquinolone</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Space administration by 2 to 4
  hours.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Carbamazepine<span>&nbsp; </span><i>plus </i></span></p>
  <p><span><span>&nbsp;</span></span></p>
  <p><span>cimetidine,<span>&nbsp; </span></span></p>
  <p><span>erythromycin, </span></p>
  <p><span>clarithromycin, </span></p>
  <p><span>or </span></p>
  <p><span>fluconazole </span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased carbamazepine levels</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor carbamazepine levels.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Phenytoin<span>&nbsp; </span><i>plus</i></span></p>
  <p><i><span></span></i></p>
  <p><span>cimetidine, </span></p>
  <p><span>erythromycin, </span></p>
  <p><span>clarithromycin, </span></p>
  <p><span>or </span></p>
  <p><span>fluconazole</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased phenytoin levels</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor phenytoin levels.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Phenobarbital <i>plus</i></span></p>
  <p><i><span></span></i></p>
  <p><span>cimetidine, </span></p>
  <p><span>erythromycin, </span></p>
  <p><span>clarithromycin,</span></p>
  <p><span>or </span></p>
  <p><span>fluconazole</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased phenobarbital levels</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor phenobarbital levels.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Phenytoin <i>plus </i></span></p>
  <p><span>rifampin</span></p>
  <p><span><span>&nbsp;</span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Decreased phenytoin levels</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor phenytoin levels.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Phenobarbital <i>plus</i></span></p>
  <p><span>rifampin</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Decreased phenobarbital levels</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor phenobarbital levels.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Carbamazepine <i>plus </i></span></p>
  <p><span>rifampin</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Decreased carbamazepine levels</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor carbamazepine levels.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Lithium <i>plus </i></span></p>
  <p><i><span></span></i></p>
  <p><span>NSAID </span></p>
  <p><span>or </span></p>
  <p><span>diuretic</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased lithium levels </span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Decrease lithium dosage by 50% and
  monitor lithium levels.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Oral contraceptive pills <i>plus </i>rifampin</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Decreased effectiveness of oral
  contraception</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Avoid combination if possible.</span></p>
  <p><span></span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Sildenafil <i>plus </i></span></p>
  <p><span>nitrates</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Dramatic hypotension</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Absolute contraindication.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Sildenafil <i>plus </i></span></p>
  <p><i><span></span></i></p>
  <p><span>cimetidine </span></p>
  <p><span>erythromycin </span></p>
  <p><span>itraconazole</span></p>
  <p><span>or </span></p>
  <p><span>ketoconazole</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased sildenafil levels</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Initiate sildenafil at a 25-mg
  dose.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>HMG-CoA reductase inhibitor<span>&nbsp; </span><i>plus</i></span></p>
  <p><i><span></span></i></p>
  <p><span>niacin, </span></p>
  <p><span>gemfibrozil, </span></p>
  <p><span>erythromycin,</span></p>
  <p><span>or </span></p>
  <p><span>itraconazole</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Possible rhabdomyolysis</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Avoid if possible. If combination
  therapy is necessary, monitor the patient for toxicity.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Lovastatin<span>&nbsp; </span><i>plus </i></span></p>
  <p><span>warfarin</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased effect of warfarin</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor INR.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>SSRI <i>plus </i></span></p>
  <p><span>tricyclic antidepressant</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased tricyclic antidepressant
  level</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor for anticholinergic excess
  and consider lower dosage of tricyclic antidepressant.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>SSRI <i>plus </i></span></p>
  <p><i><span></span></i></p>
  <p><span>selegiline or</span></p>
  <p><span>nonselective MAOI</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Hypertensive crisis</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Avoid.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>SSRI <i>plus </i></span></p>
  <p><span>tramadol </span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Increased potential for seizures;
  serotonin syndrome</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Monitor the patient for signs and
  symptoms of serotonin syndrome.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>SSRI <i>plus </i>St. John's wort</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Serotonin syndrome</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Avoid.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>SSRI <i>plus </i></span></p>
  <p><i><span></span></i></p>
  <p><span>naratriptan, </span></p>
  <p><span>rizatriptan, </span></p>
  <p><span>sumatriptan,</span></p>
  <p><span>or </span></p>
  <p><span>zolmitriptan</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Serotonin syndrome</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Avoid if possible. If combination
  therapy is necessary, monitor the patient for signs and symptoms of serotonin
  syndrome</span></p>
  </td>
 </tr>
 <tr>
  <td width=479 colspan=3 valign=top>
  <p><span>INR =
  International Normalized Ratio; NSAID = nonsteroidal anti-inflammatory drug;
  HMG-CoA = 3-hydroxy-3-methylglutaryl&shy;coenzyme A reductase inhibitor; SSRI
  = selective serotonin reuptake inhibitor; MAOI = monoamine oxidase inhibitor</span><span></span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span>Warfarin
is the most widely prescribed anticoagulant drug in the U.S. It works by
inhibiting vitamin K-dependent synthesis of clotting factors II, VII, IX, and
X, and regulatory factors protein C and protein S. When warfarin is
administered, anticoagulation does not occur immediately because it takes about
a day for the already-formed clotting factors to be metabolized. The duration
of action of a single dose of warfarin is 2 to 5 days.</span></p>

<p><span></span></p>

<p><span>Despite
its effectiveness, warfarin has several shortcomings. It interacts with many
foods (particularly fresh plant-based foods containing vitamin K) and with many
commonly used medications (see below). Its activity must be monitored using the
International Normalized Ratio (INR) to ensure proper dosing. </span></p>

<p><span></span></p>

<p><span>Drug
interactions involving warfarin are among the most dangerous interactions seen
in clinical medicine. Not surprisingly, warfarin is associated with more
lawsuits that any other drug on the market.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Warfarin + Antibiotics</span></p>

<p><span></span></p>

<p><span>Almost all
antibiotics can potentiate the effect of warfarin by inhibiting intestinal
flora, which produce vitamin K. In addition, some antibiotics inhibit warfarin
metabolism, resulting in increased bleeding. These antibiotics include
ciprofloxacin, clarithromycin, erythromycin, metronidazole, and
trimethoprim-sulfamethoxazole. <i>Unless the
prothrombin International Normalized Ratio (INR) can be monitored every other
day, ciprofloxacin, macrolide antibiotics, metronidazole and
trimethoprim-sulfamethoxazole should not be prescribed to patients who are
taking warfarin</i>. Alternative antimicrobial therapy is recommended for these
patients.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Warfarin + Acetaminophen</span></p>

<p><span></span></p>

<p><span>Recent
data suggest that the warfarin-acetaminophen interaction may be clinically
significant even at low dosages of acetaminophen. Because acetaminophen is the
most frequently ingested medicine in the United States, physicians should
counsel warfarin-treated patients about potential toxicity. If acetaminophen
therapy is needed, the dosage should be as low as possible, and the drug should
be taken for only a short period. The INR should be monitored closely.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Warfarin + Aspirin</span></p>

<p><span></span></p>

<p><span>Coadministration
of acetylsalicylic acid (aspirin) and warfarin increases the risk of bleeding.
Although concomitant use of warfarin and aspirin should generally be avoided,
certain patients may benefit from this combination. In these patients, the dose
of aspirin should not exceed 100 mg per day.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Warfarin + NSAID</span></p>

<p><span></span></p>

<p><span>Coadministration
of nonsteroidal anti-inflammatory drugs (NSAIDs) and warfarin increases the
risk of bleeding. The data suggest that the cyclooxygenase-2 inhibitors may be
safer options in patients requiring an NSAID and warfarin because these agents
have fewer antiplatelet effects. Concomitant use of NSAIDs and warfarin should
be avoided in patients who are at increased risk of gastropathy (e.g., age
greater than 65 years, history of peptic ulcer disease, systemic steroid
therapy, heavy smoking, or high NSAID dosage). If NSAID therapy is necessary, a
cyclooxygenase-2 inhibitor should be used, and the INR should be closely
monitored. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. All the antibiotics
listed &#8211; </span><span>ciprofloxacin, erythromycin,
metronidazole, and trimethoprim-sulfamethoxazole &#8211; </span><span>have potentially
dangerous interactions with warfarin. In patients taking warfarin, these
antibiotics should be avoided if possible. If avoidance is impossible, the INR
should be monitored at least every other day and the dosage of warfarin
reduced.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span lang=EN-GB>A 47-year-old woman presents to the emergency room
with a two-day history of fever, cough, and shortness of breath. She has a
history of recurrent urinary tract infections and takes an antibiotic. Physical
examination shows a diffuse maculopapular rash and crackles in both lung bases.
Laboratory tests are normal except for an absolute eosinophil count of 950/mm<sup>3
</sup>(normal: &lt;350/mm<sup>3</sup>). Sputum and blood cultures are negative.
A chest x-ray shows bilateral diffuse infiltrates and a small right pleural
effusion. Which of the following conditions is most likely?&nbsp; </span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB><span>A.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Streptococcal pneumonia</span></p>

<p><span lang=EN-GB><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Congestive heart failure</span></p>

<p><span lang=EN-GB><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Acute asthma</span></p>

<p><span lang=EN-GB><span>D.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Drug-induced lung disease</span></p>

<p><span lang=EN-GB><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Sarcoidosis</span></p>

<p><i><span></span></i></p>

<p><span><span>&nbsp;</span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>More than
400 drugs have been associated with lung disease. Recognition of drug-induced
lung disease is difficult because clinical, radiological, and histological
findings are nonspecific. To make the diagnosis, physicians must be aware of
common drug-induced lung reactions. Ultimately, drug-induced lung disease is a
diagnosis of exclusion. Drugs commonly associated with lung disease appear
below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=97 valign=top>
  <p style="text-align:center;"><span>Drug-Induced </span></p>
  <p style="text-align:center;"><span>Lung Disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=97 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=97 valign=top>
  <p><span>Bleomycin</span></p>
  </td>
 </tr>
 <tr>
  <td width=97 valign=top>
  <p><span>Methotrexate</span></p>
  </td>
 </tr>
 <tr>
  <td width=97 valign=top>
  <p><span>Nitrofurantoin</span></p>
  </td>
 </tr>
 <tr>
  <td width=97 valign=top>
  <p><span>Amiodarone</span></p>
  </td>
 </tr>
 <tr>
  <td width=97 valign=top>
  <p><span>Procainamide</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><i><span>Bleomycin </span></i><span>causes dose-related toxicity. </span></p>

<p><span></span></p>

<p><i><span>Methotrexate </span></i><span>can cause interstitial pneumonitis, which
is often reversible; progression to pulmonary fibrosis is unusual. </span></p>

<p><span></span></p>

<p><i><span>Nitrofurantoin</span></i><span> is one of the most common causes of
interstitial lung disease. It can cause acute or chronic lung injury. Fever,
rash, eosinophilia, basilar infiltrates, and pleural effusion are common.
Failure to discontinue the medication can result in chronic fibrosis. </span></p>

<p><span></span></p>

<p><i><span>Amiodarone</span></i><span> can cause acute and chronic lung
disease. Acute disease is rare; chronic disease occurs more commonly in
patients taking 400 mg daily or more. </span></p>

<p><span></span></p>

<p><i><span>Procainamide</span></i><span> is associated with drug-induced lupus,
which may result in pulmonary infiltrates and pleural effusion. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct. </span></b><span>Drug-induced lung
disease should be suspected in this case.<span >&nbsp;
</span>Nitrofurantoin is an antibiotic commonly used to treat and prevent
urinary tract infections. It is one of the most common causes of drug-induced
lung disease. Findings may include fever, cough, shortness of breath, rash,
eosinophilia, basilar pulmonary infiltrates, and pleural effusion. Symptoms
usually resolve with discontinuation of the medicine. Failure to discontinue
the medicine may lead to chronic fibrosis. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.</span></b><span> Streptococcal pneumonia
often presents with signs of lobar consolidation, which include dullness to
percussion, increased fremitus, bronchial breath sounds, egophony, and
whispered pectoriloquy.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.</span></b><span> Congestive heart
failure can cause shortness of breath, basilar crackles, and right pleural
effusion, but it is not associated with rash or eosinophilia.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Acute asthma causes
shortness of breath and wheezing.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Sarcoidosis is a
systemic disease characterized by the presence of noncaseating granulomas.
Women and African-Americans are disproportionately affected. The disease
commonly affects the lungs and lymph nodes, although any organ system can be
involved. Symptoms may include coughing and shortness of breath. Hilar
lymphadenopathy is often present on chest x-ray.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span><b></b></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 49-year old man is diagnosed with sinusitis
and given a prescription for an antibiotic. He develops a rash ten days later.
Which antibiotic most likely caused the rash?</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=204 height=289
src="_%20Tutorials_files/image599.png" alt="Description: drug_eruption" v:shapes="Picture_x0020_347413"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Amoxicillin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Erythromycin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Azithromycin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Ciprofloxacin</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Levofloxacin
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Drug eruptions can mimic a wide range of skin
disorders. They can produce different types of rash &#8211; morbilliform,
urticarial, papulosquamous, pustular, and bullous. (Some drugs cause pruritus
and dysesthesia without rash.) A drug-induced reaction should be considered in
any patient who is taking medicine and who develops a symmetric cutaneous
eruption. Drugs that commonly cause cutaneous reactions include antimicrobial
agents,</span><a href="file://localhost/javascript/showcontent('active','references')%3B"></a><sup><span> </span></sup><span>nonsteroidal
anti-inflammatory drugs, cytokines, chemotherapeutic agents, anticonvulsants,
and psychotropic agents.</span></p>

<p><span></span></p>

<p><span>The most common morphology for a drug-induced
rash is morbilliform (“measles-like”), which has both <span>macular
and papular components. Morbilliform rashes </span>usually develop<span> in the second week of exposure to a drug.
Penicillins (e.g., amoxicillin) and trimethoprim/sulfamethoxazole (Bactrim) are
the most common antibiotics causing this type of rash. Patients with
Epstein-Barr virus and Human Immunodeficiency Virus have a higher incidence of
this reaction. Morbilliform rashes present as pruritic, erythematous, finely
maculopapular lesions. They usually appear on the trunk and groin and spread
centrifugally over 24 hours. Fever is usually absent and laboratory tests are
often normal. The rash resolves in a few days to a week after the medication is
stopped. The patient’s medical record must be appropriately labeled to make
sure so that the drug is not readministered. </span></span></p>

<p><span><span>&nbsp;</span></span></p>

<p style="text-align:center;"><span><img border=0 width=96 height=146
src="_%20Tutorials_files/image601.png"
alt="Description: Penicillin_Allergy_Resulting_in_Morbilliform_Rash-124"
v:shapes="Picture_x0020_347412"><img border=0 width=104 height=146
src="_%20Tutorials_files/image603.png"
alt="Description: image_gallery?img_id=1584227&amp;t=1276092298705" v:shapes="Picture_x0020_347411"><img border=0 width=109 height=146
src="_%20Tutorials_files/image605.png" alt="Description: 79m" v:shapes="Picture_x0020_347410"></span><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;</span></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. Amoxicillin is one of
the most common causes of morbilliform rash. </span></p>

<p><span></span></p>

<p><b><span>Answers B, C, D, and E
are incorrect. </span></b><span>Erythromycin,
azithromycin, ciprofloxacin and levofloxacin do not usually produce a
morbilliform rash. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following is used as a metabolic energy source by erythrocytes after an
overnight fast?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Glucose</span></li>
 <li><span>Pyruvate</span></li>
 <li><span>Triglycerides</span></li>
 <li><span>Free fatty acids</span></li>
 <li><span>&#946;-hydroxybutyrate</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Red blood
cells are structurally simpler that most other cells in the body. They consist
mainly of hemoglobin. Although they contain many organelles in the early stages
of erythropoiesis, these organelles are extruded as the cells mature. By
“dumping” their organelles, red blood cell makes room for hemoglobin.
Organelles “dumped” by red blood cells include the nucleus, mitochondria, Golgi
apparatus, and endoplasmic reticulum. Because mature red blood cells have no
mitochondria, they cannot undertake metabolic reactions that use oxygen to
produce energy. Thus, although they can <i>carry</i>
oxygen because of the hemoglobin, they cannot <i>use</i> it. Since red blood cells lack the metabolic machinery to
oxidize metabolites for energy, they must rely on lactic acid fermentation of
glucose for energy. This is an anaerobic process that produces ATP. The first
step of the process is glycolysis, in which glucose is broken down to produce
pyruvate. The pyruvate is then converted to lactic acid. The entire process is
performed in the cytoplasm without the need for oxygen, mitochondria, or other
organelles.<span >&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>Red blood cells use
glucose as a metabolic energy source. <b><span>&nbsp;</span></b><span>&nbsp;</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect. </span></b><span>In red blood cells,
glucose is broken down to pyruvate during glycolysis. The pyruvate is then
converted to lactic acid.<span >&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><span>Triglycerides are broken
down to produce fatty acids, which are used by the heart and skeletal muscle
for energy. Fatty acids do not cross the blood-brain barrier, and so the brain
cannot use them for energy. The process of breaking down fatty acids is called
&#946;-oxidation. This process requires mitochondria and oxygen. Red blood
cells, which lack mitochondria, cannot perform &#946;-oxidation. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect. </span></b><span>Free fatty acids are
used by the heart and skeletal muscle for energy. They do not cross the
blood-brain barrier, and so the brain cannot use them for energy. The process
of breaking down fatty acids is called &#946;-oxidation. This process requires
mitochondria and oxygen. Red blood cells, which lack mitochondria, cannot
perform &#946;-oxidation. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect</span></b><span>. &#946;-hydroxybutyrate
is a ketone. Unlike fatty acids, ketones cross the blood-brain barrier. They are
used by the brain for energy when glucose in not available (e.g., fasting). Red
blood cells cannot metabolize ketones. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 58-year-old woman presents with fatigue and
arthritis. Her blood tests show the following:<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Hemoglobin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
g/dl </span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>6,500/mm<sup>3</sup></span></p>

<p><span>Platelet <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>110,000/mm<sup>3</sup>
</span></p>

<p><span></span></p>

<p><span>Glucose (fasting)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mg/dl<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>AST<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>110
U/L</span></p>

<p><span>ALT<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>86
U/L</span></p>

<p><span>Albumin<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3.1
g/dl</span></p>

<p><span></span></p>

<p><span>INR<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.3</span></p>

<p><span></span></p>

<p><span>Serum iron <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>184
ug/dl (normal: 50-170 ug/dl) </span></p>

<p><span>Total iron binding capacity <span>&nbsp;&nbsp;&nbsp; </span>282 ug/dl (normal: 262-474
ug/dl) </span></p>

<p><span>Transferrin saturation <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>65%
(normal: 25% - 35%)</span></p>

<p><span>Serum ferritin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2689
ng/ml (normal: 12-150)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of the following tests should be ordered
next? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Blood
test for viral hepatitis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Blood
test for alpha-fetoprotein</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Liver
biopsy</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Blood
test for mutation of the hemochromatosis gene (HFE)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>H</span><span>emochromatosis is an autosomal recessive disease with a high
prevalence in Caucasians. The gene responsible for the disease is known as the
HFE gene. Hemochromatosis is characterized by an accelerated rate of intestinal
iron absorption and progressive iron deposition in various tissues. Patients
may present with liver disease, heart failure, diabetes, arthritis,
hyperpigmentation, or testicular failure. A third of untreated patients develop
hepatocellular carcinoma. </span><span>Individuals who are homozygous for the C282Y mutation are at
very high risk of developing the disease.<span >&nbsp;
</span>Other mutations increase risk, but homozygosity of the C282Y mutation
carries the greatest risk.<span >&nbsp; </span>Once a patient
is found to be homozygous for the C282Y mutation, all first-degree relatives
should be screened. Patients with hemochromatosis should be instructed not to
consume iron supplements. Repeated phlebotomy is undertaken to bring the serum
ferritin level below 50ng/ml. Maintenance phlebotomy is needed thereafter.</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. The presence of
elevated liver enzymes and high serum iron levels, along with arthritis and
diabetes, suggests a diagnosis of hemochromatosis. The diagnosis can be
confirmed by testing for mutation of the hemochromatosis gene (HFE).<span>&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>.<span>&nbsp; </span>Viral hepatitis is a common cause of
elevated liver enzymes, but would not explain the abnormal serum iron studies.</span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><b>Answer B is incorrect</b>.<span>&nbsp; </span>An alpha-fetoprotein level should be
measured if hepatocellular carcinoma is suspected, but this is not a prime
diagnostic consideration at this time. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>.<span>&nbsp; </span>A liver biopsy would establish the
degree of hepatic impairment, but is not necessary for diagnosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Which of the
following is true regarding intention-to-treat analysis?</span></p>

<p></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>It is a
way of avoiding the breaking of blinding</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
should always be used in equivalency trials</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
maximizes the difference in results between treatment groups</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>It means that <span>all patients are analyzed in the group to which they were assigned,
regardless of which treatment they received</span></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p><span>A classical clinical trial with
a superiority design is analyzed on the basis of&nbsp;<i>intention to treat
(ITT)</i>&nbsp;by default. ITT means that every patient is analyzed as
belonging to the group to which he or she was allocated by randomization,
regardless of what happened with this patient afterward. In the extreme
scenario, a patient who is randomized to group A may drop out even before the
first drug dose is administered, and may be treated outside the clinical trial
by his or her physician with the drug that is actually being administered in
group B (cross-over of treatment). True ITT requires that this patient,
regardless of the data that are present or missing, is analyzed in group A,
even if he or she has experienced the effects of the drug in group B. ITT is
considered the only means of analysis that preserves the prognostic similarity
that was created at baseline. It should be noted here that many trial reports
mention an ITT analysis, but that such an analysis often is not rigorously
performed. For example, randomized patients who did not receive treatment are
often excluded from the analysis.</span></p>

<p><span>Alternatively, a trial analysis may be limited to
only those patients who completed the study (completers analysis), or to those
who completed the study while complying with the study protocol (per-protocol
analysis). Both types of analysis may introduce bias; as a consequence,
prognostic similarity should not be assumed. Dropout, for example, can occur
because of lack of efficacy, and completers may provide a less severe
representation of the entire trial population (see later). Often, a completers
analysis tends to magnify the treatment effect, and an ITT analysis is more
conservative. In a noninferiority trial, however, the situation is just the
reverse: The ITT analysis tends to favor noninferiority, and the completers
analysis or the per-protocol analysis is more conservative in this regard.</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>ITT is generally preferred in <b>superiority</b> trials (i.e., trials to
determine if one intervention is superior to another). This is because ITT
tends to minimize the difference in outcomes between treatment groups. If,
despite using ITT, there is a significant difference between groups, that
difference is more likely to be real.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>ITT is generally <i>not</i> preferred in <b>equivalency</b>,
or non-inferiority, trials (i.e., trials to determine if two interventions are
equivalent). This is because ITT, by minimizing the difference between
treatment groups, may make outcomes appear equivalent, even when they are
not.<span >&nbsp; </span></span></p>

<p></span></p>

<p></span></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span>Answer D is correct. </span></b><span>ITT means that <span>all patients are analyzed in the group to which they are assigned,
regardless of the treatment they received.</span></span></p>

<p><span></span></b></p>

<p><span>Answer A is incorrect. </span></b><span>ITT does not contribute to blinding.
Concealment of randomization helps to avoid the breaking of blinding.</span></p>

<p><span></span></b></p>

<p><span>Answer B is incorrect. </span></b><span>ITT should be used in superiority trials, not
equivalency trials. </span></p>

<p><span></span></b></p>

<p><span>Answer C is incorrect. </span></b><span>ITT<b> </b>minimizes
the difference in results between treatment groups.</span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>In the
following schematic of lipid metabolism, the targets of lipid-lowering therapy
are labeled. Which site is targeted by drugs that produce the greatest reduction
in LDL cholesterol levels?</span></p>

<p style="text-align:center;"><span><img border=0 width=416 height=329
src="_%20Tutorials_files/image607.png" v:shapes="Picture_x0020_347409"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>A
</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>D</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>.
3-hydroxy-3-methyglutaryl coenzyme A (HMG-CoA) reductase inhibitors block the
synthesis of mevalonate. This is an essential step in cholesterol synthesis.
These medicines, sometimes called “statins,” are the most effective drugs for
lowering LDL cholesterol. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>. No lipid-lowering
drugs target this site.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Bile acid sequestrants
like cholestyramine block the absorption of bile acids from the gut. The liver
manufactures bile acids through the oxidation of cholesterol. When bile acid
absorption is inhibited, the liver must metabolize more cholesterol to generate
new bile acids. This lowers cholesterol, principally LDL cholesterol, levels.
Although bile acid sequestrants lower LDL cholesterol levels, they are less effective
than HMG-CoA reductase inhibitors (“statins”) at doing so. </span></p>

<p><span></span></p>

<p><b><span>Answer D</span></b><span> <b>is
incorrect</b>. Fibrates like gemfibrozil lower triglyceride levels. They work
by increasing the expression of lipoprotein lipase on endothelial cells.
Lipoprotein lipase hydrolyzes lipids, increasing the clearance of
triglyceride-rich lipoproteins. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Thoracentesis
and lumbar puncture are two commonly performed procedures. Which of the
following locations are most appropriate for needle insertion in adult patients?</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=180 valign=top>
  <p style="text-align:center;"><span>Thoracentesis </span></p>
  <p style="text-align:center;"><span>(performed in midscapular line)</span></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><span>Lumbar puncture</span></p>
  <p style="text-align:center;"><span>(performed in intervertebral space)</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=180 valign=top>
  <p><span></span></p>
  </td>
  <td width=189 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>A</span></p>
  </td>
  <td width=180 valign=top>
  <p style="text-align:center;"><span>Above the 2<sup>nd</sup> rib</span></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><span>L1/L2 or L2/L3</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>B</span></p>
  </td>
  <td width=180 valign=top>
  <p style="text-align:center;"><span>Below the 2<sup>nd</sup> rib</span></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><span>L1/L2 or L2/L3</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>C</span></p>
  </td>
  <td width=180 valign=top>
  <p style="text-align:center;"><span>Above the 5<sup>th</sup> rib</span></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><span>L2/L3 or L3/L4</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>D</span></p>
  </td>
  <td width=180 valign=top>
  <p style="text-align:center;"><span>Below the 5<sup>th</sup> rib</span></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><span>L2/L3 or L3/L4</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>E</span></p>
  </td>
  <td width=180 valign=top>
  <p style="text-align:center;"><span>Above the 9<sup>th</sup> rib</span></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><span>L3/L4 or L4/L5</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p style="text-align:center;"><span>F</span></p>
  </td>
  <td width=180 valign=top>
  <p style="text-align:center;"><span>Below the 9<sup>th</sup> rib</span></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><span>L3/L4 or L4/L5</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. Thoracentesis is
commonly performed above the 9<sup>th</sup> rib in the midscapular line. The
needle should not be inserted below the rib, where nerves and vascular
structures lie. Lumbar puncture should be performed in the L3/L4 or L4/L5
intervertebral space. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Additive nephrotoxicity
would be expected with which of the following drug combinations?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>ceftriaxone and
     azithromycin</span></li>
 <li><span>fluconazole and
     amoxicillin<b> </b></span></li>
 <li><span>amphotericin B and
     gentamicin</span></li>
 <li><span>moxifloxacin and
     clindamycin</span></li>
 <li><span>micafungin and
     doxycycline</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Many drugs
can cause renal disease. The most important are listed here.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=246 valign=top>
  <p style="text-align:center;"><span>Drug-induced renal disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Radiographic
  contrast media</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Nonsteroidal
  anti-inflammatory drugs (NSAIDs)</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Cyclooxygenase-2
  inhibitors (COX-2 inhibitors)</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Aminoglycosides</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Amphotericin
  B</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Angiotensin-converting
  enzyme inhibitors (ACE-inhibitors)</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Cisplatin</span></p>
  </td>
 </tr>
 <tr>
  <td width=246 valign=top>
  <p><span>Cyclosporine
  and tacrolimus</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><i><span>Radiographic contrast media</span></i><span> are a common cause of
acute renal failure. The most important risk factors are pre-existing renal
disease, dehydration, and exposure to other nephrotoxins.<span>&nbsp; </span></span></p>

<p><i><span></span></i></p>

<p><i><span>Nonsteroidal anti-inflammatory drugs (NSAIDs)</span></i><span> have several acute
renal effects. The most common pattern of injury is prerenal azotemia, which
occurs in patients who are volume contracted or who have reduced effective
circulating volume (e.g., congestive heart failure, cirrhosis). Other injury
patterns include renal tubular acidosis (hyporeninemic hypoaldosteronism, which
results in hyperkalemia and a normal-anion gap metabolic acidosis) and acute
interstitial nephritis.</span></p>

<p><span></span></p>

<p><i><span>Cyclooxygenase-2 inhibitors (COX-2 inhibitors)</span></i><span> are similar to NSAIDs
in their effects on the kidney.</span></p>

<p><span></span></p>

<p><i><span>Aminoglycosides</span></i><span> cause acute renal
failure in 10% of patients receiving these drugs even when levels are within
therapeutic range. Renal failure is usually mild and the prognosis is generally
good. The risk of aminoglycoside-induced renal failure is increased by concomitant
use of other nephrotoxic drugs (e.g., amphotericin B, radiocontrast media,
cisplatin). </span></p>

<p><span></span></p>

<p><i><span>Amphotericin B</span></i><span> causes potassium and magnesium wasting
and metabolic acidosis by damaging multiple segments of the renal tubule
(proximal tubule, ascending limb, and collecting duct).</span></p>

<p><span></span></p>

<p><i><span>Angiotensin-converting enzyme inhibitors</span></i><span> <i>(ACE-inhibitors)</i> can cause acute renal failure in patients with
bilateral renal artery stenosis and in patients with advanced azotemia. </span></p>

<p><span></span></p>

<p><i><span>Cisplatin</span></i><span> causes magnesium wasting by damaging the proximal
and distal tubules. </span></p>

<p><i><span></span></i></p>

<p><i><span>Cyclosporine and tacrolimus</span></i><span> can cause acute renal
failure by inducing afferent arteriolar vasoconstriction. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. Both amphotericin B
and gentamicin can damage the kidneys.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
inexpensive screening test is available through analysis of venous blood. The
distributions of blood concentrations for persons with and without the disease
are depicted in the graph. The disease is irreversible and fatal if not
discovered and treated early. Which of the following letters represents the
most appropriate cutoff point between normal and abnormal?</span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=257 height=140
src="_%20Tutorials_files/image609.png" v:shapes="Picture_x0020_347408"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Using lab
tests to distinguish “normal” and “abnormal” states can be challenging. Rarely
are normality and abnormality defined by a <i>single</i>
test value. Instead, they are usually defined by a <i>range</i> of values &#8211; and those ranges can overlap. While values
in the non-overlapping regions are easily categorized as normal or abnormal,
values in the overlapping region are not easily categorized. The cutoff between
normal and abnormal can be placed anywhere within the region of overlap,
depending on the level of sensitivity and specificity that is sought. </span></p>

<p><span></span></p>

<p><span>When it is
extremely important to identify a disease, even at the cost of misidentifying a
few normal individuals, the range of abnormal values should be expanded so that
<i>every</i> person with the disease is
correctly identified. In other words, the cutoff point between normal and
abnormal should maximize test sensitivity. On the other hand, when it is not
crucial to identify every person with the disease, and when it is more
important to ensure that no normal person is misidentified, then the abnormal
range should be narrowed so <i>only</i>
persons with the disease are identified. In other words, the cutoff point
between normal and abnormal should maximize test specificity.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>. In this vignette, we
are told that the disease is irreversible and fatal if not discovered and
treated early. This means that the abnormal range must be defined so that every
affected patient is identified, even at the cost of misidentifying normal patients.
In other words, the cutoff point between normal and abnormal should be placed
to maximize test sensitivity. That place is represented by “B.” If the cutoff
point is placed at “C”, “D,” or “E,” some people with disease will be missed.
Placing the cutoff point at “A” would identify no additional people with
disease (compared to “B”), and would misidentify too many normal individuals.
As one moves from “B” to “E,” test specificity increases, while sensitivity
decreases; as one moves from “E” to “B,” sensitivity increases, while
specificity decreases.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
68-year-old man presents with urinary f<span>requency,
urgency, hesitancy, and intermittency. The urine stream is weak. The patient
feels that his bladder is not emptying completely. On examination, he is found
to have an enlarged prostate. His doctor prescribes a medicine to “shrink the
prostate.” What is the mechanism by which this medicine works? </span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Inhibition
of 5&#945;-reductase</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Inhibition
of cyclic guanosine monophosphate-specific phosphodiesterase type 5 (PDE-5
inhibitor)</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Gonadotropin-releasing
hormone (GnRH) analog</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Inhibition of testosterone’s negative feedback on gonadotropin
secretion</span><span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Inhibition of cytochrome P450 enzymes</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. <span>5&#945;-reductase</span> inhibitors like finasteride work
by inhibiting the conversion of testosterone to dihydrotestosterone, which
reduces the size of the prostate over time.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. PDE-5 inhibitors like
sildenafil increase the concentration of <span>cyclic
guanosine monophosphate (cGMP), which causes vasodilation and increased blood
flow to the corpus cavernosum. These medicines are used for erectile
dysfunction. </span></span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. GnRH
analogs like leuprolide bind to the luteinizing hormone-releasing hormone (LH-RH)
receptor in the pituitary. This leads to a reduction in luteinizing hormone
secretion. These medicines are used to treat metastatic prostate cancer.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Androgen
receptor antagonists like flutamide are used in conjunction with GnRH analogs
to treat metastatic prostate cancer.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>.
5&#945;-reductase</span><span>
inhibitors like finasteride do not interact with cytochrome P450 enzymes. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A new
laboratory test has been developed to identify patients with a particular
disease. </span></p>

<p><span>The table
below summarizes the results of research involving 200 subjects.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=72 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p><span></span></p>
  </td>
  <td width=119 colspan=2 valign=top>
  <p style="text-align:center;"><span>Disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p><span></span></p>
  </td>
  <td width=119 colspan=2 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p style="text-align:center;"><span>Present</span></p>
  </td>
  <td width=60 valign=top>
  <p style="text-align:center;"><span>Absent</span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p><span></span></p>
  </td>
  <td width=60 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p><span>Positive</span></p>
  </td>
  <td width=59 valign=top>
  <p style="text-align:center;"><span>80</span></p>
  </td>
  <td width=60 valign=top>
  <p style="text-align:center;"><span>20</span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top>
  <p><span>Test
  Result</span></p>
  </td>
  <td width=59 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=60 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=72 valign=top>
  <p><span></span></p>
  </td>
  <td width=59 valign=top>
  <p><span>Negative</span></p>
  </td>
  <td width=59 valign=top>
  <p style="text-align:center;"><span>40</span></p>
  </td>
  <td width=60 valign=top>
  <p style="text-align:center;"><span>60</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span>What is
the sensitivity of a positive test result?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>0.30 </span></li>
 <li><span>0.33</span></li>
 <li><span>0.60</span></li>
 <li><span>0.67</span></li>
 <li><span>0.75</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Sensitivity,
specificity, positive predictive value, and negative predictive value are
important statistical concepts. </span></p>

<p><span></span></p>

<p><span>Imagine a
study evaluating a new test that screens people for a disease. Each person
taking the test either does or does not have the disease. The test outcome can
be positive (predicting that the person has the disease) or negative
(predicting that the person does not have the disease). The test results for
each subject may or may not match the subject's actual status. In that setting:</span></p>

<p><span></span></p>

<ul type=disc>
 <li><span>True positive: Sick
     people correctly identified as sick </span></li>
 <li><span>False positive:
     Healthy people incorrectly identified as sick </span></li>
 <li><span>True negative:
     Healthy people correctly identified as healthy </span></li>
 <li><span>False negative:
     Sick people incorrectly identified as healthy</span></li>
</ul>

<p><b><span></span></b></p>

<p><b><span>Sensitivity</span></b><span> measures the proportion
of actual positives that are correctly identified as such (e.g. the percentage
of sick people who are correctly identified as having the condition).</span></p>

<p><span></span></p>

<p><span>Sensitivity
=<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>___________ <u>Number of True Positives_____________</u></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Number of
True Positives + Number of False Negatives</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Specificity</span></b><span> measures the proportion
of actual negatives that are correctly identified as such (e.g. the percentage
of healthy people who are correctly identified as not having the condition).</span></p>

<p><span></span></p>

<p><span>Specificity
=<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><u><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Number
of True Negatives____________</u></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Number of
True Negatives + Number of False Positives</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Positive
predictive value</span></b><span>
<b>(PPV) </b>is the proportion of patients
with positive test results who are correctly diagnosed.</span></p>

<p><span></span></p>

<p><span>PPV=<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>____________<u>Number of True Positives____________</u></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Number of
True Positives + Number of False Positives</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Negative
predictive value</span></b><span>
<b>(NPV)</b> is the proportion of patients
with negative test results who are correctly diagnosed.</span></p>

<p><span></span></p>

<p><span>NPV=<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>____________<u>Number of True Negatives____________</u></span></p>

<p><span><span>&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Number
of True Negatives + Number of False Negatives</span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. </span></p>

<p><span></span></p>

<p><span>The
question above provides the following data:</span></p>

<p><span></span></p>

<p><span>Number of
true positives:<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>80</span></p>

<p><span>Number of
true negatives:<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>60</span></p>

<p><span>Number of
false positives:<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>20</span></p>

<p><span>Number of
false negatives:<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>40</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Sensitivity=<span>&nbsp;&nbsp; </span><u><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Number
of True Positives____________</u><span>&nbsp;&nbsp;&nbsp; </span>= __<u>80</u>__ =<span>&nbsp; </span>0.67</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Number of True Positives + Number of False Negatives<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>80+40</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Which of the following drugs
is <i>not</i> considered teratogenic?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Lisinopril</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Isotretinoin</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Tetracycline</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Phenytoin</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>All
of these drugs are teratogenic</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Approximately 10% of all
birth defects are caused by prenatal exposure to teratogenic agents. These
agents include drugs, medications, infectious agents, and environmental and
occupational toxins. Medications can cause birth defects through any of six mechanisms:
folate antagonism, neural crest cell disruption, endocrine disruption,
oxidative stress, vascular disruption, and specific receptor- or
enzyme-mediated teratogenesis. </p>

<p></p>

<p>The following drugs are
considered teratogenic. </p>

<ul type=disc>
 <li><span>Tobacco, ethanol,
     marijuana, cocaine</span></li>
 <li><span>Blood pressure
     medicines </span></li>
 <ul type=disc>
  <li><span>ACE-Is
      (angiotensin-converting enzyme inhibitors) </span></li>
  <li><span>ARBs
      (Angiotensin-receptor blockers)</span></li>
 </ul>
 <li><span>Acne drug:
     isotretinoin</span></li>
 <li><span>Alkylating agents:
     busulfan, cyclophosphamide<span>&nbsp;&nbsp;&nbsp; </span></span></li>
 <li><span>Androgens<span>&nbsp; </span></span></li>
 <li><span>Antibiotics:
     tetracycline, doxycycline, metronidazole, and streptomycin </span></li>
 <li><span>Anticoagulant:
     warfarin<span >&nbsp; </span></span></li>
 <li><span>Anticonvulsants:
     phenytoin, carbamazepine, valproic acid </span></li>
 <li><span>Antithyroid agents:
     propylthiouracil, methimazole</span></li>
 <li><span>Chelating agent:
     penicillamine </span></li>
 <li><span>Estrogen:
     diethylstilbestrol</span></li>
 <li><span>Folic acid
     antagonists: aminopterin, methotrexate</span></li>
 <li><span>Mood stabilizer:
     lithium</span></li>
 <li><span>Sedatives:
     benzodiazepines, thalidomide</span></li>
</ul>

<p><b></b></p>

<p><b>Alcohol<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></b><span></span></p>

<p><span>F</span>etal alcohol syndrome is characterized by intrauterine growth
retardation, microcephaly, developmental delay, and dysmorphic faces. Cleft
palate and cardiac anomalies may also occur. </p>

<p><b></b></p>

<p><b>Angiotensin converting
enzyme inhibitors (ACE-Is) and Angiotensin receptor blockers (ARBs)<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></b></p>

<p>ACE-Is and ARBs have been
associated with intrauterine renal insufficiency and neonatal hypotension,
oliguria, renal failure, and hyperkalemia. The teratogenicity of ACE-Is and
ARBs is greatest in late pregnancy. ACE-Is and ARBs are absolutely
contraindicated in pregnancy. </p>

<p><b></b></p>

<p><b>Carbamazepine<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></b></p>

<p>Exposure to carbamazepine <i>in utero</i> carries a 1% risk of neural
tube defects (10 times the baseline risk). </p>

<p><b></b></p>

<p><b>Cocaine<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></b></p>

<p>Cocaine use during pregnancy
has been associated with abruptio placentae, prematurity, fetal loss, decreased
birth weight, microcephaly, limb defects, and poor neurologic development. </p>

<p><b></b></p>

<p><b><span>Warfarin<span><br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></span></b><span></span></p>

<p><span>Exposure
to warfarin in the first trimester can cause fetal warfarin syndrome, which is
characterized by nasal hypoplasia and calcific stippling of the epiphyses.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Diethylstilbestrol<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>Clear
cell adenocarcinoma of the vagina was found to be associated with
diethylstilbestrol treatment of the patient's mother during the first trimester
of pregnancy. Over 90% of the cancers occurred <i>after </i>14 years of age. </span></p>

<p><b><span></span></b></p>

<p><b><span>Folic acid antagonists: aminopterin and methotrexate<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>Aminopterin
can cause fetal death.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Hydantoins (phenytoin and trimethadione)<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>The </span><span>fetal
hydantoin syndrome is characterized by craniofacial dysmorphology as well as
hypoplasia of the distal phalanges and nail hypoplasia. </span></p>

<p><b><span></span></b></p>

<p><b><span>Isotretinoin (13-cis-retinoic acid)<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>Isotretinoin,
a synthetic vitamin A derivative used for severe cystic acne, is a potent
teratogen. Retinoic acid embryopathy is characterized by craniofacial
anomalies, cardiac defects, abnormal thymic development, and neurologic
abnormalities. </span></p>

<p><b><span></span></b></p>

<p><b><span>Lithium<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>Lithium use is associated with an increased
incidence of </span><span>Ebstein's anomaly, a rare
malformation of the tricuspid valve.<span></span></span></p>

<p><b><span></span></b></p>

<p><b><span>Misoprostol<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>Misoprostol,
a prostaglandin analogue used to treat duodenal and gastric ulcers, can cause
fetal death.</span></p>

<p><b><span></span></b></p>

<p><b><span>Tetracyclines<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>Use of tetracyclines in late pregnancy can cause y</span><span>ellow-brown discoloration of the teeth of the fetus. </span></p>

<p><b><span></span></b></p>

<p><b><span>Thalidomide<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>T</span><span>he
thalidomide tragedy alerted the world to the teratogenic potential of drugs.
Thalidomide was available for four years before its teratogenicity was
recognized. The drug produced malformations of mesodermal tissues, primarily
limbs, ears, cardiovascular system, and gut musculature. </span></p>

<p><b><span><br>
Valproate<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b><span></span></p>

<p><span>First
trimester exposure to valproate is associated with neural tube defects and
carries a 1-2% risk of meningomyelocele.</span></p>

<p><b><span></span></b></p>

<p><b></b></p>

<p><b>Answer E is correct</b>. All of the listed drugs are considered
teratogenic. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Five drugs produce the same therapeutic effect by the same mechanism, but
each has a unique toxicity. When used at a maximally effective therapeutic
dose, the drug with which of the following characteristics is most likely to have
the highest incidence of toxicity?</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=26 valign=top>
  <p><span></span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>Median Effective Dose</span></p>
  </td>
  <td width=174 valign=top>
  <p style="text-align:center;"><span>Toxic Dose<sub>1 </sub>/
  Effective Dose<sub>99</sub></span></p>
  </td>
 </tr>
 <tr>
  <td width=26 valign=top>
  <p><span></span></p>
  </td>
  <td width=148 valign=top>
  <p><span></span></p>
  </td>
  <td width=174 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=26 valign=top>
  <p><span>A</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>2x</span></p>
  </td>
  <td width=174 valign=top>
  <p style="text-align:center;"><span>3.5</span></p>
  </td>
 </tr>
 <tr>
  <td width=26 valign=top>
  <p><span>B</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>0.5x</span></p>
  </td>
  <td width=174 valign=top>
  <p style="text-align:center;"><span>2.8</span></p>
  </td>
 </tr>
 <tr>
  <td width=26 valign=top>
  <p><span>C</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>1x</span></p>
  </td>
  <td width=174 valign=top>
  <p style="text-align:center;"><span>2.1</span></p>
  </td>
 </tr>
 <tr>
  <td width=26 valign=top>
  <p><span>D</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>5x</span></p>
  </td>
  <td width=174 valign=top>
  <p style="text-align:center;"><span>4.0</span></p>
  </td>
 </tr>
 <tr>
  <td width=26 valign=top>
  <p><span>E</span></p>
  </td>
  <td width=148 valign=top>
  <p style="text-align:center;"><span>33x</span></p>
  </td>
  <td width=174 valign=top>
  <p style="text-align:center;"><span>3.0</span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The therapeutic index</span> (also known as <span>therapeutic ratio</span>) is the ratio of the toxic dose of a drug
divided by the therapeutic dose. Usually it is expressed as the toxic dose of a
drug for 50% of the population (TD<sub>50</sub>) divided by the minimum
effective dose for 50% of the population (ED<sub>50</sub>).</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=169 height=35
src="_%20Tutorials_files/image611.png"
alt="Description: \mbox{Therapeutic ratio} = \frac{\mathrm{TD}_{50}}{\mathrm{ED}_{50}}"
v:shapes="Picture_x0020_347407"></span></p>

<p style="text-align:center;"></p>

<p>A high therapeutic index is better
than a low one because a high index means the patient has to take a much higher
dose of the drug to cause toxicity than is needed for therapeutic effect.</p>

<p></p>

<p>Typically, a drug with a
narrow therapeutic window (i.e., a low therapeutic index) must have its dosage
adjusted based on serum blood levels of the drug. This may be achieved through
therapeutic drug monitoring (TDM) protocols. Drugs with a very low therapeutic
index (“dangerous” drugs) include warfarin, digoxin, theophylline, and lithium
carbonate. Antimicrobials such as aminoglycosides, vancomycin, and amphotericin
B have a low therapeutic index and require careful monitoring to balance
efficacy and toxicity.</p>

<p></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. <span>The drug with the lowest therapeutic index </span>(t<span>oxic dose<sub>1 </sub>/ effective dose<sub>99</sub>)
has the greatest potential for toxicity. In this case, the lowest therapeutic
index is 2.1 (Drug C). Drug C is, therefore, said to have the narrowest
therapeutic window of the five drugs. </span>The safest drug is the one with
the highest therapeutic index<span>. That
would be Drug D, which has an index of 4.0. (The median effective drug doses
are irrelevant in this case.)</span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
32-year-old man is brought to the emergency department because of confusion,
wheezing, vomiting, and diarrhea for the past 6 hours. He is sweating and
salivating profusely. There is generalized muscle weakness. Which of the
following substances is the most likely cause of these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Glutethimide</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Heroin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Jimson
weed (belladonna alkaloids)</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Parathion</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Phencyclidine
(PCP)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b></b></p>

<p><span><img border=0 width=472 height=268
src="_%20Tutorials_files/image613.png" v:shapes="Picture_x0020_347264"></span></p>

<p><img border=0 width=461 height=331
src="_%20Tutorials_files/image615.png" v:shapes="Picture_x0020_347265"></span></p>

<p><img border=0 width=466 height=496
src="_%20Tutorials_files/image617.png" v:shapes="Picture_x0020_347479"></span><span><br clear=all>
</span></p>

<p></span></p>

<p name=4-u1.0-B978-1-4377-1604-7..00110-X--sp00></a></p>

<p><img border=0 width=462 height=563
src="_%20Tutorials_files/image619.png" v:shapes="Picture_x0020_347481"></span></p>

<p><img border=0 width=466 height=499
src="_%20Tutorials_files/image621.png" v:shapes="Picture_x0020_347482"></span></p>

<p><img border=0 width=459 height=552
src="_%20Tutorials_files/image623.png" v:shapes="Picture_x0020_347484"></span></p>

<p><img border=0 width=459 height=510
src="_%20Tutorials_files/image625.png" v:shapes="Picture_x0020_347485"></span></p>

<p><img border=0 width=462 height=195
src="_%20Tutorials_files/image627.png" v:shapes="Picture_x0020_347486"></span></p>

<p><img border=0 width=459 height=45
src="_%20Tutorials_files/image629.png" v:shapes="Picture_x0020_347487"></span></p>

<p><b><span>Glutethimide</span></b><span> is a non-barbiturate hypnotic sedative. <a
name=s00129238></a><a name=s00129239></a><a name=s00129240></a><a
name=s00129241></a><a name=s00129242></a><a name=s00129243></a><a
name=s00129244></a><a name=s00129245></a><a name=s00129246></a>Side effects may
include drowsiness, blurred vision, clumsiness, unsteadiness, confusion,
dizziness, “hangover” effect, headache, nausea, and vomiting.</span></p>

<p><span></span></p>

<p><b><span>Heroin</span></b><span> is an opioid analgesic synthesized from morphine, a derivative of the
opium poppy. Effects include euphoria (“rush”), dry mouth, a warm flushing of
the skin, heaviness of the extremities, and clouded mental functioning. With
regular use, tolerance develops, in which the user’s physiological (and
psychological) response to the drug decreases, and more heroin is needed to achieve
the same intensity of effect. </span></p>

<p><span></span></p>

<p><b><span>Jimson weed</span></b><span> is a common name for a plant whose main ingredients
are the belladonna alkaloids, atropine and scopolamine. Atropine and
scopolamine block the neurotransmitter acetylcholine, causing anti-cholinergic
symptoms: dry mouth, dilated pupils, high temperature, reduced sweating, and
blurred vision. Psychological effects include euphoria and confusion. The
phrase “red as a beet, dry as a bone, blind as a bat, mad as a hatter” has been
used to describe Jimson’s (anti-cholinergic) effects. </span></p>

<p><span></span></p>

<p><b><span>Parathion</span></b><span> is an
organophosphate &#8211; an insecticide that functions as a cholinesterase
inhibitor. Symptoms of acute toxicity include nausea, vomiting, abdominal
cramps, diarrhea, excessive salivation and sweating, headache, confusion, wheezing,
and shortness of breath. These symptoms are caused by increased levels of
acetylcholine, which have a parasympathomimetic effect. </span></p>

<p><span></span></p>

<p><b><span>Phencyclidine (PCP) </span></b><span>works primarily as an NMDA receptor antagonist. (<span>NMDA receptor antagonists</span> are
anesthetics that block the N-methyl d-aspartate receptor.)<span>&nbsp; </span>PCP is known as a “dissociative
anesthetic” because it distorts sight and sound and produces feelings of
detachment from one’s environment and self.&nbsp; Its pharmacological effects
include sedation, immobility, amnesia, and marked analgesia.&nbsp;Numbness,
slurred speech and loss of coordination may be accompanied by a sense of
strength and invulnerability. &nbsp;A blank stare, rapid and involuntary eye
movements, and an exaggerated gait are among the more observable effects. </span></p>

<p><b>Answer D is correct.<span >&nbsp; </span></b>The
patient’s symptoms &#8211; wheezing; vomiting and diarrhea; profuse sweating
and salivation &#8211; are cholinergic symptoms. These symptoms suggest an
excess of acetylcholine, which would occur after exposure to a drug that
inhibit cholinesterase. Organophosphate insecticides, such as parathion, are
cholinesterase inhibitors. They have cholinergic (i.e., parasympathomimetic)
effects. <b></b></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Which of the
following is true regarding type 2 error?</span></p>

<p></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>The rate
is reflected by the alpha value</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It is
the finding of a significant difference between treatment groups when, in fact,
none exists </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It is <span>often due to inadequate study power</span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>It means
the investigators were dishonest in reporting their results</span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p>A <b>type I error</b><span> is</span> also known as a <b>false positive</b><span>. </span>It is an error in which a
significant difference is detected between treatment groups when, in fact, no
such difference exists in the larger population.<span> T</span>he rate of the type I error is denoted by the Greek letter <b>alpha (&#945;)</b> and usually equals the <b>significance level</b> of a test. </p>

<p></p>

<p>A <b>type II error</b> is
also known as a <b>false negative</b>. It is an error in which no significant
difference is detected between treatment groups when, in fact, such a
difference exists in the larger population. The rate of the type II error is
denoted by the Greek letter <b>beta
(&#946;)</b> and related to the <b>power </b>of
a test (which equals 1-&#946;).</p>

<p></span></p>

<p></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct. </span></b><span>Type 2 errors are often
due to not having enough subjects in the trial, referred to as being
“under-powered.”</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>The risk of a type 1
error is represented by the alpha value. The risk of a type 2 error is
represented by the beta value.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct. </span></b><span>A <span>type I error is </span>an error in which a
significant difference is detected between treatment groups when, in fact, no
such difference truly exists. A <span>type II
error</span> is an error in which no significant difference is detected between
treatment groups when, in fact, such a difference truly exists.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct.</span></b><span> Type 2 errors can occur
in any trial and have nothing to do with investigator honesty.<span>&nbsp; </span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Match each
clinical vignette with the corresponding vitamin deficiency.<span>&nbsp; </span></span></p>

<p><span></span></p>

<ol start=1 type=1>
 <li><span>A 69-year-old man has ecchymoses,
     perifollicular petechiae, and swelling of the gingiva. He has lived alone
     since the death of his wife two years ago. His diet consists primarily of
     cola and hot dogs. </span></li>
 <li><span>A 52-year-old with a history of alcoholism
     has difficulty with short-term memory. He is unable to recall the date and
     cannot remember what he ate for breakfast this morning. He thinks the
     examiner is a lost long friend and carries a conversation with the
     examiner as if they have known each other for years. </span></li>
 <li><span>A 74-year-old woman has a two-month history
     of weakness and tingling of the arms and legs. Neurologic examination
     shows weakness of the flexor and extensor muscles of the lower
     extremities. Deep tendon reflexes over the knee and ankle are exaggerated.
     Sensation to vibration and position is diminished in all extremities, but
     the decrease is more pronounced in the lower extremities.<span>&nbsp; </span></span></li>
 <li><span>A 43-year-old man with a history of
     alcoholism is brought to the hospital by friends because he is difficult
     to rouse. He is emaciated and lethargic. Examination shows severely
     restricted horizontal eye movements and ataxia. </span></li>
 <li><span>A 14-year-old girl who is a ballet dancer
     has not had a menstrual period for the past three months. She has lost
     weight over the past year; her weight is 70% of that expected for her
     height. She has purpuric lesions on her extremities and trunk. Laboratory
     tests show a macrocytic anemia. Neutrophil, lymphocyte, and platelet
     counts are below the reference range.<span >&nbsp;
     </span></span></li>
 <li><span>A 2-month-old female infant from South
     America is adopted. She has been exclusively breast-fed. The only known
     medical history is treatment with an antibiotic for a gastrointestinal
     infection prior to arrival in the Unites States. Three days after
     receiving the infant, the adoptive parents note that she no longer moves
     her left upper and lower extremity. Radiologic examination shows an
     intracranial hemorrhage without signs of head trauma. Laboratory studies
     show anemia and prolonged partial thromboplastin and prothrombin times.<span>&nbsp;&nbsp;&nbsp; </span></span></li>
 <li><span>A 51-year-old man develops neuropathy and
     sideroblastic anemia after taking isoniazid for latent tuberculosis</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Vitamin B<sub>1</sub> (thiamine) deficiency</span></li>
 <li><span>Vitamin B<sub>6</sub> (pyridoxine)
     deficiency</span></li>
 <li><span>Vitamin B<sub>9</sub> (folate) deficiency</span></li>
 <li><span>Vitamin B<sub>12</sub> (cobalamin)
     deficiency</span></li>
 <li><span>Vitamin C (ascorbic acid) deficiency</span></li>
 <li><span>Vitamin D deficiency</span></li>
 <li><span>Vitamin K deficiency</span></li>
</ol>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Generic Name</span></b></p>
  </td>
  <td width=111>
  <p style="text-align:center;"><b><span>Chemical Name</span></b></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><b><span>Solubility</span></b></p>
  </td>
  <td width=154>
  <p style="text-align:center;"><b><span>Deficiency Disease</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td width=111>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td width=154>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin A </span></b></p>
  </td>
  <td width=111>
  <p><span>Retinol
  and carotenes </span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Fat</span></p>
  </td>
  <td width=154>
  <p><span>Night-blindness
  and<br>
  Keratomalacia</span></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin B<sub>1</sub> </span></b></p>
  </td>
  <td width=111>
  <p><span>Thiamine</span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Water</span></p>
  </td>
  <td width=154>
  <p><span>Wernicke-Korsakoff;
  </span></p>
  <p><span>Beriberi<span>&nbsp; </span></span></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin B<sub>3</sub> </span></b></p>
  </td>
  <td width=111>
  <p><span>Niacin</span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Water</span></p>
  </td>
  <td width=154>
  <p><span>Pellagra</span></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin B<sub>6</sub> </span></b></p>
  </td>
  <td width=111>
  <p><span>Pyridoxine</span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Water</span></p>
  </td>
  <td width=154>
  <p><span>Peripheral
  neuropathy, sideroblastic anemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin B<sub>9</sub> </span></b></p>
  </td>
  <td width=111>
  <p><span>Folate</span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Water</span></p>
  </td>
  <td width=154>
  <p><span>Megaloblastic
  anemia; </span></p>
  <p><span>Neural
  tube defects in the newborn (if mother is folate deficient)</span></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin B<sub>12</sub> </span></b></p>
  </td>
  <td width=111>
  <p><span>Cobalamin</span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Water</span></p>
  </td>
  <td width=154>
  <p><span>Megaloblastic
  anemia;</span></p>
  <p><span>Neurologic
  disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin C </span></b></p>
  </td>
  <td width=111>
  <p><span>Ascorbic
  acid </span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Water</span></p>
  </td>
  <td width=154>
  <p><span>Scurvy</span></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin D </span></b></p>
  </td>
  <td width=111>
  <p><span>Ergocalciferol,
  cholecalciferol</span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Fat</span></p>
  </td>
  <td width=154>
  <p><span>Rickets
  and Osteomalacia</span></p>
  </td>
 </tr>
 <tr>
  <td width=111>
  <p style="text-align:center;"><b><span>Vitamin K </span></b></p>
  </td>
  <td width=111>
  <p><span>phylloquinone,
  menaquinones</span></p>
  </td>
  <td width=68>
  <p style="text-align:center;"><span>Fat</span></p>
  </td>
  <td width=154>
  <p><span>Hemorrhagic
  disease of the newborn; </span></p>
  <p><span>Bleeding
  diathesis in adults</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p>Vitamins are divided into
two groups: water-soluble (B-complex and C) and fat-soluble (A, D, E and K).
Fat-soluble vitamins are absorbed through the intestinal tract with the help of
lipids (fats). Unlike water-soluble vitamins that need regular replacement in
the body, fat-soluble vitamins are stored in the liver and fatty tissues, and
are eliminated much more slowly than water-soluble vitamins. Because
fat-soluble vitamins are stored for long periods, they generally pose a greater
risk for toxicity than water-soluble vitamins when consumed in excess.</p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span><o:p><span>&nbsp;</span></o:p></span></u></b></p>

<p><b><u><span>Selected Vitamin Deficiency Syndromes</span></u></b></p>

<p><b></b></p>

<p><b>Folate and Vitamin B<sub>12</sub> deficiency. </b>Megaloblastic anemia
may be caused by folate or vitamin B<sub>12</sub> deficiency. Both folate and B<sub>12</sub>
are required to sustain one-carbon metabolism, which is essential for
pyrimidine and purine biosynthesis. </p>

<p style="text-align:center;">Actions
of Folate and Vitamin B<sub>12</sub></p>

<p style="text-align:center;"><span><img border=0 width=412 height=275
src="_%20Tutorials_files/image631.png" alt="Description: B12" v:shapes="Picture_x0020_347406"></span></p>

<p>Folate and cobalamin
deficiency affect DNA synthesis. Cell growth and division are impaired.
Megaloblastic cells with DNA values between 2N and 4N appear because of delayed
cell division. These cells have large “immature” nuclei and a large “mature”
cytoplasm. This nuclear-cytoplasmic asynchrony is called “megaloblastic.”<span>&nbsp; </span>Megaloblastic hematopoiesis often
presents as anemia. Leukopenia and thrombocytopenia may also occur, and
hypersegmented neutrophils are commonly seen in the peripheral blood smear. </p>

<p><b></b></p>

<p style="text-align:center;"><span><img border=0 width=255 height=177
src="_%20Tutorials_files/image633.png" alt="Description: PMN" v:shapes="Picture_x0020_347405"></span></p>

<p style="text-align:center;">Folate
and B<sub>12</sub> deficiency: hypersegmented neutrophils </p>

<p><span>Thus, both
folic acid and vitamin B12<b> </b>deficiency
can produce a macrocytic anemia, characterized by an elevated mean corpuscular
volume (MCV). Folic acid deficiency is associated with elevated homocysteine
levels; vitamin B12 deficiency is associated with elevated homocysteine <i>and</i> elevated methylmalonic acid levels.
Folic acid deficiency does not have neurologic sequela; vitamin B12 deficiency <i>can</i> result in neurologic sequela. </span></p>

<p></p>

<p>Neurologic symptoms of B<sub>12
</sub>deficiency include memory loss, irritability, and sleep disturbance.
Peripheral nerve demyelination causes numbness and tingling of the extremities,
altered proprioception, poor coordination, and an ataxic gait. In extreme
cases, subacute degeneration of the spinal cord occurs, characterized by patchy
loss of myelin in the posterior and lateral columns. Patients with subacute
degeneration of the spinal cord present with progressive numbness and tingling
in the extremities, and weakness of the arms, legs, and trunk. Findings include
bilateral spastic paresis, diminished touch and vibratory sense, and a positive
Babinksi sign. Vision and cognitive changes (depression, personality change,
and psychosis) may occur. </p>

<p></p>

<p>Anemia and neurological
deficits may exist together or separately. The anemia resolves with B<sub><span>12</span></sub> supplementation, but
neurological symptoms may persist depending on the degree and duration of the
deficiency. Patients with vitamin B<sub>12</sub> deficiency typically have
elevated homocysteine and methylmalonate levels, which may be helpful
diagnostically.</p>

<p></p>

<p>The main causes of B12
deficiency are:</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=379 valign=top>
  <p style="text-align:center;">Causes of Vitamin B<sub>12</sub> deficiency</p>
  </td>
 </tr>
 <tr>
  <td width=379 valign=top>
  <p><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Inadequate
  intake of vitamin B12 (e.g., vegan diet)</p>
  <p><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Gastrectomy
  </p>
  <p><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Achlorhydria
  (e.g., use of H2-blockers and proton-pump inhibitors)</p>
  <p><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Intrinsic
  factor loss (e.g., pernicious anemia, which involves<span>&nbsp; </span>autoimmune destruction of parietal
  cells causing atrophic gastritis)</p>
  <p><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Chronic
  pancreatitis</p>
  <p><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Generalized
  malabsorption (celiac disease)</p>
  <p><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Terminal
  ileal disease (e.g., Crohn’s disease, ileal resection)</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>Folate deficiency also
causes megaloblastic anemia, but not neurologic disease. In pregnant women,
folate deficiency can lead to premature delivery, low-birth-weight baby, and
neural tube defects in the newborn. The main causes of folate deficiency are:</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=325 valign=top>
  <p style="text-align:center;">Causes of Folate deficiency</p>
  </td>
 </tr>
 <tr>
  <td width=325 valign=top>
  <p><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Decreased
  intake (e.g., fad diets, institutionalization)</p>
  <p><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Increased
  requirement (e.g., pregnancy, hemolysis)</p>
  <p><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Malabsorption
  (e.g., celiac disease, Crohn’s disease)</p>
  <p><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Drugs
  (e.g., methotrexate, alcoholism)</p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Wernicke-Korsakoff and Beriberi.<span>&nbsp; </span></span></b><span>Wernicke-Korsakoff syndrome and beriberi are
caused by thiamine (vitamin B<sub>1</sub>) deficiency. This typically occurs in
alcoholics. Wernicke-Korsakoff syndrome is a combination of two disorders:
Wernicke’s encephalopathy, which is characterized by confusion,
ophthalmoplegia, nystagmus, and ataxia; and Korsakoff syndrome, which is
characterized by amnesia, hallucinations, and confabulation. The syndrome is
associated with dysfunction of the mammillary bodies of the diencephalon. </span></p>

<p><span></span></p>

<p><span>Beriberi
exists in two forms: wet and dry. “Wet” beriberi involves the cardiovascular
system; “dry” beriberi, like Wernicke-Korsakoff syndrome, involves the nervous
system. “Wet” beriberi is characterized by vasodilation, arteriovenous shunt,
tachycardia, and high-output heart failure. Symptoms include shortness of
breath and leg edema. “Dry” beriberi is characterized by confusion, abnormal
eye movements, paresthesias, and motor weakness. </span></p>

<p><b><span></span></b></p>

<p><b>Scurvy. </b>Scurvy is caused<b> </b>by
deficiency of vitamin C (ascorbic acid), which is needed for collagen synthesis
in humans. Vitamin C is required for <span>conversion of proline to </span></span><span>hydroxyproline,
</span></span>a nonessential amino acid that is necessary for the construction
of the body’s major structural protein, collagen. Vitamin C deficiency causes
defects in collagen synthesis, which, in turn, lead to easy bruising, internal
bleeding, breakdown of connective tissue of the ligaments and tendons, and
increased risk to blood vessel damage. The breakdown of connective tissue
causes hydroxyproline to be spilled in the urine. Symptoms of vitamin C
deficiency include softening of the gums and loss of teeth, bleeding into the
skin and mucous membranes, weakness, depression, and poor wound healing.
Perifollicular petechiae are a “classic” finding. Scurvy is, therefore, a
disease of collagen synthesis resulting from vitamin C deficiency and,
ultimately, deficiency of the amino acid, hydroxyproline.<span>&nbsp;&nbsp;&nbsp; </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=217 height=230
src="_%20Tutorials_files/image635.png" alt="Description: scurvy1" v:shapes="Picture_x0020_347404"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Scurvy: perifollicular petechiae</span></p>

<p style="text-align:center;"><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Rickets and Osteomalacia. </span></b><span>Vitamin D is necessary
for proper calcium absorption in the small bowel. Deficiency of the vitamin
causes hypocalcemia, which, in turn, causes skeletal deformity and
neuromuscular symptoms (including tetany). The result is rickets (in children)
and osteomalacia (in adults). </span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=197 height=311
src="_%20Tutorials_files/image637.png" alt="Description: bow" v:shapes="Picture_x0020_347403"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Rickets: bowed legs</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=149 height=224
src="_%20Tutorials_files/image639.png" alt="Description: rosary" v:shapes="Picture_x0020_347402"></span><span></span></p>

<p><span><span>&nbsp;</span></span></p>

<p style="text-align:center;"><span>Rickets: “rachitic rosary”</span></p>

<p style="text-align:center;"><span>(bony knobs at the costochondral joints)</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>The
clinical signs of osteomalacia are nondescript. Patients may be asymptomatic or
may have diffuse skeletal pain and muscular weakness. Common laboratory
findings include hypocalcemia, hypophosphatemia, and increased alkaline
phosphatase levels. <b></b></span></p>

<p><b></b></p>

<p><b>Vitamin K deficiency. </b><span>Hemorrhagic
disease of the newborn</span> is a coagulation disturbance caused by vitamin K
deficiency. Vitamin K is responsible for &#947;-carboxylation of coagulation
factors II, VII, IX, X, C, and S by the liver. Deficiency of the vitamin
results in a bleeding diathesis. Newborns are relatively vitamin K deficient
for a variety of reasons: They have low vitamin K stores at birth, vitamin K
passes the placenta poorly, the levels of vitamin K in breast milk are low, and
the gut flora has not yet been developed (vitamin K is normally produced by
bacteria in the intestines). Antibiotics can eliminate bacteria that produce
vitamin K, thus increasing the likelihood of bleeding. </p>

<p><b><span></span></b></p>

<p><b><span>Pyridoxine deficiency. </span></b><span>Pyridoxine deficiency</span><span> is rare in developed countries. Isoniazid use can cause
pyridoxine deficiency. Findings include neuropathy and a sideroblastic anemia.
(Pyridoxine is a required cofactor in heme synthesis.) Patients taking
isoniazid should receive pyridoxine supplementation. <b></b></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answers. </span></b></p>

<p><b><span></span></b></p>

<ol start=1 type=1>
 <li><b><span>E. <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span><span>&nbsp;</span>Scurvy, which is caused by vitamin C
     (ascorbic acid) deficiency, is associated with ecchymoses, perifollicular
     petechiae, and swelling of the gingiva.<b></b></span></li>
</ol>

<p><b><span></span></b></p>

<ol start=2 type=1>
 <li><b><span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span> Korsakoff
     psychosis, which is caused by vitamin B<sub>1</sub> (thiamine) deficiency,
     is characterized by memory loss and confabulation. It typically occurs in
     alcoholics. <b></b></span></li>
</ol>

<p><b><span></span></b></p>

<ol start=3 type=1>
 <li><b><span>D. <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span><span>&nbsp;</span>Vitamin B<sub>12</sub> (cobalamin)
     deficiency can cause subacute degeneration of the spinal cord. Findings
     include diminished proprioception, bilateral spastic paresis, and
     hyperreflexia of the lower extremities.<b></b></span></li>
</ol>

<p><b><span></span></b></p>

<ol start=4 type=1>
 <li><b><span>A. <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span>Wernicke’s
     encephalopathy, which is caused by vitamin B<sub>1</sub> (thiamine)
     deficiency, is associated with ophthalmoplegia, ataxia, and confusion.<b></b></span></li>
</ol>

<p><b><span></span></b></p>

<ol start=5 type=1>
 <li><b><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span>Folate deficiency
     causes megaloblastic anemia, which is a macrocytic anemia often associated
     with pancytopenia. Vitamin B12 deficiency also causes megaloblastic
     anemia, but in this patient, poor nutrition and growth suggest folate
     deficiency as a more likely cause. (Vitamin B12 deficiency is almost never
     caused by inadequate intake.)<span >&nbsp;&nbsp;
     </span><b></b></span></li>
</ol>

<p><b><span></span></b></p>

<ol start=6 type=1>
 <li><b><span>G. <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></b><span>Vitamin K
     deficiency causes hemorrhagic disease of the newborn. Factors predisposing
     to vitamin K deficiency include exclusive breast feeding and antibiotic
     use. <b></b></span></li>
</ol>

<p><b><span></span></b></p>

<ol start=7 type=1>
 <li><b><span>B</span></b><span>. <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Vitamin
     B<sub>6</sub> (pyridoxine) deficiency causes neuropathy and sideroblastic
     anemia. Patients taking isoniazid are predisposed to pyridoxine
     deficiency.<span >&nbsp;&nbsp;&nbsp; </span><b></b></span></li>
</ol>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>What is
the primary reason for the delay in clinical effect following initiation of
warfarin therapy?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Elevated
concentration of clotting factors present during acute thromboembolism</span></p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Long
half-life of the drug</span></p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Long
half-life of clotting factor II</span></p>

<p><span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Inhibition
of warfarin effect by concurrent administration of low-molecular-weight
heparin.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br clear=all>
</span>

<p><span>Warfarin
functions as a vitamin K antagonist.<span >&nbsp;
</span>Coagulation factors II, VII, IX, and X are biologically inactive unless
their amino-terminal glutamate residues are carboxylated. This requires reduced
vitamin K. Following the carboxylation reaction, vitamin K is converted to
vitamin K epoxide. Vitamin K epoxide is converted back to vitamin K by vitamin
K epoxide reductase.<span >&nbsp; </span>Vitamin K is
subsequently reduced and can be used again in the carboxylation of coagulation factors.<span>&nbsp; </span>The primary mechanism of warfarin is
inhibition of vitamin K epoxide reductase, which results in diminished
recycling of vitamin K and diminished production of fully functional
coagulation factors II, VII, IX, and X.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=200 height=211
src="_%20Tutorials_files/image641.png" alt="Description: Graphic" v:shapes="Picture_x0020_347401"></span><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Vit
KH<sub>2</sub><span >&nbsp;&nbsp; </span>&#8211;
reduced vitamin K<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Vit
KO<span >&nbsp;&nbsp;&nbsp; </span>&#8211; vitamin K
epoxide<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Coagulation
factors <i>that have already been produced</i>
are unaffected by warfarin. They must be metabolized before the effect of
warfarin can be seen. Factor II has the longest half-life, about 60-100 hours.
The primary reason for the delayed onset of warfarin is that factor II must be
metabolized before the effect can be seen.<span >&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>.<span>&nbsp; </span>The primary reason for the delayed onset
of warfarin is that factor II, which has a half-life of 60-100 hours, must be
metabolized before the effect can be seen.<span >&nbsp;
</span><b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect</span></b><span>.<span>&nbsp; </span>Onset of warfarin is unaffected by the
presence of acute thromboembolism.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span>&nbsp; </span>Warfarin has a long half-life, about 40
hours. This influences dosing strategy, but does not affect onset of action. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Low-molecular-weight
heparin does not inhibit warfarin.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

</div>

</body>

</html>
